data_6g5r_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6g5r _Structure_validation_residue.Date_analyzed 2019-02-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 18.3 m . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.563 0.697 . . . . 1.11 109.511 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.802 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.09 171.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.098 -0.956 . . . . 1.07 110.829 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.74 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 p -120.39 179.19 4.38 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.411 -0.813 . . . . 1.71 110.644 -172.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 124' ' ' MET . 87.3 tttt -53.62 -40.22 65.59 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.485 0.491 . . . . 3.81 111.343 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.543 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 8.0 m-20 -82.56 -24.04 34.18 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 116.602 -0.272 . . . . 2.18 111.246 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 25.0 mt-10 -68.99 -34.0 74.58 Favored 'General case' 0 N--CA 1.41 -2.447 0 C-N-CA 117.826 -1.55 . . . . 0.5 109.34 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.611 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.81 -33.65 76.07 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 119.008 -1.077 . . . . 3.61 109.362 177.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.455 ' O ' HD23 ' A' ' 128' ' ' LEU . 1.8 t -66.25 -31.64 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.276 -0.874 . . . . 1.12 112.087 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.79 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -85.81 -32.82 21.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.724 -0.671 . . . . 2.07 110.779 173.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.692 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.14 -46.75 87.56 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 114.962 1.467 . . . . 1.14 114.962 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.797 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -58.98 -38.03 78.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.711 -1.996 . . . . 1.06 109.164 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.5 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 30.1 mt-10 -65.86 -32.43 73.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.652 1.215 . . . . 2.51 107.954 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -88.62 -7.74 55.86 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 112.599 -2.091 . . . . 1.06 110.948 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.5 t -122.06 1.18 9.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.22 -0.9 . . . . 1.12 109.275 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 66.56 56.87 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.535 -1.666 . . . . 2.86 111.867 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.797 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.98 147.22 27.6 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.972 -1.492 . . . . 0.88 106.972 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.62 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.01 154.65 42.75 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.003 -1.11 . . . . 0.92 108.003 -173.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -47.45 144.61 2.91 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.794 0.807 . . . . 2.42 112.339 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.11 150.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.1 -1.409 . . . . 1.08 112.079 -171.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.4 m -59.9 -50.08 75.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.865 -1.062 . . . . 1.17 111.57 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -156.93 116.02 3.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.24 -1.345 . . . . 1.24 108.836 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.808 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.21 102.77 9.65 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.938 -1.483 . . . . 3.14 111.155 -167.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.797 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.4 t -157.29 92.63 1.26 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.395 -1.275 . . . . 1.11 109.535 162.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.797 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -153.94 158.64 32.51 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.903 -1.499 . . . . 2.98 107.519 169.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -75.66 109.76 2.96 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 CA-C-N 120.421 1.186 . . . . 1.1 109.574 167.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.23 2.94 57.86 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.498 -0.858 . . . . 0.38 114.439 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.0 mt-10 -128.84 132.33 47.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.202 1.001 . . . . 1.49 108.609 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.811 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.1 m-85 -133.16 176.24 8.68 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.112 -0.635 . . . . 0.38 110.224 -166.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.808 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 12.3 p -110.12 142.19 41.94 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.711 0.767 . . . . 1.09 111.655 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.547 HG21 ' OH ' ' A' ' 133' ' ' TYR . 41.1 t -100.98 138.76 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.213 -1.358 . . . . 1.62 111.684 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.8 tp-100 -124.96 -87.54 0.61 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.479 -0.328 . . . . 2.74 110.751 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.429 ' O ' ' HE1' ' A' ' 124' ' ' MET . . . -165.39 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.728 0.27 . . . . 1.13 111.728 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.413 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 88.3 m-20 -81.52 -5.15 57.69 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.482 -0.562 . . . . 1.6 109.482 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.647 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 31.0 p -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.674 -0.694 . . . . 1.37 110.043 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.73 HG21 ' OH ' ' A' ' 133' ' ' TYR . 6.0 mt -106.73 170.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.184 -1.413 . . . . 1.05 107.184 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.811 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 24.4 tt0 -116.97 137.3 52.31 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.989 -1.485 . . . . 0.97 106.989 166.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.471 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -133.46 124.67 27.46 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.655 -0.818 . . . . 1.97 112.3 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.756 0 CA-C-N 115.669 -0.696 . . . . 1.09 109.992 173.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.807 HG11 ' N ' ' A' ' 170' ' ' ARG . 77.1 t . . . . . 0 CA--C 1.492 -1.266 0 N-CA-C 108.406 -0.961 . . . . 1.23 108.406 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.807 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -129.74 145.11 51.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.305 1.05 . . . . 2.3 113.234 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.63 163.53 15.65 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.194 -1.821 . . . . 1.04 109.83 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 74.9 ttt180 -111.94 127.15 55.77 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.97 -1.122 . . . . 4.19 107.97 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.638 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -114.84 111.38 21.13 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.402 -1.272 . . . . 1.33 110.682 -165.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 180' ' ' LEU . 96.3 m -109.31 150.49 27.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.347 0.594 . . . . 1.02 112.25 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.802 ' CD1' HD12 ' A' ' 119' ' ' ILE . 12.5 m-85 -115.65 114.09 24.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.358 -1.292 . . . . 0.44 111.853 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.44 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 21.2 t70 -104.63 103.41 13.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.74 111.393 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.82 -113.22 3.61 Favored Glycine 0 C--N 1.314 -0.691 0 C-N-CA 120.054 -1.069 . . . . 0.28 113.409 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 118' ' ' THR . 0.5 OUTLIER -112.51 8.7 19.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.262 -1.384 . . . . 1.61 107.262 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.665 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 19.5 p80 -135.71 160.99 36.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.635 -1.166 . . . . 2.16 112.315 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 174' ' ' THR . 9.2 tp -69.31 130.57 42.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 114.524 -1.216 . . . . 1.05 110.158 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.44 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -80.28 -49.99 10.82 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.426 -1.261 . . . . 1.03 110.821 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.9 t -179.99 177.46 0.66 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.903 -1.044 . . . . 1.09 110.94 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.63 ' CG1' HD13 ' A' ' 173' ' ' LEU . 2.9 mp -151.17 128.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.7 -1.963 . . . . 1.04 105.7 173.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.747 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.2 t -133.99 119.47 32.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.015 -0.674 . . . . 1.15 112.207 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 98.59 0.06 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.156 -1.053 . . . . 2.01 108.156 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 75.3 mmm -53.03 -27.26 18.81 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 112.379 -2.192 . . . . 2.01 112.741 -167.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.435 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.9 mt-10 -65.67 -43.04 90.5 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 114.164 -1.38 . . . . 0.68 110.982 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.14 -19.86 13.48 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.152 -1.385 . . . . 2.66 111.27 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.747 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.2 p30 . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 114.253 1.205 . . . . 2.15 114.253 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 179' ' ' HIS . 3.6 m . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 108.657 -0.868 . . . . 1.11 108.657 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.821 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -133.88 172.49 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-O 122.43 1.109 . . . . 1.07 111.745 -174.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.73 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.9 m -110.49 165.86 11.46 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.53 -1.668 . . . . 1.71 109.138 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -52.12 -48.15 64.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.13 0.49 . . . . 3.81 110.995 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.491 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.5 m120 -81.02 -16.73 52.55 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.967 -0.56 . . . . 2.18 110.151 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.892 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.4 mt-10 -68.23 -25.94 65.46 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.422 0.63 . . . . 0.5 109.98 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.639 ' O ' HD11 ' A' ' 128' ' ' LEU . 8.0 tpt -86.65 -28.14 23.37 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 117.882 -1.527 . . . . 3.61 109.632 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.435 ' HA ' HD13 ' A' ' 128' ' ' LEU . 2.4 t -58.71 -31.28 43.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.308 1.051 . . . . 1.12 111.986 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.717 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -81.69 -42.77 19.42 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.596 -1.184 . . . . 2.07 109.822 170.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.892 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.69 -36.68 81.58 Favored 'General case' 0 CA--C 1.463 -2.367 0 CA-C-O 117.477 -1.249 . . . . 1.14 113.768 -174.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.664 ' CD2' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.0 -40.06 96.64 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 116.356 -2.138 . . . . 1.06 108.631 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.664 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 51.8 mm-40 -68.9 -30.66 69.19 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 123.125 1.441 . . . . 2.51 108.665 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -85.03 -7.56 59.08 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 111.962 -2.381 . . . . 1.06 109.93 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.655 HG21 ' O ' ' A' ' 128' ' ' LEU . 11.8 t -121.62 -2.07 9.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.191 -0.913 . . . . 1.12 108.937 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 77.1 52.73 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 113.523 -1.671 . . . . 2.86 112.482 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.678 ' HH ' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -151.09 143.73 24.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.575 -1.639 . . . . 0.88 106.575 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.667 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -142.45 163.22 33.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.69 -1.596 . . . . 0.92 106.69 -174.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.2 161.75 1.67 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.987 0.899 . . . . 2.42 111.277 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -147.61 153.02 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.243 -1.344 . . . . 1.08 111.718 -168.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -60.04 -49.56 77.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.803 0.811 . . . . 1.17 111.695 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.592 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.95 115.35 2.67 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.212 -1.358 . . . . 1.24 109.027 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.814 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.91 101.23 6.73 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-O 123.286 1.517 . . . . 3.14 111.656 -168.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.834 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.7 t -158.33 93.62 1.23 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.493 -1.685 . . . . 1.11 109.034 161.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.834 ' HD3' ' O ' ' A' ' 140' ' ' THR . 17.6 mmt180 -151.09 164.65 19.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 113.56 -1.655 . . . . 2.98 107.176 174.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.57 110.64 2.45 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 CA-C-N 119.975 1.027 . . . . 1.1 109.903 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.59 5.38 69.19 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.461 -0.876 . . . . 0.38 114.21 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.1 mm-40 -126.62 131.5 51.46 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.331 -1.359 . . . . 1.49 107.331 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.756 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.98 175.93 9.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.08 -1.048 . . . . 0.38 110.648 -166.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.814 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 18.0 p -111.49 142.03 44.29 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.647 0.737 . . . . 1.09 111.945 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.678 HG21 ' HH ' ' A' ' 133' ' ' TYR . 65.8 t -105.76 145.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.231 -1.349 . . . . 1.62 111.676 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -132.46 -87.31 0.45 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.347 -0.141 . . . . 2.74 111.097 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.43 -82.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.587 0.217 . . . . 1.13 111.587 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -82.03 -6.56 59.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 120.834 0.349 . . . . 1.6 110.282 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.5 p -149.92 145.87 26.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.88 -0.728 . . . . 1.37 111.028 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.625 ' CG2' HD22 ' A' ' 173' ' ' LEU . 4.3 mt -109.68 166.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.136 -1.061 . . . . 1.05 108.136 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.756 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 3.2 tp10 -110.81 134.09 52.8 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.693 -1.595 . . . . 0.97 106.693 167.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -131.86 122.38 25.61 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 118.966 0.803 . . . . 1.97 112.425 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.697 HG21 ' O ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.837 0 CA-C-N 115.434 -0.803 . . . . 1.09 109.839 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.823 HG11 ' N ' ' A' ' 170' ' ' ARG . 65.2 t . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 107.613 -1.254 . . . . 1.23 107.613 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.823 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -125.23 145.21 50.09 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 122.326 1.06 . . . . 2.3 113.155 176.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.46 165.24 13.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.21 -1.813 . . . . 1.04 110.333 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.581 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 17.0 tpt180 -115.86 120.04 37.92 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.146 -1.057 . . . . 4.19 108.146 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.625 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.39 118.32 33.52 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.181 -1.372 . . . . 1.33 110.429 -164.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.564 ' O ' HD12 ' A' ' 180' ' ' LEU . 99.5 m -115.31 152.43 32.77 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.574 0.583 . . . . 1.02 112.574 -170.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.821 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.7 m-85 -114.66 109.26 17.95 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.696 -1.138 . . . . 0.44 112.294 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.458 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 27.5 t70 -98.87 96.52 7.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.047 0.451 . . . . 0.74 111.211 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.69 -117.43 4.44 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.22 -0.991 . . . . 0.28 113.179 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.501 ' O ' HG21 ' A' ' 118' ' ' THR . 0.5 OUTLIER -110.77 11.04 22.61 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.416 -1.698 . . . . 1.61 106.416 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.665 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 11.8 p-80 -138.0 161.07 37.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.141 -1.391 . . . . 2.16 111.782 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 174' ' ' THR . 9.3 tp -67.98 136.1 53.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.133 -0.94 . . . . 1.05 110.886 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.458 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -84.11 -54.01 5.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.515 -1.22 . . . . 1.03 111.412 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -178.91 176.42 0.92 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.368 -0.833 . . . . 1.09 110.496 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.612 ' CG1' HD12 ' A' ' 173' ' ' LEU . 3.0 mp -151.33 124.69 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.949 -1.5 . . . . 1.04 106.949 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.689 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.8 t -129.84 118.1 43.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.422 0.527 . . . . 1.15 112.422 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.89 101.09 0.1 Allowed 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.044 -1.095 . . . . 2.01 108.044 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.3 mmt -58.81 -16.81 18.84 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 112.833 -1.985 . . . . 2.01 112.675 -168.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.7 mt-10 -73.47 -44.35 58.17 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.743 -1.117 . . . . 0.68 110.003 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.65 -33.78 14.94 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.261 -1.336 . . . . 2.66 110.913 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.689 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.9 p30 . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 115.218 1.562 . . . . 2.15 115.218 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.6 m . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 108.649 -0.871 . . . . 1.11 108.649 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.886 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.7 pt -133.62 172.47 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.996 0.903 . . . . 1.07 111.227 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.712 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.6 t -117.47 172.18 7.5 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.019 -1.446 . . . . 1.71 109.547 -173.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 124' ' ' MET . 37.5 ttmt -56.0 -45.2 79.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.886 0.374 . . . . 3.81 111.307 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.1 m-20 -83.35 -17.34 42.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 110.249 -0.278 . . . . 2.18 110.249 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.6 mt-10 -69.27 -22.77 63.8 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.124 -0.63 . . . . 0.5 110.46 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.656 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.95 -30.53 22.72 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 118.462 -1.295 . . . . 3.61 109.366 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.5 -30.62 46.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.115 0.959 . . . . 1.12 111.952 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.626 -1.17 . . . . 2.07 109.737 171.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.45 -35.76 78.51 Favored 'General case' 0 CA--C 1.462 -2.423 0 CA-C-O 117.683 -1.151 . . . . 1.14 114.027 -172.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.847 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.5 -43.18 94.9 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 115.915 -2.314 . . . . 1.06 109.093 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.657 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 59.3 mm-40 -65.36 -27.91 68.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.808 1.289 . . . . 2.51 108.635 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -88.78 -8.16 54.92 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.258 -2.246 . . . . 1.06 110.28 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 128' ' ' LEU . 11.1 t -122.46 0.27 9.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.416 -0.811 . . . . 1.12 109.354 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 74.49 54.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.653 -1.612 . . . . 2.86 112.543 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.16 144.65 24.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.498 -1.667 . . . . 0.88 106.498 178.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.63 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -145.6 164.09 32.77 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.188 -1.782 . . . . 0.92 106.188 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.409 ' CB ' HG13 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.73 160.65 0.28 Allowed 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.207 1.003 . . . . 2.42 112.731 -177.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -148.0 151.57 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 113.946 -1.479 . . . . 1.08 112.015 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.1 m -59.74 -50.02 75.45 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.114 -0.948 . . . . 1.17 111.658 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.59 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.4 ptmt -159.03 117.04 2.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.015 -1.448 . . . . 1.24 108.66 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.816 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.85 100.55 6.39 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 123.504 1.621 . . . . 3.14 111.761 -168.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.839 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 t -158.2 90.99 1.07 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.194 -1.821 . . . . 1.11 108.677 159.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.839 ' HD3' ' O ' ' A' ' 140' ' ' THR . 9.1 mmt180 -153.95 134.51 8.17 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 113.623 -1.626 . . . . 2.98 106.705 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.98 109.25 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 121.353 1.519 . . . . 1.1 109.894 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.26 -1.39 57.42 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.689 -0.767 . . . . 0.38 114.025 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 1.5 mm-40 -125.66 131.7 52.57 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.738 -1.208 . . . . 1.49 107.738 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.87 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -130.85 175.2 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.156 -1.018 . . . . 0.38 110.169 -168.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.816 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 15.5 p -112.63 134.13 54.32 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.572 -0.451 . . . . 1.09 110.623 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -113.51 153.29 15.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.061 -0.972 . . . . 1.62 112.17 -174.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -152.95 -85.32 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.6 0.593 . . . . 2.74 112.6 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.48 -92.01 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.173 0.805 . . . . 1.13 113.173 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.401 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 87.0 m-20 -81.95 -6.99 59.57 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.687 0.28 . . . . 1.6 111.341 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.3 p -150.56 145.75 26.13 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.61 -0.836 . . . . 1.37 110.327 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.543 ' CD1' HD11 ' A' ' 128' ' ' LEU . 6.6 mt -110.04 162.45 7.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.911 -0.774 . . . . 1.05 108.911 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.87 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.4 tp10 -107.6 132.96 52.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.995 -1.483 . . . . 0.97 106.995 167.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.706 ' HG3' ' CE2' ' A' ' 145' ' ' PHE . 3.8 ttt -126.52 124.25 39.62 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.239 -0.585 . . . . 1.97 112.137 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.139 -0.689 . . . . 1.09 109.139 168.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.791 HG13 ' N ' ' A' ' 170' ' ' ARG . 66.0 t . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 109.487 -0.561 . . . . 1.23 109.487 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.791 ' N ' HG13 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -131.35 145.37 51.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.345 1.069 . . . . 2.3 113.469 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.56 165.88 12.74 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.993 -1.912 . . . . 1.04 110.921 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.42 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 2.2 tpp180 -115.65 111.89 21.3 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.747 -1.205 . . . . 4.19 107.747 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.539 HD21 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -107.92 118.15 35.99 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.217 -1.811 . . . . 1.33 109.969 -166.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.497 ' O ' HD12 ' A' ' 180' ' ' LEU . 87.5 m -114.43 150.86 34.07 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.762 0.653 . . . . 1.02 112.762 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.886 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.8 m-85 -115.26 112.47 22.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.663 -1.153 . . . . 0.44 112.212 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.522 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 25.8 t70 -102.96 98.48 8.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.965 0.412 . . . . 0.74 110.803 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.67 -120.45 5.28 Favored Glycine 0 C--N 1.317 -0.517 0 C-N-CA 120.085 -1.055 . . . . 0.28 112.85 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 118' ' ' THR . 0.4 OUTLIER -110.74 14.17 22.29 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.829 -1.545 . . . . 1.61 106.829 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.67 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 19.0 p-80 -138.96 159.06 43.04 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.024 -1.444 . . . . 2.16 111.735 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.514 HD13 HD12 ' A' ' 173' ' ' LEU . 9.6 tp -66.36 137.08 56.64 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.055 -0.975 . . . . 1.05 111.01 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.522 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -87.07 -51.48 5.98 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.48 -1.236 . . . . 1.03 111.653 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.402 HG23 ' HB ' ' A' ' 174' ' ' THR . 6.1 t -179.39 176.99 0.78 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.069 -0.969 . . . . 1.09 110.292 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.519 ' CG1' HD13 ' A' ' 173' ' ' LEU . 3.0 mp -151.68 130.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.396 -1.705 . . . . 1.04 106.396 175.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.698 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.9 t -134.24 118.45 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 120.59 -0.444 . . . . 1.15 111.853 -172.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.52 98.64 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.063 -1.088 . . . . 2.01 108.063 171.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -51.48 -25.12 5.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.877 -1.965 . . . . 2.01 112.449 -170.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.08 -40.99 71.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 113.64 -1.618 . . . . 0.68 110.643 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.04 -27.49 13.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.728 -1.578 . . . . 2.66 111.418 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.698 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.9 p-10 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 115.299 1.592 . . . . 2.15 115.299 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 179' ' ' HIS . 21.5 m . . . . . 0 N--CA 1.442 -0.872 0 CA-C-O 121.71 0.767 . . . . 1.11 111.04 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.889 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -140.15 173.61 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 114.364 -1.289 . . . . 1.07 110.858 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.7 p -121.41 174.08 6.97 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.729 -1.123 . . . . 1.71 110.098 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.65 ' O ' ' HG3' ' A' ' 124' ' ' MET . 28.5 ttpp -50.99 -47.43 61.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 3.81 111.845 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.487 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -84.21 -17.1 40.95 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 122.248 -0.282 . . . . 2.18 110.521 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.891 ' O ' HD13 ' A' ' 127' ' ' LEU . 1.7 mt-10 -70.69 -22.63 62.44 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.297 -0.561 . . . . 0.5 110.149 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.65 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -84.99 -29.13 25.29 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.457 -1.297 . . . . 3.61 109.66 178.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.02 -33.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.559 1.171 . . . . 1.12 111.605 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.743 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.74 -42.3 28.55 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.292 -1.322 . . . . 2.07 109.806 170.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.45 -38.6 84.71 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.476 -1.25 . . . . 1.14 114.163 -173.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.682 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.12 -41.01 97.82 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 116.129 -2.229 . . . . 1.06 108.67 177.096 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.665 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 64.0 mm-40 -67.27 -32.0 72.71 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 123.006 1.384 . . . . 2.51 108.658 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -84.16 -7.32 59.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.895 -2.412 . . . . 1.06 110.179 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 128' ' ' LEU . 14.4 t -121.12 1.06 10.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.114 0.959 . . . . 1.12 108.636 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 72.68 55.26 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.286 -1.779 . . . . 2.86 112.267 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.696 ' OH ' HG23 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -152.15 146.75 25.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.548 -1.649 . . . . 0.88 106.548 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.646 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.07 163.26 34.05 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.061 -1.829 . . . . 0.92 106.061 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.25 159.6 0.64 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.082 0.944 . . . . 2.42 112.041 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -146.68 150.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-N 114.147 -1.388 . . . . 1.08 111.624 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 m -60.56 -50.18 74.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.093 -0.958 . . . . 1.17 111.942 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 136' ' ' VAL . 17.9 ptmt -155.43 114.51 3.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.161 -1.382 . . . . 1.24 108.967 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.782 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.38 100.5 5.19 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 123.894 1.807 . . . . 3.14 112.041 -168.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.752 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 1.4 t -158.84 95.4 1.29 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.178 -1.828 . . . . 1.11 108.07 162.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -151.34 165.38 17.5 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.483 -1.235 . . . . 2.98 108.183 173.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.31 111.56 2.65 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 119.578 0.885 . . . . 1.1 109.982 164.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.39 13.41 78.69 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.674 -0.774 . . . . 0.38 114.049 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.9 mt-10 -131.88 130.91 42.25 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.349 -0.982 . . . . 1.49 108.349 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.901 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.84 176.63 8.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.547 -0.861 . . . . 0.38 110.279 -166.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.782 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 18.1 p -107.88 142.03 38.58 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.532 0.682 . . . . 1.09 110.932 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.565 HG21 ' HH ' ' A' ' 133' ' ' TYR . 42.4 t -100.35 134.71 39.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 114.617 -1.174 . . . . 1.62 111.08 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 151' ' ' SER . 5.3 tp-100 -147.23 54.2 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.98 0.419 . . . . 2.74 110.961 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.611 ' O ' ' HE1' ' A' ' 124' ' ' MET . . . 60.57 -100.43 0.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.35 0.87 . . . . 1.13 113.35 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.04 -5.02 58.04 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.051 0.453 . . . . 1.6 111.375 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 57.3 m -141.9 123.21 14.81 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.268 -0.573 . . . . 1.37 110.26 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.696 HG23 ' OH ' ' A' ' 133' ' ' TYR . 5.9 mt -96.19 165.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.617 -1.253 . . . . 1.05 107.617 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.901 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 5.6 tt0 -124.5 105.82 9.69 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.898 -1.121 . . . . 0.97 110.392 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.591 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.8 ppp? -106.76 125.8 51.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.061 0.458 . . . . 1.97 111.478 -166.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 116.148 -0.478 . . . . 1.09 110.316 172.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.777 HG12 ' N ' ' A' ' 170' ' ' ARG . 71.0 t . . . . . 0 CA--C 1.486 -1.513 0 N-CA-C 109.303 -0.628 . . . . 1.23 109.303 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.777 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -125.71 145.48 50.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.135 0.969 . . . . 2.3 112.712 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -112.28 166.12 11.56 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.512 -1.676 . . . . 1.04 110.22 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.69 120.48 37.55 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.439 -0.948 . . . . 4.19 108.439 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.617 HD11 ' CG1' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -115.32 137.32 52.17 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.729 -1.578 . . . . 1.33 109.901 -163.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.467 ' O ' HD13 ' A' ' 180' ' ' LEU . 82.6 m -129.83 150.24 51.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.235 0.54 . . . . 1.02 111.881 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.889 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.9 m-85 -113.24 106.82 15.09 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.424 -1.262 . . . . 0.44 112.374 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.482 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 17.7 t70 -93.67 96.66 9.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.119 0.485 . . . . 0.74 111.113 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.71 -114.77 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.185 -1.007 . . . . 0.28 113.31 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.481 ' O ' HG21 ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.04 8.99 22.1 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.004 -1.48 . . . . 1.61 107.004 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.63 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 17.6 p-80 -138.41 161.11 37.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.159 -1.382 . . . . 2.16 111.59 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.574 HD11 HD13 ' A' ' 173' ' ' LEU . 8.1 tp -63.75 144.3 57.15 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.404 -0.817 . . . . 1.05 111.731 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.482 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -94.92 -52.46 4.23 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.43 -1.259 . . . . 1.03 111.914 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 183' ' ' ILE . 6.3 t -179.24 176.19 0.88 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.463 -0.789 . . . . 1.09 110.558 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.617 ' CG1' HD11 ' A' ' 173' ' ' LEU . 3.5 mp -152.27 137.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 105.646 -1.983 . . . . 1.04 105.646 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 75.4 t -139.55 119.86 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 112.417 0.525 . . . . 1.15 112.417 -172.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.97 96.46 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.064 -1.087 . . . . 2.01 108.064 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.1 mmm -54.91 -24.3 22.87 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.141 -1.845 . . . . 2.01 113.26 -166.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.502 ' HG3' HG11 ' A' ' 169' ' ' VAL . 4.0 mt-10 -70.57 -40.92 73.04 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 114.39 -1.277 . . . . 0.68 110.957 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -93.54 -32.52 14.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.753 -1.567 . . . . 2.66 110.571 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.614 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.7 p-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 122.074 0.94 . . . . 2.15 112.765 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.529 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.8 m . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.645 -0.872 . . . . 1.11 108.645 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.878 HD12 ' CD1' ' A' ' 175' ' ' PHE . 6.1 pt -132.85 172.63 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.242 1.02 . . . . 1.07 112.069 -174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.675 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.6 m -117.06 174.04 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.581 -1.645 . . . . 1.71 110.206 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 124' ' ' MET . 14.0 mmmm -49.33 -53.78 20.45 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.599 0.592 . . . . 3.81 112.599 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.446 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 94.8 m-20 -82.89 -16.35 47.87 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 116.586 -0.279 . . . . 2.18 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.871 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.6 mt-10 -66.24 -24.09 66.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 120.274 -0.571 . . . . 0.5 110.167 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.639 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.07 -29.26 23.52 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.487 -1.285 . . . . 3.61 109.986 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.26 -31.13 50.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.436 1.112 . . . . 1.12 111.61 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.736 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.97 -42.45 23.92 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.233 -1.349 . . . . 2.07 109.735 170.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.871 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.38 81.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 CA-C-O 117.626 -1.178 . . . . 1.14 114.147 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.82 -39.56 94.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 116.233 -2.187 . . . . 1.06 108.733 177.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.658 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 55.2 mm-40 -69.56 -30.76 68.63 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.113 1.435 . . . . 2.51 108.787 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -83.64 -7.67 59.45 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 111.971 -2.377 . . . . 1.06 109.884 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.634 HG21 ' O ' ' A' ' 128' ' ' LEU . 13.8 t -121.51 -0.95 9.66 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.115 -0.948 . . . . 1.12 108.967 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 71.49 58.09 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 113.341 -1.754 . . . . 2.86 112.625 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.7 ' HH ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -152.65 146.88 25.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.106 -1.812 . . . . 0.88 106.106 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -143.34 162.59 35.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.41 -1.33 . . . . 0.92 107.41 -174.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 135' ' ' GLN . 2.6 tt0 -50.18 146.83 4.64 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.164 0.983 . . . . 2.42 112.567 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -134.56 150.84 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-N 113.702 -1.59 . . . . 1.08 112.046 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.5 m -60.34 -50.28 74.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.857 -1.065 . . . . 1.17 111.826 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.583 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.2 ptmt -155.33 113.77 3.49 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.114 -1.403 . . . . 1.24 108.812 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.796 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.7 OUTLIER -75.72 100.35 4.66 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.682 1.706 . . . . 3.14 112.05 -167.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.842 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.1 t -159.22 92.08 1.06 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.61 -1.632 . . . . 1.11 109.305 161.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.842 ' HD3' ' O ' ' A' ' 140' ' ' THR . 16.9 mmt180 -152.0 147.82 20.48 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-N 113.8 -1.546 . . . . 2.98 107.189 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.03 110.28 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 CA-C-N 120.383 1.172 . . . . 1.1 109.372 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.5 14.4 58.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.354 -0.839 . . . . 0.38 114.352 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.2 mt-10 -136.89 132.72 34.91 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.858 -1.164 . . . . 1.49 107.858 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.903 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.97 175.25 9.39 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.167 -1.013 . . . . 0.38 110.451 -168.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.796 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.4 p -108.34 141.45 40.13 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.869 0.842 . . . . 1.09 112.047 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.7 HG22 ' HH ' ' A' ' 133' ' ' TYR . 59.4 t -103.76 119.71 52.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 113.736 -1.574 . . . . 1.62 110.477 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.7 tt0 -103.88 -80.16 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.492 -0.322 . . . . 2.74 110.695 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.07 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.738 0.304 . . . . 1.13 111.009 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.97 -4.14 56.01 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.332 -0.618 . . . . 1.6 109.332 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.7 m -142.6 148.04 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.305 -0.558 . . . . 1.37 110.55 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.644 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.2 mt -106.77 169.14 2.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.727 -1.212 . . . . 1.05 107.727 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.903 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 12.4 tt0 -127.54 109.08 11.36 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.787 -0.765 . . . . 0.97 110.654 173.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.451 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 2.1 tmt? -109.71 123.2 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.747 0.308 . . . . 1.97 111.753 -169.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.251 0.548 . . . . 1.09 110.878 174.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 170' ' ' ARG . 63.4 t . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.733 -0.84 . . . . 1.23 108.733 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.805 ' N ' HG13 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -128.14 145.23 51.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.243 1.021 . . . . 2.3 112.872 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.48 164.68 13.31 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 1.04 110.541 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 22.9 ttt180 -111.67 119.97 40.48 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.999 -1.111 . . . . 4.19 107.999 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.644 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -112.37 110.48 20.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.42 -1.264 . . . . 1.33 109.956 -168.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.561 ' O ' HD11 ' A' ' 180' ' ' LEU . 32.1 m -107.65 151.35 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.329 0.492 . . . . 1.02 112.329 -169.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.878 ' CD1' HD12 ' A' ' 119' ' ' ILE . 13.7 m-85 -117.03 101.81 8.81 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.628 -1.169 . . . . 0.44 112.685 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.56 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 22.4 t70 -98.66 100.43 11.66 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.659 -0.416 . . . . 0.74 111.189 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.24 -119.11 5.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.518 -0.849 . . . . 0.28 113.051 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' THR . 3.8 t70 -110.46 8.51 23.14 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.518 -1.66 . . . . 1.61 106.518 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.709 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 25.6 p80 -138.65 160.52 39.43 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.158 -1.383 . . . . 2.16 112.061 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.561 HD11 ' O ' ' A' ' 174' ' ' THR . 7.9 tp -63.74 139.64 58.79 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 114.759 -1.11 . . . . 1.05 110.439 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.56 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -90.84 -48.82 6.79 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.442 -1.254 . . . . 1.03 111.348 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.5 t 177.36 178.02 0.31 Allowed 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.284 -0.871 . . . . 1.09 110.685 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.622 ' CG1' HD11 ' A' ' 173' ' ' LEU . 3.0 mp -150.94 127.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.909 -1.886 . . . . 1.04 105.909 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.679 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.4 t -132.87 122.09 45.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 112.568 0.581 . . . . 1.15 112.568 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -60.55 97.96 0.06 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.241 -1.022 . . . . 2.01 108.241 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.6 OUTLIER -54.56 -24.74 22.29 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 112.579 -2.1 . . . . 2.01 112.489 -168.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' A' ' 169' ' ' VAL . 3.1 mt-10 -68.58 -41.59 79.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 114.049 -1.432 . . . . 0.68 110.977 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.34 -27.96 13.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.788 -1.096 . . . . 2.66 110.808 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.679 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.7 p30 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 115.578 1.696 . . . . 2.15 115.578 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.9 m . . . . . 0 N--CA 1.44 -0.957 0 CA-C-O 121.613 0.721 . . . . 1.11 110.699 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.919 HD12 ' CD1' ' A' ' 175' ' ' PHE . 5.1 pt -138.54 172.53 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.296 -1.32 . . . . 1.07 110.235 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.71 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 11.1 p -122.56 176.27 6.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.741 -1.118 . . . . 1.71 110.151 -173.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 124' ' ' MET . 62.3 mtpt -56.03 -43.91 78.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.275 0.472 . . . . 3.81 112.275 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 26.2 t-20 -83.95 -18.36 37.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 122.042 -0.411 . . . . 2.18 110.016 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.916 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.2 mt-10 -67.36 -23.81 65.64 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 119.785 -0.766 . . . . 0.5 109.997 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.628 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.32 -27.59 25.81 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 118.576 -1.249 . . . . 3.61 109.81 177.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.01 -32.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.886 -1.052 . . . . 1.12 111.461 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.32 -40.01 31.38 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.813 -1.085 . . . . 2.07 110.291 170.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.17 -37.57 80.57 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 117.424 -1.274 . . . . 1.14 114.11 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.86 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.94 -40.02 95.48 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 116.103 -2.239 . . . . 1.06 109.227 175.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.462 ' H ' HD22 ' A' ' 128' ' ' LEU . 19.7 mt-10 -64.67 -28.82 69.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.685 1.231 . . . . 2.51 108.062 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -94.38 -6.82 43.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.827 -1.988 . . . . 1.06 111.135 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.3 t -122.52 -2.26 8.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.727 -0.67 . . . . 1.12 109.758 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 74.72 52.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.042 -1.436 . . . . 2.86 112.032 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.917 ' HH ' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -148.41 142.55 26.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.511 -1.292 . . . . 0.88 107.511 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.651 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -147.19 163.99 34.59 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.747 -1.205 . . . . 0.92 107.747 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -46.28 144.78 1.9 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 122.094 0.95 . . . . 2.42 113.202 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.603 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.7 t -137.37 151.18 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.375 0 CA-C-N 114.034 -1.439 . . . . 1.08 112.562 -173.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 m -59.77 -50.89 72.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.889 -1.05 . . . . 1.17 111.602 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.603 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.1 ptmt -157.72 117.65 3.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.019 -1.446 . . . . 1.24 108.605 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.784 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.7 OUTLIER -78.69 100.34 7.0 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 123.466 1.603 . . . . 3.14 111.991 -167.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.832 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 3.1 t -159.71 95.03 1.18 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.095 -1.411 . . . . 1.11 109.274 162.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.832 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -151.99 171.82 6.17 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 114.451 -1.25 . . . . 2.98 107.747 172.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.26 111.71 2.43 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 CA-C-N 120.452 1.197 . . . . 1.1 109.885 164.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.17 0.12 77.67 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.794 -0.717 . . . . 0.38 114.84 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 40.9 mt-10 -119.57 132.09 55.66 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.686 1.243 . . . . 1.49 109.574 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.812 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.8 m-30 -129.3 175.55 8.65 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.365 -0.534 . . . . 0.38 110.328 -166.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.784 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.0 p -111.9 139.2 47.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.871 -0.788 . . . . 1.09 108.871 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.917 HG21 ' HH ' ' A' ' 133' ' ' TYR . 2.6 p -112.37 154.43 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 112.649 0.611 . . . . 1.62 112.649 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.8 tp-100 -146.16 -95.08 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.334 -0.394 . . . . 2.74 111.146 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.487 ' O ' ' HE2' ' A' ' 124' ' ' MET . . . -155.0 -86.09 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.081 0.4 . . . . 1.13 112.081 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -83.19 -9.12 59.34 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.492 0.663 . . . . 1.6 109.665 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 46.9 m -139.51 119.74 13.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.53 -0.759 . . . . 1.37 110.579 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.579 HD13 ' SD ' ' A' ' 124' ' ' MET . 4.7 mt -96.95 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.767 -1.197 . . . . 1.05 107.767 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.812 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.1 tt0 -119.5 151.0 39.31 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.144 -1.428 . . . . 0.97 107.144 164.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.614 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -147.43 128.65 14.73 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.116 -0.634 . . . . 1.97 111.098 -177.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 110.049 -0.352 . . . . 1.09 110.049 171.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.77 HG11 ' N ' ' A' ' 170' ' ' ARG . 56.0 t . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 108.742 -0.836 . . . . 1.23 108.742 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.77 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -123.39 143.96 49.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.627 1.203 . . . . 2.3 112.582 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 153' ' ' GLU . . . -115.47 166.37 11.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 112.873 -1.967 . . . . 1.04 109.855 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 29.4 ttp180 -108.82 126.47 53.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.103 -0.703 . . . . 4.19 109.103 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.49 HD21 HG13 ' A' ' 183' ' ' ILE . 1.4 mt -84.59 152.05 24.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.357 -1.292 . . . . 1.33 110.076 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 180' ' ' LEU . 93.4 m -151.95 143.05 23.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.1 0.476 . . . . 1.02 111.22 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.919 ' CD1' HD12 ' A' ' 119' ' ' ILE . 8.3 m-85 -116.77 111.82 20.29 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.882 -1.053 . . . . 0.44 112.738 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 16.8 t70 -99.15 95.0 6.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 0.74 111.09 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.02 -114.48 3.96 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 120.199 -1.0 . . . . 0.28 113.487 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 118' ' ' THR . 8.7 t70 -110.8 8.77 22.52 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.055 -1.461 . . . . 1.61 107.055 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.65 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 34.6 p80 -138.49 160.48 39.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.174 -1.375 . . . . 2.16 111.419 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.5 ' CD2' HD12 ' A' ' 183' ' ' ILE . 7.3 tp -62.06 144.59 55.04 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.059 -0.973 . . . . 1.05 111.093 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -94.3 -51.28 4.87 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.395 -1.275 . . . . 1.03 111.215 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.7 t -178.53 176.26 1.04 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.112 -0.949 . . . . 1.09 110.556 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.1 mp -154.15 125.82 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 113.086 -1.87 . . . . 1.04 106.472 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.615 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 98.7 t -128.76 119.51 49.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.28 -0.568 . . . . 1.15 111.901 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.26 96.84 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.529 -1.286 . . . . 2.01 107.529 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.7 mmt -53.89 -24.36 15.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 112.669 -2.059 . . . . 2.01 112.304 -168.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.512 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.5 mt-10 -68.13 -44.67 75.56 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 113.992 -1.458 . . . . 0.68 110.839 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.2 -27.77 13.65 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.936 -1.484 . . . . 2.66 111.138 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.615 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.3 p30 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 115.019 1.488 . . . . 2.15 115.019 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 121.627 0.727 . . . . 1.11 110.798 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.911 HD13 ' CD1' ' A' ' 175' ' ' PHE . 5.4 pt -138.4 172.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.595 -1.184 . . . . 1.07 111.318 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.718 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 10.2 p -121.18 174.77 6.47 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.502 -1.227 . . . . 1.71 109.9 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 124' ' ' MET . 35.8 ttpt -56.22 -43.0 78.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.78 0.324 . . . . 3.81 111.824 -175.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.462 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.6 t-20 -84.17 -18.03 38.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.063 -0.398 . . . . 2.18 110.187 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.912 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.2 mt-10 -68.28 -23.77 64.79 Favored 'General case' 0 N--CA 1.422 -1.868 0 C-N-CA 119.969 -0.693 . . . . 0.5 110.176 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.653 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.27 -26.56 26.57 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 118.495 -1.282 . . . . 3.61 109.581 177.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.5 -32.06 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.845 -1.071 . . . . 1.12 111.539 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.764 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.66 -38.97 32.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.792 -1.095 . . . . 2.07 110.348 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.76 -38.18 84.32 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-O 117.548 -1.215 . . . . 1.14 114.236 -174.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.857 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -39.48 94.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 116.216 -2.193 . . . . 1.06 109.257 176.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.463 ' H ' HD21 ' A' ' 128' ' ' LEU . 22.0 mt-10 -65.02 -29.81 70.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.614 1.197 . . . . 2.51 108.113 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -92.72 -7.77 45.77 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.727 -2.033 . . . . 1.06 111.076 -170.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -121.81 -1.65 9.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.705 0.764 . . . . 1.12 109.322 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 71.25 57.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.702 -1.59 . . . . 2.86 111.996 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.857 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.08 145.51 26.4 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.587 -1.635 . . . . 0.88 106.587 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.566 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.87 164.52 31.68 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.886 -0.783 . . . . 0.92 108.886 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -45.01 144.69 1.15 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.285 1.04 . . . . 2.42 113.21 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG11 ' N ' ' A' ' 138' ' ' LYS . 5.1 t -139.98 150.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 CA-C-N 113.507 -1.679 . . . . 1.08 111.781 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 p -63.64 -49.11 74.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.935 -1.484 . . . . 1.17 111.887 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.591 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.3 ptmt -155.43 113.49 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.886 -1.506 . . . . 1.24 108.996 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.8 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -79.06 100.24 7.27 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 123.518 1.628 . . . . 3.14 111.187 -166.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.768 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.0 t -156.74 94.9 1.49 Allowed 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.313 -1.767 . . . . 1.11 107.899 164.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 140' ' ' THR . 1.8 mpt_? -151.78 171.82 6.14 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 113.675 -1.602 . . . . 2.98 107.783 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.75 111.89 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 CA-C-N 120.066 1.059 . . . . 1.1 110.15 163.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.96 4.54 86.97 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.717 -0.754 . . . . 0.38 114.665 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 81.7 mm-40 -119.28 132.59 55.92 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 117.976 0.888 . . . . 1.49 108.64 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.787 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.8 m-30 -128.81 172.93 10.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.833 -0.747 . . . . 0.38 110.255 -166.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.8 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 16.5 p -106.84 139.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.983 -0.747 . . . . 1.09 108.983 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.453 HG21 HG12 ' A' ' 152' ' ' ILE . 2.0 p -113.67 128.92 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.134 -0.627 . . . . 1.62 112.35 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 151' ' ' SER . 26.7 mp0 -116.51 -88.03 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.23 -0.441 . . . . 2.74 111.865 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.79 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.935 0.346 . . . . 1.13 111.935 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.3 -9.41 59.48 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.69 0.757 . . . . 1.6 109.352 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 17.5 m -140.35 144.13 36.13 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 114.921 -1.036 . . . . 1.37 109.643 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 153' ' ' GLU . 8.5 mt -108.73 168.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.105 -1.072 . . . . 1.05 108.105 168.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 22.7 tt0 -123.76 110.59 15.11 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.476 -0.89 . . . . 0.97 110.236 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.583 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -114.86 130.04 56.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.024 0.44 . . . . 1.97 111.021 -169.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.894 -0.41 . . . . 1.09 109.894 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 170' ' ' ARG . 69.3 t . . . . . 0 CA--C 1.492 -1.267 0 CA-C-O 120.645 0.259 . . . . 1.23 110.376 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.774 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -128.54 144.42 51.14 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 122.164 0.983 . . . . 2.3 112.41 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.3 167.22 11.04 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.481 -1.691 . . . . 1.04 110.619 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 6.7 ttp180 -115.08 120.74 40.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.847 -1.168 . . . . 4.19 107.847 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -113.41 114.1 26.13 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.927 -1.488 . . . . 1.33 110.282 -164.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 180' ' ' LEU . 64.5 m -112.36 146.42 38.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.022 -0.535 . . . . 1.02 111.744 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.911 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -118.8 117.75 29.72 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.417 -0.811 . . . . 0.44 111.905 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.447 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 14.1 t70 -98.08 99.65 10.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.69 -0.686 . . . . 0.74 111.128 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.22 -111.99 3.47 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.829 -1.176 . . . . 0.28 113.78 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER -110.67 6.55 21.76 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.135 -1.431 . . . . 1.61 107.135 -177.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.68 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 22.9 p80 -140.94 160.27 40.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.292 -1.322 . . . . 2.16 111.979 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.615 ' CD1' ' HD1' ' A' ' 175' ' ' PHE . 6.0 tp -60.73 145.43 49.52 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.774 0.797 . . . . 1.05 111.562 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.447 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -97.74 -49.64 4.76 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.282 -1.326 . . . . 1.03 111.162 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.45 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t -178.95 177.69 0.81 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.316 -0.856 . . . . 1.09 110.657 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 173' ' ' LEU . 2.7 mp -152.93 123.22 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.495 -1.668 . . . . 1.04 106.495 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.718 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 88.4 t -127.94 123.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 112.804 0.668 . . . . 1.15 112.804 -170.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -59.67 101.36 0.11 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.339 1.066 . . . . 2.01 108.255 172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 80.6 mmm -60.45 -13.85 15.95 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 113.05 -1.887 . . . . 2.01 112.788 -169.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.488 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.2 mt-10 -73.76 -45.58 50.93 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.48 -1.236 . . . . 0.68 110.752 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -104.96 -20.23 13.6 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.936 -1.029 . . . . 2.66 111.495 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.718 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 20.2 p30 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 115.254 1.575 . . . . 2.15 115.254 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 18.4 m . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.84 -0.8 . . . . 1.11 108.84 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.6 pt -128.7 172.04 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.275 1.036 . . . . 1.07 112.218 -172.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.69 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 6.3 t -120.95 170.13 9.8 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.804 -1.543 . . . . 1.71 109.398 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -52.02 -46.0 64.81 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.252 0.549 . . . . 3.81 112.278 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.453 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 18.3 m120 -84.14 -17.12 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.403 -0.362 . . . . 2.18 110.088 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.907 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -66.86 -30.87 71.15 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 120.468 -0.493 . . . . 0.5 110.361 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.536 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -85.84 -22.68 27.46 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 117.771 -1.572 . . . . 3.61 109.649 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.456 ' O ' HD23 ' A' ' 128' ' ' LEU . 2.1 t -68.22 -29.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.566 -1.197 . . . . 1.12 111.674 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.755 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.95 -39.06 26.69 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.956 -1.02 . . . . 2.07 109.326 171.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.907 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -55.57 -45.37 77.33 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 114.525 1.306 . . . . 1.14 114.525 -174.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.855 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -60.35 -39.54 87.49 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 116.784 -1.966 . . . . 1.06 109.719 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.0 mt-10 -66.54 -29.62 69.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.51 108.022 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -91.34 -8.59 47.66 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 112.926 -1.943 . . . . 1.06 110.886 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.98 -1.87 9.29 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.783 0.802 . . . . 1.12 109.552 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 70.44 56.75 0.26 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.761 -1.563 . . . . 2.86 111.882 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.855 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.08 146.41 27.71 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.378 -1.712 . . . . 0.88 106.378 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.653 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -147.69 163.83 35.43 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.127 -1.435 . . . . 0.92 107.127 -176.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 0.1 OUTLIER -47.0 158.73 0.12 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 122.453 1.12 . . . . 2.42 112.853 -176.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.576 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -148.27 150.23 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 CA-C-N 113.772 -1.558 . . . . 1.08 111.412 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -61.48 -49.45 76.7 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.375 -0.829 . . . . 1.17 111.866 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.576 ' N ' HG11 ' A' ' 136' ' ' VAL . 17.4 ptmt -153.77 115.76 4.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.187 -1.37 . . . . 1.24 108.85 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.763 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.34 99.37 4.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.842 1.782 . . . . 3.14 112.277 -168.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.77 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -158.73 91.63 1.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.29 -1.777 . . . . 1.11 108.684 159.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.77 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.2 mmt-85 -154.9 126.44 3.69 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.126 -1.805 . . . . 2.98 106.126 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.67 110.8 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 CA-C-N 121.3 1.5 . . . . 1.1 110.417 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.56 2.5 57.56 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.477 -0.783 . . . . 0.38 114.293 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 28.6 mt-10 -130.46 133.03 45.99 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.982 0.891 . . . . 1.49 108.789 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.893 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -128.34 175.17 8.69 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 120.014 -0.675 . . . . 0.38 109.985 -168.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.763 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 10.9 p -111.43 137.03 49.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.662 -0.495 . . . . 1.09 109.662 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.586 HG23 ' HH ' ' A' ' 133' ' ' TYR . 1.3 p -113.37 140.72 32.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.443 -0.799 . . . . 1.62 111.57 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 151' ' ' SER . 0.6 OUTLIER -138.35 -91.35 0.21 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.0 0.37 . . . . 2.74 112.0 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.465 ' O ' ' HE1' ' A' ' 124' ' ' MET . . . -142.34 -93.21 0.13 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.685 0.624 . . . . 1.13 112.685 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -80.33 -3.62 50.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.004 0.431 . . . . 1.6 110.44 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 148' ' ' GLN . 20.4 m -144.67 148.09 33.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.019 -0.537 . . . . 1.37 109.609 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.642 HG21 ' OH ' ' A' ' 133' ' ' TYR . 9.3 mt -108.18 167.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 107.694 -1.224 . . . . 1.05 107.694 168.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.893 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.2 tt0 -123.43 106.17 10.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.931 -1.108 . . . . 0.97 111.051 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.547 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 6.0 ttt -106.27 130.26 54.15 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.191 -0.204 . . . . 1.97 111.168 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.826 0 N-CA-C 109.277 -0.638 . . . . 1.09 109.277 169.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.788 HG12 ' N ' ' A' ' 170' ' ' ARG . 55.1 t . . . . . 0 CA--C 1.488 -1.413 0 N-CA-C 108.176 -1.046 . . . . 1.23 108.176 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.788 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -119.58 143.36 47.68 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 122.516 1.15 . . . . 2.3 113.151 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.84 166.46 13.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.719 -2.037 . . . . 1.04 110.653 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.703 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 28.6 ttp180 -114.17 114.94 26.71 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.737 -1.209 . . . . 4.19 107.737 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -103.32 105.58 15.89 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.303 -1.771 . . . . 1.33 109.573 -168.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.537 ' O ' HD13 ' A' ' 180' ' ' LEU . 55.1 m -104.16 149.25 25.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.463 -0.79 . . . . 1.02 112.655 -167.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.818 ' CD1' HD11 ' A' ' 119' ' ' ILE . 14.7 m-85 -115.51 107.51 15.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.44 113.078 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.58 ' N ' ' HB1' ' A' ' 181' ' ' ALA . 25.3 t70 -100.56 102.71 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 0.74 110.842 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.26 -121.85 5.53 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.196 -1.002 . . . . 0.28 112.925 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 118' ' ' THR . 2.0 t70 -110.34 15.59 22.16 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.511 -1.663 . . . . 1.61 106.511 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.645 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 20.8 p-80 -138.16 161.15 37.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.292 -1.322 . . . . 2.16 111.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 173' ' ' LEU . 9.5 tp -70.54 131.67 44.34 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.62 -1.173 . . . . 1.05 110.364 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.58 ' HB1' ' N ' ' A' ' 176' ' ' ASP . . . -80.7 -49.82 10.7 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.131 -1.395 . . . . 1.03 111.022 -175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.42 HG21 ' HB ' ' A' ' 174' ' ' THR . 6.7 t 177.7 178.22 0.33 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.765 -1.107 . . . . 1.09 110.413 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 173' ' ' LEU . 2.2 mp -148.28 121.2 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.759 -1.571 . . . . 1.04 106.759 174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.712 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -126.18 122.6 61.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.535 0.569 . . . . 1.15 112.535 -171.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.417 ' ND2' HG13 ' A' ' 169' ' ' VAL . 8.0 m-20 -59.3 99.75 0.06 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 122.069 0.938 . . . . 2.01 108.806 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.8 mmt -54.04 -23.55 13.96 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 112.663 -2.062 . . . . 2.01 112.635 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.521 ' HG3' HG11 ' A' ' 169' ' ' VAL . 4.1 mt-10 -68.12 -42.21 80.55 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.382 -1.281 . . . . 0.68 110.556 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.544 ' C ' HD21 ' A' ' 189' ' ' ASN . 94.4 m-20 -102.1 -27.03 13.15 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.097 -1.411 . . . . 2.66 111.363 177.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.712 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 115.241 1.571 . . . . 2.15 115.241 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.489 HG23 ' HB3' ' A' ' 179' ' ' HIS . 7.2 m . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 108.805 -0.813 . . . . 1.11 108.805 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.835 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.9 pt -134.68 171.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.906 -1.043 . . . . 1.07 110.51 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.717 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -119.58 173.91 6.72 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.872 -1.058 . . . . 1.71 108.801 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.6 -44.8 66.23 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.379 0.424 . . . . 3.81 111.011 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.499 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 64.1 t30 -82.91 -18.52 39.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.18 110.344 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.896 ' O ' HD13 ' A' ' 127' ' ' LEU . 1.8 mt-10 -71.35 -25.69 62.5 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.363 -0.535 . . . . 0.5 110.666 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.613 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.2 tpt -88.81 -24.65 22.54 Favored 'General case' 0 C--N 1.286 -2.154 0 C-N-CA 118.065 -1.454 . . . . 3.61 109.515 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.0 -31.9 48.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.651 -1.159 . . . . 1.12 111.839 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.724 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.24 -39.8 28.32 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.124 -0.944 . . . . 2.07 110.415 170.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -62.03 -37.05 83.45 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-O 117.411 -1.28 . . . . 1.14 114.077 -175.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.744 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.39 -38.82 92.62 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 116.189 -2.204 . . . . 1.06 108.935 176.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.482 ' N ' HD22 ' A' ' 128' ' ' LEU . 25.7 mt-10 -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.788 1.28 . . . . 2.51 108.116 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -93.94 -6.72 44.86 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 112.446 -2.161 . . . . 1.06 110.777 -169.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.595 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 8.8 t -122.83 0.52 9.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.86 0.838 . . . . 1.12 109.555 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 71.62 53.47 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.85 -1.523 . . . . 2.86 111.691 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.744 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.02 144.24 25.68 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.276 -1.379 . . . . 0.88 107.276 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.649 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -144.79 163.02 35.32 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.236 -1.024 . . . . 0.92 108.236 -174.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -47.35 145.88 2.22 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.85 0.833 . . . . 2.42 112.358 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.81 150.09 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.304 -1.316 . . . . 1.08 112.289 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -60.43 -49.16 78.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.667 -1.151 . . . . 1.17 111.723 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -157.19 113.95 3.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.148 -1.387 . . . . 1.24 108.619 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.784 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.8 OUTLIER -75.36 99.47 4.13 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 123.674 1.702 . . . . 3.14 112.089 -167.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.844 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.9 t -159.01 92.84 1.12 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.665 -1.607 . . . . 1.11 109.527 161.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.844 ' HD3' ' O ' ' A' ' 140' ' ' THR . 11.0 mmt180 -152.44 154.68 32.21 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 106.583 -1.636 . . . . 2.98 106.583 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.04 110.86 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 120.577 1.242 . . . . 1.1 109.911 168.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 15.38 63.48 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.536 -0.84 . . . . 0.38 113.933 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 26.6 mt-10 -134.48 131.4 38.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.743 -1.206 . . . . 1.49 107.743 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.895 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -133.75 176.25 8.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.504 -0.878 . . . . 0.38 110.612 -167.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.784 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 12.5 p -107.45 142.98 36.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.639 0.733 . . . . 1.09 111.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG21 ' OH ' ' A' ' 133' ' ' TYR . 55.5 t -106.23 134.45 47.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.344 -1.298 . . . . 1.62 111.629 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 151' ' ' SER . 24.8 mt-30 -120.1 -87.81 0.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.669 -0.241 . . . . 2.74 111.096 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -164.27 -81.08 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.693 0.283 . . . . 1.13 110.93 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -82.69 -4.28 57.6 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.065 0.46 . . . . 1.6 109.908 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 18.0 m -145.71 148.34 32.92 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.305 -0.558 . . . . 1.37 110.318 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.725 HG22 ' OH ' ' A' ' 133' ' ' TYR . 6.2 mt -110.23 168.75 4.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.562 -1.273 . . . . 1.05 107.562 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.895 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.3 tt0 -124.03 108.75 12.7 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.712 -0.795 . . . . 0.97 110.017 172.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.544 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -111.81 125.62 54.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.376 0.607 . . . . 1.97 111.45 -170.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.774 0 CA-C-N 115.549 -0.75 . . . . 1.09 109.699 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.769 HG12 ' N ' ' A' ' 170' ' ' ARG . 84.1 t . . . . . 0 CA--C 1.488 -1.435 0 N-CA-C 109.173 -0.677 . . . . 1.23 109.173 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.769 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -124.82 145.01 49.98 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.231 1.015 . . . . 2.3 112.765 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -117.61 163.73 16.01 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.414 -1.721 . . . . 1.04 110.627 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 39.6 ttt180 -113.69 118.9 35.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.646 -1.242 . . . . 4.19 107.646 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.619 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.51 106.42 14.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 113.805 -1.543 . . . . 1.33 109.973 -164.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 180' ' ' LEU . 53.5 m -105.01 149.37 25.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.609 -0.723 . . . . 1.02 112.306 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.835 ' CD1' HD12 ' A' ' 119' ' ' ILE . 9.0 m-85 -112.62 115.12 28.09 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.058 -1.428 . . . . 0.44 111.559 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.1 100.18 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.18 0.514 . . . . 0.74 111.121 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.8 -119.29 5.15 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.143 -1.027 . . . . 0.28 112.653 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -111.75 12.4 21.03 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 178.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.687 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 14.5 p-80 -137.22 160.04 40.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.544 -1.207 . . . . 2.16 111.82 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 174' ' ' THR . 7.9 tp -67.82 134.1 50.36 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.755 -1.111 . . . . 1.05 110.82 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.14 -54.57 5.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.327 -1.306 . . . . 1.03 111.066 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.2 t 178.69 177.12 0.48 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.13 -0.941 . . . . 1.09 109.896 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.509 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.39 132.22 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 1.04 107.007 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.698 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.6 t -135.17 115.77 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.887 0.699 . . . . 1.15 112.887 -167.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -59.38 100.45 0.08 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.946 -1.131 . . . . 2.01 107.946 171.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.554 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 2.7 mmt -56.87 -15.97 5.83 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 112.962 -1.926 . . . . 2.01 112.622 -169.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.419 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.1 mt-10 -73.88 -45.39 51.18 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 114.44 -1.255 . . . . 0.68 110.692 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -97.09 -24.72 15.63 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.072 -1.422 . . . . 2.66 111.368 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.698 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.5 p-10 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 114.236 1.199 . . . . 2.15 114.236 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 23.1 m . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 108.435 -0.95 . . . . 1.11 108.435 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.879 HD12 ' CD1' ' A' ' 175' ' ' PHE . 6.4 pt -125.71 171.24 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.344 1.069 . . . . 1.07 111.391 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.72 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.0 m -111.08 167.3 10.37 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.449 -1.705 . . . . 1.71 108.634 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -51.81 -45.92 64.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.031 0.443 . . . . 3.81 111.195 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.432 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 23.0 t-20 -83.66 -17.87 40.0 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.419 -0.355 . . . . 2.18 110.4 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.904 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.8 mt-10 -66.1 -25.1 66.85 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 120.409 -0.516 . . . . 0.5 110.876 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.658 ' O ' HD11 ' A' ' 128' ' ' LEU . 6.1 tpt -88.86 -24.15 22.61 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.102 -1.439 . . . . 3.61 109.723 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 122' ' ' ASN . 2.1 t -61.36 -31.19 49.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.624 -1.171 . . . . 1.12 111.786 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.728 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.89 -40.81 27.49 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.014 -0.993 . . . . 2.07 110.399 169.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.904 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.13 -36.9 81.0 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.393 -1.289 . . . . 1.14 114.108 -175.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.672 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.05 -37.24 86.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.314 -2.154 . . . . 1.06 109.008 176.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.488 ' N ' HD21 ' A' ' 128' ' ' LEU . 25.6 mt-10 -65.45 -32.29 73.83 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.88 1.324 . . . . 2.51 107.802 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -90.9 -7.03 53.32 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.383 -2.189 . . . . 1.06 110.617 -169.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.4 t -122.11 0.91 9.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.949 0.88 . . . . 1.12 109.38 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 66.1 58.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 113.62 -1.627 . . . . 2.86 111.997 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.716 ' HH ' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -150.49 143.24 24.6 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.055 -1.832 . . . . 0.88 106.055 178.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.73 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.08 163.81 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.489 -1.3 . . . . 0.92 107.489 -175.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -52.28 160.12 0.85 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.383 1.087 . . . . 2.42 111.821 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -145.34 152.65 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.326 0 CA-C-N 113.629 -1.623 . . . . 1.08 110.938 -170.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.438 ' N ' HG13 ' A' ' 136' ' ' VAL . 4.2 m -60.08 -50.12 74.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.862 0.839 . . . . 1.17 111.55 175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.579 ' N ' HG13 ' A' ' 136' ' ' VAL . 17.7 ptmt -157.48 110.06 2.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.19 -1.368 . . . . 1.24 108.902 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.672 ' CG ' ' HA ' ' A' ' 145' ' ' PHE . 5.8 ttp -68.97 100.5 1.22 Allowed 'General case' 0 N--CA 1.398 -3.075 0 CA-C-O 122.364 1.078 . . . . 3.14 113.509 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.802 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.8 t -160.11 94.85 1.13 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.162 -1.836 . . . . 1.11 108.389 157.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.802 ' HD3' ' O ' ' A' ' 140' ' ' THR . 18.3 mmt180 -149.37 169.98 8.35 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 114.056 -1.429 . . . . 2.98 107.445 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.55 111.32 2.55 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 CA-C-N 119.578 0.885 . . . . 1.1 110.87 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.25 13.14 83.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.797 -0.716 . . . . 0.38 114.188 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.9 mm-40 -122.14 132.96 54.74 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.949 -1.5 . . . . 1.49 106.949 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.794 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -130.02 174.36 9.85 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.47 -1.292 . . . . 0.38 111.493 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 139' ' ' MET . 9.4 p -111.86 139.35 47.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.801 0.81 . . . . 1.09 111.406 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.716 HG23 ' HH ' ' A' ' 133' ' ' TYR . 55.1 t -100.16 141.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.801 -1.545 . . . . 1.62 111.064 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.525 ' HB3' ' O ' ' A' ' 151' ' ' SER . 35.9 tt0 -129.16 -80.85 0.57 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.803 -0.18 . . . . 2.74 111.146 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -170.45 -88.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.638 0.256 . . . . 1.13 111.388 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -81.59 -2.25 49.39 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.464 0.65 . . . . 1.6 109.264 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.3 m -144.02 148.03 34.67 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.53 -0.759 . . . . 1.37 109.87 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 ' OH ' ' A' ' 133' ' ' TYR . 4.9 mt -109.31 171.44 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.075 -1.454 . . . . 1.05 107.075 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.794 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 11.0 tt0 -115.77 140.06 49.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.762 -1.57 . . . . 0.97 106.762 169.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.407 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.2 ppp? -138.82 131.46 29.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.832 0.742 . . . . 1.97 111.969 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 110.016 -0.365 . . . . 1.09 110.016 171.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 170' ' ' ARG . 3.0 t . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 108.203 -1.036 . . . . 1.23 108.203 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.653 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -120.03 144.23 47.65 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.781 1.277 . . . . 2.3 114.029 -176.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -110.84 167.73 10.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 112.462 -2.153 . . . . 1.04 110.414 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.428 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 3.1 ptp180 -115.59 118.76 34.01 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.078 -1.453 . . . . 4.19 107.078 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -110.45 111.01 21.98 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.097 -1.411 . . . . 1.33 109.826 -165.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.533 ' O ' HD13 ' A' ' 180' ' ' LEU . 55.1 m -109.85 149.77 29.37 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.742 0.782 . . . . 1.02 112.998 -167.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.879 ' CD1' HD12 ' A' ' 119' ' ' ILE . 5.2 m-85 -114.82 117.42 30.67 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.623 -1.626 . . . . 0.44 110.535 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.445 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 0.5 OUTLIER -113.4 108.04 16.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.964 0.888 . . . . 0.74 110.491 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.81 -122.0 6.23 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.183 -1.008 . . . . 0.28 112.788 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.493 ' O ' HG22 ' A' ' 118' ' ' THR . 2.1 t70 -111.95 12.1 20.72 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.779 -1.563 . . . . 1.61 106.779 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.699 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 6.7 p80 -140.29 160.98 38.77 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.747 -1.115 . . . . 2.16 112.326 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.555 HD11 HD11 ' A' ' 173' ' ' LEU . 9.1 tp -65.9 135.91 55.41 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 114.574 -1.193 . . . . 1.05 110.551 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.445 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.62 -51.67 6.0 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.449 -1.251 . . . . 1.03 111.444 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.5 t 175.72 177.42 0.2 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.225 -0.898 . . . . 1.09 110.115 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.474 HD12 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -149.31 123.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.523 -1.288 . . . . 1.04 107.523 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.743 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 94.3 t -126.9 119.97 54.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.395 0.517 . . . . 1.15 112.395 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 171' ' ' ALA . 8.5 m120 -60.54 97.44 0.05 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.492 1.139 . . . . 2.01 108.458 171.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 75.0 mtp -54.17 -28.65 41.73 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 112.015 -2.357 . . . . 2.01 112.652 -166.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.417 ' HG3' HG12 ' A' ' 169' ' ' VAL . 2.0 mt-10 -61.61 -42.15 98.47 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.0 -1.454 . . . . 0.68 110.122 -172.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -106.26 -27.48 11.0 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.525 -1.671 . . . . 2.66 111.218 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.743 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 28.5 t-20 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.676 0.751 . . . . 2.15 111.333 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.544 HG21 ' HB3' ' A' ' 179' ' ' HIS . 6.2 m . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 109.083 -0.71 . . . . 1.11 109.083 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.864 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.2 pt -135.12 172.74 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 115.105 -0.952 . . . . 1.07 111.096 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.709 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.4 p -124.78 177.3 6.07 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.574 -1.194 . . . . 1.71 110.482 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 124' ' ' MET . 65.4 tttp -50.7 -48.76 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.422 0.451 . . . . 3.81 111.864 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.511 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 63.3 t30 -84.23 -18.64 35.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 122.273 -0.267 . . . . 2.18 110.285 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.74 -23.53 63.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.877 -0.729 . . . . 0.5 109.813 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.644 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.5 -28.32 25.04 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.401 -1.32 . . . . 3.61 109.855 177.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.89 -33.06 56.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 122.463 1.125 . . . . 1.12 111.767 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.748 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.38 -41.71 32.46 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.379 -1.282 . . . . 2.07 110.17 169.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.39 -38.32 86.62 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-O 117.525 -1.226 . . . . 1.14 114.215 -173.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.704 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 116.184 -2.206 . . . . 1.06 108.566 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.654 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 61.5 mm-40 -67.94 -29.69 68.81 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 123.189 1.471 . . . . 2.51 108.741 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -85.55 -6.97 59.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.016 -2.357 . . . . 1.06 110.028 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 128' ' ' LEU . 13.3 t -122.54 -0.66 9.18 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.152 -0.931 . . . . 1.12 109.657 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 77.4 51.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 113.865 -1.516 . . . . 2.86 112.436 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.735 ' OH ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -151.95 145.05 24.57 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.195 -1.409 . . . . 0.88 107.195 -178.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.656 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -142.62 160.83 39.54 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.166 -1.79 . . . . 0.92 106.166 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -53.04 160.17 1.05 Allowed 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 119.383 0.992 . . . . 2.42 111.656 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.594 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.44 153.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.333 -1.303 . . . . 1.08 111.979 -169.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -60.9 -50.13 74.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.556 0.693 . . . . 1.17 111.886 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.594 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.6 ptmt -157.0 114.64 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.35 -1.296 . . . . 1.24 108.793 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.765 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.18 107.28 15.62 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 122.798 1.285 . . . . 3.14 111.242 -167.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.672 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.8 t -156.92 95.49 1.52 Allowed 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.882 -1.508 . . . . 1.11 108.584 163.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.672 ' HD3' ' O ' ' A' ' 140' ' ' THR . 19.3 mmt85 -151.54 169.64 9.08 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 113.622 -1.626 . . . . 2.98 108.099 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.03 110.47 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 N-CA-C 109.43 -1.027 . . . . 1.1 109.43 161.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.61 26.95 58.05 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.356 -0.926 . . . . 0.38 114.09 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 32.8 mt-10 -138.82 130.6 27.72 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.41 -1.33 . . . . 1.49 107.41 171.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.775 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -134.0 176.8 8.25 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.61 -0.836 . . . . 0.38 110.482 -165.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.765 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 14.3 p -113.5 138.92 49.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.829 0.823 . . . . 1.09 112.291 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.18 141.47 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 113.696 -1.593 . . . . 1.62 110.862 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -127.48 -81.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.771 -0.372 . . . . 2.74 111.071 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.48 -88.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 1.13 111.712 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -85.53 -3.02 58.74 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.296 0.569 . . . . 1.6 109.564 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 m -142.41 146.63 35.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.786 -0.643 . . . . 1.37 110.286 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.735 HG22 ' OH ' ' A' ' 133' ' ' TYR . 5.6 mt -106.34 169.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.467 -1.308 . . . . 1.05 107.467 169.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.775 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.5 tt0 -115.71 135.57 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.561 -1.644 . . . . 0.97 106.561 166.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.472 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.0 ppp? -134.66 127.9 32.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.874 0.761 . . . . 1.97 111.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.356 -0.609 . . . . 1.09 109.356 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.788 HG12 ' N ' ' A' ' 170' ' ' ARG . 54.4 t . . . . . 0 CA--C 1.48 -1.722 0 N-CA-C 108.351 -0.981 . . . . 1.23 108.351 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.788 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -120.81 142.71 49.35 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 122.524 1.155 . . . . 2.3 113.083 176.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.16 166.88 11.52 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 112.772 -2.013 . . . . 1.04 110.46 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.408 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 20.0 ttt180 -116.88 119.38 35.21 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.503 -1.295 . . . . 4.19 107.503 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.625 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.0 114.57 27.08 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.795 -1.548 . . . . 1.33 110.027 -164.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.554 ' O ' HD11 ' A' ' 180' ' ' LEU . 54.2 m -110.8 150.98 28.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 112.76 0.652 . . . . 1.02 112.76 -168.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.864 ' CD1' HD12 ' A' ' 119' ' ' ILE . 12.8 m-85 -113.59 103.47 11.28 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.38 -1.282 . . . . 0.44 112.873 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.59 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 9.9 t0 -89.76 96.1 10.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.209 0.528 . . . . 0.74 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.63 -115.56 4.04 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.099 -1.048 . . . . 0.28 113.159 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.49 ' O ' HG21 ' A' ' 118' ' ' THR . 3.2 t70 -111.07 9.44 22.04 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.756 -1.572 . . . . 1.61 106.756 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.676 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 9.5 p-80 -137.65 161.09 37.4 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.221 -1.354 . . . . 2.16 111.807 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 174' ' ' THR . 10.5 tp -67.03 137.32 56.38 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.177 -0.919 . . . . 1.05 110.849 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.59 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -89.16 -54.23 4.21 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.173 -1.376 . . . . 1.03 111.631 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.2 t -176.97 177.09 1.33 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.123 -0.944 . . . . 1.09 110.12 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.618 ' CG1' HD12 ' A' ' 173' ' ' LEU . 2.6 mp -151.84 124.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.455 -1.683 . . . . 1.04 106.455 176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.706 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 69.4 t -128.23 123.8 60.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.776 0.658 . . . . 1.15 112.776 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.87 98.49 0.05 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.317 -0.994 . . . . 2.01 108.317 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 72.0 mmm -58.9 -16.72 18.93 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 113.332 -1.758 . . . . 2.01 112.896 -168.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.551 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.8 mt-10 -72.35 -42.59 65.13 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.473 -1.24 . . . . 0.68 110.175 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.96 -26.73 13.31 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.082 -1.417 . . . . 2.66 112.007 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.706 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.5 p-10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 115.342 1.608 . . . . 2.15 115.342 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.544 HG21 ' HB3' ' A' ' 179' ' ' HIS . 8.4 m . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 108.751 -0.833 . . . . 1.11 108.751 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.826 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.56 170.6 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.104 -0.953 . . . . 1.07 110.773 -174.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.715 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.6 m -119.57 177.05 5.08 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.648 -1.16 . . . . 1.71 109.461 -170.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 124' ' ' MET . 51.3 pttt -51.6 -48.02 63.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.397 . . . . 3.81 111.671 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 121' ' ' LYS . 27.8 t-20 -84.07 -18.1 38.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.474 -0.33 . . . . 2.18 110.406 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.912 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.03 -22.67 64.04 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.911 -0.716 . . . . 0.5 110.627 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.572 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.09 -27.15 22.13 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.212 -0.995 . . . . 3.61 109.925 176.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.55 -31.77 54.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.569 -1.196 . . . . 1.12 111.565 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.751 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.27 -41.38 34.22 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.942 -1.026 . . . . 2.07 109.808 170.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.69 -40.27 83.13 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-O 117.58 -1.2 . . . . 1.14 114.116 -173.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.785 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -38.35 90.8 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 116.299 -2.16 . . . . 1.06 109.285 177.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' HD22 ' A' ' 128' ' ' LEU . 28.0 mt-10 -65.55 -32.66 74.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.679 1.228 . . . . 2.51 108.013 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -88.74 -7.51 56.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.474 -2.148 . . . . 1.06 110.632 -169.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.571 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.39 0.73 10.07 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.222 -0.899 . . . . 1.12 109.116 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 66.46 56.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.636 -1.62 . . . . 2.86 111.981 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.785 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.58 146.88 27.57 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.92 -1.511 . . . . 0.88 106.92 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.584 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.88 160.21 42.12 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.78 -1.193 . . . . 0.92 107.78 -174.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -46.99 147.78 1.27 Allowed 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 122.021 0.915 . . . . 2.42 112.664 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.607 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -139.09 151.94 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 CA-C-N 113.981 -1.463 . . . . 1.08 112.127 -172.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 m -60.1 -50.08 75.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.914 . . . . 1.17 111.438 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.607 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.04 116.65 3.11 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 1.24 108.73 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.797 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -78.47 102.32 7.78 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 123.082 1.42 . . . . 3.14 111.196 -167.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.679 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 4.1 t -157.84 95.96 1.45 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.984 -1.462 . . . . 1.11 108.646 161.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.679 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.2 mmt180 -151.51 168.84 10.36 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 113.614 -1.63 . . . . 2.98 106.905 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.84 111.39 2.49 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 CA-C-N 119.91 1.004 . . . . 1.1 109.796 162.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.5 20.63 59.81 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.469 -0.872 . . . . 0.38 114.164 172.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 38.8 mt-10 -136.94 132.11 33.96 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.074 -1.084 . . . . 1.49 108.074 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.92 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.29 175.98 9.02 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.702 -0.799 . . . . 0.38 110.408 -165.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.797 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 17.8 p -110.32 139.74 45.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.759 0.79 . . . . 1.09 112.516 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.458 HG22 ' HH ' ' A' ' 133' ' ' TYR . 52.3 t -101.2 129.2 52.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 113.733 -1.576 . . . . 1.62 110.887 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.2 tp60 -113.22 -78.55 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 121.071 -0.251 . . . . 2.74 110.775 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -169.24 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.858 0.361 . . . . 1.13 111.271 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.7 -2.55 58.62 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.625 -0.509 . . . . 1.6 109.625 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 p -145.2 143.97 30.59 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.957 -0.565 . . . . 1.37 110.533 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG21 ' OH ' ' A' ' 133' ' ' TYR . 7.4 mt -106.82 169.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.303 -1.369 . . . . 1.05 107.303 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.92 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 27.9 tt0 -126.09 111.02 14.2 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.585 -0.846 . . . . 0.97 110.518 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.467 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 10.2 tmm? -112.95 124.29 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.092 0.473 . . . . 1.97 111.872 -169.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 1.09 110.537 172.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.771 HG11 ' N ' ' A' ' 170' ' ' ARG . 77.7 t . . . . . 0 CA--C 1.484 -1.58 0 N-CA-C 108.563 -0.903 . . . . 1.23 108.563 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.771 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -121.07 144.2 48.67 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.367 1.08 . . . . 2.3 112.591 177.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -118.18 161.18 20.3 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 1.04 109.657 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 34.7 ttt180 -109.53 118.82 37.62 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.836 -1.172 . . . . 4.19 107.836 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.644 HD21 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -108.52 103.87 13.08 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.693 -1.594 . . . . 1.33 110.161 -165.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.559 ' O ' HD13 ' A' ' 180' ' ' LEU . 56.3 m -104.43 149.55 25.32 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.727 -0.67 . . . . 1.02 112.096 -169.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.826 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.0 m-85 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.397 -1.274 . . . . 0.44 112.16 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 20.7 t70 -99.57 97.25 8.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.974 0.416 . . . . 0.74 110.729 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.51 -115.58 4.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.223 -0.989 . . . . 0.28 113.699 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 118' ' ' THR . 17.4 t70 -110.74 7.55 22.17 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 106.864 -1.532 . . . . 1.61 106.864 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.678 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 16.9 p-80 -138.84 161.0 38.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.811 -1.54 . . . . 2.16 111.837 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 174' ' ' THR . 7.6 tp -68.47 131.64 45.63 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.455 -1.248 . . . . 1.05 110.459 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -79.3 -53.53 6.85 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.228 -1.351 . . . . 1.03 110.49 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.2 t 178.49 178.19 0.42 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.831 -1.077 . . . . 1.09 110.375 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.497 HG13 ' HA ' ' A' ' 173' ' ' LEU . 2.5 mp -146.36 116.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.707 -1.59 . . . . 1.04 106.707 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 99.4 t -115.77 123.66 71.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 113.243 0.831 . . . . 1.15 113.243 -170.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.492 ' OD1' HG12 ' A' ' 169' ' ' VAL . 3.9 t30 -61.13 91.83 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.485 -0.932 . . . . 2.01 108.485 174.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.431 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 70.5 mmm -58.35 -20.47 43.78 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 113.408 -1.724 . . . . 2.01 113.667 -163.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.519 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.5 mt-10 -71.15 -42.78 68.7 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.787 -1.097 . . . . 0.68 110.215 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -98.44 -31.08 12.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.768 -1.56 . . . . 2.66 110.981 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.618 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.9 p-10 . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.955 0.883 . . . . 2.15 112.35 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 23.4 m . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 109.061 -0.718 . . . . 1.11 109.061 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -130.92 171.14 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-N 115.276 -0.874 . . . . 1.07 110.889 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.689 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -123.35 178.97 4.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.494 -1.23 . . . . 1.71 109.507 -172.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 121' ' ' LYS . 12.7 mptt -56.99 -43.39 81.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.06 0.457 . . . . 3.81 111.295 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 14.1 m120 -83.6 -17.87 40.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.483 -0.326 . . . . 2.18 110.614 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.2 mt-10 -73.52 -21.61 60.35 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.288 -0.565 . . . . 0.5 111.08 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.611 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -87.87 -26.89 22.54 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.276 -0.97 . . . . 3.61 109.716 174.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.05 -30.66 50.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.62 -1.173 . . . . 1.12 111.613 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.732 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.95 -41.97 28.06 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.767 -1.106 . . . . 2.07 109.847 170.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.88 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.07 -36.43 79.61 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 117.389 -1.291 . . . . 1.14 114.27 -172.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.856 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.68 -40.53 95.56 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 116.274 -2.17 . . . . 1.06 109.511 175.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.462 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 23.4 mt-10 -64.62 -29.02 70.02 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.873 1.32 . . . . 2.51 108.03 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -93.07 -7.73 44.79 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 112.548 -2.115 . . . . 1.06 110.858 -169.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.4 t -122.09 -1.78 9.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.741 0.781 . . . . 1.12 109.853 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 70.88 57.31 0.22 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.796 -1.547 . . . . 2.86 111.746 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.856 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.95 145.02 26.24 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 106.766 -1.568 . . . . 0.88 106.766 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.662 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.35 163.68 35.68 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.67 -1.604 . . . . 0.92 106.67 -177.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -46.93 159.63 0.1 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.476 1.132 . . . . 2.42 112.828 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 138' ' ' LYS . 3.4 t -149.75 148.59 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 CA-C-N 113.513 -1.676 . . . . 1.08 111.481 -172.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 m -60.36 -49.61 76.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.241 -0.89 . . . . 1.17 111.57 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.605 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -157.68 115.29 3.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.047 -1.433 . . . . 1.24 108.861 -176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.735 ' HG3' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -75.99 104.41 6.51 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 122.999 1.381 . . . . 3.14 111.506 -168.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.809 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.9 t -157.33 94.12 1.36 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.012 -1.449 . . . . 1.11 109.02 159.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.809 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -152.3 166.26 15.7 Favored Pre-proline 0 CA--C 1.502 -0.882 0 CA-C-N 113.906 -1.497 . . . . 2.98 107.883 171.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -80.95 111.34 2.46 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 CA-C-N 119.84 0.979 . . . . 1.1 109.767 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.98 12.21 68.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.621 -0.8 . . . . 0.38 114.353 172.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.8 mt-10 -128.72 131.79 47.93 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.583 -0.895 . . . . 1.49 108.583 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.85 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.7 m-85 -130.75 174.29 10.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.549 -0.861 . . . . 0.38 110.788 -165.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.667 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 5.9 p -111.39 137.66 48.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.905 -0.776 . . . . 1.09 108.905 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.43 HG23 HG12 ' A' ' 152' ' ' ILE . 4.0 p -111.06 146.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 113.353 0.871 . . . . 1.62 113.353 -168.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.657 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.5 tt0 -154.69 174.97 14.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.591 -0.892 . . . . 2.74 108.591 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.47 ' H ' ' HG2' ' A' ' 148' ' ' GLN . . . -64.54 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.94 1.089 . . . . 1.13 113.94 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -84.71 -4.67 59.14 Favored 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 122.239 -0.288 . . . . 1.6 111.185 -174.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 28.6 p -149.95 134.68 17.65 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.65 -0.82 . . . . 1.37 110.845 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 153' ' ' GLU . 8.0 mt -100.57 171.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.565 -1.272 . . . . 1.05 107.565 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.85 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.6 tt0 -117.11 137.72 52.11 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 106.982 -1.488 . . . . 0.97 106.982 167.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.483 ' CA ' ' HE3' ' A' ' 139' ' ' MET . 1.8 tmt? -135.11 123.55 23.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.615 0.643 . . . . 1.97 112.373 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.643 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 115.932 -0.576 . . . . 1.09 110.767 174.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.787 HG12 ' N ' ' A' ' 170' ' ' ARG . 53.8 t . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.029 -1.1 . . . . 1.23 108.029 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.787 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -126.37 144.43 50.83 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.132 0.968 . . . . 2.3 113.308 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 163.09 16.49 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.457 -1.701 . . . . 1.04 110.181 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -113.0 118.13 33.97 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.46 -0.941 . . . . 4.19 108.46 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -107.32 111.36 23.68 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.677 -1.601 . . . . 1.33 110.604 -164.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.521 ' O ' HD11 ' A' ' 180' ' ' LEU . 58.7 m -109.21 152.43 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.736 0.643 . . . . 1.02 112.736 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.896 ' CD1' HD12 ' A' ' 119' ' ' ILE . 13.2 m-85 -118.46 97.87 5.98 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.141 -0.936 . . . . 0.44 112.887 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.703 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 33.9 t70 -86.05 97.02 10.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.113 0.482 . . . . 0.74 110.83 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.07 -118.31 4.82 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.164 -1.017 . . . . 0.28 112.645 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -111.32 13.55 21.63 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.532 -1.285 . . . . 1.61 107.532 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.69 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 30.8 p80 -139.37 160.98 38.56 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.413 -1.267 . . . . 2.16 111.261 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.599 HD12 HD13 ' A' ' 173' ' ' LEU . 10.2 tp -63.71 139.32 58.76 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.347 -0.842 . . . . 1.05 110.876 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.703 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -92.04 -50.48 5.67 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.414 -1.266 . . . . 1.03 111.462 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.401 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.6 t 176.33 177.34 0.25 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.573 -1.194 . . . . 1.09 110.026 -173.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -148.83 134.27 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 105.839 -1.911 . . . . 1.04 105.839 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.737 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 75.0 t -134.02 116.58 23.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 120.162 -0.615 . . . . 1.15 112.236 -171.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.1 97.81 0.05 Allowed 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.845 -1.169 . . . . 2.01 107.845 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 85.0 mmm -59.48 -16.12 22.04 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.695 -2.048 . . . . 2.01 112.98 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.482 ' HG3' HG11 ' A' ' 169' ' ' VAL . 2.2 mt-10 -72.21 -44.05 63.54 Favored 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 114.499 -1.228 . . . . 0.68 109.791 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -94.4 -33.52 13.12 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.675 -1.602 . . . . 2.66 111.109 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.737 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 5.0 p30 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 115.394 1.627 . . . . 2.15 115.394 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.534 HG21 ' HB3' ' A' ' 179' ' ' HIS . 10.3 m . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 108.927 -0.768 . . . . 1.11 108.927 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.851 HD13 ' CD1' ' A' ' 175' ' ' PHE . 4.3 pt -131.75 171.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.95 -1.023 . . . . 1.07 111.945 -171.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.72 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 21.1 t -123.93 174.76 7.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.57 -1.195 . . . . 1.71 109.39 -172.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -52.2 -42.68 63.72 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.033 0.753 . . . . 3.81 113.033 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.8 t30 -85.61 -18.04 34.44 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.397 -0.815 . . . . 2.18 110.202 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.914 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.56 -25.07 63.82 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.621 -0.432 . . . . 0.5 111.409 -175.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.72 -25.28 22.41 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.096 -1.442 . . . . 3.61 109.696 175.118 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.32 -30.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.766 -1.107 . . . . 1.12 111.737 -177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.743 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.64 -41.44 26.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.698 -1.137 . . . . 2.07 109.822 170.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.77 -40.33 83.64 Favored 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 117.598 -1.191 . . . . 1.14 114.167 -174.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.833 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.97 -38.22 90.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.35 -2.14 . . . . 1.06 109.273 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.463 ' H ' HD21 ' A' ' 128' ' ' LEU . 24.2 mt-10 -66.69 -31.36 71.98 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.86 1.314 . . . . 2.51 108.129 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -89.8 -7.27 54.76 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 112.491 -2.14 . . . . 1.06 110.711 -169.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 128' ' ' LEU . 13.9 t -121.54 -0.47 9.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.339 -0.846 . . . . 1.12 109.289 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 69.16 55.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.767 -1.56 . . . . 2.86 111.737 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.833 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.17 144.95 26.92 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.582 -1.266 . . . . 0.88 107.582 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.655 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.86 162.45 38.62 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.834 -1.172 . . . . 0.92 107.834 -175.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -47.3 146.94 1.73 Allowed 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 113.349 0.87 . . . . 2.42 113.349 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -140.73 151.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.968 -1.469 . . . . 1.08 112.066 -172.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -61.06 -50.18 74.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.703 0.763 . . . . 1.17 111.937 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.599 ' N ' HG11 ' A' ' 136' ' ' VAL . 16.9 ptmt -154.32 115.95 4.16 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.658 -1.155 . . . . 1.24 109.296 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.765 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 1.0 OUTLIER -77.35 100.58 5.98 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 123.667 1.698 . . . . 3.14 112.106 -166.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.71 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.2 t -158.97 96.37 1.34 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.593 -1.64 . . . . 1.11 109.04 163.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.71 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.4 mmt180 -151.1 169.88 8.62 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.835 -1.543 . . . . 2.98 106.835 170.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.4 111.25 2.33 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 CA-C-N 119.967 1.024 . . . . 1.1 109.874 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.1 22.32 61.23 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.265 -0.969 . . . . 0.38 114.014 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.3 mt-10 -137.4 131.03 31.44 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.912 -1.144 . . . . 1.49 107.912 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.896 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -133.08 176.57 8.39 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.912 -0.715 . . . . 0.38 109.847 -167.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.765 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 16.6 p -108.13 143.48 36.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.608 0.718 . . . . 1.09 111.543 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.79 HG22 ' HH ' ' A' ' 133' ' ' TYR . 55.2 t -106.04 119.93 56.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.268 -1.333 . . . . 1.62 110.976 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.1 tp-100 -101.72 -85.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 2.74 110.436 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.99 -82.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 120.537 0.208 . . . . 1.13 110.745 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.588 0.709 . . . . 1.6 109.389 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 47.2 p -138.96 143.08 38.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.92 -1.036 . . . . 1.37 110.05 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.624 HG21 ' N ' ' A' ' 153' ' ' GLU . 8.0 mt -104.64 171.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.574 -1.269 . . . . 1.05 107.574 170.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.896 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.7 tt0 -128.4 106.84 9.27 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.685 -0.806 . . . . 0.97 110.18 171.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.516 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.5 tmt? -110.07 125.96 53.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 1.97 111.713 -167.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 CA-C-N 116.076 -0.511 . . . . 1.09 109.949 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.821 HG11 ' N ' ' A' ' 170' ' ' ARG . 44.6 t . . . . . 0 CA--C 1.485 -1.527 0 N-CA-C 109.178 -0.675 . . . . 1.23 109.178 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.821 ' N ' HG11 ' A' ' 169' ' ' VAL . 2.2 ppt_? -120.47 143.39 48.54 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.59 1.186 . . . . 2.3 113.039 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.88 160.62 22.33 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 112.981 -1.918 . . . . 1.04 110.638 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.38 120.24 41.92 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.097 -1.075 . . . . 4.19 108.097 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.623 HD13 ' CG1' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -114.54 110.72 20.25 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.388 -1.733 . . . . 1.33 110.576 -163.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.564 ' O ' HD11 ' A' ' 180' ' ' LEU . 71.1 m -108.38 148.05 30.67 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.093 -0.38 . . . . 1.02 110.946 -173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.851 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -115.82 99.9 7.63 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.034 0.753 . . . . 0.44 113.034 176.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.523 ' N ' ' HB1' ' A' ' 181' ' ' ALA . 11.0 t0 -77.33 92.69 3.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.373 0.606 . . . . 0.74 111.321 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.54 -109.78 3.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.131 -1.033 . . . . 0.28 114.2 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 118' ' ' THR . 9.1 p-10 -110.29 7.8 23.23 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.613 -1.255 . . . . 1.61 107.613 -177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.664 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 10.3 p-80 -142.29 160.82 39.49 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.071 -1.422 . . . . 2.16 112.1 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.564 HD11 ' O ' ' A' ' 174' ' ' THR . 7.9 tp -65.61 136.43 56.33 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.165 -0.925 . . . . 1.05 110.978 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.523 ' HB1' ' N ' ' A' ' 176' ' ' ASP . . . -87.29 -53.42 4.85 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.521 -1.218 . . . . 1.03 111.54 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.8 t -177.84 176.51 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.314 -0.857 . . . . 1.09 110.382 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.623 ' CG1' HD13 ' A' ' 173' ' ' LEU . 2.6 mp -152.2 118.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 113.895 -1.502 . . . . 1.04 107.274 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.681 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 71.9 t -124.48 123.43 66.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.573 0.583 . . . . 1.15 112.573 -171.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.98 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.194 0.997 . . . . 2.01 108.91 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 88.0 mmm -58.27 -16.49 14.28 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 112.482 -2.145 . . . . 2.01 112.844 -168.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.462 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.8 mt-10 -68.3 -41.64 80.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.256 -1.338 . . . . 0.68 109.915 -176.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -112.87 -20.54 11.55 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.651 -1.613 . . . . 2.66 112.542 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.681 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 13.1 p30 . . . . . 0 C--N 1.349 0.559 0 N-CA-C 114.098 1.147 . . . . 2.15 114.098 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 17.5 m . . . . . 0 N--CA 1.432 -1.365 0 N-CA-C 109.062 -0.718 . . . . 1.11 109.062 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.93 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -127.98 172.16 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.202 1.001 . . . . 1.07 111.688 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.69 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.7 t -121.27 175.16 6.27 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 113.891 -1.504 . . . . 1.71 109.487 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.9 mttt -52.67 -48.93 66.16 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.335 0.397 . . . . 3.81 111.838 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.427 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 54.2 m-80 -83.84 -16.21 45.35 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 122.341 -0.224 . . . . 2.18 110.559 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.908 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.35 -21.27 63.83 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.451 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.7 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 0.0 OUTLIER -86.06 -26.96 25.04 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.925 -1.11 . . . . 3.61 109.774 176.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.59 -32.06 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.834 -1.076 . . . . 1.12 111.532 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.756 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.85 -40.38 32.78 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.725 -1.125 . . . . 2.07 110.171 170.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.908 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.53 82.17 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 117.469 -1.253 . . . . 1.14 114.364 -174.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.81 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.86 -38.51 91.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.247 -2.181 . . . . 1.06 109.181 176.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.493 ' H ' HD22 ' A' ' 128' ' ' LEU . 36.7 mt-10 -64.67 -32.44 74.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.893 1.33 . . . . 2.51 107.895 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -89.66 -6.71 55.9 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.332 -2.213 . . . . 1.06 110.567 -169.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 12.5 t -122.11 0.28 9.59 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.351 -0.84 . . . . 1.12 109.258 -174.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 70.12 55.9 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.682 -1.599 . . . . 2.86 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.81 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.69 146.95 25.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.954 -1.499 . . . . 0.88 106.954 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.597 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.17 159.33 42.83 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.109 -1.071 . . . . 0.92 108.109 -178.09 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.4 158.97 0.76 Allowed 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 122.19 0.995 . . . . 2.42 112.116 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.585 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -148.67 153.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 113.821 -1.536 . . . . 1.08 111.264 -169.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -50.06 75.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.937 0.875 . . . . 1.17 111.728 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.5 ptmt -157.74 113.8 2.83 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.229 -1.35 . . . . 1.24 108.682 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.757 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.32 105.06 13.08 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.229 1.49 . . . . 3.14 111.339 -166.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.809 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -157.49 93.71 1.32 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.303 -1.772 . . . . 1.11 107.969 162.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.809 ' HD3' ' O ' ' A' ' 140' ' ' THR . 23.7 mmt180 -151.35 169.6 9.1 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.447 -1.706 . . . . 2.98 107.813 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 111.4 2.75 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 CA-C-N 119.269 0.775 . . . . 1.1 110.389 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.11 78.4 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.581 -0.819 . . . . 0.38 113.886 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 1.3 mm-40 -129.59 132.2 46.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.382 -1.34 . . . . 1.49 107.382 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.791 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.0 OUTLIER -132.6 175.44 9.31 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.258 -0.977 . . . . 0.38 110.413 -169.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.757 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 12.0 p -111.18 141.9 44.08 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.954 0.883 . . . . 1.09 111.956 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.504 HG21 ' OH ' ' A' ' 133' ' ' TYR . 54.5 t -101.8 119.97 50.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.844 -1.526 . . . . 1.62 110.773 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.576 ' HB2' ' O ' ' A' ' 151' ' ' SER . 64.9 mt-30 -101.99 -78.59 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.681 -0.236 . . . . 2.74 110.741 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.63 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.717 0.294 . . . . 1.13 111.199 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -89.33 -2.93 58.62 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.84 0.829 . . . . 1.6 109.153 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 15.4 p -138.16 141.83 40.08 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.779 -1.1 . . . . 1.37 109.636 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.739 HG23 ' OH ' ' A' ' 133' ' ' TYR . 6.9 mt -104.35 170.92 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.103 -1.443 . . . . 1.05 107.103 169.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.791 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.2 tt0 -119.45 139.07 52.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.544 -1.651 . . . . 0.97 106.544 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.481 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -135.57 127.38 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 118.863 0.756 . . . . 1.97 111.935 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.379 -0.971 . . . . 1.09 108.379 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.616 HG12 ' ND2' ' A' ' 185' ' ' ASN . 12.4 t . . . . . 0 CA--C 1.495 -1.141 0 N-CA-C 108.34 -0.985 . . . . 1.23 108.34 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.684 ' HB2' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -119.77 144.81 47.09 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 122.454 1.121 . . . . 2.3 113.223 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.49 159.88 23.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.296 -1.774 . . . . 1.04 110.24 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 24.7 ttm180 -108.93 118.82 37.78 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 122.073 0.94 . . . . 4.19 108.751 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.62 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -110.2 113.33 25.93 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.568 -1.651 . . . . 1.33 110.959 -162.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.51 ' O ' HD12 ' A' ' 180' ' ' LEU . 63.5 m -112.16 149.14 32.63 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.003 -0.435 . . . . 1.02 112.152 -171.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.93 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -117.84 110.94 18.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.841 -0.618 . . . . 0.44 111.649 175.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.597 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t70 -94.35 107.24 19.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.477 -0.783 . . . . 0.74 111.042 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.8 -115.75 4.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.279 -0.962 . . . . 0.28 113.015 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.506 ' O ' HG22 ' A' ' 118' ' ' THR . 5.1 t70 -112.35 10.82 19.94 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.003 -1.481 . . . . 1.61 107.003 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.717 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 12.0 p-80 -137.51 160.75 38.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.793 -1.094 . . . . 2.16 112.734 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.566 ' CD1' ' HD1' ' A' ' 175' ' ' PHE . 9.6 tp -63.58 134.96 56.42 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.575 -0.739 . . . . 1.05 110.493 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.597 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -88.69 -49.84 6.61 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.638 -1.164 . . . . 1.03 111.32 -176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.5 t 177.49 178.47 0.3 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.96 -1.018 . . . . 1.09 110.277 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.522 ' CG1' HD12 ' A' ' 173' ' ' LEU . 2.0 mp -152.99 124.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 N-CA-C 106.075 -1.824 . . . . 1.04 106.075 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.649 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.2 t -121.1 121.73 65.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 113.101 0.778 . . . . 1.15 113.101 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.616 ' ND2' HG12 ' A' ' 169' ' ' VAL . 23.6 t-20 -58.94 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 107.797 -1.186 . . . . 2.01 107.797 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.4 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 81.4 mmm -62.0 -15.57 45.04 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-N 114.216 -1.356 . . . . 2.01 112.661 -167.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.409 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.8 mt-10 -75.12 -42.62 55.96 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 114.343 -1.299 . . . . 0.68 110.289 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -100.2 -30.39 11.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.379 -1.282 . . . . 2.66 112.039 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.649 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.0 p-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 114.665 1.357 . . . . 2.15 114.665 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 15.5 m . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.349 -0.611 . . . . 1.11 109.349 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.874 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.1 pt -132.14 172.34 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.075 -0.966 . . . . 1.07 111.251 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.694 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 65.4 p -123.97 179.45 4.84 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.697 -1.138 . . . . 1.71 110.403 -169.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 124' ' ' MET . 41.0 mmtm -60.03 -37.81 80.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.273 0.559 . . . . 3.81 110.594 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.46 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -85.45 -22.22 28.39 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.706 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.91 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.5 mt-10 -72.53 -23.16 60.96 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 119.805 -0.758 . . . . 0.5 109.74 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.568 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -85.05 -28.12 25.89 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.172 -1.011 . . . . 3.61 109.967 178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.29 -32.57 56.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.005 -0.998 . . . . 1.12 111.711 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.758 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.95 -39.96 33.13 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.833 -1.076 . . . . 2.07 110.005 171.112 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.43 -39.54 80.05 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 114.261 1.208 . . . . 1.14 114.261 -174.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.859 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.51 -38.79 92.47 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.157 -2.217 . . . . 1.06 109.08 177.253 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 21.1 mt-10 -65.7 -31.48 72.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.93 1.348 . . . . 2.51 108.09 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -89.33 -6.98 56.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.472 -2.149 . . . . 1.06 110.556 -170.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 13.4 t -122.17 2.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.973 -1.012 . . . . 1.12 109.195 -175.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 68.68 54.85 0.49 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 113.671 -1.604 . . . . 2.86 111.581 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.901 ' HH ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -152.0 146.97 25.98 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.647 -1.242 . . . . 0.88 107.647 -177.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.648 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.43 161.25 40.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.126 -1.435 . . . . 0.92 107.126 -176.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -52.06 158.23 1.14 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.201 1.001 . . . . 2.42 112.099 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.41 153.58 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 113.826 -1.533 . . . . 1.08 111.48 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.3 m -59.63 -50.89 72.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.038 0.923 . . . . 1.17 111.472 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.587 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.2 ptmt -159.91 116.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.765 -1.561 . . . . 1.24 108.035 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.731 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.2 OUTLIER -82.26 109.07 16.2 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.955 1.36 . . . . 3.14 110.925 -165.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.8 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.7 t -155.71 95.66 1.68 Allowed 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 113.549 -1.659 . . . . 1.11 108.727 162.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.8 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.6 mmt180 -151.17 167.52 12.84 Favored Pre-proline 0 N--CA 1.432 -1.375 0 CA-C-N 113.029 -1.896 . . . . 2.98 107.75 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.44 111.61 2.62 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 N-CA-C 109.644 -0.945 . . . . 1.1 109.644 160.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.77 20.81 59.03 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.657 -0.783 . . . . 0.38 114.393 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 41.2 mt-10 -137.45 131.9 32.6 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.238 -1.023 . . . . 1.49 108.238 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.813 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -132.12 176.54 8.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.827 -0.749 . . . . 0.38 110.036 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.731 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.1 p -112.66 139.97 47.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.717 0.77 . . . . 1.09 111.763 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.901 HG22 ' HH ' ' A' ' 133' ' ' TYR . 40.1 t -98.44 139.48 20.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.088 -1.415 . . . . 1.62 110.922 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 151' ' ' SER . 64.0 tt0 -125.15 -79.08 0.6 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.021 -0.272 . . . . 2.74 111.273 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.54 -81.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.75 0.31 . . . . 1.13 111.702 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.4 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 77.0 m-20 -86.71 -5.4 59.13 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.236 -0.653 . . . . 1.6 109.236 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.54 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 m -143.46 146.54 33.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.275 -0.875 . . . . 1.37 109.348 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.661 HG23 ' N ' ' A' ' 153' ' ' GLU . 6.6 mt -107.97 169.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.988 -1.486 . . . . 1.05 106.988 167.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.1 tt0 -116.19 136.37 53.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.521 -1.659 . . . . 0.97 106.521 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.458 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.3 ppp? -136.75 125.29 23.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 119.143 0.883 . . . . 1.97 112.692 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.65 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 115.928 -0.578 . . . . 1.09 110.08 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.8 HG12 ' N ' ' A' ' 170' ' ' ARG . 53.8 t . . . . . 0 CA--C 1.49 -1.359 0 N-CA-C 108.467 -0.938 . . . . 1.23 108.467 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.8 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -128.03 144.1 51.1 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 122.288 1.042 . . . . 2.3 113.427 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -111.68 168.01 9.9 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.333 -1.758 . . . . 1.04 110.664 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.519 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 39.5 ptt180 -118.42 122.34 42.54 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.147 -1.427 . . . . 4.19 107.147 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -117.78 106.82 13.43 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.574 -1.194 . . . . 1.33 110.443 -162.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.57 ' O ' HD11 ' A' ' 180' ' ' LEU . 51.8 m -105.67 150.81 25.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.67 -0.695 . . . . 1.02 112.328 -169.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.874 ' CD1' HD12 ' A' ' 119' ' ' ILE . 18.5 m-85 -115.56 106.66 14.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.32 -1.309 . . . . 0.44 112.71 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.457 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 34.5 t70 -95.96 103.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.886 0.374 . . . . 0.74 111.173 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 80.67 -118.44 4.65 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.259 -0.972 . . . . 0.28 112.602 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 118' ' ' THR . 3.4 t70 -111.31 12.82 21.65 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.578 -1.638 . . . . 1.61 106.578 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.661 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 25.4 p80 -133.8 161.05 35.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.546 -1.207 . . . . 2.16 111.694 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.57 HD11 ' O ' ' A' ' 174' ' ' THR . 7.6 tp -69.14 135.35 50.56 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.706 -1.134 . . . . 1.05 110.423 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.457 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -85.78 -50.87 6.81 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.289 -1.323 . . . . 1.03 110.946 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -179.08 177.09 0.83 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.065 -0.97 . . . . 1.09 110.727 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -150.18 121.54 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.488 -1.671 . . . . 1.04 106.488 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.737 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 72.1 t -131.63 122.18 49.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.563 0.579 . . . . 1.15 112.563 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -59.1 99.11 0.05 OUTLIER 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.001 -1.111 . . . . 2.01 108.001 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 82.4 mtp -55.6 -22.9 24.41 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 112.606 -2.088 . . . . 2.01 112.179 -169.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.485 ' HG3' HG11 ' A' ' 169' ' ' VAL . 2.7 mt-10 -66.47 -45.69 78.84 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.098 -1.41 . . . . 0.68 110.603 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.71 -20.0 13.76 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.399 -1.273 . . . . 2.66 111.668 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.737 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.6 p30 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 113.581 0.956 . . . . 2.15 113.581 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 1.11 108.938 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.835 HD12 ' CD1' ' A' ' 175' ' ' PHE . 6.2 pt -131.01 172.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 122.374 1.083 . . . . 1.07 112.452 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.71 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 7.4 m -111.9 171.32 7.57 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.547 -1.66 . . . . 1.71 110.031 -173.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 124' ' ' MET . 63.9 mttm -49.27 -54.49 16.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.093 0.473 . . . . 3.81 111.885 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 20.9 t-20 -82.51 -15.81 51.04 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.956 -0.387 . . . . 2.18 109.956 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.885 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.6 mt-10 -64.58 -24.88 67.74 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.149 -0.621 . . . . 0.5 110.19 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.612 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -85.59 -28.36 24.89 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.327 -1.349 . . . . 3.61 109.769 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -32.69 55.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.453 1.12 . . . . 1.12 111.684 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.57 -42.35 29.43 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.493 -1.23 . . . . 2.07 109.917 169.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.885 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.41 -38.51 84.26 Favored 'General case' 0 CA--C 1.463 -2.399 0 CA-C-O 117.429 -1.272 . . . . 1.14 114.101 -173.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.668 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.47 -40.93 98.23 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 116.329 -2.148 . . . . 1.06 108.717 177.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.64 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.4 mm-40 -66.87 -32.24 73.37 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.098 1.427 . . . . 2.51 108.589 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -84.98 -7.53 59.11 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 111.911 -2.404 . . . . 1.06 110.296 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 128' ' ' LEU . 12.0 t -121.46 1.71 10.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.214 1.007 . . . . 1.12 108.744 -176.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 70.95 54.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.238 -1.801 . . . . 2.86 112.109 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.65 143.27 23.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.202 -1.407 . . . . 0.88 107.202 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.657 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -143.2 162.38 35.75 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.088 -1.449 . . . . 0.92 107.088 -178.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -52.39 158.28 1.25 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.232 1.015 . . . . 2.42 112.059 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -147.04 152.32 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-N 114.002 -1.454 . . . . 1.08 111.903 -168.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 m -59.61 -49.65 76.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 1.17 111.544 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.583 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -158.54 113.55 2.58 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.982 -1.463 . . . . 1.24 108.627 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.771 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.78 106.18 14.41 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.851 1.31 . . . . 3.14 111.056 -168.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.834 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.7 t -157.45 93.94 1.34 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.942 -1.481 . . . . 1.11 109.171 162.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.834 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.0 mmt180 -152.15 170.0 8.66 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 113.145 -1.843 . . . . 2.98 107.779 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -81.88 111.71 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 CA-C-N 119.755 0.948 . . . . 1.1 110.299 162.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.64 72.85 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.575 -0.821 . . . . 0.38 114.345 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.434 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 3.2 mm-40 -127.78 130.84 49.39 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.799 -1.556 . . . . 1.49 106.799 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.759 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -133.97 176.71 8.33 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.868 -1.133 . . . . 0.38 110.638 -168.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.771 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 15.3 p -112.86 139.86 48.13 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.657 0.742 . . . . 1.09 111.799 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.658 HG21 ' HH ' ' A' ' 133' ' ' TYR . 39.3 t -98.65 141.37 16.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.097 -1.411 . . . . 1.62 111.065 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 151' ' ' SER . 10.0 tt0 -124.95 -78.73 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.833 -0.167 . . . . 2.74 110.956 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.76 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.612 0.244 . . . . 1.13 111.183 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.416 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 85.8 m-20 -81.72 -1.19 46.14 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.324 -0.621 . . . . 1.6 109.324 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 15.1 m -140.63 144.73 35.92 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.69 -0.686 . . . . 1.37 110.045 172.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 153' ' ' GLU . 5.6 mt -106.88 172.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.728 -1.212 . . . . 1.05 107.728 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.0 tt0 -118.87 135.2 54.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.512 -1.662 . . . . 0.97 106.512 166.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.47 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -136.19 127.11 27.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.111 0.868 . . . . 1.97 111.893 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 116.072 -0.513 . . . . 1.09 110.813 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 170' ' ' ARG . 71.8 t . . . . . 0 CA--C 1.487 -1.46 0 N-CA-C 107.986 -1.116 . . . . 1.23 107.986 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.799 ' N ' HG13 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -125.31 144.4 50.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.337 1.065 . . . . 2.3 113.862 177.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -114.69 164.92 13.38 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.162 -1.836 . . . . 1.04 110.737 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.46 122.78 43.57 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.815 -1.18 . . . . 4.19 107.815 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.609 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.75 121.24 41.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 113.922 -1.49 . . . . 1.33 110.575 -161.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.552 ' O ' HD12 ' A' ' 180' ' ' LEU . 54.3 m -114.62 151.83 32.85 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.307 0.484 . . . . 1.02 112.307 -170.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.835 ' CD1' HD12 ' A' ' 119' ' ' ILE . 18.4 m-85 -116.16 100.08 7.68 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.747 -1.115 . . . . 0.44 113.375 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.548 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 27.1 t70 -92.22 99.38 12.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.74 111.325 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.69 -113.72 3.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.954 -1.117 . . . . 0.28 113.948 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' THR . 0.9 OUTLIER -111.74 8.07 20.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.016 -1.475 . . . . 1.61 107.016 -177.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 20.9 p80 -138.6 161.7 36.45 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.025 -1.443 . . . . 2.16 111.786 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 174' ' ' THR . 8.7 tp -67.41 137.28 55.81 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.705 -1.134 . . . . 1.05 110.464 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.548 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -87.33 -49.67 7.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.572 -1.195 . . . . 1.03 111.44 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.6 t 179.46 177.92 0.55 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.195 -0.911 . . . . 1.09 110.277 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.578 ' CG1' HD11 ' A' ' 173' ' ' LEU . 2.1 mp -153.02 128.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 105.767 -1.938 . . . . 1.04 105.767 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.0 t -129.58 118.11 44.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 120.172 -0.611 . . . . 1.15 112.146 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.486 HD21 ' HB2' ' A' ' 171' ' ' ALA . 11.2 m120 -60.5 96.58 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.554 -1.276 . . . . 2.01 107.554 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.85 -19.07 15.48 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 113.157 -1.838 . . . . 2.01 112.971 -166.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.462 ' HG3' HG12 ' A' ' 169' ' ' VAL . 4.1 mt-10 -73.32 -43.18 61.33 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 114.342 -1.299 . . . . 0.68 109.961 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -91.93 -34.14 14.6 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.681 -1.599 . . . . 2.66 111.174 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.669 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.6 p30 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 115.216 1.561 . . . . 2.15 115.216 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 178' ' ' ASP . 24.7 m . . . . . 0 N--CA 1.438 -1.066 0 CA-C-O 121.529 0.68 . . . . 1.11 110.455 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 175' ' ' PHE . 5.0 pt -137.2 172.25 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.675 -1.148 . . . . 1.07 110.853 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.701 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.5 t -121.63 173.33 7.5 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.191 -1.368 . . . . 1.71 109.482 -172.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.551 ' O ' ' HG3' ' A' ' 124' ' ' MET . 59.0 tttm -51.51 -48.62 62.89 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.782 0.325 . . . . 3.81 111.645 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.442 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 28.5 t-20 -82.4 -18.24 42.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.844 -0.428 . . . . 2.18 109.844 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.874 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -68.8 -24.32 64.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.927 -0.709 . . . . 0.5 109.785 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.654 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.98 -29.07 23.82 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 118.337 -1.345 . . . . 3.61 109.598 177.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.81 -32.56 54.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.259 1.028 . . . . 1.12 112.052 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.743 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.04 -43.44 29.31 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.607 -1.178 . . . . 2.07 109.68 169.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.874 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.29 -37.28 82.62 Favored 'General case' 0 CA--C 1.461 -2.449 0 CA-C-O 117.539 -1.219 . . . . 1.14 113.929 -172.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.661 ' CD2' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.34 -41.13 98.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 116.211 -2.196 . . . . 1.06 108.832 176.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.661 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.7 mm-40 -67.47 -31.03 70.9 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.924 1.345 . . . . 2.51 108.577 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -84.6 -7.94 59.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 111.964 -2.38 . . . . 1.06 110.011 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' LEU . 11.5 t -121.98 1.26 9.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.149 -0.932 . . . . 1.12 108.872 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 72.94 55.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.62 -1.627 . . . . 2.86 112.466 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.671 ' HH ' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -152.15 143.76 23.52 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 106.551 -1.648 . . . . 0.88 106.551 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.74 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -142.85 159.89 41.37 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 106.833 -1.543 . . . . 0.92 106.833 -174.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -48.05 145.96 2.81 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.11 0.957 . . . . 2.42 112.559 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -136.08 152.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 CA-C-N 113.773 -1.558 . . . . 1.08 111.63 -173.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -60.48 -49.81 76.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.359 -0.837 . . . . 1.17 111.591 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -156.9 115.74 3.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.207 -1.36 . . . . 1.24 109.099 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.714 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 2.4 ppp? -77.69 103.11 7.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 123.255 1.502 . . . . 3.14 110.917 -168.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.85 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.0 t -158.65 92.21 1.11 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.466 -1.697 . . . . 1.11 108.936 158.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.85 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.9 mmt180 -152.51 149.5 22.81 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 113.749 -1.569 . . . . 2.98 106.942 174.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.73 110.59 2.15 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 CA-C-N 120.454 1.198 . . . . 1.1 109.821 169.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.06 59.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.534 -0.841 . . . . 0.38 114.222 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 33.8 mt-10 -138.64 131.88 30.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.647 -1.242 . . . . 1.49 107.647 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.84 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -132.7 176.14 8.71 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.558 -0.857 . . . . 0.38 110.691 -166.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.714 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 10.4 p -112.6 139.46 48.18 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.91 0.862 . . . . 1.09 112.038 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.671 HG23 ' HH ' ' A' ' 133' ' ' TYR . 50.0 t -100.01 139.66 21.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 1.62 111.201 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.616 ' HB2' ' O ' ' A' ' 151' ' ' SER . 56.3 mt-30 -124.12 -94.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.543 -0.299 . . . . 2.74 110.858 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.89 -77.76 0.07 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.729 0.3 . . . . 1.13 111.184 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.18 -4.44 59.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.131 0.491 . . . . 1.6 109.704 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 5.6 m -145.43 146.3 31.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.828 -0.623 . . . . 1.37 109.845 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.626 ' CG2' HD22 ' A' ' 173' ' ' LEU . 4.3 mt -106.36 165.9 3.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.316 -1.365 . . . . 1.05 107.316 167.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.84 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 7.1 tt0 -115.57 129.02 56.38 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.255 -1.387 . . . . 0.97 107.255 169.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.442 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.86 124.93 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.613 0.642 . . . . 1.97 112.393 -177.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.865 0.365 . . . . 1.09 110.17 173.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.782 HG12 ' N ' ' A' ' 170' ' ' ARG . 46.8 t . . . . . 0 CA--C 1.493 -1.214 0 N-CA-C 108.787 -0.82 . . . . 1.23 108.787 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.782 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -124.46 145.8 49.3 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.469 1.128 . . . . 2.3 113.218 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.04 167.59 10.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.084 -1.871 . . . . 1.04 110.807 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.474 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 45.2 ttt180 -117.97 109.43 16.48 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.414 -1.328 . . . . 4.19 107.414 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.626 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -100.0 112.34 24.63 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.529 -1.669 . . . . 1.33 109.665 -170.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 180' ' ' LEU . 86.5 m -109.06 150.46 27.78 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.541 0.571 . . . . 1.02 112.541 -168.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.896 ' CD1' HD12 ' A' ' 119' ' ' ILE . 11.5 m-85 -115.14 114.66 25.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.43 -1.259 . . . . 0.44 111.88 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -99.67 96.09 7.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.74 110.7 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.11 -115.49 4.03 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.268 -0.968 . . . . 0.28 113.511 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.527 ' O ' HG21 ' A' ' 118' ' ' THR . 1.2 t70 -110.75 11.09 22.63 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.681 -1.6 . . . . 1.61 106.681 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.6 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 28.2 p80 -141.06 161.03 38.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.229 -1.351 . . . . 2.16 111.644 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 173' ' ' LEU . 7.0 tp -64.81 144.39 57.29 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.309 -0.859 . . . . 1.05 111.654 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.1 -50.56 5.24 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.193 -1.367 . . . . 1.03 111.544 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.3 t 175.3 178.18 0.16 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.33 -0.85 . . . . 1.09 109.513 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 173' ' ' LEU . 3.2 mp -145.55 129.13 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.875 -1.528 . . . . 1.04 106.875 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.804 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 67.6 t -133.01 116.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.66 0.615 . . . . 1.15 112.66 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' HB1' ' A' ' 171' ' ' ALA . 10.9 m120 -60.8 97.74 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.333 1.063 . . . . 2.01 108.17 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 84.1 mtp -56.29 -22.7 31.87 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 112.168 -2.287 . . . . 2.01 112.951 -165.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.566 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.1 mt-10 -66.49 -43.5 85.2 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.721 -1.127 . . . . 0.68 110.639 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -98.48 -30.86 12.29 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.152 -1.385 . . . . 2.66 110.813 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.804 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.1 t30 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 113.474 0.916 . . . . 2.15 113.474 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 178' ' ' ASP . 22.7 m . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 108.983 -0.747 . . . . 1.11 108.983 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.834 HD13 ' CD1' ' A' ' 175' ' ' PHE . 7.6 pt -126.53 171.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.097 0.951 . . . . 1.07 111.283 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.708 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 19.4 t -114.05 170.2 8.45 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.831 -1.532 . . . . 1.71 109.319 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -52.66 -48.75 66.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 3.81 111.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 46.1 m-80 -83.86 -15.39 48.32 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.669 -0.241 . . . . 2.18 110.616 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.939 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.6 mt-10 -65.98 -24.14 66.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.277 -0.569 . . . . 0.5 110.471 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.544 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.27 -26.5 24.95 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.764 -1.174 . . . . 3.61 110.058 178.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.473 HG21 ' SD ' ' A' ' 124' ' ' MET . 2.0 t -65.16 -28.69 45.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.796 -1.093 . . . . 1.12 111.349 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.744 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -81.67 -38.53 25.73 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.642 -1.163 . . . . 2.07 110.177 171.157 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.939 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -56.17 -44.09 79.0 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 114.643 1.349 . . . . 1.14 114.643 -175.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.883 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -61.07 -39.78 91.19 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 116.778 -1.969 . . . . 1.06 109.374 177.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 21.9 mt-10 -65.6 -28.98 69.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.7 1.238 . . . . 2.51 108.088 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -92.06 -7.83 47.61 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 112.848 -1.978 . . . . 1.06 110.977 -170.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.1 t -122.13 -2.38 9.14 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.558 0.694 . . . . 1.12 109.996 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 71.07 56.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.703 -1.589 . . . . 2.86 111.829 -177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.883 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.62 146.34 27.24 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.198 -1.779 . . . . 0.88 106.198 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.666 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.09 163.81 35.09 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.668 -1.234 . . . . 0.92 107.668 -176.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -48.97 159.33 0.26 Allowed 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.404 1.097 . . . . 2.42 112.3 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.61 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.9 t -148.43 151.83 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-N 113.557 -1.656 . . . . 1.08 111.093 -172.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 m -60.19 -50.12 74.92 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.987 0.899 . . . . 1.17 111.37 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -159.06 115.76 2.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.879 -1.509 . . . . 1.24 108.424 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.743 ' CE ' ' HB3' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -83.71 108.14 16.59 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.79 1.281 . . . . 3.14 110.708 -167.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.819 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -157.33 93.95 1.35 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.649 -1.614 . . . . 1.11 108.55 161.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.9 mmt180 -151.98 170.17 8.37 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 113.352 -1.749 . . . . 2.98 107.589 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.16 111.75 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 CA-C-N 119.868 0.989 . . . . 1.1 110.478 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.8 22.69 65.88 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.824 -0.703 . . . . 0.38 114.217 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -132.22 132.56 43.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.92 -1.511 . . . . 1.49 106.92 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.851 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.4 m-85 -133.42 173.83 11.06 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.89 -1.124 . . . . 0.38 110.507 -167.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.736 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 7.7 p -112.53 136.39 52.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.276 0.56 . . . . 1.09 109.953 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.476 HG23 HG12 ' A' ' 152' ' ' ILE . 1.2 p -111.41 143.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.097 -0.956 . . . . 1.62 111.803 -171.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -129.16 -85.14 0.56 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.398 -0.364 . . . . 2.74 111.501 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.1 -83.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.141 0.423 . . . . 1.13 112.141 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.479 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 48.3 m-80 -88.24 -5.55 58.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.444 0.64 . . . . 1.6 109.709 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.9 m -143.22 146.78 33.96 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.154 -0.618 . . . . 1.37 109.643 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 153' ' ' GLU . 8.8 mt -114.48 168.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.552 -0.907 . . . . 1.05 108.552 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.851 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 20.8 tt0 -111.49 132.71 54.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.728 -1.582 . . . . 0.97 106.728 167.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.1 tmt? -134.71 124.48 25.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 118.691 0.678 . . . . 1.97 111.151 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.09 111.283 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.692 HG12 ' N ' ' A' ' 170' ' ' ARG . 71.7 t . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 107.775 -1.194 . . . . 1.23 107.775 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.743 ' HB3' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -106.5 150.15 26.39 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.986 0.898 . . . . 2.3 112.445 176.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -124.97 159.33 31.5 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 113.443 -1.708 . . . . 1.04 111.313 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.813 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.4 tpt180 -108.02 101.24 10.5 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.819 -1.178 . . . . 4.19 107.819 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.53 HD11 HD13 ' A' ' 180' ' ' LEU . 0.2 OUTLIER -93.68 113.55 25.65 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 112.988 -1.915 . . . . 1.33 110.115 -170.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.502 ' O ' HD12 ' A' ' 180' ' ' LEU . 52.6 m -112.5 148.79 33.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.654 0.613 . . . . 1.02 112.654 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.834 ' CD1' HD13 ' A' ' 119' ' ' ILE . 8.2 m-85 -116.35 112.68 21.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.011 -0.995 . . . . 0.44 111.807 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.541 ' N ' ' HB1' ' A' ' 181' ' ' ALA . 21.8 t70 -102.35 95.68 6.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.067 0.46 . . . . 0.74 110.537 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.44 -114.02 3.76 Favored Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.17 -1.014 . . . . 0.28 114.187 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.57 ' O ' HG21 ' A' ' 118' ' ' THR . 7.6 p-10 -105.75 5.0 30.56 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 108.07 -1.085 . . . . 1.61 108.07 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.675 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 21.8 p80 -141.58 160.2 40.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.604 -1.18 . . . . 2.16 112.517 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 173' ' ' LEU . 9.5 tp -65.99 134.6 53.26 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 114.391 -1.277 . . . . 1.05 109.698 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.541 ' HB1' ' N ' ' A' ' 176' ' ' ASP . . . -86.36 -48.28 8.61 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 114.387 -1.279 . . . . 1.03 111.122 -175.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.412 HG23 ' HB ' ' A' ' 174' ' ' THR . 6.2 t 175.76 177.96 0.19 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.044 -0.98 . . . . 1.09 110.386 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 173' ' ' LEU . 2.1 mp -149.38 122.51 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.999 -1.482 . . . . 1.04 106.999 175.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.678 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 97.0 t -127.09 123.66 62.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 118.965 -0.541 . . . . 1.15 112.279 -170.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.52 94.18 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.777 0.799 . . . . 2.01 109.379 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.813 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 50.2 mmm -43.22 -37.87 2.31 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 112.734 -2.03 . . . . 2.01 112.752 -172.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.465 ' HG3' HG11 ' A' ' 169' ' ' VAL . 4.3 mt-10 -63.19 -40.53 97.78 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 113.488 -1.687 . . . . 0.68 111.224 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -101.68 -30.58 11.25 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.896 -1.502 . . . . 2.66 111.471 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.678 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 14.4 p30 . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 125.141 1.376 . . . . 2.15 114.512 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 179' ' ' HIS . 15.7 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.039 -0.726 . . . . 1.11 109.039 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.868 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.8 pt -129.76 172.67 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.227 1.013 . . . . 1.07 112.0 -171.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.709 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.6 m -114.64 173.79 6.29 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.709 -1.587 . . . . 1.71 110.215 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.618 ' O ' ' HG3' ' A' ' 124' ' ' MET . 2.5 mppt? -51.58 -53.1 41.74 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.343 0.402 . . . . 3.81 111.962 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 m-20 -82.93 -15.26 52.05 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.624 -0.262 . . . . 2.18 110.71 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.903 ' O ' HD12 ' A' ' 127' ' ' LEU . 3.0 mt-10 -65.36 -23.72 67.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.002 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.653 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.28 -29.56 24.48 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 118.474 -1.29 . . . . 3.61 110.057 178.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.17 -31.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.466 1.127 . . . . 1.12 111.833 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.737 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.93 -42.51 23.9 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.169 -1.378 . . . . 2.07 109.73 170.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.903 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.53 -38.49 84.6 Favored 'General case' 0 CA--C 1.462 -2.424 0 CA-C-O 117.523 -1.227 . . . . 1.14 114.067 -173.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.715 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.57 -39.82 94.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 116.153 -2.219 . . . . 1.06 108.72 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 63.1 mm-40 -68.82 -30.68 69.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 123.04 1.4 . . . . 2.51 108.923 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -85.41 -7.6 58.85 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 111.857 -2.429 . . . . 1.06 110.23 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 128' ' ' LEU . 11.9 t -121.77 -3.94 9.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.245 -0.889 . . . . 1.12 109.387 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 131' ' ' THR . 49.1 mt-30 79.96 55.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 113.757 -1.565 . . . . 2.86 112.235 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.738 ' OH ' HG21 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -154.28 146.5 23.79 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.886 -1.524 . . . . 0.88 106.886 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.631 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -144.52 161.33 39.35 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.371 -1.714 . . . . 0.92 106.371 -177.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.24 159.4 1.94 Allowed 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 119.281 0.946 . . . . 2.42 112.029 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.466 HG12 ' CG2' ' A' ' 146' ' ' THR . 2.4 t -145.91 155.82 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-N 114.19 -1.368 . . . . 1.08 112.019 -168.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.2 m -59.51 -51.15 71.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.05 0.929 . . . . 1.17 111.639 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.3 ptmt -159.78 114.51 2.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 113.931 -1.486 . . . . 1.24 108.117 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.754 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.89 105.08 11.85 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 123.035 1.398 . . . . 3.14 111.24 -166.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.819 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.0 t -157.41 94.25 1.37 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.558 -1.655 . . . . 1.11 108.47 162.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 140' ' ' THR . 7.6 mmt180 -151.44 168.02 11.93 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 113.477 -1.692 . . . . 2.98 107.158 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.45 111.69 2.63 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 CA-C-N 119.897 0.999 . . . . 1.1 109.899 164.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.81 27.76 58.11 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.2 -1.0 . . . . 0.38 113.902 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.9 mt-10 -140.85 131.25 25.21 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.407 -1.331 . . . . 1.49 107.407 172.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.755 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -133.88 176.35 8.65 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.419 -0.913 . . . . 0.38 110.511 -167.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.754 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 17.3 p -113.09 137.54 51.28 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.962 0.886 . . . . 1.09 112.505 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.428 HG23 ' HH ' ' A' ' 133' ' ' TYR . 51.6 t -97.62 138.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.451 -1.704 . . . . 1.62 111.12 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' A' ' 151' ' ' SER . 16.6 mm100 -123.14 -90.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.935 -0.12 . . . . 2.74 110.972 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.79 -87.31 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.653 0.263 . . . . 1.13 111.337 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -82.98 -3.14 56.84 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.062 0.458 . . . . 1.6 109.786 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 20.4 m -141.33 146.13 36.32 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.371 -0.532 . . . . 1.37 110.357 172.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.738 HG21 ' OH ' ' A' ' 133' ' ' TYR . 5.6 mt -107.26 170.66 2.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.351 -1.351 . . . . 1.05 107.351 168.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.755 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.6 tt0 -116.33 136.26 53.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.764 -1.569 . . . . 0.97 106.764 165.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.453 ' C ' ' HE2' ' A' ' 139' ' ' MET . 1.1 tmt? -136.5 124.81 23.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 118.592 0.633 . . . . 1.97 112.367 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.594 -0.521 . . . . 1.09 109.594 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.765 HG11 ' N ' ' A' ' 170' ' ' ARG . 89.9 t . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 109.166 -0.679 . . . . 1.23 109.166 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.765 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -126.41 144.9 50.68 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.197 0.999 . . . . 2.3 113.165 177.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 167.67 10.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.313 -1.767 . . . . 1.04 110.517 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.729 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 48.2 ttp180 -116.22 122.74 45.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.419 -1.326 . . . . 4.19 107.419 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.675 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -112.11 110.53 20.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.288 -1.324 . . . . 1.33 110.203 -164.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.546 ' O ' HD12 ' A' ' 180' ' ' LEU . 51.9 m -107.64 150.25 27.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.229 0.538 . . . . 1.02 112.308 -169.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.6 m-85 -115.66 102.46 9.77 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.566 -1.197 . . . . 0.44 113.212 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.514 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 31.0 t70 -92.11 101.65 14.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.85 0.357 . . . . 0.74 110.972 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.66 -117.21 4.36 Favored Glycine 0 C--N 1.318 -0.461 0 C-N-CA 120.048 -1.072 . . . . 0.28 113.485 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 118' ' ' THR . 1.6 t70 -110.66 10.61 22.85 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.5 -1.667 . . . . 1.61 106.5 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 24.4 p80 -137.89 161.66 36.06 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.287 -1.324 . . . . 2.16 112.083 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 174' ' ' THR . 8.5 tp -68.19 136.38 53.53 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.607 -1.178 . . . . 1.05 110.502 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.46 -50.06 6.79 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.392 -1.276 . . . . 1.03 111.364 -176.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.6 t 179.23 178.4 0.49 Allowed 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.036 -0.984 . . . . 1.09 109.903 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.573 ' CG1' HD12 ' A' ' 173' ' ' LEU . 2.6 mp -147.89 112.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 106.459 -1.682 . . . . 1.04 106.459 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.743 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -115.16 129.8 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 113.15 0.796 . . . . 1.15 113.15 -169.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 188' ' ' ASN . 25.1 p-10 -60.07 95.52 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.108 0.956 . . . . 2.01 109.693 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 66.6 mmm -51.47 -25.61 6.78 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 113.37 -1.741 . . . . 2.01 112.949 -169.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.405 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.6 mt-10 -68.26 -42.6 79.36 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.452 -1.249 . . . . 0.68 110.635 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.406 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 5.5 t-20 -103.49 -25.73 13.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.707 -1.588 . . . . 2.66 111.663 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.743 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 10.3 p30 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 114.843 1.423 . . . . 2.15 114.843 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.676 0.274 . . . . 31.29 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.1 173.95 13.18 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.695 -0.764 . . . . 30.78 112.355 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m 63.28 38.61 10.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.246 0.546 . . . . 30.69 111.943 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.5 t -148.75 66.05 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.228 -0.656 . . . . 29.95 109.228 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -74.32 -30.6 62.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.373 -0.83 . . . . 29.85 110.143 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.33 123.17 3.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.479 -0.782 . . . . 30.29 109.446 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -67.36 -36.93 82.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 28.16 110.638 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -91.7 112.14 23.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.199 0.523 . . . . 26.24 110.196 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -108.5 152.58 24.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.764 -0.653 . . . . 26.48 110.559 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -82.02 80.94 8.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 26.97 110.831 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.5 m -61.58 109.04 1.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.684 -0.689 . . . . 24.89 110.234 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -81.23 79.99 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.072 0.463 . . . . 24.15 110.446 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -72.82 1.28 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.763 -0.732 . . . . 22.8 111.823 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 98.3 mt -113.18 17.1 18.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.841 0.353 . . . . 21.12 110.827 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.487 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 60.0 t -63.46 -54.02 47.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.85 -0.34 . . . . 20.12 110.442 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 72.5 Cg_endo -77.44 129.64 10.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.334 1.356 . . . . 19.33 111.643 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 43.01 50.74 5.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.137 0.975 . . . . 19.37 112.674 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.14 -39.12 91.78 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.007 -0.616 . . . . 15.69 112.362 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 m 60.5 54.94 3.6 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.753 0.421 . . . . 14.22 111.959 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -84.6 -23.27 29.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.432 -0.349 . . . . 13.16 110.24 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 67.3 mtm 66.03 -79.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.487 -0.779 . . . . 12.29 112.126 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -143.45 -151.38 5.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.965 -0.636 . . . . 8.13 111.853 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.3 ttp85 -85.06 71.96 10.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.343 0.592 . . . . 9.83 110.356 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.7 ptm -136.0 21.7 3.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.711 1.243 . . . . 6.46 108.05 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.72 148.94 15.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.151 -1.841 . . . . 5.19 109.083 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -66.66 145.59 55.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.309 -0.405 . . . . 4.9 110.292 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.554 HD12 ' HG2' ' A' ' 154' ' ' MET . 2.8 tm? -63.82 131.51 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.735 -0.666 . . . . 1.91 109.524 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HG2' ' HD2' ' A' ' 115' ' ' PRO . 5.0 tt0 -178.35 156.17 0.99 Allowed Pre-proline 0 CA--C 1.509 -0.606 0 N-CA-C 106.081 -1.822 . . . . 3.45 106.081 -170.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.447 ' HD2' ' HG2' ' A' ' 114' ' ' GLU . 60.2 Cg_endo -90.97 103.24 0.26 Allowed 'Trans proline' 0 N--CA 1.428 -2.349 0 CA-C-N 121.823 1.687 . . . . 3.73 113.405 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 7.8 p-10 -111.7 -2.81 15.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 103.041 -2.948 . . . . 3.24 103.041 141.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.556 ' HG3' HG22 ' A' ' 119' ' ' ILE . 26.3 tpp -84.55 143.84 29.05 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 110.803 -2.908 . . . . 2.04 112.085 -160.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 18.3 m -129.27 97.89 4.72 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.116 -0.947 . . . . 1.11 109.511 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.802 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.09 171.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.098 -0.956 . . . . 1.07 110.829 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.74 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 p -120.39 179.19 4.38 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.411 -0.813 . . . . 1.71 110.644 -172.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 124' ' ' MET . 87.3 tttt -53.62 -40.22 65.59 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.485 0.491 . . . . 3.81 111.343 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.543 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 8.0 m-20 -82.56 -24.04 34.18 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 116.602 -0.272 . . . . 2.18 111.246 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 25.0 mt-10 -68.99 -34.0 74.58 Favored 'General case' 0 N--CA 1.41 -2.447 0 C-N-CA 117.826 -1.55 . . . . 0.5 109.34 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.611 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.81 -33.65 76.07 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 119.008 -1.077 . . . . 3.61 109.362 177.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.455 ' O ' HD23 ' A' ' 128' ' ' LEU . 1.8 t -66.25 -31.64 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.276 -0.874 . . . . 1.12 112.087 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.79 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -85.81 -32.82 21.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.724 -0.671 . . . . 2.07 110.779 173.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.692 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.14 -46.75 87.56 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 114.962 1.467 . . . . 1.14 114.962 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.797 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -58.98 -38.03 78.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.711 -1.996 . . . . 1.06 109.164 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.5 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 30.1 mt-10 -65.86 -32.43 73.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.652 1.215 . . . . 2.51 107.954 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -88.62 -7.74 55.86 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 112.599 -2.091 . . . . 1.06 110.948 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.5 t -122.06 1.18 9.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.22 -0.9 . . . . 1.12 109.275 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 66.56 56.87 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.535 -1.666 . . . . 2.86 111.867 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.797 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.98 147.22 27.6 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.972 -1.492 . . . . 0.88 106.972 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.62 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.01 154.65 42.75 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.003 -1.11 . . . . 0.92 108.003 -173.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -47.45 144.61 2.91 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.794 0.807 . . . . 2.42 112.339 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.11 150.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.1 -1.409 . . . . 1.08 112.079 -171.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.4 m -59.9 -50.08 75.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.865 -1.062 . . . . 1.17 111.57 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -156.93 116.02 3.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.24 -1.345 . . . . 1.24 108.836 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.808 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.21 102.77 9.65 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.938 -1.483 . . . . 3.14 111.155 -167.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.797 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.4 t -157.29 92.63 1.26 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.395 -1.275 . . . . 1.11 109.535 162.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.797 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -153.94 158.64 32.51 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.903 -1.499 . . . . 2.98 107.519 169.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -75.66 109.76 2.96 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 CA-C-N 120.421 1.186 . . . . 1.1 109.574 167.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.23 2.94 57.86 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.498 -0.858 . . . . 0.38 114.439 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.0 mt-10 -128.84 132.33 47.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.202 1.001 . . . . 1.49 108.609 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.811 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.1 m-85 -133.16 176.24 8.68 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.112 -0.635 . . . . 0.38 110.224 -166.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.808 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 12.3 p -110.12 142.19 41.94 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.711 0.767 . . . . 1.09 111.655 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.547 HG21 ' OH ' ' A' ' 133' ' ' TYR . 41.1 t -100.98 138.76 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.213 -1.358 . . . . 1.62 111.684 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.8 tp-100 -124.96 -87.54 0.61 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.479 -0.328 . . . . 2.74 110.751 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.429 ' O ' ' HE1' ' A' ' 124' ' ' MET . . . -165.39 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.728 0.27 . . . . 1.13 111.728 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.442 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 88.3 m-20 -81.52 -5.15 57.69 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.482 -0.562 . . . . 1.6 109.482 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.647 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 31.0 p -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.674 -0.694 . . . . 1.37 110.043 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.73 HG21 ' OH ' ' A' ' 133' ' ' TYR . 6.0 mt -106.73 170.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.184 -1.413 . . . . 1.05 107.184 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.811 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 24.4 tt0 -116.97 137.3 52.31 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.989 -1.485 . . . . 0.97 106.989 166.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.554 ' HG2' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -133.46 124.67 27.46 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.655 -0.818 . . . . 1.97 112.3 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.93 130.33 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.669 -0.696 . . . . 1.09 109.992 173.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -81.72 145.13 30.66 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.607 -0.516 . . . . 3.55 109.607 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -49.78 115.63 5.32 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 123.679 0.612 . . . . 4.84 110.934 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.35 175.22 10.33 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 123.032 2.488 . . . . 2.01 113.336 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.81 115.82 14.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.78 -1.555 . . . . 5.88 108.762 173.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.564 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 45.8 m-20 -125.89 135.27 51.73 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.123 -0.944 . . . . 5.15 111.48 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.542 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.6 m-30 -118.11 167.51 11.21 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-O 121.787 0.803 . . . . 6.88 110.479 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.1 Cg_endo -75.84 -42.93 0.37 Allowed 'Trans proline' 0 N--CA 1.416 -3.048 0 C-N-CA 122.144 1.896 . . . . 9.11 110.812 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -90.7 -5.58 55.56 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 112.457 -2.156 . . . . 10.53 109.55 -174.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 3.2 m -163.96 139.53 6.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.228 -1.351 . . . . 8.25 112.658 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 160' ' ' ASP . 64.0 mttt -144.38 138.04 27.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.413 0.625 . . . . 7.11 112.044 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -171.96 -170.68 0.78 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.528 -1.215 . . . . 5.04 110.553 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.06 147.76 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.539 -0.755 . . . . 2.35 113.258 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.69 146.65 27.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.507 0.67 . . . . 3.48 109.768 170.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.807 HG11 ' N ' ' A' ' 170' ' ' ARG . 77.1 t -144.93 146.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 CA-C-N 114.734 -1.121 . . . . 1.23 108.406 173.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.807 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -129.74 145.11 51.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.305 1.05 . . . . 2.3 113.234 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.63 163.53 15.65 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.194 -1.821 . . . . 1.04 109.83 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 74.9 ttt180 -111.94 127.15 55.77 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.97 -1.122 . . . . 4.19 107.97 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.638 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -114.84 111.38 21.13 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.402 -1.272 . . . . 1.33 110.682 -165.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 180' ' ' LEU . 96.3 m -109.31 150.49 27.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.347 0.594 . . . . 1.02 112.25 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.802 ' CD1' HD12 ' A' ' 119' ' ' ILE . 12.5 m-85 -115.65 114.09 24.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.358 -1.292 . . . . 0.44 111.853 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.44 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 21.2 t70 -104.63 103.41 13.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.74 111.393 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.82 -113.22 3.61 Favored Glycine 0 C--N 1.314 -0.691 0 C-N-CA 120.054 -1.069 . . . . 0.28 113.409 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 118' ' ' THR . 0.5 OUTLIER -112.51 8.7 19.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.262 -1.384 . . . . 1.61 107.262 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.665 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 19.5 p80 -135.71 160.99 36.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.635 -1.166 . . . . 2.16 112.315 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 174' ' ' THR . 9.2 tp -69.31 130.57 42.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 114.524 -1.216 . . . . 1.05 110.158 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.44 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -80.28 -49.99 10.82 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.426 -1.261 . . . . 1.03 110.821 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 5.9 t -179.99 177.46 0.66 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.903 -1.044 . . . . 1.09 110.94 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.63 ' CG1' HD13 ' A' ' 173' ' ' LEU . 2.9 mp -151.17 128.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.7 -1.963 . . . . 1.04 105.7 173.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.747 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.2 t -133.99 119.47 32.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.015 -0.674 . . . . 1.15 112.207 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 98.59 0.06 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.156 -1.053 . . . . 2.01 108.156 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 75.3 mmm -53.03 -27.26 18.81 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 112.379 -2.192 . . . . 2.01 112.741 -167.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.435 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.9 mt-10 -65.67 -43.04 90.5 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 114.164 -1.38 . . . . 0.68 110.982 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.424 HD21 ' HG3' ' A' ' 191' ' ' GLN . 63.5 t30 -107.14 -19.86 13.48 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.152 -1.385 . . . . 2.66 111.27 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.747 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.2 p30 36.38 43.78 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.253 1.205 . . . . 2.15 114.253 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -150.55 -31.17 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.265 -0.425 . . . . 4.73 111.257 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.424 ' HG3' HD21 ' A' ' 188' ' ' ASN . 94.6 mt-30 -50.37 -57.95 6.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.3 -0.409 . . . . 4.52 111.84 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -87.94 -83.62 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.574 -0.898 . . . . 1.94 108.574 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.5 ' H ' HG23 ' A' ' 184' ' ' VAL . . . 67.13 106.15 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.23 0 CA-C-N 115.485 -0.779 . . . . 1.84 114.593 169.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.593 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 23.2 m-85 -136.83 -173.82 3.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.157 -0.522 . . . . 5.39 110.609 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -79.35 153.81 29.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.454 0.645 . . . . 7.14 112.502 -168.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.51 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -76.4 160.49 29.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.599 -1.182 . . . . 7.18 111.473 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 0.4 OUTLIER -78.71 132.94 37.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.352 -0.84 . . . . 2.04 110.649 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.51 115.6 59.05 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 3.38 110.256 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.74 145.69 94.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.782 2.321 . . . . 5.38 112.335 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.479 -0.772 . . . . 8.41 110.175 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.735 0.302 . . . . 31.29 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -67.98 3.6 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.882 -0.675 . . . . 30.78 111.971 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 m 60.67 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.057 0.543 . . . . 30.69 111.371 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 m 57.62 37.07 27.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.058 0.456 . . . . 29.95 111.202 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -123.08 51.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 29.85 110.146 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.464 ' HB3' ' H ' ' A' ' 93' ' ' HIS . 71.8 m80 65.5 -150.22 0.24 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.825 -0.625 . . . . 30.29 110.705 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.464 ' H ' ' HB3' ' A' ' 92' ' ' HIS . 82.7 m-70 74.49 133.86 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.488 0.715 . . . . 28.16 110.711 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.2 t60 70.75 -63.95 0.39 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.488 -0.778 . . . . 26.24 110.628 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -161.51 -53.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.113 -0.699 . . . . 26.48 109.113 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.3 p80 176.96 -39.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.669 -0.696 . . . . 26.97 109.175 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t 176.56 -179.27 0.17 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.218 -1.401 . . . . 24.89 107.218 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.7 m 56.03 52.78 9.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.103 0.478 . . . . 24.15 111.045 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.21 -7.32 85.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.928 -0.653 . . . . 22.8 112.744 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.26 -44.96 14.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 21.12 110.088 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t 66.75 112.63 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.679 0.612 . . . . 20.12 111.868 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.97 109.91 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.932 2.421 . . . . 19.33 111.687 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 56.13 54.0 8.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.903 -0.589 . . . . 19.37 110.848 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.03 -165.82 17.58 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.603 -0.726 . . . . 15.69 111.478 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.6 p -144.6 171.38 14.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.878 -0.415 . . . . 14.22 109.878 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 58.19 63.86 1.64 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.306 0.574 . . . . 13.16 110.213 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -69.02 -22.64 64.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 12.29 110.607 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.31 -92.75 1.59 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.772 -0.649 . . . . 8.13 111.87 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 65.29 178.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.545 0.688 . . . . 9.83 111.351 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -147.43 29.89 0.94 Allowed 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 122.361 1.077 . . . . 6.46 109.046 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 p -107.64 139.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 113.562 -1.654 . . . . 5.19 109.857 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 112' ' ' ASN . 0.9 OUTLIER -99.09 163.16 12.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.398 -0.365 . . . . 4.9 110.327 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 114' ' ' GLU . 3.6 tt -64.44 136.17 56.82 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.235 -0.654 . . . . 1.91 109.235 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.75 ' N ' HD23 ' A' ' 113' ' ' LEU . 3.5 mt-10 -171.12 161.47 5.4 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 108.628 -0.879 . . . . 3.45 108.628 -174.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 84.2 Cg_endo -90.15 100.17 0.29 Allowed 'Trans proline' 0 N--CA 1.423 -2.635 0 C-N-CA 117.629 -1.114 . . . . 3.73 112.557 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -111.91 -3.77 14.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.6 -3.111 . . . . 3.24 102.6 138.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.535 ' HG3' HG23 ' A' ' 119' ' ' ILE . 28.9 tpp -79.23 138.65 37.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.127 -2.761 . . . . 2.04 111.11 -168.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 179' ' ' HIS . 3.6 m -126.33 104.0 7.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.718 -1.128 . . . . 1.11 108.657 175.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.821 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -133.88 172.49 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-O 122.43 1.109 . . . . 1.07 111.745 -174.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.73 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.9 m -110.49 165.86 11.46 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.53 -1.668 . . . . 1.71 109.138 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -52.12 -48.15 64.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.13 0.49 . . . . 3.81 110.995 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.491 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.5 m120 -81.02 -16.73 52.55 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.967 -0.56 . . . . 2.18 110.151 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.892 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.4 mt-10 -68.23 -25.94 65.46 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.422 0.63 . . . . 0.5 109.98 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.639 ' O ' HD11 ' A' ' 128' ' ' LEU . 8.0 tpt -86.65 -28.14 23.37 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 117.882 -1.527 . . . . 3.61 109.632 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.435 ' HA ' HD13 ' A' ' 128' ' ' LEU . 2.4 t -58.71 -31.28 43.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.308 1.051 . . . . 1.12 111.986 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.717 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -81.69 -42.77 19.42 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.596 -1.184 . . . . 2.07 109.822 170.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.892 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.69 -36.68 81.58 Favored 'General case' 0 CA--C 1.463 -2.367 0 CA-C-O 117.477 -1.249 . . . . 1.14 113.768 -174.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.664 ' CD2' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.0 -40.06 96.64 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 116.356 -2.138 . . . . 1.06 108.631 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.664 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 51.8 mm-40 -68.9 -30.66 69.19 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 123.125 1.441 . . . . 2.51 108.665 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -85.03 -7.56 59.08 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 111.962 -2.381 . . . . 1.06 109.93 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.655 HG21 ' O ' ' A' ' 128' ' ' LEU . 11.8 t -121.62 -2.07 9.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.191 -0.913 . . . . 1.12 108.937 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 77.1 52.73 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 113.523 -1.671 . . . . 2.86 112.482 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.678 ' HH ' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -151.09 143.73 24.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.575 -1.639 . . . . 0.88 106.575 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.667 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -142.45 163.22 33.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.69 -1.596 . . . . 0.92 106.69 -174.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.2 161.75 1.67 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.987 0.899 . . . . 2.42 111.277 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -147.61 153.02 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.243 -1.344 . . . . 1.08 111.718 -168.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -60.04 -49.56 77.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.803 0.811 . . . . 1.17 111.695 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.592 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.95 115.35 2.67 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.212 -1.358 . . . . 1.24 109.027 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.814 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.91 101.23 6.73 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-O 123.286 1.517 . . . . 3.14 111.656 -168.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.834 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.7 t -158.33 93.62 1.23 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.493 -1.685 . . . . 1.11 109.034 161.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.834 ' HD3' ' O ' ' A' ' 140' ' ' THR . 17.6 mmt180 -151.09 164.65 19.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 113.56 -1.655 . . . . 2.98 107.176 174.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.57 110.64 2.45 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 CA-C-N 119.975 1.027 . . . . 1.1 109.903 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.59 5.38 69.19 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.461 -0.876 . . . . 0.38 114.21 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.1 mm-40 -126.62 131.5 51.46 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.331 -1.359 . . . . 1.49 107.331 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.756 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.98 175.93 9.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.08 -1.048 . . . . 0.38 110.648 -166.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.814 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 18.0 p -111.49 142.03 44.29 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.647 0.737 . . . . 1.09 111.945 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.678 HG21 ' HH ' ' A' ' 133' ' ' TYR . 65.8 t -105.76 145.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.231 -1.349 . . . . 1.62 111.676 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -132.46 -87.31 0.45 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.347 -0.141 . . . . 2.74 111.097 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.43 -82.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.587 0.217 . . . . 1.13 111.587 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -82.03 -6.56 59.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 120.834 0.349 . . . . 1.6 110.282 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.5 p -149.92 145.87 26.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.88 -0.728 . . . . 1.37 111.028 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.625 ' CG2' HD22 ' A' ' 173' ' ' LEU . 4.3 mt -109.68 166.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.136 -1.061 . . . . 1.05 108.136 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.756 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 3.2 tp10 -110.81 134.09 52.8 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.693 -1.595 . . . . 0.97 106.693 167.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -131.86 122.38 25.61 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 118.966 0.803 . . . . 1.97 112.425 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.697 HG21 ' O ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -66.93 125.64 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.434 -0.803 . . . . 1.09 109.839 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 169' ' ' VAL . 21.5 tpt180 -65.04 138.2 58.18 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.647 -0.871 . . . . 3.55 108.647 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -60.44 112.67 5.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.129 -0.323 . . . . 4.84 110.129 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 168' ' ' GLN . 15.1 Cg_endo -65.54 172.04 8.56 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.018 2.478 . . . . 2.01 114.164 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.59 151.22 29.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.084 -1.416 . . . . 5.88 110.693 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.547 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 9.7 m-20 -126.66 130.84 51.21 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.595 -0.73 . . . . 5.15 111.104 -174.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.671 ' HB2' ' O ' ' A' ' 164' ' ' SER . 79.1 m-85 -119.48 170.62 6.5 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.577 -0.738 . . . . 6.88 109.719 169.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 3.4 Cg_endo -78.99 -44.57 0.13 Allowed 'Trans proline' 0 N--CA 1.41 -3.397 0 C-N-CA 121.813 1.675 . . . . 9.11 110.932 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -93.36 -3.69 52.89 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.58 -2.1 . . . . 10.53 109.99 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.671 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -164.03 158.44 19.5 Favored 'General case' 0 C--O 1.203 -1.348 0 CA-C-N 114.23 -1.35 . . . . 8.25 110.905 -170.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.56 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 71.2 mttt -147.86 132.31 17.65 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.709 0.686 . . . . 7.11 111.21 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 9.9 pt-20 -168.71 -167.58 0.78 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.336 -0.847 . . . . 5.04 112.096 -165.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.85 57.81 4.32 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 121.018 -0.61 . . . . 2.35 112.034 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 158' ' ' PRO . 6.0 pm0 -91.76 142.6 27.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.307 1.051 . . . . 3.48 111.187 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.823 HG11 ' N ' ' A' ' 170' ' ' ARG . 65.2 t -140.38 151.54 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 CA-C-N 113.605 -1.634 . . . . 1.23 107.613 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.823 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -125.23 145.21 50.09 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 122.326 1.06 . . . . 2.3 113.155 176.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.46 165.24 13.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.21 -1.813 . . . . 1.04 110.333 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.581 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 17.0 tpt180 -115.86 120.04 37.92 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.146 -1.057 . . . . 4.19 108.146 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.625 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.39 118.32 33.52 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.181 -1.372 . . . . 1.33 110.429 -164.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.564 ' O ' HD12 ' A' ' 180' ' ' LEU . 99.5 m -115.31 152.43 32.77 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.574 0.583 . . . . 1.02 112.574 -170.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.821 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.7 m-85 -114.66 109.26 17.95 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.696 -1.138 . . . . 0.44 112.294 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.459 ' HA ' HD21 ' A' ' 197' ' ' LEU . 27.5 t70 -98.87 96.52 7.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.047 0.451 . . . . 0.74 111.211 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.69 -117.43 4.44 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.22 -0.991 . . . . 0.28 113.179 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.501 ' O ' HG21 ' A' ' 118' ' ' THR . 0.5 OUTLIER -110.77 11.04 22.61 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.416 -1.698 . . . . 1.61 106.416 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.665 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 11.8 p-80 -138.0 161.07 37.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.141 -1.391 . . . . 2.16 111.782 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 174' ' ' THR . 9.3 tp -67.98 136.1 53.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.133 -0.94 . . . . 1.05 110.886 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.458 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -84.11 -54.01 5.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.515 -1.22 . . . . 1.03 111.412 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.455 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.0 t -178.91 176.42 0.92 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.368 -0.833 . . . . 1.09 110.496 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.612 ' CG1' HD12 ' A' ' 173' ' ' LEU . 3.0 mp -151.33 124.69 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.949 -1.5 . . . . 1.04 106.949 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.689 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.8 t -129.84 118.1 43.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.422 0.527 . . . . 1.15 112.422 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.89 101.09 0.1 Allowed 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.044 -1.095 . . . . 2.01 108.044 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.3 mmt -58.81 -16.81 18.84 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 112.833 -1.985 . . . . 2.01 112.675 -168.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.7 mt-10 -73.47 -44.35 58.17 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.743 -1.117 . . . . 0.68 110.003 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.65 -33.78 14.94 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.261 -1.336 . . . . 2.66 110.913 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.689 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.9 p30 36.7 32.08 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.218 1.562 . . . . 2.15 115.218 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -138.4 -66.81 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 4.73 110.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -83.93 21.47 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.351 . . . . 4.52 111.556 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -126.58 -6.1 6.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.672 -0.492 . . . . 1.94 109.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.34 -162.7 24.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.828 -0.624 . . . . 1.84 112.097 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.405 ' O ' HG22 ' A' ' 182' ' ' THR . 98.3 m-85 -143.64 148.28 35.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.801 -0.444 . . . . 5.39 109.801 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -87.49 95.62 10.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.086 0.47 . . . . 7.14 110.487 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -134.75 144.2 47.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.958 -0.565 . . . . 7.18 110.396 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 175' ' ' PHE . 0.4 OUTLIER -161.06 123.42 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 2.04 109.108 170.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -138.41 88.59 14.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.644 . . . . 3.38 110.216 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.0 -11.79 5.27 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.731 2.287 . . . . 5.38 112.652 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.399 -0.81 . . . . 8.41 110.035 -177.722 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.009 -0.367 . . . . 31.29 110.009 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.22 59.16 2.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.769 . . . . 30.78 112.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 t -85.88 93.94 9.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.923 -0.399 . . . . 30.69 109.923 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.1 p -97.67 -7.22 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.27 0.557 . . . . 29.95 110.505 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.439 ' NE2' ' HB2' ' A' ' 94' ' ' HIS . 3.7 t60 -124.64 134.31 52.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.585 -0.895 . . . . 29.85 108.585 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -83.38 49.88 1.66 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.07 0.396 . . . . 30.29 112.07 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.4 t60 57.19 83.63 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.794 -0.639 . . . . 28.16 111.706 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.439 ' HB2' ' NE2' ' A' ' 91' ' ' HIS . 29.0 t-80 -77.23 133.87 38.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 26.24 110.331 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -81.85 82.41 7.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.08 -0.509 . . . . 26.48 110.303 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -73.05 -23.0 60.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.26 -0.427 . . . . 26.97 109.934 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 m -70.62 -21.05 62.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.696 . . . . 24.89 110.486 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.3 m -80.62 88.81 5.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.873 -0.603 . . . . 24.15 109.84 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.42 -70.02 0.26 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.564 -0.743 . . . . 22.8 111.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.9 mt 65.37 112.19 0.03 OUTLIER 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.658 0.742 . . . . 21.12 111.782 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.564 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 55.2 t -60.32 -46.56 97.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.966 -1.015 . . . . 20.12 111.533 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 32.1 Cg_endo -64.22 83.27 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.288 1.992 . . . . 19.33 112.465 174.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -78.26 -17.12 57.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.907 -0.588 . . . . 19.37 110.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.08 -47.41 24.2 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.716 -0.754 . . . . 15.69 112.009 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 p -80.9 -29.31 35.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.813 0.339 . . . . 14.22 111.41 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -93.04 92.44 7.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.946 0.403 . . . . 13.16 110.28 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 48.7 ttm -107.91 -45.1 4.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.936 -0.575 . . . . 12.29 110.029 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.49 21.86 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.921 -0.656 . . . . 8.13 112.209 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.89 170.09 17.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.645 0.259 . . . . 9.83 110.395 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -145.2 26.28 1.34 Allowed 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.234 1.016 . . . . 6.46 109.085 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.12 17.64 7.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 113.966 -1.47 . . . . 5.19 110.434 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -110.82 143.09 41.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.983 -0.553 . . . . 4.9 110.576 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 114' ' ' GLU . 5.1 tt -141.44 135.74 30.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.061 -1.089 . . . . 1.91 108.061 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.706 ' N ' HD23 ' A' ' 113' ' ' LEU . 40.5 mt-10 -159.24 162.21 26.29 Favored Pre-proline 0 CA--C 1.501 -0.937 0 N-CA-C 109.116 -0.698 . . . . 3.45 109.116 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.484 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 90.0 Cg_endo -91.16 100.64 0.23 Allowed 'Trans proline' 0 N--CA 1.425 -2.52 0 CA-C-O 122.566 0.986 . . . . 3.73 112.701 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -111.22 -4.38 15.02 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 102.555 -3.128 . . . . 3.24 102.555 139.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.454 ' HB3' HD21 ' A' ' 180' ' ' LEU . 2.7 ttm -78.02 139.42 39.12 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 110.304 -3.135 . . . . 2.04 111.67 -166.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.6 m -128.38 101.64 6.3 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.684 -1.144 . . . . 1.11 108.649 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.886 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.7 pt -133.62 172.47 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.996 0.903 . . . . 1.07 111.227 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.712 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.6 t -117.47 172.18 7.5 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.019 -1.446 . . . . 1.71 109.547 -173.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 124' ' ' MET . 37.5 ttmt -56.0 -45.2 79.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.886 0.374 . . . . 3.81 111.307 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.1 m-20 -83.35 -17.34 42.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 110.249 -0.278 . . . . 2.18 110.249 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.6 mt-10 -69.27 -22.77 63.8 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.124 -0.63 . . . . 0.5 110.46 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.656 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.95 -30.53 22.72 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 118.462 -1.295 . . . . 3.61 109.366 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.5 -30.62 46.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.115 0.959 . . . . 1.12 111.952 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.626 -1.17 . . . . 2.07 109.737 171.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.45 -35.76 78.51 Favored 'General case' 0 CA--C 1.462 -2.423 0 CA-C-O 117.683 -1.151 . . . . 1.14 114.027 -172.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.847 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.5 -43.18 94.9 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 115.915 -2.314 . . . . 1.06 109.093 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.657 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 59.3 mm-40 -65.36 -27.91 68.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.808 1.289 . . . . 2.51 108.635 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -88.78 -8.16 54.92 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.258 -2.246 . . . . 1.06 110.28 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 128' ' ' LEU . 11.1 t -122.46 0.27 9.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.416 -0.811 . . . . 1.12 109.354 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 74.49 54.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.653 -1.612 . . . . 2.86 112.543 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.847 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.16 144.65 24.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.498 -1.667 . . . . 0.88 106.498 178.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.63 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -145.6 164.09 32.77 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.188 -1.782 . . . . 0.92 106.188 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.409 ' CB ' HG13 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.73 160.65 0.28 Allowed 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.207 1.003 . . . . 2.42 112.731 -177.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -148.0 151.57 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 113.946 -1.479 . . . . 1.08 112.015 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.1 m -59.74 -50.02 75.45 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.114 -0.948 . . . . 1.17 111.658 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.59 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.4 ptmt -159.03 117.04 2.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.015 -1.448 . . . . 1.24 108.66 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.816 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.85 100.55 6.39 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 123.504 1.621 . . . . 3.14 111.761 -168.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.839 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 t -158.2 90.99 1.07 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.194 -1.821 . . . . 1.11 108.677 159.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.839 ' HD3' ' O ' ' A' ' 140' ' ' THR . 9.1 mmt180 -153.95 134.51 8.17 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 113.623 -1.626 . . . . 2.98 106.705 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.98 109.25 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 121.353 1.519 . . . . 1.1 109.894 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.26 -1.39 57.42 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.689 -0.767 . . . . 0.38 114.025 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 1.5 mm-40 -125.66 131.7 52.57 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.738 -1.208 . . . . 1.49 107.738 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.87 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -130.85 175.2 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.156 -1.018 . . . . 0.38 110.169 -168.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.816 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 15.5 p -112.63 134.13 54.32 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.572 -0.451 . . . . 1.09 110.623 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.473 HG22 HG12 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -113.51 153.29 15.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.061 -0.972 . . . . 1.62 112.17 -174.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -152.95 -85.32 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.6 0.593 . . . . 2.74 112.6 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.48 -92.01 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.173 0.805 . . . . 1.13 113.173 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.485 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 87.0 m-20 -81.95 -6.99 59.57 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.687 0.28 . . . . 1.6 111.341 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.3 p -150.56 145.75 26.13 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.61 -0.836 . . . . 1.37 110.327 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.543 ' CD1' HD11 ' A' ' 128' ' ' LEU . 6.6 mt -110.04 162.45 7.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.911 -0.774 . . . . 1.05 108.911 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.87 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.4 tp10 -107.6 132.96 52.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.995 -1.483 . . . . 0.97 106.995 167.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.706 ' HG3' ' CE2' ' A' ' 145' ' ' PHE . 3.8 ttt -126.52 124.25 39.62 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.239 -0.585 . . . . 1.97 112.137 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -71.52 132.5 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.139 -0.689 . . . . 1.09 109.139 168.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.532 ' HG2' ' H ' ' A' ' 157' ' ' ARG . 17.4 ttt180 -103.96 -176.73 3.17 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.923 -0.399 . . . . 3.55 109.923 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.532 ' H ' ' HG2' ' A' ' 156' ' ' ARG . 39.5 ttm180 -50.79 125.95 23.16 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 122.553 0.341 . . . . 4.84 111.448 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.84 158.5 55.37 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.519 2.146 . . . . 2.01 111.873 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -140.68 121.35 14.3 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.41 -0.814 . . . . 5.88 110.264 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.533 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 10.8 m-20 -130.33 127.79 40.15 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.843 -1.071 . . . . 5.15 110.164 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.509 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.5 m-30 -120.12 169.68 8.16 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-O 121.956 0.884 . . . . 6.88 111.467 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.4 Cg_endo -75.56 -42.19 0.48 Allowed 'Trans proline' 0 N--CA 1.419 -2.911 0 C-N-CA 122.472 2.115 . . . . 9.11 110.825 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.0 -8.11 52.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 112.222 -2.263 . . . . 10.53 109.509 -174.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.6 m -164.51 140.14 5.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.317 -1.31 . . . . 8.25 112.832 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.533 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 60.3 mttt -144.72 135.31 24.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.819 0.819 . . . . 7.11 113.057 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.82 -27.52 2.54 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.853 -1.521 . . . . 5.04 109.016 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.34 -124.19 6.44 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.024 -1.444 . . . . 2.35 111.851 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -73.76 152.33 40.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.251 0.548 . . . . 3.48 109.702 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.791 HG13 ' N ' ' A' ' 170' ' ' ARG . 66.0 t -134.16 145.79 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 CA-C-N 115.261 -0.882 . . . . 1.23 109.487 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.791 ' N ' HG13 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -131.35 145.37 51.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.345 1.069 . . . . 2.3 113.469 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.56 165.88 12.74 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.993 -1.912 . . . . 1.04 110.921 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.42 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 2.2 tpp180 -115.65 111.89 21.3 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.747 -1.205 . . . . 4.19 107.747 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.539 HD21 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -107.92 118.15 35.99 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.217 -1.811 . . . . 1.33 109.969 -166.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.497 ' O ' HD12 ' A' ' 180' ' ' LEU . 87.5 m -114.43 150.86 34.07 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.762 0.653 . . . . 1.02 112.762 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.886 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.8 m-85 -115.26 112.47 22.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.663 -1.153 . . . . 0.44 112.212 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.522 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 25.8 t70 -102.96 98.48 8.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.965 0.412 . . . . 0.74 110.803 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.67 -120.45 5.28 Favored Glycine 0 C--N 1.317 -0.517 0 C-N-CA 120.085 -1.055 . . . . 0.28 112.85 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 118' ' ' THR . 0.4 OUTLIER -110.74 14.17 22.29 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.829 -1.545 . . . . 1.61 106.829 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.67 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 19.0 p-80 -138.96 159.06 43.04 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.024 -1.444 . . . . 2.16 111.735 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.514 HD13 HD12 ' A' ' 173' ' ' LEU . 9.6 tp -66.36 137.08 56.64 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.055 -0.975 . . . . 1.05 111.01 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.522 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -87.07 -51.48 5.98 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.48 -1.236 . . . . 1.03 111.653 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.558 HG21 ' O ' ' A' ' 194' ' ' PHE . 6.1 t -179.39 176.99 0.78 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.069 -0.969 . . . . 1.09 110.292 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.519 ' CG1' HD13 ' A' ' 173' ' ' LEU . 3.0 mp -151.68 130.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.396 -1.705 . . . . 1.04 106.396 175.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.698 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.9 t -134.24 118.45 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 120.59 -0.444 . . . . 1.15 111.853 -172.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.52 98.64 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.063 -1.088 . . . . 2.01 108.063 171.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -51.48 -25.12 5.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.877 -1.965 . . . . 2.01 112.449 -170.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.08 -40.99 71.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 113.64 -1.618 . . . . 0.68 110.643 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.04 -27.49 13.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.728 -1.578 . . . . 2.66 111.418 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.698 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.9 p-10 35.32 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 115.299 1.592 . . . . 2.15 115.299 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -145.17 -62.29 0.35 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 4.73 109.963 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -75.23 42.09 0.19 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.142 -0.481 . . . . 4.52 111.7 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 183' ' ' ILE . 1.0 OUTLIER -157.15 -35.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 1.94 110.473 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 159.24 -149.32 19.17 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.471 -0.871 . . . . 1.84 112.946 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.558 ' O ' HG21 ' A' ' 182' ' ' THR . 44.0 p90 -157.66 145.84 19.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.476 -0.935 . . . . 5.39 108.476 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -119.38 97.88 5.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.64 0.733 . . . . 7.14 112.06 -172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -136.43 129.48 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.333 -0.849 . . . . 7.18 109.51 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -122.84 135.66 54.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.805 0.336 . . . . 2.04 110.971 -177.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -87.29 110.0 30.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.578 -0.737 . . . . 3.38 110.238 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.59 144.87 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.736 2.291 . . . . 5.38 112.798 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.661 -0.685 . . . . 8.41 109.949 177.196 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.961 0.41 . . . . 31.29 110.337 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.41 134.55 11.73 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.899 -0.667 . . . . 30.78 111.908 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 m -144.16 39.06 1.31 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.226 0.536 . . . . 30.69 110.356 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -97.81 -19.01 18.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.776 -0.647 . . . . 29.95 110.77 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -83.71 126.31 32.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.36 -0.608 . . . . 29.85 109.36 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 69.78 103.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.85 0.719 . . . . 30.29 110.86 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -95.65 143.99 26.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 28.16 110.359 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -92.51 59.33 3.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.595 0.712 . . . . 26.24 110.384 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -75.36 -48.07 24.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.347 -0.842 . . . . 26.48 110.442 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -138.38 -69.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.203 -0.453 . . . . 26.97 110.342 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.2 p -168.03 164.2 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 24.89 110.15 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m 63.54 -166.6 0.22 Allowed 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.518 0.511 . . . . 24.15 111.455 175.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.92 -43.1 1.3 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.938 -0.649 . . . . 22.8 112.242 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.83 100.44 6.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.652 0.263 . . . . 21.12 110.694 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 90.1 t -74.44 -56.25 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.545 -0.298 . . . . 20.12 110.241 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 81.4 Cg_endo -83.74 54.16 4.38 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.011 1.807 . . . . 19.33 111.317 173.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -58.2 -41.06 83.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.847 -0.615 . . . . 19.37 111.162 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.27 54.51 0.31 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.663 -0.78 . . . . 15.69 111.717 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -95.12 71.82 3.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.035 0.445 . . . . 14.22 110.188 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -122.59 152.93 39.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.043 -0.526 . . . . 13.16 110.292 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -101.14 146.03 28.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.312 -0.403 . . . . 12.29 110.126 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.27 112.32 0.66 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.795 -0.717 . . . . 8.13 111.983 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -153.45 138.07 16.9 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.446 -0.576 . . . . 9.83 109.446 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.5 ptm -149.66 31.12 0.72 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.154 0.978 . . . . 6.46 109.884 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.72 140.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.052 -1.431 . . . . 5.19 109.761 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -80.34 153.92 28.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.334 -0.394 . . . . 4.9 110.41 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 114' ' ' GLU . 3.0 tm? -71.94 146.07 48.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.083 -0.508 . . . . 1.91 110.701 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.656 ' N ' HD12 ' A' ' 113' ' ' LEU . 6.0 mt-10 -173.81 -171.2 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 118.481 -0.771 . . . . 3.45 109.236 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 22.0 Cg_exo -41.92 -175.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 124.016 3.144 . . . . 3.73 114.944 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -43.39 28.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 119.448 3.129 . . . . 3.24 119.448 -152.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.874 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.5 OUTLIER -42.27 111.7 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.817 0.818 . . . . 2.04 111.941 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 179' ' ' HIS . 21.5 m -74.48 105.58 5.68 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.373 -0.83 . . . . 1.11 111.04 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.889 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -140.15 173.61 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 114.364 -1.289 . . . . 1.07 110.858 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.7 p -121.41 174.08 6.97 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.729 -1.123 . . . . 1.71 110.098 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.65 ' O ' ' HG3' ' A' ' 124' ' ' MET . 28.5 ttpp -50.99 -47.43 61.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 3.81 111.845 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.487 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -84.21 -17.1 40.95 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 122.248 -0.282 . . . . 2.18 110.521 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.891 ' O ' HD13 ' A' ' 127' ' ' LEU . 1.7 mt-10 -70.69 -22.63 62.44 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.297 -0.561 . . . . 0.5 110.149 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.65 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -84.99 -29.13 25.29 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.457 -1.297 . . . . 3.61 109.66 178.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.02 -33.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.559 1.171 . . . . 1.12 111.605 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.743 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.74 -42.3 28.55 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.292 -1.322 . . . . 2.07 109.806 170.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.45 -38.6 84.71 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.476 -1.25 . . . . 1.14 114.163 -173.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.682 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.12 -41.01 97.82 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 116.129 -2.229 . . . . 1.06 108.67 177.096 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.665 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 64.0 mm-40 -67.27 -32.0 72.71 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 123.006 1.384 . . . . 2.51 108.658 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -84.16 -7.32 59.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.895 -2.412 . . . . 1.06 110.179 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 128' ' ' LEU . 14.4 t -121.12 1.06 10.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.114 0.959 . . . . 1.12 108.636 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 72.68 55.26 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.286 -1.779 . . . . 2.86 112.267 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.696 ' OH ' HG23 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -152.15 146.75 25.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.548 -1.649 . . . . 0.88 106.548 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.646 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.07 163.26 34.05 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.061 -1.829 . . . . 0.92 106.061 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.25 159.6 0.64 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.082 0.944 . . . . 2.42 112.041 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -146.68 150.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-N 114.147 -1.388 . . . . 1.08 111.624 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 m -60.56 -50.18 74.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.093 -0.958 . . . . 1.17 111.942 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 136' ' ' VAL . 17.9 ptmt -155.43 114.51 3.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.161 -1.382 . . . . 1.24 108.967 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.782 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.38 100.5 5.19 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 123.894 1.807 . . . . 3.14 112.041 -168.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.752 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 1.4 t -158.84 95.4 1.29 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.178 -1.828 . . . . 1.11 108.07 162.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -151.34 165.38 17.5 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.483 -1.235 . . . . 2.98 108.183 173.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.31 111.56 2.65 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 119.578 0.885 . . . . 1.1 109.982 164.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.39 13.41 78.69 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.674 -0.774 . . . . 0.38 114.049 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.9 mt-10 -131.88 130.91 42.25 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.349 -0.982 . . . . 1.49 108.349 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.901 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.84 176.63 8.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.547 -0.861 . . . . 0.38 110.279 -166.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.782 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 18.1 p -107.88 142.03 38.58 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.532 0.682 . . . . 1.09 110.932 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.565 HG21 ' HH ' ' A' ' 133' ' ' TYR . 42.4 t -100.35 134.71 39.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 114.617 -1.174 . . . . 1.62 111.08 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 151' ' ' SER . 5.3 tp-100 -147.23 54.2 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.98 0.419 . . . . 2.74 110.961 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.611 ' O ' ' HE1' ' A' ' 124' ' ' MET . . . 60.57 -100.43 0.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.35 0.87 . . . . 1.13 113.35 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.649 ' HB3' ' CD2' ' A' ' 197' ' ' LEU . 83.1 m-20 -82.04 -5.02 58.04 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.051 0.453 . . . . 1.6 111.375 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 57.3 m -141.9 123.21 14.81 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.268 -0.573 . . . . 1.37 110.26 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.696 HG23 ' OH ' ' A' ' 133' ' ' TYR . 5.9 mt -96.19 165.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.617 -1.253 . . . . 1.05 107.617 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.901 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 5.6 tt0 -124.5 105.82 9.69 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.898 -1.121 . . . . 0.97 110.392 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.591 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.8 ppp? -106.76 125.8 51.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.061 0.458 . . . . 1.97 111.478 -166.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -69.09 135.88 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.148 -0.478 . . . . 1.09 110.316 172.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 157' ' ' ARG . 29.4 ttp180 -76.32 150.49 36.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.621 -0.718 . . . . 3.55 109.226 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 42.9 ttp180 -56.77 119.63 31.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.505 -0.316 . . . . 4.84 110.382 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 157' ' ' ARG . 3.6 Cg_exo -77.38 174.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.125 2.55 . . . . 2.01 113.175 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.49 130.12 56.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.591 -1.186 . . . . 5.88 108.967 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.636 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 50.2 m-20 -129.18 136.62 50.4 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.745 0.646 . . . . 5.15 112.745 -167.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.561 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.3 m-85 -119.58 167.59 11.89 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 115.111 -0.95 . . . . 6.88 110.348 170.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.4 Cg_endo -74.82 -41.87 0.65 Allowed 'Trans proline' 0 N--CA 1.416 -3.053 0 C-N-CA 122.124 1.883 . . . . 9.11 111.077 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.24 -4.84 48.15 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 112.806 -1.997 . . . . 10.53 109.7 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -164.36 142.37 6.92 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.567 -1.197 . . . . 8.25 112.379 -170.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.636 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 69.3 mttt -142.87 147.88 36.09 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.632 0.73 . . . . 7.11 112.705 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -176.0 -154.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.082 -1.417 . . . . 5.04 109.247 -169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.58 6.69 88.92 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.865 -0.607 . . . . 2.35 112.551 172.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.17 109.3 5.13 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.781 1.277 . . . . 3.48 112.101 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.777 HG12 ' N ' ' A' ' 170' ' ' ARG . 71.0 t -131.61 145.63 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.513 0 CA-C-N 112.627 -2.079 . . . . 1.23 109.303 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.777 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -125.71 145.48 50.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.135 0.969 . . . . 2.3 112.712 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -112.28 166.12 11.56 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.512 -1.676 . . . . 1.04 110.22 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.69 120.48 37.55 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.439 -0.948 . . . . 4.19 108.439 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.617 HD11 ' CG1' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -115.32 137.32 52.17 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.729 -1.578 . . . . 1.33 109.901 -163.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.59 ' CG2' ' HB2' ' A' ' 197' ' ' LEU . 82.6 m -129.83 150.24 51.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.235 0.54 . . . . 1.02 111.881 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.889 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.9 m-85 -113.24 106.82 15.09 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.424 -1.262 . . . . 0.44 112.374 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.482 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 17.7 t70 -93.67 96.66 9.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.119 0.485 . . . . 0.74 111.113 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.71 -114.77 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.185 -1.007 . . . . 0.28 113.31 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.481 ' O ' HG21 ' A' ' 118' ' ' THR . 0.4 OUTLIER -111.04 8.99 22.1 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.004 -1.48 . . . . 1.61 107.004 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.63 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 17.6 p-80 -138.41 161.11 37.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.159 -1.382 . . . . 2.16 111.59 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.874 ' HB2' ' O ' ' A' ' 117' ' ' MET . 8.1 tp -63.75 144.3 57.15 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.404 -0.817 . . . . 1.05 111.731 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.482 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -94.92 -52.46 4.23 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.43 -1.259 . . . . 1.03 111.914 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 183' ' ' ILE . 6.3 t -179.24 176.19 0.88 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.463 -0.789 . . . . 1.09 110.558 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.617 ' CG1' HD11 ' A' ' 173' ' ' LEU . 3.5 mp -152.27 137.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 105.646 -1.983 . . . . 1.04 105.646 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 75.4 t -139.55 119.86 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 112.417 0.525 . . . . 1.15 112.417 -172.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.97 96.46 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.064 -1.087 . . . . 2.01 108.064 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.1 mmm -54.91 -24.3 22.87 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.141 -1.845 . . . . 2.01 113.26 -166.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.502 ' HG3' HG11 ' A' ' 169' ' ' VAL . 4.0 mt-10 -70.57 -40.92 73.04 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 114.39 -1.277 . . . . 0.68 110.957 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -93.54 -32.52 14.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.753 -1.567 . . . . 2.66 110.571 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.614 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.7 p-10 36.3 46.92 0.44 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.074 0.94 . . . . 2.15 112.765 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 190' ' ' ARG . 1.3 tpm_? -163.65 -53.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.967 -1.123 . . . . 4.73 107.967 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -73.02 126.03 29.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.691 -1.141 . . . . 4.52 108.084 169.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 35.7 t80 61.79 68.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.202 -0.666 . . . . 1.94 109.202 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.466 ' HA2' ' CG2' ' A' ' 184' ' ' VAL . . . -156.17 138.64 6.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.168 -1.015 . . . . 1.84 113.476 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.442 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 73.9 m-85 -131.31 -172.27 2.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.535 -0.542 . . . . 5.39 109.535 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.4 138.17 39.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.206 0.527 . . . . 7.14 110.984 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -73.88 160.49 31.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.296 -0.866 . . . . 7.18 110.009 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.649 ' CD2' ' HB3' ' A' ' 150' ' ' ASN . 15.8 tp -68.57 125.74 27.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.718 0.294 . . . . 2.04 111.067 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.04 144.74 59.61 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.101 -0.703 . . . . 3.38 109.101 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.82 78.36 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.718 2.278 . . . . 5.38 112.36 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.33 -0.843 . . . . 8.41 109.773 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.622 -0.51 . . . . 31.29 109.622 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 52.68 6.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.476 -0.869 . . . . 30.78 112.891 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 m -96.22 -18.27 20.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.411 0.624 . . . . 30.69 109.325 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 3.4 p -83.87 75.45 10.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.305 -0.862 . . . . 29.95 110.731 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.89 -30.25 63.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 29.85 110.902 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -67.99 -47.48 68.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 30.29 109.688 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' SER . 31.4 t-80 -167.91 130.09 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.876 -0.787 . . . . 28.16 108.876 175.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -67.0 101.18 0.82 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.995 0.426 . . . . 26.24 111.585 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 33.9 p80 -146.77 38.53 1.01 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 26.48 108.931 173.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 33.4 m170 71.58 174.84 0.29 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.969 -1.014 . . . . 26.97 109.951 -171.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -87.14 35.1 0.69 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.058 0.456 . . . . 24.89 110.747 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p -82.72 164.66 20.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.641 . . . . 24.15 110.398 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.65 41.34 2.39 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.672 -0.775 . . . . 22.8 112.897 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 tt -79.2 91.62 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.097 -0.705 . . . . 21.12 109.097 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.5 p -163.96 117.55 1.04 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.646 -0.706 . . . . 20.12 110.071 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.46 -56.28 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.878 2.385 . . . . 19.33 112.116 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 56.01 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.302 0.573 . . . . 19.37 111.485 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.66 20.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.824 -0.703 . . . . 15.69 111.487 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.7 t -122.68 122.91 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 14.22 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -137.26 37.49 2.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 13.16 110.487 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 12.29 109.863 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.8 62.97 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.601 -0.727 . . . . 8.13 112.301 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -104.62 -24.27 12.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.682 0.277 . . . . 9.83 111.124 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -136.07 24.66 3.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.46 1.124 . . . . 6.46 109.9 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.6 p -103.04 143.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 113.497 -1.683 . . . . 5.19 109.855 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.401 ' OD1' ' HG2' ' A' ' 157' ' ' ARG . 88.9 m-20 -88.44 142.51 27.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.026 -0.534 . . . . 4.9 109.667 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 HD22 ' C ' ' A' ' 113' ' ' LEU . 4.6 tt -80.25 110.39 15.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 1.91 109.542 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.652 ' N ' ' HD3' ' A' ' 115' ' ' PRO . 8.2 pt-20 -173.64 48.43 0.07 OUTLIER Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.41 -0.814 . . . . 3.45 111.168 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 6.9 Cg_endo -90.07 177.26 2.52 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.99 2.46 . . . . 3.73 112.174 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.96 19.31 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.387 -0.824 . . . . 3.24 110.359 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.611 ' H ' ' C ' ' A' ' 115' ' ' PRO . 12.3 ttm -48.96 138.57 11.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.536 1.134 . . . . 2.04 113.042 -169.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.529 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.8 m -128.25 100.76 5.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.603 -1.18 . . . . 1.11 108.645 175.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.878 HD12 ' CD1' ' A' ' 175' ' ' PHE . 6.1 pt -132.85 172.63 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.242 1.02 . . . . 1.07 112.069 -174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.675 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.6 m -117.06 174.04 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.581 -1.645 . . . . 1.71 110.206 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 124' ' ' MET . 14.0 mmmm -49.33 -53.78 20.45 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.599 0.592 . . . . 3.81 112.599 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.446 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 94.8 m-20 -82.89 -16.35 47.87 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 116.586 -0.279 . . . . 2.18 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.871 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.6 mt-10 -66.24 -24.09 66.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 120.274 -0.571 . . . . 0.5 110.167 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.639 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.07 -29.26 23.52 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.487 -1.285 . . . . 3.61 109.986 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.26 -31.13 50.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.436 1.112 . . . . 1.12 111.61 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.736 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.97 -42.45 23.92 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.233 -1.349 . . . . 2.07 109.735 170.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.871 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.38 81.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 CA-C-O 117.626 -1.178 . . . . 1.14 114.147 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.82 -39.56 94.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 116.233 -2.187 . . . . 1.06 108.733 177.455 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.658 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 55.2 mm-40 -69.56 -30.76 68.63 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.113 1.435 . . . . 2.51 108.787 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -83.64 -7.67 59.45 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 111.971 -2.377 . . . . 1.06 109.884 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.634 HG21 ' O ' ' A' ' 128' ' ' LEU . 13.8 t -121.51 -0.95 9.66 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.115 -0.948 . . . . 1.12 108.967 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 71.49 58.09 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 113.341 -1.754 . . . . 2.86 112.625 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.7 ' HH ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -152.65 146.88 25.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.106 -1.812 . . . . 0.88 106.106 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -143.34 162.59 35.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.41 -1.33 . . . . 0.92 107.41 -174.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 135' ' ' GLN . 2.6 tt0 -50.18 146.83 4.64 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.164 0.983 . . . . 2.42 112.567 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -134.56 150.84 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-N 113.702 -1.59 . . . . 1.08 112.046 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.5 m -60.34 -50.28 74.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.857 -1.065 . . . . 1.17 111.826 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.583 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.2 ptmt -155.33 113.77 3.49 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.114 -1.403 . . . . 1.24 108.812 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.796 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.7 OUTLIER -75.72 100.35 4.66 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.682 1.706 . . . . 3.14 112.05 -167.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.842 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.1 t -159.22 92.08 1.06 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.61 -1.632 . . . . 1.11 109.305 161.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.842 ' HD3' ' O ' ' A' ' 140' ' ' THR . 16.9 mmt180 -152.0 147.82 20.48 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-N 113.8 -1.546 . . . . 2.98 107.189 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.03 110.28 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 CA-C-N 120.383 1.172 . . . . 1.1 109.372 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.5 14.4 58.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.354 -0.839 . . . . 0.38 114.352 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.2 mt-10 -136.89 132.72 34.91 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.858 -1.164 . . . . 1.49 107.858 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.903 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.97 175.25 9.39 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.167 -1.013 . . . . 0.38 110.451 -168.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.796 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.4 p -108.34 141.45 40.13 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.869 0.842 . . . . 1.09 112.047 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.7 HG22 ' HH ' ' A' ' 133' ' ' TYR . 59.4 t -103.76 119.71 52.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 113.736 -1.574 . . . . 1.62 110.477 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.7 tt0 -103.88 -80.16 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.492 -0.322 . . . . 2.74 110.695 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.07 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.738 0.304 . . . . 1.13 111.009 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 61.0 m-20 -81.97 -4.14 56.01 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.332 -0.618 . . . . 1.6 109.332 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.7 m -142.6 148.04 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.305 -0.558 . . . . 1.37 110.55 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.644 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.2 mt -106.77 169.14 2.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.727 -1.212 . . . . 1.05 107.727 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.903 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 12.4 tt0 -127.54 109.08 11.36 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.787 -0.765 . . . . 0.97 110.654 173.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.451 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 2.1 tmt? -109.71 123.2 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.747 0.308 . . . . 1.97 111.753 -169.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -68.64 125.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.251 0.548 . . . . 1.09 110.878 174.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 169' ' ' VAL . 53.7 ttt85 -85.99 163.91 17.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.098 -0.955 . . . . 3.55 108.737 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.401 ' HG2' ' OD1' ' A' ' 112' ' ' ASN . 37.9 mmt-85 -62.01 143.8 94.48 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.476 -0.564 . . . . 4.84 109.476 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -56.25 159.76 12.17 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.651 2.234 . . . . 2.01 113.162 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -119.33 124.37 46.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.763 -1.108 . . . . 5.88 111.278 -167.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.515 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 3.7 m-20 -130.1 121.34 26.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.634 -1.166 . . . . 5.15 110.771 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.486 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -121.59 172.41 5.03 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-O 121.676 0.751 . . . . 6.88 110.784 178.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -74.48 -43.69 0.47 Allowed 'Trans proline' 0 N--CA 1.415 -3.101 0 C-N-CA 121.956 1.771 . . . . 9.11 110.245 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.18 -3.94 57.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 112.351 -2.204 . . . . 10.53 109.72 -173.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 m -163.27 135.29 5.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.384 -1.28 . . . . 8.25 112.676 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 51.6 mttt -146.29 141.58 27.46 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.68 0.752 . . . . 7.11 112.144 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.72 -162.71 0.74 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.123 -1.399 . . . . 5.04 109.87 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -103.0 -131.67 7.39 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 120.613 -0.803 . . . . 2.35 113.16 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.52 159.54 29.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.793 0.806 . . . . 3.48 111.31 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 170' ' ' ARG . 63.4 t -136.34 147.35 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 114.516 -1.22 . . . . 1.23 108.733 175.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.805 ' N ' HG13 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -128.14 145.23 51.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.243 1.021 . . . . 2.3 112.872 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.48 164.68 13.31 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 1.04 110.541 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 22.9 ttt180 -111.67 119.97 40.48 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.999 -1.111 . . . . 4.19 107.999 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.644 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -112.37 110.48 20.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.42 -1.264 . . . . 1.33 109.956 -168.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.679 ' CG2' HD11 ' A' ' 197' ' ' LEU . 32.1 m -107.65 151.35 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.329 0.492 . . . . 1.02 112.329 -169.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.878 ' CD1' HD12 ' A' ' 119' ' ' ILE . 13.7 m-85 -117.03 101.81 8.81 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.628 -1.169 . . . . 0.44 112.685 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.56 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 22.4 t70 -98.66 100.43 11.66 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.659 -0.416 . . . . 0.74 111.189 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.24 -119.11 5.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.518 -0.849 . . . . 0.28 113.051 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' THR . 3.8 t70 -110.46 8.51 23.14 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.518 -1.66 . . . . 1.61 106.518 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.709 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 25.6 p80 -138.65 160.52 39.43 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.158 -1.383 . . . . 2.16 112.061 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.561 HD11 ' O ' ' A' ' 174' ' ' THR . 7.9 tp -63.74 139.64 58.79 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 114.759 -1.11 . . . . 1.05 110.439 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.56 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -90.84 -48.82 6.79 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.442 -1.254 . . . . 1.03 111.348 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.468 ' HG1' ' HB2' ' A' ' 194' ' ' PHE . 6.5 t 177.36 178.02 0.31 Allowed 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.284 -0.871 . . . . 1.09 110.685 -174.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.622 ' CG1' HD11 ' A' ' 173' ' ' LEU . 3.0 mp -150.94 127.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.909 -1.886 . . . . 1.04 105.909 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.679 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.4 t -132.87 122.09 45.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 112.568 0.581 . . . . 1.15 112.568 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -60.55 97.96 0.06 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.241 -1.022 . . . . 2.01 108.241 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.6 OUTLIER -54.56 -24.74 22.29 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 112.579 -2.1 . . . . 2.01 112.489 -168.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' A' ' 169' ' ' VAL . 3.1 mt-10 -68.58 -41.59 79.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 114.049 -1.432 . . . . 0.68 110.977 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' A' ' 190' ' ' ARG . 1.0 OUTLIER -100.34 -27.96 13.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.788 -1.096 . . . . 2.66 110.808 176.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.679 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.7 p30 36.47 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.578 1.696 . . . . 2.15 115.578 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 188' ' ' ASN . 81.8 mtp180 -134.74 -61.52 0.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.231 -0.655 . . . . 4.73 109.231 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.3 149.27 33.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.668 -1.234 . . . . 4.52 107.668 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 8.8 t80 63.8 42.05 6.41 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.85 -1.167 . . . . 1.94 107.85 -171.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.524 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -133.64 131.66 6.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.119 -0.946 . . . . 1.84 112.82 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.468 ' HB2' ' HG1' ' A' ' 182' ' ' THR . 92.8 m-85 -131.04 -173.03 2.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 5.39 109.606 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -77.71 167.2 21.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.597 0.713 . . . . 7.14 111.958 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -133.79 164.53 27.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 7.18 110.495 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 175' ' ' PHE . 1.3 mp -67.38 161.76 24.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.37 0.507 . . . . 2.04 112.37 -172.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.2 t70 56.99 66.29 3.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.075 -0.966 . . . . 3.38 110.662 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -95.02 2.8 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.11 2.54 . . . . 5.38 112.502 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.591 -0.719 . . . . 8.41 110.295 -176.773 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.727 0.299 . . . . 31.29 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.76 -33.27 24.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 30.78 112.694 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 m -91.56 33.9 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.934 0.397 . . . . 30.69 111.017 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 t -85.18 -72.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.418 . . . . 29.95 110.698 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 35.6 m80 57.23 -97.45 0.07 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.128 -0.487 . . . . 29.85 111.233 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.8 m80 66.32 143.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.296 0.569 . . . . 30.29 111.434 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -82.53 111.1 18.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 28.16 110.738 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.62 -178.32 4.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.746 -0.661 . . . . 26.24 110.032 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -141.48 82.81 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.051 0.453 . . . . 26.48 110.22 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -130.07 -58.09 1.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.304 -0.628 . . . . 26.97 109.304 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.7 m -119.44 57.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.642 -0.708 . . . . 24.89 109.356 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 m -88.79 -3.21 58.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.438 -0.801 . . . . 24.15 110.827 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.56 -140.46 20.39 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.998 -0.62 . . . . 22.8 113.113 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.3 mt -82.3 68.77 8.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.989 0.423 . . . . 21.12 111.051 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.58 -50.54 18.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.086 -0.506 . . . . 20.12 111.424 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.69 60.91 6.06 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.976 1.784 . . . . 19.33 111.588 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -63.78 120.96 12.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.909 -0.587 . . . . 19.37 110.76 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.48 115.39 0.69 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.8 -0.636 . . . . 15.69 111.537 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.9 m -111.37 36.05 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.316 0.579 . . . . 14.22 110.639 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -89.5 -45.55 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 13.16 109.675 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 56.8 mtm -126.68 165.18 19.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 12.29 109.832 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.6 -18.07 20.36 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.524 -0.846 . . . . 8.13 112.549 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -85.53 52.74 2.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.171 0.51 . . . . 9.83 110.611 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -131.22 20.72 4.84 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.301 1.048 . . . . 6.46 109.165 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.79 111.49 30.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.503 -1.681 . . . . 5.19 109.127 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -144.17 134.27 24.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 4.9 110.892 -171.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.86 136.98 54.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.598 -0.889 . . . . 1.91 108.598 175.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.54 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 7.5 mm-40 -133.66 -179.06 0.97 Allowed Pre-proline 0 N--CA 1.443 -0.823 0 C-N-CA 120.821 -0.352 . . . . 3.45 111.138 -167.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 2.9 Cg_endo -41.53 -175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.075 3.85 . . . . 3.73 115.134 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -44.39 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 119.378 3.103 . . . . 3.24 119.378 -156.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.883 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -40.4 109.51 0.12 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.097 0.951 . . . . 2.04 111.581 174.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.9 m -74.03 104.95 5.05 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.081 -0.963 . . . . 1.11 110.699 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.919 HD12 ' CD1' ' A' ' 175' ' ' PHE . 5.1 pt -138.54 172.53 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.296 -1.32 . . . . 1.07 110.235 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.71 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 11.1 p -122.56 176.27 6.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.741 -1.118 . . . . 1.71 110.151 -173.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 124' ' ' MET . 62.3 mtpt -56.03 -43.91 78.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.275 0.472 . . . . 3.81 112.275 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 26.2 t-20 -83.95 -18.36 37.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 122.042 -0.411 . . . . 2.18 110.016 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.916 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.2 mt-10 -67.36 -23.81 65.64 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 119.785 -0.766 . . . . 0.5 109.997 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.628 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.32 -27.59 25.81 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 118.576 -1.249 . . . . 3.61 109.81 177.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.01 -32.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.886 -1.052 . . . . 1.12 111.461 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.32 -40.01 31.38 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.813 -1.085 . . . . 2.07 110.291 170.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.17 -37.57 80.57 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 117.424 -1.274 . . . . 1.14 114.11 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.86 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.94 -40.02 95.48 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 116.103 -2.239 . . . . 1.06 109.227 175.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.462 ' H ' HD22 ' A' ' 128' ' ' LEU . 19.7 mt-10 -64.67 -28.82 69.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.685 1.231 . . . . 2.51 108.062 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -94.38 -6.82 43.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.827 -1.988 . . . . 1.06 111.135 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.3 t -122.52 -2.26 8.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.727 -0.67 . . . . 1.12 109.758 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 74.72 52.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.042 -1.436 . . . . 2.86 112.032 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.917 ' HH ' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -148.41 142.55 26.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.511 -1.292 . . . . 0.88 107.511 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.651 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -147.19 163.99 34.59 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.747 -1.205 . . . . 0.92 107.747 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -46.28 144.78 1.9 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 122.094 0.95 . . . . 2.42 113.202 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.603 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.7 t -137.37 151.18 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.375 0 CA-C-N 114.034 -1.439 . . . . 1.08 112.562 -173.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 m -59.77 -50.89 72.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.889 -1.05 . . . . 1.17 111.602 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.603 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.1 ptmt -157.72 117.65 3.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.019 -1.446 . . . . 1.24 108.605 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.784 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.7 OUTLIER -78.69 100.34 7.0 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 123.466 1.603 . . . . 3.14 111.991 -167.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.832 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 3.1 t -159.71 95.03 1.18 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.095 -1.411 . . . . 1.11 109.274 162.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.832 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -151.99 171.82 6.17 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 114.451 -1.25 . . . . 2.98 107.747 172.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.26 111.71 2.43 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 CA-C-N 120.452 1.197 . . . . 1.1 109.885 164.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.17 0.12 77.67 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.794 -0.717 . . . . 0.38 114.84 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 40.9 mt-10 -119.57 132.09 55.66 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.686 1.243 . . . . 1.49 109.574 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.812 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.8 m-30 -129.3 175.55 8.65 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.365 -0.534 . . . . 0.38 110.328 -166.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.784 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.0 p -111.9 139.2 47.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.871 -0.788 . . . . 1.09 108.871 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.917 HG21 ' HH ' ' A' ' 133' ' ' TYR . 2.6 p -112.37 154.43 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 112.649 0.611 . . . . 1.62 112.649 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.8 tp-100 -146.16 -95.08 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.334 -0.394 . . . . 2.74 111.146 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.487 ' O ' ' HE2' ' A' ' 124' ' ' MET . . . -155.0 -86.09 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.081 0.4 . . . . 1.13 112.081 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -83.19 -9.12 59.34 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.492 0.663 . . . . 1.6 109.665 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 46.9 m -139.51 119.74 13.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.53 -0.759 . . . . 1.37 110.579 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.579 HD13 ' SD ' ' A' ' 124' ' ' MET . 4.7 mt -96.95 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.767 -1.197 . . . . 1.05 107.767 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.812 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.1 tt0 -119.5 151.0 39.31 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.144 -1.428 . . . . 0.97 107.144 164.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.614 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -147.43 128.65 14.73 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.116 -0.634 . . . . 1.97 111.098 -177.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -71.96 130.61 35.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.049 -0.352 . . . . 1.09 110.049 171.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -95.12 168.0 11.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.978 -0.556 . . . . 3.55 109.57 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -44.14 133.83 4.27 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 123.5 0.5 . . . . 4.84 110.5 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -49.76 153.43 5.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.938 2.425 . . . . 2.01 112.338 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -107.39 118.59 37.13 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.887 -1.052 . . . . 5.88 111.01 -169.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.612 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 7.1 m-20 -130.06 118.9 22.25 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.367 -1.288 . . . . 5.15 110.353 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 2.2 m-30 -121.1 170.85 6.69 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.301 -0.863 . . . . 6.88 110.614 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -74.48 -41.72 0.78 Allowed 'Trans proline' 0 N--CA 1.415 -3.131 0 C-N-CA 122.012 1.808 . . . . 9.11 110.205 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.15 -7.45 55.66 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 112.167 -2.288 . . . . 10.53 109.803 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.2 m -163.52 136.5 5.43 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.179 -1.373 . . . . 8.25 112.883 -169.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.612 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 54.7 mttt -145.97 146.12 30.9 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.276 0.56 . . . . 7.11 111.861 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.4 pt-20 -168.2 -161.39 0.36 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.59 -1.186 . . . . 5.04 110.376 -174.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -94.88 -124.8 4.29 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.728 -0.749 . . . . 2.35 113.53 -174.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.85 161.61 24.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.514 0.673 . . . . 3.48 111.455 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.77 HG11 ' N ' ' A' ' 170' ' ' ARG . 56.0 t -135.91 146.17 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-N 114.626 -1.17 . . . . 1.23 108.742 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.77 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -123.39 143.96 49.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.627 1.203 . . . . 2.3 112.582 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 153' ' ' GLU . . . -115.47 166.37 11.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 112.873 -1.967 . . . . 1.04 109.855 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 29.4 ttp180 -108.82 126.47 53.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.103 -0.703 . . . . 4.19 109.103 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.49 HD21 HG13 ' A' ' 183' ' ' ILE . 1.4 mt -84.59 152.05 24.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.357 -1.292 . . . . 1.33 110.076 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 180' ' ' LEU . 93.4 m -151.95 143.05 23.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.1 0.476 . . . . 1.02 111.22 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.919 ' CD1' HD12 ' A' ' 119' ' ' ILE . 8.3 m-85 -116.77 111.82 20.29 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.882 -1.053 . . . . 0.44 112.738 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 16.8 t70 -99.15 95.0 6.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 0.74 111.09 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.02 -114.48 3.96 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 120.199 -1.0 . . . . 0.28 113.487 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 118' ' ' THR . 8.7 t70 -110.8 8.77 22.52 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.055 -1.461 . . . . 1.61 107.055 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.65 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 34.6 p80 -138.49 160.48 39.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.174 -1.375 . . . . 2.16 111.419 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.883 ' HB2' ' O ' ' A' ' 117' ' ' MET . 7.3 tp -62.06 144.59 55.04 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.059 -0.973 . . . . 1.05 111.093 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -94.3 -51.28 4.87 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.395 -1.275 . . . . 1.03 111.215 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 6.7 t -178.53 176.26 1.04 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.112 -0.949 . . . . 1.09 110.556 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.1 mp -154.15 125.82 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 113.086 -1.87 . . . . 1.04 106.472 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.615 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 98.7 t -128.76 119.51 49.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.28 -0.568 . . . . 1.15 111.901 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.26 96.84 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.529 -1.286 . . . . 2.01 107.529 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.505 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.7 mmt -53.89 -24.36 15.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 112.669 -2.059 . . . . 2.01 112.304 -168.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.512 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.5 mt-10 -68.13 -44.67 75.56 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 113.992 -1.458 . . . . 0.68 110.839 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.2 -27.77 13.65 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.936 -1.484 . . . . 2.66 111.138 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.615 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.3 p30 35.81 39.75 0.08 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.019 1.488 . . . . 2.15 115.019 173.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -153.87 -55.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.021 -0.424 . . . . 4.73 110.821 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.49 41.65 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.174 0.511 . . . . 4.52 110.119 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 t80 176.96 41.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.029 -0.73 . . . . 1.94 109.029 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.485 ' HA2' HG21 ' A' ' 184' ' ' VAL . . . -128.74 140.63 11.88 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.206 -0.997 . . . . 1.84 114.239 -171.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.494 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 57.7 m-85 -133.66 -171.28 2.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.614 -0.793 . . . . 5.39 109.323 175.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -75.8 162.76 27.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.276 0.56 . . . . 7.14 111.292 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -112.47 159.69 18.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.327 -0.851 . . . . 7.18 110.896 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -76.59 135.21 39.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 2.04 111.352 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -138.81 76.81 33.9 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.657 0.741 . . . . 3.38 110.073 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.58 -65.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.779 2.32 . . . . 5.38 112.248 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.559 -0.734 . . . . 8.41 110.144 179.452 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.923 0.392 . . . . 31.29 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.97 139.94 2.87 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.843 -0.694 . . . . 30.78 112.143 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -70.81 119.96 15.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.13 -0.693 . . . . 30.69 109.13 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m 70.05 151.49 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.787 0.68 . . . . 29.95 110.268 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -86.39 6.26 30.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.434 -0.348 . . . . 29.85 111.838 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 64.67 73.37 0.42 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.634 -0.712 . . . . 30.29 110.68 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -65.33 134.51 53.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 28.16 110.927 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -138.02 173.66 11.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.823 -0.626 . . . . 26.24 109.808 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -58.2 -41.68 84.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.339 0.496 . . . . 26.48 112.339 -171.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -110.39 147.5 33.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.83 -0.348 . . . . 26.97 110.942 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.6 m 67.27 17.98 10.27 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.823 0.675 . . . . 24.89 112.823 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.9 p -160.95 122.24 2.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.789 0.328 . . . . 24.15 110.381 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.12 -20.05 4.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.493 -0.643 . . . . 22.8 111.493 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.97 -51.0 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.397 -0.594 . . . . 21.12 109.397 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.72 101.33 48.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.48 -0.782 . . . . 20.12 110.04 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.88 50.23 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.659 2.239 . . . . 19.33 111.689 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -68.62 113.99 6.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 19.37 110.898 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 105' ' ' SER . . . -89.21 -132.72 4.59 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.039 -0.824 . . . . 15.69 111.039 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 104' ' ' GLY . 41.2 t 70.23 159.59 0.19 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.309 0.576 . . . . 14.22 111.123 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -96.48 6.38 48.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 13.16 110.132 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -69.48 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 12.29 110.614 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.28 131.59 3.45 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.868 -0.682 . . . . 8.13 111.427 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -72.02 140.04 48.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.753 0.311 . . . . 9.83 110.388 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.1 ptp -136.42 23.8 3.2 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.36 1.076 . . . . 6.46 109.233 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.09 128.43 68.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.592 -1.64 . . . . 5.19 109.916 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.32 141.46 48.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.931 -0.577 . . . . 4.9 109.618 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.603 HD13 HD12 ' A' ' 173' ' ' LEU . 3.3 tm? -71.05 138.48 49.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.911 -0.774 . . . . 1.91 108.911 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 14.7 mt-10 -168.32 -171.41 0.23 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.779 -0.629 . . . . 3.45 109.649 -169.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 3.7 Cg_exo -39.45 -176.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 125.226 3.95 . . . . 3.73 115.696 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.05 28.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 119.823 3.268 . . . . 3.24 119.823 -148.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.881 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -42.27 111.88 0.29 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.707 0.765 . . . . 2.04 112.158 173.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m -73.89 106.51 5.64 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.627 0.727 . . . . 1.11 110.798 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.911 HD13 ' CD1' ' A' ' 175' ' ' PHE . 5.4 pt -138.4 172.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.595 -1.184 . . . . 1.07 111.318 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.718 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 10.2 p -121.18 174.77 6.47 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.502 -1.227 . . . . 1.71 109.9 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 124' ' ' MET . 35.8 ttpt -56.22 -43.0 78.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.78 0.324 . . . . 3.81 111.824 -175.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.462 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.6 t-20 -84.17 -18.03 38.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.063 -0.398 . . . . 2.18 110.187 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.912 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.2 mt-10 -68.28 -23.77 64.79 Favored 'General case' 0 N--CA 1.422 -1.868 0 C-N-CA 119.969 -0.693 . . . . 0.5 110.176 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.653 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.27 -26.56 26.57 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 118.495 -1.282 . . . . 3.61 109.581 177.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.5 -32.06 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.845 -1.071 . . . . 1.12 111.539 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.764 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.66 -38.97 32.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.792 -1.095 . . . . 2.07 110.348 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.76 -38.18 84.32 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-O 117.548 -1.215 . . . . 1.14 114.236 -174.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.857 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -39.48 94.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 116.216 -2.193 . . . . 1.06 109.257 176.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.463 ' H ' HD21 ' A' ' 128' ' ' LEU . 22.0 mt-10 -65.02 -29.81 70.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.614 1.197 . . . . 2.51 108.113 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -92.72 -7.77 45.77 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.727 -2.033 . . . . 1.06 111.076 -170.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -121.81 -1.65 9.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.705 0.764 . . . . 1.12 109.322 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 71.25 57.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.702 -1.59 . . . . 2.86 111.996 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.857 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.08 145.51 26.4 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.587 -1.635 . . . . 0.88 106.587 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.566 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.87 164.52 31.68 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.886 -0.783 . . . . 0.92 108.886 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -45.01 144.69 1.15 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.285 1.04 . . . . 2.42 113.21 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG11 ' N ' ' A' ' 138' ' ' LYS . 5.1 t -139.98 150.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 CA-C-N 113.507 -1.679 . . . . 1.08 111.781 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 p -63.64 -49.11 74.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.935 -1.484 . . . . 1.17 111.887 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.591 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.3 ptmt -155.43 113.49 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.886 -1.506 . . . . 1.24 108.996 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.8 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -79.06 100.24 7.27 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 123.518 1.628 . . . . 3.14 111.187 -166.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.768 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.0 t -156.74 94.9 1.49 Allowed 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.313 -1.767 . . . . 1.11 107.899 164.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.768 ' HG3' ' O ' ' A' ' 140' ' ' THR . 1.8 mpt_? -151.78 171.82 6.14 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 113.675 -1.602 . . . . 2.98 107.783 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.75 111.89 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 CA-C-N 120.066 1.059 . . . . 1.1 110.15 163.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.96 4.54 86.97 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.717 -0.754 . . . . 0.38 114.665 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 81.7 mm-40 -119.28 132.59 55.92 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 117.976 0.888 . . . . 1.49 108.64 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.787 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.8 m-30 -128.81 172.93 10.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.833 -0.747 . . . . 0.38 110.255 -166.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.8 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 16.5 p -106.84 139.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.983 -0.747 . . . . 1.09 108.983 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.453 HG21 HG12 ' A' ' 152' ' ' ILE . 2.0 p -113.67 128.92 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.134 -0.627 . . . . 1.62 112.35 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 151' ' ' SER . 26.7 mp0 -116.51 -88.03 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.23 -0.441 . . . . 2.74 111.865 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.79 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.935 0.346 . . . . 1.13 111.935 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.3 -9.41 59.48 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.69 0.757 . . . . 1.6 109.352 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 17.5 m -140.35 144.13 36.13 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 114.921 -1.036 . . . . 1.37 109.643 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 153' ' ' GLU . 8.5 mt -108.73 168.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.105 -1.072 . . . . 1.05 108.105 168.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 22.7 tt0 -123.76 110.59 15.11 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.476 -0.89 . . . . 0.97 110.236 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.583 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -114.86 130.04 56.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.024 0.44 . . . . 1.97 111.021 -169.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.634 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.37 134.21 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.894 -0.41 . . . . 1.09 109.894 172.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.462 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 40.7 ttp85 -88.36 154.88 20.04 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.014 -0.735 . . . . 3.55 109.014 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -57.61 111.54 3.58 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.591 -0.522 . . . . 4.84 109.591 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.551 ' HB2' ' O ' ' A' ' 166' ' ' GLU . 51.6 Cg_endo -70.64 179.57 4.07 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.489 2.793 . . . . 2.01 114.227 -171.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.8 143.09 38.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.767 -1.106 . . . . 5.88 111.78 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.492 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 15.1 m-20 -123.06 132.73 54.23 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.761 -1.109 . . . . 5.15 111.112 -172.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.601 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 66.6 m-85 -119.06 170.79 6.09 Favored Pre-proline 0 N--CA 1.425 -1.704 0 CA-C-O 121.618 0.723 . . . . 6.88 110.85 170.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 3.9 Cg_endo -80.36 -42.62 0.14 Allowed 'Trans proline' 0 N--CA 1.414 -3.178 0 C-N-CA 122.201 1.934 . . . . 9.11 111.521 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.67 -7.13 44.7 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.822 -1.99 . . . . 10.53 109.527 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -165.88 167.86 16.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 113.745 -1.57 . . . . 8.25 110.996 -170.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.601 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 70.5 mttt -150.45 141.08 22.6 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 118.356 0.526 . . . . 7.11 110.546 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 7.2 pt-20 -164.82 -161.74 0.58 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.77 -0.65 . . . . 5.04 112.237 -166.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 162.6 35.91 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.326 -0.852 . . . . 2.35 112.298 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.471 ' HA ' HE21 ' A' ' 168' ' ' GLN . 0.0 OUTLIER -150.46 109.8 3.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 3.48 110.677 176.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 170' ' ' ARG . 69.3 t -132.31 142.69 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-N 116.215 -0.448 . . . . 1.23 110.376 173.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.774 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -128.54 144.42 51.14 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 122.164 0.983 . . . . 2.3 112.41 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.3 167.22 11.04 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.481 -1.691 . . . . 1.04 110.619 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 6.7 ttp180 -115.08 120.74 40.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.847 -1.168 . . . . 4.19 107.847 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.603 HD12 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -113.41 114.1 26.13 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.927 -1.488 . . . . 1.33 110.282 -164.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 180' ' ' LEU . 64.5 m -112.36 146.42 38.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.022 -0.535 . . . . 1.02 111.744 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.911 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -118.8 117.75 29.72 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.417 -0.811 . . . . 0.44 111.905 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.468 ' HA ' HD22 ' A' ' 197' ' ' LEU . 14.1 t70 -98.08 99.65 10.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.69 -0.686 . . . . 0.74 111.128 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.22 -111.99 3.47 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.829 -1.176 . . . . 0.28 113.78 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER -110.67 6.55 21.76 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.135 -1.431 . . . . 1.61 107.135 -177.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.68 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 22.9 p80 -140.94 160.27 40.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.292 -1.322 . . . . 2.16 111.979 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.881 ' HB2' ' O ' ' A' ' 117' ' ' MET . 6.0 tp -60.73 145.43 49.52 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.774 0.797 . . . . 1.05 111.562 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.447 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -97.74 -49.64 4.76 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.282 -1.326 . . . . 1.03 111.162 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 194' ' ' PHE . 6.7 t -178.95 177.69 0.81 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.316 -0.856 . . . . 1.09 110.657 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 173' ' ' LEU . 2.7 mp -152.93 123.22 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.495 -1.668 . . . . 1.04 106.495 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.718 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 88.4 t -127.94 123.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 112.804 0.668 . . . . 1.15 112.804 -170.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.462 ' OD1' ' HD3' ' A' ' 156' ' ' ARG . 8.3 m-20 -59.67 101.36 0.11 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.339 1.066 . . . . 2.01 108.255 172.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 80.6 mmm -60.45 -13.85 15.95 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 113.05 -1.887 . . . . 2.01 112.788 -169.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.488 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.2 mt-10 -73.76 -45.58 50.93 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.48 -1.236 . . . . 0.68 110.752 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -104.96 -20.23 13.6 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.936 -1.029 . . . . 2.66 111.495 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.718 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 20.2 p30 37.6 33.6 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.254 1.575 . . . . 2.15 115.254 174.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.3 -68.13 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 4.73 110.39 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.49 73.78 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 4.52 110.336 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 t80 178.78 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.809 . . . . 1.94 108.944 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 176.48 -161.6 29.81 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.499 -0.773 . . . . 1.84 111.953 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 182' ' ' THR . 99.6 m-85 -143.5 122.42 12.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.806 0.336 . . . . 5.39 110.232 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -80.65 86.88 5.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.528 0.68 . . . . 7.14 111.146 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -134.81 142.15 46.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.599 -0.728 . . . . 7.18 110.268 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -153.63 130.29 10.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.952 0.406 . . . . 2.04 110.162 175.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -121.4 90.44 47.72 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 3.38 110.389 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.36 44.33 1.5 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.851 2.367 . . . . 5.38 111.858 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.535 -0.745 . . . . 8.41 110.387 -174.266 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.3 tpp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.69 0.281 . . . . 31.29 110.565 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.99 -101.81 1.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.353 -0.699 . . . . 30.78 111.353 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -84.73 52.61 2.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 30.69 109.876 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 m -75.35 104.36 5.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.613 -0.722 . . . . 29.95 111.236 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -83.17 -59.15 2.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.554 -0.748 . . . . 29.85 110.111 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 46.1 m170 59.67 83.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.724 0.64 . . . . 30.29 110.472 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.05 -43.9 90.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 28.16 111.079 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.0 m80 55.61 49.41 16.57 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.279 0.561 . . . . 26.24 109.558 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -77.96 -62.7 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.797 . . . . 26.48 110.409 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -178.02 137.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 26.97 109.742 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.5 m -106.85 90.88 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.681 -0.489 . . . . 24.89 109.681 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 m -75.46 -65.79 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.821 -0.627 . . . . 24.15 110.95 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.14 60.79 2.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.518 -0.849 . . . . 22.8 112.467 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.79 81.39 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.909 -0.404 . . . . 21.12 109.909 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.1 120.72 60.43 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.689 -0.687 . . . . 20.12 110.765 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 110' ' ' MET . 74.0 Cg_exo -42.64 113.05 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.695 2.93 . . . . 19.33 113.122 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -89.97 141.48 28.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 19.37 110.602 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 -64.07 0.55 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.995 -0.842 . . . . 15.69 110.995 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 106' ' ' HIS . 46.5 m -126.12 86.52 2.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.361 -0.607 . . . . 14.22 109.361 175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 105' ' ' SER . 52.1 m80 71.9 -61.0 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.357 0.663 . . . . 13.16 110.315 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.2 ptm -100.96 176.79 5.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.572 -0.529 . . . . 12.29 109.572 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -173.37 164.89 36.8 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.378 -0.915 . . . . 8.13 112.083 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -135.59 135.69 40.48 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.949 -0.389 . . . . 9.83 109.949 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.424 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 28.0 ptm -107.16 4.08 26.39 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.418 1.104 . . . . 6.46 108.614 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.45 HG12 ' HG1' ' A' ' 131' ' ' THR . 10.6 m -145.16 132.09 15.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 112.592 -2.095 . . . . 5.19 110.122 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.24 70.16 1.3 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.0 0.905 . . . . 4.9 109.43 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.74 ' HB3' ' SD ' ' A' ' 154' ' ' MET . 2.8 tm? -118.11 131.62 56.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.667 -1.151 . . . . 1.91 109.781 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' H ' HD23 ' A' ' 113' ' ' LEU . 9.4 tp10 176.27 145.32 0.25 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.495 -2.039 . . . . 3.45 105.495 -171.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD3' HD11 ' A' ' 183' ' ' ILE . 76.2 Cg_endo -90.22 103.04 0.31 Allowed 'Trans proline' 0 N--CA 1.433 -2.073 0 CA-C-N 122.379 1.885 . . . . 3.73 113.938 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -113.29 -4.32 13.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.463 -2.792 . . . . 3.24 103.463 140.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.544 ' HG3' HG21 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -75.05 142.07 43.79 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 111.338 -2.664 . . . . 2.04 112.194 -161.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 18.4 m -127.37 101.12 6.32 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.722 -1.127 . . . . 1.11 108.84 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.818 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.6 pt -128.7 172.04 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.275 1.036 . . . . 1.07 112.218 -172.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.69 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 6.3 t -120.95 170.13 9.8 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.804 -1.543 . . . . 1.71 109.398 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -52.02 -46.0 64.81 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.252 0.549 . . . . 3.81 112.278 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.453 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 18.3 m120 -84.14 -17.12 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.403 -0.362 . . . . 2.18 110.088 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.907 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -66.86 -30.87 71.15 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 120.468 -0.493 . . . . 0.5 110.361 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.536 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -85.84 -22.68 27.46 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 117.771 -1.572 . . . . 3.61 109.649 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.456 ' O ' HD23 ' A' ' 128' ' ' LEU . 2.1 t -68.22 -29.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.566 -1.197 . . . . 1.12 111.674 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.755 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.95 -39.06 26.69 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.956 -1.02 . . . . 2.07 109.326 171.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.907 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -55.57 -45.37 77.33 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 114.525 1.306 . . . . 1.14 114.525 -174.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.855 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -60.35 -39.54 87.49 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 116.784 -1.966 . . . . 1.06 109.719 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.0 mt-10 -66.54 -29.62 69.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.51 108.022 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -91.34 -8.59 47.66 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 112.926 -1.943 . . . . 1.06 110.886 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.98 -1.87 9.29 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.783 0.802 . . . . 1.12 109.552 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 70.44 56.75 0.26 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.761 -1.563 . . . . 2.86 111.882 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.855 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.08 146.41 27.71 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.378 -1.712 . . . . 0.88 106.378 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.653 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -147.69 163.83 35.43 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.127 -1.435 . . . . 0.92 107.127 -176.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 135' ' ' GLN . 0.1 OUTLIER -47.0 158.73 0.12 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 122.453 1.12 . . . . 2.42 112.853 -176.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.576 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -148.27 150.23 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 CA-C-N 113.772 -1.558 . . . . 1.08 111.412 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -61.48 -49.45 76.7 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.375 -0.829 . . . . 1.17 111.866 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.576 ' N ' HG11 ' A' ' 136' ' ' VAL . 17.4 ptmt -153.77 115.76 4.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.187 -1.37 . . . . 1.24 108.85 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.763 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.34 99.37 4.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.842 1.782 . . . . 3.14 112.277 -168.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.77 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -158.73 91.63 1.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.29 -1.777 . . . . 1.11 108.684 159.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.77 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.2 mmt-85 -154.9 126.44 3.69 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.126 -1.805 . . . . 2.98 106.126 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.67 110.8 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 CA-C-N 121.3 1.5 . . . . 1.1 110.417 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.56 2.5 57.56 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.477 -0.783 . . . . 0.38 114.293 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 28.6 mt-10 -130.46 133.03 45.99 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.982 0.891 . . . . 1.49 108.789 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.893 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -128.34 175.17 8.69 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 120.014 -0.675 . . . . 0.38 109.985 -168.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.763 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 10.9 p -111.43 137.03 49.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.662 -0.495 . . . . 1.09 109.662 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.586 HG23 ' HH ' ' A' ' 133' ' ' TYR . 1.3 p -113.37 140.72 32.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.443 -0.799 . . . . 1.62 111.57 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 151' ' ' SER . 0.6 OUTLIER -138.35 -91.35 0.21 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.0 0.37 . . . . 2.74 112.0 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.465 ' O ' ' HE1' ' A' ' 124' ' ' MET . . . -142.34 -93.21 0.13 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.685 0.624 . . . . 1.13 112.685 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.401 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 80.9 m-20 -80.33 -3.62 50.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.004 0.431 . . . . 1.6 110.44 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 148' ' ' GLN . 20.4 m -144.67 148.09 33.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.019 -0.537 . . . . 1.37 109.609 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.642 HG21 ' OH ' ' A' ' 133' ' ' TYR . 9.3 mt -108.18 167.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 107.694 -1.224 . . . . 1.05 107.694 168.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.893 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.2 tt0 -123.43 106.17 10.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.931 -1.108 . . . . 0.97 111.051 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.74 ' SD ' ' HB3' ' A' ' 113' ' ' LEU . 6.0 ttt -106.27 130.26 54.15 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.191 -0.204 . . . . 1.97 111.168 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.09 120.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 109.277 -0.638 . . . . 1.09 109.277 169.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -73.98 147.28 43.16 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.771 -0.825 . . . . 3.55 108.771 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.519 ' N ' ' HD3' ' A' ' 156' ' ' ARG . 3.1 tmt_? -45.68 126.41 6.51 Favored Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.694 0.622 . . . . 4.84 109.826 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -48.77 155.43 2.48 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.676 2.917 . . . . 2.01 113.102 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -92.37 120.74 33.18 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.21 1.005 . . . . 5.88 113.462 -172.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.631 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 35.1 m-20 -130.09 119.69 23.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.691 -1.595 . . . . 5.15 110.603 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.6 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 34.4 m-85 -120.71 172.29 4.9 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.071 -0.968 . . . . 6.88 110.174 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.2 Cg_endo -76.81 -44.06 0.23 Allowed 'Trans proline' 0 N--CA 1.411 -3.33 0 C-N-CA 121.695 1.596 . . . . 9.11 110.343 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -90.92 -3.94 56.92 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 112.398 -2.183 . . . . 10.53 109.705 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -163.11 145.4 10.18 Favored 'General case' 0 C--O 1.203 -1.38 0 CA-C-N 113.968 -1.469 . . . . 8.25 112.094 -171.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.631 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 59.6 mttt -150.33 139.53 21.21 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.219 0.533 . . . . 7.11 111.22 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -155.51 -164.44 1.75 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.994 -1.003 . . . . 5.04 111.489 -171.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.04 -135.33 8.71 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.606 -0.724 . . . . 2.35 113.663 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -93.02 159.23 15.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.737 0.779 . . . . 3.48 111.638 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.788 HG12 ' N ' ' A' ' 170' ' ' ARG . 55.1 t -139.17 148.83 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 CA-C-N 114.204 -1.362 . . . . 1.23 108.176 172.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.788 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -119.58 143.36 47.68 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 122.516 1.15 . . . . 2.3 113.151 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.84 166.46 13.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.719 -2.037 . . . . 1.04 110.653 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.703 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 28.6 ttp180 -114.17 114.94 26.71 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.737 -1.209 . . . . 4.19 107.737 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -103.32 105.58 15.89 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.303 -1.771 . . . . 1.33 109.573 -168.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.537 ' O ' HD13 ' A' ' 180' ' ' LEU . 55.1 m -104.16 149.25 25.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.463 -0.79 . . . . 1.02 112.655 -167.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.818 ' CD1' HD11 ' A' ' 119' ' ' ILE . 14.7 m-85 -115.51 107.51 15.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.44 113.078 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.58 ' N ' ' HB1' ' A' ' 181' ' ' ALA . 25.3 t70 -100.56 102.71 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 0.74 110.842 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.26 -121.85 5.53 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.196 -1.002 . . . . 0.28 112.925 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 118' ' ' THR . 2.0 t70 -110.34 15.59 22.16 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.511 -1.663 . . . . 1.61 106.511 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.645 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 20.8 p-80 -138.16 161.15 37.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.292 -1.322 . . . . 2.16 111.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 173' ' ' LEU . 9.5 tp -70.54 131.67 44.34 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.62 -1.173 . . . . 1.05 110.364 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.58 ' HB1' ' N ' ' A' ' 176' ' ' ASP . . . -80.7 -49.82 10.7 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.131 -1.395 . . . . 1.03 111.022 -175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.42 HG21 ' HB ' ' A' ' 174' ' ' THR . 6.7 t 177.7 178.22 0.33 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.765 -1.107 . . . . 1.09 110.413 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 173' ' ' LEU . 2.2 mp -148.28 121.2 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.759 -1.571 . . . . 1.04 106.759 174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.712 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -126.18 122.6 61.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.535 0.569 . . . . 1.15 112.535 -171.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.417 ' ND2' HG13 ' A' ' 169' ' ' VAL . 8.0 m-20 -59.3 99.75 0.06 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 122.069 0.938 . . . . 2.01 108.806 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.8 mmt -54.04 -23.55 13.96 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 112.663 -2.062 . . . . 2.01 112.635 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.521 ' HG3' HG11 ' A' ' 169' ' ' VAL . 4.1 mt-10 -68.12 -42.21 80.55 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.382 -1.281 . . . . 0.68 110.556 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.544 ' C ' HD21 ' A' ' 189' ' ' ASN . 94.4 m-20 -102.1 -27.03 13.15 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.097 -1.411 . . . . 2.66 111.363 177.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.712 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 0.1 OUTLIER 33.98 51.89 0.43 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.241 1.571 . . . . 2.15 115.241 174.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -143.96 -75.3 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.508 -0.477 . . . . 4.73 111.704 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -101.86 19.14 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.529 0.566 . . . . 4.52 112.529 -170.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -95.55 -22.39 17.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.475 -0.49 . . . . 1.94 109.776 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' A' ' 184' ' ' VAL . . . -153.97 -137.21 2.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.105 -1.045 . . . . 1.84 113.256 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.88 -172.63 2.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.045 0.45 . . . . 5.39 111.714 -172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -78.13 175.03 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 7.14 111.367 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.79 161.01 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.57 -0.741 . . . . 7.18 111.773 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.548 HD22 ' CA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -74.0 146.19 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.98 -1.009 . . . . 2.04 111.017 -176.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.55 109.19 7.21 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.497 -0.557 . . . . 3.38 109.497 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.41 156.31 52.33 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.701 2.267 . . . . 5.38 112.469 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.538 -0.744 . . . . 8.41 109.777 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.789 0.328 . . . . 31.29 110.639 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.45 121.86 2.11 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.927 -0.654 . . . . 30.78 111.987 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -73.98 -50.1 21.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.866 0.365 . . . . 30.69 110.722 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 m -96.86 -15.87 21.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 29.95 110.013 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -123.51 72.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.467 -0.788 . . . . 29.85 109.843 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -59.33 -63.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 30.29 109.979 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.2 t60 48.74 69.54 0.55 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.79 0.681 . . . . 28.16 111.112 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.451 ' CE1' ' HB2' ' A' ' 97' ' ' SER . 57.6 t60 -128.54 -73.12 0.59 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.407 -0.361 . . . . 26.24 110.732 -177.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 72.2 m-70 52.91 67.53 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.467 0.479 . . . . 26.48 110.822 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 12.2 m-70 69.93 178.78 0.25 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 26.97 111.27 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 18.2 t -169.52 136.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.504 -0.316 . . . . 24.89 110.516 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.2 m -122.86 4.27 9.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.01 0.434 . . . . 24.15 110.413 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -59.52 4.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.005 -0.617 . . . . 22.8 112.575 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.475 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 3.8 mm? -62.48 146.76 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.302 . . . . 21.12 110.748 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.9 t -103.97 100.89 22.38 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.189 -0.459 . . . . 20.12 110.485 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 100' ' ' LEU . 17.2 Cg_exo -68.16 -28.31 34.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.813 2.342 . . . . 19.33 112.646 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.43 -179.93 0.22 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.719 -0.673 . . . . 19.37 111.021 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.13 -153.39 25.05 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.567 -0.825 . . . . 15.69 112.425 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.9 p -64.86 144.49 57.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.045 0.45 . . . . 14.22 111.429 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -152.6 -14.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 13.16 111.385 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.4 ttm -78.23 -36.89 46.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.424 0.631 . . . . 12.29 109.588 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -114.14 90.25 0.53 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.319 -0.855 . . . . 8.13 111.664 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -72.73 -54.53 8.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.955 0.407 . . . . 9.83 110.081 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.0 ptm -156.8 30.64 0.31 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.838 0.828 . . . . 6.46 109.948 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.65 -29.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.424 -1.262 . . . . 5.19 110.154 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.31 75.79 3.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.668 -0.697 . . . . 4.9 109.339 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 114' ' ' GLU . 0.6 OUTLIER -67.21 126.08 28.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.434 -0.803 . . . . 1.91 110.267 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.676 ' N ' HD13 ' A' ' 113' ' ' LEU . 40.5 mt-10 -160.7 161.53 24.52 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 107.883 -1.154 . . . . 3.45 107.883 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 69.5 Cg_endo -91.03 101.19 0.24 Allowed 'Trans proline' 0 N--CA 1.428 -2.354 0 CA-C-N 120.004 1.037 . . . . 3.73 112.764 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -111.97 -6.25 14.24 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 102.583 -3.117 . . . . 3.24 102.583 138.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.488 ' HG3' HG22 ' A' ' 119' ' ' ILE . 9.8 tpt -77.03 139.02 39.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 111.1 -2.773 . . . . 2.04 111.083 -168.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.489 HG23 ' HB3' ' A' ' 179' ' ' HIS . 7.2 m -123.89 103.14 8.17 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.759 -1.11 . . . . 1.11 108.805 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.835 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.9 pt -134.68 171.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.906 -1.043 . . . . 1.07 110.51 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.717 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -119.58 173.91 6.72 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.872 -1.058 . . . . 1.71 108.801 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.6 -44.8 66.23 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.379 0.424 . . . . 3.81 111.011 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.499 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 64.1 t30 -82.91 -18.52 39.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.18 110.344 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.896 ' O ' HD13 ' A' ' 127' ' ' LEU . 1.8 mt-10 -71.35 -25.69 62.5 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.363 -0.535 . . . . 0.5 110.666 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.613 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.2 tpt -88.81 -24.65 22.54 Favored 'General case' 0 C--N 1.286 -2.154 0 C-N-CA 118.065 -1.454 . . . . 3.61 109.515 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.0 -31.9 48.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.651 -1.159 . . . . 1.12 111.839 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.724 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.24 -39.8 28.32 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.124 -0.944 . . . . 2.07 110.415 170.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.896 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -62.03 -37.05 83.45 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-O 117.411 -1.28 . . . . 1.14 114.077 -175.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.744 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.39 -38.82 92.62 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 116.189 -2.204 . . . . 1.06 108.935 176.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.482 ' N ' HD22 ' A' ' 128' ' ' LEU . 25.7 mt-10 -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.788 1.28 . . . . 2.51 108.116 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -93.94 -6.72 44.86 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 112.446 -2.161 . . . . 1.06 110.777 -169.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.595 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 8.8 t -122.83 0.52 9.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.86 0.838 . . . . 1.12 109.555 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 71.62 53.47 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.85 -1.523 . . . . 2.86 111.691 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.744 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.02 144.24 25.68 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.276 -1.379 . . . . 0.88 107.276 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.649 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -144.79 163.02 35.32 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.236 -1.024 . . . . 0.92 108.236 -174.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -47.35 145.88 2.22 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.85 0.833 . . . . 2.42 112.358 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.81 150.09 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.304 -1.316 . . . . 1.08 112.289 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -60.43 -49.16 78.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.667 -1.151 . . . . 1.17 111.723 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -157.19 113.95 3.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.148 -1.387 . . . . 1.24 108.619 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.784 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.8 OUTLIER -75.36 99.47 4.13 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 123.674 1.702 . . . . 3.14 112.089 -167.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.844 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.9 t -159.01 92.84 1.12 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.665 -1.607 . . . . 1.11 109.527 161.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.844 ' HD3' ' O ' ' A' ' 140' ' ' THR . 11.0 mmt180 -152.44 154.68 32.21 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 106.583 -1.636 . . . . 2.98 106.583 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.04 110.86 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 120.577 1.242 . . . . 1.1 109.911 168.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 15.38 63.48 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.536 -0.84 . . . . 0.38 113.933 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 26.6 mt-10 -134.48 131.4 38.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.743 -1.206 . . . . 1.49 107.743 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.895 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -133.75 176.25 8.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.504 -0.878 . . . . 0.38 110.612 -167.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.784 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 12.5 p -107.45 142.98 36.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.639 0.733 . . . . 1.09 111.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG21 ' OH ' ' A' ' 133' ' ' TYR . 55.5 t -106.23 134.45 47.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.344 -1.298 . . . . 1.62 111.629 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 151' ' ' SER . 24.8 mt-30 -120.1 -87.81 0.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.669 -0.241 . . . . 2.74 111.096 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -164.27 -81.08 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.693 0.283 . . . . 1.13 110.93 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.484 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 75.4 m-20 -82.69 -4.28 57.6 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.065 0.46 . . . . 1.6 109.908 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 18.0 m -145.71 148.34 32.92 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.305 -0.558 . . . . 1.37 110.318 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.725 HG22 ' OH ' ' A' ' 133' ' ' TYR . 6.2 mt -110.23 168.75 4.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.562 -1.273 . . . . 1.05 107.562 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.895 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.3 tt0 -124.03 108.75 12.7 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.712 -0.795 . . . . 0.97 110.017 172.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.544 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -111.81 125.62 54.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.376 0.607 . . . . 1.97 111.45 -170.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -64.76 123.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.549 -0.75 . . . . 1.09 109.699 173.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.541 ' HD3' ' N ' ' A' ' 157' ' ' ARG . 2.3 tmt_? -76.89 146.3 37.73 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.15 -0.685 . . . . 3.55 109.15 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.541 ' N ' ' HD3' ' A' ' 156' ' ' ARG . 35.5 ttp180 -44.89 120.11 4.12 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 123.779 0.675 . . . . 4.84 111.153 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 1.6 Cg_endo -77.01 175.85 10.88 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.755 2.303 . . . . 2.01 112.268 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -76.31 124.53 27.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.677 0.751 . . . . 5.88 111.421 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.651 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 20.4 m-20 -119.88 131.7 55.33 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.323 -0.853 . . . . 5.15 111.736 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.587 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 49.8 m-85 -120.71 170.14 7.68 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-N 115.479 -0.782 . . . . 6.88 110.706 168.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.9 Cg_endo -77.45 -45.35 0.16 Allowed 'Trans proline' 0 N--CA 1.414 -3.204 0 C-N-CA 122.055 1.837 . . . . 9.11 110.856 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -91.35 -4.15 56.05 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 112.9 -1.954 . . . . 10.53 109.795 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.9 m -163.77 151.67 12.93 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.197 -1.365 . . . . 8.25 111.611 -169.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.651 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 58.0 mttt -149.69 136.41 19.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.232 0.539 . . . . 7.11 110.771 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.26 -169.48 2.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.244 -0.889 . . . . 5.04 111.881 -167.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 67.4 145.51 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.996 -1.002 . . . . 2.35 113.315 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.639 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 12.7 pm0 -148.38 132.61 17.42 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.58 0.705 . . . . 3.48 109.234 164.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.769 HG12 ' N ' ' A' ' 170' ' ' ARG . 84.1 t -135.1 143.91 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-N 115.511 -0.768 . . . . 1.23 109.173 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.769 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -124.82 145.01 49.98 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.231 1.015 . . . . 2.3 112.765 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -117.61 163.73 16.01 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.414 -1.721 . . . . 1.04 110.627 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 39.6 ttt180 -113.69 118.9 35.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.646 -1.242 . . . . 4.19 107.646 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.619 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.51 106.42 14.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 113.805 -1.543 . . . . 1.33 109.973 -164.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 180' ' ' LEU . 53.5 m -105.01 149.37 25.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.609 -0.723 . . . . 1.02 112.306 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.835 ' CD1' HD12 ' A' ' 119' ' ' ILE . 9.0 m-85 -112.62 115.12 28.09 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.058 -1.428 . . . . 0.44 111.559 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -107.1 100.18 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.18 0.514 . . . . 0.74 111.121 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.8 -119.29 5.15 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.143 -1.027 . . . . 0.28 112.653 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -111.75 12.4 21.03 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 178.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.687 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 14.5 p-80 -137.22 160.04 40.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.544 -1.207 . . . . 2.16 111.82 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 174' ' ' THR . 7.9 tp -67.82 134.1 50.36 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.755 -1.111 . . . . 1.05 110.82 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.14 -54.57 5.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.327 -1.306 . . . . 1.03 111.066 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.509 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.2 t 178.69 177.12 0.48 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.13 -0.941 . . . . 1.09 109.896 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.509 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.39 132.22 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 1.04 107.007 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.698 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.6 t -135.17 115.77 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.887 0.699 . . . . 1.15 112.887 -167.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -59.38 100.45 0.08 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.946 -1.131 . . . . 2.01 107.946 171.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.554 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 2.7 mmt -56.87 -15.97 5.83 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 112.962 -1.926 . . . . 2.01 112.622 -169.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.419 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.1 mt-10 -73.88 -45.39 51.18 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 114.44 -1.255 . . . . 0.68 110.692 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -97.09 -24.72 15.63 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.072 -1.422 . . . . 2.66 111.368 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.698 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.5 p-10 36.24 43.26 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.236 1.199 . . . . 2.15 114.236 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -174.2 -56.47 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.729 -0.669 . . . . 4.73 109.431 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -79.43 60.78 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 4.52 110.598 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 26.6 t80 177.08 -40.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.235 -0.893 . . . . 1.94 109.183 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.643 ' C ' HG23 ' A' ' 184' ' ' VAL . . . 173.31 164.93 29.42 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.469 -0.787 . . . . 1.84 111.901 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -171.93 126.81 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.27 0.628 . . . . 5.39 110.228 170.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -162.18 143.57 10.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.265 -0.272 . . . . 7.14 110.265 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.91 142.57 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 7.18 110.1 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -82.66 140.27 33.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.954 -0.387 . . . . 2.04 109.954 175.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.67 82.36 48.36 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.353 0.597 . . . . 3.38 111.586 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.65 -46.41 2.66 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.2 1.933 . . . . 5.38 110.25 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.018 -0.992 . . . . 8.41 109.096 176.723 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.217 0.532 . . . . 31.29 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.25 57.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.689 -0.767 . . . . 30.78 112.178 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -79.16 -32.21 44.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.574 -0.528 . . . . 30.69 109.574 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -70.8 106.94 3.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.756 -0.656 . . . . 29.95 110.5 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -118.24 167.19 11.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.72 -0.673 . . . . 29.85 110.669 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 46.8 m170 62.76 78.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.61 0.569 . . . . 30.29 110.758 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -96.85 136.43 37.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.272 -0.422 . . . . 28.16 109.886 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -122.1 38.0 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.705 0.288 . . . . 26.24 111.253 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 61.9 87.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.682 -0.69 . . . . 26.48 111.385 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -70.31 -27.3 64.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.037 -0.528 . . . . 26.97 111.194 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.5 t -83.89 -4.42 58.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.853 0.358 . . . . 24.89 110.33 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 m -116.53 -77.53 0.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.198 -0.456 . . . . 24.15 110.025 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.35 -151.49 10.01 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.203 -0.453 . . . . 22.8 112.772 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.7 129.38 47.03 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.946 -0.761 . . . . 21.12 108.946 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.4 m -82.91 121.76 77.64 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.111 0.481 . . . . 20.12 110.77 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -87.51 61.04 3.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.831 2.354 . . . . 19.33 111.994 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -112.42 54.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.4 0.619 . . . . 19.37 110.145 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.19 56.32 4.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.758 -0.655 . . . . 15.69 111.493 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.3 m -143.27 151.78 40.94 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.04 -0.356 . . . . 14.22 110.04 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -142.02 80.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.149 0.5 . . . . 13.16 109.749 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 115' ' ' PRO . 91.7 mmm -81.19 101.11 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.722 -0.672 . . . . 12.29 110.609 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.49 102.69 0.21 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.433 -0.667 . . . . 8.13 111.433 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -89.8 -80.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.541 0.171 . . . . 9.83 111.452 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.477 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 27.0 ptt? -161.06 33.18 0.14 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.881 0.848 . . . . 6.46 111.174 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.5 -35.76 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.945 -1.025 . . . . 5.19 109.723 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -143.76 138.37 28.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.487 -0.779 . . . . 4.9 109.01 175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' O ' HD13 ' A' ' 183' ' ' ILE . 1.6 tt -88.46 100.98 13.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.802 -0.814 . . . . 1.91 108.802 176.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.583 ' N ' ' HD3' ' A' ' 115' ' ' PRO . 37.1 tt0 178.09 60.64 0.07 OUTLIER Pre-proline 0 C--N 1.317 -0.818 0 O-C-N 124.36 1.038 . . . . 3.45 109.288 165.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.649 ' C ' ' H ' ' A' ' 117' ' ' MET . 5.1 Cg_exo -79.41 178.69 7.12 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.437 2.092 . . . . 3.73 109.273 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -63.98 21.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.451 -0.34 . . . . 3.24 111.189 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.649 ' H ' ' C ' ' A' ' 115' ' ' PRO . 18.1 tpp -49.31 132.41 20.08 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.975 0.893 . . . . 2.04 110.11 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 23.1 m -125.36 95.59 4.52 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.597 -1.183 . . . . 1.11 108.435 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.879 HD12 ' CD1' ' A' ' 175' ' ' PHE . 6.4 pt -125.71 171.24 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.344 1.069 . . . . 1.07 111.391 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.72 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.0 m -111.08 167.3 10.37 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.449 -1.705 . . . . 1.71 108.634 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -51.81 -45.92 64.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.031 0.443 . . . . 3.81 111.195 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.432 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 23.0 t-20 -83.66 -17.87 40.0 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.419 -0.355 . . . . 2.18 110.4 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.904 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.8 mt-10 -66.1 -25.1 66.85 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 120.409 -0.516 . . . . 0.5 110.876 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.658 ' O ' HD11 ' A' ' 128' ' ' LEU . 6.1 tpt -88.86 -24.15 22.61 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.102 -1.439 . . . . 3.61 109.723 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 122' ' ' ASN . 2.1 t -61.36 -31.19 49.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.624 -1.171 . . . . 1.12 111.786 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.728 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.89 -40.81 27.49 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.014 -0.993 . . . . 2.07 110.399 169.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.904 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.13 -36.9 81.0 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.393 -1.289 . . . . 1.14 114.108 -175.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.672 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.05 -37.24 86.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.314 -2.154 . . . . 1.06 109.008 176.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.488 ' N ' HD21 ' A' ' 128' ' ' LEU . 25.6 mt-10 -65.45 -32.29 73.83 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.88 1.324 . . . . 2.51 107.802 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -90.9 -7.03 53.32 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.383 -2.189 . . . . 1.06 110.617 -169.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.4 t -122.11 0.91 9.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.949 0.88 . . . . 1.12 109.38 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 66.1 58.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 113.62 -1.627 . . . . 2.86 111.997 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.716 ' HH ' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -150.49 143.24 24.6 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.055 -1.832 . . . . 0.88 106.055 178.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.73 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.08 163.81 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.489 -1.3 . . . . 0.92 107.489 -175.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -52.28 160.12 0.85 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.383 1.087 . . . . 2.42 111.821 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -145.34 152.65 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.326 0 CA-C-N 113.629 -1.623 . . . . 1.08 110.938 -170.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.438 ' N ' HG13 ' A' ' 136' ' ' VAL . 4.2 m -60.08 -50.12 74.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.862 0.839 . . . . 1.17 111.55 175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.579 ' N ' HG13 ' A' ' 136' ' ' VAL . 17.7 ptmt -157.48 110.06 2.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.19 -1.368 . . . . 1.24 108.902 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.672 ' CG ' ' HA ' ' A' ' 145' ' ' PHE . 5.8 ttp -68.97 100.5 1.22 Allowed 'General case' 0 N--CA 1.398 -3.075 0 CA-C-O 122.364 1.078 . . . . 3.14 113.509 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.802 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.8 t -160.11 94.85 1.13 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.162 -1.836 . . . . 1.11 108.389 157.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.802 ' HD3' ' O ' ' A' ' 140' ' ' THR . 18.3 mmt180 -149.37 169.98 8.35 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 114.056 -1.429 . . . . 2.98 107.445 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.55 111.32 2.55 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 CA-C-N 119.578 0.885 . . . . 1.1 110.87 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.25 13.14 83.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.797 -0.716 . . . . 0.38 114.188 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.9 mm-40 -122.14 132.96 54.74 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.949 -1.5 . . . . 1.49 106.949 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.794 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -130.02 174.36 9.85 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.47 -1.292 . . . . 0.38 111.493 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 139' ' ' MET . 9.4 p -111.86 139.35 47.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.801 0.81 . . . . 1.09 111.406 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.716 HG23 ' HH ' ' A' ' 133' ' ' TYR . 55.1 t -100.16 141.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.801 -1.545 . . . . 1.62 111.064 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.525 ' HB3' ' O ' ' A' ' 151' ' ' SER . 35.9 tt0 -129.16 -80.85 0.57 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.803 -0.18 . . . . 2.74 111.146 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -170.45 -88.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.638 0.256 . . . . 1.13 111.388 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.47 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 88.9 m-20 -81.59 -2.25 49.39 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.464 0.65 . . . . 1.6 109.264 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.525 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.3 m -144.02 148.03 34.67 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.53 -0.759 . . . . 1.37 109.87 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.66 HG23 ' OH ' ' A' ' 133' ' ' TYR . 4.9 mt -109.31 171.44 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.075 -1.454 . . . . 1.05 107.075 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.794 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 11.0 tt0 -115.77 140.06 49.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.762 -1.57 . . . . 0.97 106.762 169.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.407 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.2 ppp? -138.82 131.46 29.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.832 0.742 . . . . 1.97 111.969 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -75.14 144.46 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 110.016 -0.365 . . . . 1.09 110.016 171.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.522 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 40.2 ttt180 -69.27 178.36 2.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 3.55 108.841 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 110' ' ' MET . 36.1 mtm180 -65.95 114.54 16.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 118.167 0.44 . . . . 4.84 111.031 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.498 ' HA ' ' HB2' ' A' ' 168' ' ' GLN . 63.3 Cg_endo -77.99 176.08 10.4 Favored 'Trans proline' 0 CA--C 1.515 -0.425 0 C-N-CA 122.904 2.403 . . . . 2.01 113.416 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -125.49 126.62 45.17 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.302 -1.317 . . . . 5.88 110.158 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.54 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 4.5 m-20 -129.57 123.37 31.18 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.879 -1.055 . . . . 5.15 110.365 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 0.7 OUTLIER -121.77 172.31 5.2 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 121.812 0.815 . . . . 6.88 111.204 177.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 161' ' ' PHE . 1.2 Cg_endo -76.08 -42.96 0.34 Allowed 'Trans proline' 0 N--CA 1.416 -3.053 0 C-N-CA 122.239 1.959 . . . . 9.11 110.385 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.79 -6.06 57.64 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 112.204 -2.271 . . . . 10.53 109.348 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.9 m -163.82 137.02 5.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.943 -1.48 . . . . 8.25 112.768 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.54 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 48.6 mttt -148.62 141.66 24.89 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.027 0.441 . . . . 7.11 110.763 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -165.05 -168.82 1.51 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.153 -0.93 . . . . 5.04 111.518 -172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -107.98 -169.59 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.057 -0.974 . . . . 2.35 111.908 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.532 ' CG ' ' H ' ' A' ' 169' ' ' VAL . 6.6 tp-100 -134.22 -178.02 4.85 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.169 0.509 . . . . 3.48 110.891 -166.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.532 ' H ' ' CG ' ' A' ' 168' ' ' GLN . 3.0 t -87.9 144.9 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 108.203 -1.036 . . . . 1.23 108.203 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.653 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -120.03 144.23 47.65 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.781 1.277 . . . . 2.3 114.029 -176.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -110.84 167.73 10.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 112.462 -2.153 . . . . 1.04 110.414 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.428 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 3.1 ptp180 -115.59 118.76 34.01 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.078 -1.453 . . . . 4.19 107.078 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -110.45 111.01 21.98 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.097 -1.411 . . . . 1.33 109.826 -165.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.533 ' O ' HD13 ' A' ' 180' ' ' LEU . 55.1 m -109.85 149.77 29.37 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.742 0.782 . . . . 1.02 112.998 -167.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.879 ' CD1' HD12 ' A' ' 119' ' ' ILE . 5.2 m-85 -114.82 117.42 30.67 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.623 -1.626 . . . . 0.44 110.535 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.445 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 0.5 OUTLIER -113.4 108.04 16.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.964 0.888 . . . . 0.74 110.491 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.81 -122.0 6.23 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.183 -1.008 . . . . 0.28 112.788 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.493 ' O ' HG22 ' A' ' 118' ' ' THR . 2.1 t70 -111.95 12.1 20.72 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.779 -1.563 . . . . 1.61 106.779 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.699 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 6.7 p80 -140.29 160.98 38.77 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.747 -1.115 . . . . 2.16 112.326 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.555 HD11 HD11 ' A' ' 173' ' ' LEU . 9.1 tp -65.9 135.91 55.41 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 114.574 -1.193 . . . . 1.05 110.551 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.445 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.62 -51.67 6.0 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.449 -1.251 . . . . 1.03 111.444 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 195' ' ' PHE . 4.5 t 175.72 177.42 0.2 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.225 -0.898 . . . . 1.09 110.115 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.474 HD12 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -149.31 123.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.523 -1.288 . . . . 1.04 107.523 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.743 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 94.3 t -126.9 119.97 54.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.395 0.517 . . . . 1.15 112.395 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 171' ' ' ALA . 8.5 m120 -60.54 97.44 0.05 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.492 1.139 . . . . 2.01 108.458 171.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 75.0 mtp -54.17 -28.65 41.73 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 112.015 -2.357 . . . . 2.01 112.652 -166.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.417 ' HG3' HG12 ' A' ' 169' ' ' VAL . 2.0 mt-10 -61.61 -42.15 98.47 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.0 -1.454 . . . . 0.68 110.122 -172.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -106.26 -27.48 11.0 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.525 -1.671 . . . . 2.66 111.218 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.743 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 28.5 t-20 37.25 53.4 1.26 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.676 0.751 . . . . 2.15 111.333 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 192' ' ' PHE . 5.0 ptp180 -90.8 -147.73 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.072 -0.967 . . . . 4.73 109.76 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -75.17 26.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 4.52 111.217 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 190' ' ' ARG . 20.9 t80 -73.6 -27.6 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.824 -0.806 . . . . 1.94 108.824 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -174.25 175.06 46.66 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.12 -0.946 . . . . 1.84 112.207 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -163.01 134.12 4.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.95 0.9 . . . . 5.39 108.869 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.52 ' HB3' HG21 ' A' ' 182' ' ' THR . 44.7 p90 -144.49 149.36 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.497 0.555 . . . . 7.14 112.497 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -135.1 118.07 16.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.194 -0.912 . . . . 7.18 109.09 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 2.8 mm? -120.7 126.05 49.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.141 0.496 . . . . 2.04 111.148 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.6 ' H ' ' HD2' ' A' ' 199' ' ' PRO . 5.0 m-20 -125.86 -57.66 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 3.38 111.194 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.6 ' HD2' ' H ' ' A' ' 198' ' ' ASP . 19.9 Cg_endo -60.68 121.45 9.74 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.74 1.626 . . . . 5.38 112.221 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.219 -0.896 . . . . 8.41 109.938 178.927 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.194 -0.298 . . . . 31.29 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 147.14 46.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.685 -0.769 . . . . 30.78 112.376 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m 63.77 12.88 7.02 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.811 0.444 . . . . 30.69 112.063 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 m -100.91 95.51 6.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.072 0.463 . . . . 29.95 111.049 -173.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -130.92 40.73 3.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.9 -0.591 . . . . 29.85 109.826 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -75.54 -29.01 59.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 30.29 110.921 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -71.35 -43.5 66.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 28.16 110.412 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -100.78 90.32 4.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 26.24 110.306 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.16 139.24 58.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.739 -0.664 . . . . 26.48 110.57 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -94.88 102.27 14.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.189 -0.46 . . . . 26.97 110.449 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.7 m -77.8 96.34 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.266 -0.425 . . . . 24.89 110.463 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.5 m -72.88 92.78 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 24.15 110.97 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -154.74 26.6 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.713 -0.676 . . . . 22.8 112.23 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.38 -12.96 60.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.975 0.417 . . . . 21.12 110.694 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 m -99.13 117.94 63.38 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.053 -0.521 . . . . 20.12 110.399 175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.13 -2.52 12.61 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.685 2.256 . . . . 19.33 111.95 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -102.23 124.33 47.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.885 -0.598 . . . . 19.37 110.105 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.47 -71.22 2.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.053 -0.594 . . . . 15.69 112.683 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.8 m -85.59 83.22 7.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.09 0.472 . . . . 14.22 111.043 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -167.24 144.98 4.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.795 -0.639 . . . . 13.16 109.635 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.0 tpt -78.58 -27.15 45.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.209 0.528 . . . . 12.29 110.141 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 171.88 -118.99 0.76 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.973 -0.851 . . . . 8.13 110.973 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 131' ' ' THR . 60.3 mtp180 -127.79 139.24 52.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.294 -0.632 . . . . 9.83 109.294 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.3 ptm -125.83 23.15 7.33 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.709 1.242 . . . . 6.46 109.377 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.74 133.94 49.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.088 -1.869 . . . . 5.19 109.297 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -71.65 135.17 46.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.41 -0.359 . . . . 4.9 110.375 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.696 HD21 ' N ' ' A' ' 114' ' ' GLU . 4.0 tt -75.79 131.06 39.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.101 -0.703 . . . . 1.91 109.101 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.696 ' N ' HD21 ' A' ' 113' ' ' LEU . 45.9 mt-10 -159.63 159.89 27.84 Favored Pre-proline 0 CA--C 1.498 -1.035 0 N-CA-C 108.422 -0.955 . . . . 3.45 108.422 -171.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.472 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 97.8 Cg_endo -91.2 100.61 0.23 Allowed 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 117.808 -0.994 . . . . 3.73 112.478 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.99 -7.74 14.52 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 102.582 -3.118 . . . . 3.24 102.582 139.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.536 ' HG3' HG23 ' A' ' 119' ' ' ILE . 29.8 tpp -76.71 140.88 41.01 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 110.921 -2.854 . . . . 2.04 111.229 -169.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.544 HG21 ' HB3' ' A' ' 179' ' ' HIS . 6.2 m -126.67 103.09 7.37 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.24 -0.891 . . . . 1.11 109.083 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.864 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.2 pt -135.12 172.74 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 115.105 -0.952 . . . . 1.07 111.096 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.709 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.4 p -124.78 177.3 6.07 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.574 -1.194 . . . . 1.71 110.482 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 124' ' ' MET . 65.4 tttp -50.7 -48.76 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.422 0.451 . . . . 3.81 111.864 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.511 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 63.3 t30 -84.23 -18.64 35.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 122.273 -0.267 . . . . 2.18 110.285 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.74 -23.53 63.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.877 -0.729 . . . . 0.5 109.813 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.644 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.5 -28.32 25.04 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.401 -1.32 . . . . 3.61 109.855 177.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.89 -33.06 56.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 122.463 1.125 . . . . 1.12 111.767 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.748 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.38 -41.71 32.46 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.379 -1.282 . . . . 2.07 110.17 169.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.39 -38.32 86.62 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-O 117.525 -1.226 . . . . 1.14 114.215 -173.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.704 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 116.184 -2.206 . . . . 1.06 108.566 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.654 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 61.5 mm-40 -67.94 -29.69 68.81 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 123.189 1.471 . . . . 2.51 108.741 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -85.55 -6.97 59.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.016 -2.357 . . . . 1.06 110.028 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 128' ' ' LEU . 13.3 t -122.54 -0.66 9.18 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.152 -0.931 . . . . 1.12 109.657 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 77.4 51.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 113.865 -1.516 . . . . 2.86 112.436 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.735 ' OH ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -151.95 145.05 24.57 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.195 -1.409 . . . . 0.88 107.195 -178.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.656 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -142.62 160.83 39.54 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.166 -1.79 . . . . 0.92 106.166 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -53.04 160.17 1.05 Allowed 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 119.383 0.992 . . . . 2.42 111.656 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.594 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.44 153.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.333 -1.303 . . . . 1.08 111.979 -169.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -60.9 -50.13 74.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.556 0.693 . . . . 1.17 111.886 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.594 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.6 ptmt -157.0 114.64 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.35 -1.296 . . . . 1.24 108.793 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.765 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.18 107.28 15.62 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 122.798 1.285 . . . . 3.14 111.242 -167.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.672 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.8 t -156.92 95.49 1.52 Allowed 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.882 -1.508 . . . . 1.11 108.584 163.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.672 ' HD3' ' O ' ' A' ' 140' ' ' THR . 19.3 mmt85 -151.54 169.64 9.08 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 113.622 -1.626 . . . . 2.98 108.099 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.03 110.47 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 N-CA-C 109.43 -1.027 . . . . 1.1 109.43 161.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.61 26.95 58.05 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.356 -0.926 . . . . 0.38 114.09 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 32.8 mt-10 -138.82 130.6 27.72 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.41 -1.33 . . . . 1.49 107.41 171.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.775 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -134.0 176.8 8.25 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.61 -0.836 . . . . 0.38 110.482 -165.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.765 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 14.3 p -113.5 138.92 49.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.829 0.823 . . . . 1.09 112.291 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.18 141.47 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 113.696 -1.593 . . . . 1.62 110.862 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -127.48 -81.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.771 -0.372 . . . . 2.74 111.071 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.48 -88.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 1.13 111.712 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.667 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 15.6 m120 -85.53 -3.02 58.74 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.296 0.569 . . . . 1.6 109.564 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 m -142.41 146.63 35.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.786 -0.643 . . . . 1.37 110.286 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.735 HG22 ' OH ' ' A' ' 133' ' ' TYR . 5.6 mt -106.34 169.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.467 -1.308 . . . . 1.05 107.467 169.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.775 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.5 tt0 -115.71 135.57 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.561 -1.644 . . . . 0.97 106.561 166.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.472 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.0 ppp? -134.66 127.9 32.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.874 0.761 . . . . 1.97 111.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -65.05 122.02 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.356 -0.609 . . . . 1.09 109.356 173.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.4 155.96 25.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.463 -0.569 . . . . 3.55 109.463 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -59.36 131.21 87.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.642 -0.503 . . . . 4.84 109.642 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -53.26 153.32 17.11 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.608 2.205 . . . . 2.01 112.819 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.486 ' CE1' HG23 ' A' ' 169' ' ' VAL . 2.9 p90 -139.81 157.37 45.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.444 -0.798 . . . . 5.88 112.162 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.624 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 3.4 m-20 -130.14 131.32 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.413 -1.267 . . . . 5.15 110.035 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 58.9 m-85 -119.33 168.68 9.49 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-O 121.741 0.781 . . . . 6.88 110.83 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -75.5 -44.22 0.31 Allowed 'Trans proline' 0 N--CA 1.413 -3.241 0 C-N-CA 121.843 1.696 . . . . 9.11 110.428 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -90.73 -2.5 57.81 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 112.524 -2.125 . . . . 10.53 109.397 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.2 m -164.21 137.98 5.38 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.091 -1.413 . . . . 8.25 112.836 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.624 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 58.1 mttt -146.13 138.09 25.07 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.405 0.621 . . . . 7.11 111.482 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -160.24 -167.64 1.98 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.64 -1.164 . . . . 5.04 110.874 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -108.34 -122.57 4.73 Favored Glycine 0 C--N 1.312 -0.8 0 C-N-CA 120.595 -0.812 . . . . 2.35 113.028 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -82.08 152.37 26.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.806 0.813 . . . . 3.48 109.692 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.788 HG12 ' N ' ' A' ' 170' ' ' ARG . 54.4 t -138.11 149.12 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 CA-C-N 114.354 -1.294 . . . . 1.23 108.351 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.788 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -120.81 142.71 49.35 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 122.524 1.155 . . . . 2.3 113.083 176.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.16 166.88 11.52 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 112.772 -2.013 . . . . 1.04 110.46 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.408 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 20.0 ttt180 -116.88 119.38 35.21 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.503 -1.295 . . . . 4.19 107.503 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.625 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.0 114.57 27.08 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.795 -1.548 . . . . 1.33 110.027 -164.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.554 ' O ' HD11 ' A' ' 180' ' ' LEU . 54.2 m -110.8 150.98 28.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 112.76 0.652 . . . . 1.02 112.76 -168.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.864 ' CD1' HD12 ' A' ' 119' ' ' ILE . 12.8 m-85 -113.59 103.47 11.28 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.38 -1.282 . . . . 0.44 112.873 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.59 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 9.9 t0 -89.76 96.1 10.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.209 0.528 . . . . 0.74 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.63 -115.56 4.04 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.099 -1.048 . . . . 0.28 113.159 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.49 ' O ' HG21 ' A' ' 118' ' ' THR . 3.2 t70 -111.07 9.44 22.04 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.756 -1.572 . . . . 1.61 106.756 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.676 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 9.5 p-80 -137.65 161.09 37.4 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.221 -1.354 . . . . 2.16 111.807 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 174' ' ' THR . 10.5 tp -67.03 137.32 56.38 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.177 -0.919 . . . . 1.05 110.849 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.59 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -89.16 -54.23 4.21 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.173 -1.376 . . . . 1.03 111.631 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.2 t -176.97 177.09 1.33 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.123 -0.944 . . . . 1.09 110.12 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.618 ' CG1' HD12 ' A' ' 173' ' ' LEU . 2.6 mp -151.84 124.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.455 -1.683 . . . . 1.04 106.455 176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.706 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 69.4 t -128.23 123.8 60.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.776 0.658 . . . . 1.15 112.776 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.87 98.49 0.05 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.317 -0.994 . . . . 2.01 108.317 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 72.0 mmm -58.9 -16.72 18.93 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 113.332 -1.758 . . . . 2.01 112.896 -168.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.551 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.8 mt-10 -72.35 -42.59 65.13 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.473 -1.24 . . . . 0.68 110.175 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.96 -26.73 13.31 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.082 -1.417 . . . . 2.66 112.007 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.706 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.5 p-10 41.21 29.38 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.342 1.608 . . . . 2.15 115.342 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -139.05 -64.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 4.73 110.624 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -77.42 64.81 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 4.52 110.859 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 178.61 -21.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.237 -0.892 . . . . 1.94 109.193 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 152.88 -157.82 27.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.897 -0.668 . . . . 1.84 112.494 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -162.8 147.35 11.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.954 -0.758 . . . . 5.39 108.954 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -110.64 102.69 11.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.404 0.621 . . . . 7.14 112.011 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -135.72 125.6 25.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.667 -0.697 . . . . 7.18 110.211 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.667 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 11.8 mt -131.74 125.73 32.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 2.04 111.979 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -136.61 73.44 54.99 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.281 -1.007 . . . . 3.38 108.281 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.39 81.85 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.527 2.818 . . . . 5.38 113.632 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.462 -0.78 . . . . 8.41 111.088 173.746 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.968 -0.382 . . . . 31.29 109.968 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.16 95.39 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.061 -0.59 . . . . 30.78 112.899 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -115.17 84.55 2.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.979 0.419 . . . . 30.69 110.602 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -75.28 97.97 3.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.163 -0.471 . . . . 29.95 110.656 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -74.83 119.86 19.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 29.85 110.453 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.908 -0.405 . . . . 30.29 109.908 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 58.58 69.26 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.897 -0.592 . . . . 28.16 111.459 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -128.21 129.95 47.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 26.24 110.075 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -94.39 -168.24 1.81 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.984 -0.553 . . . . 26.48 110.493 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -54.48 115.04 1.9 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.017 -0.364 . . . . 26.97 110.017 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -112.29 73.58 0.82 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.142 0.496 . . . . 24.89 110.757 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 m -71.14 138.54 49.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.071 -0.513 . . . . 24.15 110.467 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.44 -61.37 1.24 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.865 -0.683 . . . . 22.8 112.727 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.539 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -81.29 48.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.331 0.586 . . . . 21.12 111.388 -176.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -136.52 93.74 14.09 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.762 -0.654 . . . . 20.12 110.68 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.24 -53.53 2.39 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.845 2.363 . . . . 19.33 111.694 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -130.28 77.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 19.37 109.844 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.28 -168.46 29.49 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.596 -0.811 . . . . 15.69 112.406 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m 56.07 49.56 15.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.109 0.481 . . . . 14.22 111.341 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.83 28.4 7.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.192 0.52 . . . . 13.16 110.26 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 68.0 mtm -127.45 147.93 50.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.812 -0.631 . . . . 12.29 110.127 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.46 44.2 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 8.13 112.349 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 109' ' ' ARG . 5.9 mmp_? 59.16 44.47 15.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.93 0.395 . . . . 9.83 111.278 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.6 ptm -112.07 12.74 20.61 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.539 1.162 . . . . 6.46 109.698 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.68 -37.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 113.102 -1.863 . . . . 5.19 109.33 172.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.2 84.38 2.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.723 -0.843 . . . . 4.9 108.723 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.692 HD11 ' N ' ' A' ' 114' ' ' GLU . 0.6 OUTLIER -64.53 125.23 24.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 1.91 109.583 179.016 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.692 ' N ' HD11 ' A' ' 113' ' ' LEU . 31.0 tt0 -176.76 155.52 1.29 Allowed Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 106.421 -1.696 . . . . 3.45 106.421 -171.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.482 ' HA ' ' H ' ' A' ' 117' ' ' MET . 3.7 Cg_exo -83.84 101.84 0.93 Allowed 'Trans proline' 0 N--CA 1.424 -2.579 0 CA-C-N 121.252 1.483 . . . . 3.73 112.119 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -110.39 4.11 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 102.015 -3.328 . . . . 3.24 102.015 139.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.482 ' H ' ' HA ' ' A' ' 115' ' ' PRO . 9.6 tpt -96.2 139.78 31.86 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 111.261 -2.7 . . . . 2.04 111.194 -163.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.544 HG21 ' HB3' ' A' ' 179' ' ' HIS . 8.4 m -127.94 102.94 6.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.52 -1.218 . . . . 1.11 108.751 175.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.826 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.56 170.6 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.104 -0.953 . . . . 1.07 110.773 -174.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.715 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.6 m -119.57 177.05 5.08 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.648 -1.16 . . . . 1.71 109.461 -170.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 124' ' ' MET . 51.3 pttt -51.6 -48.02 63.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.397 . . . . 3.81 111.671 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 121' ' ' LYS . 27.8 t-20 -84.07 -18.1 38.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.474 -0.33 . . . . 2.18 110.406 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.912 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.03 -22.67 64.04 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.911 -0.716 . . . . 0.5 110.627 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.572 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.09 -27.15 22.13 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.212 -0.995 . . . . 3.61 109.925 176.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.55 -31.77 54.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.569 -1.196 . . . . 1.12 111.565 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.751 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.27 -41.38 34.22 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.942 -1.026 . . . . 2.07 109.808 170.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.69 -40.27 83.13 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-O 117.58 -1.2 . . . . 1.14 114.116 -173.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.785 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -38.35 90.8 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 116.299 -2.16 . . . . 1.06 109.285 177.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' HD22 ' A' ' 128' ' ' LEU . 28.0 mt-10 -65.55 -32.66 74.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.679 1.228 . . . . 2.51 108.013 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -88.74 -7.51 56.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.474 -2.148 . . . . 1.06 110.632 -169.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.571 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.39 0.73 10.07 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.222 -0.899 . . . . 1.12 109.116 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 66.46 56.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.636 -1.62 . . . . 2.86 111.981 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.785 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.58 146.88 27.57 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.92 -1.511 . . . . 0.88 106.92 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.584 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.88 160.21 42.12 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.78 -1.193 . . . . 0.92 107.78 -174.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -46.99 147.78 1.27 Allowed 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 122.021 0.915 . . . . 2.42 112.664 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.607 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -139.09 151.94 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 CA-C-N 113.981 -1.463 . . . . 1.08 112.127 -172.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 m -60.1 -50.08 75.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.914 . . . . 1.17 111.438 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.607 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.04 116.65 3.11 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 1.24 108.73 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.797 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -78.47 102.32 7.78 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 123.082 1.42 . . . . 3.14 111.196 -167.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.679 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 4.1 t -157.84 95.96 1.45 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.984 -1.462 . . . . 1.11 108.646 161.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.679 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.2 mmt180 -151.51 168.84 10.36 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 113.614 -1.63 . . . . 2.98 106.905 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.84 111.39 2.49 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 CA-C-N 119.91 1.004 . . . . 1.1 109.796 162.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.5 20.63 59.81 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.469 -0.872 . . . . 0.38 114.164 172.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 38.8 mt-10 -136.94 132.11 33.96 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.074 -1.084 . . . . 1.49 108.074 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.92 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.29 175.98 9.02 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.702 -0.799 . . . . 0.38 110.408 -165.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.797 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 17.8 p -110.32 139.74 45.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.759 0.79 . . . . 1.09 112.516 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.458 HG22 ' HH ' ' A' ' 133' ' ' TYR . 52.3 t -101.2 129.2 52.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 113.733 -1.576 . . . . 1.62 110.887 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.2 tp60 -113.22 -78.55 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 121.071 -0.251 . . . . 2.74 110.775 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -169.24 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.858 0.361 . . . . 1.13 111.271 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 17.7 m120 -86.7 -2.55 58.62 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.625 -0.509 . . . . 1.6 109.625 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 p -145.2 143.97 30.59 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.957 -0.565 . . . . 1.37 110.533 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG21 ' OH ' ' A' ' 133' ' ' TYR . 7.4 mt -106.82 169.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.303 -1.369 . . . . 1.05 107.303 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.92 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 27.9 tt0 -126.09 111.02 14.2 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.585 -0.846 . . . . 0.97 110.518 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.467 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 10.2 tmm? -112.95 124.29 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.092 0.473 . . . . 1.97 111.872 -169.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -65.99 115.09 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 1.09 110.537 172.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 169' ' ' VAL . 73.5 ttt180 -69.51 146.99 51.44 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.479 -0.782 . . . . 3.55 109.235 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -58.63 122.39 60.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.171 -0.468 . . . . 4.84 110.182 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -50.11 153.08 7.05 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.404 2.736 . . . . 2.01 113.556 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -146.6 157.28 43.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.763 -1.108 . . . . 5.88 112.021 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.552 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 6.5 m-20 -129.82 133.69 47.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.67 -1.15 . . . . 5.15 109.784 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.577 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 42.4 m-85 -119.58 169.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.327 0 CA-C-O 121.777 0.799 . . . . 6.88 111.3 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.7 Cg_endo -76.58 -43.25 0.29 Allowed 'Trans proline' 0 N--CA 1.414 -3.153 0 C-N-CA 122.154 1.903 . . . . 9.11 110.548 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.19 -2.85 57.42 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 112.558 -2.11 . . . . 10.53 109.647 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.1 m -164.12 140.79 6.59 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.08 -1.418 . . . . 8.25 112.507 -172.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.552 ' HE2' ' HB3' ' A' ' 160' ' ' ASP . 58.7 mttt -145.62 148.17 32.83 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.28 0.562 . . . . 7.11 111.46 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.45 -168.02 0.66 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.421 -1.263 . . . . 5.04 109.639 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.68 -120.5 3.31 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.654 -0.784 . . . . 2.35 112.347 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.08 149.61 32.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.58 0.705 . . . . 3.48 109.33 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.771 HG11 ' N ' ' A' ' 170' ' ' ARG . 77.7 t -136.71 148.94 26.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.996 -1.002 . . . . 1.23 108.563 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.771 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -121.07 144.2 48.67 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.367 1.08 . . . . 2.3 112.591 177.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -118.18 161.18 20.3 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 1.04 109.657 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 34.7 ttt180 -109.53 118.82 37.62 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.836 -1.172 . . . . 4.19 107.836 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.644 HD21 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -108.52 103.87 13.08 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.693 -1.594 . . . . 1.33 110.161 -165.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.583 ' CG2' HD12 ' A' ' 197' ' ' LEU . 56.3 m -104.43 149.55 25.32 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.727 -0.67 . . . . 1.02 112.096 -169.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.826 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.0 m-85 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.397 -1.274 . . . . 0.44 112.16 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 20.7 t70 -99.57 97.25 8.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.974 0.416 . . . . 0.74 110.729 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.51 -115.58 4.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.223 -0.989 . . . . 0.28 113.699 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 118' ' ' THR . 17.4 t70 -110.74 7.55 22.17 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 106.864 -1.532 . . . . 1.61 106.864 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.678 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 16.9 p-80 -138.84 161.0 38.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.811 -1.54 . . . . 2.16 111.837 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 174' ' ' THR . 7.6 tp -68.47 131.64 45.63 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.455 -1.248 . . . . 1.05 110.459 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -79.3 -53.53 6.85 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.228 -1.351 . . . . 1.03 110.49 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.714 ' OG1' ' HA3' ' A' ' 193' ' ' GLY . 6.2 t 178.49 178.19 0.42 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.831 -1.077 . . . . 1.09 110.375 -177.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.497 HG13 ' HA ' ' A' ' 173' ' ' LEU . 2.5 mp -146.36 116.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.707 -1.59 . . . . 1.04 106.707 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 99.4 t -115.77 123.66 71.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 113.243 0.831 . . . . 1.15 113.243 -170.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.492 ' OD1' HG12 ' A' ' 169' ' ' VAL . 3.9 t30 -61.13 91.83 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.485 -0.932 . . . . 2.01 108.485 174.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.431 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 70.5 mmm -58.35 -20.47 43.78 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 113.408 -1.724 . . . . 2.01 113.667 -163.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.519 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.5 mt-10 -71.15 -42.78 68.7 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.787 -1.097 . . . . 0.68 110.215 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -98.44 -31.08 12.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.768 -1.56 . . . . 2.66 110.981 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.618 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.9 p-10 36.46 40.99 0.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.955 0.883 . . . . 2.15 112.35 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -105.74 90.04 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.15 -0.932 . . . . 4.73 110.538 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 55.48 26.39 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.463 -0.79 . . . . 4.52 111.907 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 184' ' ' VAL . 0.6 OUTLIER -81.1 2.91 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.817 -0.438 . . . . 1.94 109.817 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.714 ' HA3' ' OG1' ' A' ' 182' ' ' THR . . . 128.4 -5.36 6.71 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.769 -1.205 . . . . 1.84 115.418 171.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -56.65 122.52 12.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.408 0.623 . . . . 5.39 112.244 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -144.92 171.52 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.074 -0.966 . . . . 7.14 109.209 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -94.3 137.13 33.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.088 0.471 . . . . 7.18 111.503 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 175' ' ' PHE . 0.2 OUTLIER -88.42 154.39 20.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.548 -0.751 . . . . 2.04 110.267 176.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.1 79.7 0.29 Allowed Pre-proline 0 N--CA 1.465 0.309 0 O-C-N 123.654 0.596 . . . . 3.38 111.066 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.26 -41.57 6.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.768 2.312 . . . . 5.38 112.28 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.343 -0.837 . . . . 8.41 110.523 -177.31 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.666 0.27 . . . . 31.29 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.88 -141.43 28.26 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.569 -0.824 . . . . 30.78 112.039 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -98.71 80.01 2.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.872 0.368 . . . . 30.69 110.605 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m -97.64 -64.15 1.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.126 -0.488 . . . . 29.95 111.245 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -139.55 -51.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.806 -0.179 . . . . 29.85 110.73 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.6 t60 62.95 95.62 0.04 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.649 0.593 . . . . 30.29 110.607 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -66.92 153.25 44.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.884 -0.598 . . . . 28.16 110.241 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -73.08 135.94 44.86 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.054 -0.721 . . . . 26.24 109.054 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -78.78 82.91 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.913 0.387 . . . . 26.48 110.709 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -86.14 139.26 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.403 . . . . 26.97 110.169 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.5 p -115.49 10.79 15.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.402 0.62 . . . . 24.89 110.395 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 m -103.8 36.79 2.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.518 -0.765 . . . . 24.15 110.737 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.73 49.07 3.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.057 -0.592 . . . . 22.8 112.461 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.17 116.62 24.48 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.389 -0.597 . . . . 21.12 109.389 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.9 121.38 45.97 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.058 -0.519 . . . . 20.12 110.322 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.67 80.93 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.703 2.269 . . . . 19.33 111.955 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -78.26 -40.88 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.518 . . . . 19.37 110.157 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.57 166.28 12.14 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.225 -0.75 . . . . 15.69 111.225 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.0 m 61.43 -161.67 0.29 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.119 -0.326 . . . . 14.22 110.119 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 62.66 72.67 0.49 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.985 0.421 . . . . 13.16 110.785 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.5 ttm -65.87 -40.87 92.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.845 -0.616 . . . . 12.29 111.588 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.89 67.97 1.79 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 8.13 111.428 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -80.81 124.45 29.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.983 -0.377 . . . . 9.83 109.983 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -138.22 26.06 2.67 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.481 1.134 . . . . 6.46 109.129 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' H ' ' A' ' 112' ' ' ASN . 9.3 p -118.45 168.35 10.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.319 -1.764 . . . . 5.19 109.106 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.429 ' H ' HG21 ' A' ' 111' ' ' VAL . 15.5 m120 -54.46 106.31 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.97 0.414 . . . . 4.9 111.254 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.477 HD22 ' HD3' ' A' ' 115' ' ' PRO . 2.3 tt -78.52 107.0 10.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 1.91 110.331 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.607 ' N ' ' HD3' ' A' ' 115' ' ' PRO . 5.9 tp10 178.42 57.79 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.168 0.918 . . . . 3.45 109.221 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.607 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 11.6 Cg_endo -89.59 178.32 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.211 2.608 . . . . 3.73 110.866 177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.48 20.66 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.882 -0.599 . . . . 3.24 111.124 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.598 ' H ' ' C ' ' A' ' 115' ' ' PRO . 7.4 tpt -49.1 138.2 12.39 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.565 0.746 . . . . 2.04 111.601 -172.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 23.4 m -124.66 99.66 6.27 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.295 -0.866 . . . . 1.11 109.061 171.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -130.92 171.14 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-N 115.276 -0.874 . . . . 1.07 110.889 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.689 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -123.35 178.97 4.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.494 -1.23 . . . . 1.71 109.507 -172.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 121' ' ' LYS . 12.7 mptt -56.99 -43.39 81.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.06 0.457 . . . . 3.81 111.295 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 14.1 m120 -83.6 -17.87 40.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.483 -0.326 . . . . 2.18 110.614 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.2 mt-10 -73.52 -21.61 60.35 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.288 -0.565 . . . . 0.5 111.08 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.611 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -87.87 -26.89 22.54 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.276 -0.97 . . . . 3.61 109.716 174.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.05 -30.66 50.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.62 -1.173 . . . . 1.12 111.613 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.732 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.95 -41.97 28.06 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.767 -1.106 . . . . 2.07 109.847 170.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.88 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.07 -36.43 79.61 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 117.389 -1.291 . . . . 1.14 114.27 -172.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.856 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.68 -40.53 95.56 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 116.274 -2.17 . . . . 1.06 109.511 175.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.462 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 23.4 mt-10 -64.62 -29.02 70.02 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.873 1.32 . . . . 2.51 108.03 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -93.07 -7.73 44.79 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 112.548 -2.115 . . . . 1.06 110.858 -169.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.4 t -122.09 -1.78 9.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.741 0.781 . . . . 1.12 109.853 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 70.88 57.31 0.22 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.796 -1.547 . . . . 2.86 111.746 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.856 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.95 145.02 26.24 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 106.766 -1.568 . . . . 0.88 106.766 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.662 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.35 163.68 35.68 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.67 -1.604 . . . . 0.92 106.67 -177.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -46.93 159.63 0.1 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.476 1.132 . . . . 2.42 112.828 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 138' ' ' LYS . 3.4 t -149.75 148.59 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 CA-C-N 113.513 -1.676 . . . . 1.08 111.481 -172.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 m -60.36 -49.61 76.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.241 -0.89 . . . . 1.17 111.57 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.605 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -157.68 115.29 3.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.047 -1.433 . . . . 1.24 108.861 -176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.735 ' HG3' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -75.99 104.41 6.51 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 122.999 1.381 . . . . 3.14 111.506 -168.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.809 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.9 t -157.33 94.12 1.36 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.012 -1.449 . . . . 1.11 109.02 159.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.809 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -152.3 166.26 15.7 Favored Pre-proline 0 CA--C 1.502 -0.882 0 CA-C-N 113.906 -1.497 . . . . 2.98 107.883 171.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -80.95 111.34 2.46 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 CA-C-N 119.84 0.979 . . . . 1.1 109.767 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.98 12.21 68.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.621 -0.8 . . . . 0.38 114.353 172.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.8 mt-10 -128.72 131.79 47.93 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.583 -0.895 . . . . 1.49 108.583 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.85 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.7 m-85 -130.75 174.29 10.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.549 -0.861 . . . . 0.38 110.788 -165.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.667 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 5.9 p -111.39 137.66 48.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.905 -0.776 . . . . 1.09 108.905 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.43 HG23 HG12 ' A' ' 152' ' ' ILE . 4.0 p -111.06 146.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 113.353 0.871 . . . . 1.62 113.353 -168.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.657 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.5 tt0 -154.69 174.97 14.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.591 -0.892 . . . . 2.74 108.591 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.47 ' H ' ' HG2' ' A' ' 148' ' ' GLN . . . -64.54 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.94 1.089 . . . . 1.13 113.94 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.547 ' HB3' HD12 ' A' ' 197' ' ' LEU . 78.2 m-20 -84.71 -4.67 59.14 Favored 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 122.239 -0.288 . . . . 1.6 111.185 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 28.6 p -149.95 134.68 17.65 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.65 -0.82 . . . . 1.37 110.845 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.606 HG22 ' N ' ' A' ' 153' ' ' GLU . 8.0 mt -100.57 171.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.565 -1.272 . . . . 1.05 107.565 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.85 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.6 tt0 -117.11 137.72 52.11 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 106.982 -1.488 . . . . 0.97 106.982 167.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.483 ' CA ' ' HE3' ' A' ' 139' ' ' MET . 1.8 tmt? -135.11 123.55 23.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.615 0.643 . . . . 1.97 112.373 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.643 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -67.4 137.09 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.932 -0.576 . . . . 1.09 110.767 174.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -86.06 145.18 27.18 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.905 -0.776 . . . . 3.55 108.905 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -46.37 132.32 7.74 Favored Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.7 0.625 . . . . 4.84 110.668 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 168' ' ' GLN . 7.1 Cg_endo -52.88 154.06 13.76 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.64 2.226 . . . . 2.01 112.518 -176.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.01 116.16 21.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 5.88 112.135 -172.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.37 121.65 29.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.334 -1.303 . . . . 5.15 110.242 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.602 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 75.0 m-85 -120.45 173.38 3.78 Favored Pre-proline 0 N--CA 1.426 -1.642 0 CA-C-N 115.177 -0.92 . . . . 6.88 110.3 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.0 Cg_endo -79.44 -43.79 0.14 Allowed 'Trans proline' 0 N--CA 1.411 -3.359 0 C-N-CA 121.837 1.691 . . . . 9.11 110.601 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -92.16 -1.56 57.08 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 112.756 -2.02 . . . . 10.53 109.899 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.573 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -164.31 153.59 13.68 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 114.313 -1.312 . . . . 8.25 111.807 -172.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 56.2 mttt -153.73 144.22 22.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 118.227 0.467 . . . . 7.11 110.834 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.3 pt-20 -157.81 -163.83 1.41 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.482 -0.781 . . . . 5.04 111.983 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -87.02 -153.16 23.78 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 115.767 -0.651 . . . . 2.35 114.449 -169.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.551 ' NE2' ' H ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -99.69 160.77 14.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.563 0.697 . . . . 3.48 111.846 -172.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.787 HG12 ' N ' ' A' ' 170' ' ' ARG . 53.8 t -127.11 147.56 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 CA-C-N 114.483 -1.235 . . . . 1.23 108.029 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.787 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -126.37 144.43 50.83 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.132 0.968 . . . . 2.3 113.308 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 163.09 16.49 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.457 -1.701 . . . . 1.04 110.181 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -113.0 118.13 33.97 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.46 -0.941 . . . . 4.19 108.46 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -107.32 111.36 23.68 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.677 -1.601 . . . . 1.33 110.604 -164.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.706 ' CG2' HD13 ' A' ' 197' ' ' LEU . 58.7 m -109.21 152.43 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.736 0.643 . . . . 1.02 112.736 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.896 ' CD1' HD12 ' A' ' 119' ' ' ILE . 13.2 m-85 -118.46 97.87 5.98 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.141 -0.936 . . . . 0.44 112.887 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.703 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 33.9 t70 -86.05 97.02 10.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.113 0.482 . . . . 0.74 110.83 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.07 -118.31 4.82 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.164 -1.017 . . . . 0.28 112.645 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -111.32 13.55 21.63 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.532 -1.285 . . . . 1.61 107.532 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.69 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 30.8 p80 -139.37 160.98 38.56 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.413 -1.267 . . . . 2.16 111.261 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.599 HD12 HD13 ' A' ' 173' ' ' LEU . 10.2 tp -63.71 139.32 58.76 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.347 -0.842 . . . . 1.05 110.876 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.703 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -92.04 -50.48 5.67 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.414 -1.266 . . . . 1.03 111.462 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 6.6 t 176.33 177.34 0.25 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.573 -1.194 . . . . 1.09 110.026 -173.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -148.83 134.27 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 105.839 -1.911 . . . . 1.04 105.839 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.737 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 75.0 t -134.02 116.58 23.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 120.162 -0.615 . . . . 1.15 112.236 -171.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.1 97.81 0.05 Allowed 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.845 -1.169 . . . . 2.01 107.845 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 85.0 mmm -59.48 -16.12 22.04 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.695 -2.048 . . . . 2.01 112.98 -165.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.482 ' HG3' HG11 ' A' ' 169' ' ' VAL . 2.2 mt-10 -72.21 -44.05 63.54 Favored 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 114.499 -1.228 . . . . 0.68 109.791 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -94.4 -33.52 13.12 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.675 -1.602 . . . . 2.66 111.109 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.737 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 5.0 p30 40.02 22.94 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.394 1.627 . . . . 2.15 115.394 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -141.59 -61.04 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.308 -0.245 . . . . 4.73 111.571 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -57.88 -36.3 72.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.03 0.443 . . . . 4.52 110.961 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.446 ' O ' HG12 ' A' ' 184' ' ' VAL . 39.2 t80 -117.14 103.76 10.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.38 -0.6 . . . . 1.94 109.38 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.607 ' CA ' HG23 ' A' ' 184' ' ' VAL . . . 168.75 158.98 13.35 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.025 -1.559 . . . . 1.84 114.62 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.424 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 70.7 m-85 -135.71 -172.89 3.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.503 -0.849 . . . . 5.39 109.281 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -77.4 156.01 31.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.61 0.719 . . . . 7.14 112.064 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.67 164.19 13.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.648 -1.16 . . . . 7.18 110.621 -173.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.706 HD13 ' CG2' ' A' ' 174' ' ' THR . 1.1 mp -68.03 147.63 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.854 -0.612 . . . . 2.04 111.81 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.474 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 19.0 t70 -161.99 -56.02 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.94 . . . . 3.38 109.443 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 198' ' ' ASP . 60.9 Cg_endo -74.28 125.74 9.92 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.558 1.506 . . . . 5.38 111.561 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.286 -0.864 . . . . 8.41 110.349 -179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.179 0.514 . . . . 31.29 109.962 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.65 7.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.76 -0.733 . . . . 30.78 111.684 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -58.03 -38.39 76.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 30.69 110.999 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.178 -0.464 . . . . 29.95 111.477 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -133.81 83.18 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 29.85 111.565 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 49.0 p-80 -158.97 18.3 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 30.29 110.052 175.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 55.8 m80 68.63 104.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.705 -0.68 . . . . 28.16 109.977 -170.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.83 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 26.24 109.972 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 51.83 67.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.565 -0.743 . . . . 26.48 111.308 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -119.31 20.11 12.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.968 -0.56 . . . . 26.97 110.395 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 m 61.76 -164.31 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.876 0.735 . . . . 24.89 110.066 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.9 t 68.15 106.56 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.176 0.512 . . . . 24.15 111.125 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.26 -29.85 67.96 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.783 -0.722 . . . . 22.8 112.06 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.9 tp -88.12 83.76 6.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 21.12 110.477 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 102' ' ' PRO . 8.2 p -151.71 66.03 6.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.983 0.896 . . . . 20.12 110.616 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 12.6 Cg_exo -70.62 -6.46 19.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.047 2.498 . . . . 19.33 112.821 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.535 ' HD3' ' H ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -103.63 2.18 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 19.37 110.209 177.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.47 -22.22 71.19 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 116.013 -0.54 . . . . 15.69 112.581 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.4 t -68.74 -14.31 62.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.83 0.348 . . . . 14.22 110.749 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -90.44 -77.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.106 -0.331 . . . . 13.16 110.106 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 42.9 ttp 51.76 59.71 4.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.319 0.58 . . . . 12.29 110.38 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.39 142.12 7.5 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.814 -0.708 . . . . 8.13 111.976 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -80.49 72.89 7.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.591 . . . . 9.83 110.42 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.0 ptm -157.95 28.02 0.26 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.949 0.88 . . . . 6.46 109.678 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.81 156.32 42.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.335 -1.302 . . . . 5.19 110.575 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.26 142.14 32.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.004 -0.544 . . . . 4.9 109.855 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.67 HD22 ' N ' ' A' ' 114' ' ' GLU . 5.0 tt -72.42 129.25 37.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.45 -0.944 . . . . 1.91 108.45 174.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.67 ' N ' HD22 ' A' ' 113' ' ' LEU . 43.1 mt-10 -159.07 162.65 25.87 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 107.428 -1.323 . . . . 3.45 107.428 -171.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -90.41 99.67 0.27 Allowed 'Trans proline' 0 N--CA 1.419 -2.86 0 C-N-CA 117.177 -1.416 . . . . 3.73 111.991 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -112.18 -5.42 14.21 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 102.401 -3.185 . . . . 3.24 102.401 141.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.502 ' HB3' HD23 ' A' ' 180' ' ' LEU . 9.1 tpt -82.07 143.96 31.15 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 110.786 -2.916 . . . . 2.04 111.444 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.534 HG21 ' HB3' ' A' ' 179' ' ' HIS . 10.3 m -132.31 102.82 5.91 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.917 -1.038 . . . . 1.11 108.927 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.851 HD13 ' CD1' ' A' ' 175' ' ' PHE . 4.3 pt -131.75 171.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.95 -1.023 . . . . 1.07 111.945 -171.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.72 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 21.1 t -123.93 174.76 7.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.57 -1.195 . . . . 1.71 109.39 -172.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -52.2 -42.68 63.72 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.033 0.753 . . . . 3.81 113.033 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.8 t30 -85.61 -18.04 34.44 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.397 -0.815 . . . . 2.18 110.202 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.914 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.56 -25.07 63.82 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.621 -0.432 . . . . 0.5 111.409 -175.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' HD12 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.72 -25.28 22.41 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.096 -1.442 . . . . 3.61 109.696 175.118 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.32 -30.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.766 -1.107 . . . . 1.12 111.737 -177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.743 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.64 -41.44 26.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.698 -1.137 . . . . 2.07 109.822 170.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.77 -40.33 83.64 Favored 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 117.598 -1.191 . . . . 1.14 114.167 -174.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.833 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.97 -38.22 90.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.35 -2.14 . . . . 1.06 109.273 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.463 ' H ' HD21 ' A' ' 128' ' ' LEU . 24.2 mt-10 -66.69 -31.36 71.98 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.86 1.314 . . . . 2.51 108.129 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -89.8 -7.27 54.76 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 112.491 -2.14 . . . . 1.06 110.711 -169.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 128' ' ' LEU . 13.9 t -121.54 -0.47 9.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.339 -0.846 . . . . 1.12 109.289 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 69.16 55.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.767 -1.56 . . . . 2.86 111.737 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.833 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.17 144.95 26.92 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.582 -1.266 . . . . 0.88 107.582 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.655 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.86 162.45 38.62 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.834 -1.172 . . . . 0.92 107.834 -175.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -47.3 146.94 1.73 Allowed 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 113.349 0.87 . . . . 2.42 113.349 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.599 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -140.73 151.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.968 -1.469 . . . . 1.08 112.066 -172.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -61.06 -50.18 74.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.703 0.763 . . . . 1.17 111.937 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.599 ' N ' HG11 ' A' ' 136' ' ' VAL . 16.9 ptmt -154.32 115.95 4.16 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.658 -1.155 . . . . 1.24 109.296 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.765 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 1.0 OUTLIER -77.35 100.58 5.98 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 123.667 1.698 . . . . 3.14 112.106 -166.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.71 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.2 t -158.97 96.37 1.34 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.593 -1.64 . . . . 1.11 109.04 163.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.71 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.4 mmt180 -151.1 169.88 8.62 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.835 -1.543 . . . . 2.98 106.835 170.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.4 111.25 2.33 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 CA-C-N 119.967 1.024 . . . . 1.1 109.874 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.1 22.32 61.23 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.265 -0.969 . . . . 0.38 114.014 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.3 mt-10 -137.4 131.03 31.44 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.912 -1.144 . . . . 1.49 107.912 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.896 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -133.08 176.57 8.39 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.912 -0.715 . . . . 0.38 109.847 -167.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.765 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 16.6 p -108.13 143.48 36.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.608 0.718 . . . . 1.09 111.543 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.79 HG22 ' HH ' ' A' ' 133' ' ' TYR . 55.2 t -106.04 119.93 56.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.268 -1.333 . . . . 1.62 110.976 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.1 tp-100 -101.72 -85.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 2.74 110.436 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.99 -82.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 120.537 0.208 . . . . 1.13 110.745 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.559 ' HB3' HD12 ' A' ' 197' ' ' LEU . 2.2 m-20 -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.588 0.709 . . . . 1.6 109.389 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 47.2 p -138.96 143.08 38.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.92 -1.036 . . . . 1.37 110.05 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.624 HG21 ' N ' ' A' ' 153' ' ' GLU . 8.0 mt -104.64 171.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.574 -1.269 . . . . 1.05 107.574 170.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.896 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.7 tt0 -128.4 106.84 9.27 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.685 -0.806 . . . . 0.97 110.18 171.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.516 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.5 tmt? -110.07 125.96 53.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 1.97 111.713 -167.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -66.93 125.22 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.076 -0.511 . . . . 1.09 109.949 173.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.587 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 19.5 mtp180 -91.14 -176.29 4.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 3.55 110.371 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -64.44 132.02 95.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 110.12 -0.326 . . . . 4.84 110.12 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -54.33 159.87 7.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.569 2.179 . . . . 2.01 112.353 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -94.53 123.67 38.1 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.946 0.879 . . . . 5.88 113.05 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.492 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 1.3 m-20 -130.52 118.79 21.6 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.942 -1.481 . . . . 5.15 110.492 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.613 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 44.8 m-85 -121.52 172.14 5.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.492 -0.776 . . . . 6.88 109.727 174.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.0 Cg_endo -76.97 -43.24 0.26 Allowed 'Trans proline' 0 N--CA 1.412 -3.283 0 C-N-CA 121.619 1.546 . . . . 9.11 110.572 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -95.35 1.06 54.2 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.629 -2.078 . . . . 10.53 109.926 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -162.82 143.9 9.86 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 114.214 -1.357 . . . . 8.25 112.004 -174.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.492 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 51.9 mttt -151.33 145.46 25.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.967 0.413 . . . . 7.11 110.647 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -158.36 -166.45 1.93 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.353 -0.84 . . . . 5.04 111.399 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -93.22 -149.35 24.97 Favored Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.405 -0.816 . . . . 2.35 113.568 -169.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -79.67 156.55 27.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.341 0.591 . . . . 3.48 110.74 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.821 HG11 ' N ' ' A' ' 170' ' ' ARG . 44.6 t -125.49 144.22 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-N 115.18 -0.918 . . . . 1.23 109.178 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.821 ' N ' HG11 ' A' ' 169' ' ' VAL . 2.2 ppt_? -120.47 143.39 48.54 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.59 1.186 . . . . 2.3 113.039 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.88 160.62 22.33 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 112.981 -1.918 . . . . 1.04 110.638 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.38 120.24 41.92 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.097 -1.075 . . . . 4.19 108.097 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.623 HD13 ' CG1' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -114.54 110.72 20.25 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.388 -1.733 . . . . 1.33 110.576 -163.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.564 ' O ' HD11 ' A' ' 180' ' ' LEU . 71.1 m -108.38 148.05 30.67 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.093 -0.38 . . . . 1.02 110.946 -173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.851 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -115.82 99.9 7.63 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.034 0.753 . . . . 0.44 113.034 176.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.523 ' N ' ' HB1' ' A' ' 181' ' ' ALA . 11.0 t0 -77.33 92.69 3.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.373 0.606 . . . . 0.74 111.321 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.54 -109.78 3.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.131 -1.033 . . . . 0.28 114.2 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 118' ' ' THR . 9.1 p-10 -110.29 7.8 23.23 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.613 -1.255 . . . . 1.61 107.613 -177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.664 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 10.3 p-80 -142.29 160.82 39.49 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.071 -1.422 . . . . 2.16 112.1 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.564 HD11 ' O ' ' A' ' 174' ' ' THR . 7.9 tp -65.61 136.43 56.33 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.165 -0.925 . . . . 1.05 110.978 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.523 ' HB1' ' N ' ' A' ' 176' ' ' ASP . . . -87.29 -53.42 4.85 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.521 -1.218 . . . . 1.03 111.54 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 8.8 t -177.84 176.51 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.314 -0.857 . . . . 1.09 110.382 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.623 ' CG1' HD13 ' A' ' 173' ' ' LEU . 2.6 mp -152.2 118.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 113.895 -1.502 . . . . 1.04 107.274 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.681 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 71.9 t -124.48 123.43 66.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.573 0.583 . . . . 1.15 112.573 -171.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.587 ' OD1' ' HD3' ' A' ' 156' ' ' ARG . 94.3 m-20 -60.98 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.194 0.997 . . . . 2.01 108.91 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 88.0 mmm -58.27 -16.49 14.28 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 112.482 -2.145 . . . . 2.01 112.844 -168.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.462 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.8 mt-10 -68.3 -41.64 80.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.256 -1.338 . . . . 0.68 109.915 -176.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -112.87 -20.54 11.55 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.651 -1.613 . . . . 2.66 112.542 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.681 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 13.1 p30 41.54 30.26 0.13 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 114.098 1.147 . . . . 2.15 114.098 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -133.99 -27.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 4.73 110.997 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -51.02 -54.24 26.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.081 -0.711 . . . . 4.52 109.081 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -116.38 164.17 14.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.371 -1.344 . . . . 1.94 107.371 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 176.9 126.41 0.96 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.528 -1.32 . . . . 1.84 113.125 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.461 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 29.8 m-85 -137.64 -175.24 4.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.53 . . . . 5.39 110.936 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -79.14 164.32 24.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.804 -0.635 . . . . 7.14 110.821 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.56 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -94.4 154.97 17.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.613 -0.721 . . . . 7.18 109.72 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 150' ' ' ASN . 7.0 mt -69.61 163.01 26.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.382 -0.372 . . . . 2.04 110.727 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.472 ' N ' ' HD3' ' A' ' 199' ' ' PRO . 4.8 m-20 57.11 63.23 5.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.635 . . . . 3.38 110.908 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -84.42 50.14 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.048 2.499 . . . . 5.38 111.174 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.479 -0.772 . . . . 8.41 109.829 -176.934 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.0 mtp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.945 0.402 . . . . 31.29 111.199 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.67 -49.48 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.432 -0.667 . . . . 30.78 111.432 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -122.44 -179.79 4.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.438 -0.579 . . . . 30.69 109.438 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.5 m 57.87 59.46 3.16 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.53 0.518 . . . . 29.95 111.088 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -81.22 149.8 28.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.2 -0.455 . . . . 29.85 109.986 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 60.81 72.71 0.51 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.32 0.581 . . . . 30.29 109.671 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -55.75 119.79 6.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.2 -0.909 . . . . 28.16 112.06 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -82.87 57.35 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.604 -0.725 . . . . 26.24 109.363 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -129.66 114.15 15.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 26.48 110.338 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -132.36 32.96 3.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 26.97 110.562 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 t -77.08 79.36 3.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.572 . . . . 24.89 109.461 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m -65.99 103.4 0.94 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.453 -0.794 . . . . 24.15 111.311 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.28 -21.09 15.57 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.697 -0.683 . . . . 22.8 112.328 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 54.05 71.9 0.48 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.169 0.509 . . . . 21.12 110.661 -176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.7 123.16 74.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 20.12 111.089 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.64 71.68 6.77 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.481 2.12 . . . . 19.33 110.995 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -56.76 142.32 40.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.721 -0.672 . . . . 19.37 110.735 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.97 94.35 0.03 OUTLIER Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.644 -0.707 . . . . 15.69 113.209 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -160.78 164.04 31.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 14.22 109.259 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.415 ' C ' HG12 ' A' ' 111' ' ' VAL . 39.6 m80 62.01 65.35 0.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.5 0.5 . . . . 13.16 110.492 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.34 22.85 1.5 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 12.29 110.339 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.14 41.29 3.03 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.813 -0.63 . . . . 8.13 113.507 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 56.36 23.86 7.75 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.568 0.581 . . . . 9.83 112.568 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -141.82 25.15 1.99 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.597 1.189 . . . . 6.46 109.158 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 2.9 p -143.71 -44.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.329 -1.76 . . . . 5.19 109.018 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.03 120.57 42.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.073 -1.084 . . . . 4.9 108.073 168.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 HD21 HD12 ' A' ' 173' ' ' LEU . 4.7 tt -64.14 113.13 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.969 -0.752 . . . . 1.91 108.969 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.617 ' N ' ' HD3' ' A' ' 115' ' ' PRO . 1.2 tm-20 178.68 56.63 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.844 0.715 . . . . 3.45 109.157 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 15.4 Cg_endo -90.02 178.49 2.24 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.427 2.751 . . . . 3.73 110.685 177.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.46 20.8 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.959 -0.564 . . . . 3.24 111.424 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.589 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 7.3 tpt -52.21 138.87 25.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.656 0.741 . . . . 2.04 111.733 -171.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 17.5 m -128.55 97.09 4.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.143 -0.935 . . . . 1.11 109.062 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.93 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -127.98 172.16 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.202 1.001 . . . . 1.07 111.688 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.69 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.7 t -121.27 175.16 6.27 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 113.891 -1.504 . . . . 1.71 109.487 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.9 mttt -52.67 -48.93 66.16 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.335 0.397 . . . . 3.81 111.838 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.427 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 54.2 m-80 -83.84 -16.21 45.35 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 122.341 -0.224 . . . . 2.18 110.559 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.908 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.35 -21.27 63.83 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.451 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.7 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 0.0 OUTLIER -86.06 -26.96 25.04 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.925 -1.11 . . . . 3.61 109.774 176.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.59 -32.06 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.834 -1.076 . . . . 1.12 111.532 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.756 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.85 -40.38 32.78 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.725 -1.125 . . . . 2.07 110.171 170.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.908 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.53 82.17 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 117.469 -1.253 . . . . 1.14 114.364 -174.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.81 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.86 -38.51 91.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.247 -2.181 . . . . 1.06 109.181 176.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.493 ' H ' HD22 ' A' ' 128' ' ' LEU . 36.7 mt-10 -64.67 -32.44 74.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.893 1.33 . . . . 2.51 107.895 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 126' ' ' LYS . . . -89.66 -6.71 55.9 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.332 -2.213 . . . . 1.06 110.567 -169.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 12.5 t -122.11 0.28 9.59 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.351 -0.84 . . . . 1.12 109.258 -174.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 70.12 55.9 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.682 -1.599 . . . . 2.86 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.81 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.69 146.95 25.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.954 -1.499 . . . . 0.88 106.954 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.597 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.17 159.33 42.83 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.109 -1.071 . . . . 0.92 108.109 -178.09 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.4 158.97 0.76 Allowed 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 122.19 0.995 . . . . 2.42 112.116 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.585 HG11 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -148.67 153.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 113.821 -1.536 . . . . 1.08 111.264 -169.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -50.06 75.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.937 0.875 . . . . 1.17 111.728 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' N ' HG11 ' A' ' 136' ' ' VAL . 18.5 ptmt -157.74 113.8 2.83 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.229 -1.35 . . . . 1.24 108.682 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.757 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.32 105.06 13.08 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.229 1.49 . . . . 3.14 111.339 -166.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.809 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -157.49 93.71 1.32 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.303 -1.772 . . . . 1.11 107.969 162.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.809 ' HD3' ' O ' ' A' ' 140' ' ' THR . 23.7 mmt180 -151.35 169.6 9.1 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.447 -1.706 . . . . 2.98 107.813 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 111.4 2.75 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 CA-C-N 119.269 0.775 . . . . 1.1 110.389 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.11 78.4 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.581 -0.819 . . . . 0.38 113.886 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 1.3 mm-40 -129.59 132.2 46.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.382 -1.34 . . . . 1.49 107.382 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.791 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.0 OUTLIER -132.6 175.44 9.31 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.258 -0.977 . . . . 0.38 110.413 -169.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.757 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 12.0 p -111.18 141.9 44.08 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.954 0.883 . . . . 1.09 111.956 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.504 HG21 ' OH ' ' A' ' 133' ' ' TYR . 54.5 t -101.8 119.97 50.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.844 -1.526 . . . . 1.62 110.773 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.576 ' HB2' ' O ' ' A' ' 151' ' ' SER . 64.9 mt-30 -101.99 -78.59 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.681 -0.236 . . . . 2.74 110.741 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.63 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.717 0.294 . . . . 1.13 111.199 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 84.4 m-20 -89.33 -2.93 58.62 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.84 0.829 . . . . 1.6 109.153 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 15.4 p -138.16 141.83 40.08 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.779 -1.1 . . . . 1.37 109.636 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.739 HG23 ' OH ' ' A' ' 133' ' ' TYR . 6.9 mt -104.35 170.92 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.103 -1.443 . . . . 1.05 107.103 169.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.791 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.2 tt0 -119.45 139.07 52.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.544 -1.651 . . . . 0.97 106.544 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.481 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -135.57 127.38 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 118.863 0.756 . . . . 1.97 111.935 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -71.39 140.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.379 -0.971 . . . . 1.09 108.379 169.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.719 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 30.6 ttp180 -62.3 168.37 3.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.561 -0.903 . . . . 3.55 108.561 175.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 111' ' ' VAL . 21.6 mmm180 -61.98 113.61 9.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 118.454 0.57 . . . . 4.84 110.693 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.56 ' HB3' ' HB2' ' A' ' 168' ' ' GLN . 5.1 Cg_exo -78.55 166.76 23.57 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.143 2.562 . . . . 2.01 111.503 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.96 153.26 45.54 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.841 0.829 . . . . 5.88 112.051 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.655 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 4.2 m-20 -129.39 127.57 41.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.146 -1.388 . . . . 5.15 108.985 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.599 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 42.2 m-85 -119.28 168.79 9.25 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-O 121.98 0.895 . . . . 6.88 111.433 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.1 Cg_endo -75.52 -41.85 0.53 Allowed 'Trans proline' 0 N--CA 1.414 -3.185 0 C-N-CA 122.094 1.863 . . . . 9.11 110.79 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -91.52 -5.0 54.86 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 112.68 -2.054 . . . . 10.53 109.511 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.0 m -164.54 139.2 5.47 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.076 -1.42 . . . . 8.25 112.886 -171.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.655 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 53.8 mttt -145.83 141.64 28.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.222 0.534 . . . . 7.11 111.711 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -167.77 -165.58 0.66 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.844 -1.071 . . . . 5.04 110.865 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -109.5 -135.53 7.27 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.653 -0.703 . . . . 2.35 111.686 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.719 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 8.1 tp-100 -151.15 172.75 15.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.051 0.929 . . . . 3.48 112.601 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.616 HG12 ' ND2' ' A' ' 185' ' ' ASN . 12.4 t -90.37 148.19 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 113.592 -1.64 . . . . 1.23 108.34 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.684 ' HB2' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -119.77 144.81 47.09 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 122.454 1.121 . . . . 2.3 113.223 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.49 159.88 23.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.296 -1.774 . . . . 1.04 110.24 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 24.7 ttm180 -108.93 118.82 37.78 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 122.073 0.94 . . . . 4.19 108.751 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.62 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -110.2 113.33 25.93 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.568 -1.651 . . . . 1.33 110.959 -162.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.51 ' O ' HD12 ' A' ' 180' ' ' LEU . 63.5 m -112.16 149.14 32.63 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.003 -0.435 . . . . 1.02 112.152 -171.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.93 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -117.84 110.94 18.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.841 -0.618 . . . . 0.44 111.649 175.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.597 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t70 -94.35 107.24 19.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.477 -0.783 . . . . 0.74 111.042 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.8 -115.75 4.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.279 -0.962 . . . . 0.28 113.015 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.506 ' O ' HG22 ' A' ' 118' ' ' THR . 5.1 t70 -112.35 10.82 19.94 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.003 -1.481 . . . . 1.61 107.003 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.717 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 12.0 p-80 -137.51 160.75 38.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.793 -1.094 . . . . 2.16 112.734 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 9.6 tp -63.58 134.96 56.42 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.575 -0.739 . . . . 1.05 110.493 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.597 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -88.69 -49.84 6.61 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.638 -1.164 . . . . 1.03 111.32 -176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.536 HG21 ' O ' ' A' ' 194' ' ' PHE . 5.5 t 177.49 178.47 0.3 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.96 -1.018 . . . . 1.09 110.277 -173.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.621 ' O ' ' HD1' ' A' ' 192' ' ' PHE . 2.0 mp -152.99 124.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 N-CA-C 106.075 -1.824 . . . . 1.04 106.075 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.649 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.2 t -121.1 121.73 65.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 113.101 0.778 . . . . 1.15 113.101 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.616 ' ND2' HG12 ' A' ' 169' ' ' VAL . 23.6 t-20 -58.94 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 107.797 -1.186 . . . . 2.01 107.797 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.4 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 81.4 mmm -62.0 -15.57 45.04 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-N 114.216 -1.356 . . . . 2.01 112.661 -167.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.409 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.8 mt-10 -75.12 -42.62 55.96 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 114.343 -1.299 . . . . 0.68 110.289 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -100.2 -30.39 11.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.379 -1.282 . . . . 2.66 112.039 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.649 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.0 p-10 43.03 20.4 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.665 1.357 . . . . 2.15 114.665 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -136.71 3.87 2.77 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 111.743 0.275 . . . . 4.73 111.743 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.49 -84.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.006 -0.738 . . . . 4.52 109.006 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.621 ' HD1' ' O ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -96.68 100.88 12.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.163 -1.051 . . . . 1.94 108.163 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.575 ' HA2' ' CG2' ' A' ' 184' ' ' VAL . . . -146.1 109.16 0.48 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.006 -1.092 . . . . 1.84 113.825 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.536 ' O ' HG21 ' A' ' 182' ' ' THR . 92.5 m-85 -136.47 163.61 30.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.421 -0.585 . . . . 5.39 109.421 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -165.94 102.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.135 0.493 . . . . 7.14 111.113 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.698 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 16.1 mtm-85 -132.12 115.05 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.215 -0.661 . . . . 7.18 109.215 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 196' ' ' ARG . 7.3 mt -173.17 -179.16 1.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.863 0.727 . . . . 2.04 109.316 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.501 ' HB2' ' HD3' ' A' ' 199' ' ' PRO . 2.0 m-20 -52.27 -54.32 42.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 123.177 0.298 . . . . 3.38 111.713 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 198' ' ' ASP . 3.5 Cg_endo -86.9 112.9 0.98 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.247 1.965 . . . . 5.38 111.812 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.688 -0.672 . . . . 8.41 110.568 179.427 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.175 -0.306 . . . . 31.29 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.76 -131.8 10.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.663 -0.779 . . . . 30.78 111.302 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.3 m 61.8 -171.96 0.15 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 30.69 111.497 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.4 t -129.56 124.93 35.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.371 -0.377 . . . . 29.95 111.031 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.6 m80 41.63 -97.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.57 1.169 . . . . 29.85 114.005 168.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 10.6 p-80 -101.6 38.79 1.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 30.29 111.956 -169.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.86 -27.11 40.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.253 -0.43 . . . . 28.16 111.961 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -137.2 37.88 2.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.367 0.603 . . . . 26.24 110.374 172.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 92' ' ' HIS . 36.2 m170 -128.57 102.05 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.355 -0.839 . . . . 26.48 109.233 176.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 67.27 177.76 0.24 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.151 0.5 . . . . 26.97 110.791 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 m -109.95 35.06 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.029 0.442 . . . . 24.89 110.552 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 m -71.71 99.8 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.741 -0.663 . . . . 24.15 110.475 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.52 56.8 4.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 22.8 111.193 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 pp -75.13 163.32 27.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.849 0.357 . . . . 21.12 111.058 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.4 125.7 31.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.396 . . . . 20.12 110.633 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.68 19.8 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.994 2.463 . . . . 19.33 112.582 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -121.44 167.83 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.271 -0.422 . . . . 19.37 110.099 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.99 107.51 1.96 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.784 -0.722 . . . . 15.69 111.403 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 p -66.44 -43.52 85.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.803 0.335 . . . . 14.22 111.18 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -136.5 119.05 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.684 -0.487 . . . . 13.16 109.684 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 48.3 ttm -81.9 -20.6 38.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.2 0.524 . . . . 12.29 110.062 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -115.77 109.44 2.03 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.917 -0.659 . . . . 8.13 111.808 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -82.07 81.11 8.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 9.83 111.612 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.2 ptm -137.8 20.96 2.87 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.384 1.088 . . . . 6.46 108.47 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.6 -9.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.342 -1.754 . . . . 5.19 110.101 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -143.72 101.16 3.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.647 -0.706 . . . . 4.9 110.387 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 114' ' ' GLU . 0.3 OUTLIER -88.09 135.75 33.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.697 -0.683 . . . . 1.91 110.087 178.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.665 ' N ' HD12 ' A' ' 113' ' ' LEU . 52.0 mt-10 -161.78 162.5 20.68 Favored Pre-proline 0 CA--C 1.5 -0.967 0 N-CA-C 107.646 -1.242 . . . . 3.45 107.646 -175.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.488 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 93.7 Cg_endo -92.61 103.21 0.18 Allowed 'Trans proline' 0 N--CA 1.426 -2.457 0 CA-C-N 119.665 0.916 . . . . 3.73 113.369 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.13 -4.52 14.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 102.686 -3.079 . . . . 3.24 102.686 136.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.515 ' HG3' HG21 ' A' ' 119' ' ' ILE . 34.6 tpp -76.08 143.09 41.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 110.903 -2.862 . . . . 2.04 111.879 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 179' ' ' HIS . 15.5 m -126.28 100.72 6.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.122 -0.945 . . . . 1.11 109.349 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.874 HD12 ' CD1' ' A' ' 175' ' ' PHE . 4.1 pt -132.14 172.34 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.075 -0.966 . . . . 1.07 111.251 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.694 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 65.4 p -123.97 179.45 4.84 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.697 -1.138 . . . . 1.71 110.403 -169.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 124' ' ' MET . 41.0 mmtm -60.03 -37.81 80.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.273 0.559 . . . . 3.81 110.594 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.46 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -85.45 -22.22 28.39 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.706 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.91 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.5 mt-10 -72.53 -23.16 60.96 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 119.805 -0.758 . . . . 0.5 109.74 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.568 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -85.05 -28.12 25.89 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.172 -1.011 . . . . 3.61 109.967 178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.29 -32.57 56.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.005 -0.998 . . . . 1.12 111.711 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.758 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.95 -39.96 33.13 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.833 -1.076 . . . . 2.07 110.005 171.112 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.43 -39.54 80.05 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 114.261 1.208 . . . . 1.14 114.261 -174.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.859 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.51 -38.79 92.47 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.157 -2.217 . . . . 1.06 109.08 177.253 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 21.1 mt-10 -65.7 -31.48 72.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.93 1.348 . . . . 2.51 108.09 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -89.33 -6.98 56.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.472 -2.149 . . . . 1.06 110.556 -170.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 13.4 t -122.17 2.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.973 -1.012 . . . . 1.12 109.195 -175.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 68.68 54.85 0.49 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 113.671 -1.604 . . . . 2.86 111.581 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.901 ' HH ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -152.0 146.97 25.98 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.647 -1.242 . . . . 0.88 107.647 -177.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.648 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.43 161.25 40.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.126 -1.435 . . . . 0.92 107.126 -176.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -52.06 158.23 1.14 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.201 1.001 . . . . 2.42 112.099 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.41 153.58 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 113.826 -1.533 . . . . 1.08 111.48 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.3 m -59.63 -50.89 72.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.038 0.923 . . . . 1.17 111.472 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.587 ' N ' HG13 ' A' ' 136' ' ' VAL . 18.2 ptmt -159.91 116.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.765 -1.561 . . . . 1.24 108.035 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.731 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.2 OUTLIER -82.26 109.07 16.2 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.955 1.36 . . . . 3.14 110.925 -165.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.8 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.7 t -155.71 95.66 1.68 Allowed 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 113.549 -1.659 . . . . 1.11 108.727 162.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.8 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.6 mmt180 -151.17 167.52 12.84 Favored Pre-proline 0 N--CA 1.432 -1.375 0 CA-C-N 113.029 -1.896 . . . . 2.98 107.75 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.44 111.61 2.62 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 N-CA-C 109.644 -0.945 . . . . 1.1 109.644 160.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.77 20.81 59.03 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.657 -0.783 . . . . 0.38 114.393 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 41.2 mt-10 -137.45 131.9 32.6 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.238 -1.023 . . . . 1.49 108.238 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.813 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -132.12 176.54 8.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.827 -0.749 . . . . 0.38 110.036 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.731 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.1 p -112.66 139.97 47.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.717 0.77 . . . . 1.09 111.763 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.901 HG22 ' HH ' ' A' ' 133' ' ' TYR . 40.1 t -98.44 139.48 20.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.088 -1.415 . . . . 1.62 110.922 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 151' ' ' SER . 64.0 tt0 -125.15 -79.08 0.6 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.021 -0.272 . . . . 2.74 111.273 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.54 -81.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.75 0.31 . . . . 1.13 111.702 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.448 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 77.0 m-20 -86.71 -5.4 59.13 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.236 -0.653 . . . . 1.6 109.236 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.54 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 m -143.46 146.54 33.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.275 -0.875 . . . . 1.37 109.348 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.661 HG23 ' N ' ' A' ' 153' ' ' GLU . 6.6 mt -107.97 169.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.988 -1.486 . . . . 1.05 106.988 167.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.1 tt0 -116.19 136.37 53.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.521 -1.659 . . . . 0.97 106.521 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.458 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.3 ppp? -136.75 125.29 23.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 119.143 0.883 . . . . 1.97 112.692 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.65 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -65.99 140.19 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.928 -0.578 . . . . 1.09 110.08 174.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -85.25 176.98 8.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.701 -0.852 . . . . 3.55 108.701 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -65.51 157.52 78.04 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.022 -0.732 . . . . 4.84 109.022 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.6 155.94 68.1 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.215 1.277 . . . . 2.01 110.603 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.55 124.23 44.54 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.904 0.859 . . . . 5.88 112.919 -170.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.79 124.07 30.54 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.128 -1.396 . . . . 5.15 111.958 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.58 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 40.6 m-85 -122.33 173.3 4.29 Favored Pre-proline 0 N--CA 1.423 -1.781 0 CA-C-N 115.017 -0.992 . . . . 6.88 111.003 172.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.5 Cg_endo -78.25 -43.7 0.18 Allowed 'Trans proline' 0 N--CA 1.418 -2.955 0 C-N-CA 122.332 2.021 . . . . 9.11 110.417 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.09 -12.95 54.24 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.691 -2.504 . . . . 10.53 109.653 -172.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -163.2 152.37 14.79 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 112.857 -1.974 . . . . 8.25 112.139 -168.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -149.43 146.29 27.37 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 121.159 0.504 . . . . 7.11 110.734 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.22 -164.55 1.8 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.917 -1.038 . . . . 5.04 111.198 -171.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -106.71 -135.84 8.08 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 120.786 -0.721 . . . . 2.35 113.298 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.432 HE21 ' HB3' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -90.16 153.42 20.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.878 0.847 . . . . 3.48 111.227 -173.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.8 HG12 ' N ' ' A' ' 170' ' ' ARG . 53.8 t -131.94 148.08 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.359 0 CA-C-N 114.273 -1.331 . . . . 1.23 108.467 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.8 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -128.03 144.1 51.1 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 122.288 1.042 . . . . 2.3 113.427 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -111.68 168.01 9.9 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.333 -1.758 . . . . 1.04 110.664 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.519 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 39.5 ptt180 -118.42 122.34 42.54 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.147 -1.427 . . . . 4.19 107.147 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -117.78 106.82 13.43 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.574 -1.194 . . . . 1.33 110.443 -162.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.57 ' O ' HD11 ' A' ' 180' ' ' LEU . 51.8 m -105.67 150.81 25.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.67 -0.695 . . . . 1.02 112.328 -169.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.874 ' CD1' HD12 ' A' ' 119' ' ' ILE . 18.5 m-85 -115.56 106.66 14.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.32 -1.309 . . . . 0.44 112.71 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.47 ' CA ' HD23 ' A' ' 197' ' ' LEU . 34.5 t70 -95.96 103.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.886 0.374 . . . . 0.74 111.173 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 80.67 -118.44 4.65 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.259 -0.972 . . . . 0.28 112.602 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 118' ' ' THR . 3.4 t70 -111.31 12.82 21.65 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.578 -1.638 . . . . 1.61 106.578 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.661 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 25.4 p80 -133.8 161.05 35.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.546 -1.207 . . . . 2.16 111.694 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.57 HD11 ' O ' ' A' ' 174' ' ' THR . 7.6 tp -69.14 135.35 50.56 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.706 -1.134 . . . . 1.05 110.423 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.457 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -85.78 -50.87 6.81 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.289 -1.323 . . . . 1.03 110.946 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 6.1 t -179.08 177.09 0.83 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.065 -0.97 . . . . 1.09 110.727 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -150.18 121.54 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.488 -1.671 . . . . 1.04 106.488 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.737 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 72.1 t -131.63 122.18 49.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.563 0.579 . . . . 1.15 112.563 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -59.1 99.11 0.05 OUTLIER 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.001 -1.111 . . . . 2.01 108.001 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 82.4 mtp -55.6 -22.9 24.41 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 112.606 -2.088 . . . . 2.01 112.179 -169.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.485 ' HG3' HG11 ' A' ' 169' ' ' VAL . 2.7 mt-10 -66.47 -45.69 78.84 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.098 -1.41 . . . . 0.68 110.603 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.71 -20.0 13.76 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.399 -1.273 . . . . 2.66 111.668 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.737 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.6 p30 36.16 46.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.581 0.956 . . . . 2.15 113.581 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -161.64 -26.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.117 -0.947 . . . . 4.73 110.029 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -47.81 -51.9 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.62 -0.718 . . . . 4.52 111.34 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.12 -78.86 0.52 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.473 -0.936 . . . . 1.94 108.473 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.534 ' H ' HG21 ' A' ' 184' ' ' VAL . . . 66.82 101.0 0.02 OUTLIER Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.306 -0.861 . . . . 1.84 114.849 169.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.572 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 64.7 m-85 -133.9 -174.41 3.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.985 -0.746 . . . . 5.39 108.985 172.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.2 143.97 36.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.175 0.512 . . . . 7.14 111.262 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -101.19 160.77 14.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.615 -0.72 . . . . 7.18 110.466 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.47 HD23 ' CA ' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -70.57 135.15 48.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.646 -0.706 . . . . 2.04 111.878 -177.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.55 119.88 75.55 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.836 -0.62 . . . . 3.38 109.58 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.2 132.68 40.01 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.58 2.187 . . . . 5.38 112.149 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.522 -0.751 . . . . 8.41 110.332 -178.973 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.642 0.258 . . . . 31.29 110.685 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.15 -75.59 2.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.914 -0.66 . . . . 30.78 112.069 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 p -148.81 -58.84 0.22 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.16 0.505 . . . . 30.69 109.912 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.5 m -150.81 166.49 30.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 29.95 109.96 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 68.03 109.72 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.888 0.742 . . . . 29.85 111.896 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -62.59 -40.87 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.809 -0.632 . . . . 30.29 109.808 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -96.07 103.06 14.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.35 -0.611 . . . . 28.16 109.35 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 2.7 t60 -73.91 145.13 45.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.151 -0.685 . . . . 26.24 109.151 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 94' ' ' HIS . 93.3 m-70 70.34 172.53 0.31 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.633 0.583 . . . . 26.48 110.324 -172.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 62.51 80.72 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.237 -0.438 . . . . 26.97 110.017 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.1 t 60.59 42.5 13.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.541 0.686 . . . . 24.89 110.151 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -110.19 30.77 6.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.634 -0.712 . . . . 24.15 109.59 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.37 102.65 0.9 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.573 -0.74 . . . . 22.8 111.826 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.94 131.04 35.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.097 -0.334 . . . . 21.12 110.097 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.33 112.75 36.01 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.863 -0.421 . . . . 20.12 109.863 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.63 101.92 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.793 2.328 . . . . 19.33 112.322 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.64 117.51 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.149 -0.478 . . . . 19.37 109.922 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.16 166.0 47.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.85 -0.69 . . . . 15.69 112.963 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t 63.59 48.31 3.43 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.361 0.601 . . . . 14.22 111.05 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -109.22 33.83 4.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.49 0.662 . . . . 13.16 109.217 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -125.25 27.95 6.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.497 -0.774 . . . . 12.29 109.924 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.68 177.16 32.15 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.534 -0.757 . . . . 8.13 111.514 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HB3' ' NE ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER 59.78 43.33 15.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.03 0.443 . . . . 9.83 110.899 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -100.46 13.41 34.64 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.161 1.458 . . . . 6.46 108.201 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.9 p -82.52 -17.64 11.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 111.772 -2.467 . . . . 5.19 108.902 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -113.01 156.26 23.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.901 -1.045 . . . . 4.9 109.091 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.758 HD21 ' N ' ' A' ' 114' ' ' GLU . 2.7 tt -80.62 154.44 27.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.037 -0.529 . . . . 1.91 111.855 -169.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.758 ' N ' HD21 ' A' ' 113' ' ' LEU . 31.2 tt0 -179.53 151.88 0.63 Allowed Pre-proline 0 CA--C 1.511 -0.547 0 N-CA-C 107.518 -1.29 . . . . 3.45 107.518 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 114' ' ' GLU . 78.2 Cg_endo -91.03 103.46 0.26 Allowed 'Trans proline' 0 N--CA 1.431 -2.204 0 CA-C-N 121.238 1.478 . . . . 3.73 113.627 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -111.92 -4.7 14.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 103.118 -2.919 . . . . 3.24 103.118 138.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.549 ' HG3' HG23 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -78.01 139.7 39.14 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 111.107 -2.77 . . . . 2.04 112.028 -162.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m -126.82 101.56 6.65 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.774 -1.103 . . . . 1.11 108.938 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.835 HD12 ' CD1' ' A' ' 175' ' ' PHE . 6.2 pt -131.01 172.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 122.374 1.083 . . . . 1.07 112.452 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.71 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 7.4 m -111.9 171.32 7.57 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.547 -1.66 . . . . 1.71 110.031 -173.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 124' ' ' MET . 63.9 mttm -49.27 -54.49 16.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.093 0.473 . . . . 3.81 111.885 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 20.9 t-20 -82.51 -15.81 51.04 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.956 -0.387 . . . . 2.18 109.956 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.885 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.6 mt-10 -64.58 -24.88 67.74 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.149 -0.621 . . . . 0.5 110.19 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.612 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -85.59 -28.36 24.89 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.327 -1.349 . . . . 3.61 109.769 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -32.69 55.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.453 1.12 . . . . 1.12 111.684 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.57 -42.35 29.43 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.493 -1.23 . . . . 2.07 109.917 169.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.885 HD11 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.41 -38.51 84.26 Favored 'General case' 0 CA--C 1.463 -2.399 0 CA-C-O 117.429 -1.272 . . . . 1.14 114.101 -173.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.668 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.47 -40.93 98.23 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 116.329 -2.148 . . . . 1.06 108.717 177.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.64 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.4 mm-40 -66.87 -32.24 73.37 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.098 1.427 . . . . 2.51 108.589 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -84.98 -7.53 59.11 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 111.911 -2.404 . . . . 1.06 110.296 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 128' ' ' LEU . 12.0 t -121.46 1.71 10.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.214 1.007 . . . . 1.12 108.744 -176.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 70.95 54.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.238 -1.801 . . . . 2.86 112.109 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.65 143.27 23.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.202 -1.407 . . . . 0.88 107.202 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.657 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -143.2 162.38 35.75 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.088 -1.449 . . . . 0.92 107.088 -178.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -52.39 158.28 1.25 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.232 1.015 . . . . 2.42 112.059 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -147.04 152.32 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-N 114.002 -1.454 . . . . 1.08 111.903 -168.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 m -59.61 -49.65 76.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 1.17 111.544 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.583 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -158.54 113.55 2.58 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.982 -1.463 . . . . 1.24 108.627 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.771 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.78 106.18 14.41 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.851 1.31 . . . . 3.14 111.056 -168.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.834 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.7 t -157.45 93.94 1.34 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.942 -1.481 . . . . 1.11 109.171 162.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.834 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.0 mmt180 -152.15 170.0 8.66 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 113.145 -1.843 . . . . 2.98 107.779 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -81.88 111.71 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 CA-C-N 119.755 0.948 . . . . 1.1 110.299 162.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.64 72.85 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.575 -0.821 . . . . 0.38 114.345 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.434 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 3.2 mm-40 -127.78 130.84 49.39 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.799 -1.556 . . . . 1.49 106.799 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.759 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -133.97 176.71 8.33 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.868 -1.133 . . . . 0.38 110.638 -168.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.771 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 15.3 p -112.86 139.86 48.13 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.657 0.742 . . . . 1.09 111.799 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.658 HG21 ' HH ' ' A' ' 133' ' ' TYR . 39.3 t -98.65 141.37 16.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.097 -1.411 . . . . 1.62 111.065 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 151' ' ' SER . 10.0 tt0 -124.95 -78.73 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.833 -0.167 . . . . 2.74 110.956 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.76 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.612 0.244 . . . . 1.13 111.183 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.561 ' HB3' HD13 ' A' ' 197' ' ' LEU . 85.8 m-20 -81.72 -1.19 46.14 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.324 -0.621 . . . . 1.6 109.324 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 15.1 m -140.63 144.73 35.92 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.69 -0.686 . . . . 1.37 110.045 172.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 153' ' ' GLU . 5.6 mt -106.88 172.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.728 -1.212 . . . . 1.05 107.728 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.0 tt0 -118.87 135.2 54.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.512 -1.662 . . . . 0.97 106.512 166.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.47 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -136.19 127.11 27.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.111 0.868 . . . . 1.97 111.893 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -63.66 128.18 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.072 -0.513 . . . . 1.09 110.813 176.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -70.62 153.53 42.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.406 -0.815 . . . . 3.55 110.558 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.417 ' NE ' ' HB3' ' A' ' 109' ' ' ARG . 56.5 mtt85 -49.08 118.83 8.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.503 -0.771 . . . . 4.84 110.716 174.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.595 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 18.0 Cg_endo -63.02 175.28 2.54 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.785 2.323 . . . . 2.01 112.967 176.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.04 125.55 35.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 5.88 109.689 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.454 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 1.9 m-20 -120.67 130.71 54.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.781 -0.645 . . . . 5.15 112.062 -169.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.537 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.4 m-30 -119.5 168.37 10.22 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 115.472 -0.785 . . . . 6.88 109.822 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.1 Cg_endo -74.47 -44.59 0.39 Allowed 'Trans proline' 0 N--CA 1.414 -3.155 0 C-N-CA 121.963 1.776 . . . . 9.11 110.542 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.44 -6.64 56.33 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.469 -2.15 . . . . 10.53 109.544 -173.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.8 m -164.28 140.09 6.11 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.133 -1.394 . . . . 8.25 112.617 -170.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.454 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 71.5 mttt -142.97 135.6 27.66 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.145 0.498 . . . . 7.11 111.607 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -174.7 -163.93 0.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.75 -1.113 . . . . 5.04 111.442 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 77.4 147.06 2.64 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.317 -0.856 . . . . 2.35 112.933 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -149.08 143.0 25.76 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.453 0.644 . . . . 3.48 110.45 170.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.799 HG13 ' N ' ' A' ' 170' ' ' ARG . 71.8 t -140.03 147.28 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 N-CA-C 107.986 -1.116 . . . . 1.23 107.986 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.799 ' N ' HG13 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -125.31 144.4 50.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.337 1.065 . . . . 2.3 113.862 177.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -114.69 164.92 13.38 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.162 -1.836 . . . . 1.04 110.737 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.46 122.78 43.57 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.815 -1.18 . . . . 4.19 107.815 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.609 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -116.75 121.24 41.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 113.922 -1.49 . . . . 1.33 110.575 -161.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.681 ' CG2' HD11 ' A' ' 197' ' ' LEU . 54.3 m -114.62 151.83 32.85 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.307 0.484 . . . . 1.02 112.307 -170.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.835 ' CD1' HD12 ' A' ' 119' ' ' ILE . 18.4 m-85 -116.16 100.08 7.68 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.747 -1.115 . . . . 0.44 113.375 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.548 ' N ' ' HB3' ' A' ' 181' ' ' ALA . 27.1 t70 -92.22 99.38 12.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.74 111.325 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.69 -113.72 3.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.954 -1.117 . . . . 0.28 113.948 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.433 ' O ' HG22 ' A' ' 118' ' ' THR . 0.9 OUTLIER -111.74 8.07 20.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.016 -1.475 . . . . 1.61 107.016 -177.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 20.9 p80 -138.6 161.7 36.45 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.025 -1.443 . . . . 2.16 111.786 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 174' ' ' THR . 8.7 tp -67.41 137.28 55.81 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.705 -1.134 . . . . 1.05 110.464 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.548 ' HB3' ' N ' ' A' ' 176' ' ' ASP . . . -87.33 -49.67 7.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.572 -1.195 . . . . 1.03 111.44 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 7.6 t 179.46 177.92 0.55 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.195 -0.911 . . . . 1.09 110.277 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.578 ' CG1' HD11 ' A' ' 173' ' ' LEU . 2.1 mp -153.02 128.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 105.767 -1.938 . . . . 1.04 105.767 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.0 t -129.58 118.11 44.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 120.172 -0.611 . . . . 1.15 112.146 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.486 HD21 ' HB2' ' A' ' 171' ' ' ALA . 11.2 m120 -60.5 96.58 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.554 -1.276 . . . . 2.01 107.554 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.85 -19.07 15.48 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 113.157 -1.838 . . . . 2.01 112.971 -166.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.462 ' HG3' HG12 ' A' ' 169' ' ' VAL . 4.1 mt-10 -73.32 -43.18 61.33 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 114.342 -1.299 . . . . 0.68 109.961 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -91.93 -34.14 14.6 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.681 -1.599 . . . . 2.66 111.174 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.669 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.6 p30 35.48 37.34 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.216 1.561 . . . . 2.15 115.216 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -146.9 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.948 -0.47 . . . . 4.73 111.445 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.94 -43.81 97.77 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.254 0.55 . . . . 4.52 110.409 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 12.1 t80 -98.87 59.96 1.22 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 1.94 108.998 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.494 ' HA2' HG21 ' A' ' 184' ' ' VAL . . . -139.51 143.93 14.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.331 -0.938 . . . . 1.84 113.83 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 77.9 m-85 -141.08 -171.17 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.104 0.562 . . . . 5.39 110.216 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -76.13 171.81 13.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 7.14 112.044 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -134.64 164.07 28.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.528 -0.76 . . . . 7.18 111.124 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 175' ' ' PHE . 1.1 mp -68.29 170.35 8.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.533 0.568 . . . . 2.04 112.533 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 52.72 73.7 0.9 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 114.878 -1.055 . . . . 3.38 111.78 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.86 -38.02 94.13 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.815 2.343 . . . . 5.38 112.035 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.96 -0.564 . . . . 8.41 110.547 179.818 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.879 -0.415 . . . . 31.29 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.2 63.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.4 -0.68 . . . . 30.78 111.4 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.0 m -63.71 115.81 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.661 0.267 . . . . 30.69 110.904 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.0 m 70.08 -57.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.58 0.752 . . . . 29.95 111.665 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -94.52 69.61 3.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 29.85 110.476 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -87.98 96.54 10.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.321 0.582 . . . . 30.29 110.529 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -112.56 13.58 20.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.02 -0.537 . . . . 28.16 110.774 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 65.9 18.97 11.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.503 -0.771 . . . . 26.24 110.712 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -114.73 123.12 48.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 26.48 110.358 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -145.22 127.6 15.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.745 -0.661 . . . . 26.97 109.876 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.4 p -78.61 65.22 3.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 24.89 111.396 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p -84.3 141.56 30.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.569 -0.742 . . . . 24.15 110.048 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -171.46 19.14 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.663 -0.78 . . . . 22.8 111.676 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 tp 58.85 49.32 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 21.12 110.243 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 41.8 t -75.16 -46.45 4.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 20.12 111.02 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 3.0 Cg_endo -81.25 131.39 7.65 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 19.33 111.358 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -80.25 -8.05 59.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.995 0.426 . . . . 19.37 110.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.45 34.05 5.36 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.885 -0.598 . . . . 15.69 111.803 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 p -84.28 -30.17 25.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.848 0.356 . . . . 14.22 111.516 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -84.59 -27.23 27.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.767 0.318 . . . . 13.16 110.828 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -19.28 34.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.5 . . . . 12.29 109.792 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.64 42.62 2.29 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.669 -0.696 . . . . 8.13 111.682 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -95.18 47.12 1.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.897 -0.779 . . . . 9.83 108.897 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.5 ptm -162.55 30.22 0.11 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.729 0.776 . . . . 6.46 110.302 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.43 44.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.722 -1.127 . . . . 5.19 110.579 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -118.95 175.42 5.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.559 -0.746 . . . . 4.9 110.12 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -135.18 152.42 51.57 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.035 -0.357 . . . . 1.91 110.035 -179.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 5.1 mp0 -126.13 -178.08 0.68 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.808 . . . . 3.45 113.183 -166.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 27.4 Cg_exo -42.58 -174.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.712 3.608 . . . . 3.73 114.785 165.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -47.59 28.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 118.312 2.708 . . . . 3.24 118.312 -165.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.921 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -40.32 107.59 0.07 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.477 1.132 . . . . 2.04 111.616 179.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.527 HG21 ' O ' ' A' ' 178' ' ' ASP . 24.7 m -78.59 106.73 10.76 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.861 -1.063 . . . . 1.11 110.455 -172.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 175' ' ' PHE . 5.0 pt -137.2 172.25 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.675 -1.148 . . . . 1.07 110.853 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.701 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.5 t -121.63 173.33 7.5 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.191 -1.368 . . . . 1.71 109.482 -172.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.551 ' O ' ' HG3' ' A' ' 124' ' ' MET . 59.0 tttm -51.51 -48.62 62.89 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.782 0.325 . . . . 3.81 111.645 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.442 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 28.5 t-20 -82.4 -18.24 42.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.844 -0.428 . . . . 2.18 109.844 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.874 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -68.8 -24.32 64.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.927 -0.709 . . . . 0.5 109.785 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.654 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.98 -29.07 23.82 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 118.337 -1.345 . . . . 3.61 109.598 177.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.81 -32.56 54.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.259 1.028 . . . . 1.12 112.052 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.743 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.04 -43.44 29.31 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.607 -1.178 . . . . 2.07 109.68 169.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.874 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.29 -37.28 82.62 Favored 'General case' 0 CA--C 1.461 -2.449 0 CA-C-O 117.539 -1.219 . . . . 1.14 113.929 -172.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.661 ' CD2' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.34 -41.13 98.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 116.211 -2.196 . . . . 1.06 108.832 176.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.661 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.7 mm-40 -67.47 -31.03 70.9 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.924 1.345 . . . . 2.51 108.577 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -84.6 -7.94 59.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 111.964 -2.38 . . . . 1.06 110.011 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 128' ' ' LEU . 11.5 t -121.98 1.26 9.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.149 -0.932 . . . . 1.12 108.872 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 72.94 55.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.62 -1.627 . . . . 2.86 112.466 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.671 ' HH ' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -152.15 143.76 23.52 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 106.551 -1.648 . . . . 0.88 106.551 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.74 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -142.85 159.89 41.37 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 106.833 -1.543 . . . . 0.92 106.833 -174.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -48.05 145.96 2.81 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.11 0.957 . . . . 2.42 112.559 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -136.08 152.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 CA-C-N 113.773 -1.558 . . . . 1.08 111.63 -173.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -60.48 -49.81 76.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.359 -0.837 . . . . 1.17 111.591 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -156.9 115.74 3.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.207 -1.36 . . . . 1.24 109.099 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.714 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 2.4 ppp? -77.69 103.11 7.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 123.255 1.502 . . . . 3.14 110.917 -168.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.85 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.0 t -158.65 92.21 1.11 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.466 -1.697 . . . . 1.11 108.936 158.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.85 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.9 mmt180 -152.51 149.5 22.81 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 113.749 -1.569 . . . . 2.98 106.942 174.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.73 110.59 2.15 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 CA-C-N 120.454 1.198 . . . . 1.1 109.821 169.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.06 59.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.534 -0.841 . . . . 0.38 114.222 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 33.8 mt-10 -138.64 131.88 30.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.647 -1.242 . . . . 1.49 107.647 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.84 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -132.7 176.14 8.71 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.558 -0.857 . . . . 0.38 110.691 -166.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.714 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 10.4 p -112.6 139.46 48.18 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.91 0.862 . . . . 1.09 112.038 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.671 HG23 ' HH ' ' A' ' 133' ' ' TYR . 50.0 t -100.01 139.66 21.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 1.62 111.201 -178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.616 ' HB2' ' O ' ' A' ' 151' ' ' SER . 56.3 mt-30 -124.12 -94.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.543 -0.299 . . . . 2.74 110.858 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.89 -77.76 0.07 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.729 0.3 . . . . 1.13 111.184 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.18 -4.44 59.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.131 0.491 . . . . 1.6 109.704 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 5.6 m -145.43 146.3 31.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.828 -0.623 . . . . 1.37 109.845 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.626 ' CG2' HD22 ' A' ' 173' ' ' LEU . 4.3 mt -106.36 165.9 3.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.316 -1.365 . . . . 1.05 107.316 167.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.84 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 7.1 tt0 -115.57 129.02 56.38 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.255 -1.387 . . . . 0.97 107.255 169.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.442 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.86 124.93 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.613 0.642 . . . . 1.97 112.393 -177.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -68.37 136.05 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 120.865 0.365 . . . . 1.09 110.17 173.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -86.42 139.05 31.28 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.217 -1.031 . . . . 3.55 108.217 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -47.61 139.43 8.54 Favored Pre-proline 0 C--O 1.235 0.303 0 O-C-N 123.527 0.517 . . . . 4.84 110.553 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.78 149.75 7.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.172 2.581 . . . . 2.01 113.201 -173.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -90.16 131.46 35.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 114.789 -1.096 . . . . 5.88 113.601 -167.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.414 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 2.1 m-20 -129.54 121.65 27.6 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.469 -1.696 . . . . 5.15 110.108 174.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.586 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 61.2 m-85 -120.72 172.02 5.2 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 115.628 -0.715 . . . . 6.88 109.896 172.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.3 Cg_endo -77.61 -44.5 0.18 Allowed 'Trans proline' 0 N--CA 1.409 -3.458 0 C-N-CA 121.471 1.448 . . . . 9.11 110.403 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.11 0.16 55.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.589 -2.096 . . . . 10.53 109.939 -174.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -163.94 149.35 10.77 Favored 'General case' 0 C--O 1.201 -1.485 0 CA-C-N 114.157 -1.383 . . . . 8.25 111.653 -172.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 56.8 mttt -151.54 143.08 23.57 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 120.825 0.345 . . . . 7.11 110.232 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -156.03 -164.85 1.79 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.617 -0.72 . . . . 5.04 112.844 -169.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -93.88 -137.53 8.6 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.053 -0.976 . . . . 2.35 113.297 -171.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -97.39 151.58 19.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.743 0.782 . . . . 3.48 111.587 -171.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.782 HG12 ' N ' ' A' ' 170' ' ' ARG . 46.8 t -133.69 147.77 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-N 114.285 -1.325 . . . . 1.23 108.787 174.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.782 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -124.46 145.8 49.3 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.469 1.128 . . . . 2.3 113.218 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.04 167.59 10.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.084 -1.871 . . . . 1.04 110.807 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.474 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 45.2 ttt180 -117.97 109.43 16.48 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.414 -1.328 . . . . 4.19 107.414 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.626 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -100.0 112.34 24.63 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.529 -1.669 . . . . 1.33 109.665 -170.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 180' ' ' LEU . 86.5 m -109.06 150.46 27.78 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.541 0.571 . . . . 1.02 112.541 -168.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.896 ' CD1' HD12 ' A' ' 119' ' ' ILE . 11.5 m-85 -115.14 114.66 25.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.43 -1.259 . . . . 0.44 111.88 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.417 ' HA ' HD21 ' A' ' 197' ' ' LEU . 20.6 t70 -99.67 96.09 7.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.74 110.7 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.11 -115.49 4.03 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.268 -0.968 . . . . 0.28 113.511 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.527 ' O ' HG21 ' A' ' 118' ' ' THR . 1.2 t70 -110.75 11.09 22.63 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.681 -1.6 . . . . 1.61 106.681 -178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.6 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 28.2 p80 -141.06 161.03 38.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.229 -1.351 . . . . 2.16 111.644 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.921 ' HB2' ' O ' ' A' ' 117' ' ' MET . 7.0 tp -64.81 144.39 57.29 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.309 -0.859 . . . . 1.05 111.654 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.1 -50.56 5.24 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.193 -1.367 . . . . 1.03 111.544 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.3 t 175.3 178.18 0.16 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.33 -0.85 . . . . 1.09 109.513 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 173' ' ' LEU . 3.2 mp -145.55 129.13 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.875 -1.528 . . . . 1.04 106.875 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.804 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 67.6 t -133.01 116.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.66 0.615 . . . . 1.15 112.66 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.433 ' ND2' ' HB1' ' A' ' 171' ' ' ALA . 10.9 m120 -60.8 97.74 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.333 1.063 . . . . 2.01 108.17 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 84.1 mtp -56.29 -22.7 31.87 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 112.168 -2.287 . . . . 2.01 112.951 -165.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.566 ' HG3' HG11 ' A' ' 169' ' ' VAL . 3.1 mt-10 -66.49 -43.5 85.2 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.721 -1.127 . . . . 0.68 110.639 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -98.48 -30.86 12.29 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.152 -1.385 . . . . 2.66 110.813 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.804 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.1 t30 36.65 55.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.474 0.916 . . . . 2.15 113.474 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -165.92 -65.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.56 -0.291 . . . . 4.73 110.724 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.49 ' HA ' ' OE1' ' A' ' 191' ' ' GLN . 6.0 tp60 -80.11 60.76 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.422 0.63 . . . . 4.52 110.402 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -177.39 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.179 -0.919 . . . . 1.94 109.553 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 184' ' ' VAL . . . -178.58 176.21 47.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.83 -0.7 . . . . 1.84 112.375 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.8 122.57 10.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 5.39 108.388 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -103.53 117.76 35.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.411 0.624 . . . . 7.14 111.708 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -135.4 119.03 17.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.561 -0.745 . . . . 7.18 109.152 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -147.38 142.35 26.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.831 0.348 . . . . 2.04 111.182 -175.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.44 144.22 73.83 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.393 -0.595 . . . . 3.38 109.393 171.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.53 -11.33 31.23 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.268 2.645 . . . . 5.38 114.43 -170.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.513 -0.756 . . . . 8.41 110.689 -179.919 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.686 0.279 . . . . 31.29 111.063 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.3 33.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.555 -0.831 . . . . 30.78 112.213 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -86.55 177.64 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.456 -0.201 . . . . 30.69 110.456 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.3 m 61.09 39.21 16.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 29.95 111.059 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -98.48 142.03 30.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 29.85 110.446 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -55.57 -63.22 1.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.18 0.437 . . . . 30.29 112.18 -171.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -86.49 121.32 28.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.946 -0.57 . . . . 28.16 110.437 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -83.57 2.62 36.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.152 -0.476 . . . . 26.24 111.325 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -126.12 29.45 5.85 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.96 -0.756 . . . . 26.48 108.96 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m80 69.98 157.83 0.17 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.244 -0.889 . . . . 26.97 111.211 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 m -100.08 40.95 1.2 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.083 -0.508 . . . . 24.89 110.09 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -63.47 -31.36 72.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 24.15 111.795 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.99 -10.81 74.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.561 -0.828 . . . . 22.8 112.459 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 2.8 mm? -100.9 -41.89 6.65 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.702 -0.293 . . . . 21.12 111.28 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.625 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 10.6 p -58.71 -33.0 14.53 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 114.728 1.381 . . . . 20.12 114.728 -172.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 10.9 Cg_endo -54.31 -32.79 73.28 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.973 1.782 . . . . 19.33 113.384 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -120.64 -24.11 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 19.37 111.582 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.88 -101.44 2.06 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.762 -0.935 . . . . 15.69 110.762 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 m 54.44 53.08 11.32 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.918 0.422 . . . . 14.22 111.538 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -67.53 -50.56 58.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.873 -0.788 . . . . 13.16 108.873 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm 50.32 64.53 1.76 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.334 -0.848 . . . . 12.29 111.413 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -133.18 120.7 2.66 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.451 -0.88 . . . . 8.13 112.841 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HD2' ' OG1' ' A' ' 131' ' ' THR . 6.1 tpm_? -84.54 60.36 6.02 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.422 0.63 . . . . 9.83 109.68 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -121.55 18.71 11.26 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 122.588 1.185 . . . . 6.46 108.615 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.79 147.2 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 112.982 -1.917 . . . . 5.19 109.483 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -65.12 155.66 34.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.206 -0.452 . . . . 4.9 111.01 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.542 HD21 HD12 ' A' ' 173' ' ' LEU . 3.1 tt -101.6 113.21 26.15 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.021 -0.733 . . . . 1.91 109.021 177.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.659 ' N ' ' HD3' ' A' ' 115' ' ' PRO . 7.3 tt0 -178.2 50.69 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.797 0.685 . . . . 3.45 110.208 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.659 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 7.8 Cg_endo -89.72 176.31 2.91 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.812 2.341 . . . . 3.73 111.413 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.48 21.24 0.14 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.521 -0.763 . . . . 3.24 109.743 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.566 ' H ' ' C ' ' A' ' 115' ' ' PRO . 43.2 tpp -46.57 141.66 3.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.49 1.116 . . . . 2.04 112.474 -172.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 178' ' ' ASP . 22.7 m -125.44 97.39 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.081 -0.963 . . . . 1.11 108.983 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.834 HD13 ' CD1' ' A' ' 175' ' ' PHE . 7.6 pt -126.53 171.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.097 0.951 . . . . 1.07 111.283 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.708 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 19.4 t -114.05 170.2 8.45 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.831 -1.532 . . . . 1.71 109.319 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -52.66 -48.75 66.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 3.81 111.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.437 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 46.1 m-80 -83.86 -15.39 48.32 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.669 -0.241 . . . . 2.18 110.616 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.939 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.6 mt-10 -65.98 -24.14 66.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.277 -0.569 . . . . 0.5 110.471 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.544 ' O ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.27 -26.5 24.95 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.764 -1.174 . . . . 3.61 110.058 178.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.473 HG21 ' SD ' ' A' ' 124' ' ' MET . 2.0 t -65.16 -28.69 45.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.796 -1.093 . . . . 1.12 111.349 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.744 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -81.67 -38.53 25.73 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.642 -1.163 . . . . 2.07 110.177 171.157 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.939 HD13 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -56.17 -44.09 79.0 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 114.643 1.349 . . . . 1.14 114.643 -175.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.883 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -61.07 -39.78 91.19 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 116.778 -1.969 . . . . 1.06 109.374 177.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' H ' ' CD2' ' A' ' 128' ' ' LEU . 21.9 mt-10 -65.6 -28.98 69.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.7 1.238 . . . . 2.51 108.088 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 126' ' ' LYS . . . -92.06 -7.83 47.61 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 112.848 -1.978 . . . . 1.06 110.977 -170.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.1 t -122.13 -2.38 9.14 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.558 0.694 . . . . 1.12 109.996 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 71.07 56.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.703 -1.589 . . . . 2.86 111.829 -177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.883 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.62 146.34 27.24 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.198 -1.779 . . . . 0.88 106.198 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.666 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.09 163.81 35.09 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.668 -1.234 . . . . 0.92 107.668 -176.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -48.97 159.33 0.26 Allowed 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.404 1.097 . . . . 2.42 112.3 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.61 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.9 t -148.43 151.83 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-N 113.557 -1.656 . . . . 1.08 111.093 -172.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 m -60.19 -50.12 74.92 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.987 0.899 . . . . 1.17 111.37 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -159.06 115.76 2.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.879 -1.509 . . . . 1.24 108.424 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.743 ' CE ' ' HB3' ' A' ' 170' ' ' ARG . 0.0 OUTLIER -83.71 108.14 16.59 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.79 1.281 . . . . 3.14 110.708 -167.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.819 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -157.33 93.95 1.35 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.649 -1.614 . . . . 1.11 108.55 161.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.9 mmt180 -151.98 170.17 8.37 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 113.352 -1.749 . . . . 2.98 107.589 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.16 111.75 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 CA-C-N 119.868 0.989 . . . . 1.1 110.478 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.8 22.69 65.88 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.824 -0.703 . . . . 0.38 114.217 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -132.22 132.56 43.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.92 -1.511 . . . . 1.49 106.92 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.851 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.4 m-85 -133.42 173.83 11.06 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.89 -1.124 . . . . 0.38 110.507 -167.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.736 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 7.7 p -112.53 136.39 52.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.276 0.56 . . . . 1.09 109.953 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.476 HG23 HG12 ' A' ' 152' ' ' ILE . 1.2 p -111.41 143.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.097 -0.956 . . . . 1.62 111.803 -171.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -129.16 -85.14 0.56 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.398 -0.364 . . . . 2.74 111.501 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.1 -83.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.141 0.423 . . . . 1.13 112.141 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.52 ' CB ' HD13 ' A' ' 197' ' ' LEU . 48.3 m-80 -88.24 -5.55 58.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.444 0.64 . . . . 1.6 109.709 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.9 m -143.22 146.78 33.96 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.154 -0.618 . . . . 1.37 109.643 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 153' ' ' GLU . 8.8 mt -114.48 168.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.552 -0.907 . . . . 1.05 108.552 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.851 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 20.8 tt0 -111.49 132.71 54.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.728 -1.582 . . . . 0.97 106.728 167.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.1 tmt? -134.71 124.48 25.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 118.691 0.678 . . . . 1.97 111.151 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -61.44 118.64 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.09 111.283 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 169' ' ' VAL . 13.5 tpt180 -62.69 120.24 10.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.289 -1.004 . . . . 3.55 108.289 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -47.32 127.56 9.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.807 0.692 . . . . 4.84 112.085 -174.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.424 ' HB2' ' O ' ' A' ' 166' ' ' GLU . 28.2 Cg_endo -66.47 175.82 4.73 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.971 2.447 . . . . 2.01 112.499 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.591 ' CE1' ' HA3' ' A' ' 167' ' ' GLY . 9.4 p90 -91.69 155.79 18.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 5.88 110.893 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.47 127.75 54.85 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.083 -0.962 . . . . 5.15 111.216 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 164' ' ' SER . 19.4 m-85 -119.98 169.35 8.61 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-N 115.286 -0.87 . . . . 6.88 109.435 170.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.9 Cg_endo -75.31 -42.01 0.53 Allowed 'Trans proline' 0 N--CA 1.412 -3.279 0 C-N-CA 121.565 1.51 . . . . 9.11 111.296 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.12 -5.49 40.63 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 112.728 -2.033 . . . . 10.53 108.526 -172.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 10.2 p -162.46 146.36 11.76 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-N 114.138 -1.392 . . . . 8.25 112.523 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 78.5 mttt -145.55 119.09 9.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.3 0.572 . . . . 7.11 111.842 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 9.7 pt-20 -176.13 -163.84 0.11 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.567 -1.197 . . . . 5.04 112.194 -166.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.591 ' HA3' ' CE1' ' A' ' 159' ' ' PHE . . . 78.38 58.33 3.15 Favored Glycine 0 CA--C 1.502 -0.772 0 CA-C-N 115.37 -0.832 . . . . 2.35 112.115 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -91.64 155.97 17.95 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.736 0.779 . . . . 3.48 110.983 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.692 HG12 ' N ' ' A' ' 170' ' ' ARG . 71.7 t -146.33 150.83 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 114.069 -1.423 . . . . 1.23 107.775 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.743 ' HB3' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -106.5 150.15 26.39 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.986 0.898 . . . . 2.3 112.445 176.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -124.97 159.33 31.5 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 113.443 -1.708 . . . . 1.04 111.313 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.813 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.4 tpt180 -108.02 101.24 10.5 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.819 -1.178 . . . . 4.19 107.819 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.542 HD12 HD21 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -93.68 113.55 25.65 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 112.988 -1.915 . . . . 1.33 110.115 -170.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.502 ' O ' HD12 ' A' ' 180' ' ' LEU . 52.6 m -112.5 148.79 33.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.654 0.613 . . . . 1.02 112.654 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.834 ' CD1' HD13 ' A' ' 119' ' ' ILE . 8.2 m-85 -116.35 112.68 21.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.011 -0.995 . . . . 0.44 111.807 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.541 ' N ' ' HB1' ' A' ' 181' ' ' ALA . 21.8 t70 -102.35 95.68 6.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.067 0.46 . . . . 0.74 110.537 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.44 -114.02 3.76 Favored Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.17 -1.014 . . . . 0.28 114.187 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.57 ' O ' HG21 ' A' ' 118' ' ' THR . 7.6 p-10 -105.75 5.0 30.56 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 108.07 -1.085 . . . . 1.61 108.07 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.675 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 21.8 p80 -141.58 160.2 40.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.604 -1.18 . . . . 2.16 112.517 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.53 HD13 HD11 ' A' ' 173' ' ' LEU . 9.5 tp -65.99 134.6 53.26 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 114.391 -1.277 . . . . 1.05 109.698 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.541 ' HB1' ' N ' ' A' ' 176' ' ' ASP . . . -86.36 -48.28 8.61 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 114.387 -1.279 . . . . 1.03 111.122 -175.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.412 HG23 ' HB ' ' A' ' 174' ' ' THR . 6.2 t 175.76 177.96 0.19 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.044 -0.98 . . . . 1.09 110.386 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 114' ' ' GLU . 2.1 mp -149.38 122.51 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.999 -1.482 . . . . 1.04 106.999 175.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.678 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 97.0 t -127.09 123.66 62.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 118.965 -0.541 . . . . 1.15 112.279 -170.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.52 94.18 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.777 0.799 . . . . 2.01 109.379 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.813 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 50.2 mmm -43.22 -37.87 2.31 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 112.734 -2.03 . . . . 2.01 112.752 -172.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.465 ' HG3' HG11 ' A' ' 169' ' ' VAL . 4.3 mt-10 -63.19 -40.53 97.78 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 113.488 -1.687 . . . . 0.68 111.224 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -101.68 -30.58 11.25 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.896 -1.502 . . . . 2.66 111.471 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.678 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 14.4 p30 38.58 31.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.141 1.376 . . . . 2.15 114.512 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -141.65 154.37 45.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.798 -0.816 . . . . 4.73 108.798 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 46.86 27.11 0.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.061 0.945 . . . . 4.52 112.883 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -127.83 -33.44 2.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.891 -0.781 . . . . 1.94 108.891 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.405 ' CA ' HG23 ' A' ' 184' ' ' VAL . . . 177.67 -164.28 33.22 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.209 -0.905 . . . . 1.84 112.236 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -166.35 136.25 3.24 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.372 -0.603 . . . . 5.39 109.372 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -114.04 130.46 56.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.16 0.505 . . . . 7.14 111.913 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.402 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 75.6 mtm180 -134.85 121.08 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 7.18 109.497 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.52 HD13 ' CB ' ' A' ' 150' ' ' ASN . 10.5 mt -156.84 138.59 14.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 2.04 111.83 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 8.8 p-10 -138.61 140.03 26.41 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.285 -0.635 . . . . 3.38 109.285 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 36.0 Cg_exo -57.98 107.97 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.992 2.461 . . . . 5.38 113.08 -175.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.578 -0.725 . . . . 8.41 109.576 177.217 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.494 0.188 . . . . 31.29 111.013 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.58 171.45 24.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.57 -0.824 . . . . 30.78 112.053 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 p -89.25 77.87 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 30.69 111.361 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 m 60.87 74.05 0.46 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.718 -0.673 . . . . 29.95 111.312 176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -82.09 90.44 6.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.789 -0.641 . . . . 29.85 110.487 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 62.0 m80 -79.86 81.87 6.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.619 -0.719 . . . . 30.29 109.729 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 34.7 m80 71.65 -80.19 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.3 -0.864 . . . . 28.16 111.096 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 54.87 52.14 12.49 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.501 0.667 . . . . 26.24 110.755 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -172.19 -50.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.001 -0.74 . . . . 26.48 109.001 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -136.52 135.89 38.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.723 -0.671 . . . . 26.97 109.872 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.6 m -103.73 -26.1 12.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.072 -0.513 . . . . 24.89 110.552 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -154.53 57.72 0.69 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.311 0.577 . . . . 24.15 110.046 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.22 110.52 1.89 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.894 -0.669 . . . . 22.8 112.227 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -79.42 67.69 5.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.323 0.583 . . . . 21.12 110.391 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.54 123.85 41.31 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 20.12 110.671 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.63 120.7 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.457 2.105 . . . . 19.33 112.698 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 0.8 OUTLIER -81.56 110.17 16.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.491 -0.559 . . . . 19.37 109.491 176.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 -110.54 3.94 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.724 -0.95 . . . . 15.69 110.724 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.4 t 53.0 50.83 17.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.108 0.48 . . . . 14.22 111.502 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -144.79 -175.02 4.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.499 -0.319 . . . . 13.16 111.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.46 ' HE1' ' HA ' ' A' ' 107' ' ' MET . 5.7 tpt 73.55 -59.94 0.55 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.02 0.928 . . . . 12.29 111.961 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.89 7.94 8.67 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.617 0.607 . . . . 8.13 114.617 -172.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -115.09 6.5 15.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.843 0.821 . . . . 9.83 111.157 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.57 14.63 5.99 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.058 0.932 . . . . 6.46 109.674 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 107' ' ' MET . 8.2 p -158.92 150.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.773 -1.558 . . . . 5.19 109.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.46 138.67 50.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.064 -0.717 . . . . 4.9 109.064 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.777 HD22 ' N ' ' A' ' 114' ' ' GLU . 3.8 tt -64.24 145.24 56.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.234 -0.439 . . . . 1.91 110.406 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.777 ' N ' HD22 ' A' ' 113' ' ' LEU . 5.7 tp10 -175.63 155.39 1.64 Allowed Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 107.046 -1.464 . . . . 3.45 107.046 -172.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 114' ' ' GLU . 11.7 Cg_endo -89.64 102.98 0.35 Allowed 'Trans proline' 0 N--CA 1.423 -2.647 0 CA-C-N 121.793 1.676 . . . . 3.73 112.553 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.52 -4.26 15.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 102.197 -3.261 . . . . 3.24 102.197 142.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.55 ' HG3' HG21 ' A' ' 119' ' ' ILE . 8.4 tpt -83.54 144.31 29.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 110.825 -2.898 . . . . 2.04 111.88 -161.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 179' ' ' HIS . 15.7 m -132.52 98.24 4.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.87 -1.059 . . . . 1.11 109.039 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.868 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.8 pt -129.76 172.67 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.227 1.013 . . . . 1.07 112.0 -171.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.709 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.6 m -114.64 173.79 6.29 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.709 -1.587 . . . . 1.71 110.215 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.618 ' O ' ' HG3' ' A' ' 124' ' ' MET . 2.5 mppt? -51.58 -53.1 41.74 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.343 0.402 . . . . 3.81 111.962 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 m-20 -82.93 -15.26 52.05 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.624 -0.262 . . . . 2.18 110.71 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.903 ' O ' HD12 ' A' ' 127' ' ' LEU . 3.0 mt-10 -65.36 -23.72 67.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.002 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.653 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.28 -29.56 24.48 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 118.474 -1.29 . . . . 3.61 110.057 178.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.17 -31.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.466 1.127 . . . . 1.12 111.833 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.737 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.93 -42.51 23.9 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.169 -1.378 . . . . 2.07 109.73 170.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.903 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.53 -38.49 84.6 Favored 'General case' 0 CA--C 1.462 -2.424 0 CA-C-O 117.523 -1.227 . . . . 1.14 114.067 -173.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.715 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.57 -39.82 94.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 116.153 -2.219 . . . . 1.06 108.72 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 63.1 mm-40 -68.82 -30.68 69.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 123.04 1.4 . . . . 2.51 108.923 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 126' ' ' LYS . . . -85.41 -7.6 58.85 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 111.857 -2.429 . . . . 1.06 110.23 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 128' ' ' LEU . 11.9 t -121.77 -3.94 9.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.245 -0.889 . . . . 1.12 109.387 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 131' ' ' THR . 49.1 mt-30 79.96 55.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 113.757 -1.565 . . . . 2.86 112.235 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.738 ' OH ' HG21 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -154.28 146.5 23.79 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.886 -1.524 . . . . 0.88 106.886 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.631 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -144.52 161.33 39.35 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.371 -1.714 . . . . 0.92 106.371 -177.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.24 159.4 1.94 Allowed 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 119.281 0.946 . . . . 2.42 112.029 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.466 HG12 ' CG2' ' A' ' 146' ' ' THR . 2.4 t -145.91 155.82 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-N 114.19 -1.368 . . . . 1.08 112.019 -168.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.2 m -59.51 -51.15 71.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.05 0.929 . . . . 1.17 111.639 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.3 ptmt -159.78 114.51 2.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 113.931 -1.486 . . . . 1.24 108.117 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.754 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.89 105.08 11.85 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 123.035 1.398 . . . . 3.14 111.24 -166.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.819 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.0 t -157.41 94.25 1.37 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.558 -1.655 . . . . 1.11 108.47 162.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.819 ' HD3' ' O ' ' A' ' 140' ' ' THR . 7.6 mmt180 -151.44 168.02 11.93 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 113.477 -1.692 . . . . 2.98 107.158 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.45 111.69 2.63 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 CA-C-N 119.897 0.999 . . . . 1.1 109.899 164.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.81 27.76 58.11 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.2 -1.0 . . . . 0.38 113.902 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.9 mt-10 -140.85 131.25 25.21 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.407 -1.331 . . . . 1.49 107.407 172.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.755 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -133.88 176.35 8.65 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.419 -0.913 . . . . 0.38 110.511 -167.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.754 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 17.3 p -113.09 137.54 51.28 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.962 0.886 . . . . 1.09 112.505 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.428 HG23 ' HH ' ' A' ' 133' ' ' TYR . 51.6 t -97.62 138.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.451 -1.704 . . . . 1.62 111.12 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' A' ' 151' ' ' SER . 16.6 mm100 -123.14 -90.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.935 -0.12 . . . . 2.74 110.972 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.79 -87.31 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.653 0.263 . . . . 1.13 111.337 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.618 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 47.8 m-80 -82.98 -3.14 56.84 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.062 0.458 . . . . 1.6 109.786 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 20.4 m -141.33 146.13 36.32 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.371 -0.532 . . . . 1.37 110.357 172.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.738 HG21 ' OH ' ' A' ' 133' ' ' TYR . 5.6 mt -107.26 170.66 2.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.351 -1.351 . . . . 1.05 107.351 168.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.755 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.6 tt0 -116.33 136.26 53.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.764 -1.569 . . . . 0.97 106.764 165.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.453 ' C ' ' HE2' ' A' ' 139' ' ' MET . 1.1 tmt? -136.5 124.81 23.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 118.592 0.633 . . . . 1.97 112.367 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.14 128.06 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.594 -0.521 . . . . 1.09 109.594 175.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.16 164.67 23.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.514 -0.55 . . . . 3.55 109.514 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -60.21 118.94 37.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.527 -0.306 . . . . 4.84 110.512 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.481 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 10.2 Cg_endo -61.79 168.75 8.15 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.617 2.211 . . . . 2.01 113.003 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.64 147.95 40.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.174 -0.921 . . . . 5.88 111.333 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.444 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 7.2 m-20 -126.99 133.21 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.07 -0.968 . . . . 5.15 110.643 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.631 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 86.4 m-85 -120.16 171.59 5.52 Favored Pre-proline 0 N--CA 1.424 -1.746 0 CA-C-O 121.557 0.694 . . . . 6.88 109.941 167.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 5.6 Cg_endo -80.91 -46.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.522 0 C-N-CA 121.845 1.696 . . . . 9.11 110.846 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.86 2.18 53.52 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.012 -1.903 . . . . 10.53 110.166 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -163.17 162.66 25.63 Favored 'General case' 0 C--O 1.203 -1.382 0 CA-C-N 113.934 -1.485 . . . . 8.25 110.297 -172.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.631 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 65.5 mttt -153.2 138.71 17.7 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 118.594 0.634 . . . . 7.11 110.55 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.4 -167.02 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 112.877 0.695 . . . . 5.04 112.877 -168.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 77.45 160.64 13.07 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.146 -0.934 . . . . 2.35 112.526 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 0.5 OUTLIER -150.53 138.23 19.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.033 -0.729 . . . . 3.48 109.033 170.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.765 HG11 ' N ' ' A' ' 170' ' ' ARG . 89.9 t -142.14 145.44 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.387 0 CA-C-N 115.202 -0.908 . . . . 1.23 109.166 175.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.765 ' N ' HG11 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -126.41 144.9 50.68 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.197 0.999 . . . . 2.3 113.165 177.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 167.67 10.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.313 -1.767 . . . . 1.04 110.517 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.729 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 48.2 ttp180 -116.22 122.74 45.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.419 -1.326 . . . . 4.19 107.419 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.675 HD22 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -112.11 110.53 20.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.288 -1.324 . . . . 1.33 110.203 -164.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.546 ' O ' HD12 ' A' ' 180' ' ' LEU . 51.9 m -107.64 150.25 27.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.229 0.538 . . . . 1.02 112.308 -169.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.6 m-85 -115.66 102.46 9.77 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.566 -1.197 . . . . 0.44 113.212 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.514 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 31.0 t70 -92.11 101.65 14.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.85 0.357 . . . . 0.74 110.972 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.66 -117.21 4.36 Favored Glycine 0 C--N 1.318 -0.461 0 C-N-CA 120.048 -1.072 . . . . 0.28 113.485 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 118' ' ' THR . 1.6 t70 -110.66 10.61 22.85 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.5 -1.667 . . . . 1.61 106.5 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HA ' ' N ' ' A' ' 119' ' ' ILE . 24.4 p80 -137.89 161.66 36.06 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.287 -1.324 . . . . 2.16 112.083 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 174' ' ' THR . 8.5 tp -68.19 136.38 53.53 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.607 -1.178 . . . . 1.05 110.502 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.46 -50.06 6.79 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.392 -1.276 . . . . 1.03 111.364 -176.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.6 t 179.23 178.4 0.49 Allowed 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.036 -0.984 . . . . 1.09 109.903 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.573 ' CG1' HD12 ' A' ' 173' ' ' LEU . 2.6 mp -147.89 112.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 106.459 -1.682 . . . . 1.04 106.459 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.743 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -115.16 129.8 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 113.15 0.796 . . . . 1.15 113.15 -169.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 188' ' ' ASN . 25.1 p-10 -60.07 95.52 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.108 0.956 . . . . 2.01 109.693 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 66.6 mmm -51.47 -25.61 6.78 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 113.37 -1.741 . . . . 2.01 112.949 -169.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.405 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.6 mt-10 -68.26 -42.6 79.36 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.452 -1.249 . . . . 0.68 110.635 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.406 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 5.5 t-20 -103.49 -25.73 13.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.707 -1.588 . . . . 2.66 111.663 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.743 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 10.3 p30 36.69 38.6 0.08 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.843 1.423 . . . . 2.15 114.843 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -141.63 -37.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.254 -0.43 . . . . 4.73 110.402 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.558 ' HA ' HE21 ' A' ' 191' ' ' GLN . 0.1 OUTLIER -52.57 -60.72 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 4.52 111.789 -177.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' ' 184' ' ' VAL . 1.4 m-85 -93.99 20.02 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.59 -0.444 . . . . 1.94 109.827 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.68 133.09 41.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 1.84 113.623 -170.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.65 -174.2 2.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.861 -0.669 . . . . 5.39 111.023 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -78.51 158.88 28.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.981 -0.554 . . . . 7.14 111.028 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 52.4 ttp85 -82.94 144.83 29.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.57 -0.741 . . . . 7.18 110.441 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 21.1 mt -75.64 124.64 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.177 -0.465 . . . . 2.04 111.684 -176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 52.72 73.92 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.03 -0.986 . . . . 3.38 111.096 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.88 66.14 6.78 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.242 2.628 . . . . 5.38 112.399 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.949 -0.569 . . . . 8.41 110.368 177.562 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.3 m . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.563 0.697 . . . . 0.32 109.511 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.846 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.09 171.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.098 -0.956 . . . . 0.2 110.829 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.773 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 p -120.39 179.19 4.38 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.411 -0.813 . . . . 1.29 110.644 -172.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 124' ' ' MET . 87.3 tttt -53.62 -40.22 65.59 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.485 0.491 . . . . 3.26 111.343 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 8.0 m-20 -82.56 -24.04 34.18 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 116.602 -0.272 . . . . 2.17 111.246 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.803 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 25.0 mt-10 -68.99 -34.0 74.58 Favored 'General case' 0 N--CA 1.41 -2.447 0 C-N-CA 117.826 -1.55 . . . . 0.5 109.34 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.721 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.81 -33.65 76.07 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 119.008 -1.077 . . . . 3.06 109.362 177.031 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' HD21 ' A' ' 128' ' ' LEU . 1.8 t -66.25 -31.64 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.276 -0.874 . . . . 0.35 112.087 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.803 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -85.81 -32.82 21.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.724 -0.671 . . . . 1.51 110.779 173.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.14 -46.75 87.56 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 114.962 1.467 . . . . 0.4 114.962 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.804 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -58.98 -38.03 78.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.711 -1.996 . . . . 0.32 109.164 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.555 ' N ' HD23 ' A' ' 128' ' ' LEU . 30.1 mt-10 -65.86 -32.43 73.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.652 1.215 . . . . 2.51 107.954 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.817 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.62 -7.74 55.86 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 112.599 -2.091 . . . . 0.33 110.948 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.5 t -122.06 1.18 9.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.22 -0.9 . . . . 0.36 109.275 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 66.56 56.87 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.535 -1.666 . . . . 2.19 111.867 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.804 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.98 147.22 27.6 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.972 -1.492 . . . . 0.27 106.972 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.599 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.01 154.65 42.75 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.003 -1.11 . . . . 0.69 108.003 -173.062 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -47.45 144.61 2.91 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.794 0.807 . . . . 1.96 112.339 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 134' ' ' ARG . 2.6 t -136.11 150.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.1 -1.409 . . . . 0.27 112.079 -171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.4 m -59.9 -50.08 75.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.865 -1.062 . . . . 0.73 111.57 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 19.1 ptmt -156.93 116.02 3.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.24 -1.345 . . . . 0.51 108.836 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.023 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.21 102.77 9.65 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.938 -1.483 . . . . 2.71 111.155 -167.668 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.4 t -157.29 92.63 1.26 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.395 -1.275 . . . . 0.35 109.535 162.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -153.94 158.64 32.51 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.903 -1.499 . . . . 2.38 107.519 169.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -75.66 109.76 2.96 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 CA-C-N 120.421 1.186 . . . . 0.79 109.574 167.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.23 2.94 57.86 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.498 -0.858 . . . . 0.38 114.439 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.0 mt-10 -128.84 132.33 47.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.202 1.001 . . . . 1.49 108.609 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.831 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.1 m-85 -133.16 176.24 8.68 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.112 -0.635 . . . . 0.3 110.224 -166.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 1.023 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.3 p -110.12 142.19 41.94 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.711 0.767 . . . . 0.19 111.655 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 128' ' ' LEU . 41.1 t -100.98 138.76 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.213 -1.358 . . . . 0.86 111.684 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.661 ' HB3' ' O ' ' A' ' 151' ' ' SER . 61.8 tp60 -124.96 -87.54 0.61 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.479 -0.328 . . . . 2.45 110.751 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.39 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.728 0.27 . . . . 0.49 111.728 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.4 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 88.3 m-20 -81.52 -5.15 57.69 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.482 -0.562 . . . . 1.02 109.482 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 31.0 p -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.674 -0.694 . . . . 0.94 110.043 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.642 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.0 mt -106.73 170.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.184 -1.413 . . . . 0.2 107.184 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 24.4 tt0 -116.97 137.3 52.31 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.989 -1.485 . . . . 0.97 106.989 166.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.488 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -133.46 124.67 27.46 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.655 -0.818 . . . . 1.32 112.3 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.756 0 CA-C-N 115.669 -0.696 . . . . 0.33 109.992 173.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 155' ' ' ILE . 77.1 t . . . . . 0 CA--C 1.492 -1.266 0 N-CA-C 108.406 -0.961 . . . . 0.48 108.406 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -129.74 145.11 51.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.305 1.05 . . . . 1.61 113.234 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.63 163.53 15.65 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.194 -1.821 . . . . 0.2 109.83 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 74.9 ttt180 -111.94 127.15 55.77 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.97 -1.122 . . . . 3.69 107.97 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.642 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -114.84 111.38 21.13 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.402 -1.272 . . . . 0.61 110.682 -165.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.435 ' HB ' HG22 ' A' ' 182' ' ' THR . 96.3 m -109.31 150.49 27.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.347 0.594 . . . . 0.21 112.25 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.846 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.5 m-85 -115.65 114.09 24.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.358 -1.292 . . . . 0.32 111.853 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.542 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.2 t70 -104.63 103.41 13.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.74 111.393 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.82 -113.22 3.61 Favored Glycine 0 C--N 1.314 -0.691 0 C-N-CA 120.054 -1.069 . . . . 0.27 113.409 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.51 8.7 19.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.262 -1.384 . . . . 1.61 107.262 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.777 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.5 p80 -135.71 160.99 36.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.635 -1.166 . . . . 1.28 112.315 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 183' ' ' ILE . 9.2 tp -69.31 130.57 42.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 114.524 -1.216 . . . . 0.22 110.158 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.28 -49.99 10.82 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.426 -1.261 . . . . 0.15 110.821 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.435 HG22 ' HB ' ' A' ' 174' ' ' THR . 5.9 t -179.99 177.46 0.66 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.903 -1.044 . . . . 0.28 110.94 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.802 HD11 HD21 ' A' ' 180' ' ' LEU . 2.9 mp -151.17 128.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.7 -1.963 . . . . 0.28 105.7 173.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.775 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.2 t -133.99 119.47 32.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.015 -0.674 . . . . 0.34 112.207 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 98.59 0.06 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.156 -1.053 . . . . 1.64 108.156 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 75.3 mmm -53.03 -27.26 18.81 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 112.379 -2.192 . . . . 1.42 112.741 -167.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.9 mt-10 -65.67 -43.04 90.5 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 114.164 -1.38 . . . . 0.68 110.982 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.14 -19.86 13.48 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.152 -1.385 . . . . 2.36 111.27 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.775 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.2 p30 . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 114.253 1.205 . . . . 1.8 114.253 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 179' ' ' HIS . 3.6 m . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 108.657 -0.868 . . . . 0.32 108.657 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -133.88 172.49 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-O 122.43 1.109 . . . . 0.2 111.745 -174.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.865 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.9 m -110.49 165.86 11.46 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.53 -1.668 . . . . 1.29 109.138 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -52.12 -48.15 64.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.13 0.49 . . . . 3.26 110.995 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.5 m120 -81.02 -16.73 52.55 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.967 -0.56 . . . . 2.17 110.151 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.865 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.4 mt-10 -68.23 -25.94 65.46 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.422 0.63 . . . . 0.5 109.98 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 8.0 tpt -86.65 -28.14 23.37 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 117.882 -1.527 . . . . 3.06 109.632 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.71 -31.28 43.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.308 1.051 . . . . 0.35 111.986 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.719 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -81.69 -42.77 19.42 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.596 -1.184 . . . . 1.51 109.822 170.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.93 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.69 -36.68 81.58 Favored 'General case' 0 CA--C 1.463 -2.367 0 CA-C-O 117.477 -1.249 . . . . 0.4 113.768 -174.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -63.0 -40.06 96.64 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 116.356 -2.138 . . . . 0.32 108.631 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.675 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 51.8 mm-40 -68.9 -30.66 69.19 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 123.125 1.441 . . . . 2.51 108.665 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.03 -7.56 59.08 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 111.962 -2.381 . . . . 0.33 109.93 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.8 t -121.62 -2.07 9.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.191 -0.913 . . . . 0.36 108.937 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 77.1 52.73 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 113.523 -1.671 . . . . 2.19 112.482 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -151.09 143.73 24.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.575 -1.639 . . . . 0.27 106.575 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.646 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -142.45 163.22 33.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.69 -1.596 . . . . 0.69 106.69 -174.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.2 161.75 1.67 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.987 0.899 . . . . 1.96 111.277 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -147.61 153.02 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.243 -1.344 . . . . 0.27 111.718 -168.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -60.04 -49.56 77.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.803 0.811 . . . . 0.73 111.695 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.95 115.35 2.67 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.212 -1.358 . . . . 0.51 109.027 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.049 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.91 101.23 6.73 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-O 123.286 1.517 . . . . 2.71 111.656 -168.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.808 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.7 t -158.33 93.62 1.23 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.493 -1.685 . . . . 0.35 109.034 161.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.808 ' HD3' ' O ' ' A' ' 140' ' ' THR . 17.6 mmt180 -151.09 164.65 19.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 113.56 -1.655 . . . . 2.38 107.176 174.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.57 110.64 2.45 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 CA-C-N 119.975 1.027 . . . . 0.79 109.903 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.59 5.38 69.19 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.461 -0.876 . . . . 0.38 114.21 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.1 mm-40 -126.62 131.5 51.46 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.331 -1.359 . . . . 1.49 107.331 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.772 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.98 175.93 9.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.08 -1.048 . . . . 0.3 110.648 -166.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 1.049 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.0 p -111.49 142.03 44.29 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.647 0.737 . . . . 0.19 111.945 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 65.8 t -105.76 145.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.231 -1.349 . . . . 0.86 111.676 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -132.46 -87.31 0.45 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.347 -0.141 . . . . 2.45 111.097 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.43 -82.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.587 0.217 . . . . 0.49 111.587 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -82.03 -6.56 59.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 120.834 0.349 . . . . 1.02 110.282 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.5 p -149.92 145.87 26.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.88 -0.728 . . . . 0.94 111.028 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -109.68 166.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.136 -1.061 . . . . 0.2 108.136 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.772 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 3.2 tp10 -110.81 134.09 52.8 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.693 -1.595 . . . . 0.97 106.693 167.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -131.86 122.38 25.61 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 118.966 0.803 . . . . 1.32 112.425 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.837 0 CA-C-N 115.434 -0.803 . . . . 0.33 109.839 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 187' ' ' GLU . 65.2 t . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 107.613 -1.254 . . . . 0.48 107.613 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.23 145.21 50.09 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 122.326 1.06 . . . . 1.61 113.155 176.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.46 165.24 13.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.21 -1.813 . . . . 0.2 110.333 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.6 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 17.0 tpt180 -115.86 120.04 37.92 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.146 -1.057 . . . . 3.69 108.146 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.39 118.32 33.52 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.181 -1.372 . . . . 0.61 110.429 -164.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 175' ' ' PHE . 99.5 m -115.31 152.43 32.77 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.574 0.583 . . . . 0.21 112.574 -170.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.7 m-85 -114.66 109.26 17.95 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.696 -1.138 . . . . 0.32 112.294 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.572 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 27.5 t70 -98.87 96.52 7.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.047 0.451 . . . . 0.74 111.211 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.69 -117.43 4.44 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.22 -0.991 . . . . 0.27 113.179 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.77 11.04 22.61 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.416 -1.698 . . . . 1.61 106.416 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.717 ' HB3' HG23 ' A' ' 118' ' ' THR . 11.8 p-80 -138.0 161.07 37.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.141 -1.391 . . . . 1.28 111.782 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 183' ' ' ILE . 9.3 tp -67.98 136.1 53.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.133 -0.94 . . . . 0.22 110.886 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.572 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -84.11 -54.01 5.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.515 -1.22 . . . . 0.15 111.412 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -178.91 176.42 0.92 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.28 110.496 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.803 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.33 124.69 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.949 -1.5 . . . . 0.28 106.949 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.701 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.8 t -129.84 118.1 43.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.422 0.527 . . . . 0.34 112.422 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.89 101.09 0.1 Allowed 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.044 -1.095 . . . . 1.64 108.044 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.3 mmt -58.81 -16.81 18.84 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 112.833 -1.985 . . . . 1.42 112.675 -168.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.575 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.7 mt-10 -73.47 -44.35 58.17 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.743 -1.117 . . . . 0.68 110.003 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.65 -33.78 14.94 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.261 -1.336 . . . . 2.36 110.913 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.701 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.9 p30 . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 115.218 1.562 . . . . 1.8 115.218 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.6 m . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 108.649 -0.871 . . . . 0.32 108.649 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.912 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.7 pt -133.62 172.47 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.996 0.903 . . . . 0.2 111.227 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.868 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.6 t -117.47 172.18 7.5 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.019 -1.446 . . . . 1.29 109.547 -173.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 124' ' ' MET . 37.5 ttmt -56.0 -45.2 79.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.886 0.374 . . . . 3.26 111.307 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -83.35 -17.34 42.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 110.249 -0.278 . . . . 2.17 110.249 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -69.27 -22.77 63.8 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.124 -0.63 . . . . 0.5 110.46 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.777 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.95 -30.53 22.72 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 118.462 -1.295 . . . . 3.06 109.366 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.5 -30.62 46.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.115 0.959 . . . . 0.35 111.952 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.626 -1.17 . . . . 1.51 109.737 171.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.45 -35.76 78.51 Favored 'General case' 0 CA--C 1.462 -2.423 0 CA-C-O 117.683 -1.151 . . . . 0.4 114.027 -172.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.5 -43.18 94.9 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 115.915 -2.314 . . . . 0.32 109.093 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 59.3 mm-40 -65.36 -27.91 68.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.808 1.289 . . . . 2.51 108.635 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.78 -8.16 54.92 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.258 -2.246 . . . . 0.33 110.28 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.1 t -122.46 0.27 9.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.416 -0.811 . . . . 0.36 109.354 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 74.49 54.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.653 -1.612 . . . . 2.19 112.543 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.16 144.65 24.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.498 -1.667 . . . . 0.27 106.498 178.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.616 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -145.6 164.09 32.77 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.188 -1.782 . . . . 0.69 106.188 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.571 ' CB ' HG12 ' A' ' 147' ' ' VAL . 2.8 pt20 -49.73 160.65 0.28 Allowed 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.207 1.003 . . . . 1.96 112.731 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -148.0 151.57 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 113.946 -1.479 . . . . 0.27 112.015 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.1 m -59.74 -50.02 75.45 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.114 -0.948 . . . . 0.73 111.658 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.4 ptmt -159.03 117.04 2.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.015 -1.448 . . . . 0.51 108.66 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.994 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.85 100.55 6.39 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 123.504 1.621 . . . . 2.71 111.761 -168.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.811 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 t -158.2 90.99 1.07 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.194 -1.821 . . . . 0.35 108.677 159.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.811 ' HD3' ' O ' ' A' ' 140' ' ' THR . 9.1 mmt180 -153.95 134.51 8.17 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 113.623 -1.626 . . . . 2.38 106.705 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.98 109.25 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 121.353 1.519 . . . . 0.79 109.894 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.26 -1.39 57.42 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.689 -0.767 . . . . 0.38 114.025 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 1.5 mm-40 -125.66 131.7 52.57 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.738 -1.208 . . . . 1.49 107.738 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.875 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -130.85 175.2 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.156 -1.018 . . . . 0.3 110.169 -168.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.994 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.5 p -112.63 134.13 54.32 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.572 -0.451 . . . . 0.19 110.623 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 135' ' ' GLN . 0.5 OUTLIER -113.51 153.29 15.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.061 -0.972 . . . . 0.86 112.17 -174.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -152.95 -85.32 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.6 0.593 . . . . 2.45 112.6 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.48 -92.01 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.173 0.805 . . . . 0.49 113.173 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -81.95 -6.99 59.57 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.687 0.28 . . . . 1.02 111.341 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.3 p -150.56 145.75 26.13 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.61 -0.836 . . . . 0.94 110.327 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.588 ' CD1' HD12 ' A' ' 128' ' ' LEU . 6.6 mt -110.04 162.45 7.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.911 -0.774 . . . . 0.2 108.911 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.4 tp10 -107.6 132.96 52.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.995 -1.483 . . . . 0.97 106.995 167.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.719 ' HG3' ' CE2' ' A' ' 145' ' ' PHE . 3.8 ttt -126.52 124.25 39.62 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.239 -0.585 . . . . 1.32 112.137 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.139 -0.689 . . . . 0.33 109.139 168.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.459 HG13 ' CD ' ' A' ' 187' ' ' GLU . 66.0 t . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 109.487 -0.561 . . . . 0.48 109.487 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -131.35 145.37 51.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.345 1.069 . . . . 1.61 113.469 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.56 165.88 12.74 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.993 -1.912 . . . . 0.2 110.921 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.457 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 2.2 tpp180 -115.65 111.89 21.3 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.747 -1.205 . . . . 3.69 107.747 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.578 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -107.92 118.15 35.99 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.217 -1.811 . . . . 0.61 109.969 -166.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.487 ' HB ' HG22 ' A' ' 182' ' ' THR . 87.5 m -114.43 150.86 34.07 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.762 0.653 . . . . 0.21 112.762 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.912 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.8 m-85 -115.26 112.47 22.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.663 -1.153 . . . . 0.32 112.212 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.591 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 25.8 t70 -102.96 98.48 8.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.965 0.412 . . . . 0.74 110.803 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.67 -120.45 5.28 Favored Glycine 0 C--N 1.317 -0.517 0 C-N-CA 120.085 -1.055 . . . . 0.27 112.85 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.74 14.17 22.29 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.829 -1.545 . . . . 1.61 106.829 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.0 p-80 -138.96 159.06 43.04 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.024 -1.444 . . . . 1.28 111.735 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -66.36 137.08 56.64 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.055 -0.975 . . . . 0.22 111.01 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.591 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.07 -51.48 5.98 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.48 -1.236 . . . . 0.15 111.653 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.1 t -179.39 176.99 0.78 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.069 -0.969 . . . . 0.28 110.292 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.68 130.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.396 -1.705 . . . . 0.28 106.396 175.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.721 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.9 t -134.24 118.45 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 120.59 -0.444 . . . . 0.34 111.853 -172.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.52 98.64 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.063 -1.088 . . . . 1.64 108.063 171.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -51.48 -25.12 5.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.877 -1.965 . . . . 1.42 112.449 -170.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.459 ' CD ' HG13 ' A' ' 169' ' ' VAL . 3.4 mt-10 -71.08 -40.99 71.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 113.64 -1.618 . . . . 0.68 110.643 -174.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.04 -27.49 13.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.728 -1.578 . . . . 2.36 111.418 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.721 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.9 p-10 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 115.299 1.592 . . . . 1.8 115.299 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.5 m . . . . . 0 N--CA 1.442 -0.872 0 CA-C-O 121.71 0.767 . . . . 0.32 111.04 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -140.15 173.61 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 114.364 -1.289 . . . . 0.2 110.858 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.7 p -121.41 174.08 6.97 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.729 -1.123 . . . . 1.29 110.098 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 124' ' ' MET . 28.5 ttpp -50.99 -47.43 61.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 3.26 111.845 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.486 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -84.21 -17.1 40.95 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 122.248 -0.282 . . . . 2.17 110.521 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.7 mt-10 -70.69 -22.63 62.44 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.297 -0.561 . . . . 0.5 110.149 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -84.99 -29.13 25.29 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.457 -1.297 . . . . 3.06 109.66 178.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.02 -33.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.559 1.171 . . . . 0.35 111.605 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.74 -42.3 28.55 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.292 -1.322 . . . . 1.51 109.806 170.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.45 -38.6 84.71 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.476 -1.25 . . . . 0.4 114.163 -173.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.12 -41.01 97.82 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 116.129 -2.229 . . . . 0.32 108.67 177.096 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.679 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 64.0 mm-40 -67.27 -32.0 72.71 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 123.006 1.384 . . . . 2.51 108.658 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.16 -7.32 59.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.895 -2.412 . . . . 0.33 110.179 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -121.12 1.06 10.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.114 0.959 . . . . 0.36 108.636 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 72.68 55.26 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.286 -1.779 . . . . 2.19 112.267 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 146.75 25.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.548 -1.649 . . . . 0.27 106.548 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.624 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.07 163.26 34.05 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.061 -1.829 . . . . 0.69 106.061 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.25 159.6 0.64 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.082 0.944 . . . . 1.96 112.041 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -146.68 150.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-N 114.147 -1.388 . . . . 0.27 111.624 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 m -60.56 -50.18 74.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.093 -0.958 . . . . 0.73 111.942 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.9 ptmt -155.43 114.51 3.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.161 -1.382 . . . . 0.51 108.967 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.908 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.38 100.5 5.19 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 123.894 1.807 . . . . 2.71 112.041 -168.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 1.4 t -158.84 95.4 1.29 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.178 -1.828 . . . . 0.35 108.07 162.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -151.34 165.38 17.5 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.483 -1.235 . . . . 2.38 108.183 173.127 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.31 111.56 2.65 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 119.578 0.885 . . . . 0.79 109.982 164.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.39 13.41 78.69 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.674 -0.774 . . . . 0.38 114.049 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.9 mt-10 -131.88 130.91 42.25 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.349 -0.982 . . . . 1.49 108.349 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.921 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.84 176.63 8.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.547 -0.861 . . . . 0.3 110.279 -166.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.908 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.1 p -107.88 142.03 38.58 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.532 0.682 . . . . 0.19 110.932 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.35 134.71 39.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 114.617 -1.174 . . . . 0.86 111.08 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 151' ' ' SER . 31.7 tp60 -147.23 54.2 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.98 0.419 . . . . 2.45 110.961 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 60.57 -100.43 0.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.35 0.87 . . . . 0.49 113.35 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.04 -5.02 58.04 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.051 0.453 . . . . 1.02 111.375 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 57.3 m -141.9 123.21 14.81 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.268 -0.573 . . . . 0.94 110.26 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 128' ' ' LEU . 5.9 mt -96.19 165.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.617 -1.253 . . . . 0.2 107.617 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.921 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 5.6 tt0 -124.5 105.82 9.69 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.898 -1.121 . . . . 0.97 110.392 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.61 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.8 ppp? -106.76 125.8 51.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.061 0.458 . . . . 1.32 111.478 -166.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 116.148 -0.478 . . . . 0.33 110.316 172.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.0 t . . . . . 0 CA--C 1.486 -1.513 0 N-CA-C 109.303 -0.628 . . . . 0.48 109.303 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.691 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.71 145.48 50.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.135 0.969 . . . . 1.61 112.712 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -112.28 166.12 11.56 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.512 -1.676 . . . . 0.2 110.22 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.69 120.48 37.55 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.439 -0.948 . . . . 3.69 108.439 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -115.32 137.32 52.17 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.729 -1.578 . . . . 0.61 109.901 -163.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 82.6 m -129.83 150.24 51.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.235 0.54 . . . . 0.21 111.881 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.9 m-85 -113.24 106.82 15.09 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.424 -1.262 . . . . 0.32 112.374 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.575 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 17.7 t70 -93.67 96.66 9.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.119 0.485 . . . . 0.74 111.113 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.71 -114.77 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.185 -1.007 . . . . 0.27 113.31 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.04 8.99 22.1 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.004 -1.48 . . . . 1.61 107.004 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 34.7 p80 -138.41 161.11 37.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.159 -1.382 . . . . 1.28 111.59 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 183' ' ' ILE . 8.1 tp -63.75 144.3 57.15 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.404 -0.817 . . . . 0.22 111.731 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.92 -52.46 4.23 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.43 -1.259 . . . . 0.15 111.914 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 183' ' ' ILE . 6.3 t -179.24 176.19 0.88 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.463 -0.789 . . . . 0.28 110.558 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.73 HD11 HD21 ' A' ' 180' ' ' LEU . 3.5 mp -152.27 137.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 105.646 -1.983 . . . . 0.28 105.646 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 75.4 t -139.55 119.86 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 112.417 0.525 . . . . 0.34 112.417 -172.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.97 96.46 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.064 -1.087 . . . . 1.64 108.064 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.1 mmm -54.91 -24.3 22.87 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.141 -1.845 . . . . 1.42 113.26 -166.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.0 mt-10 -70.57 -40.92 73.04 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 114.39 -1.277 . . . . 0.68 110.957 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -93.54 -32.52 14.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.753 -1.567 . . . . 2.36 110.571 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.626 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.7 p-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 122.074 0.94 . . . . 1.8 112.765 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.783 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.8 m . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.32 108.645 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.1 pt -132.85 172.63 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.242 1.02 . . . . 0.2 112.069 -174.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.825 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.6 m -117.06 174.04 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.581 -1.645 . . . . 1.29 110.206 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 124' ' ' MET . 14.0 mmmm -49.33 -53.78 20.45 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.599 0.592 . . . . 3.26 112.599 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 94.8 m-20 -82.89 -16.35 47.87 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 116.586 -0.279 . . . . 2.17 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.887 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -66.24 -24.09 66.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 120.274 -0.571 . . . . 0.5 110.167 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.77 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.07 -29.26 23.52 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.487 -1.285 . . . . 3.06 109.986 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.26 -31.13 50.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.436 1.112 . . . . 0.35 111.61 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.97 -42.45 23.92 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.233 -1.349 . . . . 1.51 109.735 170.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.38 81.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 CA-C-O 117.626 -1.178 . . . . 0.4 114.147 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.82 -39.56 94.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 116.233 -2.187 . . . . 0.32 108.733 177.455 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.668 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 55.2 mm-40 -69.56 -30.76 68.63 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.113 1.435 . . . . 2.51 108.787 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.885 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -83.64 -7.67 59.45 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 111.971 -2.377 . . . . 0.33 109.884 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.699 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.51 -0.95 9.66 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.115 -0.948 . . . . 0.36 108.967 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 71.49 58.09 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 113.341 -1.754 . . . . 2.19 112.625 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.675 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.65 146.88 25.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.106 -1.812 . . . . 0.27 106.106 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -143.34 162.59 35.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.41 -1.33 . . . . 0.69 107.41 -174.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.18 146.83 4.64 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.164 0.983 . . . . 1.96 112.567 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -134.56 150.84 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-N 113.702 -1.59 . . . . 0.27 112.046 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.5 m -60.34 -50.28 74.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.857 -1.065 . . . . 0.73 111.826 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.2 ptmt -155.33 113.77 3.49 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.114 -1.403 . . . . 0.51 108.812 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.871 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -75.72 100.35 4.66 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.682 1.706 . . . . 2.71 112.05 -167.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.823 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.1 t -159.22 92.08 1.06 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.61 -1.632 . . . . 0.35 109.305 161.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.823 ' HD3' ' O ' ' A' ' 140' ' ' THR . 16.9 mmt180 -152.0 147.82 20.48 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-N 113.8 -1.546 . . . . 2.38 107.189 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.03 110.28 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 CA-C-N 120.383 1.172 . . . . 0.79 109.372 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.5 14.4 58.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.354 -0.839 . . . . 0.38 114.352 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.2 mt-10 -136.89 132.72 34.91 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.858 -1.164 . . . . 1.49 107.858 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.92 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.97 175.25 9.39 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.167 -1.013 . . . . 0.3 110.451 -168.039 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.871 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.4 p -108.34 141.45 40.13 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.869 0.842 . . . . 0.19 112.047 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.76 119.71 52.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 113.736 -1.574 . . . . 0.86 110.477 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 151' ' ' SER . 51.8 tt0 -103.88 -80.16 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.492 -0.322 . . . . 2.45 110.695 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.07 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.738 0.304 . . . . 0.49 111.009 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.97 -4.14 56.01 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.332 -0.618 . . . . 1.02 109.332 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.7 m -142.6 148.04 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.55 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -106.77 169.14 2.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.727 -1.212 . . . . 0.2 107.727 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.92 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 12.4 tt0 -127.54 109.08 11.36 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.787 -0.765 . . . . 0.97 110.654 173.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 2.1 tmt? -109.71 123.2 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.747 0.308 . . . . 1.32 111.753 -169.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.251 0.548 . . . . 0.33 110.878 174.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 187' ' ' GLU . 63.4 t . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.733 -0.84 . . . . 0.48 108.733 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.14 145.23 51.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.243 1.021 . . . . 1.61 112.872 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.48 164.68 13.31 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 0.2 110.541 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 22.9 ttt180 -111.67 119.97 40.48 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.999 -1.111 . . . . 3.69 107.999 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.678 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -112.37 110.48 20.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.42 -1.264 . . . . 0.61 109.956 -168.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 181' ' ' ALA . 32.1 m -107.65 151.35 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.329 0.492 . . . . 0.21 112.329 -169.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.7 m-85 -117.03 101.81 8.81 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.628 -1.169 . . . . 0.32 112.685 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 22.4 t70 -98.66 100.43 11.66 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.659 -0.416 . . . . 0.74 111.189 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.24 -119.11 5.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.518 -0.849 . . . . 0.27 113.051 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.46 8.51 23.14 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.518 -1.66 . . . . 1.61 106.518 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.783 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.6 p80 -138.65 160.52 39.43 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.158 -1.383 . . . . 1.28 112.061 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -63.74 139.64 58.79 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 114.759 -1.11 . . . . 0.22 110.439 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.631 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -90.84 -48.82 6.79 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.442 -1.254 . . . . 0.15 111.348 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.457 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.5 t 177.36 178.02 0.31 Allowed 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.284 -0.871 . . . . 0.28 110.685 -174.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.74 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -150.94 127.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.909 -1.886 . . . . 0.28 105.909 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.69 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.4 t -132.87 122.09 45.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 112.568 0.581 . . . . 0.34 112.568 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -60.55 97.96 0.06 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.241 -1.022 . . . . 1.64 108.241 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.554 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.6 OUTLIER -54.56 -24.74 22.29 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 112.579 -2.1 . . . . 1.42 112.489 -168.365 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -68.58 -41.59 79.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 114.049 -1.432 . . . . 0.68 110.977 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.34 -27.96 13.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.788 -1.096 . . . . 2.36 110.808 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.69 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.7 p30 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 115.578 1.696 . . . . 1.8 115.578 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.9 m . . . . . 0 N--CA 1.44 -0.957 0 CA-C-O 121.613 0.721 . . . . 0.32 110.699 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.1 pt -138.54 172.53 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.296 -1.32 . . . . 0.2 110.235 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.885 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 11.1 p -122.56 176.27 6.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.741 -1.118 . . . . 1.29 110.151 -173.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' MET . 62.3 mtpt -56.03 -43.91 78.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.275 0.472 . . . . 3.26 112.275 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 26.2 t-20 -83.95 -18.36 37.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 122.042 -0.411 . . . . 2.17 110.016 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.959 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -67.36 -23.81 65.64 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 119.785 -0.766 . . . . 0.5 109.997 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.681 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.32 -27.59 25.81 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 118.576 -1.249 . . . . 3.06 109.81 177.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.01 -32.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.886 -1.052 . . . . 0.35 111.461 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.789 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.32 -40.01 31.38 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.813 -1.085 . . . . 1.51 110.291 170.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.17 -37.57 80.57 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 117.424 -1.274 . . . . 0.4 114.11 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.867 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.94 -40.02 95.48 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 116.103 -2.239 . . . . 0.32 109.227 175.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' H ' HD22 ' A' ' 128' ' ' LEU . 19.7 mt-10 -64.67 -28.82 69.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.685 1.231 . . . . 2.51 108.062 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -94.38 -6.82 43.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.827 -1.988 . . . . 0.33 111.135 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.3 t -122.52 -2.26 8.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.36 109.758 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 74.72 52.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.042 -1.436 . . . . 2.19 112.032 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.867 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -148.41 142.55 26.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.511 -1.292 . . . . 0.27 107.511 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.637 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -147.19 163.99 34.59 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.747 -1.205 . . . . 0.69 107.747 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -46.28 144.78 1.9 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 122.094 0.95 . . . . 1.96 113.202 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.7 t -137.37 151.18 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.375 0 CA-C-N 114.034 -1.439 . . . . 0.27 112.562 -173.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 m -59.77 -50.89 72.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.889 -1.05 . . . . 0.73 111.602 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.1 ptmt -157.72 117.65 3.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.019 -1.446 . . . . 0.51 108.605 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.916 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -78.69 100.34 7.0 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 123.466 1.603 . . . . 2.71 111.991 -167.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.806 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 3.1 t -159.71 95.03 1.18 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.095 -1.411 . . . . 0.35 109.274 162.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.806 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -151.99 171.82 6.17 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 114.451 -1.25 . . . . 2.38 107.747 172.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.26 111.71 2.43 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 CA-C-N 120.452 1.197 . . . . 0.79 109.885 164.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.17 0.12 77.67 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.794 -0.717 . . . . 0.38 114.84 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 40.9 mt-10 -119.57 132.09 55.66 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.686 1.243 . . . . 1.49 109.574 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.815 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.8 m-30 -129.3 175.55 8.65 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.365 -0.534 . . . . 0.3 110.328 -166.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.916 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.0 p -111.9 139.2 47.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.871 -0.788 . . . . 0.19 108.871 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.435 ' CB ' ' OH ' ' A' ' 133' ' ' TYR . 2.6 p -112.37 154.43 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 112.649 0.611 . . . . 0.86 112.649 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 151' ' ' SER . 46.8 tp60 -146.16 -95.08 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.334 -0.394 . . . . 2.45 111.146 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.0 -86.09 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.081 0.4 . . . . 0.49 112.081 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -83.19 -9.12 59.34 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.492 0.663 . . . . 1.02 109.665 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 46.9 m -139.51 119.74 13.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.53 -0.759 . . . . 0.94 110.579 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.549 HD11 ' SD ' ' A' ' 124' ' ' MET . 4.7 mt -96.95 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.767 -1.197 . . . . 0.2 107.767 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.815 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.1 tt0 -119.5 151.0 39.31 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.144 -1.428 . . . . 0.97 107.144 164.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.619 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -147.43 128.65 14.73 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.116 -0.634 . . . . 1.32 111.098 -177.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 110.049 -0.352 . . . . 0.33 110.049 171.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 187' ' ' GLU . 56.0 t . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 108.742 -0.836 . . . . 0.48 108.742 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -123.39 143.96 49.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.627 1.203 . . . . 1.61 112.582 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 153' ' ' GLU . . . -115.47 166.37 11.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 112.873 -1.967 . . . . 0.2 109.855 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.4 ttp180 -108.82 126.47 53.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.103 -0.703 . . . . 3.69 109.103 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.485 HD23 HG13 ' A' ' 183' ' ' ILE . 1.4 mt -84.59 152.05 24.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.357 -1.292 . . . . 0.61 110.076 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 181' ' ' ALA . 93.4 m -151.95 143.05 23.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.1 0.476 . . . . 0.21 111.22 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.932 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.3 m-85 -116.77 111.82 20.29 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.882 -1.053 . . . . 0.32 112.738 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.539 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 16.8 t70 -99.15 95.0 6.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 0.74 111.09 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.02 -114.48 3.96 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 120.199 -1.0 . . . . 0.27 113.487 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -110.8 8.77 22.52 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.055 -1.461 . . . . 1.61 107.055 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.744 ' HB3' HG23 ' A' ' 118' ' ' THR . 34.6 p80 -138.49 160.48 39.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.174 -1.375 . . . . 1.28 111.419 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.851 HD21 HD11 ' A' ' 183' ' ' ILE . 7.3 tp -62.06 144.59 55.04 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.059 -0.973 . . . . 0.22 111.093 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.3 -51.28 4.87 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.395 -1.275 . . . . 0.15 111.215 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.458 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t -178.53 176.26 1.04 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.112 -0.949 . . . . 0.28 110.556 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.851 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -154.15 125.82 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 113.086 -1.87 . . . . 0.28 106.472 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.629 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 98.7 t -128.76 119.51 49.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.28 -0.568 . . . . 0.34 111.901 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.26 96.84 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.529 -1.286 . . . . 1.64 107.529 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.7 mmt -53.89 -24.36 15.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 112.669 -2.059 . . . . 1.42 112.304 -168.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.555 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.5 mt-10 -68.13 -44.67 75.56 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 113.992 -1.458 . . . . 0.68 110.839 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.2 -27.77 13.65 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.936 -1.484 . . . . 2.36 111.138 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.3 p30 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 115.019 1.488 . . . . 1.8 115.019 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 121.627 0.727 . . . . 0.32 110.798 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.946 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.4 pt -138.4 172.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.595 -1.184 . . . . 0.2 111.318 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.898 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 10.2 p -121.18 174.77 6.47 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.502 -1.227 . . . . 1.29 109.9 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 124' ' ' MET . 35.8 ttpt -56.22 -43.0 78.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.78 0.324 . . . . 3.26 111.824 -175.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.6 t-20 -84.17 -18.03 38.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.063 -0.398 . . . . 2.17 110.187 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -68.28 -23.77 64.79 Favored 'General case' 0 N--CA 1.422 -1.868 0 C-N-CA 119.969 -0.693 . . . . 0.5 110.176 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.7 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.27 -26.56 26.57 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 118.495 -1.282 . . . . 3.06 109.581 177.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.5 -32.06 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.845 -1.071 . . . . 0.35 111.539 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.786 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.66 -38.97 32.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.792 -1.095 . . . . 1.51 110.348 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.76 -38.18 84.32 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-O 117.548 -1.215 . . . . 0.4 114.236 -174.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.866 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -39.48 94.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 116.216 -2.193 . . . . 0.32 109.257 176.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 22.0 mt-10 -65.02 -29.81 70.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.614 1.197 . . . . 2.51 108.113 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.72 -7.77 45.77 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.727 -2.033 . . . . 0.33 111.076 -170.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -121.81 -1.65 9.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.705 0.764 . . . . 0.36 109.322 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 71.25 57.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.702 -1.59 . . . . 2.19 111.996 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.866 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.08 145.51 26.4 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.587 -1.635 . . . . 0.27 106.587 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.558 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.87 164.52 31.68 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.886 -0.783 . . . . 0.69 108.886 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.42 ' CB ' HG12 ' A' ' 147' ' ' VAL . 18.3 tt0 -45.01 144.69 1.15 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.285 1.04 . . . . 1.96 113.21 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 138' ' ' LYS . 5.1 t -139.98 150.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 CA-C-N 113.507 -1.679 . . . . 0.27 111.781 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 p -63.64 -49.11 74.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.935 -1.484 . . . . 0.73 111.887 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -155.43 113.49 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.886 -1.506 . . . . 0.51 108.996 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.036 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -79.06 100.24 7.27 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 123.518 1.628 . . . . 2.71 111.187 -166.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.729 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.0 t -156.74 94.9 1.49 Allowed 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.313 -1.767 . . . . 0.35 107.899 164.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 140' ' ' THR . 1.8 mpt_? -151.78 171.82 6.14 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 113.675 -1.602 . . . . 2.38 107.783 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.75 111.89 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 CA-C-N 120.066 1.059 . . . . 0.79 110.15 163.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.96 4.54 86.97 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.717 -0.754 . . . . 0.38 114.665 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 81.7 mm-40 -119.28 132.59 55.92 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 117.976 0.888 . . . . 1.49 108.64 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.797 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.8 m-30 -128.81 172.93 10.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.833 -0.747 . . . . 0.3 110.255 -166.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 1.036 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.5 p -106.84 139.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.983 -0.747 . . . . 0.19 108.983 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 152' ' ' ILE . 2.0 p -113.67 128.92 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.134 -0.627 . . . . 0.86 112.35 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 151' ' ' SER . 26.7 mp0 -116.51 -88.03 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.23 -0.441 . . . . 2.45 111.865 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.79 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.935 0.346 . . . . 0.49 111.935 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.3 -9.41 59.48 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.69 0.757 . . . . 1.02 109.352 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 17.5 m -140.35 144.13 36.13 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 114.921 -1.036 . . . . 0.94 109.643 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.5 mt -108.73 168.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.105 -1.072 . . . . 0.2 108.105 168.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.797 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 22.7 tt0 -123.76 110.59 15.11 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.476 -0.89 . . . . 0.97 110.236 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.595 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -114.86 130.04 56.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.024 0.44 . . . . 1.32 111.021 -169.37 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.894 -0.41 . . . . 0.33 109.894 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 187' ' ' GLU . 69.3 t . . . . . 0 CA--C 1.492 -1.267 0 CA-C-O 120.645 0.259 . . . . 0.48 110.376 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -128.54 144.42 51.14 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 122.164 0.983 . . . . 1.61 112.41 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.3 167.22 11.04 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.481 -1.691 . . . . 0.2 110.619 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.7 ttp180 -115.08 120.74 40.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.847 -1.168 . . . . 3.69 107.847 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -113.41 114.1 26.13 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.927 -1.488 . . . . 0.61 110.282 -164.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.554 ' HB ' HG22 ' A' ' 182' ' ' THR . 64.5 m -112.36 146.42 38.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.022 -0.535 . . . . 0.21 111.744 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.946 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -118.8 117.75 29.72 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.417 -0.811 . . . . 0.32 111.905 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 14.1 t70 -98.08 99.65 10.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.69 -0.686 . . . . 0.74 111.128 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.22 -111.99 3.47 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.829 -1.176 . . . . 0.27 113.78 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.67 6.55 21.76 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.135 -1.431 . . . . 1.61 107.135 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.776 ' HB3' HG23 ' A' ' 118' ' ' THR . 22.9 p80 -140.94 160.27 40.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.979 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.833 HD21 HD11 ' A' ' 183' ' ' ILE . 6.0 tp -60.73 145.43 49.52 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.774 0.797 . . . . 0.22 111.562 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 174' ' ' THR . . . -97.74 -49.64 4.76 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.282 -1.326 . . . . 0.15 111.162 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.554 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t -178.95 177.69 0.81 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.316 -0.856 . . . . 0.28 110.657 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 180' ' ' LEU . 2.7 mp -152.93 123.22 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.495 -1.668 . . . . 0.28 106.495 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.74 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 88.4 t -127.94 123.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 112.804 0.668 . . . . 0.34 112.804 -170.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -59.67 101.36 0.11 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.339 1.066 . . . . 1.64 108.255 172.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.43 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 80.6 mmm -60.45 -13.85 15.95 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 113.05 -1.887 . . . . 1.42 112.788 -169.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.2 mt-10 -73.76 -45.58 50.93 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.48 -1.236 . . . . 0.68 110.752 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -104.96 -20.23 13.6 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.936 -1.029 . . . . 2.36 111.495 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.74 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 20.2 p30 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 115.254 1.575 . . . . 1.8 115.254 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.4 m . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.84 -0.8 . . . . 0.32 108.84 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.851 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.6 pt -128.7 172.04 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.275 1.036 . . . . 0.2 112.218 -172.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.844 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 6.3 t -120.95 170.13 9.8 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.804 -1.543 . . . . 1.29 109.398 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -52.02 -46.0 64.81 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.252 0.549 . . . . 3.26 112.278 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.443 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 18.3 m120 -84.14 -17.12 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.403 -0.362 . . . . 2.17 110.088 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.972 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -66.86 -30.87 71.15 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 120.468 -0.493 . . . . 0.5 110.361 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.84 -22.68 27.46 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 117.771 -1.572 . . . . 3.06 109.649 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' HD21 ' A' ' 128' ' ' LEU . 2.1 t -68.22 -29.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.566 -1.197 . . . . 0.35 111.674 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.95 -39.06 26.69 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.956 -1.02 . . . . 1.51 109.326 171.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -55.57 -45.37 77.33 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 114.525 1.306 . . . . 0.4 114.525 -174.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -60.35 -39.54 87.49 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 116.784 -1.966 . . . . 0.32 109.719 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.0 mt-10 -66.54 -29.62 69.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.51 108.022 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -91.34 -8.59 47.66 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 112.926 -1.943 . . . . 0.33 110.886 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.98 -1.87 9.29 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.783 0.802 . . . . 0.36 109.552 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 70.44 56.75 0.26 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.761 -1.563 . . . . 2.19 111.882 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.08 146.41 27.71 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.378 -1.712 . . . . 0.27 106.378 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -147.69 163.83 35.43 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.127 -1.435 . . . . 0.69 107.127 -176.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.549 ' CB ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -47.0 158.73 0.12 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 122.453 1.12 . . . . 1.96 112.853 -176.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -148.27 150.23 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 CA-C-N 113.772 -1.558 . . . . 0.27 111.412 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -61.48 -49.45 76.7 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.375 -0.829 . . . . 0.73 111.866 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 17.4 ptmt -153.77 115.76 4.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.187 -1.37 . . . . 0.51 108.85 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.874 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.34 99.37 4.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.842 1.782 . . . . 2.71 112.277 -168.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.738 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -158.73 91.63 1.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.29 -1.777 . . . . 0.35 108.684 159.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.2 mmt-85 -154.9 126.44 3.69 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.126 -1.805 . . . . 2.38 106.126 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.67 110.8 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 CA-C-N 121.3 1.5 . . . . 0.79 110.417 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.56 2.5 57.56 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.477 -0.783 . . . . 0.38 114.293 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 28.6 mt-10 -130.46 133.03 45.99 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.982 0.891 . . . . 1.49 108.789 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -128.34 175.17 8.69 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 120.014 -0.675 . . . . 0.3 109.985 -168.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.874 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.9 p -111.43 137.03 49.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.662 -0.495 . . . . 0.19 109.662 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 152' ' ' ILE . 1.3 p -113.37 140.72 32.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.443 -0.799 . . . . 0.86 111.57 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 151' ' ' SER . 3.3 pt20 -138.35 -91.35 0.21 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.0 0.37 . . . . 2.45 112.0 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 -93.21 0.13 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.685 0.624 . . . . 0.49 112.685 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -80.33 -3.62 50.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.004 0.431 . . . . 1.02 110.44 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 148' ' ' GLN . 20.4 m -144.67 148.09 33.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.019 -0.537 . . . . 0.94 109.609 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.561 ' CG2' HD23 ' A' ' 173' ' ' LEU . 9.3 mt -108.18 167.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 107.694 -1.224 . . . . 0.2 107.694 168.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.2 tt0 -123.43 106.17 10.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.931 -1.108 . . . . 0.97 111.051 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.555 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 6.0 ttt -106.27 130.26 54.15 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.191 -0.204 . . . . 1.32 111.168 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 169.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 187' ' ' GLU . 55.1 t . . . . . 0 CA--C 1.488 -1.413 0 N-CA-C 108.176 -1.046 . . . . 0.48 108.176 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -119.58 143.36 47.68 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 122.516 1.15 . . . . 1.61 113.151 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.84 166.46 13.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.719 -2.037 . . . . 0.2 110.653 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.74 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 28.6 ttp180 -114.17 114.94 26.71 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.737 -1.209 . . . . 3.69 107.737 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -103.32 105.58 15.89 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.303 -1.771 . . . . 0.61 109.573 -168.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.511 ' HB ' HG22 ' A' ' 182' ' ' THR . 55.1 m -104.16 149.25 25.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.463 -0.79 . . . . 0.21 112.655 -167.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.851 ' CD1' HD11 ' A' ' 119' ' ' ILE . 14.7 m-85 -115.51 107.51 15.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.32 113.078 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.636 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 25.3 t70 -100.56 102.71 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 0.74 110.842 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.26 -121.85 5.53 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.196 -1.002 . . . . 0.27 112.925 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -110.34 15.59 22.16 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.511 -1.663 . . . . 1.61 106.511 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.768 ' HB3' HG23 ' A' ' 118' ' ' THR . 29.6 p80 -138.16 161.15 37.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -70.54 131.67 44.34 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.62 -1.173 . . . . 0.22 110.364 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.636 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.7 -49.82 10.7 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.131 -1.395 . . . . 0.15 111.022 -175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t 177.7 178.22 0.33 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.765 -1.107 . . . . 0.28 110.413 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 180' ' ' LEU . 2.2 mp -148.28 121.2 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.759 -1.571 . . . . 0.28 106.759 174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.723 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -126.18 122.6 61.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.535 0.569 . . . . 0.34 112.535 -171.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.3 99.75 0.06 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 122.069 0.938 . . . . 1.64 108.806 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.8 mmt -54.04 -23.55 13.96 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 112.663 -2.062 . . . . 1.42 112.635 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.567 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -68.12 -42.21 80.55 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.382 -1.281 . . . . 0.68 110.556 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.1 -27.03 13.15 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.097 -1.411 . . . . 2.36 111.363 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.723 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.2 p-10 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 115.241 1.571 . . . . 1.8 115.241 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 179' ' ' HIS . 7.2 m . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 108.805 -0.813 . . . . 0.32 108.805 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.9 pt -134.68 171.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.906 -1.043 . . . . 0.2 110.51 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.872 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -119.58 173.91 6.72 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.872 -1.058 . . . . 1.29 108.801 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.6 -44.8 66.23 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.379 0.424 . . . . 3.26 111.011 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 64.1 t30 -82.91 -18.52 39.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.17 110.344 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -71.35 -25.69 62.5 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.363 -0.535 . . . . 0.5 110.666 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.2 tpt -88.81 -24.65 22.54 Favored 'General case' 0 C--N 1.286 -2.154 0 C-N-CA 118.065 -1.454 . . . . 3.06 109.515 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 2.3 t -60.0 -31.9 48.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.651 -1.159 . . . . 0.35 111.839 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.73 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.24 -39.8 28.32 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.124 -0.944 . . . . 1.51 110.415 170.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.902 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.03 -37.05 83.45 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-O 117.411 -1.28 . . . . 0.4 114.077 -175.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.773 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -63.39 -38.82 92.62 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 116.189 -2.204 . . . . 0.32 108.935 176.227 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 25.7 mt-10 -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.788 1.28 . . . . 2.51 108.116 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.94 -6.72 44.86 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 112.446 -2.161 . . . . 0.33 110.777 -169.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 128' ' ' LEU . 8.8 t -122.83 0.52 9.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.86 0.838 . . . . 0.36 109.555 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 71.62 53.47 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.85 -1.523 . . . . 2.19 111.691 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.02 144.24 25.68 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.276 -1.379 . . . . 0.27 107.276 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.627 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -144.79 163.02 35.32 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.236 -1.024 . . . . 0.69 108.236 -174.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -47.35 145.88 2.22 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.85 0.833 . . . . 1.96 112.358 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.81 150.09 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.304 -1.316 . . . . 0.27 112.289 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -60.43 -49.16 78.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.667 -1.151 . . . . 0.73 111.723 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.3 ptmt -157.19 113.95 3.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.148 -1.387 . . . . 0.51 108.619 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.896 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.8 OUTLIER -75.36 99.47 4.13 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 123.674 1.702 . . . . 2.71 112.089 -167.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.812 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.9 t -159.01 92.84 1.12 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.665 -1.607 . . . . 0.35 109.527 161.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.812 ' HD3' ' O ' ' A' ' 140' ' ' THR . 11.0 mmt180 -152.44 154.68 32.21 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 106.583 -1.636 . . . . 2.38 106.583 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.04 110.86 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 120.577 1.242 . . . . 0.79 109.911 168.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 15.38 63.48 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.536 -0.84 . . . . 0.38 113.933 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 26.6 mt-10 -134.48 131.4 38.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.743 -1.206 . . . . 1.49 107.743 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.913 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -133.75 176.25 8.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.504 -0.878 . . . . 0.3 110.612 -167.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.896 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.5 p -107.45 142.98 36.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.639 0.733 . . . . 0.19 111.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.23 134.45 47.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.344 -1.298 . . . . 0.86 111.629 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 151' ' ' SER . 77.0 mt-30 -120.1 -87.81 0.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.669 -0.241 . . . . 2.45 111.096 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -164.27 -81.08 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.693 0.283 . . . . 0.49 110.93 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -82.69 -4.28 57.6 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.065 0.46 . . . . 1.02 109.908 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 18.0 m -145.71 148.34 32.92 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.318 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -110.23 168.75 4.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.562 -1.273 . . . . 0.2 107.562 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.913 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.3 tt0 -124.03 108.75 12.7 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.712 -0.795 . . . . 0.97 110.017 172.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.564 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -111.81 125.62 54.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.376 0.607 . . . . 1.32 111.45 -170.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.774 0 CA-C-N 115.549 -0.75 . . . . 0.33 109.699 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 155' ' ' ILE . 84.1 t . . . . . 0 CA--C 1.488 -1.435 0 N-CA-C 109.173 -0.677 . . . . 0.48 109.173 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.82 145.01 49.98 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.231 1.015 . . . . 1.61 112.765 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -117.61 163.73 16.01 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.414 -1.721 . . . . 0.2 110.627 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.593 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 39.6 ttt180 -113.69 118.9 35.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.646 -1.242 . . . . 3.69 107.646 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.629 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.51 106.42 14.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 113.805 -1.543 . . . . 0.61 109.973 -164.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 53.5 m -105.01 149.37 25.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.609 -0.723 . . . . 0.21 112.306 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.854 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.0 m-85 -112.62 115.12 28.09 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.058 -1.428 . . . . 0.32 111.559 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 14.5 t70 -107.1 100.18 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.18 0.514 . . . . 0.74 111.121 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.8 -119.29 5.15 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.143 -1.027 . . . . 0.27 112.653 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.75 12.4 21.03 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.755 ' HB3' HG23 ' A' ' 118' ' ' THR . 14.5 p-80 -137.22 160.04 40.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.544 -1.207 . . . . 1.28 111.82 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -67.82 134.1 50.36 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.755 -1.111 . . . . 0.22 110.82 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.481 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -82.14 -54.57 5.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.327 -1.306 . . . . 0.15 111.066 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.2 t 178.69 177.12 0.48 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.13 -0.941 . . . . 0.28 109.896 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.39 132.22 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.28 107.007 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.6 t -135.17 115.77 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.887 0.699 . . . . 0.34 112.887 -167.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -59.38 100.45 0.08 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.946 -1.131 . . . . 1.64 107.946 171.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 2.7 mmt -56.87 -15.97 5.83 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 112.962 -1.926 . . . . 1.42 112.622 -169.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.468 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -73.88 -45.39 51.18 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 114.44 -1.255 . . . . 0.68 110.692 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -97.09 -24.72 15.63 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.072 -1.422 . . . . 2.36 111.368 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.716 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.5 p-10 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 114.236 1.199 . . . . 1.8 114.236 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.85 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.1 m . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 108.435 -0.95 . . . . 0.32 108.435 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.4 pt -125.71 171.24 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.344 1.069 . . . . 0.2 111.391 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.86 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.0 m -111.08 167.3 10.37 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.449 -1.705 . . . . 1.29 108.634 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -51.81 -45.92 64.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.031 0.443 . . . . 3.26 111.195 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.43 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 23.0 t-20 -83.66 -17.87 40.0 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.419 -0.355 . . . . 2.17 110.4 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -66.1 -25.1 66.85 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 120.409 -0.516 . . . . 0.5 110.876 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.74 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.1 tpt -88.86 -24.15 22.61 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.102 -1.439 . . . . 3.06 109.723 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 122' ' ' ASN . 2.1 t -61.36 -31.19 49.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.624 -1.171 . . . . 0.35 111.786 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.734 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.89 -40.81 27.49 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.014 -0.993 . . . . 1.51 110.399 169.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.13 -36.9 81.0 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.393 -1.289 . . . . 0.4 114.108 -175.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.774 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -64.05 -37.24 86.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.314 -2.154 . . . . 0.32 109.008 176.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 128' ' ' LEU . 25.6 mt-10 -65.45 -32.29 73.83 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.88 1.324 . . . . 2.51 107.802 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.898 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -90.9 -7.03 53.32 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.383 -2.189 . . . . 0.33 110.617 -169.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.4 t -122.11 0.91 9.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.949 0.88 . . . . 0.36 109.38 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 66.1 58.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 113.62 -1.627 . . . . 2.19 111.997 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.49 143.24 24.6 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.055 -1.832 . . . . 0.27 106.055 178.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.08 163.81 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.489 -1.3 . . . . 0.69 107.489 -175.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -52.28 160.12 0.85 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.383 1.087 . . . . 1.96 111.821 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 2.3 t -145.34 152.65 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.326 0 CA-C-N 113.629 -1.623 . . . . 0.27 110.938 -170.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -60.08 -50.12 74.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.862 0.839 . . . . 0.73 111.55 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 17.7 ptmt -157.48 110.06 2.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.19 -1.368 . . . . 0.51 108.902 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.88 ' HE1' ' HG2' ' A' ' 153' ' ' GLU . 5.8 ttp -68.97 100.5 1.22 Allowed 'General case' 0 N--CA 1.398 -3.075 0 CA-C-O 122.364 1.078 . . . . 2.71 113.509 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.8 t -160.11 94.85 1.13 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.162 -1.836 . . . . 0.35 108.389 157.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HD3' ' O ' ' A' ' 140' ' ' THR . 18.3 mmt180 -149.37 169.98 8.35 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 114.056 -1.429 . . . . 2.38 107.445 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.55 111.32 2.55 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 CA-C-N 119.578 0.885 . . . . 0.79 110.87 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.25 13.14 83.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.797 -0.716 . . . . 0.38 114.188 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.9 mm-40 -122.14 132.96 54.74 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.949 -1.5 . . . . 1.49 106.949 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -130.02 174.36 9.85 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.47 -1.292 . . . . 0.3 111.493 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.574 ' CG2' ' HB2' ' A' ' 139' ' ' MET . 9.4 p -111.86 139.35 47.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.801 0.81 . . . . 0.19 111.406 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.16 141.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.801 -1.545 . . . . 0.86 111.064 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 151' ' ' SER . 35.9 tt0 -129.16 -80.85 0.57 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.803 -0.18 . . . . 2.45 111.146 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -170.45 -88.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.638 0.256 . . . . 0.49 111.388 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -81.59 -2.25 49.39 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.464 0.65 . . . . 1.02 109.264 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.3 m -144.02 148.03 34.67 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.53 -0.759 . . . . 0.94 109.87 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 173' ' ' LEU . 4.9 mt -109.31 171.44 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.075 -1.454 . . . . 0.2 107.075 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.88 ' HG2' ' HE1' ' A' ' 139' ' ' MET . 11.0 tt0 -115.77 140.06 49.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.762 -1.57 . . . . 0.97 106.762 169.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.413 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.2 ppp? -138.82 131.46 29.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.832 0.742 . . . . 1.32 111.969 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 110.016 -0.365 . . . . 0.33 110.016 171.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.722 HG13 ' HG3' ' A' ' 187' ' ' GLU . 3.0 t . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 108.203 -1.036 . . . . 0.48 108.203 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -120.03 144.23 47.65 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.781 1.277 . . . . 1.61 114.029 -176.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -110.84 167.73 10.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 112.462 -2.153 . . . . 0.2 110.414 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 3.1 ptp180 -115.59 118.76 34.01 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.078 -1.453 . . . . 3.69 107.078 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -110.45 111.01 21.98 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.097 -1.411 . . . . 0.61 109.826 -165.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 55.1 m -109.85 149.77 29.37 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.742 0.782 . . . . 0.21 112.998 -167.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.913 ' CD1' HD11 ' A' ' 119' ' ' ILE . 5.2 m-85 -114.82 117.42 30.67 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.623 -1.626 . . . . 0.32 110.535 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.533 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 0.5 OUTLIER -113.4 108.04 16.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.964 0.888 . . . . 0.74 110.491 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.81 -122.0 6.23 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.183 -1.008 . . . . 0.27 112.788 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -111.95 12.1 20.72 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.779 -1.563 . . . . 1.61 106.779 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.85 ' HB3' HG23 ' A' ' 118' ' ' THR . 6.7 p80 -140.29 160.98 38.77 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.747 -1.115 . . . . 1.28 112.326 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.714 HD21 HD11 ' A' ' 183' ' ' ILE . 9.1 tp -65.9 135.91 55.41 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.22 110.551 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.533 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.62 -51.67 6.0 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.449 -1.251 . . . . 0.15 111.444 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.5 t 175.72 177.42 0.2 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.225 -0.898 . . . . 0.28 110.115 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -149.31 123.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.523 -1.288 . . . . 0.28 107.523 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 94.3 t -126.9 119.97 54.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.395 0.517 . . . . 0.34 112.395 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -60.54 97.44 0.05 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.492 1.139 . . . . 1.64 108.458 171.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 75.0 mtp -54.17 -28.65 41.73 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 112.015 -2.357 . . . . 1.42 112.652 -166.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.722 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.0 mt-10 -61.61 -42.15 98.47 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.0 -1.454 . . . . 0.68 110.122 -172.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -106.26 -27.48 11.0 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.525 -1.671 . . . . 2.36 111.218 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.771 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 28.5 t-20 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.676 0.751 . . . . 1.8 111.333 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.823 HG23 ' HB3' ' A' ' 179' ' ' HIS . 6.2 m . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 109.083 -0.71 . . . . 0.32 109.083 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.888 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.2 pt -135.12 172.74 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 115.105 -0.952 . . . . 0.2 111.096 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.842 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.4 p -124.78 177.3 6.07 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.574 -1.194 . . . . 1.29 110.482 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 124' ' ' MET . 65.4 tttp -50.7 -48.76 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.422 0.451 . . . . 3.26 111.864 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 63.3 t30 -84.23 -18.64 35.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 122.273 -0.267 . . . . 2.17 110.285 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.74 -23.53 63.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.877 -0.729 . . . . 0.5 109.813 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.766 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.5 -28.32 25.04 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.401 -1.32 . . . . 3.06 109.855 177.363 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.89 -33.06 56.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 122.463 1.125 . . . . 0.35 111.767 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.38 -41.71 32.46 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.379 -1.282 . . . . 1.51 110.17 169.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.912 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.39 -38.32 86.62 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-O 117.525 -1.226 . . . . 0.4 114.215 -173.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 116.184 -2.206 . . . . 0.32 108.566 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.665 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 61.5 mm-40 -67.94 -29.69 68.81 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 123.189 1.471 . . . . 2.51 108.741 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.55 -6.97 59.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.016 -2.357 . . . . 0.33 110.028 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.742 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -122.54 -0.66 9.18 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.152 -0.931 . . . . 0.36 109.657 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 77.4 51.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 113.865 -1.516 . . . . 2.19 112.436 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.95 145.05 24.57 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.195 -1.409 . . . . 0.27 107.195 -178.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.632 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -142.62 160.83 39.54 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.166 -1.79 . . . . 0.69 106.166 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -53.04 160.17 1.05 Allowed 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 119.383 0.992 . . . . 1.96 111.656 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.44 153.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.333 -1.303 . . . . 0.27 111.979 -169.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -60.9 -50.13 74.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.556 0.693 . . . . 0.73 111.886 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.537 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.6 ptmt -157.0 114.64 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.35 -1.296 . . . . 0.51 108.793 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.009 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.18 107.28 15.62 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 122.798 1.285 . . . . 2.71 111.242 -167.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.635 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.8 t -156.92 95.49 1.52 Allowed 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.882 -1.508 . . . . 0.35 108.584 163.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 140' ' ' THR . 19.3 mmt85 -151.54 169.64 9.08 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 113.622 -1.626 . . . . 2.38 108.099 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.03 110.47 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 N-CA-C 109.43 -1.027 . . . . 0.79 109.43 161.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.61 26.95 58.05 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.356 -0.926 . . . . 0.38 114.09 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 32.8 mt-10 -138.82 130.6 27.72 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.41 -1.33 . . . . 1.49 107.41 171.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -134.0 176.8 8.25 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.61 -0.836 . . . . 0.3 110.482 -165.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 1.009 HG23 ' HB3' ' A' ' 139' ' ' MET . 14.3 p -113.5 138.92 49.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.829 0.823 . . . . 0.19 112.291 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.18 141.47 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 113.696 -1.593 . . . . 0.86 110.862 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -127.48 -81.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.771 -0.372 . . . . 2.45 111.071 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.48 -88.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 0.49 111.712 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -85.53 -3.02 58.74 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.296 0.569 . . . . 1.02 109.564 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 m -142.41 146.63 35.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.786 -0.643 . . . . 0.94 110.286 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.34 169.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.467 -1.308 . . . . 0.2 107.467 169.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.796 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.5 tt0 -115.71 135.57 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.561 -1.644 . . . . 0.97 106.561 166.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.484 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.0 ppp? -134.66 127.9 32.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.874 0.761 . . . . 1.32 111.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.356 -0.609 . . . . 0.33 109.356 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 54.4 t . . . . . 0 CA--C 1.48 -1.722 0 N-CA-C 108.351 -0.981 . . . . 0.48 108.351 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.4 OUTLIER -120.81 142.71 49.35 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 122.524 1.155 . . . . 1.61 113.083 176.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.16 166.88 11.52 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 112.772 -2.013 . . . . 0.2 110.46 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 20.0 ttt180 -116.88 119.38 35.21 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.503 -1.295 . . . . 3.69 107.503 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.0 114.57 27.08 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.795 -1.548 . . . . 0.61 110.027 -164.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 182' ' ' THR . 54.2 m -110.8 150.98 28.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 112.76 0.652 . . . . 0.21 112.76 -168.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.888 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.8 m-85 -113.59 103.47 11.28 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.38 -1.282 . . . . 0.32 112.873 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.69 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 9.9 t0 -89.76 96.1 10.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.209 0.528 . . . . 0.74 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.63 -115.56 4.04 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.099 -1.048 . . . . 0.27 113.159 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -111.07 9.44 22.04 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.756 -1.572 . . . . 1.61 106.756 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.823 ' HB3' HG23 ' A' ' 118' ' ' THR . 9.5 p-80 -137.65 161.09 37.4 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.221 -1.354 . . . . 1.28 111.807 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 183' ' ' ILE . 10.5 tp -67.03 137.32 56.38 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.177 -0.919 . . . . 0.22 110.849 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.69 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -89.16 -54.23 4.21 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.173 -1.376 . . . . 0.15 111.631 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.457 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.2 t -176.97 177.09 1.33 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.123 -0.944 . . . . 0.28 110.12 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -151.84 124.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.455 -1.683 . . . . 0.28 106.455 176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.734 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 69.4 t -128.23 123.8 60.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.776 0.658 . . . . 0.34 112.776 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.87 98.49 0.05 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.317 -0.994 . . . . 1.64 108.317 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 72.0 mmm -58.9 -16.72 18.93 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 113.332 -1.758 . . . . 1.42 112.896 -168.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.8 mt-10 -72.35 -42.59 65.13 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.473 -1.24 . . . . 0.68 110.175 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.96 -26.73 13.31 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.082 -1.417 . . . . 2.36 112.007 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.734 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.5 p-10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 115.342 1.608 . . . . 1.8 115.342 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.78 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.4 m . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 108.751 -0.833 . . . . 0.32 108.751 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.847 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.56 170.6 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.104 -0.953 . . . . 0.2 110.773 -174.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.6 m -119.57 177.05 5.08 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.648 -1.16 . . . . 1.29 109.461 -170.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 124' ' ' MET . 51.3 pttt -51.6 -48.02 63.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.397 . . . . 3.26 111.671 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 121' ' ' LYS . 27.8 t-20 -84.07 -18.1 38.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.474 -0.33 . . . . 2.17 110.406 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.916 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.03 -22.67 64.04 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.911 -0.716 . . . . 0.5 110.627 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.692 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.09 -27.15 22.13 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.212 -0.995 . . . . 3.06 109.925 176.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.55 -31.77 54.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.569 -1.196 . . . . 0.35 111.565 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.777 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.27 -41.38 34.22 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.942 -1.026 . . . . 1.51 109.808 170.52 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.916 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.69 -40.27 83.13 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-O 117.58 -1.2 . . . . 0.4 114.116 -173.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.79 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -38.35 90.8 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 116.299 -2.16 . . . . 0.32 109.285 177.311 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 28.0 mt-10 -65.55 -32.66 74.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.679 1.228 . . . . 2.51 108.013 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.826 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.74 -7.51 56.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.474 -2.148 . . . . 0.33 110.632 -169.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.39 0.73 10.07 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.222 -0.899 . . . . 0.36 109.116 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 66.46 56.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.636 -1.62 . . . . 2.19 111.981 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.79 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.58 146.88 27.57 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.92 -1.511 . . . . 0.27 106.92 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.584 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.88 160.21 42.12 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.78 -1.193 . . . . 0.69 107.78 -174.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -46.99 147.78 1.27 Allowed 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 122.021 0.915 . . . . 1.96 112.664 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -139.09 151.94 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 CA-C-N 113.981 -1.463 . . . . 0.27 112.127 -172.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 m -60.1 -50.08 75.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.914 . . . . 0.73 111.438 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.04 116.65 3.11 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.51 108.73 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.979 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -78.47 102.32 7.78 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 123.082 1.42 . . . . 2.71 111.196 -167.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.658 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 4.1 t -157.84 95.96 1.45 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.984 -1.462 . . . . 0.35 108.646 161.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.2 mmt180 -151.51 168.84 10.36 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 113.614 -1.63 . . . . 2.38 106.905 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.84 111.39 2.49 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 CA-C-N 119.91 1.004 . . . . 0.79 109.796 162.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.5 20.63 59.81 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.469 -0.872 . . . . 0.38 114.164 172.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 38.8 mt-10 -136.94 132.11 33.96 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.074 -1.084 . . . . 1.49 108.074 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.939 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.29 175.98 9.02 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.702 -0.799 . . . . 0.3 110.408 -165.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.8 p -110.32 139.74 45.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.759 0.79 . . . . 0.19 112.516 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 52.3 t -101.2 129.2 52.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 113.733 -1.576 . . . . 0.86 110.887 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.2 tp60 -113.22 -78.55 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 121.071 -0.251 . . . . 2.45 110.775 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -169.24 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.858 0.361 . . . . 0.49 111.271 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.7 -2.55 58.62 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.625 -0.509 . . . . 1.02 109.625 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 p -145.2 143.97 30.59 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.957 -0.565 . . . . 0.94 110.533 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.652 ' CG2' HD23 ' A' ' 173' ' ' LEU . 7.4 mt -106.82 169.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.2 107.303 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.939 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 27.9 tt0 -126.09 111.02 14.2 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.585 -0.846 . . . . 0.97 110.518 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 10.2 tmm? -112.95 124.29 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.092 0.473 . . . . 1.32 111.872 -169.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.725 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.33 110.537 172.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 187' ' ' GLU . 77.7 t . . . . . 0 CA--C 1.484 -1.58 0 N-CA-C 108.563 -0.903 . . . . 0.48 108.563 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.725 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -121.07 144.2 48.67 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.367 1.08 . . . . 1.61 112.591 177.299 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -118.18 161.18 20.3 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.2 109.657 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.416 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 34.7 ttt180 -109.53 118.82 37.62 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.836 -1.172 . . . . 3.69 107.836 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.652 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -108.52 103.87 13.08 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.693 -1.594 . . . . 0.61 110.161 -165.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 56.3 m -104.43 149.55 25.32 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.727 -0.67 . . . . 0.21 112.096 -169.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.847 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.0 m-85 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.397 -1.274 . . . . 0.32 112.16 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.557 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 20.7 t70 -99.57 97.25 8.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.974 0.416 . . . . 0.74 110.729 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.51 -115.58 4.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.223 -0.989 . . . . 0.27 113.699 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -110.74 7.55 22.17 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 106.864 -1.532 . . . . 1.61 106.864 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.78 ' HB3' HG23 ' A' ' 118' ' ' THR . 33.8 p80 -138.84 161.0 38.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.811 -1.54 . . . . 1.28 111.837 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -68.47 131.64 45.63 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.455 -1.248 . . . . 0.22 110.459 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.557 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -79.3 -53.53 6.85 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.228 -1.351 . . . . 0.15 110.49 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.2 t 178.49 178.19 0.42 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.831 -1.077 . . . . 0.28 110.375 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.5 mp -146.36 116.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.707 -1.59 . . . . 0.28 106.707 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.631 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 99.4 t -115.77 123.66 71.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 113.243 0.831 . . . . 0.34 113.243 -170.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -61.13 91.83 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.482 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 70.5 mmm -58.35 -20.47 43.78 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 113.408 -1.724 . . . . 1.42 113.667 -163.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.5 mt-10 -71.15 -42.78 68.7 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.787 -1.097 . . . . 0.68 110.215 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -98.44 -31.08 12.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.768 -1.56 . . . . 2.36 110.981 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.631 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.9 p-10 . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.955 0.883 . . . . 1.8 112.35 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.4 m . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 109.061 -0.718 . . . . 0.32 109.061 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.911 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -130.92 171.14 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-N 115.276 -0.874 . . . . 0.2 110.889 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -123.35 178.97 4.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.494 -1.23 . . . . 1.29 109.507 -172.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 121' ' ' LYS . 12.7 mptt -56.99 -43.39 81.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.06 0.457 . . . . 3.26 111.295 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 14.1 m120 -83.6 -17.87 40.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.483 -0.326 . . . . 2.17 110.614 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.893 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -73.52 -21.61 60.35 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.288 -0.565 . . . . 0.5 111.08 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.688 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -87.87 -26.89 22.54 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.276 -0.97 . . . . 3.06 109.716 174.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 2.1 t -63.05 -30.66 50.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.62 -1.173 . . . . 0.35 111.613 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.95 -41.97 28.06 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.767 -1.106 . . . . 1.51 109.847 170.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.07 -36.43 79.61 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 117.389 -1.291 . . . . 0.4 114.27 -172.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.861 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.68 -40.53 95.56 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 116.274 -2.17 . . . . 0.32 109.511 175.284 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.4 mt-10 -64.62 -29.02 70.02 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.873 1.32 . . . . 2.51 108.03 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.07 -7.73 44.79 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 112.548 -2.115 . . . . 0.33 110.858 -169.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.4 t -122.09 -1.78 9.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.741 0.781 . . . . 0.36 109.853 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 70.88 57.31 0.22 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.796 -1.547 . . . . 2.19 111.746 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.861 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.95 145.02 26.24 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 106.766 -1.568 . . . . 0.27 106.766 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.662 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.35 163.68 35.68 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.67 -1.604 . . . . 0.69 106.67 -177.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 147' ' ' VAL . 2.2 pt20 -46.93 159.63 0.1 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.476 1.132 . . . . 1.96 112.828 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 138' ' ' LYS . 3.4 t -149.75 148.59 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 CA-C-N 113.513 -1.676 . . . . 0.27 111.481 -172.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 m -60.36 -49.61 76.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.241 -0.89 . . . . 0.73 111.57 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -157.68 115.29 3.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.51 108.861 -176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.781 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -75.99 104.41 6.51 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 122.999 1.381 . . . . 2.71 111.506 -168.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.8 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.9 t -157.33 94.12 1.36 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.012 -1.449 . . . . 0.35 109.02 159.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.8 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -152.3 166.26 15.7 Favored Pre-proline 0 CA--C 1.502 -0.882 0 CA-C-N 113.906 -1.497 . . . . 2.38 107.883 171.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -80.95 111.34 2.46 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 CA-C-N 119.84 0.979 . . . . 0.79 109.767 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.98 12.21 68.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.621 -0.8 . . . . 0.38 114.353 172.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.8 mt-10 -128.72 131.79 47.93 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.583 -0.895 . . . . 1.49 108.583 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.7 m-85 -130.75 174.29 10.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.549 -0.861 . . . . 0.3 110.788 -165.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 139' ' ' MET . 5.9 p -111.39 137.66 48.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.905 -0.776 . . . . 0.19 108.905 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.454 HG12 ' CB ' ' A' ' 135' ' ' GLN . 4.0 p -111.06 146.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 113.353 0.871 . . . . 0.86 113.353 -168.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 151' ' ' SER . 51.2 tt0 -154.69 174.97 14.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.591 -0.892 . . . . 2.45 108.591 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.48 ' H ' ' HG2' ' A' ' 148' ' ' GLN . . . -64.54 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.94 1.089 . . . . 0.49 113.94 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -84.71 -4.67 59.14 Favored 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 122.239 -0.288 . . . . 1.02 111.185 -174.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.666 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 28.6 p -149.95 134.68 17.65 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.65 -0.82 . . . . 0.94 110.845 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.581 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.0 mt -100.57 171.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.565 -1.272 . . . . 0.2 107.565 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.6 tt0 -117.11 137.72 52.11 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 106.982 -1.488 . . . . 0.97 106.982 167.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.498 ' CA ' ' HE1' ' A' ' 139' ' ' MET . 1.8 tmt? -135.11 123.55 23.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.615 0.643 . . . . 1.32 112.373 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 115.932 -0.576 . . . . 0.33 110.767 174.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.029 -1.1 . . . . 0.48 108.029 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.67 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -126.37 144.43 50.83 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.132 0.968 . . . . 1.61 113.308 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 163.09 16.49 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.457 -1.701 . . . . 0.2 110.181 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.404 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.0 ttm180 -113.0 118.13 33.97 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.46 -0.941 . . . . 3.69 108.46 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -107.32 111.36 23.68 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.677 -1.601 . . . . 0.61 110.604 -164.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 182' ' ' THR . 58.7 m -109.21 152.43 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.736 0.643 . . . . 0.21 112.736 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.911 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.2 m-85 -118.46 97.87 5.98 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.141 -0.936 . . . . 0.32 112.887 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.759 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 33.9 t70 -86.05 97.02 10.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.113 0.482 . . . . 0.74 110.83 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.07 -118.31 4.82 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.164 -1.017 . . . . 0.27 112.645 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.32 13.55 21.63 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.532 -1.285 . . . . 1.61 107.532 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 30.8 p80 -139.37 160.98 38.56 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.413 -1.267 . . . . 1.28 111.261 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 183' ' ' ILE . 10.2 tp -63.71 139.32 58.76 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.347 -0.842 . . . . 0.22 110.876 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -92.04 -50.48 5.67 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.414 -1.266 . . . . 0.15 111.462 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.6 t 176.33 177.34 0.25 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.573 -1.194 . . . . 0.28 110.026 -173.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -148.83 134.27 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 105.839 -1.911 . . . . 0.28 105.839 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.745 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 75.0 t -134.02 116.58 23.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 120.162 -0.615 . . . . 0.34 112.236 -171.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.1 97.81 0.05 Allowed 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.845 -1.169 . . . . 1.64 107.845 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 85.0 mmm -59.48 -16.12 22.04 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.695 -2.048 . . . . 1.42 112.98 -165.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.2 mt-10 -72.21 -44.05 63.54 Favored 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 114.499 -1.228 . . . . 0.68 109.791 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -94.4 -33.52 13.12 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.675 -1.602 . . . . 2.36 111.109 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.745 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 5.0 p30 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 115.394 1.627 . . . . 1.8 115.394 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.846 HG23 ' HB3' ' A' ' 179' ' ' HIS . 10.3 m . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 108.927 -0.768 . . . . 0.32 108.927 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.876 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.3 pt -131.75 171.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.95 -1.023 . . . . 0.2 111.945 -171.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.837 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 21.1 t -123.93 174.76 7.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.57 -1.195 . . . . 1.29 109.39 -172.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -52.2 -42.68 63.72 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.033 0.753 . . . . 3.26 113.033 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.8 t30 -85.61 -18.04 34.44 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.397 -0.815 . . . . 2.17 110.202 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.56 -25.07 63.82 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.621 -0.432 . . . . 0.5 111.409 -175.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.668 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.72 -25.28 22.41 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.096 -1.442 . . . . 3.06 109.696 175.118 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.32 -30.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.766 -1.107 . . . . 0.35 111.737 -177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.64 -41.44 26.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.698 -1.137 . . . . 1.51 109.822 170.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.77 -40.33 83.64 Favored 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 117.598 -1.191 . . . . 0.4 114.167 -174.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.839 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.97 -38.22 90.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.35 -2.14 . . . . 0.32 109.273 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 128' ' ' LEU . 24.2 mt-10 -66.69 -31.36 71.98 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.86 1.314 . . . . 2.51 108.129 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.86 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.8 -7.27 54.76 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 112.491 -2.14 . . . . 0.33 110.711 -169.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.9 t -121.54 -0.47 9.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.36 109.289 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 69.16 55.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.767 -1.56 . . . . 2.19 111.737 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.839 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.17 144.95 26.92 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.582 -1.266 . . . . 0.27 107.582 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.655 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.86 162.45 38.62 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.834 -1.172 . . . . 0.69 107.834 -175.362 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -47.3 146.94 1.73 Allowed 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 113.349 0.87 . . . . 1.96 113.349 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -140.73 151.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.968 -1.469 . . . . 0.27 112.066 -172.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -61.06 -50.18 74.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.73 111.937 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.9 ptmt -154.32 115.95 4.16 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.658 -1.155 . . . . 0.51 109.296 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.907 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -77.35 100.58 5.98 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 123.667 1.698 . . . . 2.71 112.106 -166.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.69 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.2 t -158.97 96.37 1.34 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.593 -1.64 . . . . 0.35 109.04 163.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.69 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.4 mmt180 -151.1 169.88 8.62 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.835 -1.543 . . . . 2.38 106.835 170.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.4 111.25 2.33 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 CA-C-N 119.967 1.024 . . . . 0.79 109.874 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.1 22.32 61.23 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.265 -0.969 . . . . 0.38 114.014 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.3 mt-10 -137.4 131.03 31.44 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.912 -1.144 . . . . 1.49 107.912 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.912 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -133.08 176.57 8.39 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.912 -0.715 . . . . 0.3 109.847 -167.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.907 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.6 p -108.13 143.48 36.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.608 0.718 . . . . 0.19 111.543 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.633 HG22 ' OH ' ' A' ' 133' ' ' TYR . 55.2 t -106.04 119.93 56.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.268 -1.333 . . . . 0.86 110.976 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 151' ' ' SER . 52.9 tp60 -101.72 -85.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 2.45 110.436 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.99 -82.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 120.537 0.208 . . . . 0.49 110.745 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.588 0.709 . . . . 1.02 109.389 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 47.2 p -138.96 143.08 38.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.92 -1.036 . . . . 0.94 110.05 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.638 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.0 mt -104.64 171.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.574 -1.269 . . . . 0.2 107.574 170.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.912 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.7 tt0 -128.4 106.84 9.27 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.685 -0.806 . . . . 0.97 110.18 171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.532 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.5 tmt? -110.07 125.96 53.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 1.32 111.713 -167.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 CA-C-N 116.076 -0.511 . . . . 0.33 109.949 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.603 HG13 ' HG3' ' A' ' 187' ' ' GLU . 44.6 t . . . . . 0 CA--C 1.485 -1.527 0 N-CA-C 109.178 -0.675 . . . . 0.48 109.178 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 2.2 ppt_? -120.47 143.39 48.54 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.59 1.186 . . . . 1.61 113.039 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.88 160.62 22.33 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 112.981 -1.918 . . . . 0.2 110.638 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.38 120.24 41.92 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.097 -1.075 . . . . 3.69 108.097 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 180' ' ' LEU . 0.2 OUTLIER -114.54 110.72 20.25 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.388 -1.733 . . . . 0.61 110.576 -163.103 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 71.1 m -108.38 148.05 30.67 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.093 -0.38 . . . . 0.21 110.946 -173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.876 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -115.82 99.9 7.63 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.034 0.753 . . . . 0.32 113.034 176.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.614 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 11.0 t0 -77.33 92.69 3.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.373 0.606 . . . . 0.74 111.321 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.54 -109.78 3.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.131 -1.033 . . . . 0.27 114.2 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.29 7.8 23.23 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.613 -1.255 . . . . 1.61 107.613 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.846 ' HB3' HG23 ' A' ' 118' ' ' THR . 10.3 p-80 -142.29 160.82 39.49 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.071 -1.422 . . . . 1.28 112.1 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -65.61 136.43 56.33 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.165 -0.925 . . . . 0.22 110.978 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.614 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.29 -53.42 4.85 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.521 -1.218 . . . . 0.15 111.54 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.8 t -177.84 176.51 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.314 -0.857 . . . . 0.28 110.382 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -152.2 118.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 113.895 -1.502 . . . . 0.28 107.274 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.71 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 71.9 t -124.48 123.43 66.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.573 0.583 . . . . 0.34 112.573 -171.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.98 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.194 0.997 . . . . 1.64 108.91 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 88.0 mmm -58.27 -16.49 14.28 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 112.482 -2.145 . . . . 1.42 112.844 -168.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.603 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.8 mt-10 -68.3 -41.64 80.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.256 -1.338 . . . . 0.68 109.915 -176.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -112.87 -20.54 11.55 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.651 -1.613 . . . . 2.36 112.542 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.71 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 13.1 p30 . . . . . 0 C--N 1.349 0.559 0 N-CA-C 114.098 1.147 . . . . 1.8 114.098 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.859 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.5 m . . . . . 0 N--CA 1.432 -1.365 0 N-CA-C 109.062 -0.718 . . . . 0.32 109.062 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -127.98 172.16 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.202 1.001 . . . . 0.2 111.688 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.835 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.7 t -121.27 175.16 6.27 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 113.891 -1.504 . . . . 1.29 109.487 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.9 mttt -52.67 -48.93 66.16 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.335 0.397 . . . . 3.26 111.838 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 54.2 m-80 -83.84 -16.21 45.35 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 122.341 -0.224 . . . . 2.17 110.559 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.35 -21.27 63.83 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.451 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.06 -26.96 25.04 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.925 -1.11 . . . . 3.06 109.774 176.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.59 -32.06 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.834 -1.076 . . . . 0.35 111.532 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.776 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.85 -40.38 32.78 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.725 -1.125 . . . . 1.51 110.171 170.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.53 82.17 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 117.469 -1.253 . . . . 0.4 114.364 -174.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.818 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.86 -38.51 91.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.247 -2.181 . . . . 0.32 109.181 176.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.505 ' H ' HD22 ' A' ' 128' ' ' LEU . 36.7 mt-10 -64.67 -32.44 74.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.893 1.33 . . . . 2.51 107.895 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.66 -6.71 55.9 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.332 -2.213 . . . . 0.33 110.567 -169.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.5 t -122.11 0.28 9.59 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.351 -0.84 . . . . 0.36 109.258 -174.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 70.12 55.9 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.682 -1.599 . . . . 2.19 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.69 146.95 25.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.954 -1.499 . . . . 0.27 106.954 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.575 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.17 159.33 42.83 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.109 -1.071 . . . . 0.69 108.109 -178.09 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.4 158.97 0.76 Allowed 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 122.19 0.995 . . . . 1.96 112.116 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -148.67 153.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 113.821 -1.536 . . . . 0.27 111.264 -169.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -50.06 75.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.937 0.875 . . . . 0.73 111.728 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -157.74 113.8 2.83 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.229 -1.35 . . . . 0.51 108.682 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.957 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.32 105.06 13.08 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.229 1.49 . . . . 2.71 111.339 -166.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -157.49 93.71 1.32 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.303 -1.772 . . . . 0.35 107.969 162.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 23.7 mmt180 -151.35 169.6 9.1 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.447 -1.706 . . . . 2.38 107.813 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 111.4 2.75 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 CA-C-N 119.269 0.775 . . . . 0.79 110.389 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.11 78.4 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.581 -0.819 . . . . 0.38 113.886 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 1.3 mm-40 -129.59 132.2 46.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.382 -1.34 . . . . 1.49 107.382 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.807 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.0 OUTLIER -132.6 175.44 9.31 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.258 -0.977 . . . . 0.3 110.413 -169.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.0 p -111.18 141.9 44.08 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.954 0.883 . . . . 0.19 111.956 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 54.5 t -101.8 119.97 50.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.844 -1.526 . . . . 0.86 110.773 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 151' ' ' SER . 64.9 mt-30 -101.99 -78.59 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.681 -0.236 . . . . 2.45 110.741 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.63 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.717 0.294 . . . . 0.49 111.199 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -89.33 -2.93 58.62 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.84 0.829 . . . . 1.02 109.153 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.572 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 15.4 p -138.16 141.83 40.08 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.779 -1.1 . . . . 0.94 109.636 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.629 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.9 mt -104.35 170.92 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.103 -1.443 . . . . 0.2 107.103 169.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.2 tt0 -119.45 139.07 52.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.544 -1.651 . . . . 0.97 106.544 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.494 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -135.57 127.38 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 118.863 0.756 . . . . 1.32 111.935 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.33 108.379 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.639 HG11 ' ND2' ' A' ' 185' ' ' ASN . 12.4 t . . . . . 0 CA--C 1.495 -1.141 0 N-CA-C 108.34 -0.985 . . . . 0.48 108.34 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -119.77 144.81 47.09 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 122.454 1.121 . . . . 1.61 113.223 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.49 159.88 23.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.296 -1.774 . . . . 0.2 110.24 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HA ' ' HG3' ' A' ' 153' ' ' GLU . 24.7 ttm180 -108.93 118.82 37.78 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 122.073 0.94 . . . . 3.69 108.751 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.629 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -110.2 113.33 25.93 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.568 -1.651 . . . . 0.61 110.959 -162.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 63.5 m -112.16 149.14 32.63 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.003 -0.435 . . . . 0.21 112.152 -171.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.967 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -117.84 110.94 18.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.841 -0.618 . . . . 0.32 111.649 175.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.642 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 3.3 t70 -94.35 107.24 19.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.477 -0.783 . . . . 0.74 111.042 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.8 -115.75 4.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.279 -0.962 . . . . 0.27 113.015 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.35 10.82 19.94 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.003 -1.481 . . . . 1.61 107.003 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.859 ' HB3' HG23 ' A' ' 118' ' ' THR . 12.0 p-80 -137.51 160.75 38.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.793 -1.094 . . . . 1.28 112.734 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -63.58 134.96 56.42 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.575 -0.739 . . . . 0.22 110.493 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.642 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -88.69 -49.84 6.61 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.638 -1.164 . . . . 0.15 111.32 -176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.5 t 177.49 178.47 0.3 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.96 -1.018 . . . . 0.28 110.277 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.794 HD11 HD21 ' A' ' 180' ' ' LEU . 2.0 mp -152.99 124.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 N-CA-C 106.075 -1.824 . . . . 0.28 106.075 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.657 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.2 t -121.1 121.73 65.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 113.101 0.778 . . . . 0.34 113.101 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.639 ' ND2' HG11 ' A' ' 169' ' ' VAL . 23.6 t-20 -58.94 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 107.797 -1.186 . . . . 1.64 107.797 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.459 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 81.4 mmm -62.0 -15.57 45.04 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-N 114.216 -1.356 . . . . 1.42 112.661 -167.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.12 -42.62 55.96 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 114.343 -1.299 . . . . 0.68 110.289 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -100.2 -30.39 11.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.379 -1.282 . . . . 2.36 112.039 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.657 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.0 p-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 114.665 1.357 . . . . 1.8 114.665 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.5 m . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.349 -0.611 . . . . 0.32 109.349 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.885 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.1 pt -132.14 172.34 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.075 -0.966 . . . . 0.2 111.251 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.857 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 65.4 p -123.97 179.45 4.84 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.697 -1.138 . . . . 1.29 110.403 -169.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 124' ' ' MET . 41.0 mmtm -60.03 -37.81 80.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.273 0.559 . . . . 3.26 110.594 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -85.45 -22.22 28.39 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 116.213 -0.449 . . . . 2.17 110.706 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.943 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.5 mt-10 -72.53 -23.16 60.96 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 119.805 -0.758 . . . . 0.5 109.74 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.705 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -85.05 -28.12 25.89 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.172 -1.011 . . . . 3.06 109.967 178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.29 -32.57 56.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.005 -0.998 . . . . 0.35 111.711 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.782 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.95 -39.96 33.13 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.833 -1.076 . . . . 1.51 110.005 171.112 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.43 -39.54 80.05 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 114.261 1.208 . . . . 0.4 114.261 -174.33 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.51 -38.79 92.47 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.157 -2.217 . . . . 0.32 109.08 177.253 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.502 ' H ' HD22 ' A' ' 128' ' ' LEU . 21.1 mt-10 -65.7 -31.48 72.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.93 1.348 . . . . 2.51 108.09 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.33 -6.98 56.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.472 -2.149 . . . . 0.33 110.556 -170.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.4 t -122.17 2.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.973 -1.012 . . . . 0.36 109.195 -175.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 68.68 54.85 0.49 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 113.671 -1.604 . . . . 2.19 111.581 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.0 146.97 25.98 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.647 -1.242 . . . . 0.27 107.647 -177.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.648 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.43 161.25 40.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.126 -1.435 . . . . 0.69 107.126 -176.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -52.06 158.23 1.14 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.201 1.001 . . . . 1.96 112.099 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.41 153.58 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 113.826 -1.533 . . . . 0.27 111.48 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.3 m -59.63 -50.89 72.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.038 0.923 . . . . 0.73 111.472 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -159.91 116.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.765 -1.561 . . . . 0.51 108.035 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.971 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -82.26 109.07 16.2 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.955 1.36 . . . . 2.71 110.925 -165.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.7 t -155.71 95.66 1.68 Allowed 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 113.549 -1.659 . . . . 0.35 108.727 162.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.6 mmt180 -151.17 167.52 12.84 Favored Pre-proline 0 N--CA 1.432 -1.375 0 CA-C-N 113.029 -1.896 . . . . 2.38 107.75 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.44 111.61 2.62 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 N-CA-C 109.644 -0.945 . . . . 0.79 109.644 160.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.77 20.81 59.03 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.657 -0.783 . . . . 0.38 114.393 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 41.2 mt-10 -137.45 131.9 32.6 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.238 -1.023 . . . . 1.49 108.238 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.832 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -132.12 176.54 8.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.827 -0.749 . . . . 0.3 110.036 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.1 p -112.66 139.97 47.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.717 0.77 . . . . 0.19 111.763 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG2' ' OH ' ' A' ' 133' ' ' TYR . 40.1 t -98.44 139.48 20.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.088 -1.415 . . . . 0.86 110.922 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 151' ' ' SER . 64.0 tt0 -125.15 -79.08 0.6 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.021 -0.272 . . . . 2.45 111.273 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.54 -81.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.75 0.31 . . . . 0.49 111.702 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -86.71 -5.4 59.13 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.236 -0.653 . . . . 1.02 109.236 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 m -143.46 146.54 33.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.275 -0.875 . . . . 0.94 109.348 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.631 HG22 HD23 ' A' ' 173' ' ' LEU . 6.6 mt -107.97 169.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.988 -1.486 . . . . 0.2 106.988 167.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.832 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.1 tt0 -116.19 136.37 53.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.521 -1.659 . . . . 0.97 106.521 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.467 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.3 ppp? -136.75 125.29 23.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 119.143 0.883 . . . . 1.32 112.692 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.33 110.08 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.546 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t . . . . . 0 CA--C 1.49 -1.359 0 N-CA-C 108.467 -0.938 . . . . 0.48 108.467 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.03 144.1 51.1 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 122.288 1.042 . . . . 1.61 113.427 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -111.68 168.01 9.9 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.333 -1.758 . . . . 0.2 110.664 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.526 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 39.5 ptt180 -118.42 122.34 42.54 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.147 -1.427 . . . . 3.69 107.147 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -117.78 106.82 13.43 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.574 -1.194 . . . . 0.61 110.443 -162.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 51.8 m -105.67 150.81 25.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.67 -0.695 . . . . 0.21 112.328 -169.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.885 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.5 m-85 -115.56 106.66 14.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.32 -1.309 . . . . 0.32 112.71 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.561 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 34.5 t70 -95.96 103.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.886 0.374 . . . . 0.74 111.173 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 80.67 -118.44 4.65 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.259 -0.972 . . . . 0.27 112.602 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.31 12.82 21.65 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.578 -1.638 . . . . 1.61 106.578 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.4 p80 -133.8 161.05 35.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.546 -1.207 . . . . 1.28 111.694 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -69.14 135.35 50.56 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.706 -1.134 . . . . 0.22 110.423 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.561 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -85.78 -50.87 6.81 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.289 -1.323 . . . . 0.15 110.946 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -179.08 177.09 0.83 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.065 -0.97 . . . . 0.28 110.727 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -150.18 121.54 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.488 -1.671 . . . . 0.28 106.488 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.756 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 72.1 t -131.63 122.18 49.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.563 0.579 . . . . 0.34 112.563 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -59.1 99.11 0.05 OUTLIER 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.001 -1.111 . . . . 1.64 108.001 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 82.4 mtp -55.6 -22.9 24.41 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 112.606 -2.088 . . . . 1.42 112.179 -169.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.7 mt-10 -66.47 -45.69 78.84 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.098 -1.41 . . . . 0.68 110.603 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.71 -20.0 13.76 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.399 -1.273 . . . . 2.36 111.668 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.756 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.6 p30 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 113.581 0.956 . . . . 1.8 113.581 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.32 108.938 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.2 pt -131.01 172.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 122.374 1.083 . . . . 0.2 112.452 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.84 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 7.4 m -111.9 171.32 7.57 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.547 -1.66 . . . . 1.29 110.031 -173.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.623 ' O ' ' HG3' ' A' ' 124' ' ' MET . 63.9 mttm -49.27 -54.49 16.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.093 0.473 . . . . 3.26 111.885 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 20.9 t-20 -82.51 -15.81 51.04 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.956 -0.387 . . . . 2.17 109.956 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -64.58 -24.88 67.74 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.149 -0.621 . . . . 0.5 110.19 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.763 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.59 -28.36 24.89 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.327 -1.349 . . . . 3.06 109.769 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -32.69 55.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.453 1.12 . . . . 0.35 111.684 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.57 -42.35 29.43 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.493 -1.23 . . . . 1.51 109.917 169.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.41 -38.51 84.26 Favored 'General case' 0 CA--C 1.463 -2.399 0 CA-C-O 117.429 -1.272 . . . . 0.4 114.101 -173.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.47 -40.93 98.23 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 116.329 -2.148 . . . . 0.32 108.717 177.221 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.651 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.4 mm-40 -66.87 -32.24 73.37 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.098 1.427 . . . . 2.51 108.589 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.98 -7.53 59.11 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 111.911 -2.404 . . . . 0.33 110.296 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.0 t -121.46 1.71 10.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.214 1.007 . . . . 0.36 108.744 -176.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 70.95 54.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.238 -1.801 . . . . 2.19 112.109 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.65 143.27 23.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.202 -1.407 . . . . 0.27 107.202 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -143.2 162.38 35.75 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.088 -1.449 . . . . 0.69 107.088 -178.193 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -52.39 158.28 1.25 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.232 1.015 . . . . 1.96 112.059 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -147.04 152.32 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-N 114.002 -1.454 . . . . 0.27 111.903 -168.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 m -59.61 -49.65 76.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.73 111.544 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -158.54 113.55 2.58 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.982 -1.463 . . . . 0.51 108.627 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.003 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.78 106.18 14.41 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.851 1.31 . . . . 2.71 111.056 -168.04 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.805 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.7 t -157.45 93.94 1.34 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.942 -1.481 . . . . 0.35 109.171 162.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.805 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.0 mmt180 -152.15 170.0 8.66 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 113.145 -1.843 . . . . 2.38 107.779 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -81.88 111.71 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 CA-C-N 119.755 0.948 . . . . 0.79 110.299 162.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.64 72.85 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.575 -0.821 . . . . 0.38 114.345 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.434 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 3.2 mm-40 -127.78 130.84 49.39 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.799 -1.556 . . . . 1.49 106.799 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.778 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -133.97 176.71 8.33 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.868 -1.133 . . . . 0.3 110.638 -168.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 1.003 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.3 p -112.86 139.86 48.13 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.657 0.742 . . . . 0.19 111.799 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -98.65 141.37 16.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.097 -1.411 . . . . 0.86 111.065 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 151' ' ' SER . 63.2 tt0 -124.95 -78.73 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.833 -0.167 . . . . 2.45 110.956 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.76 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.612 0.244 . . . . 0.49 111.183 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.406 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 85.8 m-20 -81.72 -1.19 46.14 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.324 -0.621 . . . . 1.02 109.324 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 15.1 m -140.63 144.73 35.92 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.69 -0.686 . . . . 0.94 110.045 172.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.88 172.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.728 -1.212 . . . . 0.2 107.728 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.0 tt0 -118.87 135.2 54.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.512 -1.662 . . . . 0.97 106.512 166.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.485 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -136.19 127.11 27.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.111 0.868 . . . . 1.32 111.893 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.33 110.813 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.619 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.8 t . . . . . 0 CA--C 1.487 -1.46 0 N-CA-C 107.986 -1.116 . . . . 0.48 107.986 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.31 144.4 50.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.337 1.065 . . . . 1.61 113.862 177.592 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -114.69 164.92 13.38 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.162 -1.836 . . . . 0.2 110.737 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.46 122.78 43.57 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.815 -1.18 . . . . 3.69 107.815 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -116.75 121.24 41.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 113.922 -1.49 . . . . 0.61 110.575 -161.03 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.435 HG22 ' CB ' ' A' ' 181' ' ' ALA . 54.3 m -114.62 151.83 32.85 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.307 0.484 . . . . 0.21 112.307 -170.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.859 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.4 m-85 -116.16 100.08 7.68 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.747 -1.115 . . . . 0.32 113.375 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.641 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 27.1 t70 -92.22 99.38 12.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.74 111.325 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.69 -113.72 3.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.954 -1.117 . . . . 0.27 113.948 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 8.07 20.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.016 -1.475 . . . . 1.61 107.016 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 20.9 p80 -138.6 161.7 36.45 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.025 -1.443 . . . . 1.28 111.786 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 183' ' ' ILE . 8.7 tp -67.41 137.28 55.81 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.705 -1.134 . . . . 0.22 110.464 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.641 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.33 -49.67 7.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.572 -1.195 . . . . 0.15 111.44 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 174' ' ' THR . 7.6 t 179.46 177.92 0.55 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.195 -0.911 . . . . 0.28 110.277 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -153.02 128.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 105.767 -1.938 . . . . 0.28 105.767 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.671 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.0 t -129.58 118.11 44.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 120.172 -0.611 . . . . 0.34 112.146 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -60.5 96.58 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.554 -1.276 . . . . 1.64 107.554 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.85 -19.07 15.48 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 113.157 -1.838 . . . . 1.42 112.971 -166.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.619 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -73.32 -43.18 61.33 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 114.342 -1.299 . . . . 0.68 109.961 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -91.93 -34.14 14.6 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.681 -1.599 . . . . 2.36 111.174 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.671 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.6 p30 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 115.216 1.561 . . . . 1.8 115.216 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.774 HG23 ' HB3' ' A' ' 179' ' ' HIS . 24.7 m . . . . . 0 N--CA 1.438 -1.066 0 CA-C-O 121.529 0.68 . . . . 0.32 110.455 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.0 pt -137.2 172.25 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.675 -1.148 . . . . 0.2 110.853 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.853 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.5 t -121.63 173.33 7.5 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.191 -1.368 . . . . 1.29 109.482 -172.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 124' ' ' MET . 59.0 tttm -51.51 -48.62 62.89 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.782 0.325 . . . . 3.26 111.645 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.425 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 28.5 t-20 -82.4 -18.24 42.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.844 -0.428 . . . . 2.17 109.844 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -68.8 -24.32 64.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.927 -0.709 . . . . 0.5 109.785 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.774 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.98 -29.07 23.82 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 118.337 -1.345 . . . . 3.06 109.598 177.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.81 -32.56 54.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.259 1.028 . . . . 0.35 112.052 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.04 -43.44 29.31 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.607 -1.178 . . . . 1.51 109.68 169.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.89 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.29 -37.28 82.62 Favored 'General case' 0 CA--C 1.461 -2.449 0 CA-C-O 117.539 -1.219 . . . . 0.4 113.929 -172.176 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -63.34 -41.13 98.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 116.211 -2.196 . . . . 0.32 108.832 176.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.673 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.7 mm-40 -67.47 -31.03 70.9 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.924 1.345 . . . . 2.51 108.577 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.6 -7.94 59.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 111.964 -2.38 . . . . 0.33 110.011 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.5 t -121.98 1.26 9.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.149 -0.932 . . . . 0.36 108.872 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 72.94 55.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.62 -1.627 . . . . 2.19 112.466 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 143.76 23.52 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 106.551 -1.648 . . . . 0.27 106.551 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.703 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -142.85 159.89 41.37 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 106.833 -1.543 . . . . 0.69 106.833 -174.044 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -48.05 145.96 2.81 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.11 0.957 . . . . 1.96 112.559 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -136.08 152.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 CA-C-N 113.773 -1.558 . . . . 0.27 111.63 -173.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -60.48 -49.81 76.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.359 -0.837 . . . . 0.73 111.591 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -156.9 115.74 3.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.207 -1.36 . . . . 0.51 109.099 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.849 ' HB3' HG23 ' A' ' 146' ' ' THR . 2.4 ppp? -77.69 103.11 7.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 123.255 1.502 . . . . 2.71 110.917 -168.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.813 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.0 t -158.65 92.21 1.11 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.466 -1.697 . . . . 0.35 108.936 158.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.9 mmt180 -152.51 149.5 22.81 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 113.749 -1.569 . . . . 2.38 106.942 174.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.73 110.59 2.15 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 CA-C-N 120.454 1.198 . . . . 0.79 109.821 169.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.06 59.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.534 -0.841 . . . . 0.38 114.222 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 33.8 mt-10 -138.64 131.88 30.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.647 -1.242 . . . . 1.49 107.647 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -132.7 176.14 8.71 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.558 -0.857 . . . . 0.3 110.691 -166.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.849 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.4 p -112.6 139.46 48.18 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.91 0.862 . . . . 0.19 112.038 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.01 139.66 21.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 0.86 111.201 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.614 ' HB2' ' O ' ' A' ' 151' ' ' SER . 56.3 mt-30 -124.12 -94.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.543 -0.299 . . . . 2.45 110.858 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.89 -77.76 0.07 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.729 0.3 . . . . 0.49 111.184 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.18 -4.44 59.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.131 0.491 . . . . 1.02 109.704 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 5.6 m -145.43 146.3 31.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.828 -0.623 . . . . 0.94 109.845 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.709 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -106.36 165.9 3.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.316 -1.365 . . . . 0.2 107.316 167.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 7.1 tt0 -115.57 129.02 56.38 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.255 -1.387 . . . . 0.97 107.255 169.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.452 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.86 124.93 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.613 0.642 . . . . 1.32 112.393 -177.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.865 0.365 . . . . 0.33 110.17 173.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 46.8 t . . . . . 0 CA--C 1.493 -1.214 0 N-CA-C 108.787 -0.82 . . . . 0.48 108.787 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.46 145.8 49.3 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.469 1.128 . . . . 1.61 113.218 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.04 167.59 10.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.084 -1.871 . . . . 0.2 110.807 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 45.2 ttt180 -117.97 109.43 16.48 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.414 -1.328 . . . . 3.69 107.414 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -100.0 112.34 24.63 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.529 -1.669 . . . . 0.61 109.665 -170.083 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 86.5 m -109.06 150.46 27.78 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.541 0.571 . . . . 0.21 112.541 -168.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 11.5 m-85 -115.14 114.66 25.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.43 -1.259 . . . . 0.32 111.88 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.468 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 20.6 t70 -99.67 96.09 7.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.74 110.7 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.11 -115.49 4.03 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.268 -0.968 . . . . 0.27 113.511 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.75 11.09 22.63 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.681 -1.6 . . . . 1.61 106.681 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.774 ' HB3' HG23 ' A' ' 118' ' ' THR . 28.2 p80 -141.06 161.03 38.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.229 -1.351 . . . . 1.28 111.644 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 183' ' ' ILE . 7.0 tp -64.81 144.39 57.29 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.309 -0.859 . . . . 0.22 111.654 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.468 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.1 -50.56 5.24 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.193 -1.367 . . . . 0.15 111.544 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.3 t 175.3 178.18 0.16 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.28 109.513 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.55 129.13 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.875 -1.528 . . . . 0.28 106.875 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.834 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 67.6 t -133.01 116.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.66 0.615 . . . . 0.34 112.66 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -60.8 97.74 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.333 1.063 . . . . 1.64 108.17 171.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 84.1 mtp -56.29 -22.7 31.87 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 112.168 -2.287 . . . . 1.42 112.951 -165.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -66.49 -43.5 85.2 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.721 -1.127 . . . . 0.68 110.639 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -98.48 -30.86 12.29 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.152 -1.385 . . . . 2.36 110.813 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.834 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.1 t30 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 113.474 0.916 . . . . 1.8 113.474 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.807 HG23 ' HB3' ' A' ' 179' ' ' HIS . 22.7 m . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 108.983 -0.747 . . . . 0.32 108.983 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.868 HD11 ' CD1' ' A' ' 175' ' ' PHE . 7.6 pt -126.53 171.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.097 0.951 . . . . 0.2 111.283 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.859 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 19.4 t -114.05 170.2 8.45 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.831 -1.532 . . . . 1.29 109.319 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -52.66 -48.75 66.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 3.26 111.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 46.1 m-80 -83.86 -15.39 48.32 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.669 -0.241 . . . . 2.17 110.616 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.95 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -65.98 -24.14 66.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.277 -0.569 . . . . 0.5 110.471 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.27 -26.5 24.95 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.764 -1.174 . . . . 3.06 110.058 178.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG23 ' SD ' ' A' ' 124' ' ' MET . 2.0 t -65.16 -28.69 45.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.796 -1.093 . . . . 0.35 111.349 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.76 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -81.67 -38.53 25.73 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.642 -1.163 . . . . 1.51 110.177 171.157 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.95 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -56.17 -44.09 79.0 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 114.643 1.349 . . . . 0.4 114.643 -175.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.891 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -61.07 -39.78 91.19 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 116.778 -1.969 . . . . 0.32 109.374 177.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 21.9 mt-10 -65.6 -28.98 69.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.7 1.238 . . . . 2.51 108.088 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.06 -7.83 47.61 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 112.848 -1.978 . . . . 0.33 110.977 -170.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.1 t -122.13 -2.38 9.14 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.558 0.694 . . . . 0.36 109.996 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 71.07 56.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.703 -1.589 . . . . 2.19 111.829 -177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.62 146.34 27.24 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.198 -1.779 . . . . 0.27 106.198 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.666 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.09 163.81 35.09 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.668 -1.234 . . . . 0.69 107.668 -176.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.526 ' CB ' HG12 ' A' ' 147' ' ' VAL . 4.3 pt20 -48.97 159.33 0.26 Allowed 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.404 1.097 . . . . 1.96 112.3 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.9 t -148.43 151.83 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-N 113.557 -1.656 . . . . 0.27 111.093 -172.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 m -60.19 -50.12 74.92 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.987 0.899 . . . . 0.73 111.37 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -159.06 115.76 2.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.879 -1.509 . . . . 0.51 108.424 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.943 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.71 108.14 16.59 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.79 1.281 . . . . 2.71 110.708 -167.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.791 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -157.33 93.95 1.35 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.649 -1.614 . . . . 0.35 108.55 161.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.9 mmt180 -151.98 170.17 8.37 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 113.352 -1.749 . . . . 2.38 107.589 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.16 111.75 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 CA-C-N 119.868 0.989 . . . . 0.79 110.478 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.8 22.69 65.88 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.824 -0.703 . . . . 0.38 114.217 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -132.22 132.56 43.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.92 -1.511 . . . . 1.49 106.92 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.4 m-85 -133.42 173.83 11.06 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.89 -1.124 . . . . 0.3 110.507 -167.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 139' ' ' MET . 7.7 p -112.53 136.39 52.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.276 0.56 . . . . 0.19 109.953 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 135' ' ' GLN . 1.2 p -111.41 143.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.097 -0.956 . . . . 0.86 111.803 -171.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -129.16 -85.14 0.56 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.398 -0.364 . . . . 2.45 111.501 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.1 -83.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.141 0.423 . . . . 0.49 112.141 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.47 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 48.3 m-80 -88.24 -5.55 58.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.444 0.64 . . . . 1.02 109.709 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.9 m -143.22 146.78 33.96 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.154 -0.618 . . . . 0.94 109.643 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.8 mt -114.48 168.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.552 -0.907 . . . . 0.2 108.552 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 20.8 tt0 -111.49 132.71 54.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.728 -1.582 . . . . 0.97 106.728 167.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.1 tmt? -134.71 124.48 25.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 118.691 0.678 . . . . 1.32 111.151 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.33 111.283 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.7 t . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 107.775 -1.194 . . . . 0.48 107.775 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.756 ' HB3' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -106.5 150.15 26.39 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.986 0.898 . . . . 1.61 112.445 176.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -124.97 159.33 31.5 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 113.443 -1.708 . . . . 0.2 111.313 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.85 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.4 tpt180 -108.02 101.24 10.5 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.819 -1.178 . . . . 3.69 107.819 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.552 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -93.68 113.55 25.65 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 112.988 -1.915 . . . . 0.61 110.115 -170.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 181' ' ' ALA . 52.6 m -112.5 148.79 33.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.654 0.613 . . . . 0.21 112.654 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.2 m-85 -116.35 112.68 21.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.011 -0.995 . . . . 0.32 111.807 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.594 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.8 t70 -102.35 95.68 6.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.067 0.46 . . . . 0.74 110.537 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.44 -114.02 3.76 Favored Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.17 -1.014 . . . . 0.27 114.187 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -105.75 5.0 30.56 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 108.07 -1.085 . . . . 1.61 108.07 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.807 ' HB3' HG23 ' A' ' 118' ' ' THR . 21.8 p80 -141.58 160.2 40.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.604 -1.18 . . . . 1.28 112.517 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.766 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -65.99 134.6 53.26 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 114.391 -1.277 . . . . 0.22 109.698 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.36 -48.28 8.61 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 114.387 -1.279 . . . . 0.15 111.122 -175.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.502 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.2 t 175.76 177.96 0.19 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.044 -0.98 . . . . 0.28 110.386 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.766 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -149.38 122.51 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.999 -1.482 . . . . 0.28 106.999 175.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.696 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 97.0 t -127.09 123.66 62.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 118.965 -0.541 . . . . 0.34 112.279 -170.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.52 94.18 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.777 0.799 . . . . 1.64 109.379 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.85 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 50.2 mmm -43.22 -37.87 2.31 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 112.734 -2.03 . . . . 1.42 112.752 -172.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.589 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.3 mt-10 -63.19 -40.53 97.78 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 113.488 -1.687 . . . . 0.68 111.224 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -101.68 -30.58 11.25 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.896 -1.502 . . . . 2.36 111.471 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.696 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 14.4 p30 . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 125.141 1.376 . . . . 1.8 114.512 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.7 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.039 -0.726 . . . . 0.32 109.039 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.887 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.8 pt -129.76 172.67 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.227 1.013 . . . . 0.2 112.0 -171.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.6 m -114.64 173.79 6.29 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.709 -1.587 . . . . 1.29 110.215 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.632 ' O ' ' HG3' ' A' ' 124' ' ' MET . 2.5 mppt? -51.58 -53.1 41.74 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.343 0.402 . . . . 3.26 111.962 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 m-20 -82.93 -15.26 52.05 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.624 -0.262 . . . . 2.17 110.71 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.904 ' O ' HD12 ' A' ' 127' ' ' LEU . 3.0 mt-10 -65.36 -23.72 67.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.002 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.28 -29.56 24.48 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 118.474 -1.29 . . . . 3.06 110.057 178.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.17 -31.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.466 1.127 . . . . 0.35 111.833 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.755 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.93 -42.51 23.9 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.169 -1.378 . . . . 1.51 109.73 170.705 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.53 -38.49 84.6 Favored 'General case' 0 CA--C 1.462 -2.424 0 CA-C-O 117.523 -1.227 . . . . 0.4 114.067 -173.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.57 -39.82 94.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 116.153 -2.219 . . . . 0.32 108.72 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.682 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 63.1 mm-40 -68.82 -30.68 69.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 123.04 1.4 . . . . 2.51 108.923 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.41 -7.6 58.85 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 111.857 -2.429 . . . . 0.33 110.23 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.77 -3.94 9.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.245 -0.889 . . . . 0.36 109.387 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 131' ' ' THR . 49.1 mt-30 79.96 55.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 113.757 -1.565 . . . . 2.19 112.235 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -154.28 146.5 23.79 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.886 -1.524 . . . . 0.27 106.886 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.607 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -144.52 161.33 39.35 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.371 -1.714 . . . . 0.69 106.371 -177.325 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.24 159.4 1.94 Allowed 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 119.281 0.946 . . . . 1.96 112.029 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -145.91 155.82 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-N 114.19 -1.368 . . . . 0.27 112.019 -168.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.2 m -59.51 -51.15 71.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.05 0.929 . . . . 0.73 111.639 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.532 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -159.78 114.51 2.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 113.931 -1.486 . . . . 0.51 108.117 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.972 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.89 105.08 11.85 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 123.035 1.398 . . . . 2.71 111.24 -166.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.803 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.0 t -157.41 94.25 1.37 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.558 -1.655 . . . . 0.35 108.47 162.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.803 ' HD3' ' O ' ' A' ' 140' ' ' THR . 7.6 mmt180 -151.44 168.02 11.93 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 113.477 -1.692 . . . . 2.38 107.158 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.45 111.69 2.63 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 CA-C-N 119.897 0.999 . . . . 0.79 109.899 164.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.81 27.76 58.11 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.2 -1.0 . . . . 0.38 113.902 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.9 mt-10 -140.85 131.25 25.21 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.407 -1.331 . . . . 1.49 107.407 172.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.78 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -133.88 176.35 8.65 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.419 -0.913 . . . . 0.3 110.511 -167.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.972 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.3 p -113.09 137.54 51.28 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.962 0.886 . . . . 0.19 112.505 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 51.6 t -97.62 138.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.451 -1.704 . . . . 0.86 111.12 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 151' ' ' SER . 88.0 mm-40 -123.14 -90.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.935 -0.12 . . . . 2.45 110.972 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.79 -87.31 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.653 0.263 . . . . 0.49 111.337 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -82.98 -3.14 56.84 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.062 0.458 . . . . 1.02 109.786 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 20.4 m -141.33 146.13 36.32 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.371 -0.532 . . . . 0.94 110.357 172.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -107.26 170.66 2.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.351 -1.351 . . . . 0.2 107.351 168.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.6 tt0 -116.33 136.26 53.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.764 -1.569 . . . . 0.97 106.764 165.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.429 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.1 tmt? -136.5 124.81 23.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 118.592 0.633 . . . . 1.32 112.367 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.594 -0.521 . . . . 0.33 109.594 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 170' ' ' ARG . 89.9 t . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 109.166 -0.679 . . . . 0.48 109.166 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HB2' ' CE ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -126.41 144.9 50.68 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.197 0.999 . . . . 1.61 113.165 177.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 167.67 10.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.313 -1.767 . . . . 0.2 110.517 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.764 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 48.2 ttp180 -116.22 122.74 45.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.419 -1.326 . . . . 3.69 107.419 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -112.11 110.53 20.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.288 -1.324 . . . . 0.61 110.203 -164.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 181' ' ' ALA . 51.9 m -107.64 150.25 27.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.229 0.538 . . . . 0.21 112.308 -169.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.887 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.6 m-85 -115.66 102.46 9.77 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.566 -1.197 . . . . 0.32 113.212 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.621 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 31.0 t70 -92.11 101.65 14.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.85 0.357 . . . . 0.74 110.972 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.66 -117.21 4.36 Favored Glycine 0 C--N 1.318 -0.461 0 C-N-CA 120.048 -1.072 . . . . 0.27 113.485 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.66 10.61 22.85 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.5 -1.667 . . . . 1.61 106.5 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.804 ' HB3' HG23 ' A' ' 118' ' ' THR . 24.4 p80 -137.89 161.66 36.06 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.287 -1.324 . . . . 1.28 112.083 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 183' ' ' ILE . 8.5 tp -68.19 136.38 53.53 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.607 -1.178 . . . . 0.22 110.502 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.621 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.46 -50.06 6.79 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.392 -1.276 . . . . 0.15 111.364 -176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.6 t 179.23 178.4 0.49 Allowed 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.036 -0.984 . . . . 0.28 109.903 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.765 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -147.89 112.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 106.459 -1.682 . . . . 0.28 106.459 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.767 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -115.16 129.8 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 113.15 0.796 . . . . 0.34 113.15 -169.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 188' ' ' ASN . 25.1 p-10 -60.07 95.52 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.108 0.956 . . . . 1.64 109.693 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 66.6 mmm -51.47 -25.61 6.78 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 113.37 -1.741 . . . . 1.42 112.949 -169.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.6 mt-10 -68.26 -42.6 79.36 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.452 -1.249 . . . . 0.68 110.635 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.416 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 5.5 t-20 -103.49 -25.73 13.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.707 -1.588 . . . . 2.36 111.663 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.767 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 10.3 p30 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 114.843 1.423 . . . . 1.8 114.843 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.676 0.274 . . . . 31.14 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.1 173.95 13.18 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.695 -0.764 . . . . 30.65 112.355 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m 63.28 38.61 10.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.246 0.546 . . . . 30.65 111.943 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.5 t -148.75 66.05 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.228 -0.656 . . . . 29.78 109.228 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -74.32 -30.6 62.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.373 -0.83 . . . . 29.55 110.143 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.33 123.17 3.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.479 -0.782 . . . . 29.87 109.446 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -67.36 -36.93 82.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 27.89 110.638 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -91.7 112.14 23.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.199 0.523 . . . . 26.19 110.196 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -108.5 152.58 24.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.764 -0.653 . . . . 26.23 110.559 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -82.02 80.94 8.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 26.64 110.831 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.5 m -61.58 109.04 1.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.684 -0.689 . . . . 24.71 110.234 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -81.23 79.99 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.072 0.463 . . . . 24.15 110.446 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -72.82 1.28 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.763 -0.732 . . . . 22.66 111.823 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 98.3 mt -113.18 17.1 18.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.841 0.353 . . . . 20.88 110.827 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 60.0 t -63.46 -54.02 47.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.85 -0.34 . . . . 19.88 110.442 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 72.5 Cg_endo -77.44 129.64 10.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.334 1.356 . . . . 18.7 111.643 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 43.01 50.74 5.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.137 0.975 . . . . 18.91 112.674 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.14 -39.12 91.78 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.007 -0.616 . . . . 15.32 112.362 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 m 60.5 54.94 3.6 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.753 0.421 . . . . 14.03 111.959 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -84.6 -23.27 29.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.432 -0.349 . . . . 12.65 110.24 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 67.3 mtm 66.03 -79.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.487 -0.779 . . . . 11.98 112.126 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -143.45 -151.38 5.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.965 -0.636 . . . . 8.1 111.853 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 130' ' ' ALA . 26.3 ttp85 -85.06 71.96 10.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.343 0.592 . . . . 9.18 110.356 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.7 ptm -136.0 21.7 3.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.711 1.243 . . . . 6.14 108.05 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.72 148.94 15.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.151 -1.841 . . . . 4.84 109.083 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -66.66 145.59 55.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.309 -0.405 . . . . 4.29 110.292 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 173' ' ' LEU . 2.8 tm? -63.82 131.51 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.735 -0.666 . . . . 1.69 109.524 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HG2' ' HD2' ' A' ' 115' ' ' PRO . 5.0 tt0 -178.35 156.17 0.99 Allowed Pre-proline 0 CA--C 1.509 -0.606 0 N-CA-C 106.081 -1.822 . . . . 3.45 106.081 -170.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HA ' ' H ' ' A' ' 117' ' ' MET . 60.2 Cg_endo -90.97 103.24 0.26 Allowed 'Trans proline' 0 N--CA 1.428 -2.349 0 CA-C-N 121.823 1.687 . . . . 3.06 113.405 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 7.8 p-10 -111.7 -2.81 15.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 103.041 -2.948 . . . . 3.24 103.041 141.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.592 ' HG3' HG23 ' A' ' 119' ' ' ILE . 26.3 tpp -84.55 143.84 29.05 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 110.803 -2.908 . . . . 1.45 112.085 -160.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.3 m -129.27 97.89 4.72 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.116 -0.947 . . . . 0.32 109.511 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.846 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.09 171.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.098 -0.956 . . . . 0.2 110.829 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.773 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 p -120.39 179.19 4.38 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.411 -0.813 . . . . 1.29 110.644 -172.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 124' ' ' MET . 87.3 tttt -53.62 -40.22 65.59 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.485 0.491 . . . . 3.26 111.343 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 8.0 m-20 -82.56 -24.04 34.18 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 116.602 -0.272 . . . . 2.17 111.246 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.803 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 25.0 mt-10 -68.99 -34.0 74.58 Favored 'General case' 0 N--CA 1.41 -2.447 0 C-N-CA 117.826 -1.55 . . . . 0.5 109.34 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.721 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.81 -33.65 76.07 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 119.008 -1.077 . . . . 3.06 109.362 177.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' HD21 ' A' ' 128' ' ' LEU . 1.8 t -66.25 -31.64 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.276 -0.874 . . . . 0.35 112.087 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.803 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -85.81 -32.82 21.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.724 -0.671 . . . . 1.51 110.779 173.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.14 -46.75 87.56 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 114.962 1.467 . . . . 0.4 114.962 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.804 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -58.98 -38.03 78.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.711 -1.996 . . . . 0.32 109.164 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.555 ' N ' HD23 ' A' ' 128' ' ' LEU . 30.1 mt-10 -65.86 -32.43 73.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.652 1.215 . . . . 2.51 107.954 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.817 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.62 -7.74 55.86 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 112.599 -2.091 . . . . 0.33 110.948 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.5 t -122.06 1.18 9.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.22 -0.9 . . . . 0.36 109.275 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 66.56 56.87 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.535 -1.666 . . . . 2.19 111.867 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.804 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.98 147.22 27.6 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.972 -1.492 . . . . 0.27 106.972 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.599 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.01 154.65 42.75 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.003 -1.11 . . . . 0.69 108.003 -173.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -47.45 144.61 2.91 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.794 0.807 . . . . 1.96 112.339 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 134' ' ' ARG . 2.6 t -136.11 150.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.1 -1.409 . . . . 0.27 112.079 -171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.4 m -59.9 -50.08 75.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.865 -1.062 . . . . 0.73 111.57 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 19.1 ptmt -156.93 116.02 3.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.24 -1.345 . . . . 0.51 108.836 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.023 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.21 102.77 9.65 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.938 -1.483 . . . . 2.71 111.155 -167.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.4 t -157.29 92.63 1.26 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.395 -1.275 . . . . 0.35 109.535 162.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -153.94 158.64 32.51 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.903 -1.499 . . . . 2.38 107.519 169.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -75.66 109.76 2.96 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 CA-C-N 120.421 1.186 . . . . 0.79 109.574 167.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.23 2.94 57.86 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.498 -0.858 . . . . 0.38 114.439 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.0 mt-10 -128.84 132.33 47.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.202 1.001 . . . . 1.49 108.609 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.831 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.1 m-85 -133.16 176.24 8.68 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.112 -0.635 . . . . 0.3 110.224 -166.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 1.023 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.3 p -110.12 142.19 41.94 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.711 0.767 . . . . 0.19 111.655 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 128' ' ' LEU . 41.1 t -100.98 138.76 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.213 -1.358 . . . . 0.86 111.684 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.661 ' HB3' ' O ' ' A' ' 151' ' ' SER . 61.8 tp60 -124.96 -87.54 0.61 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.479 -0.328 . . . . 2.45 110.751 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.39 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.728 0.27 . . . . 0.49 111.728 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 88.3 m-20 -81.52 -5.15 57.69 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.482 -0.562 . . . . 1.02 109.482 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 31.0 p -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.674 -0.694 . . . . 0.94 110.043 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.642 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.0 mt -106.73 170.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.184 -1.413 . . . . 0.2 107.184 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 24.4 tt0 -116.97 137.3 52.31 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.989 -1.485 . . . . 0.97 106.989 166.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -133.46 124.67 27.46 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.655 -0.818 . . . . 1.32 112.3 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.93 130.33 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.669 -0.696 . . . . 0.33 109.992 173.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.408 HH11 ' HE1' ' A' ' 154' ' ' MET . 31.0 tpt180 -81.72 145.13 30.66 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.607 -0.516 . . . . 3.1 109.607 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -49.78 115.63 5.32 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 123.679 0.612 . . . . 4.26 110.934 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.35 175.22 10.33 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 123.032 2.488 . . . . 2.01 113.336 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.81 115.82 14.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.78 -1.555 . . . . 5.12 108.762 173.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.564 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 45.8 m-20 -125.89 135.27 51.73 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.123 -0.944 . . . . 5.15 111.48 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.6 m-30 -118.11 167.51 11.21 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-O 121.787 0.803 . . . . 6.81 110.479 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.1 Cg_endo -75.84 -42.93 0.37 Allowed 'Trans proline' 0 N--CA 1.416 -3.048 0 C-N-CA 122.144 1.896 . . . . 8.97 110.812 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -90.7 -5.58 55.56 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 112.457 -2.156 . . . . 10.53 109.55 -174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 3.2 m -163.96 139.53 6.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.228 -1.351 . . . . 7.9 112.658 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 160' ' ' ASP . 64.0 mttt -144.38 138.04 27.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.413 0.625 . . . . 6.69 112.044 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -171.96 -170.68 0.78 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.528 -1.215 . . . . 5.04 110.553 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.06 147.76 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.539 -0.755 . . . . 2.11 113.258 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.69 146.65 27.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.507 0.67 . . . . 2.93 109.768 170.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 155' ' ' ILE . 77.1 t -144.93 146.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 CA-C-N 114.734 -1.121 . . . . 0.48 108.406 173.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -129.74 145.11 51.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.305 1.05 . . . . 1.61 113.234 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.63 163.53 15.65 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.194 -1.821 . . . . 0.2 109.83 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 74.9 ttt180 -111.94 127.15 55.77 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.97 -1.122 . . . . 3.69 107.97 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -114.84 111.38 21.13 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.402 -1.272 . . . . 0.61 110.682 -165.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.552 ' CG2' HD23 ' A' ' 197' ' ' LEU . 96.3 m -109.31 150.49 27.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.347 0.594 . . . . 0.21 112.25 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.846 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.5 m-85 -115.65 114.09 24.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.358 -1.292 . . . . 0.32 111.853 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.542 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.2 t70 -104.63 103.41 13.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.74 111.393 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.82 -113.22 3.61 Favored Glycine 0 C--N 1.314 -0.691 0 C-N-CA 120.054 -1.069 . . . . 0.27 113.409 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.51 8.7 19.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.262 -1.384 . . . . 1.61 107.262 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.777 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.5 p80 -135.71 160.99 36.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.635 -1.166 . . . . 1.28 112.315 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 183' ' ' ILE . 9.2 tp -69.31 130.57 42.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 114.524 -1.216 . . . . 0.22 110.158 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.28 -49.99 10.82 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.426 -1.261 . . . . 0.15 110.821 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 5.9 t -179.99 177.46 0.66 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.903 -1.044 . . . . 0.28 110.94 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.802 HD11 HD21 ' A' ' 180' ' ' LEU . 2.9 mp -151.17 128.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.7 -1.963 . . . . 0.28 105.7 173.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.775 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.2 t -133.99 119.47 32.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.015 -0.674 . . . . 0.34 112.207 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 98.59 0.06 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.156 -1.053 . . . . 1.64 108.156 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 75.3 mmm -53.03 -27.26 18.81 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 112.379 -2.192 . . . . 1.42 112.741 -167.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.9 mt-10 -65.67 -43.04 90.5 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 114.164 -1.38 . . . . 0.68 110.982 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -107.14 -19.86 13.48 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.152 -1.385 . . . . 2.36 111.27 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.775 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.2 p30 36.38 43.78 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.253 1.205 . . . . 1.8 114.253 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -150.55 -31.17 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.265 -0.425 . . . . 4.13 111.257 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -50.37 -57.95 6.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.3 -0.409 . . . . 4.05 111.84 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -87.94 -83.62 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.574 -0.898 . . . . 1.83 108.574 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 184' ' ' VAL . . . 67.13 106.15 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.23 0 CA-C-N 115.485 -0.779 . . . . 1.84 114.593 169.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 23.2 m-85 -136.83 -173.82 3.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.157 -0.522 . . . . 4.57 110.609 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -79.35 153.81 29.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.454 0.645 . . . . 6.25 112.502 -168.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.601 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -76.4 160.49 29.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.599 -1.182 . . . . 6.4 111.473 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.552 HD23 ' CG2' ' A' ' 174' ' ' THR . 0.4 OUTLIER -78.71 132.94 37.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.352 -0.84 . . . . 1.4 110.649 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.51 115.6 59.05 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 3.38 110.256 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.74 145.69 94.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.782 2.321 . . . . 4.74 112.335 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.479 -0.772 . . . . 7.73 110.175 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.735 0.302 . . . . 31.14 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -67.98 3.6 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.882 -0.675 . . . . 30.65 111.971 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 m 60.67 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.057 0.543 . . . . 30.65 111.371 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 m 57.62 37.07 27.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.058 0.456 . . . . 29.78 111.202 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -123.08 51.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 29.55 110.146 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 71.8 m80 65.5 -150.22 0.24 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.825 -0.625 . . . . 29.87 110.705 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 80.0 m80 74.49 133.86 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.488 0.715 . . . . 27.89 110.711 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.2 t60 70.75 -63.95 0.39 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.488 -0.778 . . . . 26.19 110.628 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -161.51 -53.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.113 -0.699 . . . . 26.23 109.113 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.3 p80 176.96 -39.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.669 -0.696 . . . . 26.64 109.175 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t 176.56 -179.27 0.17 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.218 -1.401 . . . . 24.71 107.218 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.7 m 56.03 52.78 9.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.103 0.478 . . . . 24.15 111.045 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.21 -7.32 85.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.928 -0.653 . . . . 22.66 112.744 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.26 -44.96 14.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 20.88 110.088 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t 66.75 112.63 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.679 0.612 . . . . 19.88 111.868 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.97 109.91 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.932 2.421 . . . . 18.7 111.687 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 56.13 54.0 8.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.903 -0.589 . . . . 18.91 110.848 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.03 -165.82 17.58 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.603 -0.726 . . . . 15.32 111.478 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.6 p -144.6 171.38 14.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.878 -0.415 . . . . 14.03 109.878 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 58.19 63.86 1.64 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.306 0.574 . . . . 12.65 110.213 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -69.02 -22.64 64.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 11.98 110.607 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.31 -92.75 1.59 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.772 -0.649 . . . . 8.1 111.87 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 65.29 178.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.545 0.688 . . . . 9.18 111.351 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -147.43 29.89 0.94 Allowed 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 122.361 1.077 . . . . 6.14 109.046 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 p -107.64 139.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 113.562 -1.654 . . . . 4.84 109.857 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -99.09 163.16 12.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.398 -0.365 . . . . 4.29 110.327 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 114' ' ' GLU . 3.6 tt -64.44 136.17 56.82 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.235 -0.654 . . . . 1.69 109.235 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.642 ' N ' HD23 ' A' ' 113' ' ' LEU . 3.5 mt-10 -171.12 161.47 5.4 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 108.628 -0.879 . . . . 3.45 108.628 -174.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.551 ' HA ' ' H ' ' A' ' 117' ' ' MET . 84.2 Cg_endo -90.15 100.17 0.29 Allowed 'Trans proline' 0 N--CA 1.423 -2.635 0 C-N-CA 117.629 -1.114 . . . . 3.06 112.557 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -111.91 -3.77 14.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.6 -3.111 . . . . 3.24 102.6 138.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.634 ' HG3' HG23 ' A' ' 119' ' ' ILE . 28.9 tpp -79.23 138.65 37.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.127 -2.761 . . . . 1.45 111.11 -168.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 179' ' ' HIS . 3.6 m -126.33 104.0 7.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.718 -1.128 . . . . 0.32 108.657 175.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -133.88 172.49 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-O 122.43 1.109 . . . . 0.2 111.745 -174.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.865 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.9 m -110.49 165.86 11.46 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.53 -1.668 . . . . 1.29 109.138 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -52.12 -48.15 64.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.13 0.49 . . . . 3.26 110.995 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.5 m120 -81.02 -16.73 52.55 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.967 -0.56 . . . . 2.17 110.151 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.865 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.4 mt-10 -68.23 -25.94 65.46 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.422 0.63 . . . . 0.5 109.98 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 8.0 tpt -86.65 -28.14 23.37 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 117.882 -1.527 . . . . 3.06 109.632 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.71 -31.28 43.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.308 1.051 . . . . 0.35 111.986 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.719 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -81.69 -42.77 19.42 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.596 -1.184 . . . . 1.51 109.822 170.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.93 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.69 -36.68 81.58 Favored 'General case' 0 CA--C 1.463 -2.367 0 CA-C-O 117.477 -1.249 . . . . 0.4 113.768 -174.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -63.0 -40.06 96.64 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 116.356 -2.138 . . . . 0.32 108.631 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.675 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 51.8 mm-40 -68.9 -30.66 69.19 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 123.125 1.441 . . . . 2.51 108.665 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.03 -7.56 59.08 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 111.962 -2.381 . . . . 0.33 109.93 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.8 t -121.62 -2.07 9.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.191 -0.913 . . . . 0.36 108.937 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 77.1 52.73 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 113.523 -1.671 . . . . 2.19 112.482 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -151.09 143.73 24.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.575 -1.639 . . . . 0.27 106.575 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.646 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -142.45 163.22 33.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.69 -1.596 . . . . 0.69 106.69 -174.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.2 161.75 1.67 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.987 0.899 . . . . 1.96 111.277 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -147.61 153.02 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.243 -1.344 . . . . 0.27 111.718 -168.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -60.04 -49.56 77.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.803 0.811 . . . . 0.73 111.695 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.95 115.35 2.67 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.212 -1.358 . . . . 0.51 109.027 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.049 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.91 101.23 6.73 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-O 123.286 1.517 . . . . 2.71 111.656 -168.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.808 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.7 t -158.33 93.62 1.23 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.493 -1.685 . . . . 0.35 109.034 161.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.808 ' HD3' ' O ' ' A' ' 140' ' ' THR . 17.6 mmt180 -151.09 164.65 19.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 113.56 -1.655 . . . . 2.38 107.176 174.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.57 110.64 2.45 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 CA-C-N 119.975 1.027 . . . . 0.79 109.903 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.59 5.38 69.19 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.461 -0.876 . . . . 0.38 114.21 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.1 mm-40 -126.62 131.5 51.46 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.331 -1.359 . . . . 1.49 107.331 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.772 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.98 175.93 9.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.08 -1.048 . . . . 0.3 110.648 -166.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 1.049 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.0 p -111.49 142.03 44.29 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.647 0.737 . . . . 0.19 111.945 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 65.8 t -105.76 145.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.231 -1.349 . . . . 0.86 111.676 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -132.46 -87.31 0.45 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.347 -0.141 . . . . 2.45 111.097 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.43 -82.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.587 0.217 . . . . 0.49 111.587 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.414 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 17.3 m120 -82.03 -6.56 59.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 120.834 0.349 . . . . 1.02 110.282 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.5 p -149.92 145.87 26.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.88 -0.728 . . . . 0.94 111.028 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -109.68 166.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.136 -1.061 . . . . 0.2 108.136 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.772 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 3.2 tp10 -110.81 134.09 52.8 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.693 -1.595 . . . . 0.97 106.693 167.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -131.86 122.38 25.61 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 118.966 0.803 . . . . 1.32 112.425 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -66.93 125.64 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.434 -0.803 . . . . 0.33 109.839 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 169' ' ' VAL . 21.5 tpt180 -65.04 138.2 58.18 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.647 -0.871 . . . . 3.1 108.647 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -60.44 112.67 5.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.129 -0.323 . . . . 4.26 110.129 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 168' ' ' GLN . 15.1 Cg_endo -65.54 172.04 8.56 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.018 2.478 . . . . 2.01 114.164 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.59 151.22 29.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.084 -1.416 . . . . 5.12 110.693 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.554 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 9.7 m-20 -126.66 130.84 51.21 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.595 -0.73 . . . . 5.15 111.104 -174.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.682 ' HB2' ' O ' ' A' ' 164' ' ' SER . 79.1 m-85 -119.48 170.62 6.5 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.577 -0.738 . . . . 6.81 109.719 169.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 3.4 Cg_endo -78.99 -44.57 0.13 Allowed 'Trans proline' 0 N--CA 1.41 -3.397 0 C-N-CA 121.813 1.675 . . . . 8.97 110.932 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -93.36 -3.69 52.89 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.58 -2.1 . . . . 10.53 109.99 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.682 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -164.03 158.44 19.5 Favored 'General case' 0 C--O 1.203 -1.348 0 CA-C-N 114.23 -1.35 . . . . 7.9 110.905 -170.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.606 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 71.2 mttt -147.86 132.31 17.65 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.709 0.686 . . . . 6.69 111.21 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 9.9 pt-20 -168.71 -167.58 0.78 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.336 -0.847 . . . . 5.04 112.096 -165.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.85 57.81 4.32 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 121.018 -0.61 . . . . 2.11 112.034 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 158' ' ' PRO . 6.0 pm0 -91.76 142.6 27.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.307 1.051 . . . . 2.93 111.187 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 187' ' ' GLU . 65.2 t -140.38 151.54 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 CA-C-N 113.605 -1.634 . . . . 0.48 107.613 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.23 145.21 50.09 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 122.326 1.06 . . . . 1.61 113.155 176.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.46 165.24 13.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.21 -1.813 . . . . 0.2 110.333 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.6 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 17.0 tpt180 -115.86 120.04 37.92 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.146 -1.057 . . . . 3.69 108.146 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.39 118.32 33.52 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.181 -1.372 . . . . 0.61 110.429 -164.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.603 ' CG2' HD23 ' A' ' 197' ' ' LEU . 99.5 m -115.31 152.43 32.77 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.574 0.583 . . . . 0.21 112.574 -170.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.7 m-85 -114.66 109.26 17.95 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.696 -1.138 . . . . 0.32 112.294 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.733 ' HA ' HD21 ' A' ' 197' ' ' LEU . 27.5 t70 -98.87 96.52 7.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.047 0.451 . . . . 0.74 111.211 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.69 -117.43 4.44 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.22 -0.991 . . . . 0.27 113.179 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.77 11.04 22.61 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.416 -1.698 . . . . 1.61 106.416 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.717 ' HB3' HG23 ' A' ' 118' ' ' THR . 11.8 p-80 -138.0 161.07 37.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.141 -1.391 . . . . 1.28 111.782 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 183' ' ' ILE . 9.3 tp -67.98 136.1 53.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.133 -0.94 . . . . 0.22 110.886 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.572 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -84.11 -54.01 5.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.515 -1.22 . . . . 0.15 111.412 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.48 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.0 t -178.91 176.42 0.92 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.28 110.496 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.803 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.33 124.69 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.949 -1.5 . . . . 0.28 106.949 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.701 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.8 t -129.84 118.1 43.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.422 0.527 . . . . 0.34 112.422 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.89 101.09 0.1 Allowed 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.044 -1.095 . . . . 1.64 108.044 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.3 mmt -58.81 -16.81 18.84 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 112.833 -1.985 . . . . 1.42 112.675 -168.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.575 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.7 mt-10 -73.47 -44.35 58.17 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.743 -1.117 . . . . 0.68 110.003 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.65 -33.78 14.94 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.261 -1.336 . . . . 2.36 110.913 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.701 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.9 p30 36.7 32.08 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.218 1.562 . . . . 1.8 115.218 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -138.4 -66.81 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 4.13 110.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -83.93 21.47 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.351 . . . . 4.05 111.556 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -126.58 -6.1 6.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.672 -0.492 . . . . 1.83 109.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.34 -162.7 24.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.828 -0.624 . . . . 1.84 112.097 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.44 ' O ' HG21 ' A' ' 182' ' ' THR . 98.3 m-85 -143.64 148.28 35.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.801 -0.444 . . . . 4.57 109.801 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -87.49 95.62 10.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.086 0.47 . . . . 6.25 110.487 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -134.75 144.2 47.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.958 -0.565 . . . . 6.4 110.396 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.4 OUTLIER -161.06 123.42 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 1.4 109.108 170.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -138.41 88.59 14.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.644 . . . . 3.38 110.216 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.0 -11.79 5.27 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.731 2.287 . . . . 4.74 112.652 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.399 -0.81 . . . . 7.73 110.035 -177.722 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.009 -0.367 . . . . 31.14 110.009 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.22 59.16 2.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.769 . . . . 30.65 112.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 t -85.88 93.94 9.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.923 -0.399 . . . . 30.65 109.923 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.1 p -97.67 -7.22 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.27 0.557 . . . . 29.78 110.505 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 94' ' ' HIS . 3.7 t60 -124.64 134.31 52.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.585 -0.895 . . . . 29.55 108.585 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -83.38 49.88 1.66 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.07 0.396 . . . . 29.87 112.07 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.4 t60 57.19 83.63 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.794 -0.639 . . . . 27.89 111.706 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' HB2' ' NE2' ' A' ' 91' ' ' HIS . 29.0 t-80 -77.23 133.87 38.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 26.19 110.331 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -81.85 82.41 7.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.08 -0.509 . . . . 26.23 110.303 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -73.05 -23.0 60.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.26 -0.427 . . . . 26.64 109.934 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 m -70.62 -21.05 62.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.696 . . . . 24.71 110.486 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.3 m -80.62 88.81 5.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.873 -0.603 . . . . 24.15 109.84 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.42 -70.02 0.26 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.564 -0.743 . . . . 22.66 111.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.9 mt 65.37 112.19 0.03 OUTLIER 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.658 0.742 . . . . 20.88 111.782 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.571 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 55.2 t -60.32 -46.56 97.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.966 -1.015 . . . . 19.88 111.533 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 32.1 Cg_endo -64.22 83.27 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.288 1.992 . . . . 18.7 112.465 174.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -78.26 -17.12 57.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.907 -0.588 . . . . 18.91 110.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.08 -47.41 24.2 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.716 -0.754 . . . . 15.32 112.009 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 p -80.9 -29.31 35.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.813 0.339 . . . . 14.03 111.41 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -93.04 92.44 7.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.946 0.403 . . . . 12.65 110.28 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 48.7 ttm -107.91 -45.1 4.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.936 -0.575 . . . . 11.98 110.029 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.49 21.86 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.921 -0.656 . . . . 8.1 112.209 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -163.89 170.09 17.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.645 0.259 . . . . 9.18 110.395 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -145.2 26.28 1.34 Allowed 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.234 1.016 . . . . 6.14 109.085 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.12 17.64 7.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 113.966 -1.47 . . . . 4.84 110.434 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -110.82 143.09 41.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.983 -0.553 . . . . 4.29 110.576 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.674 ' HB3' ' SD ' ' A' ' 154' ' ' MET . 5.1 tt -141.44 135.74 30.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.061 -1.089 . . . . 1.69 108.061 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.647 ' N ' HD23 ' A' ' 113' ' ' LEU . 40.5 mt-10 -159.24 162.21 26.29 Favored Pre-proline 0 CA--C 1.501 -0.937 0 N-CA-C 109.116 -0.698 . . . . 3.45 109.116 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.545 ' HA ' ' H ' ' A' ' 117' ' ' MET . 90.0 Cg_endo -91.16 100.64 0.23 Allowed 'Trans proline' 0 N--CA 1.425 -2.52 0 CA-C-O 122.566 0.986 . . . . 3.06 112.701 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -111.22 -4.38 15.02 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 102.555 -3.128 . . . . 3.24 102.555 139.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.623 ' CG ' HG23 ' A' ' 119' ' ' ILE . 2.7 ttm -78.02 139.42 39.12 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 110.304 -3.135 . . . . 1.45 111.67 -166.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.6 m -128.38 101.64 6.3 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.684 -1.144 . . . . 0.32 108.649 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.912 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.7 pt -133.62 172.47 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.996 0.903 . . . . 0.2 111.227 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.868 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.6 t -117.47 172.18 7.5 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.019 -1.446 . . . . 1.29 109.547 -173.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 124' ' ' MET . 37.5 ttmt -56.0 -45.2 79.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.886 0.374 . . . . 3.26 111.307 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -83.35 -17.34 42.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 110.249 -0.278 . . . . 2.17 110.249 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -69.27 -22.77 63.8 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.124 -0.63 . . . . 0.5 110.46 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.777 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.95 -30.53 22.72 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 118.462 -1.295 . . . . 3.06 109.366 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.5 -30.62 46.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.115 0.959 . . . . 0.35 111.952 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.626 -1.17 . . . . 1.51 109.737 171.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.45 -35.76 78.51 Favored 'General case' 0 CA--C 1.462 -2.423 0 CA-C-O 117.683 -1.151 . . . . 0.4 114.027 -172.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.5 -43.18 94.9 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 115.915 -2.314 . . . . 0.32 109.093 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 59.3 mm-40 -65.36 -27.91 68.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.808 1.289 . . . . 2.51 108.635 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.78 -8.16 54.92 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.258 -2.246 . . . . 0.33 110.28 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.1 t -122.46 0.27 9.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.416 -0.811 . . . . 0.36 109.354 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 74.49 54.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.653 -1.612 . . . . 2.19 112.543 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.16 144.65 24.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.498 -1.667 . . . . 0.27 106.498 178.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.616 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -145.6 164.09 32.77 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.188 -1.782 . . . . 0.69 106.188 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.571 ' CB ' HG12 ' A' ' 147' ' ' VAL . 2.8 pt20 -49.73 160.65 0.28 Allowed 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.207 1.003 . . . . 1.96 112.731 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -148.0 151.57 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 113.946 -1.479 . . . . 0.27 112.015 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.1 m -59.74 -50.02 75.45 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.114 -0.948 . . . . 0.73 111.658 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.4 ptmt -159.03 117.04 2.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.015 -1.448 . . . . 0.51 108.66 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.994 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.85 100.55 6.39 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 123.504 1.621 . . . . 2.71 111.761 -168.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.811 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 t -158.2 90.99 1.07 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.194 -1.821 . . . . 0.35 108.677 159.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.811 ' HD3' ' O ' ' A' ' 140' ' ' THR . 9.1 mmt180 -153.95 134.51 8.17 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 113.623 -1.626 . . . . 2.38 106.705 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.98 109.25 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 121.353 1.519 . . . . 0.79 109.894 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.26 -1.39 57.42 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.689 -0.767 . . . . 0.38 114.025 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 1.5 mm-40 -125.66 131.7 52.57 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.738 -1.208 . . . . 1.49 107.738 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.875 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -130.85 175.2 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.156 -1.018 . . . . 0.3 110.169 -168.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.994 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.5 p -112.63 134.13 54.32 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.572 -0.451 . . . . 0.19 110.623 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 135' ' ' GLN . 0.5 OUTLIER -113.51 153.29 15.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.061 -0.972 . . . . 0.86 112.17 -174.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -152.95 -85.32 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.6 0.593 . . . . 2.45 112.6 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.48 -92.01 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.173 0.805 . . . . 0.49 113.173 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 87.0 m-20 -81.95 -6.99 59.57 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.687 0.28 . . . . 1.02 111.341 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.3 p -150.56 145.75 26.13 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.61 -0.836 . . . . 0.94 110.327 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.588 ' CD1' HD12 ' A' ' 128' ' ' LEU . 6.6 mt -110.04 162.45 7.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.911 -0.774 . . . . 0.2 108.911 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.4 tp10 -107.6 132.96 52.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.995 -1.483 . . . . 0.97 106.995 167.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.719 ' HG3' ' CE2' ' A' ' 145' ' ' PHE . 3.8 ttt -126.52 124.25 39.62 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.239 -0.585 . . . . 1.32 112.137 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -71.52 132.5 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.139 -0.689 . . . . 0.33 109.139 168.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' A' ' 157' ' ' ARG . 17.4 ttt180 -103.96 -176.73 3.17 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.923 -0.399 . . . . 3.1 109.923 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.526 ' H ' ' HG2' ' A' ' 156' ' ' ARG . 39.5 ttm180 -50.79 125.95 23.16 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 122.553 0.341 . . . . 4.26 111.448 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 157' ' ' ARG . 7.9 Cg_exo -70.84 158.5 55.37 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.519 2.146 . . . . 2.01 111.873 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -140.68 121.35 14.3 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.41 -0.814 . . . . 5.12 110.264 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.534 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 10.8 m-20 -130.33 127.79 40.15 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.843 -1.071 . . . . 5.15 110.164 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.497 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.5 m-30 -120.12 169.68 8.16 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-O 121.956 0.884 . . . . 6.81 111.467 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.4 Cg_endo -75.56 -42.19 0.48 Allowed 'Trans proline' 0 N--CA 1.419 -2.911 0 C-N-CA 122.472 2.115 . . . . 8.97 110.825 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.0 -8.11 52.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 112.222 -2.263 . . . . 10.53 109.509 -174.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.6 m -164.51 140.14 5.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.317 -1.31 . . . . 7.9 112.832 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.534 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 60.3 mttt -144.72 135.31 24.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.819 0.819 . . . . 6.69 113.057 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.82 -27.52 2.54 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.853 -1.521 . . . . 5.04 109.016 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.34 -124.19 6.44 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.024 -1.444 . . . . 2.11 111.851 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.457 ' CD ' ' H ' ' A' ' 168' ' ' GLN . 5.5 pm0 -73.76 152.33 40.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.251 0.548 . . . . 2.93 109.702 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.459 HG13 ' CD ' ' A' ' 187' ' ' GLU . 66.0 t -134.16 145.79 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 CA-C-N 115.261 -0.882 . . . . 0.48 109.487 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -131.35 145.37 51.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.345 1.069 . . . . 1.61 113.469 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.56 165.88 12.74 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.993 -1.912 . . . . 0.2 110.921 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.457 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 2.2 tpp180 -115.65 111.89 21.3 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.747 -1.205 . . . . 3.69 107.747 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.578 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -107.92 118.15 35.99 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.217 -1.811 . . . . 0.61 109.969 -166.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.607 ' CG2' HD23 ' A' ' 197' ' ' LEU . 87.5 m -114.43 150.86 34.07 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.762 0.653 . . . . 0.21 112.762 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.912 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.8 m-85 -115.26 112.47 22.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.663 -1.153 . . . . 0.32 112.212 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' A' ' 197' ' ' LEU . 25.8 t70 -102.96 98.48 8.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.965 0.412 . . . . 0.74 110.803 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.67 -120.45 5.28 Favored Glycine 0 C--N 1.317 -0.517 0 C-N-CA 120.085 -1.055 . . . . 0.27 112.85 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.74 14.17 22.29 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.829 -1.545 . . . . 1.61 106.829 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.0 p-80 -138.96 159.06 43.04 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.024 -1.444 . . . . 1.28 111.735 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -66.36 137.08 56.64 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.055 -0.975 . . . . 0.22 111.01 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.591 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.07 -51.48 5.98 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.48 -1.236 . . . . 0.15 111.653 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.635 HG21 ' O ' ' A' ' 194' ' ' PHE . 6.1 t -179.39 176.99 0.78 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.069 -0.969 . . . . 0.28 110.292 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.68 130.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.396 -1.705 . . . . 0.28 106.396 175.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.721 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.9 t -134.24 118.45 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 120.59 -0.444 . . . . 0.34 111.853 -172.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.52 98.64 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.063 -1.088 . . . . 1.64 108.063 171.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -51.48 -25.12 5.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.877 -1.965 . . . . 1.42 112.449 -170.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.459 ' CD ' HG13 ' A' ' 169' ' ' VAL . 3.4 mt-10 -71.08 -40.99 71.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 113.64 -1.618 . . . . 0.68 110.643 -174.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.04 -27.49 13.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.728 -1.578 . . . . 2.36 111.418 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.721 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.9 p-10 35.32 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 115.299 1.592 . . . . 1.8 115.299 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -145.17 -62.29 0.35 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 4.13 109.963 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -75.23 42.09 0.19 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.142 -0.481 . . . . 4.05 111.7 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 183' ' ' ILE . 1.0 OUTLIER -157.15 -35.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 1.83 110.473 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 159.24 -149.32 19.17 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.471 -0.871 . . . . 1.84 112.946 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.635 ' O ' HG21 ' A' ' 182' ' ' THR . 44.0 p90 -157.66 145.84 19.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.476 -0.935 . . . . 4.57 108.476 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -119.38 97.88 5.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.64 0.733 . . . . 6.25 112.06 -172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -136.43 129.48 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.333 -0.849 . . . . 6.4 109.51 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.84 135.66 54.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.805 0.336 . . . . 1.4 110.971 -177.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -87.29 110.0 30.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.578 -0.737 . . . . 3.38 110.238 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.59 144.87 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.736 2.291 . . . . 4.74 112.798 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.661 -0.685 . . . . 7.73 109.949 177.196 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.961 0.41 . . . . 31.14 110.337 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.41 134.55 11.73 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.899 -0.667 . . . . 30.65 111.908 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 m -144.16 39.06 1.31 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.226 0.536 . . . . 30.65 110.356 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -97.81 -19.01 18.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.776 -0.647 . . . . 29.78 110.77 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -83.71 126.31 32.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.36 -0.608 . . . . 29.55 109.36 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 69.78 103.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.85 0.719 . . . . 29.87 110.86 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -95.65 143.99 26.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 27.89 110.359 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -92.51 59.33 3.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.595 0.712 . . . . 26.19 110.384 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -75.36 -48.07 24.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.347 -0.842 . . . . 26.23 110.442 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -138.38 -69.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.203 -0.453 . . . . 26.64 110.342 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.2 p -168.03 164.2 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 24.71 110.15 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m 63.54 -166.6 0.22 Allowed 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.518 0.511 . . . . 24.15 111.455 175.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.92 -43.1 1.3 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.938 -0.649 . . . . 22.66 112.242 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.83 100.44 6.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.652 0.263 . . . . 20.88 110.694 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.603 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 90.1 t -74.44 -56.25 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.545 -0.298 . . . . 19.88 110.241 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 81.4 Cg_endo -83.74 54.16 4.38 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.011 1.807 . . . . 18.7 111.317 173.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -58.2 -41.06 83.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.847 -0.615 . . . . 18.91 111.162 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.27 54.51 0.31 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.663 -0.78 . . . . 15.32 111.717 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -95.12 71.82 3.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.035 0.445 . . . . 14.03 110.188 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -122.59 152.93 39.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.043 -0.526 . . . . 12.65 110.292 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -101.14 146.03 28.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.312 -0.403 . . . . 11.98 110.126 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.27 112.32 0.66 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.795 -0.717 . . . . 8.1 111.983 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -153.45 138.07 16.9 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.446 -0.576 . . . . 9.18 109.446 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.5 ptm -149.66 31.12 0.72 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.154 0.978 . . . . 6.14 109.884 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.72 140.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.052 -1.431 . . . . 4.84 109.761 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -80.34 153.92 28.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.334 -0.394 . . . . 4.29 110.41 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.666 HD11 HD13 ' A' ' 173' ' ' LEU . 3.0 tm? -71.94 146.07 48.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.083 -0.508 . . . . 1.69 110.701 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.661 ' N ' HD13 ' A' ' 113' ' ' LEU . 6.0 mt-10 -173.81 -171.2 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 118.481 -0.771 . . . . 3.45 109.236 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 22.0 Cg_exo -41.92 -175.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 124.016 3.144 . . . . 3.06 114.944 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 180' ' ' LEU . 2.3 m-20 -43.39 28.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 119.448 3.129 . . . . 3.24 119.448 -152.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.884 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.5 OUTLIER -42.27 111.7 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.817 0.818 . . . . 1.45 111.941 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.5 m -74.48 105.58 5.68 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.373 -0.83 . . . . 0.32 111.04 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -140.15 173.61 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 114.364 -1.289 . . . . 0.2 110.858 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.7 p -121.41 174.08 6.97 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.729 -1.123 . . . . 1.29 110.098 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 124' ' ' MET . 28.5 ttpp -50.99 -47.43 61.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 3.26 111.845 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.486 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -84.21 -17.1 40.95 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 122.248 -0.282 . . . . 2.17 110.521 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.7 mt-10 -70.69 -22.63 62.44 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.297 -0.561 . . . . 0.5 110.149 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -84.99 -29.13 25.29 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.457 -1.297 . . . . 3.06 109.66 178.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.02 -33.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.559 1.171 . . . . 0.35 111.605 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.74 -42.3 28.55 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.292 -1.322 . . . . 1.51 109.806 170.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.45 -38.6 84.71 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.476 -1.25 . . . . 0.4 114.163 -173.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.12 -41.01 97.82 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 116.129 -2.229 . . . . 0.32 108.67 177.096 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.679 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 64.0 mm-40 -67.27 -32.0 72.71 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 123.006 1.384 . . . . 2.51 108.658 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.16 -7.32 59.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.895 -2.412 . . . . 0.33 110.179 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -121.12 1.06 10.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.114 0.959 . . . . 0.36 108.636 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 72.68 55.26 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.286 -1.779 . . . . 2.19 112.267 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 146.75 25.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.548 -1.649 . . . . 0.27 106.548 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.624 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.07 163.26 34.05 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.061 -1.829 . . . . 0.69 106.061 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.25 159.6 0.64 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.082 0.944 . . . . 1.96 112.041 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -146.68 150.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-N 114.147 -1.388 . . . . 0.27 111.624 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 m -60.56 -50.18 74.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.093 -0.958 . . . . 0.73 111.942 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.9 ptmt -155.43 114.51 3.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.161 -1.382 . . . . 0.51 108.967 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.908 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.38 100.5 5.19 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 123.894 1.807 . . . . 2.71 112.041 -168.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 1.4 t -158.84 95.4 1.29 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.178 -1.828 . . . . 0.35 108.07 162.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -151.34 165.38 17.5 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.483 -1.235 . . . . 2.38 108.183 173.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.31 111.56 2.65 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 119.578 0.885 . . . . 0.79 109.982 164.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.39 13.41 78.69 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.674 -0.774 . . . . 0.38 114.049 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.9 mt-10 -131.88 130.91 42.25 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.349 -0.982 . . . . 1.49 108.349 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.921 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.84 176.63 8.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.547 -0.861 . . . . 0.3 110.279 -166.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.908 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.1 p -107.88 142.03 38.58 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.532 0.682 . . . . 0.19 110.932 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.35 134.71 39.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 114.617 -1.174 . . . . 0.86 111.08 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 151' ' ' SER . 31.7 tp60 -147.23 54.2 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.98 0.419 . . . . 2.45 110.961 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 60.57 -100.43 0.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.35 0.87 . . . . 0.49 113.35 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.735 ' HB3' HD23 ' A' ' 197' ' ' LEU . 83.1 m-20 -82.04 -5.02 58.04 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.051 0.453 . . . . 1.02 111.375 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 57.3 m -141.9 123.21 14.81 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.268 -0.573 . . . . 0.94 110.26 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 128' ' ' LEU . 5.9 mt -96.19 165.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.617 -1.253 . . . . 0.2 107.617 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.921 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 5.6 tt0 -124.5 105.82 9.69 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.898 -1.121 . . . . 0.97 110.392 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.61 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.8 ppp? -106.76 125.8 51.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.061 0.458 . . . . 1.32 111.478 -166.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -69.09 135.88 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.148 -0.478 . . . . 0.33 110.316 172.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 157' ' ' ARG . 29.4 ttp180 -76.32 150.49 36.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.621 -0.718 . . . . 3.1 109.226 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 42.9 ttp180 -56.77 119.63 31.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.505 -0.316 . . . . 4.26 110.382 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 157' ' ' ARG . 3.6 Cg_exo -77.38 174.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.125 2.55 . . . . 2.01 113.175 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.49 130.12 56.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.591 -1.186 . . . . 5.12 108.967 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.644 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 50.2 m-20 -129.18 136.62 50.4 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.745 0.646 . . . . 5.15 112.745 -167.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.3 m-85 -119.58 167.59 11.89 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 115.111 -0.95 . . . . 6.81 110.348 170.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.4 Cg_endo -74.82 -41.87 0.65 Allowed 'Trans proline' 0 N--CA 1.416 -3.053 0 C-N-CA 122.124 1.883 . . . . 8.97 111.077 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.24 -4.84 48.15 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 112.806 -1.997 . . . . 10.53 109.7 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -164.36 142.37 6.92 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.567 -1.197 . . . . 7.9 112.379 -170.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.644 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 69.3 mttt -142.87 147.88 36.09 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.632 0.73 . . . . 6.69 112.705 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.8 pt-20 -176.0 -154.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.082 -1.417 . . . . 5.04 109.247 -169.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . 79.58 6.69 88.92 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.865 -0.607 . . . . 2.11 112.551 172.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.17 109.3 5.13 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.781 1.277 . . . . 2.93 112.101 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.0 t -131.61 145.63 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.513 0 CA-C-N 112.627 -2.079 . . . . 0.48 109.303 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.691 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.71 145.48 50.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.135 0.969 . . . . 1.61 112.712 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -112.28 166.12 11.56 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.512 -1.676 . . . . 0.2 110.22 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.69 120.48 37.55 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.439 -0.948 . . . . 3.69 108.439 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -115.32 137.32 52.17 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.729 -1.578 . . . . 0.61 109.901 -163.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.604 ' CG2' ' HB2' ' A' ' 197' ' ' LEU . 82.6 m -129.83 150.24 51.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.235 0.54 . . . . 0.21 111.881 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.9 m-85 -113.24 106.82 15.09 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.424 -1.262 . . . . 0.32 112.374 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.608 ' HA ' HD13 ' A' ' 197' ' ' LEU . 17.7 t70 -93.67 96.66 9.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.119 0.485 . . . . 0.74 111.113 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.71 -114.77 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.185 -1.007 . . . . 0.27 113.31 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.04 8.99 22.1 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.004 -1.48 . . . . 1.61 107.004 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 34.7 p80 -138.41 161.11 37.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.159 -1.382 . . . . 1.28 111.59 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.884 ' HB2' ' O ' ' A' ' 117' ' ' MET . 8.1 tp -63.75 144.3 57.15 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.404 -0.817 . . . . 0.22 111.731 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.92 -52.46 4.23 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.43 -1.259 . . . . 0.15 111.914 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 6.3 t -179.24 176.19 0.88 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.463 -0.789 . . . . 0.28 110.558 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.73 HD11 HD21 ' A' ' 180' ' ' LEU . 3.5 mp -152.27 137.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 105.646 -1.983 . . . . 0.28 105.646 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.956 HG22 ' HA2' ' A' ' 193' ' ' GLY . 75.4 t -139.55 119.86 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 112.417 0.525 . . . . 0.34 112.417 -172.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.97 96.46 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.064 -1.087 . . . . 1.64 108.064 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.1 mmm -54.91 -24.3 22.87 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.141 -1.845 . . . . 1.42 113.26 -166.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.0 mt-10 -70.57 -40.92 73.04 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 114.39 -1.277 . . . . 0.68 110.957 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -93.54 -32.52 14.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.753 -1.567 . . . . 2.36 110.571 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.626 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.7 p-10 36.3 46.92 0.44 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.074 0.94 . . . . 1.8 112.765 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 190' ' ' ARG . 1.3 tpm_? -163.65 -53.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.967 -1.123 . . . . 4.13 107.967 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -73.02 126.03 29.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.691 -1.141 . . . . 4.05 108.084 169.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 35.7 t80 61.79 68.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.202 -0.666 . . . . 1.83 109.202 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.956 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -156.17 138.64 6.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.168 -1.015 . . . . 1.84 113.476 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.441 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 73.9 m-85 -131.31 -172.27 2.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.535 -0.542 . . . . 4.57 109.535 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.4 138.17 39.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.206 0.527 . . . . 6.25 110.984 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 196' ' ' ARG . 41.4 ttm180 -73.88 160.49 31.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.296 -0.866 . . . . 6.4 110.009 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 150' ' ' ASN . 15.8 tp -68.57 125.74 27.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.718 0.294 . . . . 1.4 111.067 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.04 144.74 59.61 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.101 -0.703 . . . . 3.38 109.101 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.82 78.36 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.718 2.278 . . . . 4.74 112.36 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.33 -0.843 . . . . 7.73 109.773 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.622 -0.51 . . . . 31.14 109.622 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 52.68 6.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.476 -0.869 . . . . 30.65 112.891 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 m -96.22 -18.27 20.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.411 0.624 . . . . 30.65 109.325 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 3.4 p -83.87 75.45 10.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.305 -0.862 . . . . 29.78 110.731 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.89 -30.25 63.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 29.55 110.902 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -67.99 -47.48 68.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 29.87 109.688 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' SER . 31.4 t-80 -167.91 130.09 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.876 -0.787 . . . . 27.89 108.876 175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 82.3 m-70 -67.0 101.18 0.82 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.995 0.426 . . . . 26.19 111.585 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 33.9 p80 -146.77 38.53 1.01 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 26.23 108.931 173.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 33.4 m170 71.58 174.84 0.29 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.969 -1.014 . . . . 26.64 109.951 -171.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -87.14 35.1 0.69 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.058 0.456 . . . . 24.71 110.747 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p -82.72 164.66 20.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.641 . . . . 24.15 110.398 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.65 41.34 2.39 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.672 -0.775 . . . . 22.66 112.897 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 tt -79.2 91.62 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.097 -0.705 . . . . 20.88 109.097 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.5 p -163.96 117.55 1.04 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.646 -0.706 . . . . 19.88 110.071 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.46 -56.28 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.878 2.385 . . . . 18.7 112.116 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 56.01 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.302 0.573 . . . . 18.91 111.485 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.66 20.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.824 -0.703 . . . . 15.32 111.487 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.7 t -122.68 122.91 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 14.03 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -137.26 37.49 2.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 12.65 110.487 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 11.98 109.863 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.8 62.97 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.601 -0.727 . . . . 8.1 112.301 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -104.62 -24.27 12.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.682 0.277 . . . . 9.18 111.124 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -136.07 24.66 3.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.46 1.124 . . . . 6.14 109.9 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.6 p -103.04 143.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 113.497 -1.683 . . . . 4.84 109.855 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' OD1' ' HG2' ' A' ' 157' ' ' ARG . 88.9 m-20 -88.44 142.51 27.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.026 -0.534 . . . . 4.29 109.667 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 173' ' ' LEU . 4.6 tt -80.25 110.39 15.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 1.69 109.542 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.709 ' HA ' HD13 ' A' ' 183' ' ' ILE . 8.2 pt-20 -173.64 48.43 0.07 OUTLIER Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.41 -0.814 . . . . 3.45 111.168 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 6.9 Cg_endo -90.07 177.26 2.52 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.99 2.46 . . . . 3.06 112.174 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.96 19.31 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.387 -0.824 . . . . 3.24 110.359 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.706 ' CG ' HG23 ' A' ' 119' ' ' ILE . 12.3 ttm -48.96 138.57 11.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.536 1.134 . . . . 1.45 113.042 -169.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.783 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.8 m -128.25 100.76 5.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.603 -1.18 . . . . 0.32 108.645 175.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.1 pt -132.85 172.63 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.242 1.02 . . . . 0.2 112.069 -174.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.825 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.6 m -117.06 174.04 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.581 -1.645 . . . . 1.29 110.206 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 124' ' ' MET . 14.0 mmmm -49.33 -53.78 20.45 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.599 0.592 . . . . 3.26 112.599 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 94.8 m-20 -82.89 -16.35 47.87 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 116.586 -0.279 . . . . 2.17 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.887 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -66.24 -24.09 66.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 120.274 -0.571 . . . . 0.5 110.167 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.77 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.07 -29.26 23.52 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.487 -1.285 . . . . 3.06 109.986 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.26 -31.13 50.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.436 1.112 . . . . 0.35 111.61 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.97 -42.45 23.92 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.233 -1.349 . . . . 1.51 109.735 170.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.38 81.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 CA-C-O 117.626 -1.178 . . . . 0.4 114.147 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.82 -39.56 94.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 116.233 -2.187 . . . . 0.32 108.733 177.455 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.668 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 55.2 mm-40 -69.56 -30.76 68.63 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.113 1.435 . . . . 2.51 108.787 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.885 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -83.64 -7.67 59.45 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 111.971 -2.377 . . . . 0.33 109.884 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.699 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.51 -0.95 9.66 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.115 -0.948 . . . . 0.36 108.967 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 71.49 58.09 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 113.341 -1.754 . . . . 2.19 112.625 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.675 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.65 146.88 25.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.106 -1.812 . . . . 0.27 106.106 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -143.34 162.59 35.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.41 -1.33 . . . . 0.69 107.41 -174.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -50.18 146.83 4.64 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.164 0.983 . . . . 1.96 112.567 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -134.56 150.84 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-N 113.702 -1.59 . . . . 0.27 112.046 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.5 m -60.34 -50.28 74.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.857 -1.065 . . . . 0.73 111.826 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.2 ptmt -155.33 113.77 3.49 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.114 -1.403 . . . . 0.51 108.812 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.871 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -75.72 100.35 4.66 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.682 1.706 . . . . 2.71 112.05 -167.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.823 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.1 t -159.22 92.08 1.06 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.61 -1.632 . . . . 0.35 109.305 161.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.823 ' HD3' ' O ' ' A' ' 140' ' ' THR . 16.9 mmt180 -152.0 147.82 20.48 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-N 113.8 -1.546 . . . . 2.38 107.189 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.03 110.28 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 CA-C-N 120.383 1.172 . . . . 0.79 109.372 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.5 14.4 58.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.354 -0.839 . . . . 0.38 114.352 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.2 mt-10 -136.89 132.72 34.91 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.858 -1.164 . . . . 1.49 107.858 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.92 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.97 175.25 9.39 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.167 -1.013 . . . . 0.3 110.451 -168.039 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.871 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.4 p -108.34 141.45 40.13 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.869 0.842 . . . . 0.19 112.047 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.76 119.71 52.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 113.736 -1.574 . . . . 0.86 110.477 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 151' ' ' SER . 51.8 tt0 -103.88 -80.16 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.492 -0.322 . . . . 2.45 110.695 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.07 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.738 0.304 . . . . 0.49 111.009 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.874 ' HB3' HD13 ' A' ' 197' ' ' LEU . 61.0 m-20 -81.97 -4.14 56.01 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.332 -0.618 . . . . 1.02 109.332 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.7 m -142.6 148.04 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.55 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -106.77 169.14 2.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.727 -1.212 . . . . 0.2 107.727 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.92 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 12.4 tt0 -127.54 109.08 11.36 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.787 -0.765 . . . . 0.97 110.654 173.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 2.1 tmt? -109.71 123.2 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.747 0.308 . . . . 1.32 111.753 -169.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -68.64 125.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.251 0.548 . . . . 0.33 110.878 174.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 169' ' ' VAL . 53.7 ttt85 -85.99 163.91 17.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.098 -0.955 . . . . 3.1 108.737 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 37.9 mmt-85 -62.01 143.8 94.48 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.476 -0.564 . . . . 4.26 109.476 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 157' ' ' ARG . 37.1 Cg_exo -56.25 159.76 12.17 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.651 2.234 . . . . 2.01 113.162 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -119.33 124.37 46.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.763 -1.108 . . . . 5.12 111.278 -167.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.511 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 3.7 m-20 -130.1 121.34 26.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.634 -1.166 . . . . 5.15 110.771 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -121.59 172.41 5.03 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-O 121.676 0.751 . . . . 6.81 110.784 178.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -74.48 -43.69 0.47 Allowed 'Trans proline' 0 N--CA 1.415 -3.101 0 C-N-CA 121.956 1.771 . . . . 8.97 110.245 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.18 -3.94 57.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 112.351 -2.204 . . . . 10.53 109.72 -173.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 m -163.27 135.29 5.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.384 -1.28 . . . . 7.9 112.676 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.511 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 51.6 mttt -146.29 141.58 27.46 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.68 0.752 . . . . 6.69 112.144 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.72 -162.71 0.74 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.123 -1.399 . . . . 5.04 109.87 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -103.0 -131.67 7.39 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 120.613 -0.803 . . . . 2.11 113.16 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -67.52 159.54 29.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.793 0.806 . . . . 2.93 111.31 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 187' ' ' GLU . 63.4 t -136.34 147.35 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 114.516 -1.22 . . . . 0.48 108.733 175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.14 145.23 51.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.243 1.021 . . . . 1.61 112.872 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.48 164.68 13.31 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 0.2 110.541 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 22.9 ttt180 -111.67 119.97 40.48 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.999 -1.111 . . . . 3.69 107.999 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.678 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -112.37 110.48 20.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.42 -1.264 . . . . 0.61 109.956 -168.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.544 ' CG2' HD12 ' A' ' 197' ' ' LEU . 32.1 m -107.65 151.35 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.329 0.492 . . . . 0.21 112.329 -169.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.7 m-85 -117.03 101.81 8.81 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.628 -1.169 . . . . 0.32 112.685 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 22.4 t70 -98.66 100.43 11.66 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.659 -0.416 . . . . 0.74 111.189 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.24 -119.11 5.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.518 -0.849 . . . . 0.27 113.051 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.46 8.51 23.14 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.518 -1.66 . . . . 1.61 106.518 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.783 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.6 p80 -138.65 160.52 39.43 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.158 -1.383 . . . . 1.28 112.061 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -63.74 139.64 58.79 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 114.759 -1.11 . . . . 0.22 110.439 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.631 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -90.84 -48.82 6.79 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.442 -1.254 . . . . 0.15 111.348 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 6.5 t 177.36 178.02 0.31 Allowed 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.284 -0.871 . . . . 0.28 110.685 -174.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.74 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -150.94 127.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.909 -1.886 . . . . 0.28 105.909 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.873 HG22 ' HA2' ' A' ' 193' ' ' GLY . 84.4 t -132.87 122.09 45.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 112.568 0.581 . . . . 0.34 112.568 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -60.55 97.96 0.06 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.241 -1.022 . . . . 1.64 108.241 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.554 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.6 OUTLIER -54.56 -24.74 22.29 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 112.579 -2.1 . . . . 1.42 112.489 -168.365 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -68.58 -41.59 79.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 114.049 -1.432 . . . . 0.68 110.977 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' A' ' 190' ' ' ARG . 1.0 OUTLIER -100.34 -27.96 13.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.788 -1.096 . . . . 2.36 110.808 176.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.69 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.7 p30 36.47 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.578 1.696 . . . . 1.8 115.578 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 188' ' ' ASN . 81.8 mtp180 -134.74 -61.52 0.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.231 -0.655 . . . . 4.13 109.231 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.3 149.27 33.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.668 -1.234 . . . . 4.05 107.668 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 8.8 t80 63.8 42.05 6.41 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.85 -1.167 . . . . 1.83 107.85 -171.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.873 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -133.64 131.66 6.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.119 -0.946 . . . . 1.84 112.82 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 92.8 m-85 -131.04 -173.03 2.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 4.57 109.606 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -77.71 167.2 21.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.597 0.713 . . . . 6.25 111.958 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -133.79 164.53 27.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 6.4 110.495 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 150' ' ' ASN . 1.3 mp -67.38 161.76 24.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.37 0.507 . . . . 1.4 112.37 -172.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.2 t70 56.99 66.29 3.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.075 -0.966 . . . . 3.38 110.662 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -95.02 2.8 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.11 2.54 . . . . 4.74 112.502 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.591 -0.719 . . . . 7.73 110.295 -176.773 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.727 0.299 . . . . 31.14 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.76 -33.27 24.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 30.65 112.694 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 m -91.56 33.9 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.934 0.397 . . . . 30.65 111.017 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 t -85.18 -72.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.418 . . . . 29.78 110.698 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 35.6 m80 57.23 -97.45 0.07 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.128 -0.487 . . . . 29.55 111.233 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.8 m80 66.32 143.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.296 0.569 . . . . 29.87 111.434 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -82.53 111.1 18.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 27.89 110.738 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.62 -178.32 4.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.746 -0.661 . . . . 26.19 110.032 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -141.48 82.81 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.051 0.453 . . . . 26.23 110.22 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -130.07 -58.09 1.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.304 -0.628 . . . . 26.64 109.304 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.7 m -119.44 57.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.642 -0.708 . . . . 24.71 109.356 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 m -88.79 -3.21 58.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.438 -0.801 . . . . 24.15 110.827 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.56 -140.46 20.39 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.998 -0.62 . . . . 22.66 113.113 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.3 mt -82.3 68.77 8.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.989 0.423 . . . . 20.88 111.051 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 48.9 t -69.58 -50.54 18.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.086 -0.506 . . . . 19.88 111.424 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 71.7 Cg_endo -75.69 60.91 6.06 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.976 1.784 . . . . 18.7 111.588 176.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -63.78 120.96 12.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.909 -0.587 . . . . 18.91 110.76 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.48 115.39 0.69 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.8 -0.636 . . . . 15.32 111.537 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.9 m -111.37 36.05 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.316 0.579 . . . . 14.03 110.639 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -89.5 -45.55 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 12.65 109.675 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 56.8 mtm -126.68 165.18 19.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 11.98 109.832 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.6 -18.07 20.36 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.524 -0.846 . . . . 8.1 112.549 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -85.53 52.74 2.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.171 0.51 . . . . 9.18 110.611 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -131.22 20.72 4.84 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.301 1.048 . . . . 6.14 109.165 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.79 111.49 30.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.503 -1.681 . . . . 4.84 109.127 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -144.17 134.27 24.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 4.29 110.892 -171.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HG ' HD11 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -67.86 136.98 54.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.598 -0.889 . . . . 1.69 108.598 175.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 7.5 mm-40 -133.66 -179.06 0.97 Allowed Pre-proline 0 N--CA 1.443 -0.823 0 C-N-CA 120.821 -0.352 . . . . 3.45 111.138 -167.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 2.9 Cg_endo -41.53 -175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.075 3.85 . . . . 3.06 115.134 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -44.39 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 119.378 3.103 . . . . 3.24 119.378 -156.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.895 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -40.4 109.51 0.12 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.097 0.951 . . . . 1.45 111.581 174.088 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.9 m -74.03 104.95 5.05 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.081 -0.963 . . . . 0.32 110.699 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.1 pt -138.54 172.53 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.296 -1.32 . . . . 0.2 110.235 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.885 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 11.1 p -122.56 176.27 6.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.741 -1.118 . . . . 1.29 110.151 -173.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' MET . 62.3 mtpt -56.03 -43.91 78.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.275 0.472 . . . . 3.26 112.275 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 26.2 t-20 -83.95 -18.36 37.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 122.042 -0.411 . . . . 2.17 110.016 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.959 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -67.36 -23.81 65.64 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 119.785 -0.766 . . . . 0.5 109.997 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.681 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.32 -27.59 25.81 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 118.576 -1.249 . . . . 3.06 109.81 177.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.01 -32.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.886 -1.052 . . . . 0.35 111.461 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.789 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.32 -40.01 31.38 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.813 -1.085 . . . . 1.51 110.291 170.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.17 -37.57 80.57 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 117.424 -1.274 . . . . 0.4 114.11 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.867 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.94 -40.02 95.48 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 116.103 -2.239 . . . . 0.32 109.227 175.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' H ' HD22 ' A' ' 128' ' ' LEU . 19.7 mt-10 -64.67 -28.82 69.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.685 1.231 . . . . 2.51 108.062 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -94.38 -6.82 43.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.827 -1.988 . . . . 0.33 111.135 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.3 t -122.52 -2.26 8.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.36 109.758 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 74.72 52.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.042 -1.436 . . . . 2.19 112.032 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.867 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -148.41 142.55 26.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.511 -1.292 . . . . 0.27 107.511 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.637 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -147.19 163.99 34.59 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.747 -1.205 . . . . 0.69 107.747 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -46.28 144.78 1.9 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 122.094 0.95 . . . . 1.96 113.202 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.7 t -137.37 151.18 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.375 0 CA-C-N 114.034 -1.439 . . . . 0.27 112.562 -173.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 m -59.77 -50.89 72.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.889 -1.05 . . . . 0.73 111.602 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.1 ptmt -157.72 117.65 3.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.019 -1.446 . . . . 0.51 108.605 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.916 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -78.69 100.34 7.0 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 123.466 1.603 . . . . 2.71 111.991 -167.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.806 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 3.1 t -159.71 95.03 1.18 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.095 -1.411 . . . . 0.35 109.274 162.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.806 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -151.99 171.82 6.17 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 114.451 -1.25 . . . . 2.38 107.747 172.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.26 111.71 2.43 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 CA-C-N 120.452 1.197 . . . . 0.79 109.885 164.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.17 0.12 77.67 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.794 -0.717 . . . . 0.38 114.84 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 40.9 mt-10 -119.57 132.09 55.66 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.686 1.243 . . . . 1.49 109.574 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.815 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.8 m-30 -129.3 175.55 8.65 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.365 -0.534 . . . . 0.3 110.328 -166.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.916 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.0 p -111.9 139.2 47.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.871 -0.788 . . . . 0.19 108.871 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.435 ' CB ' ' OH ' ' A' ' 133' ' ' TYR . 2.6 p -112.37 154.43 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 112.649 0.611 . . . . 0.86 112.649 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 151' ' ' SER . 46.8 tp60 -146.16 -95.08 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.334 -0.394 . . . . 2.45 111.146 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.0 -86.09 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.081 0.4 . . . . 0.49 112.081 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -83.19 -9.12 59.34 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.492 0.663 . . . . 1.02 109.665 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 46.9 m -139.51 119.74 13.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.53 -0.759 . . . . 0.94 110.579 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.549 HD11 ' SD ' ' A' ' 124' ' ' MET . 4.7 mt -96.95 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.767 -1.197 . . . . 0.2 107.767 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.815 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.1 tt0 -119.5 151.0 39.31 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.144 -1.428 . . . . 0.97 107.144 164.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.619 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -147.43 128.65 14.73 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.116 -0.634 . . . . 1.32 111.098 -177.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -71.96 130.61 35.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.049 -0.352 . . . . 0.33 110.049 171.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -95.12 168.0 11.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.978 -0.556 . . . . 3.1 109.57 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -44.14 133.83 4.27 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 123.5 0.5 . . . . 4.26 110.5 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -49.76 153.43 5.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.938 2.425 . . . . 2.01 112.338 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -107.39 118.59 37.13 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.887 -1.052 . . . . 5.12 111.01 -169.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.611 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 7.1 m-20 -130.06 118.9 22.25 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.367 -1.288 . . . . 5.15 110.353 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.546 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 2.2 m-30 -121.1 170.85 6.69 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.301 -0.863 . . . . 6.81 110.614 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -74.48 -41.72 0.78 Allowed 'Trans proline' 0 N--CA 1.415 -3.131 0 C-N-CA 122.012 1.808 . . . . 8.97 110.205 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.15 -7.45 55.66 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 112.167 -2.288 . . . . 10.53 109.803 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.2 m -163.52 136.5 5.43 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.179 -1.373 . . . . 7.9 112.883 -169.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.611 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 54.7 mttt -145.97 146.12 30.9 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.276 0.56 . . . . 6.69 111.861 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -168.2 -161.39 0.36 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.59 -1.186 . . . . 5.04 110.376 -174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -94.88 -124.8 4.29 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.728 -0.749 . . . . 2.11 113.53 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.404 ' H ' ' CD ' ' A' ' 168' ' ' GLN . 5.5 pm0 -80.85 161.61 24.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.514 0.673 . . . . 2.93 111.455 -172.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 187' ' ' GLU . 56.0 t -135.91 146.17 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-N 114.626 -1.17 . . . . 0.48 108.742 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -123.39 143.96 49.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.627 1.203 . . . . 1.61 112.582 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 153' ' ' GLU . . . -115.47 166.37 11.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 112.873 -1.967 . . . . 0.2 109.855 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.4 ttp180 -108.82 126.47 53.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.103 -0.703 . . . . 3.69 109.103 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.485 HD23 HG13 ' A' ' 183' ' ' ILE . 1.4 mt -84.59 152.05 24.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.357 -1.292 . . . . 0.61 110.076 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.608 ' CG2' HD23 ' A' ' 197' ' ' LEU . 93.4 m -151.95 143.05 23.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.1 0.476 . . . . 0.21 111.22 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.932 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.3 m-85 -116.77 111.82 20.29 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.882 -1.053 . . . . 0.32 112.738 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.679 ' HA ' HD21 ' A' ' 197' ' ' LEU . 16.8 t70 -99.15 95.0 6.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 0.74 111.09 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.02 -114.48 3.96 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 120.199 -1.0 . . . . 0.27 113.487 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -110.8 8.77 22.52 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.055 -1.461 . . . . 1.61 107.055 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.744 ' HB3' HG23 ' A' ' 118' ' ' THR . 34.6 p80 -138.49 160.48 39.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.174 -1.375 . . . . 1.28 111.419 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.895 ' HB2' ' O ' ' A' ' 117' ' ' MET . 7.3 tp -62.06 144.59 55.04 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.059 -0.973 . . . . 0.22 111.093 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.3 -51.28 4.87 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.395 -1.275 . . . . 0.15 111.215 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 6.7 t -178.53 176.26 1.04 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.112 -0.949 . . . . 0.28 110.556 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.851 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -154.15 125.82 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 113.086 -1.87 . . . . 0.28 106.472 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.772 HG22 ' HA2' ' A' ' 193' ' ' GLY . 98.7 t -128.76 119.51 49.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.28 -0.568 . . . . 0.34 111.901 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.26 96.84 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.529 -1.286 . . . . 1.64 107.529 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.7 mmt -53.89 -24.36 15.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 112.669 -2.059 . . . . 1.42 112.304 -168.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.555 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.5 mt-10 -68.13 -44.67 75.56 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 113.992 -1.458 . . . . 0.68 110.839 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.2 -27.77 13.65 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.936 -1.484 . . . . 2.36 111.138 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.3 p30 35.81 39.75 0.08 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.019 1.488 . . . . 1.8 115.019 173.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -153.87 -55.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.021 -0.424 . . . . 4.13 110.821 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.49 41.65 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.174 0.511 . . . . 4.05 110.119 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 t80 176.96 41.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.029 -0.73 . . . . 1.83 109.029 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.772 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -128.74 140.63 11.88 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.206 -0.997 . . . . 1.84 114.239 -171.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.495 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 57.7 m-85 -133.66 -171.28 2.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.614 -0.793 . . . . 4.57 109.323 175.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -75.8 162.76 27.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.276 0.56 . . . . 6.25 111.292 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -112.47 159.69 18.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.327 -0.851 . . . . 6.4 110.896 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.679 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -76.59 135.21 39.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 1.4 111.352 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -138.81 76.81 33.9 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.657 0.741 . . . . 3.38 110.073 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.58 -65.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.779 2.32 . . . . 4.74 112.248 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.559 -0.734 . . . . 7.73 110.144 179.452 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.923 0.392 . . . . 31.14 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.97 139.94 2.87 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.843 -0.694 . . . . 30.65 112.143 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -70.81 119.96 15.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.13 -0.693 . . . . 30.65 109.13 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m 70.05 151.49 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.787 0.68 . . . . 29.78 110.268 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -86.39 6.26 30.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.434 -0.348 . . . . 29.55 111.838 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 64.67 73.37 0.42 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.634 -0.712 . . . . 29.87 110.68 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -65.33 134.51 53.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 27.89 110.927 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -138.02 173.66 11.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.823 -0.626 . . . . 26.19 109.808 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -58.2 -41.68 84.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.339 0.496 . . . . 26.23 112.339 -171.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -110.39 147.5 33.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.83 -0.348 . . . . 26.64 110.942 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.6 m 67.27 17.98 10.27 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.823 0.675 . . . . 24.71 112.823 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.9 p -160.95 122.24 2.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.789 0.328 . . . . 24.15 110.381 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.12 -20.05 4.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.493 -0.643 . . . . 22.66 111.493 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.97 -51.0 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.397 -0.594 . . . . 20.88 109.397 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.72 101.33 48.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.48 -0.782 . . . . 19.88 110.04 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.88 50.23 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.659 2.239 . . . . 18.7 111.689 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -68.62 113.99 6.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 18.91 110.898 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 105' ' ' SER . . . -89.21 -132.72 4.59 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.039 -0.824 . . . . 15.32 111.039 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 104' ' ' GLY . 41.2 t 70.23 159.59 0.19 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.309 0.576 . . . . 14.03 111.123 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -96.48 6.38 48.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 12.65 110.132 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -69.48 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 11.98 110.614 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.28 131.59 3.45 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.868 -0.682 . . . . 8.1 111.427 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -72.02 140.04 48.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.753 0.311 . . . . 9.18 110.388 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.1 ptp -136.42 23.8 3.2 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.36 1.076 . . . . 6.14 109.233 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.09 128.43 68.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.592 -1.64 . . . . 4.84 109.916 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.32 141.46 48.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.931 -0.577 . . . . 4.29 109.618 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.778 HD11 HD13 ' A' ' 173' ' ' LEU . 3.3 tm? -71.05 138.48 49.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.911 -0.774 . . . . 1.69 108.911 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 14.7 mt-10 -168.32 -171.41 0.23 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.779 -0.629 . . . . 3.45 109.649 -169.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 3.7 Cg_exo -39.45 -176.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 125.226 3.95 . . . . 3.06 115.696 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.05 28.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 119.823 3.268 . . . . 3.24 119.823 -148.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.887 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -42.27 111.88 0.29 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.707 0.765 . . . . 1.45 112.158 173.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m -73.89 106.51 5.64 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.627 0.727 . . . . 0.32 110.798 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.946 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.4 pt -138.4 172.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.595 -1.184 . . . . 0.2 111.318 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.898 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 10.2 p -121.18 174.77 6.47 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.502 -1.227 . . . . 1.29 109.9 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 124' ' ' MET . 35.8 ttpt -56.22 -43.0 78.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.78 0.324 . . . . 3.26 111.824 -175.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.6 t-20 -84.17 -18.03 38.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.063 -0.398 . . . . 2.17 110.187 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -68.28 -23.77 64.79 Favored 'General case' 0 N--CA 1.422 -1.868 0 C-N-CA 119.969 -0.693 . . . . 0.5 110.176 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.7 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.27 -26.56 26.57 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 118.495 -1.282 . . . . 3.06 109.581 177.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.5 -32.06 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.845 -1.071 . . . . 0.35 111.539 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.786 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.66 -38.97 32.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.792 -1.095 . . . . 1.51 110.348 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.76 -38.18 84.32 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-O 117.548 -1.215 . . . . 0.4 114.236 -174.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.866 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -39.48 94.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 116.216 -2.193 . . . . 0.32 109.257 176.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 22.0 mt-10 -65.02 -29.81 70.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.614 1.197 . . . . 2.51 108.113 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.72 -7.77 45.77 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.727 -2.033 . . . . 0.33 111.076 -170.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -121.81 -1.65 9.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.705 0.764 . . . . 0.36 109.322 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 71.25 57.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.702 -1.59 . . . . 2.19 111.996 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.866 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.08 145.51 26.4 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.587 -1.635 . . . . 0.27 106.587 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.558 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.87 164.52 31.68 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.886 -0.783 . . . . 0.69 108.886 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' CB ' HG12 ' A' ' 147' ' ' VAL . 18.3 tt0 -45.01 144.69 1.15 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.285 1.04 . . . . 1.96 113.21 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 138' ' ' LYS . 5.1 t -139.98 150.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 CA-C-N 113.507 -1.679 . . . . 0.27 111.781 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 p -63.64 -49.11 74.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.935 -1.484 . . . . 0.73 111.887 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -155.43 113.49 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.886 -1.506 . . . . 0.51 108.996 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.036 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -79.06 100.24 7.27 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 123.518 1.628 . . . . 2.71 111.187 -166.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.729 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.0 t -156.74 94.9 1.49 Allowed 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.313 -1.767 . . . . 0.35 107.899 164.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 140' ' ' THR . 1.8 mpt_? -151.78 171.82 6.14 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 113.675 -1.602 . . . . 2.38 107.783 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.75 111.89 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 CA-C-N 120.066 1.059 . . . . 0.79 110.15 163.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.96 4.54 86.97 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.717 -0.754 . . . . 0.38 114.665 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 81.7 mm-40 -119.28 132.59 55.92 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 117.976 0.888 . . . . 1.49 108.64 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.797 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.8 m-30 -128.81 172.93 10.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.833 -0.747 . . . . 0.3 110.255 -166.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 1.036 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.5 p -106.84 139.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.983 -0.747 . . . . 0.19 108.983 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 152' ' ' ILE . 2.0 p -113.67 128.92 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.134 -0.627 . . . . 0.86 112.35 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 151' ' ' SER . 26.7 mp0 -116.51 -88.03 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.23 -0.441 . . . . 2.45 111.865 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.79 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.935 0.346 . . . . 0.49 111.935 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.3 -9.41 59.48 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.69 0.757 . . . . 1.02 109.352 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 17.5 m -140.35 144.13 36.13 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 114.921 -1.036 . . . . 0.94 109.643 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.5 mt -108.73 168.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.105 -1.072 . . . . 0.2 108.105 168.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.797 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 22.7 tt0 -123.76 110.59 15.11 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.476 -0.89 . . . . 0.97 110.236 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.595 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -114.86 130.04 56.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.024 0.44 . . . . 1.32 111.021 -169.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.37 134.21 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.894 -0.41 . . . . 0.33 109.894 172.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.475 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 40.7 ttp85 -88.36 154.88 20.04 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.014 -0.735 . . . . 3.1 109.014 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.421 ' HD3' ' HD2' ' A' ' 158' ' ' PRO . 16.3 tpp180 -57.61 111.54 3.58 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.591 -0.522 . . . . 4.26 109.591 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.555 ' HB2' ' O ' ' A' ' 166' ' ' GLU . 51.6 Cg_endo -70.64 179.57 4.07 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.489 2.793 . . . . 2.01 114.227 -171.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.8 143.09 38.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.767 -1.106 . . . . 5.12 111.78 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.501 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 15.1 m-20 -123.06 132.73 54.23 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.761 -1.109 . . . . 5.15 111.112 -172.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.655 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 66.6 m-85 -119.06 170.79 6.09 Favored Pre-proline 0 N--CA 1.425 -1.704 0 CA-C-O 121.618 0.723 . . . . 6.81 110.85 170.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 3.9 Cg_endo -80.36 -42.62 0.14 Allowed 'Trans proline' 0 N--CA 1.414 -3.178 0 C-N-CA 122.201 1.934 . . . . 8.97 111.521 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.67 -7.13 44.7 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.822 -1.99 . . . . 10.53 109.527 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -165.88 167.86 16.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 113.745 -1.57 . . . . 7.9 110.996 -170.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.655 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 70.5 mttt -150.45 141.08 22.6 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 118.356 0.526 . . . . 6.69 110.546 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 7.2 pt-20 -164.82 -161.74 0.58 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.77 -0.65 . . . . 5.04 112.237 -166.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 162.6 35.91 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.326 -0.852 . . . . 2.11 112.298 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.519 ' HA ' HE21 ' A' ' 168' ' ' GLN . 0.0 OUTLIER -150.46 109.8 3.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 2.93 110.677 176.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 187' ' ' GLU . 69.3 t -132.31 142.69 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-N 116.215 -0.448 . . . . 0.48 110.376 173.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -128.54 144.42 51.14 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 122.164 0.983 . . . . 1.61 112.41 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.3 167.22 11.04 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.481 -1.691 . . . . 0.2 110.619 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.7 ttp180 -115.08 120.74 40.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.847 -1.168 . . . . 3.69 107.847 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.778 HD13 HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -113.41 114.1 26.13 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.927 -1.488 . . . . 0.61 110.282 -164.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.605 ' CG2' HD23 ' A' ' 197' ' ' LEU . 64.5 m -112.36 146.42 38.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.022 -0.535 . . . . 0.21 111.744 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.946 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -118.8 117.75 29.72 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.417 -0.811 . . . . 0.32 111.905 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.785 ' HA ' HD21 ' A' ' 197' ' ' LEU . 14.1 t70 -98.08 99.65 10.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.69 -0.686 . . . . 0.74 111.128 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.22 -111.99 3.47 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.829 -1.176 . . . . 0.27 113.78 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.67 6.55 21.76 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.135 -1.431 . . . . 1.61 107.135 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.776 ' HB3' HG23 ' A' ' 118' ' ' THR . 22.9 p80 -140.94 160.27 40.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.979 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.887 ' HB2' ' O ' ' A' ' 117' ' ' MET . 6.0 tp -60.73 145.43 49.52 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.774 0.797 . . . . 0.22 111.562 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 174' ' ' THR . . . -97.74 -49.64 4.76 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.282 -1.326 . . . . 0.15 111.162 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.554 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t -178.95 177.69 0.81 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.316 -0.856 . . . . 0.28 110.657 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 180' ' ' LEU . 2.7 mp -152.93 123.22 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.495 -1.668 . . . . 0.28 106.495 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.74 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 88.4 t -127.94 123.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 112.804 0.668 . . . . 0.34 112.804 -170.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.475 ' OD1' ' HD3' ' A' ' 156' ' ' ARG . 8.3 m-20 -59.67 101.36 0.11 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.339 1.066 . . . . 1.64 108.255 172.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.43 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 80.6 mmm -60.45 -13.85 15.95 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 113.05 -1.887 . . . . 1.42 112.788 -169.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.2 mt-10 -73.76 -45.58 50.93 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.48 -1.236 . . . . 0.68 110.752 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -104.96 -20.23 13.6 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.936 -1.029 . . . . 2.36 111.495 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.74 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 20.2 p30 37.6 33.6 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.254 1.575 . . . . 1.8 115.254 174.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.3 -68.13 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 4.13 110.39 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -78.49 73.78 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 4.05 110.336 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 t80 178.78 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.809 . . . . 1.83 108.944 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 176.48 -161.6 29.81 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.499 -0.773 . . . . 1.84 111.953 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.547 ' O ' HG21 ' A' ' 182' ' ' THR . 99.6 m-85 -143.5 122.42 12.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.806 0.336 . . . . 4.57 110.232 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -80.65 86.88 5.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.528 0.68 . . . . 6.25 111.146 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -134.81 142.15 46.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.599 -0.728 . . . . 6.4 110.268 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.785 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -153.63 130.29 10.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.952 0.406 . . . . 1.4 110.162 175.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -121.4 90.44 47.72 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 3.38 110.389 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.36 44.33 1.5 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.851 2.367 . . . . 4.74 111.858 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.535 -0.745 . . . . 7.73 110.387 -174.266 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.695 ' N ' ' HG ' ' A' ' 90' ' ' SER . 49.3 tpp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.69 0.281 . . . . 31.14 110.565 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.99 -101.81 1.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.353 -0.699 . . . . 30.65 111.353 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -84.73 52.61 2.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 30.65 109.876 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.695 ' HG ' ' N ' ' A' ' 87' ' ' MET . 25.5 m -75.35 104.36 5.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.613 -0.722 . . . . 29.78 111.236 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -83.17 -59.15 2.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.554 -0.748 . . . . 29.55 110.111 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 46.1 m170 59.67 83.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.724 0.64 . . . . 29.87 110.472 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.05 -43.9 90.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 27.89 111.079 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 55.61 49.41 16.57 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.279 0.561 . . . . 26.19 109.558 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -77.96 -62.7 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.797 . . . . 26.23 110.409 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -178.02 137.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 26.64 109.742 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.5 m -106.85 90.88 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.681 -0.489 . . . . 24.71 109.681 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 m -75.46 -65.79 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.821 -0.627 . . . . 24.15 110.95 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.14 60.79 2.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.518 -0.849 . . . . 22.66 112.467 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.79 81.39 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.909 -0.404 . . . . 20.88 109.909 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.1 120.72 60.43 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.689 -0.687 . . . . 19.88 110.765 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 110' ' ' MET . 74.0 Cg_exo -42.64 113.05 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.695 2.93 . . . . 18.7 113.122 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -89.97 141.48 28.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 18.91 110.602 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 -64.07 0.55 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.995 -0.842 . . . . 15.32 110.995 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 106' ' ' HIS . 46.5 m -126.12 86.52 2.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.361 -0.607 . . . . 14.03 109.361 175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 105' ' ' SER . 52.1 m80 71.9 -61.0 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.357 0.663 . . . . 12.65 110.315 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.2 ptm -100.96 176.79 5.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.572 -0.529 . . . . 11.98 109.572 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -173.37 164.89 36.8 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.378 -0.915 . . . . 8.1 112.083 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -135.59 135.69 40.48 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.949 -0.389 . . . . 9.18 109.949 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.415 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 28.0 ptm -107.16 4.08 26.39 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.418 1.104 . . . . 6.14 108.614 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 m -145.16 132.09 15.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 112.592 -2.095 . . . . 4.84 110.122 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.24 70.16 1.3 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.0 0.905 . . . . 4.29 109.43 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.749 ' HB3' ' SD ' ' A' ' 154' ' ' MET . 2.8 tm? -118.11 131.62 56.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.667 -1.151 . . . . 1.69 109.781 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.435 ' H ' HD22 ' A' ' 113' ' ' LEU . 9.4 tp10 176.27 145.32 0.25 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.495 -2.039 . . . . 3.45 105.495 -171.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 183' ' ' ILE . 76.2 Cg_endo -90.22 103.04 0.31 Allowed 'Trans proline' 0 N--CA 1.433 -2.073 0 CA-C-N 122.379 1.885 . . . . 3.06 113.938 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -113.29 -4.32 13.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.463 -2.792 . . . . 3.24 103.463 140.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.535 ' HG3' HG23 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -75.05 142.07 43.79 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 111.338 -2.664 . . . . 1.45 112.194 -161.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.4 m -127.37 101.12 6.32 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.722 -1.127 . . . . 0.32 108.84 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.851 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.6 pt -128.7 172.04 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.275 1.036 . . . . 0.2 112.218 -172.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.844 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 6.3 t -120.95 170.13 9.8 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.804 -1.543 . . . . 1.29 109.398 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -52.02 -46.0 64.81 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.252 0.549 . . . . 3.26 112.278 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.443 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 18.3 m120 -84.14 -17.12 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.403 -0.362 . . . . 2.17 110.088 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.972 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -66.86 -30.87 71.15 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 120.468 -0.493 . . . . 0.5 110.361 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.84 -22.68 27.46 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 117.771 -1.572 . . . . 3.06 109.649 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' HD21 ' A' ' 128' ' ' LEU . 2.1 t -68.22 -29.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.566 -1.197 . . . . 0.35 111.674 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.95 -39.06 26.69 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.956 -1.02 . . . . 1.51 109.326 171.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -55.57 -45.37 77.33 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 114.525 1.306 . . . . 0.4 114.525 -174.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -60.35 -39.54 87.49 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 116.784 -1.966 . . . . 0.32 109.719 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.0 mt-10 -66.54 -29.62 69.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.51 108.022 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -91.34 -8.59 47.66 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 112.926 -1.943 . . . . 0.33 110.886 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.98 -1.87 9.29 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.783 0.802 . . . . 0.36 109.552 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 70.44 56.75 0.26 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.761 -1.563 . . . . 2.19 111.882 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.08 146.41 27.71 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.378 -1.712 . . . . 0.27 106.378 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -147.69 163.83 35.43 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.127 -1.435 . . . . 0.69 107.127 -176.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.549 ' CB ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -47.0 158.73 0.12 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 122.453 1.12 . . . . 1.96 112.853 -176.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -148.27 150.23 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 CA-C-N 113.772 -1.558 . . . . 0.27 111.412 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -61.48 -49.45 76.7 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.375 -0.829 . . . . 0.73 111.866 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 17.4 ptmt -153.77 115.76 4.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.187 -1.37 . . . . 0.51 108.85 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.874 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.34 99.37 4.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.842 1.782 . . . . 2.71 112.277 -168.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.738 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -158.73 91.63 1.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.29 -1.777 . . . . 0.35 108.684 159.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.2 mmt-85 -154.9 126.44 3.69 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.126 -1.805 . . . . 2.38 106.126 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.67 110.8 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 CA-C-N 121.3 1.5 . . . . 0.79 110.417 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.56 2.5 57.56 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.477 -0.783 . . . . 0.38 114.293 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 28.6 mt-10 -130.46 133.03 45.99 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.982 0.891 . . . . 1.49 108.789 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -128.34 175.17 8.69 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 120.014 -0.675 . . . . 0.3 109.985 -168.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.874 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.9 p -111.43 137.03 49.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.662 -0.495 . . . . 0.19 109.662 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 152' ' ' ILE . 1.3 p -113.37 140.72 32.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.443 -0.799 . . . . 0.86 111.57 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 151' ' ' SER . 3.3 pt20 -138.35 -91.35 0.21 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.0 0.37 . . . . 2.45 112.0 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 -93.21 0.13 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.685 0.624 . . . . 0.49 112.685 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.437 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 80.9 m-20 -80.33 -3.62 50.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.004 0.431 . . . . 1.02 110.44 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 148' ' ' GLN . 20.4 m -144.67 148.09 33.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.019 -0.537 . . . . 0.94 109.609 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.561 ' CG2' HD23 ' A' ' 173' ' ' LEU . 9.3 mt -108.18 167.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 107.694 -1.224 . . . . 0.2 107.694 168.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.2 tt0 -123.43 106.17 10.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.931 -1.108 . . . . 0.97 111.051 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.749 ' SD ' ' HB3' ' A' ' 113' ' ' LEU . 6.0 ttt -106.27 130.26 54.15 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.191 -0.204 . . . . 1.32 111.168 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.09 120.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 169.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -73.98 147.28 43.16 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.771 -0.825 . . . . 3.1 108.771 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.529 ' N ' ' HD3' ' A' ' 156' ' ' ARG . 3.1 tmt_? -45.68 126.41 6.51 Favored Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.694 0.622 . . . . 4.26 109.826 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -48.77 155.43 2.48 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.676 2.917 . . . . 2.01 113.102 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -92.37 120.74 33.18 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.21 1.005 . . . . 5.12 113.462 -172.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.634 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 35.1 m-20 -130.09 119.69 23.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.691 -1.595 . . . . 5.15 110.603 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.631 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 34.4 m-85 -120.71 172.29 4.9 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.071 -0.968 . . . . 6.81 110.174 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.2 Cg_endo -76.81 -44.06 0.23 Allowed 'Trans proline' 0 N--CA 1.411 -3.33 0 C-N-CA 121.695 1.596 . . . . 8.97 110.343 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -90.92 -3.94 56.92 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 112.398 -2.183 . . . . 10.53 109.705 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -163.11 145.4 10.18 Favored 'General case' 0 C--O 1.203 -1.38 0 CA-C-N 113.968 -1.469 . . . . 7.9 112.094 -171.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.634 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 59.6 mttt -150.33 139.53 21.21 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.219 0.533 . . . . 6.69 111.22 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.2 pt-20 -155.51 -164.44 1.75 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.994 -1.003 . . . . 5.04 111.489 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -98.04 -135.33 8.71 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.606 -0.724 . . . . 2.11 113.663 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -93.02 159.23 15.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.737 0.779 . . . . 2.93 111.638 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 187' ' ' GLU . 55.1 t -139.17 148.83 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 CA-C-N 114.204 -1.362 . . . . 0.48 108.176 172.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -119.58 143.36 47.68 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 122.516 1.15 . . . . 1.61 113.151 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.84 166.46 13.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.719 -2.037 . . . . 0.2 110.653 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.74 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 28.6 ttp180 -114.17 114.94 26.71 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.737 -1.209 . . . . 3.69 107.737 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -103.32 105.58 15.89 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.303 -1.771 . . . . 0.61 109.573 -168.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.677 ' CG2' HD23 ' A' ' 197' ' ' LEU . 55.1 m -104.16 149.25 25.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.463 -0.79 . . . . 0.21 112.655 -167.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.851 ' CD1' HD11 ' A' ' 119' ' ' ILE . 14.7 m-85 -115.51 107.51 15.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.32 113.078 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.779 ' HA ' HD21 ' A' ' 197' ' ' LEU . 25.3 t70 -100.56 102.71 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 0.74 110.842 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.26 -121.85 5.53 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.196 -1.002 . . . . 0.27 112.925 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -110.34 15.59 22.16 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.511 -1.663 . . . . 1.61 106.511 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.768 ' HB3' HG23 ' A' ' 118' ' ' THR . 29.6 p80 -138.16 161.15 37.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -70.54 131.67 44.34 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.62 -1.173 . . . . 0.22 110.364 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.636 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.7 -49.82 10.7 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.131 -1.395 . . . . 0.15 111.022 -175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t 177.7 178.22 0.33 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.765 -1.107 . . . . 0.28 110.413 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 180' ' ' LEU . 2.2 mp -148.28 121.2 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.759 -1.571 . . . . 0.28 106.759 174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.723 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -126.18 122.6 61.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.535 0.569 . . . . 0.34 112.535 -171.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.3 99.75 0.06 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 122.069 0.938 . . . . 1.64 108.806 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.8 mmt -54.04 -23.55 13.96 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 112.663 -2.062 . . . . 1.42 112.635 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.567 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -68.12 -42.21 80.55 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.382 -1.281 . . . . 0.68 110.556 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.1 -27.03 13.15 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.097 -1.411 . . . . 2.36 111.363 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.723 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.2 p-10 33.98 51.89 0.43 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.241 1.571 . . . . 1.8 115.241 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -143.96 -75.3 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.508 -0.477 . . . . 4.13 111.704 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -101.86 19.14 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.529 0.566 . . . . 4.05 112.529 -170.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -95.55 -22.39 17.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.475 -0.49 . . . . 1.83 109.776 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.631 ' HA3' HG22 ' A' ' 184' ' ' VAL . . . -153.97 -137.21 2.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.105 -1.045 . . . . 1.84 113.256 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.88 -172.63 2.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.045 0.45 . . . . 4.57 111.714 -172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -78.13 175.03 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 6.25 111.367 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.79 161.01 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.57 -0.741 . . . . 6.4 111.773 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -74.0 146.19 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.98 -1.009 . . . . 1.4 111.017 -176.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.55 109.19 7.21 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.497 -0.557 . . . . 3.38 109.497 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.41 156.31 52.33 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.701 2.267 . . . . 4.74 112.469 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.538 -0.744 . . . . 7.73 109.777 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.789 0.328 . . . . 31.14 110.639 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.45 121.86 2.11 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.927 -0.654 . . . . 30.65 111.987 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -73.98 -50.1 21.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.866 0.365 . . . . 30.65 110.722 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 m -96.86 -15.87 21.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 29.78 110.013 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -123.51 72.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.467 -0.788 . . . . 29.55 109.843 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -59.33 -63.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 29.87 109.979 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.2 t60 48.74 69.54 0.55 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.79 0.681 . . . . 27.89 111.112 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 97' ' ' SER . 57.6 t60 -128.54 -73.12 0.59 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.407 -0.361 . . . . 26.19 110.732 -177.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 72.2 m-70 52.91 67.53 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.467 0.479 . . . . 26.23 110.822 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 12.2 m-70 69.93 178.78 0.25 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 26.64 111.27 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.465 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 18.2 t -169.52 136.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.504 -0.316 . . . . 24.71 110.516 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.2 m -122.86 4.27 9.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.01 0.434 . . . . 24.15 110.413 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -59.52 4.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.005 -0.617 . . . . 22.66 112.575 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 3.8 mm? -62.48 146.76 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.302 . . . . 20.88 110.748 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.9 t -103.97 100.89 22.38 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.189 -0.459 . . . . 19.88 110.485 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 100' ' ' LEU . 17.2 Cg_exo -68.16 -28.31 34.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.813 2.342 . . . . 18.7 112.646 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.43 -179.93 0.22 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.719 -0.673 . . . . 18.91 111.021 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.13 -153.39 25.05 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.567 -0.825 . . . . 15.32 112.425 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.9 p -64.86 144.49 57.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.045 0.45 . . . . 14.03 111.429 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -152.6 -14.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 12.65 111.385 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.4 ttm -78.23 -36.89 46.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.424 0.631 . . . . 11.98 109.588 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -114.14 90.25 0.53 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.319 -0.855 . . . . 8.1 111.664 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -72.73 -54.53 8.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.955 0.407 . . . . 9.18 110.081 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.0 ptm -156.8 30.64 0.31 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.838 0.828 . . . . 6.14 109.948 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.65 -29.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.424 -1.262 . . . . 4.84 110.154 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.31 75.79 3.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.668 -0.697 . . . . 4.29 109.339 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.788 HD12 ' N ' ' A' ' 114' ' ' GLU . 0.6 OUTLIER -67.21 126.08 28.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.434 -0.803 . . . . 1.69 110.267 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.788 ' N ' HD12 ' A' ' 113' ' ' LEU . 40.5 mt-10 -160.7 161.53 24.52 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 107.883 -1.154 . . . . 3.45 107.883 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 69.5 Cg_endo -91.03 101.19 0.24 Allowed 'Trans proline' 0 N--CA 1.428 -2.354 0 CA-C-N 120.004 1.037 . . . . 3.06 112.764 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -111.97 -6.25 14.24 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 102.583 -3.117 . . . . 3.24 102.583 138.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.579 ' HG3' HG23 ' A' ' 119' ' ' ILE . 9.8 tpt -77.03 139.02 39.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 111.1 -2.773 . . . . 1.45 111.083 -168.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 179' ' ' HIS . 7.2 m -123.89 103.14 8.17 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.759 -1.11 . . . . 0.32 108.805 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.9 pt -134.68 171.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.906 -1.043 . . . . 0.2 110.51 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.872 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -119.58 173.91 6.72 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.872 -1.058 . . . . 1.29 108.801 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.6 -44.8 66.23 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.379 0.424 . . . . 3.26 111.011 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 64.1 t30 -82.91 -18.52 39.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.17 110.344 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -71.35 -25.69 62.5 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.363 -0.535 . . . . 0.5 110.666 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.2 tpt -88.81 -24.65 22.54 Favored 'General case' 0 C--N 1.286 -2.154 0 C-N-CA 118.065 -1.454 . . . . 3.06 109.515 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 2.3 t -60.0 -31.9 48.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.651 -1.159 . . . . 0.35 111.839 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.73 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.24 -39.8 28.32 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.124 -0.944 . . . . 1.51 110.415 170.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.902 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.03 -37.05 83.45 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-O 117.411 -1.28 . . . . 0.4 114.077 -175.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.773 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -63.39 -38.82 92.62 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 116.189 -2.204 . . . . 0.32 108.935 176.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 25.7 mt-10 -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.788 1.28 . . . . 2.51 108.116 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.94 -6.72 44.86 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 112.446 -2.161 . . . . 0.33 110.777 -169.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 128' ' ' LEU . 8.8 t -122.83 0.52 9.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.86 0.838 . . . . 0.36 109.555 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 71.62 53.47 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.85 -1.523 . . . . 2.19 111.691 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.02 144.24 25.68 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.276 -1.379 . . . . 0.27 107.276 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.627 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -144.79 163.02 35.32 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.236 -1.024 . . . . 0.69 108.236 -174.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -47.35 145.88 2.22 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.85 0.833 . . . . 1.96 112.358 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.81 150.09 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.304 -1.316 . . . . 0.27 112.289 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -60.43 -49.16 78.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.667 -1.151 . . . . 0.73 111.723 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.3 ptmt -157.19 113.95 3.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.148 -1.387 . . . . 0.51 108.619 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.896 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.8 OUTLIER -75.36 99.47 4.13 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 123.674 1.702 . . . . 2.71 112.089 -167.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.812 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.9 t -159.01 92.84 1.12 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.665 -1.607 . . . . 0.35 109.527 161.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.812 ' HD3' ' O ' ' A' ' 140' ' ' THR . 11.0 mmt180 -152.44 154.68 32.21 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 106.583 -1.636 . . . . 2.38 106.583 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.04 110.86 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 120.577 1.242 . . . . 0.79 109.911 168.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 15.38 63.48 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.536 -0.84 . . . . 0.38 113.933 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 26.6 mt-10 -134.48 131.4 38.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.743 -1.206 . . . . 1.49 107.743 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.913 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -133.75 176.25 8.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.504 -0.878 . . . . 0.3 110.612 -167.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.896 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.5 p -107.45 142.98 36.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.639 0.733 . . . . 0.19 111.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.23 134.45 47.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.344 -1.298 . . . . 0.86 111.629 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 151' ' ' SER . 77.0 mt-30 -120.1 -87.81 0.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.669 -0.241 . . . . 2.45 111.096 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -164.27 -81.08 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.693 0.283 . . . . 0.49 110.93 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.499 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 75.4 m-20 -82.69 -4.28 57.6 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.065 0.46 . . . . 1.02 109.908 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 18.0 m -145.71 148.34 32.92 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.318 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -110.23 168.75 4.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.562 -1.273 . . . . 0.2 107.562 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.913 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.3 tt0 -124.03 108.75 12.7 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.712 -0.795 . . . . 0.97 110.017 172.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.564 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -111.81 125.62 54.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.376 0.607 . . . . 1.32 111.45 -170.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -64.76 123.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.549 -0.75 . . . . 0.33 109.699 173.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.539 ' HD3' ' N ' ' A' ' 157' ' ' ARG . 2.3 tmt_? -76.89 146.3 37.73 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.15 -0.685 . . . . 3.1 109.15 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 156' ' ' ARG . 35.5 ttp180 -44.89 120.11 4.12 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 123.779 0.675 . . . . 4.26 111.153 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 1.6 Cg_endo -77.01 175.85 10.88 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.755 2.303 . . . . 2.01 112.268 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -76.31 124.53 27.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.677 0.751 . . . . 5.12 111.421 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.654 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 20.4 m-20 -119.88 131.7 55.33 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.323 -0.853 . . . . 5.15 111.736 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.611 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 49.8 m-85 -120.71 170.14 7.68 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-N 115.479 -0.782 . . . . 6.81 110.706 168.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.9 Cg_endo -77.45 -45.35 0.16 Allowed 'Trans proline' 0 N--CA 1.414 -3.204 0 C-N-CA 122.055 1.837 . . . . 8.97 110.856 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -91.35 -4.15 56.05 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 112.9 -1.954 . . . . 10.53 109.795 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.9 m -163.77 151.67 12.93 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.197 -1.365 . . . . 7.9 111.611 -169.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.654 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 58.0 mttt -149.69 136.41 19.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.232 0.539 . . . . 6.69 110.771 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.26 -169.48 2.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.244 -0.889 . . . . 5.04 111.881 -167.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 67.4 145.51 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.996 -1.002 . . . . 2.11 113.315 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.603 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 12.7 pm0 -148.38 132.61 17.42 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.58 0.705 . . . . 2.93 109.234 164.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 155' ' ' ILE . 84.1 t -135.1 143.91 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-N 115.511 -0.768 . . . . 0.48 109.173 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.82 145.01 49.98 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.231 1.015 . . . . 1.61 112.765 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -117.61 163.73 16.01 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.414 -1.721 . . . . 0.2 110.627 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.593 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 39.6 ttt180 -113.69 118.9 35.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.646 -1.242 . . . . 3.69 107.646 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.651 HD22 HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -113.51 106.42 14.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 113.805 -1.543 . . . . 0.61 109.973 -164.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.494 HG21 HD23 ' A' ' 197' ' ' LEU . 53.5 m -105.01 149.37 25.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.609 -0.723 . . . . 0.21 112.306 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.854 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.0 m-85 -112.62 115.12 28.09 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.058 -1.428 . . . . 0.32 111.559 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 14.5 t70 -107.1 100.18 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.18 0.514 . . . . 0.74 111.121 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.8 -119.29 5.15 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.143 -1.027 . . . . 0.27 112.653 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.75 12.4 21.03 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.755 ' HB3' HG23 ' A' ' 118' ' ' THR . 14.5 p-80 -137.22 160.04 40.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.544 -1.207 . . . . 1.28 111.82 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -67.82 134.1 50.36 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.755 -1.111 . . . . 0.22 110.82 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.481 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -82.14 -54.57 5.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.327 -1.306 . . . . 0.15 111.066 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.531 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.2 t 178.69 177.12 0.48 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.13 -0.941 . . . . 0.28 109.896 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.39 132.22 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.28 107.007 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.6 t -135.17 115.77 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.887 0.699 . . . . 0.34 112.887 -167.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -59.38 100.45 0.08 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.946 -1.131 . . . . 1.64 107.946 171.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 2.7 mmt -56.87 -15.97 5.83 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 112.962 -1.926 . . . . 1.42 112.622 -169.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.468 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -73.88 -45.39 51.18 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 114.44 -1.255 . . . . 0.68 110.692 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -97.09 -24.72 15.63 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.072 -1.422 . . . . 2.36 111.368 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.716 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.5 p-10 36.24 43.26 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.236 1.199 . . . . 1.8 114.236 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -174.2 -56.47 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.729 -0.669 . . . . 4.13 109.431 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -79.43 60.78 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 4.05 110.598 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 26.6 t80 177.08 -40.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.235 -0.893 . . . . 1.83 109.183 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.566 ' C ' HG22 ' A' ' 184' ' ' VAL . . . 173.31 164.93 29.42 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.469 -0.787 . . . . 1.84 111.901 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -171.93 126.81 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.27 0.628 . . . . 4.57 110.228 170.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.408 ' CD2' ' HB1' ' A' ' 181' ' ' ALA . 53.0 t80 -162.18 143.57 10.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.265 -0.272 . . . . 6.25 110.265 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.91 142.57 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 6.4 110.1 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -82.66 140.27 33.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.954 -0.387 . . . . 1.4 109.954 175.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.67 82.36 48.36 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.353 0.597 . . . . 3.38 111.586 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.65 -46.41 2.66 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.2 1.933 . . . . 4.74 110.25 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.018 -0.992 . . . . 7.73 109.096 176.723 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.217 0.532 . . . . 31.14 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.25 57.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.689 -0.767 . . . . 30.65 112.178 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -79.16 -32.21 44.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.574 -0.528 . . . . 30.65 109.574 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -70.8 106.94 3.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.756 -0.656 . . . . 29.78 110.5 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -118.24 167.19 11.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.72 -0.673 . . . . 29.55 110.669 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 46.8 m170 62.76 78.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.61 0.569 . . . . 29.87 110.758 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -96.85 136.43 37.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.272 -0.422 . . . . 27.89 109.886 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -122.1 38.0 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.705 0.288 . . . . 26.19 111.253 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 61.9 87.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.682 -0.69 . . . . 26.23 111.385 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -70.31 -27.3 64.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.037 -0.528 . . . . 26.64 111.194 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.5 t -83.89 -4.42 58.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.853 0.358 . . . . 24.71 110.33 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 m -116.53 -77.53 0.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.198 -0.456 . . . . 24.15 110.025 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.35 -151.49 10.01 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.203 -0.453 . . . . 22.66 112.772 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.7 129.38 47.03 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.946 -0.761 . . . . 20.88 108.946 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.4 m -82.91 121.76 77.64 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.111 0.481 . . . . 19.88 110.77 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -87.51 61.04 3.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.831 2.354 . . . . 18.7 111.994 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -112.42 54.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.4 0.619 . . . . 18.91 110.145 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.19 56.32 4.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.758 -0.655 . . . . 15.32 111.493 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.3 m -143.27 151.78 40.94 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.04 -0.356 . . . . 14.03 110.04 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -142.02 80.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.149 0.5 . . . . 12.65 109.749 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 115' ' ' PRO . 91.7 mmm -81.19 101.11 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.722 -0.672 . . . . 11.98 110.609 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.49 102.69 0.21 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.433 -0.667 . . . . 8.1 111.433 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -89.8 -80.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.541 0.171 . . . . 9.18 111.452 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.495 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 27.0 ptt? -161.06 33.18 0.14 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.881 0.848 . . . . 6.14 111.174 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.5 -35.76 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.945 -1.025 . . . . 4.84 109.723 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -143.76 138.37 28.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.487 -0.779 . . . . 4.29 109.01 175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.441 ' O ' HD13 ' A' ' 183' ' ' ILE . 1.6 tt -88.46 100.98 13.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.802 -0.814 . . . . 1.69 108.802 176.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.585 ' N ' ' HD3' ' A' ' 115' ' ' PRO . 37.1 tt0 178.09 60.64 0.07 OUTLIER Pre-proline 0 C--N 1.317 -0.818 0 O-C-N 124.36 1.038 . . . . 3.45 109.288 165.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.639 ' C ' ' H ' ' A' ' 117' ' ' MET . 5.1 Cg_exo -79.41 178.69 7.12 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.437 2.092 . . . . 3.06 109.273 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -63.98 21.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.451 -0.34 . . . . 3.24 111.189 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.654 ' HG3' HG23 ' A' ' 119' ' ' ILE . 18.1 tpp -49.31 132.41 20.08 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.975 0.893 . . . . 1.45 110.11 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.85 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.1 m -125.36 95.59 4.52 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.597 -1.183 . . . . 0.32 108.435 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.4 pt -125.71 171.24 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.344 1.069 . . . . 0.2 111.391 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.86 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.0 m -111.08 167.3 10.37 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.449 -1.705 . . . . 1.29 108.634 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -51.81 -45.92 64.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.031 0.443 . . . . 3.26 111.195 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.43 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 23.0 t-20 -83.66 -17.87 40.0 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.419 -0.355 . . . . 2.17 110.4 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -66.1 -25.1 66.85 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 120.409 -0.516 . . . . 0.5 110.876 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.74 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.1 tpt -88.86 -24.15 22.61 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.102 -1.439 . . . . 3.06 109.723 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 122' ' ' ASN . 2.1 t -61.36 -31.19 49.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.624 -1.171 . . . . 0.35 111.786 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.734 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.89 -40.81 27.49 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.014 -0.993 . . . . 1.51 110.399 169.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.13 -36.9 81.0 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.393 -1.289 . . . . 0.4 114.108 -175.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.774 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -64.05 -37.24 86.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.314 -2.154 . . . . 0.32 109.008 176.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 128' ' ' LEU . 25.6 mt-10 -65.45 -32.29 73.83 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.88 1.324 . . . . 2.51 107.802 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.898 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -90.9 -7.03 53.32 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.383 -2.189 . . . . 0.33 110.617 -169.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.4 t -122.11 0.91 9.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.949 0.88 . . . . 0.36 109.38 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 66.1 58.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 113.62 -1.627 . . . . 2.19 111.997 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.49 143.24 24.6 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.055 -1.832 . . . . 0.27 106.055 178.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.08 163.81 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.489 -1.3 . . . . 0.69 107.489 -175.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -52.28 160.12 0.85 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.383 1.087 . . . . 1.96 111.821 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 2.3 t -145.34 152.65 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.326 0 CA-C-N 113.629 -1.623 . . . . 0.27 110.938 -170.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -60.08 -50.12 74.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.862 0.839 . . . . 0.73 111.55 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 17.7 ptmt -157.48 110.06 2.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.19 -1.368 . . . . 0.51 108.902 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.88 ' HE1' ' HG2' ' A' ' 153' ' ' GLU . 5.8 ttp -68.97 100.5 1.22 Allowed 'General case' 0 N--CA 1.398 -3.075 0 CA-C-O 122.364 1.078 . . . . 2.71 113.509 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.8 t -160.11 94.85 1.13 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.162 -1.836 . . . . 0.35 108.389 157.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HD3' ' O ' ' A' ' 140' ' ' THR . 18.3 mmt180 -149.37 169.98 8.35 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 114.056 -1.429 . . . . 2.38 107.445 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.55 111.32 2.55 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 CA-C-N 119.578 0.885 . . . . 0.79 110.87 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.25 13.14 83.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.797 -0.716 . . . . 0.38 114.188 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.9 mm-40 -122.14 132.96 54.74 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.949 -1.5 . . . . 1.49 106.949 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -130.02 174.36 9.85 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.47 -1.292 . . . . 0.3 111.493 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.574 ' CG2' ' HB2' ' A' ' 139' ' ' MET . 9.4 p -111.86 139.35 47.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.801 0.81 . . . . 0.19 111.406 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.16 141.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.801 -1.545 . . . . 0.86 111.064 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 151' ' ' SER . 35.9 tt0 -129.16 -80.85 0.57 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.803 -0.18 . . . . 2.45 111.146 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -170.45 -88.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.638 0.256 . . . . 0.49 111.388 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 88.9 m-20 -81.59 -2.25 49.39 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.464 0.65 . . . . 1.02 109.264 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.3 m -144.02 148.03 34.67 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.53 -0.759 . . . . 0.94 109.87 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 173' ' ' LEU . 4.9 mt -109.31 171.44 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.075 -1.454 . . . . 0.2 107.075 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.88 ' HG2' ' HE1' ' A' ' 139' ' ' MET . 11.0 tt0 -115.77 140.06 49.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.762 -1.57 . . . . 0.97 106.762 169.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.413 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.2 ppp? -138.82 131.46 29.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.832 0.742 . . . . 1.32 111.969 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -75.14 144.46 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 110.016 -0.365 . . . . 0.33 110.016 171.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 40.2 ttt180 -69.27 178.36 2.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 3.1 108.841 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 110' ' ' MET . 36.1 mtm180 -65.95 114.54 16.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 118.167 0.44 . . . . 4.26 111.031 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 168' ' ' GLN . 63.3 Cg_endo -77.99 176.08 10.4 Favored 'Trans proline' 0 CA--C 1.515 -0.425 0 C-N-CA 122.904 2.403 . . . . 2.01 113.416 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -125.49 126.62 45.17 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.302 -1.317 . . . . 5.12 110.158 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.53 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 4.5 m-20 -129.57 123.37 31.18 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.879 -1.055 . . . . 5.15 110.365 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 0.7 OUTLIER -121.77 172.31 5.2 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 121.812 0.815 . . . . 6.81 111.204 177.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 161' ' ' PHE . 1.2 Cg_endo -76.08 -42.96 0.34 Allowed 'Trans proline' 0 N--CA 1.416 -3.053 0 C-N-CA 122.239 1.959 . . . . 8.97 110.385 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.79 -6.06 57.64 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 112.204 -2.271 . . . . 10.53 109.348 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.9 m -163.82 137.02 5.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.943 -1.48 . . . . 7.9 112.768 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 48.6 mttt -148.62 141.66 24.89 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.027 0.441 . . . . 6.69 110.763 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -165.05 -168.82 1.51 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.153 -0.93 . . . . 5.04 111.518 -172.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -107.98 -169.59 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.057 -0.974 . . . . 2.11 111.908 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 6.6 tp-100 -134.22 -178.02 4.85 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.169 0.509 . . . . 2.93 110.891 -166.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.722 HG13 ' HG3' ' A' ' 187' ' ' GLU . 3.0 t -87.9 144.9 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 108.203 -1.036 . . . . 0.48 108.203 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -120.03 144.23 47.65 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.781 1.277 . . . . 1.61 114.029 -176.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -110.84 167.73 10.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 112.462 -2.153 . . . . 0.2 110.414 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 3.1 ptp180 -115.59 118.76 34.01 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.078 -1.453 . . . . 3.69 107.078 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -110.45 111.01 21.98 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.097 -1.411 . . . . 0.61 109.826 -165.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.438 HG21 HD23 ' A' ' 197' ' ' LEU . 55.1 m -109.85 149.77 29.37 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.742 0.782 . . . . 0.21 112.998 -167.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.913 ' CD1' HD11 ' A' ' 119' ' ' ILE . 5.2 m-85 -114.82 117.42 30.67 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.623 -1.626 . . . . 0.32 110.535 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.533 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 0.5 OUTLIER -113.4 108.04 16.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.964 0.888 . . . . 0.74 110.491 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.81 -122.0 6.23 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.183 -1.008 . . . . 0.27 112.788 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -111.95 12.1 20.72 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.779 -1.563 . . . . 1.61 106.779 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.85 ' HB3' HG23 ' A' ' 118' ' ' THR . 6.7 p80 -140.29 160.98 38.77 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.747 -1.115 . . . . 1.28 112.326 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.714 HD21 HD11 ' A' ' 183' ' ' ILE . 9.1 tp -65.9 135.91 55.41 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.22 110.551 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.533 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.62 -51.67 6.0 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.449 -1.251 . . . . 0.15 111.444 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 195' ' ' PHE . 4.5 t 175.72 177.42 0.2 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.225 -0.898 . . . . 0.28 110.115 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -149.31 123.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.523 -1.288 . . . . 0.28 107.523 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 94.3 t -126.9 119.97 54.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.395 0.517 . . . . 0.34 112.395 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 171' ' ' ALA . 8.5 m120 -60.54 97.44 0.05 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.492 1.139 . . . . 1.64 108.458 171.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 75.0 mtp -54.17 -28.65 41.73 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 112.015 -2.357 . . . . 1.42 112.652 -166.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.722 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.0 mt-10 -61.61 -42.15 98.47 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.0 -1.454 . . . . 0.68 110.122 -172.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -106.26 -27.48 11.0 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.525 -1.671 . . . . 2.36 111.218 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.771 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 28.5 t-20 37.25 53.4 1.26 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.676 0.751 . . . . 1.8 111.333 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 192' ' ' PHE . 5.0 ptp180 -90.8 -147.73 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.072 -0.967 . . . . 4.13 109.76 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -75.17 26.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 4.05 111.217 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 190' ' ' ARG . 20.9 t80 -73.6 -27.6 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.824 -0.806 . . . . 1.83 108.824 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.46 ' CA ' HG22 ' A' ' 184' ' ' VAL . . . -174.25 175.06 46.66 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.12 -0.946 . . . . 1.84 112.207 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -163.01 134.12 4.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.95 0.9 . . . . 4.57 108.869 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.563 ' HB3' HG22 ' A' ' 182' ' ' THR . 44.7 p90 -144.49 149.36 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.497 0.555 . . . . 6.25 112.497 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -135.1 118.07 16.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.194 -0.912 . . . . 6.4 109.09 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 2.8 mm? -120.7 126.05 49.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.141 0.496 . . . . 1.4 111.148 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.696 ' H ' ' HD2' ' A' ' 199' ' ' PRO . 5.0 m-20 -125.86 -57.66 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 3.38 111.194 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.696 ' HD2' ' H ' ' A' ' 198' ' ' ASP . 19.9 Cg_endo -60.68 121.45 9.74 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.74 1.626 . . . . 4.74 112.221 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.219 -0.896 . . . . 7.73 109.938 178.927 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.194 -0.298 . . . . 31.14 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 147.14 46.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.685 -0.769 . . . . 30.65 112.376 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m 63.77 12.88 7.02 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.811 0.444 . . . . 30.65 112.063 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 m -100.91 95.51 6.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.072 0.463 . . . . 29.78 111.049 -173.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -130.92 40.73 3.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.9 -0.591 . . . . 29.55 109.826 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -75.54 -29.01 59.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 29.87 110.921 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -71.35 -43.5 66.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 27.89 110.412 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -100.78 90.32 4.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 26.19 110.306 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.16 139.24 58.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.739 -0.664 . . . . 26.23 110.57 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -94.88 102.27 14.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.189 -0.46 . . . . 26.64 110.449 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.7 m -77.8 96.34 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.266 -0.425 . . . . 24.71 110.463 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.5 m -72.88 92.78 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 24.15 110.97 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -154.74 26.6 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.713 -0.676 . . . . 22.66 112.23 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.38 -12.96 60.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.975 0.417 . . . . 20.88 110.694 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 m -99.13 117.94 63.38 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.053 -0.521 . . . . 19.88 110.399 175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.13 -2.52 12.61 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.685 2.256 . . . . 18.7 111.95 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -102.23 124.33 47.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.885 -0.598 . . . . 18.91 110.105 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.47 -71.22 2.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.053 -0.594 . . . . 15.32 112.683 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.8 m -85.59 83.22 7.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.09 0.472 . . . . 14.03 111.043 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -167.24 144.98 4.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.795 -0.639 . . . . 12.65 109.635 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.0 tpt -78.58 -27.15 45.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.209 0.528 . . . . 11.98 110.141 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 171.88 -118.99 0.76 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.973 -0.851 . . . . 8.1 110.973 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 131' ' ' THR . 60.3 mtp180 -127.79 139.24 52.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.294 -0.632 . . . . 9.18 109.294 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.3 ptm -125.83 23.15 7.33 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.709 1.242 . . . . 6.14 109.377 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.74 133.94 49.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.088 -1.869 . . . . 4.84 109.297 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -71.65 135.17 46.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.41 -0.359 . . . . 4.29 110.375 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 114' ' ' GLU . 4.0 tt -75.79 131.06 39.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.101 -0.703 . . . . 1.69 109.101 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.63 ' N ' HD23 ' A' ' 113' ' ' LEU . 45.9 mt-10 -159.63 159.89 27.84 Favored Pre-proline 0 CA--C 1.498 -1.035 0 N-CA-C 108.422 -0.955 . . . . 3.45 108.422 -171.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 97.8 Cg_endo -91.2 100.61 0.23 Allowed 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 117.808 -0.994 . . . . 3.06 112.478 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.99 -7.74 14.52 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 102.582 -3.118 . . . . 3.24 102.582 139.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.645 ' HG3' HG23 ' A' ' 119' ' ' ILE . 29.8 tpp -76.71 140.88 41.01 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 110.921 -2.854 . . . . 1.45 111.229 -169.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.823 HG23 ' HB3' ' A' ' 179' ' ' HIS . 6.2 m -126.67 103.09 7.37 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.24 -0.891 . . . . 0.32 109.083 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.888 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.2 pt -135.12 172.74 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 115.105 -0.952 . . . . 0.2 111.096 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.842 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.4 p -124.78 177.3 6.07 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.574 -1.194 . . . . 1.29 110.482 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 124' ' ' MET . 65.4 tttp -50.7 -48.76 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.422 0.451 . . . . 3.26 111.864 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 63.3 t30 -84.23 -18.64 35.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 122.273 -0.267 . . . . 2.17 110.285 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.74 -23.53 63.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.877 -0.729 . . . . 0.5 109.813 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.766 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.5 -28.32 25.04 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.401 -1.32 . . . . 3.06 109.855 177.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.89 -33.06 56.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 122.463 1.125 . . . . 0.35 111.767 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.38 -41.71 32.46 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.379 -1.282 . . . . 1.51 110.17 169.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.912 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.39 -38.32 86.62 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-O 117.525 -1.226 . . . . 0.4 114.215 -173.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 116.184 -2.206 . . . . 0.32 108.566 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.665 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 61.5 mm-40 -67.94 -29.69 68.81 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 123.189 1.471 . . . . 2.51 108.741 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.55 -6.97 59.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.016 -2.357 . . . . 0.33 110.028 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.742 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -122.54 -0.66 9.18 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.152 -0.931 . . . . 0.36 109.657 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 77.4 51.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 113.865 -1.516 . . . . 2.19 112.436 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.95 145.05 24.57 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.195 -1.409 . . . . 0.27 107.195 -178.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.632 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -142.62 160.83 39.54 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.166 -1.79 . . . . 0.69 106.166 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -53.04 160.17 1.05 Allowed 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 119.383 0.992 . . . . 1.96 111.656 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.44 153.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.333 -1.303 . . . . 0.27 111.979 -169.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -60.9 -50.13 74.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.556 0.693 . . . . 0.73 111.886 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.537 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.6 ptmt -157.0 114.64 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.35 -1.296 . . . . 0.51 108.793 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.009 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.18 107.28 15.62 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 122.798 1.285 . . . . 2.71 111.242 -167.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.635 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.8 t -156.92 95.49 1.52 Allowed 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.882 -1.508 . . . . 0.35 108.584 163.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 140' ' ' THR . 19.3 mmt85 -151.54 169.64 9.08 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 113.622 -1.626 . . . . 2.38 108.099 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.03 110.47 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 N-CA-C 109.43 -1.027 . . . . 0.79 109.43 161.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.61 26.95 58.05 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.356 -0.926 . . . . 0.38 114.09 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 32.8 mt-10 -138.82 130.6 27.72 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.41 -1.33 . . . . 1.49 107.41 171.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -134.0 176.8 8.25 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.61 -0.836 . . . . 0.3 110.482 -165.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 1.009 HG23 ' HB3' ' A' ' 139' ' ' MET . 14.3 p -113.5 138.92 49.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.829 0.823 . . . . 0.19 112.291 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.18 141.47 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 113.696 -1.593 . . . . 0.86 110.862 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -127.48 -81.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.771 -0.372 . . . . 2.45 111.071 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.48 -88.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 0.49 111.712 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.673 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 15.6 m120 -85.53 -3.02 58.74 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.296 0.569 . . . . 1.02 109.564 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 m -142.41 146.63 35.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.786 -0.643 . . . . 0.94 110.286 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.34 169.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.467 -1.308 . . . . 0.2 107.467 169.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.796 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.5 tt0 -115.71 135.57 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.561 -1.644 . . . . 0.97 106.561 166.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.484 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.0 ppp? -134.66 127.9 32.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.874 0.761 . . . . 1.32 111.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -65.05 122.02 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.356 -0.609 . . . . 0.33 109.356 173.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.4 155.96 25.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.463 -0.569 . . . . 3.1 109.463 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -59.36 131.21 87.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.642 -0.503 . . . . 4.26 109.642 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -53.26 153.32 17.11 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.608 2.205 . . . . 2.01 112.819 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.458 ' CE1' HG21 ' A' ' 169' ' ' VAL . 2.9 p90 -139.81 157.37 45.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.444 -0.798 . . . . 5.12 112.162 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.631 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 3.4 m-20 -130.14 131.32 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.413 -1.267 . . . . 5.15 110.035 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.606 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 58.9 m-85 -119.33 168.68 9.49 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-O 121.741 0.781 . . . . 6.81 110.83 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -75.5 -44.22 0.31 Allowed 'Trans proline' 0 N--CA 1.413 -3.241 0 C-N-CA 121.843 1.696 . . . . 8.97 110.428 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -90.73 -2.5 57.81 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 112.524 -2.125 . . . . 10.53 109.397 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.2 m -164.21 137.98 5.38 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.091 -1.413 . . . . 7.9 112.836 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.631 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 58.1 mttt -146.13 138.09 25.07 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.405 0.621 . . . . 6.69 111.482 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -160.24 -167.64 1.98 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.64 -1.164 . . . . 5.04 110.874 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -108.34 -122.57 4.73 Favored Glycine 0 C--N 1.312 -0.8 0 C-N-CA 120.595 -0.812 . . . . 2.11 113.028 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -82.08 152.37 26.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.806 0.813 . . . . 2.93 109.692 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 54.4 t -138.11 149.12 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 CA-C-N 114.354 -1.294 . . . . 0.48 108.351 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.4 OUTLIER -120.81 142.71 49.35 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 122.524 1.155 . . . . 1.61 113.083 176.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.16 166.88 11.52 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 112.772 -2.013 . . . . 0.2 110.46 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 20.0 ttt180 -116.88 119.38 35.21 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.503 -1.295 . . . . 3.69 107.503 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.0 114.57 27.08 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.795 -1.548 . . . . 0.61 110.027 -164.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 182' ' ' THR . 54.2 m -110.8 150.98 28.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 112.76 0.652 . . . . 0.21 112.76 -168.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.888 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.8 m-85 -113.59 103.47 11.28 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.38 -1.282 . . . . 0.32 112.873 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.69 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 9.9 t0 -89.76 96.1 10.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.209 0.528 . . . . 0.74 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.63 -115.56 4.04 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.099 -1.048 . . . . 0.27 113.159 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -111.07 9.44 22.04 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.756 -1.572 . . . . 1.61 106.756 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.823 ' HB3' HG23 ' A' ' 118' ' ' THR . 9.5 p-80 -137.65 161.09 37.4 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.221 -1.354 . . . . 1.28 111.807 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 183' ' ' ILE . 10.5 tp -67.03 137.32 56.38 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.177 -0.919 . . . . 0.22 110.849 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.69 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -89.16 -54.23 4.21 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.173 -1.376 . . . . 0.15 111.631 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.504 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.2 t -176.97 177.09 1.33 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.123 -0.944 . . . . 0.28 110.12 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -151.84 124.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.455 -1.683 . . . . 0.28 106.455 176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.734 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 69.4 t -128.23 123.8 60.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.776 0.658 . . . . 0.34 112.776 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.87 98.49 0.05 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.317 -0.994 . . . . 1.64 108.317 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 72.0 mmm -58.9 -16.72 18.93 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 113.332 -1.758 . . . . 1.42 112.896 -168.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.8 mt-10 -72.35 -42.59 65.13 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.473 -1.24 . . . . 0.68 110.175 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.96 -26.73 13.31 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.082 -1.417 . . . . 2.36 112.007 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.734 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.5 p-10 41.21 29.38 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.342 1.608 . . . . 1.8 115.342 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -139.05 -64.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 4.13 110.624 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -77.42 64.81 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 4.05 110.859 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 178.61 -21.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.237 -0.892 . . . . 1.83 109.193 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 152.88 -157.82 27.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.897 -0.668 . . . . 1.84 112.494 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.402 ' O ' HG21 ' A' ' 182' ' ' THR . 33.2 p90 -162.8 147.35 11.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.954 -0.758 . . . . 4.57 108.954 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -110.64 102.69 11.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.404 0.621 . . . . 6.25 112.011 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -135.72 125.6 25.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.667 -0.697 . . . . 6.4 110.211 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.673 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 11.8 mt -131.74 125.73 32.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 1.4 111.979 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -136.61 73.44 54.99 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.281 -1.007 . . . . 3.38 108.281 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.39 81.85 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.527 2.818 . . . . 4.74 113.632 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.462 -0.78 . . . . 7.73 111.088 173.746 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.968 -0.382 . . . . 31.14 109.968 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.16 95.39 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.061 -0.59 . . . . 30.65 112.899 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -115.17 84.55 2.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.979 0.419 . . . . 30.65 110.602 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -75.28 97.97 3.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.163 -0.471 . . . . 29.78 110.656 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -74.83 119.86 19.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 29.55 110.453 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.908 -0.405 . . . . 29.87 109.908 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 58.58 69.26 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.897 -0.592 . . . . 27.89 111.459 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -128.21 129.95 47.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 26.19 110.075 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -94.39 -168.24 1.81 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.984 -0.553 . . . . 26.23 110.493 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -54.48 115.04 1.9 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.017 -0.364 . . . . 26.64 110.017 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -112.29 73.58 0.82 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.142 0.496 . . . . 24.71 110.757 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 m -71.14 138.54 49.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.071 -0.513 . . . . 24.15 110.467 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.44 -61.37 1.24 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.865 -0.683 . . . . 22.66 112.727 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -81.29 48.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.331 0.586 . . . . 20.88 111.388 -176.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -136.52 93.74 14.09 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.762 -0.654 . . . . 19.88 110.68 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.24 -53.53 2.39 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.845 2.363 . . . . 18.7 111.694 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -130.28 77.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 18.91 109.844 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.28 -168.46 29.49 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.596 -0.811 . . . . 15.32 112.406 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m 56.07 49.56 15.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.109 0.481 . . . . 14.03 111.341 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.83 28.4 7.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.192 0.52 . . . . 12.65 110.26 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 68.0 mtm -127.45 147.93 50.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.812 -0.631 . . . . 11.98 110.127 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.46 44.2 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 8.1 112.349 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.472 ' NE ' ' HA ' ' A' ' 109' ' ' ARG . 5.9 mmp_? 59.16 44.47 15.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.93 0.395 . . . . 9.18 111.278 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.6 ptm -112.07 12.74 20.61 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.539 1.162 . . . . 6.14 109.698 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.68 -37.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 113.102 -1.863 . . . . 4.84 109.33 172.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.2 84.38 2.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.723 -0.843 . . . . 4.29 108.723 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.794 HD12 ' N ' ' A' ' 114' ' ' GLU . 0.6 OUTLIER -64.53 125.23 24.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 1.69 109.583 179.016 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.794 ' N ' HD12 ' A' ' 113' ' ' LEU . 31.0 tt0 -176.76 155.52 1.29 Allowed Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 106.421 -1.696 . . . . 3.45 106.421 -171.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.618 ' HA ' ' H ' ' A' ' 117' ' ' MET . 3.7 Cg_exo -83.84 101.84 0.93 Allowed 'Trans proline' 0 N--CA 1.424 -2.579 0 CA-C-N 121.252 1.483 . . . . 3.06 112.119 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -110.39 4.11 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 102.015 -3.328 . . . . 3.24 102.015 139.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.618 ' H ' ' HA ' ' A' ' 115' ' ' PRO . 9.6 tpt -96.2 139.78 31.86 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 111.261 -2.7 . . . . 1.45 111.194 -163.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.78 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.4 m -127.94 102.94 6.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.52 -1.218 . . . . 0.32 108.751 175.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.847 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.56 170.6 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.104 -0.953 . . . . 0.2 110.773 -174.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.6 m -119.57 177.05 5.08 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.648 -1.16 . . . . 1.29 109.461 -170.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 124' ' ' MET . 51.3 pttt -51.6 -48.02 63.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.397 . . . . 3.26 111.671 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 121' ' ' LYS . 27.8 t-20 -84.07 -18.1 38.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.474 -0.33 . . . . 2.17 110.406 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.916 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.03 -22.67 64.04 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.911 -0.716 . . . . 0.5 110.627 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.692 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.09 -27.15 22.13 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.212 -0.995 . . . . 3.06 109.925 176.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.55 -31.77 54.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.569 -1.196 . . . . 0.35 111.565 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.777 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.27 -41.38 34.22 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.942 -1.026 . . . . 1.51 109.808 170.52 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.916 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.69 -40.27 83.13 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-O 117.58 -1.2 . . . . 0.4 114.116 -173.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.79 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -38.35 90.8 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 116.299 -2.16 . . . . 0.32 109.285 177.311 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 28.0 mt-10 -65.55 -32.66 74.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.679 1.228 . . . . 2.51 108.013 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.826 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.74 -7.51 56.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.474 -2.148 . . . . 0.33 110.632 -169.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.39 0.73 10.07 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.222 -0.899 . . . . 0.36 109.116 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 66.46 56.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.636 -1.62 . . . . 2.19 111.981 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.79 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.58 146.88 27.57 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.92 -1.511 . . . . 0.27 106.92 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.584 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.88 160.21 42.12 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.78 -1.193 . . . . 0.69 107.78 -174.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -46.99 147.78 1.27 Allowed 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 122.021 0.915 . . . . 1.96 112.664 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -139.09 151.94 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 CA-C-N 113.981 -1.463 . . . . 0.27 112.127 -172.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 m -60.1 -50.08 75.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.914 . . . . 0.73 111.438 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.04 116.65 3.11 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.51 108.73 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.979 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -78.47 102.32 7.78 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 123.082 1.42 . . . . 2.71 111.196 -167.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.658 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 4.1 t -157.84 95.96 1.45 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.984 -1.462 . . . . 0.35 108.646 161.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.2 mmt180 -151.51 168.84 10.36 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 113.614 -1.63 . . . . 2.38 106.905 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.84 111.39 2.49 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 CA-C-N 119.91 1.004 . . . . 0.79 109.796 162.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.5 20.63 59.81 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.469 -0.872 . . . . 0.38 114.164 172.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 38.8 mt-10 -136.94 132.11 33.96 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.074 -1.084 . . . . 1.49 108.074 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.939 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.29 175.98 9.02 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.702 -0.799 . . . . 0.3 110.408 -165.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.8 p -110.32 139.74 45.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.759 0.79 . . . . 0.19 112.516 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 52.3 t -101.2 129.2 52.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 113.733 -1.576 . . . . 0.86 110.887 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.2 tp60 -113.22 -78.55 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 121.071 -0.251 . . . . 2.45 110.775 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -169.24 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.858 0.361 . . . . 0.49 111.271 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.803 ' HB3' HD13 ' A' ' 197' ' ' LEU . 17.7 m120 -86.7 -2.55 58.62 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.625 -0.509 . . . . 1.02 109.625 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 p -145.2 143.97 30.59 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.957 -0.565 . . . . 0.94 110.533 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.652 ' CG2' HD23 ' A' ' 173' ' ' LEU . 7.4 mt -106.82 169.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.2 107.303 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.939 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 27.9 tt0 -126.09 111.02 14.2 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.585 -0.846 . . . . 0.97 110.518 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 10.2 tmm? -112.95 124.29 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.092 0.473 . . . . 1.32 111.872 -169.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.725 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -65.99 115.09 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.33 110.537 172.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 169' ' ' VAL . 73.5 ttt180 -69.51 146.99 51.44 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.479 -0.782 . . . . 3.1 109.235 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -58.63 122.39 60.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.171 -0.468 . . . . 4.26 110.182 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -50.11 153.08 7.05 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.404 2.736 . . . . 2.01 113.556 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -146.6 157.28 43.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.763 -1.108 . . . . 5.12 112.021 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.554 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 6.5 m-20 -129.82 133.69 47.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.67 -1.15 . . . . 5.15 109.784 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.596 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 42.4 m-85 -119.58 169.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.327 0 CA-C-O 121.777 0.799 . . . . 6.81 111.3 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.7 Cg_endo -76.58 -43.25 0.29 Allowed 'Trans proline' 0 N--CA 1.414 -3.153 0 C-N-CA 122.154 1.903 . . . . 8.97 110.548 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.19 -2.85 57.42 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 112.558 -2.11 . . . . 10.53 109.647 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.1 m -164.12 140.79 6.59 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.08 -1.418 . . . . 7.9 112.507 -172.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.554 ' HE2' ' HB3' ' A' ' 160' ' ' ASP . 58.7 mttt -145.62 148.17 32.83 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.28 0.562 . . . . 6.69 111.46 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.45 -168.02 0.66 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.421 -1.263 . . . . 5.04 109.639 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.68 -120.5 3.31 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.654 -0.784 . . . . 2.11 112.347 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.08 149.61 32.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.58 0.705 . . . . 2.93 109.33 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 187' ' ' GLU . 77.7 t -136.71 148.94 26.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.996 -1.002 . . . . 0.48 108.563 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.725 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -121.07 144.2 48.67 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.367 1.08 . . . . 1.61 112.591 177.299 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -118.18 161.18 20.3 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.2 109.657 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.416 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 34.7 ttt180 -109.53 118.82 37.62 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.836 -1.172 . . . . 3.69 107.836 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.652 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -108.52 103.87 13.08 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.693 -1.594 . . . . 0.61 110.161 -165.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.416 ' CG2' HD12 ' A' ' 197' ' ' LEU . 56.3 m -104.43 149.55 25.32 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.727 -0.67 . . . . 0.21 112.096 -169.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.847 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.0 m-85 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.397 -1.274 . . . . 0.32 112.16 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.557 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 20.7 t70 -99.57 97.25 8.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.974 0.416 . . . . 0.74 110.729 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.51 -115.58 4.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.223 -0.989 . . . . 0.27 113.699 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -110.74 7.55 22.17 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 106.864 -1.532 . . . . 1.61 106.864 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.78 ' HB3' HG23 ' A' ' 118' ' ' THR . 33.8 p80 -138.84 161.0 38.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.811 -1.54 . . . . 1.28 111.837 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -68.47 131.64 45.63 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.455 -1.248 . . . . 0.22 110.459 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.557 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -79.3 -53.53 6.85 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.228 -1.351 . . . . 0.15 110.49 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.719 ' OG1' ' HA3' ' A' ' 193' ' ' GLY . 6.2 t 178.49 178.19 0.42 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.831 -1.077 . . . . 0.28 110.375 -177.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.5 mp -146.36 116.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.707 -1.59 . . . . 0.28 106.707 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.631 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 99.4 t -115.77 123.66 71.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 113.243 0.831 . . . . 0.34 113.243 -170.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -61.13 91.83 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.482 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 70.5 mmm -58.35 -20.47 43.78 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 113.408 -1.724 . . . . 1.42 113.667 -163.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.5 mt-10 -71.15 -42.78 68.7 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.787 -1.097 . . . . 0.68 110.215 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -98.44 -31.08 12.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.768 -1.56 . . . . 2.36 110.981 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.631 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.9 p-10 36.46 40.99 0.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.955 0.883 . . . . 1.8 112.35 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -105.74 90.04 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.15 -0.932 . . . . 4.13 110.538 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 55.48 26.39 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.463 -0.79 . . . . 4.05 111.907 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.585 ' HD1' ' HA ' ' A' ' 184' ' ' VAL . 0.6 OUTLIER -81.1 2.91 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.817 -0.438 . . . . 1.83 109.817 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.719 ' HA3' ' OG1' ' A' ' 182' ' ' THR . . . 128.4 -5.36 6.71 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.769 -1.205 . . . . 1.84 115.418 171.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.556 ' HB3' HG21 ' A' ' 184' ' ' VAL . 3.9 p90 -56.65 122.52 12.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.408 0.623 . . . . 4.57 112.244 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -144.92 171.52 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.074 -0.966 . . . . 6.25 109.209 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -94.3 137.13 33.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.088 0.471 . . . . 6.4 111.503 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.803 HD13 ' HB3' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -88.42 154.39 20.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.548 -0.751 . . . . 1.4 110.267 176.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.1 79.7 0.29 Allowed Pre-proline 0 N--CA 1.465 0.309 0 O-C-N 123.654 0.596 . . . . 3.38 111.066 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.26 -41.57 6.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.768 2.312 . . . . 4.74 112.28 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.343 -0.837 . . . . 7.73 110.523 -177.31 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.666 0.27 . . . . 31.14 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.88 -141.43 28.26 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.569 -0.824 . . . . 30.65 112.039 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -98.71 80.01 2.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.872 0.368 . . . . 30.65 110.605 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m -97.64 -64.15 1.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.126 -0.488 . . . . 29.78 111.245 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -139.55 -51.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.806 -0.179 . . . . 29.55 110.73 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.6 t60 62.95 95.62 0.04 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.649 0.593 . . . . 29.87 110.607 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -66.92 153.25 44.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.884 -0.598 . . . . 27.89 110.241 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -73.08 135.94 44.86 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.054 -0.721 . . . . 26.19 109.054 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -78.78 82.91 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.913 0.387 . . . . 26.23 110.709 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -86.14 139.26 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.403 . . . . 26.64 110.169 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.5 p -115.49 10.79 15.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.402 0.62 . . . . 24.71 110.395 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 m -103.8 36.79 2.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.518 -0.765 . . . . 24.15 110.737 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.73 49.07 3.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.057 -0.592 . . . . 22.66 112.461 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.17 116.62 24.48 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.389 -0.597 . . . . 20.88 109.389 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.9 121.38 45.97 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.058 -0.519 . . . . 19.88 110.322 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.67 80.93 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.703 2.269 . . . . 18.7 111.955 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -78.26 -40.88 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.518 . . . . 18.91 110.157 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.57 166.28 12.14 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.225 -0.75 . . . . 15.32 111.225 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.0 m 61.43 -161.67 0.29 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.119 -0.326 . . . . 14.03 110.119 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 62.66 72.67 0.49 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.985 0.421 . . . . 12.65 110.785 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.404 ' SD ' ' HD3' ' A' ' 109' ' ' ARG . 51.5 ttm -65.87 -40.87 92.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.845 -0.616 . . . . 11.98 111.588 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.89 67.97 1.79 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 8.1 111.428 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' HD3' ' SD ' ' A' ' 107' ' ' MET . 15.2 tpt180 -80.81 124.45 29.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.983 -0.377 . . . . 9.18 109.983 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -138.22 26.06 2.67 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.481 1.134 . . . . 6.14 109.129 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 112' ' ' ASN . 9.3 p -118.45 168.35 10.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.319 -1.764 . . . . 4.84 109.106 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 111' ' ' VAL . 90.9 m-20 -54.46 106.31 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.97 0.414 . . . . 4.29 111.254 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.575 HD23 ' HD3' ' A' ' 115' ' ' PRO . 2.3 tt -78.52 107.0 10.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 1.69 110.331 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.631 ' HA ' HD13 ' A' ' 183' ' ' ILE . 5.9 tp10 178.42 57.79 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.168 0.918 . . . . 3.45 109.221 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 11.6 Cg_endo -89.59 178.32 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.211 2.608 . . . . 3.06 110.866 177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.48 20.66 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.882 -0.599 . . . . 3.24 111.124 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.621 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 7.4 tpt -49.1 138.2 12.39 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.565 0.746 . . . . 1.45 111.601 -172.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.4 m -124.66 99.66 6.27 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.295 -0.866 . . . . 0.32 109.061 171.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.911 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -130.92 171.14 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-N 115.276 -0.874 . . . . 0.2 110.889 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -123.35 178.97 4.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.494 -1.23 . . . . 1.29 109.507 -172.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 121' ' ' LYS . 12.7 mptt -56.99 -43.39 81.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.06 0.457 . . . . 3.26 111.295 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 14.1 m120 -83.6 -17.87 40.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.483 -0.326 . . . . 2.17 110.614 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.893 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -73.52 -21.61 60.35 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.288 -0.565 . . . . 0.5 111.08 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.688 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -87.87 -26.89 22.54 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.276 -0.97 . . . . 3.06 109.716 174.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 2.1 t -63.05 -30.66 50.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.62 -1.173 . . . . 0.35 111.613 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.95 -41.97 28.06 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.767 -1.106 . . . . 1.51 109.847 170.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.07 -36.43 79.61 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 117.389 -1.291 . . . . 0.4 114.27 -172.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.861 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.68 -40.53 95.56 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 116.274 -2.17 . . . . 0.32 109.511 175.284 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.4 mt-10 -64.62 -29.02 70.02 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.873 1.32 . . . . 2.51 108.03 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.07 -7.73 44.79 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 112.548 -2.115 . . . . 0.33 110.858 -169.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.4 t -122.09 -1.78 9.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.741 0.781 . . . . 0.36 109.853 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 70.88 57.31 0.22 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.796 -1.547 . . . . 2.19 111.746 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.861 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.95 145.02 26.24 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 106.766 -1.568 . . . . 0.27 106.766 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.662 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.35 163.68 35.68 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.67 -1.604 . . . . 0.69 106.67 -177.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 147' ' ' VAL . 2.2 pt20 -46.93 159.63 0.1 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.476 1.132 . . . . 1.96 112.828 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 138' ' ' LYS . 3.4 t -149.75 148.59 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 CA-C-N 113.513 -1.676 . . . . 0.27 111.481 -172.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 m -60.36 -49.61 76.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.241 -0.89 . . . . 0.73 111.57 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -157.68 115.29 3.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.51 108.861 -176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.781 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -75.99 104.41 6.51 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 122.999 1.381 . . . . 2.71 111.506 -168.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.8 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.9 t -157.33 94.12 1.36 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.012 -1.449 . . . . 0.35 109.02 159.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.8 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -152.3 166.26 15.7 Favored Pre-proline 0 CA--C 1.502 -0.882 0 CA-C-N 113.906 -1.497 . . . . 2.38 107.883 171.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -80.95 111.34 2.46 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 CA-C-N 119.84 0.979 . . . . 0.79 109.767 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.98 12.21 68.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.621 -0.8 . . . . 0.38 114.353 172.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.8 mt-10 -128.72 131.79 47.93 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.583 -0.895 . . . . 1.49 108.583 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.7 m-85 -130.75 174.29 10.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.549 -0.861 . . . . 0.3 110.788 -165.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 139' ' ' MET . 5.9 p -111.39 137.66 48.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.905 -0.776 . . . . 0.19 108.905 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.454 HG12 ' CB ' ' A' ' 135' ' ' GLN . 4.0 p -111.06 146.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 113.353 0.871 . . . . 0.86 113.353 -168.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 151' ' ' SER . 51.2 tt0 -154.69 174.97 14.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.591 -0.892 . . . . 2.45 108.591 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.48 ' H ' ' HG2' ' A' ' 148' ' ' GLN . . . -64.54 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.94 1.089 . . . . 0.49 113.94 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.903 ' HB3' HD13 ' A' ' 197' ' ' LEU . 78.2 m-20 -84.71 -4.67 59.14 Favored 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 122.239 -0.288 . . . . 1.02 111.185 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.666 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 28.6 p -149.95 134.68 17.65 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.65 -0.82 . . . . 0.94 110.845 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.581 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.0 mt -100.57 171.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.565 -1.272 . . . . 0.2 107.565 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.6 tt0 -117.11 137.72 52.11 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 106.982 -1.488 . . . . 0.97 106.982 167.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.498 ' CA ' ' HE1' ' A' ' 139' ' ' MET . 1.8 tmt? -135.11 123.55 23.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.615 0.643 . . . . 1.32 112.373 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -67.4 137.09 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.932 -0.576 . . . . 0.33 110.767 174.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -86.06 145.18 27.18 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.905 -0.776 . . . . 3.1 108.905 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -46.37 132.32 7.74 Favored Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.7 0.625 . . . . 4.26 110.668 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 168' ' ' GLN . 7.1 Cg_endo -52.88 154.06 13.76 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.64 2.226 . . . . 2.01 112.518 -176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.01 116.16 21.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 5.12 112.135 -172.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.37 121.65 29.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.334 -1.303 . . . . 5.15 110.242 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 75.0 m-85 -120.45 173.38 3.78 Favored Pre-proline 0 N--CA 1.426 -1.642 0 CA-C-N 115.177 -0.92 . . . . 6.81 110.3 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.0 Cg_endo -79.44 -43.79 0.14 Allowed 'Trans proline' 0 N--CA 1.411 -3.359 0 C-N-CA 121.837 1.691 . . . . 8.97 110.601 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -92.16 -1.56 57.08 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 112.756 -2.02 . . . . 10.53 109.899 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -164.31 153.59 13.68 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 114.313 -1.312 . . . . 7.9 111.807 -172.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.476 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 56.2 mttt -153.73 144.22 22.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 118.227 0.467 . . . . 6.69 110.834 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.81 -163.83 1.41 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.482 -0.781 . . . . 5.04 111.983 -172.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.02 -153.16 23.78 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 115.767 -0.651 . . . . 2.11 114.449 -169.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 158' ' ' PRO . 0.8 OUTLIER -99.69 160.77 14.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.563 0.697 . . . . 2.93 111.846 -172.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t -127.11 147.56 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 CA-C-N 114.483 -1.235 . . . . 0.48 108.029 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.67 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -126.37 144.43 50.83 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.132 0.968 . . . . 1.61 113.308 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 163.09 16.49 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.457 -1.701 . . . . 0.2 110.181 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.404 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.0 ttm180 -113.0 118.13 33.97 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.46 -0.941 . . . . 3.69 108.46 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -107.32 111.36 23.68 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.677 -1.601 . . . . 0.61 110.604 -164.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.568 ' CG2' HD12 ' A' ' 197' ' ' LEU . 58.7 m -109.21 152.43 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.736 0.643 . . . . 0.21 112.736 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.911 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.2 m-85 -118.46 97.87 5.98 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.141 -0.936 . . . . 0.32 112.887 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.759 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 33.9 t70 -86.05 97.02 10.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.113 0.482 . . . . 0.74 110.83 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.07 -118.31 4.82 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.164 -1.017 . . . . 0.27 112.645 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.32 13.55 21.63 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.532 -1.285 . . . . 1.61 107.532 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 30.8 p80 -139.37 160.98 38.56 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.413 -1.267 . . . . 1.28 111.261 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 183' ' ' ILE . 10.2 tp -63.71 139.32 58.76 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.347 -0.842 . . . . 0.22 110.876 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -92.04 -50.48 5.67 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.414 -1.266 . . . . 0.15 111.462 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.6 t 176.33 177.34 0.25 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.573 -1.194 . . . . 0.28 110.026 -173.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -148.83 134.27 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 105.839 -1.911 . . . . 0.28 105.839 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.745 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 75.0 t -134.02 116.58 23.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 120.162 -0.615 . . . . 0.34 112.236 -171.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.1 97.81 0.05 Allowed 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.845 -1.169 . . . . 1.64 107.845 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 85.0 mmm -59.48 -16.12 22.04 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.695 -2.048 . . . . 1.42 112.98 -165.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.2 mt-10 -72.21 -44.05 63.54 Favored 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 114.499 -1.228 . . . . 0.68 109.791 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -94.4 -33.52 13.12 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.675 -1.602 . . . . 2.36 111.109 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.745 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 5.0 p30 40.02 22.94 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.394 1.627 . . . . 1.8 115.394 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -141.59 -61.04 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.308 -0.245 . . . . 4.13 111.571 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -57.88 -36.3 72.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.03 0.443 . . . . 4.05 110.961 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.487 ' O ' HG13 ' A' ' 184' ' ' VAL . 39.2 t80 -117.14 103.76 10.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.38 -0.6 . . . . 1.83 109.38 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.613 ' CA ' HG22 ' A' ' 184' ' ' VAL . . . 168.75 158.98 13.35 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.025 -1.559 . . . . 1.84 114.62 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 70.7 m-85 -135.71 -172.89 3.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.503 -0.849 . . . . 4.57 109.281 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -77.4 156.01 31.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.61 0.719 . . . . 6.25 112.064 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.67 164.19 13.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.648 -1.16 . . . . 6.4 110.621 -173.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.903 HD13 ' HB3' ' A' ' 150' ' ' ASN . 1.1 mp -68.03 147.63 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.854 -0.612 . . . . 1.4 111.81 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.507 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 19.0 t70 -161.99 -56.02 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.94 . . . . 3.38 109.443 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 198' ' ' ASP . 60.9 Cg_endo -74.28 125.74 9.92 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.558 1.506 . . . . 4.74 111.561 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 200' ' ' ARG . 1.2 tmm_? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.286 -0.864 . . . . 7.73 110.349 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.179 0.514 . . . . 31.14 109.962 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.65 7.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.76 -0.733 . . . . 30.65 111.684 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -58.03 -38.39 76.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 30.65 110.999 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.178 -0.464 . . . . 29.78 111.477 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -133.81 83.18 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 29.55 111.565 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 49.0 p-80 -158.97 18.3 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 29.87 110.052 175.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 55.8 m80 68.63 104.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.705 -0.68 . . . . 27.89 109.977 -170.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.83 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 26.19 109.972 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 51.83 67.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.565 -0.743 . . . . 26.23 111.308 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -119.31 20.11 12.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.968 -0.56 . . . . 26.64 110.395 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 m 61.76 -164.31 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.876 0.735 . . . . 24.71 110.066 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.9 t 68.15 106.56 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.176 0.512 . . . . 24.15 111.125 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.26 -29.85 67.96 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.783 -0.722 . . . . 22.66 112.06 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.9 tp -88.12 83.76 6.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 20.88 110.477 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.421 ' N ' ' HD3' ' A' ' 102' ' ' PRO . 8.2 p -151.71 66.03 6.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.983 0.896 . . . . 19.88 110.616 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 12.6 Cg_exo -70.62 -6.46 19.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.047 2.498 . . . . 18.7 112.821 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.604 ' HD3' ' H ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -103.63 2.18 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 18.91 110.209 177.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.47 -22.22 71.19 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 116.013 -0.54 . . . . 15.32 112.581 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.4 t -68.74 -14.31 62.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.83 0.348 . . . . 14.03 110.749 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -90.44 -77.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.106 -0.331 . . . . 12.65 110.106 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 42.9 ttp 51.76 59.71 4.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.319 0.58 . . . . 11.98 110.38 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.39 142.12 7.5 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.814 -0.708 . . . . 8.1 111.976 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -80.49 72.89 7.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.591 . . . . 9.18 110.42 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.0 ptm -157.95 28.02 0.26 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.949 0.88 . . . . 6.14 109.678 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.81 156.32 42.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.335 -1.302 . . . . 4.84 110.575 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.26 142.14 32.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.004 -0.544 . . . . 4.29 109.855 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 114' ' ' GLU . 5.0 tt -72.42 129.25 37.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.45 -0.944 . . . . 1.69 108.45 174.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.62 ' N ' HD23 ' A' ' 113' ' ' LEU . 43.1 mt-10 -159.07 162.65 25.87 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 107.428 -1.323 . . . . 3.45 107.428 -171.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.487 ' HA ' ' H ' ' A' ' 117' ' ' MET . 57.2 Cg_endo -90.41 99.67 0.27 Allowed 'Trans proline' 0 N--CA 1.419 -2.86 0 C-N-CA 117.177 -1.416 . . . . 3.06 111.991 173.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -112.18 -5.42 14.21 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 102.401 -3.185 . . . . 3.24 102.401 141.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 119' ' ' ILE . 9.1 tpt -82.07 143.96 31.15 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 110.786 -2.916 . . . . 1.45 111.444 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.846 HG23 ' HB3' ' A' ' 179' ' ' HIS . 10.3 m -132.31 102.82 5.91 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.917 -1.038 . . . . 0.32 108.927 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.876 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.3 pt -131.75 171.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.95 -1.023 . . . . 0.2 111.945 -171.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.837 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 21.1 t -123.93 174.76 7.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.57 -1.195 . . . . 1.29 109.39 -172.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -52.2 -42.68 63.72 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.033 0.753 . . . . 3.26 113.033 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.8 t30 -85.61 -18.04 34.44 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.397 -0.815 . . . . 2.17 110.202 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.56 -25.07 63.82 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.621 -0.432 . . . . 0.5 111.409 -175.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.668 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.72 -25.28 22.41 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.096 -1.442 . . . . 3.06 109.696 175.118 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.32 -30.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.766 -1.107 . . . . 0.35 111.737 -177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.64 -41.44 26.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.698 -1.137 . . . . 1.51 109.822 170.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.77 -40.33 83.64 Favored 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 117.598 -1.191 . . . . 0.4 114.167 -174.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.839 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.97 -38.22 90.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.35 -2.14 . . . . 0.32 109.273 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 128' ' ' LEU . 24.2 mt-10 -66.69 -31.36 71.98 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.86 1.314 . . . . 2.51 108.129 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.86 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.8 -7.27 54.76 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 112.491 -2.14 . . . . 0.33 110.711 -169.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.9 t -121.54 -0.47 9.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.36 109.289 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 69.16 55.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.767 -1.56 . . . . 2.19 111.737 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.839 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.17 144.95 26.92 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.582 -1.266 . . . . 0.27 107.582 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.655 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.86 162.45 38.62 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.834 -1.172 . . . . 0.69 107.834 -175.362 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -47.3 146.94 1.73 Allowed 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 113.349 0.87 . . . . 1.96 113.349 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -140.73 151.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.968 -1.469 . . . . 0.27 112.066 -172.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -61.06 -50.18 74.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.73 111.937 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.9 ptmt -154.32 115.95 4.16 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.658 -1.155 . . . . 0.51 109.296 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.907 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -77.35 100.58 5.98 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 123.667 1.698 . . . . 2.71 112.106 -166.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.69 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.2 t -158.97 96.37 1.34 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.593 -1.64 . . . . 0.35 109.04 163.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.69 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.4 mmt180 -151.1 169.88 8.62 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.835 -1.543 . . . . 2.38 106.835 170.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.4 111.25 2.33 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 CA-C-N 119.967 1.024 . . . . 0.79 109.874 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.1 22.32 61.23 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.265 -0.969 . . . . 0.38 114.014 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.3 mt-10 -137.4 131.03 31.44 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.912 -1.144 . . . . 1.49 107.912 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.912 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -133.08 176.57 8.39 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.912 -0.715 . . . . 0.3 109.847 -167.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.907 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.6 p -108.13 143.48 36.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.608 0.718 . . . . 0.19 111.543 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.633 HG22 ' OH ' ' A' ' 133' ' ' TYR . 55.2 t -106.04 119.93 56.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.268 -1.333 . . . . 0.86 110.976 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 151' ' ' SER . 52.9 tp60 -101.72 -85.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 2.45 110.436 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.99 -82.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 120.537 0.208 . . . . 0.49 110.745 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.945 ' HB3' HD12 ' A' ' 197' ' ' LEU . 2.2 m-20 -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.588 0.709 . . . . 1.02 109.389 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 47.2 p -138.96 143.08 38.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.92 -1.036 . . . . 0.94 110.05 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.638 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.0 mt -104.64 171.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.574 -1.269 . . . . 0.2 107.574 170.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.912 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.7 tt0 -128.4 106.84 9.27 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.685 -0.806 . . . . 0.97 110.18 171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.532 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.5 tmt? -110.07 125.96 53.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 1.32 111.713 -167.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -66.93 125.22 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.076 -0.511 . . . . 0.33 109.949 173.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.602 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 19.5 mtp180 -91.14 -176.29 4.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 3.1 110.371 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -64.44 132.02 95.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 110.12 -0.326 . . . . 4.26 110.12 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -54.33 159.87 7.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.569 2.179 . . . . 2.01 112.353 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -94.53 123.67 38.1 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.946 0.879 . . . . 5.12 113.05 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.497 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 1.3 m-20 -130.52 118.79 21.6 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.942 -1.481 . . . . 5.15 110.492 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 44.8 m-85 -121.52 172.14 5.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.492 -0.776 . . . . 6.81 109.727 174.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.0 Cg_endo -76.97 -43.24 0.26 Allowed 'Trans proline' 0 N--CA 1.412 -3.283 0 C-N-CA 121.619 1.546 . . . . 8.97 110.572 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -95.35 1.06 54.2 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.629 -2.078 . . . . 10.53 109.926 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -162.82 143.9 9.86 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 114.214 -1.357 . . . . 7.9 112.004 -174.088 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.497 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 51.9 mttt -151.33 145.46 25.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.967 0.413 . . . . 6.69 110.647 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 4.9 pt-20 -158.36 -166.45 1.93 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.353 -0.84 . . . . 5.04 111.399 -173.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -93.22 -149.35 24.97 Favored Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.405 -0.816 . . . . 2.11 113.568 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -79.67 156.55 27.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.341 0.591 . . . . 2.93 110.74 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.603 HG13 ' HG3' ' A' ' 187' ' ' GLU . 44.6 t -125.49 144.22 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-N 115.18 -0.918 . . . . 0.48 109.178 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 2.2 ppt_? -120.47 143.39 48.54 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.59 1.186 . . . . 1.61 113.039 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.88 160.62 22.33 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 112.981 -1.918 . . . . 0.2 110.638 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.38 120.24 41.92 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.097 -1.075 . . . . 3.69 108.097 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 180' ' ' LEU . 0.2 OUTLIER -114.54 110.72 20.25 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.388 -1.733 . . . . 0.61 110.576 -163.103 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.433 ' CG2' ' HG ' ' A' ' 197' ' ' LEU . 71.1 m -108.38 148.05 30.67 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.093 -0.38 . . . . 0.21 110.946 -173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.876 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -115.82 99.9 7.63 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.034 0.753 . . . . 0.32 113.034 176.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.614 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 11.0 t0 -77.33 92.69 3.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.373 0.606 . . . . 0.74 111.321 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.54 -109.78 3.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.131 -1.033 . . . . 0.27 114.2 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.29 7.8 23.23 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.613 -1.255 . . . . 1.61 107.613 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.846 ' HB3' HG23 ' A' ' 118' ' ' THR . 10.3 p-80 -142.29 160.82 39.49 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.071 -1.422 . . . . 1.28 112.1 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -65.61 136.43 56.33 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.165 -0.925 . . . . 0.22 110.978 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.614 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.29 -53.42 4.85 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.521 -1.218 . . . . 0.15 111.54 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 8.8 t -177.84 176.51 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.314 -0.857 . . . . 0.28 110.382 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -152.2 118.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 113.895 -1.502 . . . . 0.28 107.274 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.71 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 71.9 t -124.48 123.43 66.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.573 0.583 . . . . 0.34 112.573 -171.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.602 ' OD1' ' HD3' ' A' ' 156' ' ' ARG . 94.3 m-20 -60.98 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.194 0.997 . . . . 1.64 108.91 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 88.0 mmm -58.27 -16.49 14.28 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 112.482 -2.145 . . . . 1.42 112.844 -168.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.603 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.8 mt-10 -68.3 -41.64 80.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.256 -1.338 . . . . 0.68 109.915 -176.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -112.87 -20.54 11.55 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.651 -1.613 . . . . 2.36 112.542 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.71 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 13.1 p30 41.54 30.26 0.13 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 114.098 1.147 . . . . 1.8 114.098 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -133.99 -27.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 4.13 110.997 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -51.02 -54.24 26.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.081 -0.711 . . . . 4.05 109.081 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -116.38 164.17 14.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.371 -1.344 . . . . 1.83 107.371 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 176.9 126.41 0.96 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.528 -1.32 . . . . 1.84 113.125 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 29.8 m-85 -137.64 -175.24 4.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.53 . . . . 4.57 110.936 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -79.14 164.32 24.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.804 -0.635 . . . . 6.25 110.821 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.657 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -94.4 154.97 17.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.613 -0.721 . . . . 6.4 109.72 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.945 HD12 ' HB3' ' A' ' 150' ' ' ASN . 7.0 mt -69.61 163.01 26.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.382 -0.372 . . . . 1.4 110.727 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 199' ' ' PRO . 4.8 m-20 57.11 63.23 5.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.635 . . . . 3.38 110.908 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -84.42 50.14 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.048 2.499 . . . . 4.74 111.174 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.479 -0.772 . . . . 7.73 109.829 -176.934 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.0 mtp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.945 0.402 . . . . 31.14 111.199 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.67 -49.48 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.432 -0.667 . . . . 30.65 111.432 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -122.44 -179.79 4.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.438 -0.579 . . . . 30.65 109.438 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.5 m 57.87 59.46 3.16 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.53 0.518 . . . . 29.78 111.088 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -81.22 149.8 28.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.2 -0.455 . . . . 29.55 109.986 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 60.81 72.71 0.51 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.32 0.581 . . . . 29.87 109.671 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -55.75 119.79 6.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.2 -0.909 . . . . 27.89 112.06 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -82.87 57.35 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.604 -0.725 . . . . 26.19 109.363 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -129.66 114.15 15.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 26.23 110.338 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -132.36 32.96 3.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 26.64 110.562 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 t -77.08 79.36 3.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.572 . . . . 24.71 109.461 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m -65.99 103.4 0.94 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.453 -0.794 . . . . 24.15 111.311 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.28 -21.09 15.57 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.697 -0.683 . . . . 22.66 112.328 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.3 mm? 54.05 71.9 0.48 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.169 0.509 . . . . 20.88 110.661 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.7 123.16 74.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 19.88 111.089 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.64 71.68 6.77 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.481 2.12 . . . . 18.7 110.995 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 103' ' ' ARG . 12.0 ptp180 -56.76 142.32 40.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.721 -0.672 . . . . 18.91 110.735 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.97 94.35 0.03 OUTLIER Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.644 -0.707 . . . . 15.32 113.209 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -160.78 164.04 31.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 14.03 109.259 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.424 ' C ' HG11 ' A' ' 111' ' ' VAL . 39.6 m80 62.01 65.35 0.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.5 0.5 . . . . 12.65 110.492 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.34 22.85 1.5 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 11.98 110.339 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.14 41.29 3.03 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.813 -0.63 . . . . 8.1 113.507 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 56.36 23.86 7.75 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.568 0.581 . . . . 9.18 112.568 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -141.82 25.15 1.99 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.597 1.189 . . . . 6.14 109.158 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 2.9 p -143.71 -44.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.329 -1.76 . . . . 4.84 109.018 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.03 120.57 42.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.073 -1.084 . . . . 4.29 108.073 168.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 173' ' ' LEU . 4.7 tt -64.14 113.13 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.969 -0.752 . . . . 1.69 108.969 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 183' ' ' ILE . 1.2 tm-20 178.68 56.63 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.844 0.715 . . . . 3.45 109.157 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 15.4 Cg_endo -90.02 178.49 2.24 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.427 2.751 . . . . 3.06 110.685 177.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.46 20.8 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.959 -0.564 . . . . 3.24 111.424 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.621 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 7.3 tpt -52.21 138.87 25.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.656 0.741 . . . . 1.45 111.733 -171.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.859 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.5 m -128.55 97.09 4.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.143 -0.935 . . . . 0.32 109.062 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -127.98 172.16 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.202 1.001 . . . . 0.2 111.688 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.835 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.7 t -121.27 175.16 6.27 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 113.891 -1.504 . . . . 1.29 109.487 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.9 mttt -52.67 -48.93 66.16 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.335 0.397 . . . . 3.26 111.838 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 54.2 m-80 -83.84 -16.21 45.35 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 122.341 -0.224 . . . . 2.17 110.559 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.35 -21.27 63.83 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.451 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.06 -26.96 25.04 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.925 -1.11 . . . . 3.06 109.774 176.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.59 -32.06 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.834 -1.076 . . . . 0.35 111.532 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.776 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.85 -40.38 32.78 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.725 -1.125 . . . . 1.51 110.171 170.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.53 82.17 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 117.469 -1.253 . . . . 0.4 114.364 -174.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.818 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.86 -38.51 91.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.247 -2.181 . . . . 0.32 109.181 176.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.505 ' H ' HD22 ' A' ' 128' ' ' LEU . 36.7 mt-10 -64.67 -32.44 74.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.893 1.33 . . . . 2.51 107.895 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.66 -6.71 55.9 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.332 -2.213 . . . . 0.33 110.567 -169.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.5 t -122.11 0.28 9.59 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.351 -0.84 . . . . 0.36 109.258 -174.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 70.12 55.9 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.682 -1.599 . . . . 2.19 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.69 146.95 25.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.954 -1.499 . . . . 0.27 106.954 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.575 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.17 159.33 42.83 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.109 -1.071 . . . . 0.69 108.109 -178.09 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.4 158.97 0.76 Allowed 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 122.19 0.995 . . . . 1.96 112.116 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -148.67 153.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 113.821 -1.536 . . . . 0.27 111.264 -169.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -50.06 75.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.937 0.875 . . . . 0.73 111.728 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -157.74 113.8 2.83 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.229 -1.35 . . . . 0.51 108.682 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.957 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.32 105.06 13.08 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.229 1.49 . . . . 2.71 111.339 -166.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -157.49 93.71 1.32 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.303 -1.772 . . . . 0.35 107.969 162.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 23.7 mmt180 -151.35 169.6 9.1 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.447 -1.706 . . . . 2.38 107.813 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 111.4 2.75 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 CA-C-N 119.269 0.775 . . . . 0.79 110.389 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.11 78.4 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.581 -0.819 . . . . 0.38 113.886 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 1.3 mm-40 -129.59 132.2 46.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.382 -1.34 . . . . 1.49 107.382 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.807 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.0 OUTLIER -132.6 175.44 9.31 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.258 -0.977 . . . . 0.3 110.413 -169.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.0 p -111.18 141.9 44.08 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.954 0.883 . . . . 0.19 111.956 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 54.5 t -101.8 119.97 50.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.844 -1.526 . . . . 0.86 110.773 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 151' ' ' SER . 64.9 mt-30 -101.99 -78.59 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.681 -0.236 . . . . 2.45 110.741 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.63 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.717 0.294 . . . . 0.49 111.199 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.685 ' HB3' HD13 ' A' ' 197' ' ' LEU . 84.4 m-20 -89.33 -2.93 58.62 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.84 0.829 . . . . 1.02 109.153 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.572 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 15.4 p -138.16 141.83 40.08 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.779 -1.1 . . . . 0.94 109.636 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.629 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.9 mt -104.35 170.92 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.103 -1.443 . . . . 0.2 107.103 169.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.2 tt0 -119.45 139.07 52.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.544 -1.651 . . . . 0.97 106.544 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.494 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -135.57 127.38 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 118.863 0.756 . . . . 1.32 111.935 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -71.39 140.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.33 108.379 169.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.734 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 30.6 ttp180 -62.3 168.37 3.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.561 -0.903 . . . . 3.1 108.561 175.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 111' ' ' VAL . 21.6 mmm180 -61.98 113.61 9.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 118.454 0.57 . . . . 4.26 110.693 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 168' ' ' GLN . 5.1 Cg_exo -78.55 166.76 23.57 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.143 2.562 . . . . 2.01 111.503 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.96 153.26 45.54 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.841 0.829 . . . . 5.12 112.051 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.664 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 4.2 m-20 -129.39 127.57 41.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.146 -1.388 . . . . 5.15 108.985 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.621 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 42.2 m-85 -119.28 168.79 9.25 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-O 121.98 0.895 . . . . 6.81 111.433 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.1 Cg_endo -75.52 -41.85 0.53 Allowed 'Trans proline' 0 N--CA 1.414 -3.185 0 C-N-CA 122.094 1.863 . . . . 8.97 110.79 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -91.52 -5.0 54.86 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 112.68 -2.054 . . . . 10.53 109.511 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.0 m -164.54 139.2 5.47 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.076 -1.42 . . . . 7.9 112.886 -171.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.664 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 53.8 mttt -145.83 141.64 28.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.222 0.534 . . . . 6.69 111.711 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -167.77 -165.58 0.66 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.844 -1.071 . . . . 5.04 110.865 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -109.5 -135.53 7.27 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.653 -0.703 . . . . 2.11 111.686 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.734 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 8.1 tp-100 -151.15 172.75 15.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.051 0.929 . . . . 2.93 112.601 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.639 HG11 ' ND2' ' A' ' 185' ' ' ASN . 12.4 t -90.37 148.19 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 113.592 -1.64 . . . . 0.48 108.34 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -119.77 144.81 47.09 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 122.454 1.121 . . . . 1.61 113.223 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.49 159.88 23.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.296 -1.774 . . . . 0.2 110.24 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HA ' ' HG3' ' A' ' 153' ' ' GLU . 24.7 ttm180 -108.93 118.82 37.78 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 122.073 0.94 . . . . 3.69 108.751 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.629 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -110.2 113.33 25.93 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.568 -1.651 . . . . 0.61 110.959 -162.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 63.5 m -112.16 149.14 32.63 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.003 -0.435 . . . . 0.21 112.152 -171.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.967 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -117.84 110.94 18.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.841 -0.618 . . . . 0.32 111.649 175.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.642 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 3.3 t70 -94.35 107.24 19.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.477 -0.783 . . . . 0.74 111.042 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.8 -115.75 4.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.279 -0.962 . . . . 0.27 113.015 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.35 10.82 19.94 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.003 -1.481 . . . . 1.61 107.003 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.859 ' HB3' HG23 ' A' ' 118' ' ' THR . 12.0 p-80 -137.51 160.75 38.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.793 -1.094 . . . . 1.28 112.734 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -63.58 134.96 56.42 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.575 -0.739 . . . . 0.22 110.493 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.642 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -88.69 -49.84 6.61 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.638 -1.164 . . . . 0.15 111.32 -176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.607 HG21 ' O ' ' A' ' 194' ' ' PHE . 5.5 t 177.49 178.47 0.3 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.96 -1.018 . . . . 0.28 110.277 -173.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.794 HD11 HD21 ' A' ' 180' ' ' LEU . 2.0 mp -152.99 124.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 N-CA-C 106.075 -1.824 . . . . 0.28 106.075 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.924 HG22 ' HA2' ' A' ' 193' ' ' GLY . 86.2 t -121.1 121.73 65.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 113.101 0.778 . . . . 0.34 113.101 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.639 ' ND2' HG11 ' A' ' 169' ' ' VAL . 23.6 t-20 -58.94 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 107.797 -1.186 . . . . 1.64 107.797 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.459 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 81.4 mmm -62.0 -15.57 45.04 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-N 114.216 -1.356 . . . . 1.42 112.661 -167.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.12 -42.62 55.96 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 114.343 -1.299 . . . . 0.68 110.289 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -100.2 -30.39 11.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.379 -1.282 . . . . 2.36 112.039 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.657 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.0 p-10 43.03 20.4 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.665 1.357 . . . . 1.8 114.665 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -136.71 3.87 2.77 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 111.743 0.275 . . . . 4.13 111.743 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.49 -84.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.006 -0.738 . . . . 4.05 109.006 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.62 ' HD1' ' O ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -96.68 100.88 12.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.163 -1.051 . . . . 1.83 108.163 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.924 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -146.1 109.16 0.48 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.006 -1.092 . . . . 1.84 113.825 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.607 ' O ' HG21 ' A' ' 182' ' ' THR . 92.5 m-85 -136.47 163.61 30.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.421 -0.585 . . . . 4.57 109.421 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -165.94 102.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.135 0.493 . . . . 6.25 111.113 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.705 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 16.1 mtm-85 -132.12 115.05 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.215 -0.661 . . . . 6.4 109.215 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 196' ' ' ARG . 7.3 mt -173.17 -179.16 1.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.863 0.727 . . . . 1.4 109.316 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.537 ' HB2' ' HD3' ' A' ' 199' ' ' PRO . 2.0 m-20 -52.27 -54.32 42.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 123.177 0.298 . . . . 3.38 111.713 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 198' ' ' ASP . 3.5 Cg_endo -86.9 112.9 0.98 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.247 1.965 . . . . 4.74 111.812 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.688 -0.672 . . . . 7.73 110.568 179.427 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.175 -0.306 . . . . 31.14 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.76 -131.8 10.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.663 -0.779 . . . . 30.65 111.302 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.3 m 61.8 -171.96 0.15 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 30.65 111.497 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.4 t -129.56 124.93 35.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.371 -0.377 . . . . 29.78 111.031 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.6 m80 41.63 -97.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.57 1.169 . . . . 29.55 114.005 168.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 10.6 p-80 -101.6 38.79 1.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 29.87 111.956 -169.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.86 -27.11 40.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.253 -0.43 . . . . 27.89 111.961 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -137.2 37.88 2.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.367 0.603 . . . . 26.19 110.374 172.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 92' ' ' HIS . 36.2 m170 -128.57 102.05 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.355 -0.839 . . . . 26.23 109.233 176.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 67.27 177.76 0.24 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.151 0.5 . . . . 26.64 110.791 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.442 ' HB3' HD23 ' A' ' 100' ' ' LEU . 20.2 m -109.95 35.06 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.029 0.442 . . . . 24.71 110.552 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 m -71.71 99.8 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.741 -0.663 . . . . 24.15 110.475 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.52 56.8 4.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 22.66 111.193 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 97' ' ' SER . 4.3 pp -75.13 163.32 27.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.849 0.357 . . . . 20.88 111.058 -177.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.4 125.7 31.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.396 . . . . 19.88 110.633 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.68 19.8 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.994 2.463 . . . . 18.7 112.582 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -121.44 167.83 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.271 -0.422 . . . . 18.91 110.099 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.99 107.51 1.96 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.784 -0.722 . . . . 15.32 111.403 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 p -66.44 -43.52 85.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.803 0.335 . . . . 14.03 111.18 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -136.5 119.05 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.684 -0.487 . . . . 12.65 109.684 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 48.3 ttm -81.9 -20.6 38.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.2 0.524 . . . . 11.98 110.062 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -115.77 109.44 2.03 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.917 -0.659 . . . . 8.1 111.808 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -82.07 81.11 8.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 9.18 111.612 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.2 ptm -137.8 20.96 2.87 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.384 1.088 . . . . 6.14 108.47 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.6 -9.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.342 -1.754 . . . . 4.84 110.101 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -143.72 101.16 3.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.647 -0.706 . . . . 4.29 110.387 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.768 HD12 ' N ' ' A' ' 114' ' ' GLU . 0.3 OUTLIER -88.09 135.75 33.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.697 -0.683 . . . . 1.69 110.087 178.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.768 ' N ' HD12 ' A' ' 113' ' ' LEU . 52.0 mt-10 -161.78 162.5 20.68 Favored Pre-proline 0 CA--C 1.5 -0.967 0 N-CA-C 107.646 -1.242 . . . . 3.45 107.646 -175.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 93.7 Cg_endo -92.61 103.21 0.18 Allowed 'Trans proline' 0 N--CA 1.426 -2.457 0 CA-C-N 119.665 0.916 . . . . 3.06 113.369 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.13 -4.52 14.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 102.686 -3.079 . . . . 3.24 102.686 136.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.634 ' HG3' HG23 ' A' ' 119' ' ' ILE . 34.6 tpp -76.08 143.09 41.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 110.903 -2.862 . . . . 1.45 111.879 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.5 m -126.28 100.72 6.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.122 -0.945 . . . . 0.32 109.349 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.885 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.1 pt -132.14 172.34 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.075 -0.966 . . . . 0.2 111.251 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.857 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 65.4 p -123.97 179.45 4.84 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.697 -1.138 . . . . 1.29 110.403 -169.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 124' ' ' MET . 41.0 mmtm -60.03 -37.81 80.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.273 0.559 . . . . 3.26 110.594 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -85.45 -22.22 28.39 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 116.213 -0.449 . . . . 2.17 110.706 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.943 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.5 mt-10 -72.53 -23.16 60.96 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 119.805 -0.758 . . . . 0.5 109.74 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.705 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -85.05 -28.12 25.89 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.172 -1.011 . . . . 3.06 109.967 178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.29 -32.57 56.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.005 -0.998 . . . . 0.35 111.711 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.782 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.95 -39.96 33.13 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.833 -1.076 . . . . 1.51 110.005 171.112 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.43 -39.54 80.05 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 114.261 1.208 . . . . 0.4 114.261 -174.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.51 -38.79 92.47 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.157 -2.217 . . . . 0.32 109.08 177.253 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.502 ' H ' HD22 ' A' ' 128' ' ' LEU . 21.1 mt-10 -65.7 -31.48 72.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.93 1.348 . . . . 2.51 108.09 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.33 -6.98 56.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.472 -2.149 . . . . 0.33 110.556 -170.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.4 t -122.17 2.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.973 -1.012 . . . . 0.36 109.195 -175.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 68.68 54.85 0.49 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 113.671 -1.604 . . . . 2.19 111.581 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.0 146.97 25.98 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.647 -1.242 . . . . 0.27 107.647 -177.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.648 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.43 161.25 40.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.126 -1.435 . . . . 0.69 107.126 -176.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -52.06 158.23 1.14 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.201 1.001 . . . . 1.96 112.099 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.41 153.58 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 113.826 -1.533 . . . . 0.27 111.48 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.3 m -59.63 -50.89 72.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.038 0.923 . . . . 0.73 111.472 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -159.91 116.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.765 -1.561 . . . . 0.51 108.035 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.971 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -82.26 109.07 16.2 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.955 1.36 . . . . 2.71 110.925 -165.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.7 t -155.71 95.66 1.68 Allowed 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 113.549 -1.659 . . . . 0.35 108.727 162.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.6 mmt180 -151.17 167.52 12.84 Favored Pre-proline 0 N--CA 1.432 -1.375 0 CA-C-N 113.029 -1.896 . . . . 2.38 107.75 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.44 111.61 2.62 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 N-CA-C 109.644 -0.945 . . . . 0.79 109.644 160.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.77 20.81 59.03 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.657 -0.783 . . . . 0.38 114.393 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 41.2 mt-10 -137.45 131.9 32.6 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.238 -1.023 . . . . 1.49 108.238 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.832 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -132.12 176.54 8.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.827 -0.749 . . . . 0.3 110.036 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.1 p -112.66 139.97 47.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.717 0.77 . . . . 0.19 111.763 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG2' ' OH ' ' A' ' 133' ' ' TYR . 40.1 t -98.44 139.48 20.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.088 -1.415 . . . . 0.86 110.922 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 151' ' ' SER . 64.0 tt0 -125.15 -79.08 0.6 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.021 -0.272 . . . . 2.45 111.273 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.54 -81.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.75 0.31 . . . . 0.49 111.702 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.464 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 77.0 m-20 -86.71 -5.4 59.13 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.236 -0.653 . . . . 1.02 109.236 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 m -143.46 146.54 33.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.275 -0.875 . . . . 0.94 109.348 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.631 HG22 HD23 ' A' ' 173' ' ' LEU . 6.6 mt -107.97 169.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.988 -1.486 . . . . 0.2 106.988 167.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.832 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.1 tt0 -116.19 136.37 53.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.521 -1.659 . . . . 0.97 106.521 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.467 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.3 ppp? -136.75 125.29 23.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 119.143 0.883 . . . . 1.32 112.692 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -65.99 140.19 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.33 110.08 174.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -85.25 176.98 8.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.701 -0.852 . . . . 3.1 108.701 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -65.51 157.52 78.04 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.022 -0.732 . . . . 4.26 109.022 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.6 155.94 68.1 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.215 1.277 . . . . 2.01 110.603 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.414 ' HB3' ' HG3' ' A' ' 166' ' ' GLU . 0.6 OUTLIER -99.55 124.23 44.54 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.904 0.859 . . . . 5.12 112.919 -170.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.79 124.07 30.54 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.128 -1.396 . . . . 5.15 111.958 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.598 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 40.6 m-85 -122.33 173.3 4.29 Favored Pre-proline 0 N--CA 1.423 -1.781 0 CA-C-N 115.017 -0.992 . . . . 6.81 111.003 172.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.5 Cg_endo -78.25 -43.7 0.18 Allowed 'Trans proline' 0 N--CA 1.418 -2.955 0 C-N-CA 122.332 2.021 . . . . 8.97 110.417 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.09 -12.95 54.24 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.691 -2.504 . . . . 10.53 109.653 -172.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -163.2 152.37 14.79 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 112.857 -1.974 . . . . 7.9 112.139 -168.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -149.43 146.29 27.37 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 121.159 0.504 . . . . 6.69 110.734 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 159' ' ' PHE . 4.7 pt-20 -155.22 -164.55 1.8 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.917 -1.038 . . . . 5.04 111.198 -171.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -106.71 -135.84 8.08 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 120.786 -0.721 . . . . 2.11 113.298 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -90.16 153.42 20.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.878 0.847 . . . . 2.93 111.227 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.546 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t -131.94 148.08 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.359 0 CA-C-N 114.273 -1.331 . . . . 0.48 108.467 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.03 144.1 51.1 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 122.288 1.042 . . . . 1.61 113.427 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -111.68 168.01 9.9 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.333 -1.758 . . . . 0.2 110.664 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.526 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 39.5 ptt180 -118.42 122.34 42.54 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.147 -1.427 . . . . 3.69 107.147 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.69 HD22 HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -117.78 106.82 13.43 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.574 -1.194 . . . . 0.61 110.443 -162.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.659 ' CG2' HD23 ' A' ' 197' ' ' LEU . 51.8 m -105.67 150.81 25.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.67 -0.695 . . . . 0.21 112.328 -169.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.885 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.5 m-85 -115.56 106.66 14.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.32 -1.309 . . . . 0.32 112.71 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.802 ' HA ' HD21 ' A' ' 197' ' ' LEU . 34.5 t70 -95.96 103.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.886 0.374 . . . . 0.74 111.173 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 80.67 -118.44 4.65 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.259 -0.972 . . . . 0.27 112.602 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.31 12.82 21.65 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.578 -1.638 . . . . 1.61 106.578 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.4 p80 -133.8 161.05 35.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.546 -1.207 . . . . 1.28 111.694 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -69.14 135.35 50.56 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.706 -1.134 . . . . 0.22 110.423 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.561 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -85.78 -50.87 6.81 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.289 -1.323 . . . . 0.15 110.946 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 6.1 t -179.08 177.09 0.83 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.065 -0.97 . . . . 0.28 110.727 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -150.18 121.54 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.488 -1.671 . . . . 0.28 106.488 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.756 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 72.1 t -131.63 122.18 49.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.563 0.579 . . . . 0.34 112.563 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -59.1 99.11 0.05 OUTLIER 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.001 -1.111 . . . . 1.64 108.001 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 82.4 mtp -55.6 -22.9 24.41 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 112.606 -2.088 . . . . 1.42 112.179 -169.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.7 mt-10 -66.47 -45.69 78.84 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.098 -1.41 . . . . 0.68 110.603 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.71 -20.0 13.76 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.399 -1.273 . . . . 2.36 111.668 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.756 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.6 p30 36.16 46.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.581 0.956 . . . . 1.8 113.581 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -161.64 -26.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.117 -0.947 . . . . 4.13 110.029 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -47.81 -51.9 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.62 -0.718 . . . . 4.05 111.34 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.12 -78.86 0.52 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.473 -0.936 . . . . 1.83 108.473 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.641 ' H ' HG22 ' A' ' 184' ' ' VAL . . . 66.82 101.0 0.02 OUTLIER Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.306 -0.861 . . . . 1.84 114.849 169.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 64.7 m-85 -133.9 -174.41 3.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.985 -0.746 . . . . 4.57 108.985 172.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.2 143.97 36.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.175 0.512 . . . . 6.25 111.262 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -101.19 160.77 14.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.615 -0.72 . . . . 6.4 110.466 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -70.57 135.15 48.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.646 -0.706 . . . . 1.4 111.878 -177.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.55 119.88 75.55 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.836 -0.62 . . . . 3.38 109.58 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.2 132.68 40.01 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.58 2.187 . . . . 4.74 112.149 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.522 -0.751 . . . . 7.73 110.332 -178.973 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.642 0.258 . . . . 31.14 110.685 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.15 -75.59 2.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.914 -0.66 . . . . 30.65 112.069 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 p -148.81 -58.84 0.22 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.16 0.505 . . . . 30.65 109.912 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.5 m -150.81 166.49 30.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 29.78 109.96 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 68.03 109.72 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.888 0.742 . . . . 29.55 111.896 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -62.59 -40.87 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.809 -0.632 . . . . 29.87 109.808 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -96.07 103.06 14.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.35 -0.611 . . . . 27.89 109.35 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 2.7 t60 -73.91 145.13 45.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.151 -0.685 . . . . 26.19 109.151 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 94' ' ' HIS . 93.3 m-70 70.34 172.53 0.31 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.633 0.583 . . . . 26.23 110.324 -172.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 62.51 80.72 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.237 -0.438 . . . . 26.64 110.017 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.1 t 60.59 42.5 13.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.541 0.686 . . . . 24.71 110.151 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -110.19 30.77 6.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.634 -0.712 . . . . 24.15 109.59 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.37 102.65 0.9 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.573 -0.74 . . . . 22.66 111.826 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.94 131.04 35.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.097 -0.334 . . . . 20.88 110.097 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.33 112.75 36.01 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.863 -0.421 . . . . 19.88 109.863 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.63 101.92 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.793 2.328 . . . . 18.7 112.322 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.64 117.51 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.149 -0.478 . . . . 18.91 109.922 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.16 166.0 47.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.85 -0.69 . . . . 15.32 112.963 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t 63.59 48.31 3.43 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.361 0.601 . . . . 14.03 111.05 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -109.22 33.83 4.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.49 0.662 . . . . 12.65 109.217 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -125.25 27.95 6.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.497 -0.774 . . . . 11.98 109.924 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.68 177.16 32.15 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.534 -0.757 . . . . 8.1 111.514 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.432 ' HB3' ' NE ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER 59.78 43.33 15.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.03 0.443 . . . . 9.18 110.899 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -100.46 13.41 34.64 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.161 1.458 . . . . 6.14 108.201 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.9 p -82.52 -17.64 11.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 111.772 -2.467 . . . . 4.84 108.902 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -113.01 156.26 23.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.901 -1.045 . . . . 4.29 109.091 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 114' ' ' GLU . 2.7 tt -80.62 154.44 27.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.037 -0.529 . . . . 1.69 111.855 -169.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.732 ' N ' HD23 ' A' ' 113' ' ' LEU . 31.2 tt0 -179.53 151.88 0.63 Allowed Pre-proline 0 CA--C 1.511 -0.547 0 N-CA-C 107.518 -1.29 . . . . 3.45 107.518 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.613 ' HD3' HD13 ' A' ' 183' ' ' ILE . 78.2 Cg_endo -91.03 103.46 0.26 Allowed 'Trans proline' 0 N--CA 1.431 -2.204 0 CA-C-N 121.238 1.478 . . . . 3.06 113.627 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -111.92 -4.7 14.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 103.118 -2.919 . . . . 3.24 103.118 138.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.602 ' HG3' HG23 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -78.01 139.7 39.14 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 111.107 -2.77 . . . . 1.45 112.028 -162.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m -126.82 101.56 6.65 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.774 -1.103 . . . . 0.32 108.938 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.2 pt -131.01 172.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 122.374 1.083 . . . . 0.2 112.452 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.84 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 7.4 m -111.9 171.32 7.57 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.547 -1.66 . . . . 1.29 110.031 -173.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.623 ' O ' ' HG3' ' A' ' 124' ' ' MET . 63.9 mttm -49.27 -54.49 16.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.093 0.473 . . . . 3.26 111.885 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 20.9 t-20 -82.51 -15.81 51.04 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.956 -0.387 . . . . 2.17 109.956 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -64.58 -24.88 67.74 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.149 -0.621 . . . . 0.5 110.19 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.763 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.59 -28.36 24.89 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.327 -1.349 . . . . 3.06 109.769 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -32.69 55.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.453 1.12 . . . . 0.35 111.684 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.57 -42.35 29.43 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.493 -1.23 . . . . 1.51 109.917 169.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.41 -38.51 84.26 Favored 'General case' 0 CA--C 1.463 -2.399 0 CA-C-O 117.429 -1.272 . . . . 0.4 114.101 -173.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.47 -40.93 98.23 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 116.329 -2.148 . . . . 0.32 108.717 177.221 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.651 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.4 mm-40 -66.87 -32.24 73.37 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.098 1.427 . . . . 2.51 108.589 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.98 -7.53 59.11 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 111.911 -2.404 . . . . 0.33 110.296 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.0 t -121.46 1.71 10.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.214 1.007 . . . . 0.36 108.744 -176.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 70.95 54.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.238 -1.801 . . . . 2.19 112.109 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.65 143.27 23.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.202 -1.407 . . . . 0.27 107.202 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -143.2 162.38 35.75 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.088 -1.449 . . . . 0.69 107.088 -178.193 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -52.39 158.28 1.25 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.232 1.015 . . . . 1.96 112.059 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -147.04 152.32 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-N 114.002 -1.454 . . . . 0.27 111.903 -168.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 m -59.61 -49.65 76.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.73 111.544 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -158.54 113.55 2.58 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.982 -1.463 . . . . 0.51 108.627 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.003 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.78 106.18 14.41 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.851 1.31 . . . . 2.71 111.056 -168.04 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.805 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.7 t -157.45 93.94 1.34 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.942 -1.481 . . . . 0.35 109.171 162.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.805 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.0 mmt180 -152.15 170.0 8.66 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 113.145 -1.843 . . . . 2.38 107.779 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -81.88 111.71 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 CA-C-N 119.755 0.948 . . . . 0.79 110.299 162.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.64 72.85 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.575 -0.821 . . . . 0.38 114.345 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.434 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 3.2 mm-40 -127.78 130.84 49.39 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.799 -1.556 . . . . 1.49 106.799 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.778 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -133.97 176.71 8.33 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.868 -1.133 . . . . 0.3 110.638 -168.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 1.003 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.3 p -112.86 139.86 48.13 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.657 0.742 . . . . 0.19 111.799 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -98.65 141.37 16.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.097 -1.411 . . . . 0.86 111.065 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 151' ' ' SER . 63.2 tt0 -124.95 -78.73 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.833 -0.167 . . . . 2.45 110.956 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.76 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.612 0.244 . . . . 0.49 111.183 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.883 ' HB3' HD13 ' A' ' 197' ' ' LEU . 85.8 m-20 -81.72 -1.19 46.14 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.324 -0.621 . . . . 1.02 109.324 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 15.1 m -140.63 144.73 35.92 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.69 -0.686 . . . . 0.94 110.045 172.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.88 172.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.728 -1.212 . . . . 0.2 107.728 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.0 tt0 -118.87 135.2 54.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.512 -1.662 . . . . 0.97 106.512 166.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.485 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -136.19 127.11 27.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.111 0.868 . . . . 1.32 111.893 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -63.66 128.18 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.33 110.813 176.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 169' ' ' VAL . 34.7 ttt180 -70.62 153.53 42.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.406 -0.815 . . . . 3.1 110.558 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.432 ' NE ' ' HB3' ' A' ' 109' ' ' ARG . 56.5 mtt85 -49.08 118.83 8.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.503 -0.771 . . . . 4.26 110.716 174.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.603 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 18.0 Cg_endo -63.02 175.28 2.54 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.785 2.323 . . . . 2.01 112.967 176.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.04 125.55 35.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 5.12 109.689 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.462 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 1.9 m-20 -120.67 130.71 54.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.781 -0.645 . . . . 5.15 112.062 -169.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.4 m-30 -119.5 168.37 10.22 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 115.472 -0.785 . . . . 6.81 109.822 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.1 Cg_endo -74.47 -44.59 0.39 Allowed 'Trans proline' 0 N--CA 1.414 -3.155 0 C-N-CA 121.963 1.776 . . . . 8.97 110.542 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.44 -6.64 56.33 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.469 -2.15 . . . . 10.53 109.544 -173.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.8 m -164.28 140.09 6.11 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.133 -1.394 . . . . 7.9 112.617 -170.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.462 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 71.5 mttt -142.97 135.6 27.66 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.145 0.498 . . . . 6.69 111.607 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -174.7 -163.93 0.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.75 -1.113 . . . . 5.04 111.442 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 77.4 147.06 2.64 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.317 -0.856 . . . . 2.11 112.933 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 3.5 pm0 -149.08 143.0 25.76 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.453 0.644 . . . . 2.93 110.45 170.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.619 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.8 t -140.03 147.28 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 N-CA-C 107.986 -1.116 . . . . 0.48 107.986 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.31 144.4 50.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.337 1.065 . . . . 1.61 113.862 177.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -114.69 164.92 13.38 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.162 -1.836 . . . . 0.2 110.737 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.46 122.78 43.57 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.815 -1.18 . . . . 3.69 107.815 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -116.75 121.24 41.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 113.922 -1.49 . . . . 0.61 110.575 -161.03 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.523 ' CG2' HD12 ' A' ' 197' ' ' LEU . 54.3 m -114.62 151.83 32.85 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.307 0.484 . . . . 0.21 112.307 -170.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.859 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.4 m-85 -116.16 100.08 7.68 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.747 -1.115 . . . . 0.32 113.375 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.641 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 27.1 t70 -92.22 99.38 12.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.74 111.325 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.69 -113.72 3.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.954 -1.117 . . . . 0.27 113.948 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 8.07 20.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.016 -1.475 . . . . 1.61 107.016 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 20.9 p80 -138.6 161.7 36.45 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.025 -1.443 . . . . 1.28 111.786 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 183' ' ' ILE . 8.7 tp -67.41 137.28 55.81 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.705 -1.134 . . . . 0.22 110.464 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.641 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.33 -49.67 7.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.572 -1.195 . . . . 0.15 111.44 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 7.6 t 179.46 177.92 0.55 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.195 -0.911 . . . . 0.28 110.277 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -153.02 128.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 105.767 -1.938 . . . . 0.28 105.767 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.856 HG22 ' HA2' ' A' ' 193' ' ' GLY . 84.0 t -129.58 118.11 44.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 120.172 -0.611 . . . . 0.34 112.146 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.621 HD22 ' HB2' ' A' ' 171' ' ' ALA . 11.2 m120 -60.5 96.58 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.554 -1.276 . . . . 1.64 107.554 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.85 -19.07 15.48 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 113.157 -1.838 . . . . 1.42 112.971 -166.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.619 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -73.32 -43.18 61.33 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 114.342 -1.299 . . . . 0.68 109.961 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -91.93 -34.14 14.6 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.681 -1.599 . . . . 2.36 111.174 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.671 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.6 p30 35.48 37.34 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.216 1.561 . . . . 1.8 115.216 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -146.9 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.948 -0.47 . . . . 4.13 111.445 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.94 -43.81 97.77 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.254 0.55 . . . . 4.05 110.409 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 12.1 t80 -98.87 59.96 1.22 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 1.83 108.998 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.856 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -139.51 143.93 14.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.331 -0.938 . . . . 1.84 113.83 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 77.9 m-85 -141.08 -171.17 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.104 0.562 . . . . 4.57 110.216 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -76.13 171.81 13.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 6.25 112.044 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -134.64 164.07 28.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.528 -0.76 . . . . 6.4 111.124 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.883 HD13 ' HB3' ' A' ' 150' ' ' ASN . 1.1 mp -68.29 170.35 8.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.533 0.568 . . . . 1.4 112.533 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 52.72 73.7 0.9 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 114.878 -1.055 . . . . 3.38 111.78 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.86 -38.02 94.13 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.815 2.343 . . . . 4.74 112.035 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.96 -0.564 . . . . 7.73 110.547 179.818 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.879 -0.415 . . . . 31.14 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.2 63.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.4 -0.68 . . . . 30.65 111.4 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.0 m -63.71 115.81 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.661 0.267 . . . . 30.65 110.904 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.0 m 70.08 -57.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.58 0.752 . . . . 29.78 111.665 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -94.52 69.61 3.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 29.55 110.476 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -87.98 96.54 10.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.321 0.582 . . . . 29.87 110.529 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -112.56 13.58 20.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.02 -0.537 . . . . 27.89 110.774 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 65.9 18.97 11.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.503 -0.771 . . . . 26.19 110.712 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -114.73 123.12 48.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 26.23 110.358 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -145.22 127.6 15.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.745 -0.661 . . . . 26.64 109.876 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.4 p -78.61 65.22 3.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 24.71 111.396 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p -84.3 141.56 30.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.569 -0.742 . . . . 24.15 110.048 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -171.46 19.14 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.663 -0.78 . . . . 22.66 111.676 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 tp 58.85 49.32 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 20.88 110.243 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 41.8 t -75.16 -46.45 4.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 19.88 111.02 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 3.0 Cg_endo -81.25 131.39 7.65 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 18.7 111.358 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -80.25 -8.05 59.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.995 0.426 . . . . 18.91 110.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.45 34.05 5.36 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.885 -0.598 . . . . 15.32 111.803 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 p -84.28 -30.17 25.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.848 0.356 . . . . 14.03 111.516 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -84.59 -27.23 27.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.767 0.318 . . . . 12.65 110.828 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -19.28 34.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.5 . . . . 11.98 109.792 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.64 42.62 2.29 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.669 -0.696 . . . . 8.1 111.682 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -95.18 47.12 1.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.897 -0.779 . . . . 9.18 108.897 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.5 ptm -162.55 30.22 0.11 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.729 0.776 . . . . 6.14 110.302 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.43 44.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.722 -1.127 . . . . 4.84 110.579 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -118.95 175.42 5.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.559 -0.746 . . . . 4.29 110.12 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HG ' HD13 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -135.18 152.42 51.57 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.035 -0.357 . . . . 1.69 110.035 -179.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 5.1 mp0 -126.13 -178.08 0.68 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.808 . . . . 3.45 113.183 -166.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 27.4 Cg_exo -42.58 -174.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.712 3.608 . . . . 3.06 114.785 165.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -47.59 28.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 118.312 2.708 . . . . 3.24 118.312 -165.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.933 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -40.32 107.59 0.07 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.477 1.132 . . . . 1.45 111.616 179.214 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.774 HG23 ' HB3' ' A' ' 179' ' ' HIS . 24.7 m -78.59 106.73 10.76 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.861 -1.063 . . . . 0.32 110.455 -172.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.0 pt -137.2 172.25 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.675 -1.148 . . . . 0.2 110.853 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.853 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.5 t -121.63 173.33 7.5 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.191 -1.368 . . . . 1.29 109.482 -172.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 124' ' ' MET . 59.0 tttm -51.51 -48.62 62.89 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.782 0.325 . . . . 3.26 111.645 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.425 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 28.5 t-20 -82.4 -18.24 42.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.844 -0.428 . . . . 2.17 109.844 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -68.8 -24.32 64.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.927 -0.709 . . . . 0.5 109.785 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.774 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.98 -29.07 23.82 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 118.337 -1.345 . . . . 3.06 109.598 177.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.81 -32.56 54.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.259 1.028 . . . . 0.35 112.052 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.04 -43.44 29.31 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.607 -1.178 . . . . 1.51 109.68 169.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.89 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.29 -37.28 82.62 Favored 'General case' 0 CA--C 1.461 -2.449 0 CA-C-O 117.539 -1.219 . . . . 0.4 113.929 -172.176 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -63.34 -41.13 98.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 116.211 -2.196 . . . . 0.32 108.832 176.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.673 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.7 mm-40 -67.47 -31.03 70.9 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.924 1.345 . . . . 2.51 108.577 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.6 -7.94 59.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 111.964 -2.38 . . . . 0.33 110.011 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.5 t -121.98 1.26 9.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.149 -0.932 . . . . 0.36 108.872 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 72.94 55.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.62 -1.627 . . . . 2.19 112.466 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 143.76 23.52 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 106.551 -1.648 . . . . 0.27 106.551 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.703 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -142.85 159.89 41.37 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 106.833 -1.543 . . . . 0.69 106.833 -174.044 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -48.05 145.96 2.81 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.11 0.957 . . . . 1.96 112.559 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -136.08 152.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 CA-C-N 113.773 -1.558 . . . . 0.27 111.63 -173.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -60.48 -49.81 76.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.359 -0.837 . . . . 0.73 111.591 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -156.9 115.74 3.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.207 -1.36 . . . . 0.51 109.099 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.849 ' HB3' HG23 ' A' ' 146' ' ' THR . 2.4 ppp? -77.69 103.11 7.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 123.255 1.502 . . . . 2.71 110.917 -168.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.813 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.0 t -158.65 92.21 1.11 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.466 -1.697 . . . . 0.35 108.936 158.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.9 mmt180 -152.51 149.5 22.81 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 113.749 -1.569 . . . . 2.38 106.942 174.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.73 110.59 2.15 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 CA-C-N 120.454 1.198 . . . . 0.79 109.821 169.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.06 59.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.534 -0.841 . . . . 0.38 114.222 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 33.8 mt-10 -138.64 131.88 30.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.647 -1.242 . . . . 1.49 107.647 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -132.7 176.14 8.71 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.558 -0.857 . . . . 0.3 110.691 -166.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.849 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.4 p -112.6 139.46 48.18 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.91 0.862 . . . . 0.19 112.038 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.01 139.66 21.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 0.86 111.201 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.614 ' HB2' ' O ' ' A' ' 151' ' ' SER . 56.3 mt-30 -124.12 -94.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.543 -0.299 . . . . 2.45 110.858 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.89 -77.76 0.07 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.729 0.3 . . . . 0.49 111.184 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.18 -4.44 59.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.131 0.491 . . . . 1.02 109.704 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 5.6 m -145.43 146.3 31.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.828 -0.623 . . . . 0.94 109.845 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.709 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -106.36 165.9 3.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.316 -1.365 . . . . 0.2 107.316 167.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 7.1 tt0 -115.57 129.02 56.38 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.255 -1.387 . . . . 0.97 107.255 169.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.452 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.86 124.93 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.613 0.642 . . . . 1.32 112.393 -177.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -68.37 136.05 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 120.865 0.365 . . . . 0.33 110.17 173.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -86.42 139.05 31.28 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.217 -1.031 . . . . 3.1 108.217 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 157' ' ' ARG . 12.8 ptt180 -47.61 139.43 8.54 Favored Pre-proline 0 C--O 1.235 0.303 0 O-C-N 123.527 0.517 . . . . 4.26 110.553 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.78 149.75 7.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.172 2.581 . . . . 2.01 113.201 -173.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -90.16 131.46 35.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 114.789 -1.096 . . . . 5.12 113.601 -167.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.42 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 2.1 m-20 -129.54 121.65 27.6 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.469 -1.696 . . . . 5.15 110.108 174.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.63 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 61.2 m-85 -120.72 172.02 5.2 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 115.628 -0.715 . . . . 6.81 109.896 172.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.3 Cg_endo -77.61 -44.5 0.18 Allowed 'Trans proline' 0 N--CA 1.409 -3.458 0 C-N-CA 121.471 1.448 . . . . 8.97 110.403 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.11 0.16 55.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.589 -2.096 . . . . 10.53 109.939 -174.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -163.94 149.35 10.77 Favored 'General case' 0 C--O 1.201 -1.485 0 CA-C-N 114.157 -1.383 . . . . 7.9 111.653 -172.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 56.8 mttt -151.54 143.08 23.57 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 120.825 0.345 . . . . 6.69 110.232 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.407 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.7 pt-20 -156.03 -164.85 1.79 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.617 -0.72 . . . . 5.04 112.844 -169.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -93.88 -137.53 8.6 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.053 -0.976 . . . . 2.11 113.297 -171.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.39 151.58 19.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.743 0.782 . . . . 2.93 111.587 -171.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 46.8 t -133.69 147.77 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-N 114.285 -1.325 . . . . 0.48 108.787 174.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.46 145.8 49.3 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.469 1.128 . . . . 1.61 113.218 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.04 167.59 10.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.084 -1.871 . . . . 0.2 110.807 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 45.2 ttt180 -117.97 109.43 16.48 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.414 -1.328 . . . . 3.69 107.414 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -100.0 112.34 24.63 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.529 -1.669 . . . . 0.61 109.665 -170.083 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.58 ' CG2' HD23 ' A' ' 197' ' ' LEU . 86.5 m -109.06 150.46 27.78 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.541 0.571 . . . . 0.21 112.541 -168.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 11.5 m-85 -115.14 114.66 25.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.43 -1.259 . . . . 0.32 111.88 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.65 ' HA ' HD21 ' A' ' 197' ' ' LEU . 20.6 t70 -99.67 96.09 7.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.74 110.7 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.11 -115.49 4.03 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.268 -0.968 . . . . 0.27 113.511 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.75 11.09 22.63 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.681 -1.6 . . . . 1.61 106.681 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.774 ' HB3' HG23 ' A' ' 118' ' ' THR . 28.2 p80 -141.06 161.03 38.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.229 -1.351 . . . . 1.28 111.644 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.933 ' HB2' ' O ' ' A' ' 117' ' ' MET . 7.0 tp -64.81 144.39 57.29 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.309 -0.859 . . . . 0.22 111.654 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.468 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.1 -50.56 5.24 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.193 -1.367 . . . . 0.15 111.544 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.3 t 175.3 178.18 0.16 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.28 109.513 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.55 129.13 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.875 -1.528 . . . . 0.28 106.875 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.834 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 67.6 t -133.01 116.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.66 0.615 . . . . 0.34 112.66 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 171' ' ' ALA . 10.9 m120 -60.8 97.74 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.333 1.063 . . . . 1.64 108.17 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 84.1 mtp -56.29 -22.7 31.87 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 112.168 -2.287 . . . . 1.42 112.951 -165.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -66.49 -43.5 85.2 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.721 -1.127 . . . . 0.68 110.639 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -98.48 -30.86 12.29 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.152 -1.385 . . . . 2.36 110.813 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.834 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.1 t30 36.65 55.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.474 0.916 . . . . 1.8 113.474 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -165.92 -65.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.56 -0.291 . . . . 4.13 110.724 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' A' ' 191' ' ' GLN . 6.0 tp60 -80.11 60.76 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.422 0.63 . . . . 4.05 110.402 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -177.39 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.179 -0.919 . . . . 1.83 109.553 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.538 ' HA3' HG22 ' A' ' 184' ' ' VAL . . . -178.58 176.21 47.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.83 -0.7 . . . . 1.84 112.375 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.8 122.57 10.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 4.57 108.388 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -103.53 117.76 35.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.411 0.624 . . . . 6.25 111.708 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -135.4 119.03 17.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.561 -0.745 . . . . 6.4 109.152 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -147.38 142.35 26.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.831 0.348 . . . . 1.4 111.182 -175.25 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.44 144.22 73.83 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.393 -0.595 . . . . 3.38 109.393 171.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.53 -11.33 31.23 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.268 2.645 . . . . 4.74 114.43 -170.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 200' ' ' ARG . 40.2 mtm180 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.513 -0.756 . . . . 7.73 110.689 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.686 0.279 . . . . 31.14 111.063 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.3 33.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.555 -0.831 . . . . 30.65 112.213 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -86.55 177.64 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.456 -0.201 . . . . 30.65 110.456 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.3 m 61.09 39.21 16.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 29.78 111.059 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -98.48 142.03 30.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 29.55 110.446 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -55.57 -63.22 1.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.18 0.437 . . . . 29.87 112.18 -171.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -86.49 121.32 28.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.946 -0.57 . . . . 27.89 110.437 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -83.57 2.62 36.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.152 -0.476 . . . . 26.19 111.325 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -126.12 29.45 5.85 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.96 -0.756 . . . . 26.23 108.96 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m80 69.98 157.83 0.17 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.244 -0.889 . . . . 26.64 111.211 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 m -100.08 40.95 1.2 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.083 -0.508 . . . . 24.71 110.09 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -63.47 -31.36 72.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 24.15 111.795 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.99 -10.81 74.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.561 -0.828 . . . . 22.66 112.459 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 2.8 mm? -100.9 -41.89 6.65 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.702 -0.293 . . . . 20.88 111.28 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.636 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 10.6 p -58.71 -33.0 14.53 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 114.728 1.381 . . . . 19.88 114.728 -172.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 10.9 Cg_endo -54.31 -32.79 73.28 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.973 1.782 . . . . 18.7 113.384 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -120.64 -24.11 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 18.91 111.582 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.88 -101.44 2.06 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.762 -0.935 . . . . 15.32 110.762 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 m 54.44 53.08 11.32 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.918 0.422 . . . . 14.03 111.538 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -67.53 -50.56 58.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.873 -0.788 . . . . 12.65 108.873 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm 50.32 64.53 1.76 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.334 -0.848 . . . . 11.98 111.413 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -133.18 120.7 2.66 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.451 -0.88 . . . . 8.1 112.841 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.448 ' HD2' ' OG1' ' A' ' 131' ' ' THR . 6.1 tpm_? -84.54 60.36 6.02 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.422 0.63 . . . . 9.18 109.68 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -121.55 18.71 11.26 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 122.588 1.185 . . . . 6.14 108.615 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.79 147.2 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 112.982 -1.917 . . . . 4.84 109.483 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -65.12 155.66 34.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.206 -0.452 . . . . 4.29 111.01 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.782 HD23 ' HD3' ' A' ' 115' ' ' PRO . 3.1 tt -101.6 113.21 26.15 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.021 -0.733 . . . . 1.69 109.021 177.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.747 ' HA ' HD13 ' A' ' 183' ' ' ILE . 7.3 tt0 -178.2 50.69 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.797 0.685 . . . . 3.45 110.208 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.782 ' HD3' HD23 ' A' ' 113' ' ' LEU . 7.8 Cg_endo -89.72 176.31 2.91 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.812 2.341 . . . . 3.06 111.413 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.48 21.24 0.14 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.521 -0.763 . . . . 3.24 109.743 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.792 ' HG3' HG23 ' A' ' 119' ' ' ILE . 43.2 tpp -46.57 141.66 3.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.49 1.116 . . . . 1.45 112.474 -172.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.807 HG23 ' HB3' ' A' ' 179' ' ' HIS . 22.7 m -125.44 97.39 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.081 -0.963 . . . . 0.32 108.983 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.868 HD11 ' CD1' ' A' ' 175' ' ' PHE . 7.6 pt -126.53 171.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.097 0.951 . . . . 0.2 111.283 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.859 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 19.4 t -114.05 170.2 8.45 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.831 -1.532 . . . . 1.29 109.319 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -52.66 -48.75 66.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 3.26 111.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 46.1 m-80 -83.86 -15.39 48.32 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.669 -0.241 . . . . 2.17 110.616 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.95 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -65.98 -24.14 66.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.277 -0.569 . . . . 0.5 110.471 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.27 -26.5 24.95 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.764 -1.174 . . . . 3.06 110.058 178.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG23 ' SD ' ' A' ' 124' ' ' MET . 2.0 t -65.16 -28.69 45.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.796 -1.093 . . . . 0.35 111.349 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.76 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -81.67 -38.53 25.73 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.642 -1.163 . . . . 1.51 110.177 171.157 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.95 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -56.17 -44.09 79.0 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 114.643 1.349 . . . . 0.4 114.643 -175.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.891 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -61.07 -39.78 91.19 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 116.778 -1.969 . . . . 0.32 109.374 177.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 21.9 mt-10 -65.6 -28.98 69.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.7 1.238 . . . . 2.51 108.088 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.06 -7.83 47.61 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 112.848 -1.978 . . . . 0.33 110.977 -170.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.1 t -122.13 -2.38 9.14 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.558 0.694 . . . . 0.36 109.996 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 71.07 56.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.703 -1.589 . . . . 2.19 111.829 -177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.62 146.34 27.24 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.198 -1.779 . . . . 0.27 106.198 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.666 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.09 163.81 35.09 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.668 -1.234 . . . . 0.69 107.668 -176.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.526 ' CB ' HG12 ' A' ' 147' ' ' VAL . 4.3 pt20 -48.97 159.33 0.26 Allowed 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.404 1.097 . . . . 1.96 112.3 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.9 t -148.43 151.83 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-N 113.557 -1.656 . . . . 0.27 111.093 -172.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 m -60.19 -50.12 74.92 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.987 0.899 . . . . 0.73 111.37 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -159.06 115.76 2.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.879 -1.509 . . . . 0.51 108.424 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.943 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.71 108.14 16.59 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.79 1.281 . . . . 2.71 110.708 -167.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.791 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -157.33 93.95 1.35 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.649 -1.614 . . . . 0.35 108.55 161.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.9 mmt180 -151.98 170.17 8.37 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 113.352 -1.749 . . . . 2.38 107.589 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.16 111.75 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 CA-C-N 119.868 0.989 . . . . 0.79 110.478 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.8 22.69 65.88 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.824 -0.703 . . . . 0.38 114.217 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -132.22 132.56 43.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.92 -1.511 . . . . 1.49 106.92 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.4 m-85 -133.42 173.83 11.06 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.89 -1.124 . . . . 0.3 110.507 -167.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 139' ' ' MET . 7.7 p -112.53 136.39 52.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.276 0.56 . . . . 0.19 109.953 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 135' ' ' GLN . 1.2 p -111.41 143.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.097 -0.956 . . . . 0.86 111.803 -171.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -129.16 -85.14 0.56 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.398 -0.364 . . . . 2.45 111.501 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.1 -83.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.141 0.423 . . . . 0.49 112.141 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.616 ' CB ' HD13 ' A' ' 197' ' ' LEU . 48.3 m-80 -88.24 -5.55 58.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.444 0.64 . . . . 1.02 109.709 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.9 m -143.22 146.78 33.96 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.154 -0.618 . . . . 0.94 109.643 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.8 mt -114.48 168.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.552 -0.907 . . . . 0.2 108.552 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 20.8 tt0 -111.49 132.71 54.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.728 -1.582 . . . . 0.97 106.728 167.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.1 tmt? -134.71 124.48 25.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 118.691 0.678 . . . . 1.32 111.151 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -61.44 118.64 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.33 111.283 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 169' ' ' VAL . 13.5 tpt180 -62.69 120.24 10.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.289 -1.004 . . . . 3.1 108.289 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -47.32 127.56 9.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.807 0.692 . . . . 4.26 112.085 -174.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.433 ' HB2' ' O ' ' A' ' 166' ' ' GLU . 28.2 Cg_endo -66.47 175.82 4.73 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.971 2.447 . . . . 2.01 112.499 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.62 ' CE1' ' HA3' ' A' ' 167' ' ' GLY . 9.4 p90 -91.69 155.79 18.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 5.12 110.893 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.47 127.75 54.85 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.083 -0.962 . . . . 5.15 111.216 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.637 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 19.4 m-85 -119.98 169.35 8.61 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-N 115.286 -0.87 . . . . 6.81 109.435 170.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.9 Cg_endo -75.31 -42.01 0.53 Allowed 'Trans proline' 0 N--CA 1.412 -3.279 0 C-N-CA 121.565 1.51 . . . . 8.97 111.296 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.12 -5.49 40.63 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 112.728 -2.033 . . . . 10.53 108.526 -172.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 10.2 p -162.46 146.36 11.76 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-N 114.138 -1.392 . . . . 7.9 112.523 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.44 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 78.5 mttt -145.55 119.09 9.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.3 0.572 . . . . 6.69 111.842 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 9.7 pt-20 -176.13 -163.84 0.11 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.567 -1.197 . . . . 5.04 112.194 -166.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.62 ' HA3' ' CE1' ' A' ' 159' ' ' PHE . . . 78.38 58.33 3.15 Favored Glycine 0 CA--C 1.502 -0.772 0 CA-C-N 115.37 -0.832 . . . . 2.11 112.115 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -91.64 155.97 17.95 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.736 0.779 . . . . 2.93 110.983 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.7 t -146.33 150.83 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 114.069 -1.423 . . . . 0.48 107.775 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.756 ' HB3' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -106.5 150.15 26.39 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.986 0.898 . . . . 1.61 112.445 176.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -124.97 159.33 31.5 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 113.443 -1.708 . . . . 0.2 111.313 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.85 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.4 tpt180 -108.02 101.24 10.5 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.819 -1.178 . . . . 3.69 107.819 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.552 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -93.68 113.55 25.65 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 112.988 -1.915 . . . . 0.61 110.115 -170.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 181' ' ' ALA . 52.6 m -112.5 148.79 33.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.654 0.613 . . . . 0.21 112.654 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.2 m-85 -116.35 112.68 21.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.011 -0.995 . . . . 0.32 111.807 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.594 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.8 t70 -102.35 95.68 6.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.067 0.46 . . . . 0.74 110.537 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.44 -114.02 3.76 Favored Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.17 -1.014 . . . . 0.27 114.187 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -105.75 5.0 30.56 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 108.07 -1.085 . . . . 1.61 108.07 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.807 ' HB3' HG23 ' A' ' 118' ' ' THR . 21.8 p80 -141.58 160.2 40.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.604 -1.18 . . . . 1.28 112.517 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.766 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -65.99 134.6 53.26 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 114.391 -1.277 . . . . 0.22 109.698 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.36 -48.28 8.61 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 114.387 -1.279 . . . . 0.15 111.122 -175.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.502 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.2 t 175.76 177.96 0.19 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.044 -0.98 . . . . 0.28 110.386 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.766 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -149.38 122.51 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.999 -1.482 . . . . 0.28 106.999 175.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.696 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 97.0 t -127.09 123.66 62.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 118.965 -0.541 . . . . 0.34 112.279 -170.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.52 94.18 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.777 0.799 . . . . 1.64 109.379 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.85 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 50.2 mmm -43.22 -37.87 2.31 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 112.734 -2.03 . . . . 1.42 112.752 -172.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.589 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.3 mt-10 -63.19 -40.53 97.78 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 113.488 -1.687 . . . . 0.68 111.224 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -101.68 -30.58 11.25 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.896 -1.502 . . . . 2.36 111.471 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.696 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 14.4 p30 38.58 31.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.141 1.376 . . . . 1.8 114.512 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -141.65 154.37 45.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.798 -0.816 . . . . 4.13 108.798 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 46.86 27.11 0.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.061 0.945 . . . . 4.05 112.883 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -127.83 -33.44 2.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.891 -0.781 . . . . 1.83 108.891 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' HG22 ' A' ' 184' ' ' VAL . . . 177.67 -164.28 33.22 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.209 -0.905 . . . . 1.84 112.236 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -166.35 136.25 3.24 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.372 -0.603 . . . . 4.57 109.372 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -114.04 130.46 56.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.16 0.505 . . . . 6.25 111.913 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 75.6 mtm180 -134.85 121.08 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 6.4 109.497 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.616 HD13 ' CB ' ' A' ' 150' ' ' ASN . 10.5 mt -156.84 138.59 14.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 1.4 111.83 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 8.8 p-10 -138.61 140.03 26.41 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.285 -0.635 . . . . 3.38 109.285 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 36.0 Cg_exo -57.98 107.97 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.992 2.461 . . . . 4.74 113.08 -175.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.578 -0.725 . . . . 7.73 109.576 177.217 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.494 0.188 . . . . 31.14 111.013 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.58 171.45 24.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.57 -0.824 . . . . 30.65 112.053 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 p -89.25 77.87 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 30.65 111.361 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 m 60.87 74.05 0.46 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.718 -0.673 . . . . 29.78 111.312 176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -82.09 90.44 6.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.789 -0.641 . . . . 29.55 110.487 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 62.0 m80 -79.86 81.87 6.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.619 -0.719 . . . . 29.87 109.729 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 34.7 m80 71.65 -80.19 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.3 -0.864 . . . . 27.89 111.096 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 54.87 52.14 12.49 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.501 0.667 . . . . 26.19 110.755 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -172.19 -50.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.001 -0.74 . . . . 26.23 109.001 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -136.52 135.89 38.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.723 -0.671 . . . . 26.64 109.872 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.6 m -103.73 -26.1 12.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.072 -0.513 . . . . 24.71 110.552 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -154.53 57.72 0.69 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.311 0.577 . . . . 24.15 110.046 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.22 110.52 1.89 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.894 -0.669 . . . . 22.66 112.227 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -79.42 67.69 5.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.323 0.583 . . . . 20.88 110.391 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.54 123.85 41.31 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 19.88 110.671 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.63 120.7 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.457 2.105 . . . . 18.7 112.698 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 0.8 OUTLIER -81.56 110.17 16.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.491 -0.559 . . . . 18.91 109.491 176.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 -110.54 3.94 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.724 -0.95 . . . . 15.32 110.724 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.4 t 53.0 50.83 17.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.108 0.48 . . . . 14.03 111.502 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -144.79 -175.02 4.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.499 -0.319 . . . . 12.65 111.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.453 ' O ' HG12 ' A' ' 111' ' ' VAL . 5.7 tpt 73.55 -59.94 0.55 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.02 0.928 . . . . 11.98 111.961 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.89 7.94 8.67 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.617 0.607 . . . . 8.1 114.617 -172.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -115.09 6.5 15.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.843 0.821 . . . . 9.18 111.157 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.57 14.63 5.99 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.058 0.932 . . . . 6.14 109.674 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 107' ' ' MET . 8.2 p -158.92 150.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.773 -1.558 . . . . 4.84 109.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.46 138.67 50.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.064 -0.717 . . . . 4.29 109.064 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 114' ' ' GLU . 3.8 tt -64.24 145.24 56.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.234 -0.439 . . . . 1.69 110.406 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.726 ' N ' HD23 ' A' ' 113' ' ' LEU . 5.7 tp10 -175.63 155.39 1.64 Allowed Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 107.046 -1.464 . . . . 3.45 107.046 -172.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 114' ' ' GLU . 11.7 Cg_endo -89.64 102.98 0.35 Allowed 'Trans proline' 0 N--CA 1.423 -2.647 0 CA-C-N 121.793 1.676 . . . . 3.06 112.553 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.52 -4.26 15.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 102.197 -3.261 . . . . 3.24 102.197 142.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.569 ' HG3' HG23 ' A' ' 119' ' ' ILE . 8.4 tpt -83.54 144.31 29.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 110.825 -2.898 . . . . 1.45 111.88 -161.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.7 m -132.52 98.24 4.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.87 -1.059 . . . . 0.32 109.039 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.887 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.8 pt -129.76 172.67 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.227 1.013 . . . . 0.2 112.0 -171.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.6 m -114.64 173.79 6.29 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.709 -1.587 . . . . 1.29 110.215 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.632 ' O ' ' HG3' ' A' ' 124' ' ' MET . 2.5 mppt? -51.58 -53.1 41.74 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.343 0.402 . . . . 3.26 111.962 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 m-20 -82.93 -15.26 52.05 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.624 -0.262 . . . . 2.17 110.71 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.904 ' O ' HD12 ' A' ' 127' ' ' LEU . 3.0 mt-10 -65.36 -23.72 67.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.002 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.28 -29.56 24.48 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 118.474 -1.29 . . . . 3.06 110.057 178.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.17 -31.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.466 1.127 . . . . 0.35 111.833 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.755 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.93 -42.51 23.9 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.169 -1.378 . . . . 1.51 109.73 170.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.53 -38.49 84.6 Favored 'General case' 0 CA--C 1.462 -2.424 0 CA-C-O 117.523 -1.227 . . . . 0.4 114.067 -173.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.57 -39.82 94.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 116.153 -2.219 . . . . 0.32 108.72 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.682 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 63.1 mm-40 -68.82 -30.68 69.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 123.04 1.4 . . . . 2.51 108.923 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.41 -7.6 58.85 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 111.857 -2.429 . . . . 0.33 110.23 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.77 -3.94 9.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.245 -0.889 . . . . 0.36 109.387 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 131' ' ' THR . 49.1 mt-30 79.96 55.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 113.757 -1.565 . . . . 2.19 112.235 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -154.28 146.5 23.79 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.886 -1.524 . . . . 0.27 106.886 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.607 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -144.52 161.33 39.35 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.371 -1.714 . . . . 0.69 106.371 -177.325 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.24 159.4 1.94 Allowed 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 119.281 0.946 . . . . 1.96 112.029 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -145.91 155.82 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-N 114.19 -1.368 . . . . 0.27 112.019 -168.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.2 m -59.51 -51.15 71.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.05 0.929 . . . . 0.73 111.639 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.532 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -159.78 114.51 2.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 113.931 -1.486 . . . . 0.51 108.117 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.972 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.89 105.08 11.85 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 123.035 1.398 . . . . 2.71 111.24 -166.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.803 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.0 t -157.41 94.25 1.37 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.558 -1.655 . . . . 0.35 108.47 162.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.803 ' HD3' ' O ' ' A' ' 140' ' ' THR . 7.6 mmt180 -151.44 168.02 11.93 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 113.477 -1.692 . . . . 2.38 107.158 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.45 111.69 2.63 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 CA-C-N 119.897 0.999 . . . . 0.79 109.899 164.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.81 27.76 58.11 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.2 -1.0 . . . . 0.38 113.902 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.9 mt-10 -140.85 131.25 25.21 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.407 -1.331 . . . . 1.49 107.407 172.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.78 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -133.88 176.35 8.65 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.419 -0.913 . . . . 0.3 110.511 -167.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.972 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.3 p -113.09 137.54 51.28 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.962 0.886 . . . . 0.19 112.505 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 51.6 t -97.62 138.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.451 -1.704 . . . . 0.86 111.12 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 151' ' ' SER . 88.0 mm-40 -123.14 -90.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.935 -0.12 . . . . 2.45 110.972 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.79 -87.31 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.653 0.263 . . . . 0.49 111.337 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 47.8 m-80 -82.98 -3.14 56.84 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.062 0.458 . . . . 1.02 109.786 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 20.4 m -141.33 146.13 36.32 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.371 -0.532 . . . . 0.94 110.357 172.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -107.26 170.66 2.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.351 -1.351 . . . . 0.2 107.351 168.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.6 tt0 -116.33 136.26 53.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.764 -1.569 . . . . 0.97 106.764 165.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.429 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.1 tmt? -136.5 124.81 23.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 118.592 0.633 . . . . 1.32 112.367 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.14 128.06 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.594 -0.521 . . . . 0.33 109.594 175.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.16 164.67 23.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.514 -0.55 . . . . 3.1 109.514 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -60.21 118.94 37.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.527 -0.306 . . . . 4.26 110.512 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 10.2 Cg_endo -61.79 168.75 8.15 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.617 2.211 . . . . 2.01 113.003 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.64 147.95 40.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.174 -0.921 . . . . 5.12 111.333 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.46 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 7.2 m-20 -126.99 133.21 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.07 -0.968 . . . . 5.15 110.643 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.687 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 86.4 m-85 -120.16 171.59 5.52 Favored Pre-proline 0 N--CA 1.424 -1.746 0 CA-C-O 121.557 0.694 . . . . 6.81 109.941 167.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 5.6 Cg_endo -80.91 -46.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.522 0 C-N-CA 121.845 1.696 . . . . 8.97 110.846 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.86 2.18 53.52 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.012 -1.903 . . . . 10.53 110.166 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -163.17 162.66 25.63 Favored 'General case' 0 C--O 1.203 -1.382 0 CA-C-N 113.934 -1.485 . . . . 7.9 110.297 -172.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.687 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 65.5 mttt -153.2 138.71 17.7 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 118.594 0.634 . . . . 6.69 110.55 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.4 -167.02 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 112.877 0.695 . . . . 5.04 112.877 -168.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 77.45 160.64 13.07 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.146 -0.934 . . . . 2.11 112.526 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 0.5 OUTLIER -150.53 138.23 19.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.033 -0.729 . . . . 2.93 109.033 170.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 170' ' ' ARG . 89.9 t -142.14 145.44 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.387 0 CA-C-N 115.202 -0.908 . . . . 0.48 109.166 175.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HB2' ' CE ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -126.41 144.9 50.68 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.197 0.999 . . . . 1.61 113.165 177.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 167.67 10.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.313 -1.767 . . . . 0.2 110.517 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.764 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 48.2 ttp180 -116.22 122.74 45.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.419 -1.326 . . . . 3.69 107.419 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -112.11 110.53 20.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.288 -1.324 . . . . 0.61 110.203 -164.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.512 ' CG2' HD11 ' A' ' 197' ' ' LEU . 51.9 m -107.64 150.25 27.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.229 0.538 . . . . 0.21 112.308 -169.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.887 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.6 m-85 -115.66 102.46 9.77 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.566 -1.197 . . . . 0.32 113.212 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.621 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 31.0 t70 -92.11 101.65 14.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.85 0.357 . . . . 0.74 110.972 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.66 -117.21 4.36 Favored Glycine 0 C--N 1.318 -0.461 0 C-N-CA 120.048 -1.072 . . . . 0.27 113.485 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.66 10.61 22.85 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.5 -1.667 . . . . 1.61 106.5 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.804 ' HB3' HG23 ' A' ' 118' ' ' THR . 24.4 p80 -137.89 161.66 36.06 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.287 -1.324 . . . . 1.28 112.083 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 183' ' ' ILE . 8.5 tp -68.19 136.38 53.53 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.607 -1.178 . . . . 0.22 110.502 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.621 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.46 -50.06 6.79 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.392 -1.276 . . . . 0.15 111.364 -176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.6 t 179.23 178.4 0.49 Allowed 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.036 -0.984 . . . . 0.28 109.903 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.765 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -147.89 112.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 106.459 -1.682 . . . . 0.28 106.459 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.767 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -115.16 129.8 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 113.15 0.796 . . . . 0.34 113.15 -169.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 188' ' ' ASN . 25.1 p-10 -60.07 95.52 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.108 0.956 . . . . 1.64 109.693 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 66.6 mmm -51.47 -25.61 6.78 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 113.37 -1.741 . . . . 1.42 112.949 -169.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.6 mt-10 -68.26 -42.6 79.36 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.452 -1.249 . . . . 0.68 110.635 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.416 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 5.5 t-20 -103.49 -25.73 13.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.707 -1.588 . . . . 2.36 111.663 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.767 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 10.3 p30 36.69 38.6 0.08 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.843 1.423 . . . . 1.8 114.843 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -141.63 -37.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.254 -0.43 . . . . 4.13 110.402 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -52.57 -60.72 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 4.05 111.789 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 184' ' ' VAL . 1.4 m-85 -93.99 20.02 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.59 -0.444 . . . . 1.83 109.827 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.68 133.09 41.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 1.84 113.623 -170.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.65 -174.2 2.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.861 -0.669 . . . . 4.57 111.023 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -78.51 158.88 28.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.981 -0.554 . . . . 6.25 111.028 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 199' ' ' PRO . 52.4 ttp85 -82.94 144.83 29.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.57 -0.741 . . . . 6.4 110.441 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.628 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 21.1 mt -75.64 124.64 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.177 -0.465 . . . . 1.4 111.684 -176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 52.72 73.92 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.03 -0.986 . . . . 3.38 111.096 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.407 ' HA ' ' NH2' ' A' ' 196' ' ' ARG . 2.8 Cg_exo -75.88 66.14 6.78 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.242 2.628 . . . . 4.74 112.399 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.949 -0.569 . . . . 7.73 110.368 177.562 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.3 m . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 121.563 0.697 . . . . 0.32 109.511 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.846 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.09 171.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.098 -0.956 . . . . 0.2 110.829 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.773 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 p -120.39 179.19 4.38 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.411 -0.813 . . . . 1.29 110.644 -172.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 124' ' ' MET . 87.3 tttt -53.62 -40.22 65.59 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.485 0.491 . . . . 3.26 111.343 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 8.0 m-20 -82.56 -24.04 34.18 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 116.602 -0.272 . . . . 2.17 111.246 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.803 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 25.0 mt-10 -68.99 -34.0 74.58 Favored 'General case' 0 N--CA 1.41 -2.447 0 C-N-CA 117.826 -1.55 . . . . 0.5 109.34 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.721 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.81 -33.65 76.07 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 119.008 -1.077 . . . . 3.06 109.362 177.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' HD21 ' A' ' 128' ' ' LEU . 1.8 t -66.25 -31.64 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.276 -0.874 . . . . 0.35 112.087 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.803 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -85.81 -32.82 21.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.724 -0.671 . . . . 1.51 110.779 173.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.14 -46.75 87.56 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 114.962 1.467 . . . . 0.4 114.962 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.804 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -58.98 -38.03 78.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.711 -1.996 . . . . 0.32 109.164 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.555 ' N ' HD23 ' A' ' 128' ' ' LEU . 30.1 mt-10 -65.86 -32.43 73.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.652 1.215 . . . . 2.51 107.954 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.817 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.62 -7.74 55.86 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 112.599 -2.091 . . . . 0.33 110.948 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.5 t -122.06 1.18 9.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.22 -0.9 . . . . 0.36 109.275 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 66.56 56.87 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.535 -1.666 . . . . 2.19 111.867 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.804 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.98 147.22 27.6 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.972 -1.492 . . . . 0.27 106.972 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.599 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.01 154.65 42.75 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.003 -1.11 . . . . 0.69 108.003 -173.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -47.45 144.61 2.91 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.794 0.807 . . . . 1.96 112.339 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 134' ' ' ARG . 2.6 t -136.11 150.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.1 -1.409 . . . . 0.27 112.079 -171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.4 m -59.9 -50.08 75.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.865 -1.062 . . . . 0.73 111.57 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 19.1 ptmt -156.93 116.02 3.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.24 -1.345 . . . . 0.51 108.836 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.023 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.21 102.77 9.65 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.938 -1.483 . . . . 2.71 111.155 -167.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.4 t -157.29 92.63 1.26 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.395 -1.275 . . . . 0.35 109.535 162.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -153.94 158.64 32.51 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.903 -1.499 . . . . 2.38 107.519 169.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -75.66 109.76 2.96 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 CA-C-N 120.421 1.186 . . . . 0.79 109.574 167.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.23 2.94 57.86 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.498 -0.858 . . . . 0.38 114.439 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.0 mt-10 -128.84 132.33 47.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.202 1.001 . . . . 1.49 108.609 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.831 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.1 m-85 -133.16 176.24 8.68 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.112 -0.635 . . . . 0.3 110.224 -166.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 1.023 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.3 p -110.12 142.19 41.94 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.711 0.767 . . . . 0.19 111.655 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 128' ' ' LEU . 41.1 t -100.98 138.76 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.213 -1.358 . . . . 0.86 111.684 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.661 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.8 tp-100 -124.96 -87.54 0.61 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.479 -0.328 . . . . 2.45 110.751 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.39 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.728 0.27 . . . . 0.49 111.728 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.4 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 88.3 m-20 -81.52 -5.15 57.69 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.482 -0.562 . . . . 1.02 109.482 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 31.0 p -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.674 -0.694 . . . . 0.94 110.043 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.642 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.0 mt -106.73 170.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.184 -1.413 . . . . 0.2 107.184 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 24.4 tt0 -116.97 137.3 52.31 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.989 -1.485 . . . . 0.97 106.989 166.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.488 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -133.46 124.67 27.46 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.655 -0.818 . . . . 1.32 112.3 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.756 0 CA-C-N 115.669 -0.696 . . . . 0.33 109.992 173.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 155' ' ' ILE . 77.1 t . . . . . 0 CA--C 1.492 -1.266 0 N-CA-C 108.406 -0.961 . . . . 0.48 108.406 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -129.74 145.11 51.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.305 1.05 . . . . 1.61 113.234 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.63 163.53 15.65 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.194 -1.821 . . . . 0.2 109.83 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 74.9 ttt180 -111.94 127.15 55.77 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.97 -1.122 . . . . 3.69 107.97 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.642 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -114.84 111.38 21.13 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.402 -1.272 . . . . 0.61 110.682 -165.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.435 ' HB ' HG22 ' A' ' 182' ' ' THR . 96.3 m -109.31 150.49 27.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.347 0.594 . . . . 0.21 112.25 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.846 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.5 m-85 -115.65 114.09 24.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.358 -1.292 . . . . 0.32 111.853 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.542 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.2 t70 -104.63 103.41 13.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.74 111.393 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.82 -113.22 3.61 Favored Glycine 0 C--N 1.314 -0.691 0 C-N-CA 120.054 -1.069 . . . . 0.27 113.409 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.51 8.7 19.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.262 -1.384 . . . . 1.61 107.262 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.777 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.5 p80 -135.71 160.99 36.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.635 -1.166 . . . . 1.28 112.315 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 183' ' ' ILE . 9.2 tp -69.31 130.57 42.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 114.524 -1.216 . . . . 0.22 110.158 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.28 -49.99 10.82 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.426 -1.261 . . . . 0.15 110.821 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.435 HG22 ' HB ' ' A' ' 174' ' ' THR . 5.9 t -179.99 177.46 0.66 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.903 -1.044 . . . . 0.28 110.94 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.802 HD11 HD21 ' A' ' 180' ' ' LEU . 2.9 mp -151.17 128.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.7 -1.963 . . . . 0.28 105.7 173.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.775 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.2 t -133.99 119.47 32.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.015 -0.674 . . . . 0.34 112.207 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 98.59 0.06 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.156 -1.053 . . . . 1.64 108.156 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 75.3 mmm -53.03 -27.26 18.81 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 112.379 -2.192 . . . . 1.42 112.741 -167.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.9 mt-10 -65.67 -43.04 90.5 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 114.164 -1.38 . . . . 0.68 110.982 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.14 -19.86 13.48 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.152 -1.385 . . . . 2.36 111.27 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.775 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.2 p30 . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 114.253 1.205 . . . . 1.8 114.253 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 179' ' ' HIS . 3.6 m . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 108.657 -0.868 . . . . 0.32 108.657 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -133.88 172.49 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-O 122.43 1.109 . . . . 0.2 111.745 -174.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.865 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.9 m -110.49 165.86 11.46 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.53 -1.668 . . . . 1.29 109.138 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -52.12 -48.15 64.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.13 0.49 . . . . 3.26 110.995 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.5 m120 -81.02 -16.73 52.55 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.967 -0.56 . . . . 2.17 110.151 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.865 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.4 mt-10 -68.23 -25.94 65.46 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.422 0.63 . . . . 0.5 109.98 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 8.0 tpt -86.65 -28.14 23.37 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 117.882 -1.527 . . . . 3.06 109.632 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.71 -31.28 43.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.308 1.051 . . . . 0.35 111.986 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.719 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -81.69 -42.77 19.42 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.596 -1.184 . . . . 1.51 109.822 170.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.93 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.69 -36.68 81.58 Favored 'General case' 0 CA--C 1.463 -2.367 0 CA-C-O 117.477 -1.249 . . . . 0.4 113.768 -174.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -63.0 -40.06 96.64 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 116.356 -2.138 . . . . 0.32 108.631 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.675 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 51.8 mm-40 -68.9 -30.66 69.19 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 123.125 1.441 . . . . 2.51 108.665 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.03 -7.56 59.08 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 111.962 -2.381 . . . . 0.33 109.93 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.8 t -121.62 -2.07 9.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.191 -0.913 . . . . 0.36 108.937 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 77.1 52.73 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 113.523 -1.671 . . . . 2.19 112.482 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -151.09 143.73 24.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.575 -1.639 . . . . 0.27 106.575 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.646 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -142.45 163.22 33.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.69 -1.596 . . . . 0.69 106.69 -174.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.2 161.75 1.67 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.987 0.899 . . . . 1.96 111.277 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -147.61 153.02 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.243 -1.344 . . . . 0.27 111.718 -168.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -60.04 -49.56 77.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.803 0.811 . . . . 0.73 111.695 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.95 115.35 2.67 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.212 -1.358 . . . . 0.51 109.027 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.049 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.91 101.23 6.73 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-O 123.286 1.517 . . . . 2.71 111.656 -168.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.808 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.7 t -158.33 93.62 1.23 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.493 -1.685 . . . . 0.35 109.034 161.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.808 ' HD3' ' O ' ' A' ' 140' ' ' THR . 17.6 mmt180 -151.09 164.65 19.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 113.56 -1.655 . . . . 2.38 107.176 174.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.57 110.64 2.45 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 CA-C-N 119.975 1.027 . . . . 0.79 109.903 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.59 5.38 69.19 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.461 -0.876 . . . . 0.38 114.21 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.1 mm-40 -126.62 131.5 51.46 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.331 -1.359 . . . . 1.49 107.331 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.772 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.98 175.93 9.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.08 -1.048 . . . . 0.3 110.648 -166.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 1.049 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.0 p -111.49 142.03 44.29 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.647 0.737 . . . . 0.19 111.945 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 65.8 t -105.76 145.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.231 -1.349 . . . . 0.86 111.676 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -132.46 -87.31 0.45 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.347 -0.141 . . . . 2.45 111.097 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.43 -82.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.587 0.217 . . . . 0.49 111.587 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -82.03 -6.56 59.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 120.834 0.349 . . . . 1.02 110.282 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.5 p -149.92 145.87 26.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.88 -0.728 . . . . 0.94 111.028 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -109.68 166.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.136 -1.061 . . . . 0.2 108.136 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.772 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 3.2 tp10 -110.81 134.09 52.8 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.693 -1.595 . . . . 0.97 106.693 167.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -131.86 122.38 25.61 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 118.966 0.803 . . . . 1.32 112.425 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.837 0 CA-C-N 115.434 -0.803 . . . . 0.33 109.839 173.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 187' ' ' GLU . 65.2 t . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 107.613 -1.254 . . . . 0.48 107.613 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.23 145.21 50.09 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 122.326 1.06 . . . . 1.61 113.155 176.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.46 165.24 13.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.21 -1.813 . . . . 0.2 110.333 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.6 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 17.0 tpt180 -115.86 120.04 37.92 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.146 -1.057 . . . . 3.69 108.146 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.39 118.32 33.52 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.181 -1.372 . . . . 0.61 110.429 -164.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 175' ' ' PHE . 99.5 m -115.31 152.43 32.77 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.574 0.583 . . . . 0.21 112.574 -170.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.7 m-85 -114.66 109.26 17.95 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.696 -1.138 . . . . 0.32 112.294 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.572 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 27.5 t70 -98.87 96.52 7.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.047 0.451 . . . . 0.74 111.211 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.69 -117.43 4.44 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.22 -0.991 . . . . 0.27 113.179 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.77 11.04 22.61 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.416 -1.698 . . . . 1.61 106.416 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.717 ' HB3' HG23 ' A' ' 118' ' ' THR . 11.8 p-80 -138.0 161.07 37.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.141 -1.391 . . . . 1.28 111.782 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 183' ' ' ILE . 9.3 tp -67.98 136.1 53.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.133 -0.94 . . . . 0.22 110.886 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.572 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -84.11 -54.01 5.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.515 -1.22 . . . . 0.15 111.412 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.0 t -178.91 176.42 0.92 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.28 110.496 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.803 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.33 124.69 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.949 -1.5 . . . . 0.28 106.949 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.701 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.8 t -129.84 118.1 43.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.422 0.527 . . . . 0.34 112.422 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.89 101.09 0.1 Allowed 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.044 -1.095 . . . . 1.64 108.044 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.3 mmt -58.81 -16.81 18.84 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 112.833 -1.985 . . . . 1.42 112.675 -168.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.575 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.7 mt-10 -73.47 -44.35 58.17 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.743 -1.117 . . . . 0.68 110.003 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.65 -33.78 14.94 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.261 -1.336 . . . . 2.36 110.913 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.701 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.9 p30 . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 115.218 1.562 . . . . 1.8 115.218 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.6 m . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 108.649 -0.871 . . . . 0.32 108.649 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.912 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.7 pt -133.62 172.47 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.996 0.903 . . . . 0.2 111.227 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.868 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.6 t -117.47 172.18 7.5 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.019 -1.446 . . . . 1.29 109.547 -173.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 124' ' ' MET . 37.5 ttmt -56.0 -45.2 79.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.886 0.374 . . . . 3.26 111.307 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -83.35 -17.34 42.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 110.249 -0.278 . . . . 2.17 110.249 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -69.27 -22.77 63.8 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.124 -0.63 . . . . 0.5 110.46 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.777 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.95 -30.53 22.72 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 118.462 -1.295 . . . . 3.06 109.366 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.5 -30.62 46.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.115 0.959 . . . . 0.35 111.952 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.626 -1.17 . . . . 1.51 109.737 171.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.45 -35.76 78.51 Favored 'General case' 0 CA--C 1.462 -2.423 0 CA-C-O 117.683 -1.151 . . . . 0.4 114.027 -172.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.5 -43.18 94.9 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 115.915 -2.314 . . . . 0.32 109.093 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 59.3 mm-40 -65.36 -27.91 68.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.808 1.289 . . . . 2.51 108.635 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.78 -8.16 54.92 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.258 -2.246 . . . . 0.33 110.28 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.1 t -122.46 0.27 9.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.416 -0.811 . . . . 0.36 109.354 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 74.49 54.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.653 -1.612 . . . . 2.19 112.543 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.16 144.65 24.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.498 -1.667 . . . . 0.27 106.498 178.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.616 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -145.6 164.09 32.77 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.188 -1.782 . . . . 0.69 106.188 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.571 ' CB ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.73 160.65 0.28 Allowed 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.207 1.003 . . . . 1.96 112.731 -177.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -148.0 151.57 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 113.946 -1.479 . . . . 0.27 112.015 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.1 m -59.74 -50.02 75.45 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.114 -0.948 . . . . 0.73 111.658 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.4 ptmt -159.03 117.04 2.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.015 -1.448 . . . . 0.51 108.66 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.994 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.85 100.55 6.39 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 123.504 1.621 . . . . 2.71 111.761 -168.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.811 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 t -158.2 90.99 1.07 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.194 -1.821 . . . . 0.35 108.677 159.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.811 ' HD3' ' O ' ' A' ' 140' ' ' THR . 9.1 mmt180 -153.95 134.51 8.17 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 113.623 -1.626 . . . . 2.38 106.705 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.98 109.25 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 121.353 1.519 . . . . 0.79 109.894 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.26 -1.39 57.42 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.689 -0.767 . . . . 0.38 114.025 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 1.5 mm-40 -125.66 131.7 52.57 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.738 -1.208 . . . . 1.49 107.738 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.875 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -130.85 175.2 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.156 -1.018 . . . . 0.3 110.169 -168.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.994 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.5 p -112.63 134.13 54.32 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.572 -0.451 . . . . 0.19 110.623 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 135' ' ' GLN . 0.5 OUTLIER -113.51 153.29 15.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.061 -0.972 . . . . 0.86 112.17 -174.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -152.95 -85.32 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.6 0.593 . . . . 2.45 112.6 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.48 -92.01 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.173 0.805 . . . . 0.49 113.173 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -81.95 -6.99 59.57 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.687 0.28 . . . . 1.02 111.341 -174.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.3 p -150.56 145.75 26.13 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.61 -0.836 . . . . 0.94 110.327 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.588 ' CD1' HD12 ' A' ' 128' ' ' LEU . 6.6 mt -110.04 162.45 7.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.911 -0.774 . . . . 0.2 108.911 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.4 tp10 -107.6 132.96 52.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.995 -1.483 . . . . 0.97 106.995 167.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.719 ' HG3' ' CE2' ' A' ' 145' ' ' PHE . 3.8 ttt -126.52 124.25 39.62 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.239 -0.585 . . . . 1.32 112.137 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.139 -0.689 . . . . 0.33 109.139 168.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.459 HG13 ' CD ' ' A' ' 187' ' ' GLU . 66.0 t . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 109.487 -0.561 . . . . 0.48 109.487 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -131.35 145.37 51.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.345 1.069 . . . . 1.61 113.469 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.56 165.88 12.74 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.993 -1.912 . . . . 0.2 110.921 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.457 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 2.2 tpp180 -115.65 111.89 21.3 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.747 -1.205 . . . . 3.69 107.747 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.578 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -107.92 118.15 35.99 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.217 -1.811 . . . . 0.61 109.969 -166.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.487 ' HB ' HG22 ' A' ' 182' ' ' THR . 87.5 m -114.43 150.86 34.07 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.762 0.653 . . . . 0.21 112.762 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.912 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.8 m-85 -115.26 112.47 22.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.663 -1.153 . . . . 0.32 112.212 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.591 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 25.8 t70 -102.96 98.48 8.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.965 0.412 . . . . 0.74 110.803 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.67 -120.45 5.28 Favored Glycine 0 C--N 1.317 -0.517 0 C-N-CA 120.085 -1.055 . . . . 0.27 112.85 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.74 14.17 22.29 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.829 -1.545 . . . . 1.61 106.829 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.0 p-80 -138.96 159.06 43.04 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.024 -1.444 . . . . 1.28 111.735 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -66.36 137.08 56.64 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.055 -0.975 . . . . 0.22 111.01 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.591 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.07 -51.48 5.98 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.48 -1.236 . . . . 0.15 111.653 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.1 t -179.39 176.99 0.78 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.069 -0.969 . . . . 0.28 110.292 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.68 130.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.396 -1.705 . . . . 0.28 106.396 175.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.721 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.9 t -134.24 118.45 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 120.59 -0.444 . . . . 0.34 111.853 -172.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.52 98.64 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.063 -1.088 . . . . 1.64 108.063 171.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -51.48 -25.12 5.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.877 -1.965 . . . . 1.42 112.449 -170.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.459 ' CD ' HG13 ' A' ' 169' ' ' VAL . 3.4 mt-10 -71.08 -40.99 71.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 113.64 -1.618 . . . . 0.68 110.643 -174.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.04 -27.49 13.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.728 -1.578 . . . . 2.36 111.418 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.721 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.9 p-10 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 115.299 1.592 . . . . 1.8 115.299 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.5 m . . . . . 0 N--CA 1.442 -0.872 0 CA-C-O 121.71 0.767 . . . . 0.32 111.04 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -140.15 173.61 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 114.364 -1.289 . . . . 0.2 110.858 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.7 p -121.41 174.08 6.97 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.729 -1.123 . . . . 1.29 110.098 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 124' ' ' MET . 28.5 ttpp -50.99 -47.43 61.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 3.26 111.845 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.486 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -84.21 -17.1 40.95 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 122.248 -0.282 . . . . 2.17 110.521 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.7 mt-10 -70.69 -22.63 62.44 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.297 -0.561 . . . . 0.5 110.149 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -84.99 -29.13 25.29 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.457 -1.297 . . . . 3.06 109.66 178.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.02 -33.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.559 1.171 . . . . 0.35 111.605 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.74 -42.3 28.55 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.292 -1.322 . . . . 1.51 109.806 170.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.45 -38.6 84.71 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.476 -1.25 . . . . 0.4 114.163 -173.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.12 -41.01 97.82 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 116.129 -2.229 . . . . 0.32 108.67 177.096 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.679 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 64.0 mm-40 -67.27 -32.0 72.71 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 123.006 1.384 . . . . 2.51 108.658 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.16 -7.32 59.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.895 -2.412 . . . . 0.33 110.179 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -121.12 1.06 10.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.114 0.959 . . . . 0.36 108.636 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 72.68 55.26 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.286 -1.779 . . . . 2.19 112.267 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 146.75 25.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.548 -1.649 . . . . 0.27 106.548 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.624 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.07 163.26 34.05 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.061 -1.829 . . . . 0.69 106.061 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.25 159.6 0.64 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.082 0.944 . . . . 1.96 112.041 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -146.68 150.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-N 114.147 -1.388 . . . . 0.27 111.624 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 m -60.56 -50.18 74.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.093 -0.958 . . . . 0.73 111.942 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.9 ptmt -155.43 114.51 3.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.161 -1.382 . . . . 0.51 108.967 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.908 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.38 100.5 5.19 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 123.894 1.807 . . . . 2.71 112.041 -168.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 1.4 t -158.84 95.4 1.29 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.178 -1.828 . . . . 0.35 108.07 162.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -151.34 165.38 17.5 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.483 -1.235 . . . . 2.38 108.183 173.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.31 111.56 2.65 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 119.578 0.885 . . . . 0.79 109.982 164.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.39 13.41 78.69 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.674 -0.774 . . . . 0.38 114.049 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.9 mt-10 -131.88 130.91 42.25 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.349 -0.982 . . . . 1.49 108.349 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.921 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.84 176.63 8.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.547 -0.861 . . . . 0.3 110.279 -166.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.908 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.1 p -107.88 142.03 38.58 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.532 0.682 . . . . 0.19 110.932 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.35 134.71 39.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 114.617 -1.174 . . . . 0.86 111.08 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 151' ' ' SER . 5.3 tp-100 -147.23 54.2 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.98 0.419 . . . . 2.45 110.961 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 60.57 -100.43 0.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.35 0.87 . . . . 0.49 113.35 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.04 -5.02 58.04 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.051 0.453 . . . . 1.02 111.375 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 57.3 m -141.9 123.21 14.81 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.268 -0.573 . . . . 0.94 110.26 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 128' ' ' LEU . 5.9 mt -96.19 165.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.617 -1.253 . . . . 0.2 107.617 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.921 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 5.6 tt0 -124.5 105.82 9.69 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.898 -1.121 . . . . 0.97 110.392 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.61 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.8 ppp? -106.76 125.8 51.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.061 0.458 . . . . 1.32 111.478 -166.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 116.148 -0.478 . . . . 0.33 110.316 172.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.0 t . . . . . 0 CA--C 1.486 -1.513 0 N-CA-C 109.303 -0.628 . . . . 0.48 109.303 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.691 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.71 145.48 50.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.135 0.969 . . . . 1.61 112.712 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -112.28 166.12 11.56 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.512 -1.676 . . . . 0.2 110.22 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.69 120.48 37.55 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.439 -0.948 . . . . 3.69 108.439 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -115.32 137.32 52.17 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.729 -1.578 . . . . 0.61 109.901 -163.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 82.6 m -129.83 150.24 51.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.235 0.54 . . . . 0.21 111.881 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.9 m-85 -113.24 106.82 15.09 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.424 -1.262 . . . . 0.32 112.374 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.575 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 17.7 t70 -93.67 96.66 9.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.119 0.485 . . . . 0.74 111.113 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.71 -114.77 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.185 -1.007 . . . . 0.27 113.31 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.04 8.99 22.1 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.004 -1.48 . . . . 1.61 107.004 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 17.6 p-80 -138.41 161.11 37.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.159 -1.382 . . . . 1.28 111.59 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 183' ' ' ILE . 8.1 tp -63.75 144.3 57.15 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.404 -0.817 . . . . 0.22 111.731 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.92 -52.46 4.23 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.43 -1.259 . . . . 0.15 111.914 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 183' ' ' ILE . 6.3 t -179.24 176.19 0.88 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.463 -0.789 . . . . 0.28 110.558 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.73 HD11 HD21 ' A' ' 180' ' ' LEU . 3.5 mp -152.27 137.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 105.646 -1.983 . . . . 0.28 105.646 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 171' ' ' ALA . 75.4 t -139.55 119.86 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 112.417 0.525 . . . . 0.34 112.417 -172.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.97 96.46 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.064 -1.087 . . . . 1.64 108.064 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.1 mmm -54.91 -24.3 22.87 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.141 -1.845 . . . . 1.42 113.26 -166.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.0 mt-10 -70.57 -40.92 73.04 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 114.39 -1.277 . . . . 0.68 110.957 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -93.54 -32.52 14.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.753 -1.567 . . . . 2.36 110.571 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.626 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.7 p-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 122.074 0.94 . . . . 1.8 112.765 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.783 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.8 m . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.32 108.645 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.1 pt -132.85 172.63 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.242 1.02 . . . . 0.2 112.069 -174.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.825 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.6 m -117.06 174.04 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.581 -1.645 . . . . 1.29 110.206 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 124' ' ' MET . 14.0 mmmm -49.33 -53.78 20.45 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.599 0.592 . . . . 3.26 112.599 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 94.8 m-20 -82.89 -16.35 47.87 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 116.586 -0.279 . . . . 2.17 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.887 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -66.24 -24.09 66.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 120.274 -0.571 . . . . 0.5 110.167 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.77 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.07 -29.26 23.52 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.487 -1.285 . . . . 3.06 109.986 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.26 -31.13 50.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.436 1.112 . . . . 0.35 111.61 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.97 -42.45 23.92 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.233 -1.349 . . . . 1.51 109.735 170.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.38 81.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 CA-C-O 117.626 -1.178 . . . . 0.4 114.147 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.82 -39.56 94.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 116.233 -2.187 . . . . 0.32 108.733 177.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.668 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 55.2 mm-40 -69.56 -30.76 68.63 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.113 1.435 . . . . 2.51 108.787 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.885 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -83.64 -7.67 59.45 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 111.971 -2.377 . . . . 0.33 109.884 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.699 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.51 -0.95 9.66 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.115 -0.948 . . . . 0.36 108.967 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 71.49 58.09 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 113.341 -1.754 . . . . 2.19 112.625 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.675 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.65 146.88 25.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.106 -1.812 . . . . 0.27 106.106 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -143.34 162.59 35.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.41 -1.33 . . . . 0.69 107.41 -174.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 135' ' ' GLN . 2.6 tt0 -50.18 146.83 4.64 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.164 0.983 . . . . 1.96 112.567 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -134.56 150.84 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-N 113.702 -1.59 . . . . 0.27 112.046 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.5 m -60.34 -50.28 74.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.857 -1.065 . . . . 0.73 111.826 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.2 ptmt -155.33 113.77 3.49 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.114 -1.403 . . . . 0.51 108.812 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.871 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -75.72 100.35 4.66 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.682 1.706 . . . . 2.71 112.05 -167.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.823 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.1 t -159.22 92.08 1.06 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.61 -1.632 . . . . 0.35 109.305 161.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.823 ' HD3' ' O ' ' A' ' 140' ' ' THR . 16.9 mmt180 -152.0 147.82 20.48 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-N 113.8 -1.546 . . . . 2.38 107.189 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.03 110.28 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 CA-C-N 120.383 1.172 . . . . 0.79 109.372 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.5 14.4 58.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.354 -0.839 . . . . 0.38 114.352 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.2 mt-10 -136.89 132.72 34.91 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.858 -1.164 . . . . 1.49 107.858 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.92 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.97 175.25 9.39 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.167 -1.013 . . . . 0.3 110.451 -168.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.871 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.4 p -108.34 141.45 40.13 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.869 0.842 . . . . 0.19 112.047 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.76 119.71 52.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 113.736 -1.574 . . . . 0.86 110.477 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.7 tt0 -103.88 -80.16 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.492 -0.322 . . . . 2.45 110.695 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.07 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.738 0.304 . . . . 0.49 111.009 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.97 -4.14 56.01 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.332 -0.618 . . . . 1.02 109.332 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.7 m -142.6 148.04 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.55 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -106.77 169.14 2.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.727 -1.212 . . . . 0.2 107.727 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.92 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 12.4 tt0 -127.54 109.08 11.36 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.787 -0.765 . . . . 0.97 110.654 173.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 2.1 tmt? -109.71 123.2 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.747 0.308 . . . . 1.32 111.753 -169.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.251 0.548 . . . . 0.33 110.878 174.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 187' ' ' GLU . 63.4 t . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.733 -0.84 . . . . 0.48 108.733 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.14 145.23 51.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.243 1.021 . . . . 1.61 112.872 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.48 164.68 13.31 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 0.2 110.541 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 22.9 ttt180 -111.67 119.97 40.48 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.999 -1.111 . . . . 3.69 107.999 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.678 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -112.37 110.48 20.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.42 -1.264 . . . . 0.61 109.956 -168.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 181' ' ' ALA . 32.1 m -107.65 151.35 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.329 0.492 . . . . 0.21 112.329 -169.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.7 m-85 -117.03 101.81 8.81 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.628 -1.169 . . . . 0.32 112.685 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 22.4 t70 -98.66 100.43 11.66 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.659 -0.416 . . . . 0.74 111.189 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.24 -119.11 5.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.518 -0.849 . . . . 0.27 113.051 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.46 8.51 23.14 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.518 -1.66 . . . . 1.61 106.518 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.783 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.6 p80 -138.65 160.52 39.43 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.158 -1.383 . . . . 1.28 112.061 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -63.74 139.64 58.79 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 114.759 -1.11 . . . . 0.22 110.439 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.631 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -90.84 -48.82 6.79 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.442 -1.254 . . . . 0.15 111.348 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.457 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.5 t 177.36 178.02 0.31 Allowed 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.284 -0.871 . . . . 0.28 110.685 -174.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.74 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -150.94 127.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.909 -1.886 . . . . 0.28 105.909 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.69 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.4 t -132.87 122.09 45.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 112.568 0.581 . . . . 0.34 112.568 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -60.55 97.96 0.06 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.241 -1.022 . . . . 1.64 108.241 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.554 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.6 OUTLIER -54.56 -24.74 22.29 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 112.579 -2.1 . . . . 1.42 112.489 -168.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -68.58 -41.59 79.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 114.049 -1.432 . . . . 0.68 110.977 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.34 -27.96 13.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.788 -1.096 . . . . 2.36 110.808 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.69 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.7 p30 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 115.578 1.696 . . . . 1.8 115.578 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.9 m . . . . . 0 N--CA 1.44 -0.957 0 CA-C-O 121.613 0.721 . . . . 0.32 110.699 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.1 pt -138.54 172.53 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.296 -1.32 . . . . 0.2 110.235 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.885 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 11.1 p -122.56 176.27 6.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.741 -1.118 . . . . 1.29 110.151 -173.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' MET . 62.3 mtpt -56.03 -43.91 78.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.275 0.472 . . . . 3.26 112.275 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 26.2 t-20 -83.95 -18.36 37.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 122.042 -0.411 . . . . 2.17 110.016 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.959 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -67.36 -23.81 65.64 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 119.785 -0.766 . . . . 0.5 109.997 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.681 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.32 -27.59 25.81 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 118.576 -1.249 . . . . 3.06 109.81 177.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.01 -32.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.886 -1.052 . . . . 0.35 111.461 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.789 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.32 -40.01 31.38 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.813 -1.085 . . . . 1.51 110.291 170.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.17 -37.57 80.57 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 117.424 -1.274 . . . . 0.4 114.11 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.867 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.94 -40.02 95.48 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 116.103 -2.239 . . . . 0.32 109.227 175.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' H ' HD22 ' A' ' 128' ' ' LEU . 19.7 mt-10 -64.67 -28.82 69.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.685 1.231 . . . . 2.51 108.062 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -94.38 -6.82 43.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.827 -1.988 . . . . 0.33 111.135 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.3 t -122.52 -2.26 8.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.36 109.758 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 74.72 52.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.042 -1.436 . . . . 2.19 112.032 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.867 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -148.41 142.55 26.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.511 -1.292 . . . . 0.27 107.511 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.637 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -147.19 163.99 34.59 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.747 -1.205 . . . . 0.69 107.747 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -46.28 144.78 1.9 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 122.094 0.95 . . . . 1.96 113.202 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.7 t -137.37 151.18 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.375 0 CA-C-N 114.034 -1.439 . . . . 0.27 112.562 -173.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 m -59.77 -50.89 72.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.889 -1.05 . . . . 0.73 111.602 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.1 ptmt -157.72 117.65 3.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.019 -1.446 . . . . 0.51 108.605 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.916 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -78.69 100.34 7.0 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 123.466 1.603 . . . . 2.71 111.991 -167.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.806 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 3.1 t -159.71 95.03 1.18 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.095 -1.411 . . . . 0.35 109.274 162.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.806 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -151.99 171.82 6.17 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 114.451 -1.25 . . . . 2.38 107.747 172.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.26 111.71 2.43 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 CA-C-N 120.452 1.197 . . . . 0.79 109.885 164.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.17 0.12 77.67 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.794 -0.717 . . . . 0.38 114.84 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 40.9 mt-10 -119.57 132.09 55.66 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.686 1.243 . . . . 1.49 109.574 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.815 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.8 m-30 -129.3 175.55 8.65 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.365 -0.534 . . . . 0.3 110.328 -166.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.916 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.0 p -111.9 139.2 47.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.871 -0.788 . . . . 0.19 108.871 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.435 ' CB ' ' OH ' ' A' ' 133' ' ' TYR . 2.6 p -112.37 154.43 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 112.649 0.611 . . . . 0.86 112.649 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.8 tp-100 -146.16 -95.08 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.334 -0.394 . . . . 2.45 111.146 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.0 -86.09 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.081 0.4 . . . . 0.49 112.081 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -83.19 -9.12 59.34 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.492 0.663 . . . . 1.02 109.665 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 46.9 m -139.51 119.74 13.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.53 -0.759 . . . . 0.94 110.579 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.549 HD11 ' SD ' ' A' ' 124' ' ' MET . 4.7 mt -96.95 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.767 -1.197 . . . . 0.2 107.767 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.815 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.1 tt0 -119.5 151.0 39.31 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.144 -1.428 . . . . 0.97 107.144 164.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.619 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -147.43 128.65 14.73 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.116 -0.634 . . . . 1.32 111.098 -177.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 110.049 -0.352 . . . . 0.33 110.049 171.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 187' ' ' GLU . 56.0 t . . . . . 0 CA--C 1.488 -1.421 0 N-CA-C 108.742 -0.836 . . . . 0.48 108.742 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -123.39 143.96 49.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.627 1.203 . . . . 1.61 112.582 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 153' ' ' GLU . . . -115.47 166.37 11.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 112.873 -1.967 . . . . 0.2 109.855 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.4 ttp180 -108.82 126.47 53.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.103 -0.703 . . . . 3.69 109.103 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.485 HD23 HG13 ' A' ' 183' ' ' ILE . 1.4 mt -84.59 152.05 24.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.357 -1.292 . . . . 0.61 110.076 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 181' ' ' ALA . 93.4 m -151.95 143.05 23.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.1 0.476 . . . . 0.21 111.22 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.932 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.3 m-85 -116.77 111.82 20.29 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.882 -1.053 . . . . 0.32 112.738 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.539 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 16.8 t70 -99.15 95.0 6.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 0.74 111.09 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.02 -114.48 3.96 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 120.199 -1.0 . . . . 0.27 113.487 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -110.8 8.77 22.52 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.055 -1.461 . . . . 1.61 107.055 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.744 ' HB3' HG23 ' A' ' 118' ' ' THR . 34.6 p80 -138.49 160.48 39.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.174 -1.375 . . . . 1.28 111.419 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.851 HD21 HD11 ' A' ' 183' ' ' ILE . 7.3 tp -62.06 144.59 55.04 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.059 -0.973 . . . . 0.22 111.093 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.3 -51.28 4.87 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.395 -1.275 . . . . 0.15 111.215 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.458 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t -178.53 176.26 1.04 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.112 -0.949 . . . . 0.28 110.556 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.851 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -154.15 125.82 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 113.086 -1.87 . . . . 0.28 106.472 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.629 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 98.7 t -128.76 119.51 49.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.28 -0.568 . . . . 0.34 111.901 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.26 96.84 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.529 -1.286 . . . . 1.64 107.529 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.7 mmt -53.89 -24.36 15.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 112.669 -2.059 . . . . 1.42 112.304 -168.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.555 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.5 mt-10 -68.13 -44.67 75.56 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 113.992 -1.458 . . . . 0.68 110.839 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.2 -27.77 13.65 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.936 -1.484 . . . . 2.36 111.138 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.3 p30 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 115.019 1.488 . . . . 1.8 115.019 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 121.627 0.727 . . . . 0.32 110.798 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.946 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.4 pt -138.4 172.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.595 -1.184 . . . . 0.2 111.318 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.898 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 10.2 p -121.18 174.77 6.47 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.502 -1.227 . . . . 1.29 109.9 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 124' ' ' MET . 35.8 ttpt -56.22 -43.0 78.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.78 0.324 . . . . 3.26 111.824 -175.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.6 t-20 -84.17 -18.03 38.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.063 -0.398 . . . . 2.17 110.187 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -68.28 -23.77 64.79 Favored 'General case' 0 N--CA 1.422 -1.868 0 C-N-CA 119.969 -0.693 . . . . 0.5 110.176 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.7 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.27 -26.56 26.57 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 118.495 -1.282 . . . . 3.06 109.581 177.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.5 -32.06 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.845 -1.071 . . . . 0.35 111.539 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.786 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.66 -38.97 32.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.792 -1.095 . . . . 1.51 110.348 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.76 -38.18 84.32 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-O 117.548 -1.215 . . . . 0.4 114.236 -174.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.866 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -39.48 94.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 116.216 -2.193 . . . . 0.32 109.257 176.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 22.0 mt-10 -65.02 -29.81 70.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.614 1.197 . . . . 2.51 108.113 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.72 -7.77 45.77 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.727 -2.033 . . . . 0.33 111.076 -170.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -121.81 -1.65 9.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.705 0.764 . . . . 0.36 109.322 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 71.25 57.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.702 -1.59 . . . . 2.19 111.996 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.866 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.08 145.51 26.4 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.587 -1.635 . . . . 0.27 106.587 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.558 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.87 164.52 31.68 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.886 -0.783 . . . . 0.69 108.886 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.42 ' CB ' HG12 ' A' ' 147' ' ' VAL . 18.3 tt0 -45.01 144.69 1.15 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.285 1.04 . . . . 1.96 113.21 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 138' ' ' LYS . 5.1 t -139.98 150.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 CA-C-N 113.507 -1.679 . . . . 0.27 111.781 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 p -63.64 -49.11 74.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.935 -1.484 . . . . 0.73 111.887 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -155.43 113.49 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.886 -1.506 . . . . 0.51 108.996 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.036 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -79.06 100.24 7.27 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 123.518 1.628 . . . . 2.71 111.187 -166.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.729 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.0 t -156.74 94.9 1.49 Allowed 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.313 -1.767 . . . . 0.35 107.899 164.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 140' ' ' THR . 1.8 mpt_? -151.78 171.82 6.14 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 113.675 -1.602 . . . . 2.38 107.783 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.75 111.89 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 CA-C-N 120.066 1.059 . . . . 0.79 110.15 163.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.96 4.54 86.97 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.717 -0.754 . . . . 0.38 114.665 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 81.7 mm-40 -119.28 132.59 55.92 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 117.976 0.888 . . . . 1.49 108.64 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.797 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.8 m-30 -128.81 172.93 10.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.833 -0.747 . . . . 0.3 110.255 -166.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 1.036 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.5 p -106.84 139.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.983 -0.747 . . . . 0.19 108.983 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 152' ' ' ILE . 2.0 p -113.67 128.92 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.134 -0.627 . . . . 0.86 112.35 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 151' ' ' SER . 26.7 mp0 -116.51 -88.03 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.23 -0.441 . . . . 2.45 111.865 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.79 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.935 0.346 . . . . 0.49 111.935 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.3 -9.41 59.48 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.69 0.757 . . . . 1.02 109.352 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 17.5 m -140.35 144.13 36.13 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 114.921 -1.036 . . . . 0.94 109.643 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.5 mt -108.73 168.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.105 -1.072 . . . . 0.2 108.105 168.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.797 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 22.7 tt0 -123.76 110.59 15.11 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.476 -0.89 . . . . 0.97 110.236 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.595 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -114.86 130.04 56.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.024 0.44 . . . . 1.32 111.021 -169.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.894 -0.41 . . . . 0.33 109.894 172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 187' ' ' GLU . 69.3 t . . . . . 0 CA--C 1.492 -1.267 0 CA-C-O 120.645 0.259 . . . . 0.48 110.376 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -128.54 144.42 51.14 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 122.164 0.983 . . . . 1.61 112.41 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.3 167.22 11.04 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.481 -1.691 . . . . 0.2 110.619 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.7 ttp180 -115.08 120.74 40.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.847 -1.168 . . . . 3.69 107.847 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -113.41 114.1 26.13 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.927 -1.488 . . . . 0.61 110.282 -164.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.554 ' HB ' HG22 ' A' ' 182' ' ' THR . 64.5 m -112.36 146.42 38.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.022 -0.535 . . . . 0.21 111.744 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.946 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -118.8 117.75 29.72 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.417 -0.811 . . . . 0.32 111.905 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 14.1 t70 -98.08 99.65 10.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.69 -0.686 . . . . 0.74 111.128 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.22 -111.99 3.47 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.829 -1.176 . . . . 0.27 113.78 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.67 6.55 21.76 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.135 -1.431 . . . . 1.61 107.135 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.776 ' HB3' HG23 ' A' ' 118' ' ' THR . 22.9 p80 -140.94 160.27 40.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.979 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.833 HD21 HD11 ' A' ' 183' ' ' ILE . 6.0 tp -60.73 145.43 49.52 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.774 0.797 . . . . 0.22 111.562 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 174' ' ' THR . . . -97.74 -49.64 4.76 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.282 -1.326 . . . . 0.15 111.162 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.554 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t -178.95 177.69 0.81 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.316 -0.856 . . . . 0.28 110.657 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 180' ' ' LEU . 2.7 mp -152.93 123.22 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.495 -1.668 . . . . 0.28 106.495 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.74 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 88.4 t -127.94 123.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 112.804 0.668 . . . . 0.34 112.804 -170.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -59.67 101.36 0.11 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.339 1.066 . . . . 1.64 108.255 172.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.43 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 80.6 mmm -60.45 -13.85 15.95 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 113.05 -1.887 . . . . 1.42 112.788 -169.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.2 mt-10 -73.76 -45.58 50.93 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.48 -1.236 . . . . 0.68 110.752 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -104.96 -20.23 13.6 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.936 -1.029 . . . . 2.36 111.495 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.74 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 20.2 p30 . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 115.254 1.575 . . . . 1.8 115.254 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.4 m . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.84 -0.8 . . . . 0.32 108.84 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.851 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.6 pt -128.7 172.04 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.275 1.036 . . . . 0.2 112.218 -172.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.844 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 6.3 t -120.95 170.13 9.8 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.804 -1.543 . . . . 1.29 109.398 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -52.02 -46.0 64.81 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.252 0.549 . . . . 3.26 112.278 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.443 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 18.3 m120 -84.14 -17.12 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.403 -0.362 . . . . 2.17 110.088 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.972 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -66.86 -30.87 71.15 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 120.468 -0.493 . . . . 0.5 110.361 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.84 -22.68 27.46 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 117.771 -1.572 . . . . 3.06 109.649 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' HD21 ' A' ' 128' ' ' LEU . 2.1 t -68.22 -29.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.566 -1.197 . . . . 0.35 111.674 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.95 -39.06 26.69 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.956 -1.02 . . . . 1.51 109.326 171.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -55.57 -45.37 77.33 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 114.525 1.306 . . . . 0.4 114.525 -174.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -60.35 -39.54 87.49 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 116.784 -1.966 . . . . 0.32 109.719 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.0 mt-10 -66.54 -29.62 69.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.51 108.022 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -91.34 -8.59 47.66 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 112.926 -1.943 . . . . 0.33 110.886 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.98 -1.87 9.29 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.783 0.802 . . . . 0.36 109.552 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 70.44 56.75 0.26 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.761 -1.563 . . . . 2.19 111.882 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.08 146.41 27.71 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.378 -1.712 . . . . 0.27 106.378 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -147.69 163.83 35.43 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.127 -1.435 . . . . 0.69 107.127 -176.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.549 ' CB ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -47.0 158.73 0.12 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 122.453 1.12 . . . . 1.96 112.853 -176.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -148.27 150.23 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 CA-C-N 113.772 -1.558 . . . . 0.27 111.412 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -61.48 -49.45 76.7 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.375 -0.829 . . . . 0.73 111.866 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 17.4 ptmt -153.77 115.76 4.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.187 -1.37 . . . . 0.51 108.85 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.874 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.34 99.37 4.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.842 1.782 . . . . 2.71 112.277 -168.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.738 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -158.73 91.63 1.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.29 -1.777 . . . . 0.35 108.684 159.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.2 mmt-85 -154.9 126.44 3.69 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.126 -1.805 . . . . 2.38 106.126 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.67 110.8 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 CA-C-N 121.3 1.5 . . . . 0.79 110.417 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.56 2.5 57.56 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.477 -0.783 . . . . 0.38 114.293 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 28.6 mt-10 -130.46 133.03 45.99 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.982 0.891 . . . . 1.49 108.789 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -128.34 175.17 8.69 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 120.014 -0.675 . . . . 0.3 109.985 -168.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.874 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.9 p -111.43 137.03 49.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.662 -0.495 . . . . 0.19 109.662 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 152' ' ' ILE . 1.3 p -113.37 140.72 32.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.443 -0.799 . . . . 0.86 111.57 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 151' ' ' SER . 0.6 OUTLIER -138.35 -91.35 0.21 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.0 0.37 . . . . 2.45 112.0 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 -93.21 0.13 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.685 0.624 . . . . 0.49 112.685 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -80.33 -3.62 50.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.004 0.431 . . . . 1.02 110.44 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 148' ' ' GLN . 20.4 m -144.67 148.09 33.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.019 -0.537 . . . . 0.94 109.609 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.561 ' CG2' HD23 ' A' ' 173' ' ' LEU . 9.3 mt -108.18 167.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 107.694 -1.224 . . . . 0.2 107.694 168.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.2 tt0 -123.43 106.17 10.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.931 -1.108 . . . . 0.97 111.051 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.555 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 6.0 ttt -106.27 130.26 54.15 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.191 -0.204 . . . . 1.32 111.168 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 169.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 187' ' ' GLU . 55.1 t . . . . . 0 CA--C 1.488 -1.413 0 N-CA-C 108.176 -1.046 . . . . 0.48 108.176 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -119.58 143.36 47.68 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 122.516 1.15 . . . . 1.61 113.151 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.84 166.46 13.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.719 -2.037 . . . . 0.2 110.653 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.74 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 28.6 ttp180 -114.17 114.94 26.71 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.737 -1.209 . . . . 3.69 107.737 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -103.32 105.58 15.89 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.303 -1.771 . . . . 0.61 109.573 -168.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.511 ' HB ' HG22 ' A' ' 182' ' ' THR . 55.1 m -104.16 149.25 25.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.463 -0.79 . . . . 0.21 112.655 -167.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.851 ' CD1' HD11 ' A' ' 119' ' ' ILE . 14.7 m-85 -115.51 107.51 15.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.32 113.078 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.636 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 25.3 t70 -100.56 102.71 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 0.74 110.842 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.26 -121.85 5.53 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.196 -1.002 . . . . 0.27 112.925 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -110.34 15.59 22.16 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.511 -1.663 . . . . 1.61 106.511 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.768 ' HB3' HG23 ' A' ' 118' ' ' THR . 20.8 p-80 -138.16 161.15 37.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -70.54 131.67 44.34 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.62 -1.173 . . . . 0.22 110.364 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.636 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.7 -49.82 10.7 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.131 -1.395 . . . . 0.15 111.022 -175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t 177.7 178.22 0.33 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.765 -1.107 . . . . 0.28 110.413 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 180' ' ' LEU . 2.2 mp -148.28 121.2 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.759 -1.571 . . . . 0.28 106.759 174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.723 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -126.18 122.6 61.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.535 0.569 . . . . 0.34 112.535 -171.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.3 99.75 0.06 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 122.069 0.938 . . . . 1.64 108.806 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.8 mmt -54.04 -23.55 13.96 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 112.663 -2.062 . . . . 1.42 112.635 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.567 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -68.12 -42.21 80.55 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.382 -1.281 . . . . 0.68 110.556 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.563 ' C ' HD22 ' A' ' 189' ' ' ASN . 94.4 m-20 -102.1 -27.03 13.15 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.097 -1.411 . . . . 2.36 111.363 177.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.723 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 115.241 1.571 . . . . 1.8 115.241 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 179' ' ' HIS . 7.2 m . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 108.805 -0.813 . . . . 0.32 108.805 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.9 pt -134.68 171.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.906 -1.043 . . . . 0.2 110.51 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.872 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -119.58 173.91 6.72 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.872 -1.058 . . . . 1.29 108.801 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.6 -44.8 66.23 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.379 0.424 . . . . 3.26 111.011 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 64.1 t30 -82.91 -18.52 39.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.17 110.344 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -71.35 -25.69 62.5 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.363 -0.535 . . . . 0.5 110.666 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.2 tpt -88.81 -24.65 22.54 Favored 'General case' 0 C--N 1.286 -2.154 0 C-N-CA 118.065 -1.454 . . . . 3.06 109.515 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 2.3 t -60.0 -31.9 48.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.651 -1.159 . . . . 0.35 111.839 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.73 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.24 -39.8 28.32 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.124 -0.944 . . . . 1.51 110.415 170.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.902 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.03 -37.05 83.45 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-O 117.411 -1.28 . . . . 0.4 114.077 -175.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.773 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -63.39 -38.82 92.62 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 116.189 -2.204 . . . . 0.32 108.935 176.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 25.7 mt-10 -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.788 1.28 . . . . 2.51 108.116 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.94 -6.72 44.86 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 112.446 -2.161 . . . . 0.33 110.777 -169.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 128' ' ' LEU . 8.8 t -122.83 0.52 9.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.86 0.838 . . . . 0.36 109.555 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 71.62 53.47 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.85 -1.523 . . . . 2.19 111.691 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.02 144.24 25.68 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.276 -1.379 . . . . 0.27 107.276 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.627 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -144.79 163.02 35.32 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.236 -1.024 . . . . 0.69 108.236 -174.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -47.35 145.88 2.22 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.85 0.833 . . . . 1.96 112.358 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.81 150.09 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.304 -1.316 . . . . 0.27 112.289 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -60.43 -49.16 78.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.667 -1.151 . . . . 0.73 111.723 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.3 ptmt -157.19 113.95 3.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.148 -1.387 . . . . 0.51 108.619 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.896 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.8 OUTLIER -75.36 99.47 4.13 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 123.674 1.702 . . . . 2.71 112.089 -167.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.812 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.9 t -159.01 92.84 1.12 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.665 -1.607 . . . . 0.35 109.527 161.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.812 ' HD3' ' O ' ' A' ' 140' ' ' THR . 11.0 mmt180 -152.44 154.68 32.21 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 106.583 -1.636 . . . . 2.38 106.583 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.04 110.86 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 120.577 1.242 . . . . 0.79 109.911 168.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 15.38 63.48 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.536 -0.84 . . . . 0.38 113.933 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 26.6 mt-10 -134.48 131.4 38.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.743 -1.206 . . . . 1.49 107.743 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.913 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -133.75 176.25 8.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.504 -0.878 . . . . 0.3 110.612 -167.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.896 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.5 p -107.45 142.98 36.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.639 0.733 . . . . 0.19 111.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.23 134.45 47.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.344 -1.298 . . . . 0.86 111.629 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 151' ' ' SER . 24.8 mt-30 -120.1 -87.81 0.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.669 -0.241 . . . . 2.45 111.096 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -164.27 -81.08 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.693 0.283 . . . . 0.49 110.93 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -82.69 -4.28 57.6 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.065 0.46 . . . . 1.02 109.908 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 18.0 m -145.71 148.34 32.92 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.318 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -110.23 168.75 4.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.562 -1.273 . . . . 0.2 107.562 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.913 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.3 tt0 -124.03 108.75 12.7 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.712 -0.795 . . . . 0.97 110.017 172.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.564 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -111.81 125.62 54.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.376 0.607 . . . . 1.32 111.45 -170.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.774 0 CA-C-N 115.549 -0.75 . . . . 0.33 109.699 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 155' ' ' ILE . 84.1 t . . . . . 0 CA--C 1.488 -1.435 0 N-CA-C 109.173 -0.677 . . . . 0.48 109.173 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.82 145.01 49.98 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.231 1.015 . . . . 1.61 112.765 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -117.61 163.73 16.01 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.414 -1.721 . . . . 0.2 110.627 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.593 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 39.6 ttt180 -113.69 118.9 35.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.646 -1.242 . . . . 3.69 107.646 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.629 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.51 106.42 14.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 113.805 -1.543 . . . . 0.61 109.973 -164.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 53.5 m -105.01 149.37 25.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.609 -0.723 . . . . 0.21 112.306 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.854 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.0 m-85 -112.62 115.12 28.09 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.058 -1.428 . . . . 0.32 111.559 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 14.5 t70 -107.1 100.18 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.18 0.514 . . . . 0.74 111.121 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.8 -119.29 5.15 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.143 -1.027 . . . . 0.27 112.653 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.75 12.4 21.03 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.755 ' HB3' HG23 ' A' ' 118' ' ' THR . 14.5 p-80 -137.22 160.04 40.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.544 -1.207 . . . . 1.28 111.82 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -67.82 134.1 50.36 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.755 -1.111 . . . . 0.22 110.82 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.481 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -82.14 -54.57 5.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.327 -1.306 . . . . 0.15 111.066 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.2 t 178.69 177.12 0.48 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.13 -0.941 . . . . 0.28 109.896 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.39 132.22 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.28 107.007 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.6 t -135.17 115.77 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.887 0.699 . . . . 0.34 112.887 -167.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -59.38 100.45 0.08 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.946 -1.131 . . . . 1.64 107.946 171.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 2.7 mmt -56.87 -15.97 5.83 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 112.962 -1.926 . . . . 1.42 112.622 -169.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.468 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -73.88 -45.39 51.18 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 114.44 -1.255 . . . . 0.68 110.692 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -97.09 -24.72 15.63 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.072 -1.422 . . . . 2.36 111.368 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.716 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.5 p-10 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 114.236 1.199 . . . . 1.8 114.236 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.85 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.1 m . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 108.435 -0.95 . . . . 0.32 108.435 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.4 pt -125.71 171.24 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.344 1.069 . . . . 0.2 111.391 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.86 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.0 m -111.08 167.3 10.37 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.449 -1.705 . . . . 1.29 108.634 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -51.81 -45.92 64.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.031 0.443 . . . . 3.26 111.195 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.43 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 23.0 t-20 -83.66 -17.87 40.0 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.419 -0.355 . . . . 2.17 110.4 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -66.1 -25.1 66.85 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 120.409 -0.516 . . . . 0.5 110.876 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.74 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.1 tpt -88.86 -24.15 22.61 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.102 -1.439 . . . . 3.06 109.723 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 122' ' ' ASN . 2.1 t -61.36 -31.19 49.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.624 -1.171 . . . . 0.35 111.786 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.734 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.89 -40.81 27.49 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.014 -0.993 . . . . 1.51 110.399 169.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.13 -36.9 81.0 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.393 -1.289 . . . . 0.4 114.108 -175.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.774 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -64.05 -37.24 86.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.314 -2.154 . . . . 0.32 109.008 176.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 128' ' ' LEU . 25.6 mt-10 -65.45 -32.29 73.83 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.88 1.324 . . . . 2.51 107.802 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.898 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -90.9 -7.03 53.32 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.383 -2.189 . . . . 0.33 110.617 -169.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.4 t -122.11 0.91 9.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.949 0.88 . . . . 0.36 109.38 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 66.1 58.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 113.62 -1.627 . . . . 2.19 111.997 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.49 143.24 24.6 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.055 -1.832 . . . . 0.27 106.055 178.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.08 163.81 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.489 -1.3 . . . . 0.69 107.489 -175.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -52.28 160.12 0.85 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.383 1.087 . . . . 1.96 111.821 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 2.3 t -145.34 152.65 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.326 0 CA-C-N 113.629 -1.623 . . . . 0.27 110.938 -170.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -60.08 -50.12 74.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.862 0.839 . . . . 0.73 111.55 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 17.7 ptmt -157.48 110.06 2.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.19 -1.368 . . . . 0.51 108.902 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.88 ' HE1' ' HG2' ' A' ' 153' ' ' GLU . 5.8 ttp -68.97 100.5 1.22 Allowed 'General case' 0 N--CA 1.398 -3.075 0 CA-C-O 122.364 1.078 . . . . 2.71 113.509 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.8 t -160.11 94.85 1.13 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.162 -1.836 . . . . 0.35 108.389 157.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HD3' ' O ' ' A' ' 140' ' ' THR . 18.3 mmt180 -149.37 169.98 8.35 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 114.056 -1.429 . . . . 2.38 107.445 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.55 111.32 2.55 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 CA-C-N 119.578 0.885 . . . . 0.79 110.87 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.25 13.14 83.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.797 -0.716 . . . . 0.38 114.188 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.9 mm-40 -122.14 132.96 54.74 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.949 -1.5 . . . . 1.49 106.949 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -130.02 174.36 9.85 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.47 -1.292 . . . . 0.3 111.493 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.574 ' CG2' ' HB2' ' A' ' 139' ' ' MET . 9.4 p -111.86 139.35 47.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.801 0.81 . . . . 0.19 111.406 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.16 141.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.801 -1.545 . . . . 0.86 111.064 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 151' ' ' SER . 35.9 tt0 -129.16 -80.85 0.57 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.803 -0.18 . . . . 2.45 111.146 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -170.45 -88.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.638 0.256 . . . . 0.49 111.388 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -81.59 -2.25 49.39 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.464 0.65 . . . . 1.02 109.264 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.3 m -144.02 148.03 34.67 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.53 -0.759 . . . . 0.94 109.87 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 173' ' ' LEU . 4.9 mt -109.31 171.44 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.075 -1.454 . . . . 0.2 107.075 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.88 ' HG2' ' HE1' ' A' ' 139' ' ' MET . 11.0 tt0 -115.77 140.06 49.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.762 -1.57 . . . . 0.97 106.762 169.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.413 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.2 ppp? -138.82 131.46 29.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.832 0.742 . . . . 1.32 111.969 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 110.016 -0.365 . . . . 0.33 110.016 171.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.722 HG13 ' HG3' ' A' ' 187' ' ' GLU . 3.0 t . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 108.203 -1.036 . . . . 0.48 108.203 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -120.03 144.23 47.65 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.781 1.277 . . . . 1.61 114.029 -176.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -110.84 167.73 10.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 112.462 -2.153 . . . . 0.2 110.414 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 3.1 ptp180 -115.59 118.76 34.01 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.078 -1.453 . . . . 3.69 107.078 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -110.45 111.01 21.98 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.097 -1.411 . . . . 0.61 109.826 -165.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 55.1 m -109.85 149.77 29.37 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.742 0.782 . . . . 0.21 112.998 -167.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.913 ' CD1' HD11 ' A' ' 119' ' ' ILE . 5.2 m-85 -114.82 117.42 30.67 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.623 -1.626 . . . . 0.32 110.535 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.533 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 0.5 OUTLIER -113.4 108.04 16.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.964 0.888 . . . . 0.74 110.491 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.81 -122.0 6.23 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.183 -1.008 . . . . 0.27 112.788 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -111.95 12.1 20.72 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.779 -1.563 . . . . 1.61 106.779 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.85 ' HB3' HG23 ' A' ' 118' ' ' THR . 6.7 p80 -140.29 160.98 38.77 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.747 -1.115 . . . . 1.28 112.326 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.714 HD21 HD11 ' A' ' 183' ' ' ILE . 9.1 tp -65.9 135.91 55.41 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.22 110.551 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.533 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.62 -51.67 6.0 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.449 -1.251 . . . . 0.15 111.444 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.5 t 175.72 177.42 0.2 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.225 -0.898 . . . . 0.28 110.115 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -149.31 123.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.523 -1.288 . . . . 0.28 107.523 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 94.3 t -126.9 119.97 54.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.395 0.517 . . . . 0.34 112.395 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 171' ' ' ALA . 8.5 m120 -60.54 97.44 0.05 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.492 1.139 . . . . 1.64 108.458 171.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 75.0 mtp -54.17 -28.65 41.73 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 112.015 -2.357 . . . . 1.42 112.652 -166.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.722 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.0 mt-10 -61.61 -42.15 98.47 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.0 -1.454 . . . . 0.68 110.122 -172.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -106.26 -27.48 11.0 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.525 -1.671 . . . . 2.36 111.218 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.771 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 28.5 t-20 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.676 0.751 . . . . 1.8 111.333 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.823 HG23 ' HB3' ' A' ' 179' ' ' HIS . 6.2 m . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 109.083 -0.71 . . . . 0.32 109.083 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.888 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.2 pt -135.12 172.74 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 115.105 -0.952 . . . . 0.2 111.096 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.842 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.4 p -124.78 177.3 6.07 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.574 -1.194 . . . . 1.29 110.482 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 124' ' ' MET . 65.4 tttp -50.7 -48.76 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.422 0.451 . . . . 3.26 111.864 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 63.3 t30 -84.23 -18.64 35.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 122.273 -0.267 . . . . 2.17 110.285 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.74 -23.53 63.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.877 -0.729 . . . . 0.5 109.813 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.766 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.5 -28.32 25.04 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.401 -1.32 . . . . 3.06 109.855 177.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.89 -33.06 56.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 122.463 1.125 . . . . 0.35 111.767 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.38 -41.71 32.46 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.379 -1.282 . . . . 1.51 110.17 169.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.912 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.39 -38.32 86.62 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-O 117.525 -1.226 . . . . 0.4 114.215 -173.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 116.184 -2.206 . . . . 0.32 108.566 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.665 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 61.5 mm-40 -67.94 -29.69 68.81 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 123.189 1.471 . . . . 2.51 108.741 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.55 -6.97 59.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.016 -2.357 . . . . 0.33 110.028 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.742 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -122.54 -0.66 9.18 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.152 -0.931 . . . . 0.36 109.657 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 77.4 51.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 113.865 -1.516 . . . . 2.19 112.436 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.95 145.05 24.57 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.195 -1.409 . . . . 0.27 107.195 -178.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.632 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -142.62 160.83 39.54 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.166 -1.79 . . . . 0.69 106.166 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -53.04 160.17 1.05 Allowed 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 119.383 0.992 . . . . 1.96 111.656 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.44 153.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.333 -1.303 . . . . 0.27 111.979 -169.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -60.9 -50.13 74.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.556 0.693 . . . . 0.73 111.886 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.537 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.6 ptmt -157.0 114.64 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.35 -1.296 . . . . 0.51 108.793 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.009 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.18 107.28 15.62 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 122.798 1.285 . . . . 2.71 111.242 -167.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.635 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.8 t -156.92 95.49 1.52 Allowed 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.882 -1.508 . . . . 0.35 108.584 163.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 140' ' ' THR . 19.3 mmt85 -151.54 169.64 9.08 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 113.622 -1.626 . . . . 2.38 108.099 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.03 110.47 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 N-CA-C 109.43 -1.027 . . . . 0.79 109.43 161.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.61 26.95 58.05 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.356 -0.926 . . . . 0.38 114.09 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 32.8 mt-10 -138.82 130.6 27.72 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.41 -1.33 . . . . 1.49 107.41 171.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -134.0 176.8 8.25 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.61 -0.836 . . . . 0.3 110.482 -165.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 1.009 HG23 ' HB3' ' A' ' 139' ' ' MET . 14.3 p -113.5 138.92 49.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.829 0.823 . . . . 0.19 112.291 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.18 141.47 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 113.696 -1.593 . . . . 0.86 110.862 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -127.48 -81.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.771 -0.372 . . . . 2.45 111.071 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.48 -88.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 0.49 111.712 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -85.53 -3.02 58.74 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.296 0.569 . . . . 1.02 109.564 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 m -142.41 146.63 35.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.786 -0.643 . . . . 0.94 110.286 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.34 169.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.467 -1.308 . . . . 0.2 107.467 169.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.796 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.5 tt0 -115.71 135.57 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.561 -1.644 . . . . 0.97 106.561 166.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.484 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.0 ppp? -134.66 127.9 32.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.874 0.761 . . . . 1.32 111.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.356 -0.609 . . . . 0.33 109.356 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 54.4 t . . . . . 0 CA--C 1.48 -1.722 0 N-CA-C 108.351 -0.981 . . . . 0.48 108.351 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.4 OUTLIER -120.81 142.71 49.35 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 122.524 1.155 . . . . 1.61 113.083 176.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.16 166.88 11.52 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 112.772 -2.013 . . . . 0.2 110.46 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 20.0 ttt180 -116.88 119.38 35.21 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.503 -1.295 . . . . 3.69 107.503 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.0 114.57 27.08 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.795 -1.548 . . . . 0.61 110.027 -164.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 182' ' ' THR . 54.2 m -110.8 150.98 28.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 112.76 0.652 . . . . 0.21 112.76 -168.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.888 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.8 m-85 -113.59 103.47 11.28 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.38 -1.282 . . . . 0.32 112.873 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.69 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 9.9 t0 -89.76 96.1 10.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.209 0.528 . . . . 0.74 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.63 -115.56 4.04 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.099 -1.048 . . . . 0.27 113.159 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -111.07 9.44 22.04 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.756 -1.572 . . . . 1.61 106.756 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.823 ' HB3' HG23 ' A' ' 118' ' ' THR . 9.5 p-80 -137.65 161.09 37.4 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.221 -1.354 . . . . 1.28 111.807 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 183' ' ' ILE . 10.5 tp -67.03 137.32 56.38 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.177 -0.919 . . . . 0.22 110.849 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.69 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -89.16 -54.23 4.21 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.173 -1.376 . . . . 0.15 111.631 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.457 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.2 t -176.97 177.09 1.33 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.123 -0.944 . . . . 0.28 110.12 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -151.84 124.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.455 -1.683 . . . . 0.28 106.455 176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.734 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 69.4 t -128.23 123.8 60.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.776 0.658 . . . . 0.34 112.776 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.87 98.49 0.05 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.317 -0.994 . . . . 1.64 108.317 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 72.0 mmm -58.9 -16.72 18.93 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 113.332 -1.758 . . . . 1.42 112.896 -168.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.8 mt-10 -72.35 -42.59 65.13 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.473 -1.24 . . . . 0.68 110.175 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.96 -26.73 13.31 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.082 -1.417 . . . . 2.36 112.007 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.734 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.5 p-10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 115.342 1.608 . . . . 1.8 115.342 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.78 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.4 m . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 108.751 -0.833 . . . . 0.32 108.751 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.847 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.56 170.6 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.104 -0.953 . . . . 0.2 110.773 -174.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.6 m -119.57 177.05 5.08 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.648 -1.16 . . . . 1.29 109.461 -170.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 124' ' ' MET . 51.3 pttt -51.6 -48.02 63.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.397 . . . . 3.26 111.671 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 121' ' ' LYS . 27.8 t-20 -84.07 -18.1 38.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.474 -0.33 . . . . 2.17 110.406 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.916 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.03 -22.67 64.04 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.911 -0.716 . . . . 0.5 110.627 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.692 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.09 -27.15 22.13 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.212 -0.995 . . . . 3.06 109.925 176.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.55 -31.77 54.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.569 -1.196 . . . . 0.35 111.565 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.777 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.27 -41.38 34.22 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.942 -1.026 . . . . 1.51 109.808 170.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.916 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.69 -40.27 83.13 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-O 117.58 -1.2 . . . . 0.4 114.116 -173.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.79 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -38.35 90.8 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 116.299 -2.16 . . . . 0.32 109.285 177.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 28.0 mt-10 -65.55 -32.66 74.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.679 1.228 . . . . 2.51 108.013 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.826 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.74 -7.51 56.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.474 -2.148 . . . . 0.33 110.632 -169.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.39 0.73 10.07 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.222 -0.899 . . . . 0.36 109.116 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 66.46 56.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.636 -1.62 . . . . 2.19 111.981 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.79 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.58 146.88 27.57 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.92 -1.511 . . . . 0.27 106.92 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.584 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.88 160.21 42.12 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.78 -1.193 . . . . 0.69 107.78 -174.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -46.99 147.78 1.27 Allowed 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 122.021 0.915 . . . . 1.96 112.664 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -139.09 151.94 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 CA-C-N 113.981 -1.463 . . . . 0.27 112.127 -172.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 m -60.1 -50.08 75.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.914 . . . . 0.73 111.438 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.04 116.65 3.11 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.51 108.73 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.979 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -78.47 102.32 7.78 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 123.082 1.42 . . . . 2.71 111.196 -167.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.658 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 4.1 t -157.84 95.96 1.45 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.984 -1.462 . . . . 0.35 108.646 161.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.2 mmt180 -151.51 168.84 10.36 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 113.614 -1.63 . . . . 2.38 106.905 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.84 111.39 2.49 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 CA-C-N 119.91 1.004 . . . . 0.79 109.796 162.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.5 20.63 59.81 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.469 -0.872 . . . . 0.38 114.164 172.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 38.8 mt-10 -136.94 132.11 33.96 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.074 -1.084 . . . . 1.49 108.074 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.939 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.29 175.98 9.02 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.702 -0.799 . . . . 0.3 110.408 -165.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.8 p -110.32 139.74 45.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.759 0.79 . . . . 0.19 112.516 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 52.3 t -101.2 129.2 52.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 113.733 -1.576 . . . . 0.86 110.887 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.2 tp60 -113.22 -78.55 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 121.071 -0.251 . . . . 2.45 110.775 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -169.24 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.858 0.361 . . . . 0.49 111.271 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.7 -2.55 58.62 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.625 -0.509 . . . . 1.02 109.625 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 p -145.2 143.97 30.59 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.957 -0.565 . . . . 0.94 110.533 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.652 ' CG2' HD23 ' A' ' 173' ' ' LEU . 7.4 mt -106.82 169.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.2 107.303 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.939 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 27.9 tt0 -126.09 111.02 14.2 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.585 -0.846 . . . . 0.97 110.518 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 10.2 tmm? -112.95 124.29 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.092 0.473 . . . . 1.32 111.872 -169.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.725 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.33 110.537 172.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 187' ' ' GLU . 77.7 t . . . . . 0 CA--C 1.484 -1.58 0 N-CA-C 108.563 -0.903 . . . . 0.48 108.563 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.725 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -121.07 144.2 48.67 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.367 1.08 . . . . 1.61 112.591 177.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -118.18 161.18 20.3 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.2 109.657 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.416 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 34.7 ttt180 -109.53 118.82 37.62 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.836 -1.172 . . . . 3.69 107.836 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.652 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -108.52 103.87 13.08 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.693 -1.594 . . . . 0.61 110.161 -165.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 56.3 m -104.43 149.55 25.32 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.727 -0.67 . . . . 0.21 112.096 -169.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.847 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.0 m-85 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.397 -1.274 . . . . 0.32 112.16 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.557 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 20.7 t70 -99.57 97.25 8.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.974 0.416 . . . . 0.74 110.729 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.51 -115.58 4.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.223 -0.989 . . . . 0.27 113.699 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -110.74 7.55 22.17 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 106.864 -1.532 . . . . 1.61 106.864 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.78 ' HB3' HG23 ' A' ' 118' ' ' THR . 16.9 p-80 -138.84 161.0 38.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.811 -1.54 . . . . 1.28 111.837 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -68.47 131.64 45.63 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.455 -1.248 . . . . 0.22 110.459 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.557 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -79.3 -53.53 6.85 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.228 -1.351 . . . . 0.15 110.49 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.2 t 178.49 178.19 0.42 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.831 -1.077 . . . . 0.28 110.375 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.5 mp -146.36 116.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.707 -1.59 . . . . 0.28 106.707 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.631 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 99.4 t -115.77 123.66 71.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 113.243 0.831 . . . . 0.34 113.243 -170.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -61.13 91.83 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.482 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 70.5 mmm -58.35 -20.47 43.78 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 113.408 -1.724 . . . . 1.42 113.667 -163.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.5 mt-10 -71.15 -42.78 68.7 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.787 -1.097 . . . . 0.68 110.215 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -98.44 -31.08 12.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.768 -1.56 . . . . 2.36 110.981 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.631 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.9 p-10 . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.955 0.883 . . . . 1.8 112.35 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.4 m . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 109.061 -0.718 . . . . 0.32 109.061 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.911 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -130.92 171.14 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-N 115.276 -0.874 . . . . 0.2 110.889 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -123.35 178.97 4.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.494 -1.23 . . . . 1.29 109.507 -172.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 121' ' ' LYS . 12.7 mptt -56.99 -43.39 81.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.06 0.457 . . . . 3.26 111.295 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 14.1 m120 -83.6 -17.87 40.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.483 -0.326 . . . . 2.17 110.614 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.893 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -73.52 -21.61 60.35 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.288 -0.565 . . . . 0.5 111.08 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.688 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -87.87 -26.89 22.54 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.276 -0.97 . . . . 3.06 109.716 174.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 2.1 t -63.05 -30.66 50.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.62 -1.173 . . . . 0.35 111.613 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.95 -41.97 28.06 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.767 -1.106 . . . . 1.51 109.847 170.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.07 -36.43 79.61 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 117.389 -1.291 . . . . 0.4 114.27 -172.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.861 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.68 -40.53 95.56 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 116.274 -2.17 . . . . 0.32 109.511 175.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.4 mt-10 -64.62 -29.02 70.02 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.873 1.32 . . . . 2.51 108.03 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.07 -7.73 44.79 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 112.548 -2.115 . . . . 0.33 110.858 -169.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.4 t -122.09 -1.78 9.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.741 0.781 . . . . 0.36 109.853 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 70.88 57.31 0.22 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.796 -1.547 . . . . 2.19 111.746 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.861 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.95 145.02 26.24 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 106.766 -1.568 . . . . 0.27 106.766 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.662 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.35 163.68 35.68 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.67 -1.604 . . . . 0.69 106.67 -177.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 147' ' ' VAL . 2.2 pt20 -46.93 159.63 0.1 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.476 1.132 . . . . 1.96 112.828 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 138' ' ' LYS . 3.4 t -149.75 148.59 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 CA-C-N 113.513 -1.676 . . . . 0.27 111.481 -172.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 m -60.36 -49.61 76.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.241 -0.89 . . . . 0.73 111.57 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -157.68 115.29 3.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.51 108.861 -176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.781 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -75.99 104.41 6.51 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 122.999 1.381 . . . . 2.71 111.506 -168.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.8 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.9 t -157.33 94.12 1.36 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.012 -1.449 . . . . 0.35 109.02 159.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.8 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -152.3 166.26 15.7 Favored Pre-proline 0 CA--C 1.502 -0.882 0 CA-C-N 113.906 -1.497 . . . . 2.38 107.883 171.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -80.95 111.34 2.46 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 CA-C-N 119.84 0.979 . . . . 0.79 109.767 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.98 12.21 68.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.621 -0.8 . . . . 0.38 114.353 172.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.8 mt-10 -128.72 131.79 47.93 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.583 -0.895 . . . . 1.49 108.583 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.7 m-85 -130.75 174.29 10.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.549 -0.861 . . . . 0.3 110.788 -165.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 139' ' ' MET . 5.9 p -111.39 137.66 48.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.905 -0.776 . . . . 0.19 108.905 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.454 HG12 ' CB ' ' A' ' 135' ' ' GLN . 4.0 p -111.06 146.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 113.353 0.871 . . . . 0.86 113.353 -168.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.5 tt0 -154.69 174.97 14.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.591 -0.892 . . . . 2.45 108.591 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.48 ' H ' ' HG2' ' A' ' 148' ' ' GLN . . . -64.54 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.94 1.089 . . . . 0.49 113.94 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -84.71 -4.67 59.14 Favored 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 122.239 -0.288 . . . . 1.02 111.185 -174.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.666 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 28.6 p -149.95 134.68 17.65 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.65 -0.82 . . . . 0.94 110.845 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.581 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.0 mt -100.57 171.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.565 -1.272 . . . . 0.2 107.565 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.6 tt0 -117.11 137.72 52.11 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 106.982 -1.488 . . . . 0.97 106.982 167.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.498 ' CA ' ' HE1' ' A' ' 139' ' ' MET . 1.8 tmt? -135.11 123.55 23.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.615 0.643 . . . . 1.32 112.373 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 115.932 -0.576 . . . . 0.33 110.767 174.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.029 -1.1 . . . . 0.48 108.029 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.67 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -126.37 144.43 50.83 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.132 0.968 . . . . 1.61 113.308 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 163.09 16.49 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.457 -1.701 . . . . 0.2 110.181 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.404 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.0 ttm180 -113.0 118.13 33.97 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.46 -0.941 . . . . 3.69 108.46 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -107.32 111.36 23.68 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.677 -1.601 . . . . 0.61 110.604 -164.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 182' ' ' THR . 58.7 m -109.21 152.43 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.736 0.643 . . . . 0.21 112.736 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.911 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.2 m-85 -118.46 97.87 5.98 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.141 -0.936 . . . . 0.32 112.887 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.759 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 33.9 t70 -86.05 97.02 10.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.113 0.482 . . . . 0.74 110.83 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.07 -118.31 4.82 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.164 -1.017 . . . . 0.27 112.645 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.32 13.55 21.63 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.532 -1.285 . . . . 1.61 107.532 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 30.8 p80 -139.37 160.98 38.56 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.413 -1.267 . . . . 1.28 111.261 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 183' ' ' ILE . 10.2 tp -63.71 139.32 58.76 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.347 -0.842 . . . . 0.22 110.876 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -92.04 -50.48 5.67 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.414 -1.266 . . . . 0.15 111.462 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.6 t 176.33 177.34 0.25 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.573 -1.194 . . . . 0.28 110.026 -173.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -148.83 134.27 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 105.839 -1.911 . . . . 0.28 105.839 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.745 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 75.0 t -134.02 116.58 23.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 120.162 -0.615 . . . . 0.34 112.236 -171.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.1 97.81 0.05 Allowed 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.845 -1.169 . . . . 1.64 107.845 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 85.0 mmm -59.48 -16.12 22.04 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.695 -2.048 . . . . 1.42 112.98 -165.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.2 mt-10 -72.21 -44.05 63.54 Favored 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 114.499 -1.228 . . . . 0.68 109.791 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -94.4 -33.52 13.12 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.675 -1.602 . . . . 2.36 111.109 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.745 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 5.0 p30 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 115.394 1.627 . . . . 1.8 115.394 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.846 HG23 ' HB3' ' A' ' 179' ' ' HIS . 10.3 m . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 108.927 -0.768 . . . . 0.32 108.927 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.876 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.3 pt -131.75 171.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.95 -1.023 . . . . 0.2 111.945 -171.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.837 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 21.1 t -123.93 174.76 7.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.57 -1.195 . . . . 1.29 109.39 -172.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -52.2 -42.68 63.72 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.033 0.753 . . . . 3.26 113.033 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.8 t30 -85.61 -18.04 34.44 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.397 -0.815 . . . . 2.17 110.202 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.56 -25.07 63.82 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.621 -0.432 . . . . 0.5 111.409 -175.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.668 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.72 -25.28 22.41 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.096 -1.442 . . . . 3.06 109.696 175.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.32 -30.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.766 -1.107 . . . . 0.35 111.737 -177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.64 -41.44 26.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.698 -1.137 . . . . 1.51 109.822 170.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.77 -40.33 83.64 Favored 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 117.598 -1.191 . . . . 0.4 114.167 -174.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.839 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.97 -38.22 90.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.35 -2.14 . . . . 0.32 109.273 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 128' ' ' LEU . 24.2 mt-10 -66.69 -31.36 71.98 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.86 1.314 . . . . 2.51 108.129 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.86 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.8 -7.27 54.76 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 112.491 -2.14 . . . . 0.33 110.711 -169.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.9 t -121.54 -0.47 9.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.36 109.289 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 69.16 55.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.767 -1.56 . . . . 2.19 111.737 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.839 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.17 144.95 26.92 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.582 -1.266 . . . . 0.27 107.582 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.655 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.86 162.45 38.62 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.834 -1.172 . . . . 0.69 107.834 -175.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -47.3 146.94 1.73 Allowed 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 113.349 0.87 . . . . 1.96 113.349 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -140.73 151.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.968 -1.469 . . . . 0.27 112.066 -172.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -61.06 -50.18 74.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.73 111.937 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.9 ptmt -154.32 115.95 4.16 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.658 -1.155 . . . . 0.51 109.296 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.907 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -77.35 100.58 5.98 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 123.667 1.698 . . . . 2.71 112.106 -166.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.69 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.2 t -158.97 96.37 1.34 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.593 -1.64 . . . . 0.35 109.04 163.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.69 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.4 mmt180 -151.1 169.88 8.62 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.835 -1.543 . . . . 2.38 106.835 170.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.4 111.25 2.33 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 CA-C-N 119.967 1.024 . . . . 0.79 109.874 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.1 22.32 61.23 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.265 -0.969 . . . . 0.38 114.014 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.3 mt-10 -137.4 131.03 31.44 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.912 -1.144 . . . . 1.49 107.912 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.912 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -133.08 176.57 8.39 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.912 -0.715 . . . . 0.3 109.847 -167.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.907 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.6 p -108.13 143.48 36.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.608 0.718 . . . . 0.19 111.543 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.633 HG22 ' OH ' ' A' ' 133' ' ' TYR . 55.2 t -106.04 119.93 56.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.268 -1.333 . . . . 0.86 110.976 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.1 tp-100 -101.72 -85.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 2.45 110.436 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.99 -82.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 120.537 0.208 . . . . 0.49 110.745 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.588 0.709 . . . . 1.02 109.389 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 47.2 p -138.96 143.08 38.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.92 -1.036 . . . . 0.94 110.05 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.638 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.0 mt -104.64 171.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.574 -1.269 . . . . 0.2 107.574 170.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.912 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.7 tt0 -128.4 106.84 9.27 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.685 -0.806 . . . . 0.97 110.18 171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.532 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.5 tmt? -110.07 125.96 53.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 1.32 111.713 -167.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 CA-C-N 116.076 -0.511 . . . . 0.33 109.949 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.603 HG13 ' HG3' ' A' ' 187' ' ' GLU . 44.6 t . . . . . 0 CA--C 1.485 -1.527 0 N-CA-C 109.178 -0.675 . . . . 0.48 109.178 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 2.2 ppt_? -120.47 143.39 48.54 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.59 1.186 . . . . 1.61 113.039 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.88 160.62 22.33 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 112.981 -1.918 . . . . 0.2 110.638 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.38 120.24 41.92 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.097 -1.075 . . . . 3.69 108.097 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 180' ' ' LEU . 0.2 OUTLIER -114.54 110.72 20.25 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.388 -1.733 . . . . 0.61 110.576 -163.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 71.1 m -108.38 148.05 30.67 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.093 -0.38 . . . . 0.21 110.946 -173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.876 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -115.82 99.9 7.63 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.034 0.753 . . . . 0.32 113.034 176.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.614 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 11.0 t0 -77.33 92.69 3.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.373 0.606 . . . . 0.74 111.321 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.54 -109.78 3.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.131 -1.033 . . . . 0.27 114.2 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.29 7.8 23.23 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.613 -1.255 . . . . 1.61 107.613 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.846 ' HB3' HG23 ' A' ' 118' ' ' THR . 10.3 p-80 -142.29 160.82 39.49 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.071 -1.422 . . . . 1.28 112.1 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -65.61 136.43 56.33 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.165 -0.925 . . . . 0.22 110.978 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.614 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.29 -53.42 4.85 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.521 -1.218 . . . . 0.15 111.54 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 8.8 t -177.84 176.51 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.314 -0.857 . . . . 0.28 110.382 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -152.2 118.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 113.895 -1.502 . . . . 0.28 107.274 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.71 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 71.9 t -124.48 123.43 66.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.573 0.583 . . . . 0.34 112.573 -171.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.98 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.194 0.997 . . . . 1.64 108.91 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 88.0 mmm -58.27 -16.49 14.28 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 112.482 -2.145 . . . . 1.42 112.844 -168.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.603 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.8 mt-10 -68.3 -41.64 80.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.256 -1.338 . . . . 0.68 109.915 -176.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -112.87 -20.54 11.55 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.651 -1.613 . . . . 2.36 112.542 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.71 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 13.1 p30 . . . . . 0 C--N 1.349 0.559 0 N-CA-C 114.098 1.147 . . . . 1.8 114.098 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.859 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.5 m . . . . . 0 N--CA 1.432 -1.365 0 N-CA-C 109.062 -0.718 . . . . 0.32 109.062 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -127.98 172.16 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.202 1.001 . . . . 0.2 111.688 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.835 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.7 t -121.27 175.16 6.27 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 113.891 -1.504 . . . . 1.29 109.487 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.9 mttt -52.67 -48.93 66.16 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.335 0.397 . . . . 3.26 111.838 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 54.2 m-80 -83.84 -16.21 45.35 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 122.341 -0.224 . . . . 2.17 110.559 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.35 -21.27 63.83 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.451 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.06 -26.96 25.04 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.925 -1.11 . . . . 3.06 109.774 176.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.59 -32.06 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.834 -1.076 . . . . 0.35 111.532 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.776 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.85 -40.38 32.78 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.725 -1.125 . . . . 1.51 110.171 170.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.53 82.17 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 117.469 -1.253 . . . . 0.4 114.364 -174.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.818 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.86 -38.51 91.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.247 -2.181 . . . . 0.32 109.181 176.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.505 ' H ' HD22 ' A' ' 128' ' ' LEU . 36.7 mt-10 -64.67 -32.44 74.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.893 1.33 . . . . 2.51 107.895 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.66 -6.71 55.9 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.332 -2.213 . . . . 0.33 110.567 -169.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.5 t -122.11 0.28 9.59 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.351 -0.84 . . . . 0.36 109.258 -174.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 70.12 55.9 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.682 -1.599 . . . . 2.19 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.69 146.95 25.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.954 -1.499 . . . . 0.27 106.954 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.575 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.17 159.33 42.83 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.109 -1.071 . . . . 0.69 108.109 -178.09 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.4 158.97 0.76 Allowed 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 122.19 0.995 . . . . 1.96 112.116 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -148.67 153.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 113.821 -1.536 . . . . 0.27 111.264 -169.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -50.06 75.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.937 0.875 . . . . 0.73 111.728 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -157.74 113.8 2.83 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.229 -1.35 . . . . 0.51 108.682 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.957 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.32 105.06 13.08 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.229 1.49 . . . . 2.71 111.339 -166.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -157.49 93.71 1.32 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.303 -1.772 . . . . 0.35 107.969 162.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 23.7 mmt180 -151.35 169.6 9.1 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.447 -1.706 . . . . 2.38 107.813 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 111.4 2.75 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 CA-C-N 119.269 0.775 . . . . 0.79 110.389 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.11 78.4 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.581 -0.819 . . . . 0.38 113.886 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 1.3 mm-40 -129.59 132.2 46.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.382 -1.34 . . . . 1.49 107.382 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.807 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.0 OUTLIER -132.6 175.44 9.31 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.258 -0.977 . . . . 0.3 110.413 -169.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.0 p -111.18 141.9 44.08 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.954 0.883 . . . . 0.19 111.956 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 54.5 t -101.8 119.97 50.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.844 -1.526 . . . . 0.86 110.773 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 151' ' ' SER . 64.9 mt-30 -101.99 -78.59 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.681 -0.236 . . . . 2.45 110.741 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.63 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.717 0.294 . . . . 0.49 111.199 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -89.33 -2.93 58.62 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.84 0.829 . . . . 1.02 109.153 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.572 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 15.4 p -138.16 141.83 40.08 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.779 -1.1 . . . . 0.94 109.636 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.629 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.9 mt -104.35 170.92 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.103 -1.443 . . . . 0.2 107.103 169.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.2 tt0 -119.45 139.07 52.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.544 -1.651 . . . . 0.97 106.544 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.494 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -135.57 127.38 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 118.863 0.756 . . . . 1.32 111.935 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.33 108.379 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.639 HG11 ' ND2' ' A' ' 185' ' ' ASN . 12.4 t . . . . . 0 CA--C 1.495 -1.141 0 N-CA-C 108.34 -0.985 . . . . 0.48 108.34 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -119.77 144.81 47.09 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 122.454 1.121 . . . . 1.61 113.223 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.49 159.88 23.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.296 -1.774 . . . . 0.2 110.24 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HA ' ' HG3' ' A' ' 153' ' ' GLU . 24.7 ttm180 -108.93 118.82 37.78 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 122.073 0.94 . . . . 3.69 108.751 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.629 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -110.2 113.33 25.93 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.568 -1.651 . . . . 0.61 110.959 -162.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 63.5 m -112.16 149.14 32.63 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.003 -0.435 . . . . 0.21 112.152 -171.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.967 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -117.84 110.94 18.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.841 -0.618 . . . . 0.32 111.649 175.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.642 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 3.3 t70 -94.35 107.24 19.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.477 -0.783 . . . . 0.74 111.042 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.8 -115.75 4.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.279 -0.962 . . . . 0.27 113.015 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.35 10.82 19.94 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.003 -1.481 . . . . 1.61 107.003 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.859 ' HB3' HG23 ' A' ' 118' ' ' THR . 12.0 p-80 -137.51 160.75 38.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.793 -1.094 . . . . 1.28 112.734 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -63.58 134.96 56.42 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.575 -0.739 . . . . 0.22 110.493 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.642 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -88.69 -49.84 6.61 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.638 -1.164 . . . . 0.15 111.32 -176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.5 t 177.49 178.47 0.3 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.96 -1.018 . . . . 0.28 110.277 -173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.794 HD11 HD21 ' A' ' 180' ' ' LEU . 2.0 mp -152.99 124.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 N-CA-C 106.075 -1.824 . . . . 0.28 106.075 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.657 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.2 t -121.1 121.73 65.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 113.101 0.778 . . . . 0.34 113.101 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.639 ' ND2' HG11 ' A' ' 169' ' ' VAL . 23.6 t-20 -58.94 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 107.797 -1.186 . . . . 1.64 107.797 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.459 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 81.4 mmm -62.0 -15.57 45.04 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-N 114.216 -1.356 . . . . 1.42 112.661 -167.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.12 -42.62 55.96 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 114.343 -1.299 . . . . 0.68 110.289 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -100.2 -30.39 11.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.379 -1.282 . . . . 2.36 112.039 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.657 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.0 p-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 114.665 1.357 . . . . 1.8 114.665 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.5 m . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.349 -0.611 . . . . 0.32 109.349 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.885 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.1 pt -132.14 172.34 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.075 -0.966 . . . . 0.2 111.251 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.857 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 65.4 p -123.97 179.45 4.84 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.697 -1.138 . . . . 1.29 110.403 -169.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 124' ' ' MET . 41.0 mmtm -60.03 -37.81 80.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.273 0.559 . . . . 3.26 110.594 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -85.45 -22.22 28.39 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 116.213 -0.449 . . . . 2.17 110.706 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.943 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.5 mt-10 -72.53 -23.16 60.96 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 119.805 -0.758 . . . . 0.5 109.74 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.705 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -85.05 -28.12 25.89 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.172 -1.011 . . . . 3.06 109.967 178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.29 -32.57 56.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.005 -0.998 . . . . 0.35 111.711 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.782 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.95 -39.96 33.13 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.833 -1.076 . . . . 1.51 110.005 171.112 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.43 -39.54 80.05 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 114.261 1.208 . . . . 0.4 114.261 -174.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.51 -38.79 92.47 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.157 -2.217 . . . . 0.32 109.08 177.253 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.502 ' H ' HD22 ' A' ' 128' ' ' LEU . 21.1 mt-10 -65.7 -31.48 72.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.93 1.348 . . . . 2.51 108.09 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.33 -6.98 56.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.472 -2.149 . . . . 0.33 110.556 -170.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.4 t -122.17 2.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.973 -1.012 . . . . 0.36 109.195 -175.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 68.68 54.85 0.49 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 113.671 -1.604 . . . . 2.19 111.581 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.0 146.97 25.98 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.647 -1.242 . . . . 0.27 107.647 -177.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.648 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.43 161.25 40.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.126 -1.435 . . . . 0.69 107.126 -176.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -52.06 158.23 1.14 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.201 1.001 . . . . 1.96 112.099 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.41 153.58 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 113.826 -1.533 . . . . 0.27 111.48 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.3 m -59.63 -50.89 72.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.038 0.923 . . . . 0.73 111.472 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -159.91 116.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.765 -1.561 . . . . 0.51 108.035 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.971 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -82.26 109.07 16.2 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.955 1.36 . . . . 2.71 110.925 -165.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.7 t -155.71 95.66 1.68 Allowed 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 113.549 -1.659 . . . . 0.35 108.727 162.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.6 mmt180 -151.17 167.52 12.84 Favored Pre-proline 0 N--CA 1.432 -1.375 0 CA-C-N 113.029 -1.896 . . . . 2.38 107.75 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.44 111.61 2.62 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 N-CA-C 109.644 -0.945 . . . . 0.79 109.644 160.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.77 20.81 59.03 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.657 -0.783 . . . . 0.38 114.393 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 41.2 mt-10 -137.45 131.9 32.6 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.238 -1.023 . . . . 1.49 108.238 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.832 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -132.12 176.54 8.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.827 -0.749 . . . . 0.3 110.036 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.1 p -112.66 139.97 47.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.717 0.77 . . . . 0.19 111.763 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG2' ' OH ' ' A' ' 133' ' ' TYR . 40.1 t -98.44 139.48 20.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.088 -1.415 . . . . 0.86 110.922 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 151' ' ' SER . 64.0 tt0 -125.15 -79.08 0.6 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.021 -0.272 . . . . 2.45 111.273 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.54 -81.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.75 0.31 . . . . 0.49 111.702 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -86.71 -5.4 59.13 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.236 -0.653 . . . . 1.02 109.236 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 m -143.46 146.54 33.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.275 -0.875 . . . . 0.94 109.348 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.631 HG22 HD23 ' A' ' 173' ' ' LEU . 6.6 mt -107.97 169.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.988 -1.486 . . . . 0.2 106.988 167.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.832 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.1 tt0 -116.19 136.37 53.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.521 -1.659 . . . . 0.97 106.521 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.467 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.3 ppp? -136.75 125.29 23.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 119.143 0.883 . . . . 1.32 112.692 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.33 110.08 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.546 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t . . . . . 0 CA--C 1.49 -1.359 0 N-CA-C 108.467 -0.938 . . . . 0.48 108.467 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.03 144.1 51.1 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 122.288 1.042 . . . . 1.61 113.427 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -111.68 168.01 9.9 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.333 -1.758 . . . . 0.2 110.664 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.526 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 39.5 ptt180 -118.42 122.34 42.54 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.147 -1.427 . . . . 3.69 107.147 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -117.78 106.82 13.43 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.574 -1.194 . . . . 0.61 110.443 -162.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 51.8 m -105.67 150.81 25.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.67 -0.695 . . . . 0.21 112.328 -169.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.885 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.5 m-85 -115.56 106.66 14.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.32 -1.309 . . . . 0.32 112.71 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.561 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 34.5 t70 -95.96 103.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.886 0.374 . . . . 0.74 111.173 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 80.67 -118.44 4.65 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.259 -0.972 . . . . 0.27 112.602 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.31 12.82 21.65 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.578 -1.638 . . . . 1.61 106.578 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.4 p80 -133.8 161.05 35.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.546 -1.207 . . . . 1.28 111.694 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -69.14 135.35 50.56 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.706 -1.134 . . . . 0.22 110.423 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.561 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -85.78 -50.87 6.81 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.289 -1.323 . . . . 0.15 110.946 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 t -179.08 177.09 0.83 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.065 -0.97 . . . . 0.28 110.727 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -150.18 121.54 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.488 -1.671 . . . . 0.28 106.488 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.756 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 72.1 t -131.63 122.18 49.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.563 0.579 . . . . 0.34 112.563 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -59.1 99.11 0.05 OUTLIER 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.001 -1.111 . . . . 1.64 108.001 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 82.4 mtp -55.6 -22.9 24.41 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 112.606 -2.088 . . . . 1.42 112.179 -169.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.7 mt-10 -66.47 -45.69 78.84 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.098 -1.41 . . . . 0.68 110.603 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.71 -20.0 13.76 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.399 -1.273 . . . . 2.36 111.668 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.756 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.6 p30 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 113.581 0.956 . . . . 1.8 113.581 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.32 108.938 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.2 pt -131.01 172.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 122.374 1.083 . . . . 0.2 112.452 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.84 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 7.4 m -111.9 171.32 7.57 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.547 -1.66 . . . . 1.29 110.031 -173.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.623 ' O ' ' HG3' ' A' ' 124' ' ' MET . 63.9 mttm -49.27 -54.49 16.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.093 0.473 . . . . 3.26 111.885 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 20.9 t-20 -82.51 -15.81 51.04 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.956 -0.387 . . . . 2.17 109.956 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -64.58 -24.88 67.74 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.149 -0.621 . . . . 0.5 110.19 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.763 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.59 -28.36 24.89 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.327 -1.349 . . . . 3.06 109.769 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -32.69 55.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.453 1.12 . . . . 0.35 111.684 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.57 -42.35 29.43 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.493 -1.23 . . . . 1.51 109.917 169.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.41 -38.51 84.26 Favored 'General case' 0 CA--C 1.463 -2.399 0 CA-C-O 117.429 -1.272 . . . . 0.4 114.101 -173.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.47 -40.93 98.23 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 116.329 -2.148 . . . . 0.32 108.717 177.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.651 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.4 mm-40 -66.87 -32.24 73.37 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.098 1.427 . . . . 2.51 108.589 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.98 -7.53 59.11 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 111.911 -2.404 . . . . 0.33 110.296 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.0 t -121.46 1.71 10.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.214 1.007 . . . . 0.36 108.744 -176.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 70.95 54.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.238 -1.801 . . . . 2.19 112.109 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.65 143.27 23.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.202 -1.407 . . . . 0.27 107.202 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -143.2 162.38 35.75 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.088 -1.449 . . . . 0.69 107.088 -178.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -52.39 158.28 1.25 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.232 1.015 . . . . 1.96 112.059 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -147.04 152.32 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-N 114.002 -1.454 . . . . 0.27 111.903 -168.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 m -59.61 -49.65 76.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.73 111.544 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -158.54 113.55 2.58 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.982 -1.463 . . . . 0.51 108.627 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.003 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.78 106.18 14.41 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.851 1.31 . . . . 2.71 111.056 -168.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.805 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.7 t -157.45 93.94 1.34 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.942 -1.481 . . . . 0.35 109.171 162.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.805 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.0 mmt180 -152.15 170.0 8.66 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 113.145 -1.843 . . . . 2.38 107.779 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -81.88 111.71 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 CA-C-N 119.755 0.948 . . . . 0.79 110.299 162.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.64 72.85 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.575 -0.821 . . . . 0.38 114.345 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.434 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 3.2 mm-40 -127.78 130.84 49.39 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.799 -1.556 . . . . 1.49 106.799 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.778 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -133.97 176.71 8.33 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.868 -1.133 . . . . 0.3 110.638 -168.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 1.003 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.3 p -112.86 139.86 48.13 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.657 0.742 . . . . 0.19 111.799 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -98.65 141.37 16.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.097 -1.411 . . . . 0.86 111.065 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 151' ' ' SER . 10.0 tt0 -124.95 -78.73 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.833 -0.167 . . . . 2.45 110.956 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.76 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.612 0.244 . . . . 0.49 111.183 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.406 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 85.8 m-20 -81.72 -1.19 46.14 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.324 -0.621 . . . . 1.02 109.324 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 15.1 m -140.63 144.73 35.92 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.69 -0.686 . . . . 0.94 110.045 172.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.88 172.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.728 -1.212 . . . . 0.2 107.728 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.0 tt0 -118.87 135.2 54.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.512 -1.662 . . . . 0.97 106.512 166.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.485 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -136.19 127.11 27.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.111 0.868 . . . . 1.32 111.893 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.33 110.813 176.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.619 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.8 t . . . . . 0 CA--C 1.487 -1.46 0 N-CA-C 107.986 -1.116 . . . . 0.48 107.986 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.31 144.4 50.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.337 1.065 . . . . 1.61 113.862 177.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -114.69 164.92 13.38 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.162 -1.836 . . . . 0.2 110.737 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.46 122.78 43.57 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.815 -1.18 . . . . 3.69 107.815 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -116.75 121.24 41.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 113.922 -1.49 . . . . 0.61 110.575 -161.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.435 HG22 ' CB ' ' A' ' 181' ' ' ALA . 54.3 m -114.62 151.83 32.85 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.307 0.484 . . . . 0.21 112.307 -170.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.859 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.4 m-85 -116.16 100.08 7.68 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.747 -1.115 . . . . 0.32 113.375 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.641 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 27.1 t70 -92.22 99.38 12.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.74 111.325 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.69 -113.72 3.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.954 -1.117 . . . . 0.27 113.948 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 8.07 20.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.016 -1.475 . . . . 1.61 107.016 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 20.9 p80 -138.6 161.7 36.45 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.025 -1.443 . . . . 1.28 111.786 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 183' ' ' ILE . 8.7 tp -67.41 137.28 55.81 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.705 -1.134 . . . . 0.22 110.464 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.641 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.33 -49.67 7.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.572 -1.195 . . . . 0.15 111.44 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 174' ' ' THR . 7.6 t 179.46 177.92 0.55 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.195 -0.911 . . . . 0.28 110.277 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -153.02 128.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 105.767 -1.938 . . . . 0.28 105.767 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.671 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 84.0 t -129.58 118.11 44.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 120.172 -0.611 . . . . 0.34 112.146 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.621 HD22 ' HB2' ' A' ' 171' ' ' ALA . 11.2 m120 -60.5 96.58 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.554 -1.276 . . . . 1.64 107.554 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.85 -19.07 15.48 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 113.157 -1.838 . . . . 1.42 112.971 -166.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.619 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -73.32 -43.18 61.33 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 114.342 -1.299 . . . . 0.68 109.961 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -91.93 -34.14 14.6 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.681 -1.599 . . . . 2.36 111.174 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.671 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.6 p30 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 115.216 1.561 . . . . 1.8 115.216 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.774 HG23 ' HB3' ' A' ' 179' ' ' HIS . 24.7 m . . . . . 0 N--CA 1.438 -1.066 0 CA-C-O 121.529 0.68 . . . . 0.32 110.455 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.0 pt -137.2 172.25 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.675 -1.148 . . . . 0.2 110.853 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.853 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.5 t -121.63 173.33 7.5 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.191 -1.368 . . . . 1.29 109.482 -172.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 124' ' ' MET . 59.0 tttm -51.51 -48.62 62.89 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.782 0.325 . . . . 3.26 111.645 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.425 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 28.5 t-20 -82.4 -18.24 42.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.844 -0.428 . . . . 2.17 109.844 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -68.8 -24.32 64.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.927 -0.709 . . . . 0.5 109.785 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.774 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.98 -29.07 23.82 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 118.337 -1.345 . . . . 3.06 109.598 177.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.81 -32.56 54.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.259 1.028 . . . . 0.35 112.052 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.04 -43.44 29.31 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.607 -1.178 . . . . 1.51 109.68 169.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.89 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.29 -37.28 82.62 Favored 'General case' 0 CA--C 1.461 -2.449 0 CA-C-O 117.539 -1.219 . . . . 0.4 113.929 -172.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -63.34 -41.13 98.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 116.211 -2.196 . . . . 0.32 108.832 176.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.673 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.7 mm-40 -67.47 -31.03 70.9 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.924 1.345 . . . . 2.51 108.577 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.6 -7.94 59.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 111.964 -2.38 . . . . 0.33 110.011 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.5 t -121.98 1.26 9.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.149 -0.932 . . . . 0.36 108.872 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 72.94 55.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.62 -1.627 . . . . 2.19 112.466 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 143.76 23.52 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 106.551 -1.648 . . . . 0.27 106.551 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.703 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -142.85 159.89 41.37 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 106.833 -1.543 . . . . 0.69 106.833 -174.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -48.05 145.96 2.81 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.11 0.957 . . . . 1.96 112.559 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -136.08 152.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 CA-C-N 113.773 -1.558 . . . . 0.27 111.63 -173.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -60.48 -49.81 76.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.359 -0.837 . . . . 0.73 111.591 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -156.9 115.74 3.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.207 -1.36 . . . . 0.51 109.099 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.849 ' HB3' HG23 ' A' ' 146' ' ' THR . 2.4 ppp? -77.69 103.11 7.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 123.255 1.502 . . . . 2.71 110.917 -168.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.813 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.0 t -158.65 92.21 1.11 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.466 -1.697 . . . . 0.35 108.936 158.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.9 mmt180 -152.51 149.5 22.81 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 113.749 -1.569 . . . . 2.38 106.942 174.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.73 110.59 2.15 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 CA-C-N 120.454 1.198 . . . . 0.79 109.821 169.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.06 59.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.534 -0.841 . . . . 0.38 114.222 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 33.8 mt-10 -138.64 131.88 30.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.647 -1.242 . . . . 1.49 107.647 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -132.7 176.14 8.71 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.558 -0.857 . . . . 0.3 110.691 -166.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.849 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.4 p -112.6 139.46 48.18 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.91 0.862 . . . . 0.19 112.038 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.01 139.66 21.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 0.86 111.201 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.614 ' HB2' ' O ' ' A' ' 151' ' ' SER . 56.3 mt-30 -124.12 -94.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.543 -0.299 . . . . 2.45 110.858 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.89 -77.76 0.07 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.729 0.3 . . . . 0.49 111.184 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.18 -4.44 59.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.131 0.491 . . . . 1.02 109.704 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 5.6 m -145.43 146.3 31.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.828 -0.623 . . . . 0.94 109.845 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.709 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -106.36 165.9 3.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.316 -1.365 . . . . 0.2 107.316 167.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 7.1 tt0 -115.57 129.02 56.38 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.255 -1.387 . . . . 0.97 107.255 169.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.452 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.86 124.93 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.613 0.642 . . . . 1.32 112.393 -177.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.865 0.365 . . . . 0.33 110.17 173.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 46.8 t . . . . . 0 CA--C 1.493 -1.214 0 N-CA-C 108.787 -0.82 . . . . 0.48 108.787 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.46 145.8 49.3 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.469 1.128 . . . . 1.61 113.218 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.04 167.59 10.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.084 -1.871 . . . . 0.2 110.807 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 45.2 ttt180 -117.97 109.43 16.48 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.414 -1.328 . . . . 3.69 107.414 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -100.0 112.34 24.63 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.529 -1.669 . . . . 0.61 109.665 -170.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 86.5 m -109.06 150.46 27.78 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.541 0.571 . . . . 0.21 112.541 -168.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 11.5 m-85 -115.14 114.66 25.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.43 -1.259 . . . . 0.32 111.88 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.468 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 20.6 t70 -99.67 96.09 7.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.74 110.7 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.11 -115.49 4.03 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.268 -0.968 . . . . 0.27 113.511 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.75 11.09 22.63 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.681 -1.6 . . . . 1.61 106.681 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.774 ' HB3' HG23 ' A' ' 118' ' ' THR . 28.2 p80 -141.06 161.03 38.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.229 -1.351 . . . . 1.28 111.644 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 183' ' ' ILE . 7.0 tp -64.81 144.39 57.29 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.309 -0.859 . . . . 0.22 111.654 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.468 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.1 -50.56 5.24 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.193 -1.367 . . . . 0.15 111.544 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.3 t 175.3 178.18 0.16 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.28 109.513 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.55 129.13 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.875 -1.528 . . . . 0.28 106.875 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.834 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 67.6 t -133.01 116.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.66 0.615 . . . . 0.34 112.66 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 171' ' ' ALA . 10.9 m120 -60.8 97.74 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.333 1.063 . . . . 1.64 108.17 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 84.1 mtp -56.29 -22.7 31.87 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 112.168 -2.287 . . . . 1.42 112.951 -165.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -66.49 -43.5 85.2 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.721 -1.127 . . . . 0.68 110.639 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -98.48 -30.86 12.29 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.152 -1.385 . . . . 2.36 110.813 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.834 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.1 t30 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 113.474 0.916 . . . . 1.8 113.474 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.807 HG23 ' HB3' ' A' ' 179' ' ' HIS . 22.7 m . . . . . 0 N--CA 1.443 -0.806 0 N-CA-C 108.983 -0.747 . . . . 0.32 108.983 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.868 HD11 ' CD1' ' A' ' 175' ' ' PHE . 7.6 pt -126.53 171.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.097 0.951 . . . . 0.2 111.283 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.859 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 19.4 t -114.05 170.2 8.45 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.831 -1.532 . . . . 1.29 109.319 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -52.66 -48.75 66.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 3.26 111.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 46.1 m-80 -83.86 -15.39 48.32 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.669 -0.241 . . . . 2.17 110.616 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.95 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -65.98 -24.14 66.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.277 -0.569 . . . . 0.5 110.471 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.27 -26.5 24.95 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.764 -1.174 . . . . 3.06 110.058 178.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG23 ' SD ' ' A' ' 124' ' ' MET . 2.0 t -65.16 -28.69 45.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.796 -1.093 . . . . 0.35 111.349 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.76 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -81.67 -38.53 25.73 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.642 -1.163 . . . . 1.51 110.177 171.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.95 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -56.17 -44.09 79.0 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 114.643 1.349 . . . . 0.4 114.643 -175.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.891 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -61.07 -39.78 91.19 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 116.778 -1.969 . . . . 0.32 109.374 177.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 21.9 mt-10 -65.6 -28.98 69.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.7 1.238 . . . . 2.51 108.088 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.06 -7.83 47.61 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 112.848 -1.978 . . . . 0.33 110.977 -170.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.1 t -122.13 -2.38 9.14 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.558 0.694 . . . . 0.36 109.996 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 71.07 56.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.703 -1.589 . . . . 2.19 111.829 -177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.62 146.34 27.24 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.198 -1.779 . . . . 0.27 106.198 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.666 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.09 163.81 35.09 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.668 -1.234 . . . . 0.69 107.668 -176.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.526 ' CB ' HG12 ' A' ' 147' ' ' VAL . 4.3 pt20 -48.97 159.33 0.26 Allowed 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.404 1.097 . . . . 1.96 112.3 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.9 t -148.43 151.83 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-N 113.557 -1.656 . . . . 0.27 111.093 -172.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 m -60.19 -50.12 74.92 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.987 0.899 . . . . 0.73 111.37 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -159.06 115.76 2.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.879 -1.509 . . . . 0.51 108.424 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.943 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.71 108.14 16.59 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.79 1.281 . . . . 2.71 110.708 -167.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.791 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -157.33 93.95 1.35 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.649 -1.614 . . . . 0.35 108.55 161.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.9 mmt180 -151.98 170.17 8.37 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 113.352 -1.749 . . . . 2.38 107.589 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.16 111.75 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 CA-C-N 119.868 0.989 . . . . 0.79 110.478 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.8 22.69 65.88 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.824 -0.703 . . . . 0.38 114.217 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -132.22 132.56 43.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.92 -1.511 . . . . 1.49 106.92 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.4 m-85 -133.42 173.83 11.06 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.89 -1.124 . . . . 0.3 110.507 -167.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 139' ' ' MET . 7.7 p -112.53 136.39 52.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.276 0.56 . . . . 0.19 109.953 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 135' ' ' GLN . 1.2 p -111.41 143.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.097 -0.956 . . . . 0.86 111.803 -171.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -129.16 -85.14 0.56 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.398 -0.364 . . . . 2.45 111.501 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.1 -83.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.141 0.423 . . . . 0.49 112.141 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.47 ' C ' ' HD2' ' A' ' 175' ' ' PHE . 48.3 m-80 -88.24 -5.55 58.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.444 0.64 . . . . 1.02 109.709 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.9 m -143.22 146.78 33.96 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.154 -0.618 . . . . 0.94 109.643 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.8 mt -114.48 168.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.552 -0.907 . . . . 0.2 108.552 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 20.8 tt0 -111.49 132.71 54.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.728 -1.582 . . . . 0.97 106.728 167.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.1 tmt? -134.71 124.48 25.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 118.691 0.678 . . . . 1.32 111.151 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.33 111.283 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.7 t . . . . . 0 CA--C 1.483 -1.615 0 N-CA-C 107.775 -1.194 . . . . 0.48 107.775 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.756 ' HB3' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -106.5 150.15 26.39 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.986 0.898 . . . . 1.61 112.445 176.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -124.97 159.33 31.5 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 113.443 -1.708 . . . . 0.2 111.313 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.85 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.4 tpt180 -108.02 101.24 10.5 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.819 -1.178 . . . . 3.69 107.819 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.552 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -93.68 113.55 25.65 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 112.988 -1.915 . . . . 0.61 110.115 -170.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 181' ' ' ALA . 52.6 m -112.5 148.79 33.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.654 0.613 . . . . 0.21 112.654 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.2 m-85 -116.35 112.68 21.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.011 -0.995 . . . . 0.32 111.807 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.594 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.8 t70 -102.35 95.68 6.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.067 0.46 . . . . 0.74 110.537 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.44 -114.02 3.76 Favored Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.17 -1.014 . . . . 0.27 114.187 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -105.75 5.0 30.56 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 108.07 -1.085 . . . . 1.61 108.07 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.807 ' HB3' HG23 ' A' ' 118' ' ' THR . 21.8 p80 -141.58 160.2 40.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.604 -1.18 . . . . 1.28 112.517 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.766 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -65.99 134.6 53.26 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 114.391 -1.277 . . . . 0.22 109.698 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.36 -48.28 8.61 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 114.387 -1.279 . . . . 0.15 111.122 -175.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.502 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.2 t 175.76 177.96 0.19 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.044 -0.98 . . . . 0.28 110.386 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.766 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -149.38 122.51 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.999 -1.482 . . . . 0.28 106.999 175.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.696 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 97.0 t -127.09 123.66 62.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 118.965 -0.541 . . . . 0.34 112.279 -170.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.52 94.18 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.777 0.799 . . . . 1.64 109.379 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.85 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 50.2 mmm -43.22 -37.87 2.31 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 112.734 -2.03 . . . . 1.42 112.752 -172.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.589 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.3 mt-10 -63.19 -40.53 97.78 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 113.488 -1.687 . . . . 0.68 111.224 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -101.68 -30.58 11.25 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.896 -1.502 . . . . 2.36 111.471 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.696 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 14.4 p30 . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 125.141 1.376 . . . . 1.8 114.512 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.7 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.039 -0.726 . . . . 0.32 109.039 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.887 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.8 pt -129.76 172.67 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.227 1.013 . . . . 0.2 112.0 -171.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.6 m -114.64 173.79 6.29 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.709 -1.587 . . . . 1.29 110.215 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.632 ' O ' ' HG3' ' A' ' 124' ' ' MET . 2.5 mppt? -51.58 -53.1 41.74 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.343 0.402 . . . . 3.26 111.962 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 m-20 -82.93 -15.26 52.05 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.624 -0.262 . . . . 2.17 110.71 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.904 ' O ' HD12 ' A' ' 127' ' ' LEU . 3.0 mt-10 -65.36 -23.72 67.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.002 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.28 -29.56 24.48 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 118.474 -1.29 . . . . 3.06 110.057 178.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.17 -31.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.466 1.127 . . . . 0.35 111.833 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.755 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.93 -42.51 23.9 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.169 -1.378 . . . . 1.51 109.73 170.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.53 -38.49 84.6 Favored 'General case' 0 CA--C 1.462 -2.424 0 CA-C-O 117.523 -1.227 . . . . 0.4 114.067 -173.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.57 -39.82 94.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 116.153 -2.219 . . . . 0.32 108.72 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.682 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 63.1 mm-40 -68.82 -30.68 69.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 123.04 1.4 . . . . 2.51 108.923 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.41 -7.6 58.85 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 111.857 -2.429 . . . . 0.33 110.23 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.77 -3.94 9.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.245 -0.889 . . . . 0.36 109.387 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 131' ' ' THR . 49.1 mt-30 79.96 55.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 113.757 -1.565 . . . . 2.19 112.235 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -154.28 146.5 23.79 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.886 -1.524 . . . . 0.27 106.886 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.607 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -144.52 161.33 39.35 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.371 -1.714 . . . . 0.69 106.371 -177.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.24 159.4 1.94 Allowed 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 119.281 0.946 . . . . 1.96 112.029 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -145.91 155.82 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-N 114.19 -1.368 . . . . 0.27 112.019 -168.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.2 m -59.51 -51.15 71.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.05 0.929 . . . . 0.73 111.639 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.532 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -159.78 114.51 2.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 113.931 -1.486 . . . . 0.51 108.117 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.972 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.89 105.08 11.85 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 123.035 1.398 . . . . 2.71 111.24 -166.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.803 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.0 t -157.41 94.25 1.37 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.558 -1.655 . . . . 0.35 108.47 162.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.803 ' HD3' ' O ' ' A' ' 140' ' ' THR . 7.6 mmt180 -151.44 168.02 11.93 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 113.477 -1.692 . . . . 2.38 107.158 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.45 111.69 2.63 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 CA-C-N 119.897 0.999 . . . . 0.79 109.899 164.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.81 27.76 58.11 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.2 -1.0 . . . . 0.38 113.902 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.9 mt-10 -140.85 131.25 25.21 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.407 -1.331 . . . . 1.49 107.407 172.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.78 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -133.88 176.35 8.65 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.419 -0.913 . . . . 0.3 110.511 -167.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.972 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.3 p -113.09 137.54 51.28 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.962 0.886 . . . . 0.19 112.505 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 51.6 t -97.62 138.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.451 -1.704 . . . . 0.86 111.12 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 151' ' ' SER . 16.6 mm100 -123.14 -90.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.935 -0.12 . . . . 2.45 110.972 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.79 -87.31 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.653 0.263 . . . . 0.49 111.337 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -82.98 -3.14 56.84 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.062 0.458 . . . . 1.02 109.786 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 20.4 m -141.33 146.13 36.32 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.371 -0.532 . . . . 0.94 110.357 172.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -107.26 170.66 2.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.351 -1.351 . . . . 0.2 107.351 168.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.6 tt0 -116.33 136.26 53.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.764 -1.569 . . . . 0.97 106.764 165.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.429 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.1 tmt? -136.5 124.81 23.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 118.592 0.633 . . . . 1.32 112.367 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.594 -0.521 . . . . 0.33 109.594 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 170' ' ' ARG . 89.9 t . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 109.166 -0.679 . . . . 0.48 109.166 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HB2' ' CE ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -126.41 144.9 50.68 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.197 0.999 . . . . 1.61 113.165 177.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 167.67 10.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.313 -1.767 . . . . 0.2 110.517 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.764 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 48.2 ttp180 -116.22 122.74 45.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.419 -1.326 . . . . 3.69 107.419 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -112.11 110.53 20.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.288 -1.324 . . . . 0.61 110.203 -164.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 181' ' ' ALA . 51.9 m -107.64 150.25 27.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.229 0.538 . . . . 0.21 112.308 -169.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.887 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.6 m-85 -115.66 102.46 9.77 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.566 -1.197 . . . . 0.32 113.212 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.621 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 31.0 t70 -92.11 101.65 14.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.85 0.357 . . . . 0.74 110.972 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.66 -117.21 4.36 Favored Glycine 0 C--N 1.318 -0.461 0 C-N-CA 120.048 -1.072 . . . . 0.27 113.485 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.66 10.61 22.85 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.5 -1.667 . . . . 1.61 106.5 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.804 ' HB3' HG23 ' A' ' 118' ' ' THR . 24.4 p80 -137.89 161.66 36.06 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.287 -1.324 . . . . 1.28 112.083 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 183' ' ' ILE . 8.5 tp -68.19 136.38 53.53 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.607 -1.178 . . . . 0.22 110.502 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.621 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.46 -50.06 6.79 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.392 -1.276 . . . . 0.15 111.364 -176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.6 t 179.23 178.4 0.49 Allowed 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.036 -0.984 . . . . 0.28 109.903 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.765 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -147.89 112.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 106.459 -1.682 . . . . 0.28 106.459 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.767 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -115.16 129.8 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 113.15 0.796 . . . . 0.34 113.15 -169.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 188' ' ' ASN . 25.1 p-10 -60.07 95.52 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.108 0.956 . . . . 1.64 109.693 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 66.6 mmm -51.47 -25.61 6.78 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 113.37 -1.741 . . . . 1.42 112.949 -169.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.6 mt-10 -68.26 -42.6 79.36 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.452 -1.249 . . . . 0.68 110.635 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.416 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 5.5 t-20 -103.49 -25.73 13.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.707 -1.588 . . . . 2.36 111.663 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.767 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 10.3 p30 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 114.843 1.423 . . . . 1.8 114.843 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.676 0.274 . . . . 31.14 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.1 173.95 13.18 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.695 -0.764 . . . . 30.65 112.355 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m 63.28 38.61 10.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.246 0.546 . . . . 30.65 111.943 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.5 t -148.75 66.05 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.228 -0.656 . . . . 29.78 109.228 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -74.32 -30.6 62.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.373 -0.83 . . . . 29.55 110.143 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.33 123.17 3.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.479 -0.782 . . . . 29.87 109.446 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -67.36 -36.93 82.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.939 -0.573 . . . . 27.89 110.638 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -91.7 112.14 23.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.199 0.523 . . . . 26.19 110.196 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -108.5 152.58 24.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.764 -0.653 . . . . 26.23 110.559 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -82.02 80.94 8.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 26.64 110.831 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.5 m -61.58 109.04 1.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.684 -0.689 . . . . 24.71 110.234 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.1 m -81.23 79.99 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.072 0.463 . . . . 24.15 110.446 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -72.82 1.28 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.763 -0.732 . . . . 22.66 111.823 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 116' ' ' ASP . 98.3 mt -113.18 17.1 18.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.841 0.353 . . . . 20.88 110.827 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 60.0 t -63.46 -54.02 47.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.85 -0.34 . . . . 19.88 110.442 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 72.5 Cg_endo -77.44 129.64 10.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.334 1.356 . . . . 18.7 111.643 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 43.01 50.74 5.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.137 0.975 . . . . 18.91 112.674 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.14 -39.12 91.78 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.007 -0.616 . . . . 15.32 112.362 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.2 m 60.5 54.94 3.6 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.753 0.421 . . . . 14.03 111.959 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -84.6 -23.27 29.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.432 -0.349 . . . . 12.65 110.24 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 67.3 mtm 66.03 -79.72 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.487 -0.779 . . . . 11.98 112.126 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -143.45 -151.38 5.46 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.965 -0.636 . . . . 8.1 111.853 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 130' ' ' ALA . 26.3 ttp85 -85.06 71.96 10.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.343 0.592 . . . . 9.18 110.356 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.7 ptm -136.0 21.7 3.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 122.711 1.243 . . . . 6.14 108.05 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.72 148.94 15.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.151 -1.841 . . . . 4.84 109.083 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -66.66 145.59 55.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.309 -0.405 . . . . 4.29 110.292 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 173' ' ' LEU . 2.8 tm? -63.82 131.51 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.735 -0.666 . . . . 1.69 109.524 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HG2' ' HD2' ' A' ' 115' ' ' PRO . 5.0 tt0 -178.35 156.17 0.99 Allowed Pre-proline 0 CA--C 1.509 -0.606 0 N-CA-C 106.081 -1.822 . . . . 3.45 106.081 -170.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HA ' ' H ' ' A' ' 117' ' ' MET . 60.2 Cg_endo -90.97 103.24 0.26 Allowed 'Trans proline' 0 N--CA 1.428 -2.349 0 CA-C-N 121.823 1.687 . . . . 3.06 113.405 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 7.8 p-10 -111.7 -2.81 15.22 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 103.041 -2.948 . . . . 3.24 103.041 141.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.592 ' HG3' HG23 ' A' ' 119' ' ' ILE . 26.3 tpp -84.55 143.84 29.05 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 110.803 -2.908 . . . . 1.45 112.085 -160.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.3 m -129.27 97.89 4.72 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.116 -0.947 . . . . 0.32 109.511 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.846 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.09 171.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 115.098 -0.956 . . . . 0.2 110.829 -172.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.773 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 p -120.39 179.19 4.38 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.411 -0.813 . . . . 1.29 110.644 -172.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 124' ' ' MET . 87.3 tttt -53.62 -40.22 65.59 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.485 0.491 . . . . 3.26 111.343 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 8.0 m-20 -82.56 -24.04 34.18 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 116.602 -0.272 . . . . 2.17 111.246 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.803 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . 25.0 mt-10 -68.99 -34.0 74.58 Favored 'General case' 0 N--CA 1.41 -2.447 0 C-N-CA 117.826 -1.55 . . . . 0.5 109.34 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.721 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.81 -33.65 76.07 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 119.008 -1.077 . . . . 3.06 109.362 177.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' HD21 ' A' ' 128' ' ' LEU . 1.8 t -66.25 -31.64 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.276 -0.874 . . . . 0.35 112.087 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.803 ' HD2' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -85.81 -32.82 21.57 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.724 -0.671 . . . . 1.51 110.779 173.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.817 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -59.14 -46.75 87.56 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 114.962 1.467 . . . . 0.4 114.962 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.804 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -58.98 -38.03 78.19 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 116.711 -1.996 . . . . 0.32 109.164 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.555 ' N ' HD23 ' A' ' 128' ' ' LEU . 30.1 mt-10 -65.86 -32.43 73.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.652 1.215 . . . . 2.51 107.954 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.817 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.62 -7.74 55.86 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 112.599 -2.091 . . . . 0.33 110.948 -170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.5 t -122.06 1.18 9.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.22 -0.9 . . . . 0.36 109.275 -174.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 66.56 56.87 0.72 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 113.535 -1.666 . . . . 2.19 111.867 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.804 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.98 147.22 27.6 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.972 -1.492 . . . . 0.27 106.972 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.599 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.01 154.65 42.75 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.003 -1.11 . . . . 0.69 108.003 -173.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -47.45 144.61 2.91 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 121.794 0.807 . . . . 1.96 112.339 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 134' ' ' ARG . 2.6 t -136.11 150.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 CA-C-N 114.1 -1.409 . . . . 0.27 112.079 -171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.4 m -59.9 -50.08 75.18 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.865 -1.062 . . . . 0.73 111.57 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 19.1 ptmt -156.93 116.02 3.37 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.24 -1.345 . . . . 0.51 108.836 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.023 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.21 102.77 9.65 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.938 -1.483 . . . . 2.71 111.155 -167.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.4 t -157.29 92.63 1.26 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.395 -1.275 . . . . 0.35 109.535 162.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -153.94 158.64 32.51 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.903 -1.499 . . . . 2.38 107.519 169.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -75.66 109.76 2.96 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 CA-C-N 120.421 1.186 . . . . 0.79 109.574 167.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.23 2.94 57.86 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.498 -0.858 . . . . 0.38 114.439 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.0 mt-10 -128.84 132.33 47.78 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 118.202 1.001 . . . . 1.49 108.609 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.831 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.1 m-85 -133.16 176.24 8.68 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.112 -0.635 . . . . 0.3 110.224 -166.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 1.023 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.3 p -110.12 142.19 41.94 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.711 0.767 . . . . 0.19 111.655 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 128' ' ' LEU . 41.1 t -100.98 138.76 24.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 114.213 -1.358 . . . . 0.86 111.684 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.661 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.8 tp-100 -124.96 -87.54 0.61 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.479 -0.328 . . . . 2.45 110.751 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.39 -84.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.728 0.27 . . . . 0.49 111.728 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.453 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 88.3 m-20 -81.52 -5.15 57.69 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.482 -0.562 . . . . 1.02 109.482 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 31.0 p -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.674 -0.694 . . . . 0.94 110.043 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.642 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.0 mt -106.73 170.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 107.184 -1.413 . . . . 0.2 107.184 170.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 24.4 tt0 -116.97 137.3 52.31 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.989 -1.485 . . . . 0.97 106.989 166.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -133.46 124.67 27.46 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.655 -0.818 . . . . 1.32 112.3 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.93 130.33 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.669 -0.696 . . . . 0.33 109.992 173.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.408 HH11 ' HE1' ' A' ' 154' ' ' MET . 31.0 tpt180 -81.72 145.13 30.66 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.607 -0.516 . . . . 3.1 109.607 -176.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -49.78 115.63 5.32 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 123.679 0.612 . . . . 4.26 110.934 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.35 175.22 10.33 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 123.032 2.488 . . . . 2.01 113.336 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.81 115.82 14.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.78 -1.555 . . . . 5.12 108.762 173.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.564 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 45.8 m-20 -125.89 135.27 51.73 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.123 -0.944 . . . . 5.15 111.48 -170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 3.6 m-30 -118.11 167.51 11.21 Favored Pre-proline 0 N--CA 1.434 -1.242 0 CA-C-O 121.787 0.803 . . . . 6.81 110.479 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.1 Cg_endo -75.84 -42.93 0.37 Allowed 'Trans proline' 0 N--CA 1.416 -3.048 0 C-N-CA 122.144 1.896 . . . . 8.97 110.812 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -90.7 -5.58 55.56 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 112.457 -2.156 . . . . 10.53 109.55 -174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 3.2 m -163.96 139.53 6.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.228 -1.351 . . . . 7.9 112.658 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.564 ' HE2' ' HB3' ' A' ' 160' ' ' ASP . 64.0 mttt -144.38 138.04 27.5 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.413 0.625 . . . . 6.69 112.044 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -171.96 -170.68 0.78 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.528 -1.215 . . . . 5.04 110.553 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.06 147.76 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.539 -0.755 . . . . 2.11 113.258 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.69 146.65 27.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.507 0.67 . . . . 2.93 109.768 170.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 155' ' ' ILE . 77.1 t -144.93 146.91 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 CA-C-N 114.734 -1.121 . . . . 0.48 108.406 173.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -129.74 145.11 51.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 122.305 1.05 . . . . 1.61 113.234 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.63 163.53 15.65 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.194 -1.821 . . . . 0.2 109.83 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 74.9 ttt180 -111.94 127.15 55.77 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.97 -1.122 . . . . 3.69 107.97 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -114.84 111.38 21.13 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.402 -1.272 . . . . 0.61 110.682 -165.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.552 ' CG2' HD23 ' A' ' 197' ' ' LEU . 96.3 m -109.31 150.49 27.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.347 0.594 . . . . 0.21 112.25 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.846 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.5 m-85 -115.65 114.09 24.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.358 -1.292 . . . . 0.32 111.853 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.542 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.2 t70 -104.63 103.41 13.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.74 111.393 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.82 -113.22 3.61 Favored Glycine 0 C--N 1.314 -0.691 0 C-N-CA 120.054 -1.069 . . . . 0.27 113.409 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.51 8.7 19.4 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.262 -1.384 . . . . 1.61 107.262 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.777 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.5 p80 -135.71 160.99 36.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.635 -1.166 . . . . 1.28 112.315 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 183' ' ' ILE . 9.2 tp -69.31 130.57 42.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 114.524 -1.216 . . . . 0.22 110.158 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.28 -49.99 10.82 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.426 -1.261 . . . . 0.15 110.821 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 5.9 t -179.99 177.46 0.66 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.903 -1.044 . . . . 0.28 110.94 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.802 HD11 HD21 ' A' ' 180' ' ' LEU . 2.9 mp -151.17 128.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 105.7 -1.963 . . . . 0.28 105.7 173.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.775 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.2 t -133.99 119.47 32.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.015 -0.674 . . . . 0.34 112.207 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 98.59 0.06 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.156 -1.053 . . . . 1.64 108.156 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 75.3 mmm -53.03 -27.26 18.81 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 112.379 -2.192 . . . . 1.42 112.741 -167.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.9 mt-10 -65.67 -43.04 90.5 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-N 114.164 -1.38 . . . . 0.68 110.982 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.491 HD22 ' HG3' ' A' ' 191' ' ' GLN . 63.5 t30 -107.14 -19.86 13.48 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.152 -1.385 . . . . 2.36 111.27 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.775 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.2 p30 36.38 43.78 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.253 1.205 . . . . 1.8 114.253 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -150.55 -31.17 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.265 -0.425 . . . . 4.13 111.257 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.491 ' HG3' HD22 ' A' ' 188' ' ' ASN . 94.6 mt-30 -50.37 -57.95 6.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.3 -0.409 . . . . 4.05 111.84 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -87.94 -83.62 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.574 -0.898 . . . . 1.83 108.574 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 184' ' ' VAL . . . 67.13 106.15 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.23 0 CA-C-N 115.485 -0.779 . . . . 1.84 114.593 169.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 23.2 m-85 -136.83 -173.82 3.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.157 -0.522 . . . . 4.57 110.609 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -79.35 153.81 29.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.454 0.645 . . . . 6.25 112.502 -168.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.601 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -76.4 160.49 29.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.599 -1.182 . . . . 6.4 111.473 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.552 HD23 ' CG2' ' A' ' 174' ' ' THR . 0.4 OUTLIER -78.71 132.94 37.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.352 -0.84 . . . . 1.4 110.649 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.51 115.6 59.05 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 3.38 110.256 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.74 145.69 94.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.782 2.321 . . . . 4.74 112.335 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 . . . . . 0 C--O 1.245 0.855 0 CA-C-O 118.479 -0.772 . . . . 7.73 110.175 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.735 0.302 . . . . 31.14 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -67.98 3.6 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.882 -0.675 . . . . 30.65 111.971 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 m 60.67 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.057 0.543 . . . . 30.65 111.371 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 m 57.62 37.07 27.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.058 0.456 . . . . 29.78 111.202 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -123.08 51.43 1.44 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.012 -0.54 . . . . 29.55 110.146 -176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 71.8 m80 65.5 -150.22 0.24 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.825 -0.625 . . . . 29.87 110.705 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 82.7 m-70 74.49 133.86 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.488 0.715 . . . . 27.89 110.711 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.2 t60 70.75 -63.95 0.39 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.488 -0.778 . . . . 26.19 110.628 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -161.51 -53.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.113 -0.699 . . . . 26.23 109.113 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.3 p80 176.96 -39.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.669 -0.696 . . . . 26.64 109.175 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t 176.56 -179.27 0.17 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.218 -1.401 . . . . 24.71 107.218 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.7 m 56.03 52.78 9.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.103 0.478 . . . . 24.15 111.045 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.21 -7.32 85.27 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.928 -0.653 . . . . 22.66 112.744 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.26 -44.96 14.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 20.88 110.088 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.2 t 66.75 112.63 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.679 0.612 . . . . 19.88 111.868 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -59.97 109.91 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.932 2.421 . . . . 18.7 111.687 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 56.13 54.0 8.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.903 -0.589 . . . . 18.91 110.848 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.03 -165.82 17.58 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.603 -0.726 . . . . 15.32 111.478 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.6 p -144.6 171.38 14.45 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.878 -0.415 . . . . 14.03 109.878 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 58.19 63.86 1.64 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.306 0.574 . . . . 12.65 110.213 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -69.02 -22.64 64.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 11.98 110.607 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.31 -92.75 1.59 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.772 -0.649 . . . . 8.1 111.87 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 65.29 178.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.545 0.688 . . . . 9.18 111.351 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -147.43 29.89 0.94 Allowed 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 122.361 1.077 . . . . 6.14 109.046 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 p -107.64 139.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 113.562 -1.654 . . . . 4.84 109.857 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.451 ' N ' HD22 ' A' ' 112' ' ' ASN . 0.9 OUTLIER -99.09 163.16 12.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.398 -0.365 . . . . 4.29 110.327 -179.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 114' ' ' GLU . 3.6 tt -64.44 136.17 56.82 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.235 -0.654 . . . . 1.69 109.235 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.642 ' N ' HD23 ' A' ' 113' ' ' LEU . 3.5 mt-10 -171.12 161.47 5.4 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 108.628 -0.879 . . . . 3.45 108.628 -174.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.551 ' HA ' ' H ' ' A' ' 117' ' ' MET . 84.2 Cg_endo -90.15 100.17 0.29 Allowed 'Trans proline' 0 N--CA 1.423 -2.635 0 C-N-CA 117.629 -1.114 . . . . 3.06 112.557 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -111.91 -3.77 14.76 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 102.6 -3.111 . . . . 3.24 102.6 138.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.634 ' HG3' HG23 ' A' ' 119' ' ' ILE . 28.9 tpp -79.23 138.65 37.89 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.127 -2.761 . . . . 1.45 111.11 -168.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.717 HG23 ' HB3' ' A' ' 179' ' ' HIS . 3.6 m -126.33 104.0 7.95 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.718 -1.128 . . . . 0.32 108.657 175.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -133.88 172.49 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-O 122.43 1.109 . . . . 0.2 111.745 -174.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.865 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.9 m -110.49 165.86 11.46 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.53 -1.668 . . . . 1.29 109.138 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -52.12 -48.15 64.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.13 0.49 . . . . 3.26 110.995 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.488 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.5 m120 -81.02 -16.73 52.55 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 115.967 -0.56 . . . . 2.17 110.151 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.865 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.4 mt-10 -68.23 -25.94 65.46 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-O 121.422 0.63 . . . . 0.5 109.98 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 8.0 tpt -86.65 -28.14 23.37 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 117.882 -1.527 . . . . 3.06 109.632 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.71 -31.28 43.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.308 1.051 . . . . 0.35 111.986 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.719 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -81.69 -42.77 19.42 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.596 -1.184 . . . . 1.51 109.822 170.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.93 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.69 -36.68 81.58 Favored 'General case' 0 CA--C 1.463 -2.367 0 CA-C-O 117.477 -1.249 . . . . 0.4 113.768 -174.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -63.0 -40.06 96.64 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 116.356 -2.138 . . . . 0.32 108.631 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.675 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 51.8 mm-40 -68.9 -30.66 69.19 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 123.125 1.441 . . . . 2.51 108.665 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.93 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.03 -7.56 59.08 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 111.962 -2.381 . . . . 0.33 109.93 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.8 t -121.62 -2.07 9.45 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.191 -0.913 . . . . 0.36 108.937 -175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 77.1 52.73 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 113.523 -1.671 . . . . 2.19 112.482 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -151.09 143.73 24.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.575 -1.639 . . . . 0.27 106.575 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.646 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -142.45 163.22 33.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.69 -1.596 . . . . 0.69 106.69 -174.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -55.2 161.75 1.67 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.987 0.899 . . . . 1.96 111.277 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.3 t -147.61 153.02 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.243 -1.344 . . . . 0.27 111.718 -168.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -60.04 -49.56 77.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.803 0.811 . . . . 0.73 111.695 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.475 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.95 115.35 2.67 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.212 -1.358 . . . . 0.51 109.027 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.049 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.91 101.23 6.73 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-O 123.286 1.517 . . . . 2.71 111.656 -168.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.808 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.7 t -158.33 93.62 1.23 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.493 -1.685 . . . . 0.35 109.034 161.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.808 ' HD3' ' O ' ' A' ' 140' ' ' THR . 17.6 mmt180 -151.09 164.65 19.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 113.56 -1.655 . . . . 2.38 107.176 174.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.57 110.64 2.45 Favored 'Trans proline' 0 N--CA 1.437 -1.831 0 CA-C-N 119.975 1.027 . . . . 0.79 109.903 165.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.59 5.38 69.19 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.461 -0.876 . . . . 0.38 114.21 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.1 mm-40 -126.62 131.5 51.46 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.331 -1.359 . . . . 1.49 107.331 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.772 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.98 175.93 9.12 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.08 -1.048 . . . . 0.3 110.648 -166.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 1.049 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.0 p -111.49 142.03 44.29 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.647 0.737 . . . . 0.19 111.945 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 65.8 t -105.76 145.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.231 -1.349 . . . . 0.86 111.676 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -132.46 -87.31 0.45 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.347 -0.141 . . . . 2.45 111.097 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.43 -82.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.587 0.217 . . . . 0.49 111.587 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.414 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 17.3 m120 -82.03 -6.56 59.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 120.834 0.349 . . . . 1.02 110.282 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.5 p -149.92 145.87 26.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.88 -0.728 . . . . 0.94 111.028 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -109.68 166.43 4.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.136 -1.061 . . . . 0.2 108.136 171.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.772 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 3.2 tp10 -110.81 134.09 52.8 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.693 -1.595 . . . . 0.97 106.693 167.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -131.86 122.38 25.61 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 118.966 0.803 . . . . 1.32 112.425 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -66.93 125.64 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.434 -0.803 . . . . 0.33 109.839 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 169' ' ' VAL . 21.5 tpt180 -65.04 138.2 58.18 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.647 -0.871 . . . . 3.1 108.647 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -60.44 112.67 5.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.129 -0.323 . . . . 4.26 110.129 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 168' ' ' GLN . 15.1 Cg_endo -65.54 172.04 8.56 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.018 2.478 . . . . 2.01 114.164 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.59 151.22 29.38 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.084 -1.416 . . . . 5.12 110.693 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.554 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 9.7 m-20 -126.66 130.84 51.21 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.595 -0.73 . . . . 5.15 111.104 -174.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.682 ' HB2' ' O ' ' A' ' 164' ' ' SER . 79.1 m-85 -119.48 170.62 6.5 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.577 -0.738 . . . . 6.81 109.719 169.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 3.4 Cg_endo -78.99 -44.57 0.13 Allowed 'Trans proline' 0 N--CA 1.41 -3.397 0 C-N-CA 121.813 1.675 . . . . 8.97 110.932 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -93.36 -3.69 52.89 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.58 -2.1 . . . . 10.53 109.99 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.682 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -164.03 158.44 19.5 Favored 'General case' 0 C--O 1.203 -1.348 0 CA-C-N 114.23 -1.35 . . . . 7.9 110.905 -170.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.606 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 71.2 mttt -147.86 132.31 17.65 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.709 0.686 . . . . 6.69 111.21 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 9.9 pt-20 -168.71 -167.58 0.78 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.336 -0.847 . . . . 5.04 112.096 -165.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.85 57.81 4.32 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 121.018 -0.61 . . . . 2.11 112.034 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 158' ' ' PRO . 6.0 pm0 -91.76 142.6 27.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.307 1.051 . . . . 2.93 111.187 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.575 HG13 ' HG3' ' A' ' 187' ' ' GLU . 65.2 t -140.38 151.54 21.19 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 CA-C-N 113.605 -1.634 . . . . 0.48 107.613 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.23 145.21 50.09 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 122.326 1.06 . . . . 1.61 113.155 176.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.46 165.24 13.45 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.21 -1.813 . . . . 0.2 110.333 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.6 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 17.0 tpt180 -115.86 120.04 37.92 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.146 -1.057 . . . . 3.69 108.146 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.39 118.32 33.52 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.181 -1.372 . . . . 0.61 110.429 -164.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.603 ' CG2' HD23 ' A' ' 197' ' ' LEU . 99.5 m -115.31 152.43 32.77 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.574 0.583 . . . . 0.21 112.574 -170.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.7 m-85 -114.66 109.26 17.95 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.696 -1.138 . . . . 0.32 112.294 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.733 ' HA ' HD21 ' A' ' 197' ' ' LEU . 27.5 t70 -98.87 96.52 7.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.047 0.451 . . . . 0.74 111.211 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.69 -117.43 4.44 Favored Glycine 0 C--N 1.319 -0.389 0 C-N-CA 120.22 -0.991 . . . . 0.27 113.179 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.77 11.04 22.61 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.416 -1.698 . . . . 1.61 106.416 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.717 ' HB3' HG23 ' A' ' 118' ' ' THR . 11.8 p-80 -138.0 161.07 37.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.141 -1.391 . . . . 1.28 111.782 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 183' ' ' ILE . 9.3 tp -67.98 136.1 53.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.133 -0.94 . . . . 0.22 110.886 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.572 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -84.11 -54.01 5.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.515 -1.22 . . . . 0.15 111.412 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.48 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.0 t -178.91 176.42 0.92 Allowed 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 115.368 -0.833 . . . . 0.28 110.496 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.803 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.33 124.69 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.949 -1.5 . . . . 0.28 106.949 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.701 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.8 t -129.84 118.1 43.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.422 0.527 . . . . 0.34 112.422 -171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.89 101.09 0.1 Allowed 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.044 -1.095 . . . . 1.64 108.044 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.3 mmt -58.81 -16.81 18.84 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 112.833 -1.985 . . . . 1.42 112.675 -168.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.575 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.7 mt-10 -73.47 -44.35 58.17 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.743 -1.117 . . . . 0.68 110.003 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.65 -33.78 14.94 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.261 -1.336 . . . . 2.36 110.913 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.701 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.9 p30 36.7 32.08 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.218 1.562 . . . . 1.8 115.218 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -138.4 -66.81 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 4.13 110.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -83.93 21.47 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.351 . . . . 4.05 111.556 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -126.58 -6.1 6.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.672 -0.492 . . . . 1.83 109.672 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.34 -162.7 24.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.828 -0.624 . . . . 1.84 112.097 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.44 ' O ' HG21 ' A' ' 182' ' ' THR . 98.3 m-85 -143.64 148.28 35.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.801 -0.444 . . . . 4.57 109.801 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -87.49 95.62 10.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.086 0.47 . . . . 6.25 110.487 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -134.75 144.2 47.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.958 -0.565 . . . . 6.4 110.396 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.4 OUTLIER -161.06 123.42 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 1.4 109.108 170.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -138.41 88.59 14.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.644 . . . . 3.38 110.216 -176.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.0 -11.79 5.27 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.731 2.287 . . . . 4.74 112.652 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.399 -0.81 . . . . 7.73 110.035 -177.722 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.009 -0.367 . . . . 31.14 110.009 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.22 59.16 2.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.769 . . . . 30.65 112.265 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.5 t -85.88 93.94 9.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.923 -0.399 . . . . 30.65 109.923 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.1 p -97.67 -7.22 31.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.27 0.557 . . . . 29.78 110.505 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.456 ' NE2' ' HB2' ' A' ' 94' ' ' HIS . 3.7 t60 -124.64 134.31 52.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.585 -0.895 . . . . 29.55 108.585 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -83.38 49.88 1.66 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.07 0.396 . . . . 29.87 112.07 -172.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.4 t60 57.19 83.63 0.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.794 -0.639 . . . . 27.89 111.706 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.456 ' HB2' ' NE2' ' A' ' 91' ' ' HIS . 29.0 t-80 -77.23 133.87 38.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 26.19 110.331 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -81.85 82.41 7.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.08 -0.509 . . . . 26.23 110.303 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -73.05 -23.0 60.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.26 -0.427 . . . . 26.64 109.934 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.1 m -70.62 -21.05 62.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.696 . . . . 24.71 110.486 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.3 m -80.62 88.81 5.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.873 -0.603 . . . . 24.15 109.84 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.42 -70.02 0.26 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.564 -0.743 . . . . 22.66 111.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.9 mt 65.37 112.19 0.03 OUTLIER 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.658 0.742 . . . . 20.88 111.782 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.571 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 55.2 t -60.32 -46.56 97.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.966 -1.015 . . . . 19.88 111.533 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 32.1 Cg_endo -64.22 83.27 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.288 1.992 . . . . 18.7 112.465 174.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -78.26 -17.12 57.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.907 -0.588 . . . . 18.91 110.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.08 -47.41 24.2 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.716 -0.754 . . . . 15.32 112.009 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 p -80.9 -29.31 35.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.813 0.339 . . . . 14.03 111.41 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -93.04 92.44 7.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.946 0.403 . . . . 12.65 110.28 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 48.7 ttm -107.91 -45.1 4.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.936 -0.575 . . . . 11.98 110.029 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.49 21.86 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.921 -0.656 . . . . 8.1 112.209 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -163.89 170.09 17.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.645 0.259 . . . . 9.18 110.395 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -145.2 26.28 1.34 Allowed 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.234 1.016 . . . . 6.14 109.085 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.12 17.64 7.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 113.966 -1.47 . . . . 4.84 110.434 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -110.82 143.09 41.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.983 -0.553 . . . . 4.29 110.576 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.674 ' HB3' ' SD ' ' A' ' 154' ' ' MET . 5.1 tt -141.44 135.74 30.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.061 -1.089 . . . . 1.69 108.061 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.647 ' N ' HD23 ' A' ' 113' ' ' LEU . 40.5 mt-10 -159.24 162.21 26.29 Favored Pre-proline 0 CA--C 1.501 -0.937 0 N-CA-C 109.116 -0.698 . . . . 3.45 109.116 -173.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.545 ' HA ' ' H ' ' A' ' 117' ' ' MET . 90.0 Cg_endo -91.16 100.64 0.23 Allowed 'Trans proline' 0 N--CA 1.425 -2.52 0 CA-C-O 122.566 0.986 . . . . 3.06 112.701 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -111.22 -4.38 15.02 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 102.555 -3.128 . . . . 3.24 102.555 139.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.623 ' CG ' HG23 ' A' ' 119' ' ' ILE . 2.7 ttm -78.02 139.42 39.12 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 110.304 -3.135 . . . . 1.45 111.67 -166.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.6 m -128.38 101.64 6.3 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.684 -1.144 . . . . 0.32 108.649 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.912 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.7 pt -133.62 172.47 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-O 121.996 0.903 . . . . 0.2 111.227 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.868 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.6 t -117.47 172.18 7.5 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.019 -1.446 . . . . 1.29 109.547 -173.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 124' ' ' MET . 37.5 ttmt -56.0 -45.2 79.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.886 0.374 . . . . 3.26 111.307 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -83.35 -17.34 42.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 110.249 -0.278 . . . . 2.17 110.249 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -69.27 -22.77 63.8 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.124 -0.63 . . . . 0.5 110.46 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.777 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.95 -30.53 22.72 Favored 'General case' 0 C--N 1.282 -2.348 0 C-N-CA 118.462 -1.295 . . . . 3.06 109.366 176.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.5 -30.62 46.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 122.115 0.959 . . . . 0.35 111.952 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.626 -1.17 . . . . 1.51 109.737 171.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.45 -35.76 78.51 Favored 'General case' 0 CA--C 1.462 -2.423 0 CA-C-O 117.683 -1.151 . . . . 0.4 114.027 -172.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.5 -43.18 94.9 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 115.915 -2.314 . . . . 0.32 109.093 175.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 59.3 mm-40 -65.36 -27.91 68.91 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.808 1.289 . . . . 2.51 108.635 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.78 -8.16 54.92 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.258 -2.246 . . . . 0.33 110.28 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.776 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.1 t -122.46 0.27 9.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.416 -0.811 . . . . 0.36 109.354 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 74.49 54.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.653 -1.612 . . . . 2.19 112.543 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.16 144.65 24.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.498 -1.667 . . . . 0.27 106.498 178.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.616 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -145.6 164.09 32.77 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.188 -1.782 . . . . 0.69 106.188 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.571 ' CB ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.73 160.65 0.28 Allowed 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.207 1.003 . . . . 1.96 112.731 -177.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -148.0 151.57 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 CA-C-N 113.946 -1.479 . . . . 0.27 112.015 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.1 m -59.74 -50.02 75.45 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.114 -0.948 . . . . 0.73 111.658 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.4 ptmt -159.03 117.04 2.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.015 -1.448 . . . . 0.51 108.66 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.994 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -77.85 100.55 6.39 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 123.504 1.621 . . . . 2.71 111.761 -168.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.811 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 t -158.2 90.99 1.07 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 113.194 -1.821 . . . . 0.35 108.677 159.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.811 ' HD3' ' O ' ' A' ' 140' ' ' THR . 9.1 mmt180 -153.95 134.51 8.17 Favored Pre-proline 0 C--N 1.307 -1.273 0 CA-C-N 113.623 -1.626 . . . . 2.38 106.705 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.98 109.25 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 121.353 1.519 . . . . 0.79 109.894 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.26 -1.39 57.42 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.689 -0.767 . . . . 0.38 114.025 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 1.5 mm-40 -125.66 131.7 52.57 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.738 -1.208 . . . . 1.49 107.738 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.875 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -130.85 175.2 9.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.156 -1.018 . . . . 0.3 110.169 -168.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.994 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.5 p -112.63 134.13 54.32 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.572 -0.451 . . . . 0.19 110.623 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 135' ' ' GLN . 0.5 OUTLIER -113.51 153.29 15.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.061 -0.972 . . . . 0.86 112.17 -174.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -152.95 -85.32 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.6 0.593 . . . . 2.45 112.6 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.48 -92.01 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.173 0.805 . . . . 0.49 113.173 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 87.0 m-20 -81.95 -6.99 59.57 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-O 120.687 0.28 . . . . 1.02 111.341 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.3 p -150.56 145.75 26.13 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.61 -0.836 . . . . 0.94 110.327 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.588 ' CD1' HD12 ' A' ' 128' ' ' LEU . 6.6 mt -110.04 162.45 7.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.911 -0.774 . . . . 0.2 108.911 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.875 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.4 tp10 -107.6 132.96 52.73 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.995 -1.483 . . . . 0.97 106.995 167.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.719 ' HG3' ' CE2' ' A' ' 145' ' ' PHE . 3.8 ttt -126.52 124.25 39.62 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.239 -0.585 . . . . 1.32 112.137 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -71.52 132.5 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.139 -0.689 . . . . 0.33 109.139 168.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' A' ' 157' ' ' ARG . 17.4 ttt180 -103.96 -176.73 3.17 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.923 -0.399 . . . . 3.1 109.923 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.526 ' H ' ' HG2' ' A' ' 156' ' ' ARG . 39.5 ttm180 -50.79 125.95 23.16 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 122.553 0.341 . . . . 4.26 111.448 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 157' ' ' ARG . 7.9 Cg_exo -70.84 158.5 55.37 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.519 2.146 . . . . 2.01 111.873 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -140.68 121.35 14.3 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.41 -0.814 . . . . 5.12 110.264 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.534 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 10.8 m-20 -130.33 127.79 40.15 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.843 -1.071 . . . . 5.15 110.164 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.497 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.5 m-30 -120.12 169.68 8.16 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-O 121.956 0.884 . . . . 6.81 111.467 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.4 Cg_endo -75.56 -42.19 0.48 Allowed 'Trans proline' 0 N--CA 1.419 -2.911 0 C-N-CA 122.472 2.115 . . . . 8.97 110.825 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -90.0 -8.11 52.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 112.222 -2.263 . . . . 10.53 109.509 -174.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.6 m -164.51 140.14 5.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.317 -1.31 . . . . 7.9 112.832 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.534 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 60.3 mttt -144.72 135.31 24.56 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.819 0.819 . . . . 6.69 113.057 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.82 -27.52 2.54 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.853 -1.521 . . . . 5.04 109.016 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.34 -124.19 6.44 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.024 -1.444 . . . . 2.11 111.851 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.457 ' CD ' ' H ' ' A' ' 168' ' ' GLN . 5.5 pm0 -73.76 152.33 40.38 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.251 0.548 . . . . 2.93 109.702 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.459 HG13 ' CD ' ' A' ' 187' ' ' GLU . 66.0 t -134.16 145.79 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 CA-C-N 115.261 -0.882 . . . . 0.48 109.487 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -131.35 145.37 51.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.345 1.069 . . . . 1.61 113.469 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.56 165.88 12.74 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.993 -1.912 . . . . 0.2 110.921 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.457 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 2.2 tpp180 -115.65 111.89 21.3 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.747 -1.205 . . . . 3.69 107.747 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.578 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -107.92 118.15 35.99 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.217 -1.811 . . . . 0.61 109.969 -166.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.607 ' CG2' HD23 ' A' ' 197' ' ' LEU . 87.5 m -114.43 150.86 34.07 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.762 0.653 . . . . 0.21 112.762 -169.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.912 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.8 m-85 -115.26 112.47 22.49 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 114.663 -1.153 . . . . 0.32 112.212 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' A' ' 197' ' ' LEU . 25.8 t70 -102.96 98.48 8.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.965 0.412 . . . . 0.74 110.803 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.67 -120.45 5.28 Favored Glycine 0 C--N 1.317 -0.517 0 C-N-CA 120.085 -1.055 . . . . 0.27 112.85 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.74 14.17 22.29 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 106.829 -1.545 . . . . 1.61 106.829 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 19.0 p-80 -138.96 159.06 43.04 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.024 -1.444 . . . . 1.28 111.735 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -66.36 137.08 56.64 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.055 -0.975 . . . . 0.22 111.01 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.591 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.07 -51.48 5.98 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 114.48 -1.236 . . . . 0.15 111.653 -176.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.635 HG21 ' O ' ' A' ' 194' ' ' PHE . 6.1 t -179.39 176.99 0.78 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.069 -0.969 . . . . 0.28 110.292 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -151.68 130.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.396 -1.705 . . . . 0.28 106.396 175.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.721 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 86.9 t -134.24 118.45 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 120.59 -0.444 . . . . 0.34 111.853 -172.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -59.52 98.64 0.05 OUTLIER 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.063 -1.088 . . . . 1.64 108.063 171.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -51.48 -25.12 5.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.877 -1.965 . . . . 1.42 112.449 -170.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.459 ' CD ' HG13 ' A' ' 169' ' ' VAL . 3.4 mt-10 -71.08 -40.99 71.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 CA-C-N 113.64 -1.618 . . . . 0.68 110.643 -174.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.04 -27.49 13.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.728 -1.578 . . . . 2.36 111.418 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.721 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.9 p-10 35.32 32.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 115.299 1.592 . . . . 1.8 115.299 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -145.17 -62.29 0.35 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 4.13 109.963 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -75.23 42.09 0.19 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.142 -0.481 . . . . 4.05 111.7 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 183' ' ' ILE . 1.0 OUTLIER -157.15 -35.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 1.83 110.473 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 159.24 -149.32 19.17 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.471 -0.871 . . . . 1.84 112.946 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.635 ' O ' HG21 ' A' ' 182' ' ' THR . 44.0 p90 -157.66 145.84 19.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.476 -0.935 . . . . 4.57 108.476 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -119.38 97.88 5.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.64 0.733 . . . . 6.25 112.06 -172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -136.43 129.48 31.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.333 -0.849 . . . . 6.4 109.51 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -122.84 135.66 54.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.805 0.336 . . . . 1.4 110.971 -177.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -87.29 110.0 30.14 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.578 -0.737 . . . . 3.38 110.238 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.59 144.87 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.736 2.291 . . . . 4.74 112.798 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.661 -0.685 . . . . 7.73 109.949 177.196 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.961 0.41 . . . . 31.14 110.337 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.41 134.55 11.73 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.899 -0.667 . . . . 30.65 111.908 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 m -144.16 39.06 1.31 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.226 0.536 . . . . 30.65 110.356 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -97.81 -19.01 18.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.776 -0.647 . . . . 29.78 110.77 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -83.71 126.31 32.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.36 -0.608 . . . . 29.55 109.36 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 69.78 103.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.85 0.719 . . . . 29.87 110.86 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -95.65 143.99 26.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 27.89 110.359 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -92.51 59.33 3.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.595 0.712 . . . . 26.19 110.384 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -75.36 -48.07 24.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.347 -0.842 . . . . 26.23 110.442 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -138.38 -69.27 0.44 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.203 -0.453 . . . . 26.64 110.342 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.2 p -168.03 164.2 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 24.71 110.15 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.8 m 63.54 -166.6 0.22 Allowed 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.518 0.511 . . . . 24.15 111.455 175.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.92 -43.1 1.3 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.938 -0.649 . . . . 22.66 112.242 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.83 100.44 6.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.652 0.263 . . . . 20.88 110.694 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.603 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 90.1 t -74.44 -56.25 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.545 -0.298 . . . . 19.88 110.241 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 81.4 Cg_endo -83.74 54.16 4.38 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.011 1.807 . . . . 18.7 111.317 173.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -58.2 -41.06 83.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.847 -0.615 . . . . 18.91 111.162 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.27 54.51 0.31 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.663 -0.78 . . . . 15.32 111.717 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -95.12 71.82 3.33 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.035 0.445 . . . . 14.03 110.188 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -122.59 152.93 39.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.043 -0.526 . . . . 12.65 110.292 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -101.14 146.03 28.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.312 -0.403 . . . . 11.98 110.126 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.27 112.32 0.66 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.795 -0.717 . . . . 8.1 111.983 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -153.45 138.07 16.9 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.446 -0.576 . . . . 9.18 109.446 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.5 ptm -149.66 31.12 0.72 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.154 0.978 . . . . 6.14 109.884 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.2 p -102.72 140.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.052 -1.431 . . . . 4.84 109.761 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -80.34 153.92 28.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.334 -0.394 . . . . 4.29 110.41 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.666 HD11 HD13 ' A' ' 173' ' ' LEU . 3.0 tm? -71.94 146.07 48.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.083 -0.508 . . . . 1.69 110.701 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.661 ' N ' HD13 ' A' ' 113' ' ' LEU . 6.0 mt-10 -173.81 -171.2 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-O 118.481 -0.771 . . . . 3.45 109.236 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 22.0 Cg_exo -41.92 -175.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 124.016 3.144 . . . . 3.06 114.944 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 180' ' ' LEU . 2.3 m-20 -43.39 28.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 119.448 3.129 . . . . 3.24 119.448 -152.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.884 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.5 OUTLIER -42.27 111.7 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.817 0.818 . . . . 1.45 111.941 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.803 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.5 m -74.48 105.58 5.68 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.373 -0.83 . . . . 0.32 111.04 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.926 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.7 pt -140.15 173.61 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 114.364 -1.289 . . . . 0.2 110.858 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.7 p -121.41 174.08 6.97 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.729 -1.123 . . . . 1.29 110.098 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 124' ' ' MET . 28.5 ttpp -50.99 -47.43 61.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.982 0.42 . . . . 3.26 111.845 -177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.486 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -84.21 -17.1 40.95 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 122.248 -0.282 . . . . 2.17 110.521 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.7 mt-10 -70.69 -22.63 62.44 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.297 -0.561 . . . . 0.5 110.149 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -84.99 -29.13 25.29 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.457 -1.297 . . . . 3.06 109.66 178.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.02 -33.24 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.559 1.171 . . . . 0.35 111.605 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.74 -42.3 28.55 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.292 -1.322 . . . . 1.51 109.806 170.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.45 -38.6 84.71 Favored 'General case' 0 CA--C 1.462 -2.421 0 CA-C-O 117.476 -1.25 . . . . 0.4 114.163 -173.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.12 -41.01 97.82 Favored 'General case' 0 N--CA 1.418 -2.026 0 C-N-CA 116.129 -2.229 . . . . 0.32 108.67 177.096 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.679 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 64.0 mm-40 -67.27 -32.0 72.71 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 123.006 1.384 . . . . 2.51 108.658 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.16 -7.32 59.4 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.895 -2.412 . . . . 0.33 110.179 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -121.12 1.06 10.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.114 0.959 . . . . 0.36 108.636 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 72.68 55.26 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.286 -1.779 . . . . 2.19 112.267 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 146.75 25.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 106.548 -1.649 . . . . 0.27 106.548 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.624 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.07 163.26 34.05 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.061 -1.829 . . . . 0.69 106.061 -175.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.25 159.6 0.64 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.082 0.944 . . . . 1.96 112.041 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -146.68 150.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 CA-C-N 114.147 -1.388 . . . . 0.27 111.624 -170.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 m -60.56 -50.18 74.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.093 -0.958 . . . . 0.73 111.942 173.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.9 ptmt -155.43 114.51 3.58 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.161 -1.382 . . . . 0.51 108.967 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.908 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.38 100.5 5.19 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-O 123.894 1.807 . . . . 2.71 112.041 -168.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 1.4 t -158.84 95.4 1.29 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.178 -1.828 . . . . 0.35 108.07 162.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -151.34 165.38 17.5 Favored Pre-proline 0 N--CA 1.433 -1.304 0 CA-C-N 114.483 -1.235 . . . . 2.38 108.183 173.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.31 111.56 2.65 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 119.578 0.885 . . . . 0.79 109.982 164.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.39 13.41 78.69 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.674 -0.774 . . . . 0.38 114.049 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.9 mt-10 -131.88 130.91 42.25 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.349 -0.982 . . . . 1.49 108.349 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.921 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.84 176.63 8.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.547 -0.861 . . . . 0.3 110.279 -166.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.908 HG23 ' HB3' ' A' ' 139' ' ' MET . 18.1 p -107.88 142.03 38.58 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.532 0.682 . . . . 0.19 110.932 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.4 t -100.35 134.71 39.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 114.617 -1.174 . . . . 0.86 111.08 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 151' ' ' SER . 5.3 tp-100 -147.23 54.2 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.98 0.419 . . . . 2.45 110.961 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 60.57 -100.43 0.1 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.35 0.87 . . . . 0.49 113.35 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.735 ' HB3' HD23 ' A' ' 197' ' ' LEU . 83.1 m-20 -82.04 -5.02 58.04 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.051 0.453 . . . . 1.02 111.375 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 57.3 m -141.9 123.21 14.81 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.268 -0.573 . . . . 0.94 110.26 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 128' ' ' LEU . 5.9 mt -96.19 165.66 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.617 -1.253 . . . . 0.2 107.617 173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.921 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 5.6 tt0 -124.5 105.82 9.69 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.898 -1.121 . . . . 0.97 110.392 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.61 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.8 ppp? -106.76 125.8 51.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.061 0.458 . . . . 1.32 111.478 -166.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -69.09 135.88 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.148 -0.478 . . . . 0.33 110.316 172.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 157' ' ' ARG . 29.4 ttp180 -76.32 150.49 36.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.621 -0.718 . . . . 3.1 109.226 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 42.9 ttp180 -56.77 119.63 31.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.505 -0.316 . . . . 4.26 110.382 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 157' ' ' ARG . 3.6 Cg_exo -77.38 174.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.125 2.55 . . . . 2.01 113.175 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.49 130.12 56.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.591 -1.186 . . . . 5.12 108.967 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.644 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 50.2 m-20 -129.18 136.62 50.4 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.745 0.646 . . . . 5.15 112.745 -167.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.3 m-85 -119.58 167.59 11.89 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 115.111 -0.95 . . . . 6.81 110.348 170.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.4 Cg_endo -74.82 -41.87 0.65 Allowed 'Trans proline' 0 N--CA 1.416 -3.053 0 C-N-CA 122.124 1.883 . . . . 8.97 111.077 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.24 -4.84 48.15 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 112.806 -1.997 . . . . 10.53 109.7 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -164.36 142.37 6.92 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.567 -1.197 . . . . 7.9 112.379 -170.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.644 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 69.3 mttt -142.87 147.88 36.09 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.632 0.73 . . . . 6.69 112.705 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.8 pt-20 -176.0 -154.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.082 -1.417 . . . . 5.04 109.247 -169.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . 79.58 6.69 88.92 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.865 -0.607 . . . . 2.11 112.551 172.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.17 109.3 5.13 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.781 1.277 . . . . 2.93 112.101 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.0 t -131.61 145.63 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.513 0 CA-C-N 112.627 -2.079 . . . . 0.48 109.303 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.691 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.71 145.48 50.16 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 122.135 0.969 . . . . 1.61 112.712 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -112.28 166.12 11.56 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.512 -1.676 . . . . 0.2 110.22 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.69 120.48 37.55 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.439 -0.948 . . . . 3.69 108.439 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.669 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -115.32 137.32 52.17 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.729 -1.578 . . . . 0.61 109.901 -163.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.604 ' CG2' ' HB2' ' A' ' 197' ' ' LEU . 82.6 m -129.83 150.24 51.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.235 0.54 . . . . 0.21 111.881 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.926 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.9 m-85 -113.24 106.82 15.09 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.424 -1.262 . . . . 0.32 112.374 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.608 ' HA ' HD13 ' A' ' 197' ' ' LEU . 17.7 t70 -93.67 96.66 9.96 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.119 0.485 . . . . 0.74 111.113 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.71 -114.77 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.185 -1.007 . . . . 0.27 113.31 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.04 8.99 22.1 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.004 -1.48 . . . . 1.61 107.004 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.803 ' HB3' HG23 ' A' ' 118' ' ' THR . 17.6 p-80 -138.41 161.11 37.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.159 -1.382 . . . . 1.28 111.59 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.884 ' HB2' ' O ' ' A' ' 117' ' ' MET . 8.1 tp -63.75 144.3 57.15 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.404 -0.817 . . . . 0.22 111.731 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.92 -52.46 4.23 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.43 -1.259 . . . . 0.15 111.914 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 6.3 t -179.24 176.19 0.88 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.463 -0.789 . . . . 0.28 110.558 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.73 HD11 HD21 ' A' ' 180' ' ' LEU . 3.5 mp -152.27 137.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 105.646 -1.983 . . . . 0.28 105.646 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.956 HG22 ' HA2' ' A' ' 193' ' ' GLY . 75.4 t -139.55 119.86 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 N-CA-C 112.417 0.525 . . . . 0.34 112.417 -172.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.97 96.46 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.064 -1.087 . . . . 1.64 108.064 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 65.1 mmm -54.91 -24.3 22.87 Favored 'General case' 0 CA--C 1.486 -1.481 0 CA-C-N 113.141 -1.845 . . . . 1.42 113.26 -166.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.0 mt-10 -70.57 -40.92 73.04 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 114.39 -1.277 . . . . 0.68 110.957 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -93.54 -32.52 14.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.753 -1.567 . . . . 2.36 110.571 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.626 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.7 p-10 36.3 46.92 0.44 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.074 0.94 . . . . 1.8 112.765 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 190' ' ' ARG . 1.3 tpm_? -163.65 -53.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.967 -1.123 . . . . 4.13 107.967 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -73.02 126.03 29.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.691 -1.141 . . . . 4.05 108.084 169.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 35.7 t80 61.79 68.87 0.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.202 -0.666 . . . . 1.83 109.202 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.956 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -156.17 138.64 6.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.168 -1.015 . . . . 1.84 113.476 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.441 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 73.9 m-85 -131.31 -172.27 2.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.535 -0.542 . . . . 4.57 109.535 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.4 138.17 39.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.206 0.527 . . . . 6.25 110.984 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 196' ' ' ARG . 41.4 ttm180 -73.88 160.49 31.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.296 -0.866 . . . . 6.4 110.009 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 150' ' ' ASN . 15.8 tp -68.57 125.74 27.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.718 0.294 . . . . 1.4 111.067 -176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.04 144.74 59.61 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.101 -0.703 . . . . 3.38 109.101 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.82 78.36 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.718 2.278 . . . . 4.74 112.36 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.33 -0.843 . . . . 7.73 109.773 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.622 -0.51 . . . . 31.14 109.622 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 52.68 6.77 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.476 -0.869 . . . . 30.65 112.891 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 m -96.22 -18.27 20.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.411 0.624 . . . . 30.65 109.325 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 93' ' ' HIS . 3.4 p -83.87 75.45 10.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.305 -0.862 . . . . 29.78 110.731 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.89 -30.25 63.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 29.55 110.902 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -67.99 -47.48 68.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 29.87 109.688 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' SER . 31.4 t-80 -167.91 130.09 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.876 -0.787 . . . . 27.89 108.876 175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 82.3 m-70 -67.0 101.18 0.82 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.995 0.426 . . . . 26.19 111.585 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 33.9 p80 -146.77 38.53 1.01 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 26.23 108.931 173.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 33.4 m170 71.58 174.84 0.29 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 114.969 -1.014 . . . . 26.64 109.951 -171.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -87.14 35.1 0.69 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.058 0.456 . . . . 24.71 110.747 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p -82.72 164.66 20.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.641 . . . . 24.15 110.398 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.65 41.34 2.39 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.672 -0.775 . . . . 22.66 112.897 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.1 tt -79.2 91.62 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.097 -0.705 . . . . 20.88 109.097 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.5 p -163.96 117.55 1.04 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.646 -0.706 . . . . 19.88 110.071 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.46 -56.28 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.878 2.385 . . . . 18.7 112.116 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 56.01 95.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.302 0.573 . . . . 18.91 111.485 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.66 20.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.824 -0.703 . . . . 15.32 111.487 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.7 t -122.68 122.91 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.854 0.359 . . . . 14.03 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -137.26 37.49 2.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 12.65 110.487 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 11.98 109.863 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.8 62.97 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.601 -0.727 . . . . 8.1 112.301 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -104.62 -24.27 12.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.682 0.277 . . . . 9.18 111.124 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -136.07 24.66 3.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.46 1.124 . . . . 6.14 109.9 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.6 p -103.04 143.06 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 113.497 -1.683 . . . . 4.84 109.855 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' OD1' ' HG2' ' A' ' 157' ' ' ARG . 88.9 m-20 -88.44 142.51 27.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.026 -0.534 . . . . 4.29 109.667 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.635 HD13 HD22 ' A' ' 173' ' ' LEU . 4.6 tt -80.25 110.39 15.63 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.542 -0.54 . . . . 1.69 109.542 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.709 ' HA ' HD13 ' A' ' 183' ' ' ILE . 8.2 pt-20 -173.64 48.43 0.07 OUTLIER Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.41 -0.814 . . . . 3.45 111.168 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 6.9 Cg_endo -90.07 177.26 2.52 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.99 2.46 . . . . 3.06 112.174 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.96 19.31 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.387 -0.824 . . . . 3.24 110.359 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.706 ' CG ' HG23 ' A' ' 119' ' ' ILE . 12.3 ttm -48.96 138.57 11.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.536 1.134 . . . . 1.45 113.042 -169.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.783 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.8 m -128.25 100.76 5.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.603 -1.18 . . . . 0.32 108.645 175.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.1 pt -132.85 172.63 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.242 1.02 . . . . 0.2 112.069 -174.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.825 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.6 m -117.06 174.04 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.581 -1.645 . . . . 1.29 110.206 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 124' ' ' MET . 14.0 mmmm -49.33 -53.78 20.45 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.599 0.592 . . . . 3.26 112.599 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 94.8 m-20 -82.89 -16.35 47.87 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 116.586 -0.279 . . . . 2.17 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.887 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -66.24 -24.09 66.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 120.274 -0.571 . . . . 0.5 110.167 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.77 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.07 -29.26 23.52 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.487 -1.285 . . . . 3.06 109.986 178.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.26 -31.13 50.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 122.436 1.112 . . . . 0.35 111.61 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.97 -42.45 23.92 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.233 -1.349 . . . . 1.51 109.735 170.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.38 81.74 Favored 'General case' 0 CA--C 1.463 -2.373 0 CA-C-O 117.626 -1.178 . . . . 0.4 114.147 -173.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.82 -39.56 94.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 116.233 -2.187 . . . . 0.32 108.733 177.455 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.668 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 55.2 mm-40 -69.56 -30.76 68.63 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.113 1.435 . . . . 2.51 108.787 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.885 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -83.64 -7.67 59.45 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 111.971 -2.377 . . . . 0.33 109.884 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.699 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.51 -0.95 9.66 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.115 -0.948 . . . . 0.36 108.967 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 71.49 58.09 0.18 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 113.341 -1.754 . . . . 2.19 112.625 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.675 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.65 146.88 25.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.106 -1.812 . . . . 0.27 106.106 177.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -143.34 162.59 35.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.41 -1.33 . . . . 0.69 107.41 -174.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 135' ' ' GLN . 2.6 tt0 -50.18 146.83 4.64 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.164 0.983 . . . . 1.96 112.567 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -134.56 150.84 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-N 113.702 -1.59 . . . . 0.27 112.046 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.5 m -60.34 -50.28 74.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.857 -1.065 . . . . 0.73 111.826 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.2 ptmt -155.33 113.77 3.49 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.114 -1.403 . . . . 0.51 108.812 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.871 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -75.72 100.35 4.66 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 123.682 1.706 . . . . 2.71 112.05 -167.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.823 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.1 t -159.22 92.08 1.06 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.61 -1.632 . . . . 0.35 109.305 161.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.823 ' HD3' ' O ' ' A' ' 140' ' ' THR . 16.9 mmt180 -152.0 147.82 20.48 Favored Pre-proline 0 N--CA 1.433 -1.314 0 CA-C-N 113.8 -1.546 . . . . 2.38 107.189 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.03 110.28 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 CA-C-N 120.383 1.172 . . . . 0.79 109.372 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.5 14.4 58.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.354 -0.839 . . . . 0.38 114.352 173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.2 mt-10 -136.89 132.72 34.91 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.858 -1.164 . . . . 1.49 107.858 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.92 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -131.97 175.25 9.39 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.167 -1.013 . . . . 0.3 110.451 -168.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.871 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.4 p -108.34 141.45 40.13 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 121.869 0.842 . . . . 0.19 112.047 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.76 119.71 52.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 113.736 -1.574 . . . . 0.86 110.477 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.7 tt0 -103.88 -80.16 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.492 -0.322 . . . . 2.45 110.695 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.07 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.738 0.304 . . . . 0.49 111.009 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.874 ' HB3' HD13 ' A' ' 197' ' ' LEU . 61.0 m-20 -81.97 -4.14 56.01 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 109.332 -0.618 . . . . 1.02 109.332 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.7 m -142.6 148.04 36.83 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.55 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -106.77 169.14 2.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.727 -1.212 . . . . 0.2 107.727 168.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.92 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 12.4 tt0 -127.54 109.08 11.36 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.787 -0.765 . . . . 0.97 110.654 173.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.466 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 2.1 tmt? -109.71 123.2 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.747 0.308 . . . . 1.32 111.753 -169.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -68.64 125.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 121.251 0.548 . . . . 0.33 110.878 174.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 169' ' ' VAL . 53.7 ttt85 -85.99 163.91 17.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.098 -0.955 . . . . 3.1 108.737 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . 37.9 mmt-85 -62.01 143.8 94.48 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.476 -0.564 . . . . 4.26 109.476 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 157' ' ' ARG . 37.1 Cg_exo -56.25 159.76 12.17 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.651 2.234 . . . . 2.01 113.162 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -119.33 124.37 46.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.763 -1.108 . . . . 5.12 111.278 -167.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.511 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 3.7 m-20 -130.1 121.34 26.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.634 -1.166 . . . . 5.15 110.771 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -121.59 172.41 5.03 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-O 121.676 0.751 . . . . 6.81 110.784 178.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -74.48 -43.69 0.47 Allowed 'Trans proline' 0 N--CA 1.415 -3.101 0 C-N-CA 121.956 1.771 . . . . 8.97 110.245 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.18 -3.94 57.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 112.351 -2.204 . . . . 10.53 109.72 -173.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 m -163.27 135.29 5.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.384 -1.28 . . . . 7.9 112.676 -172.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.511 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 51.6 mttt -146.29 141.58 27.46 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.68 0.752 . . . . 6.69 112.144 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -163.72 -162.71 0.74 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.123 -1.399 . . . . 5.04 109.87 -174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -103.0 -131.67 7.39 Favored Glycine 0 C--N 1.311 -0.856 0 C-N-CA 120.613 -0.803 . . . . 2.11 113.16 -174.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.418 HE22 ' HA ' ' A' ' 140' ' ' THR . 11.1 pt20 -67.52 159.54 29.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.793 0.806 . . . . 2.93 111.31 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 187' ' ' GLU . 63.4 t -136.34 147.35 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 114.516 -1.22 . . . . 0.48 108.733 175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.14 145.23 51.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.243 1.021 . . . . 1.61 112.872 179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.48 164.68 13.31 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.434 -1.712 . . . . 0.2 110.541 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 22.9 ttt180 -111.67 119.97 40.48 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.999 -1.111 . . . . 3.69 107.999 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.678 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -112.37 110.48 20.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.42 -1.264 . . . . 0.61 109.956 -168.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.544 ' CG2' HD12 ' A' ' 197' ' ' LEU . 32.1 m -107.65 151.35 25.76 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.329 0.492 . . . . 0.21 112.329 -169.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.7 m-85 -117.03 101.81 8.81 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.628 -1.169 . . . . 0.32 112.685 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 22.4 t70 -98.66 100.43 11.66 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.659 -0.416 . . . . 0.74 111.189 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.24 -119.11 5.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.518 -0.849 . . . . 0.27 113.051 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.46 8.51 23.14 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 106.518 -1.66 . . . . 1.61 106.518 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.783 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.6 p80 -138.65 160.52 39.43 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.158 -1.383 . . . . 1.28 112.061 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -63.74 139.64 58.79 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 114.759 -1.11 . . . . 0.22 110.439 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.631 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -90.84 -48.82 6.79 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.442 -1.254 . . . . 0.15 111.348 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 6.5 t 177.36 178.02 0.31 Allowed 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.284 -0.871 . . . . 0.28 110.685 -174.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.74 HD11 HD21 ' A' ' 180' ' ' LEU . 3.0 mp -150.94 127.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.909 -1.886 . . . . 0.28 105.909 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.873 HG22 ' HA2' ' A' ' 193' ' ' GLY . 84.4 t -132.87 122.09 45.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 112.568 0.581 . . . . 0.34 112.568 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -60.55 97.96 0.06 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.241 -1.022 . . . . 1.64 108.241 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.554 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 0.6 OUTLIER -54.56 -24.74 22.29 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 112.579 -2.1 . . . . 1.42 112.489 -168.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -68.58 -41.59 79.43 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 114.049 -1.432 . . . . 0.68 110.977 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' A' ' 190' ' ' ARG . 1.0 OUTLIER -100.34 -27.96 13.2 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.788 -1.096 . . . . 2.36 110.808 176.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.69 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.7 p30 36.47 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.578 1.696 . . . . 1.8 115.578 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 188' ' ' ASN . 81.8 mtp180 -134.74 -61.52 0.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.231 -0.655 . . . . 4.13 109.231 177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -78.3 149.27 33.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.668 -1.234 . . . . 4.05 107.668 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 8.8 t80 63.8 42.05 6.41 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.85 -1.167 . . . . 1.83 107.85 -171.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.873 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -133.64 131.66 6.14 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.119 -0.946 . . . . 1.84 112.82 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 92.8 m-85 -131.04 -173.03 2.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 4.57 109.606 177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -77.71 167.2 21.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.597 0.713 . . . . 6.25 111.958 -169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -133.79 164.53 27.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 6.4 110.495 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 150' ' ' ASN . 1.3 mp -67.38 161.76 24.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.37 0.507 . . . . 1.4 112.37 -172.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.2 t70 56.99 66.29 3.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.075 -0.966 . . . . 3.38 110.662 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -95.02 2.8 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.11 2.54 . . . . 4.74 112.502 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.591 -0.719 . . . . 7.73 110.295 -176.773 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.727 0.299 . . . . 31.14 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.76 -33.27 24.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 30.65 112.694 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 m -91.56 33.9 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.934 0.397 . . . . 30.65 111.017 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 t -85.18 -72.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.418 . . . . 29.78 110.698 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 35.6 m80 57.23 -97.45 0.07 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.128 -0.487 . . . . 29.55 111.233 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.8 m80 66.32 143.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.296 0.569 . . . . 29.87 111.434 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -82.53 111.1 18.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 27.89 110.738 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.62 -178.32 4.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.746 -0.661 . . . . 26.19 110.032 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -141.48 82.81 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.051 0.453 . . . . 26.23 110.22 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -130.07 -58.09 1.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.304 -0.628 . . . . 26.64 109.304 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.7 m -119.44 57.01 0.91 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.642 -0.708 . . . . 24.71 109.356 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 m -88.79 -3.21 58.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.438 -0.801 . . . . 24.15 110.827 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.56 -140.46 20.39 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.998 -0.62 . . . . 22.66 113.113 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.3 mt -82.3 68.77 8.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.989 0.423 . . . . 20.88 111.051 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 48.9 t -69.58 -50.54 18.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.086 -0.506 . . . . 19.88 111.424 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 71.7 Cg_endo -75.69 60.91 6.06 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.976 1.784 . . . . 18.7 111.588 176.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -63.78 120.96 12.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.909 -0.587 . . . . 18.91 110.76 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.48 115.39 0.69 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.8 -0.636 . . . . 15.32 111.537 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.9 m -111.37 36.05 3.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.316 0.579 . . . . 14.03 110.639 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -89.5 -45.55 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 12.65 109.675 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 56.8 mtm -126.68 165.18 19.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.391 -0.822 . . . . 11.98 109.832 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.6 -18.07 20.36 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.524 -0.846 . . . . 8.1 112.549 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -85.53 52.74 2.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.171 0.51 . . . . 9.18 110.611 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -131.22 20.72 4.84 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.301 1.048 . . . . 6.14 109.165 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.79 111.49 30.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 113.503 -1.681 . . . . 4.84 109.127 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -144.17 134.27 24.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.179 -0.464 . . . . 4.29 110.892 -171.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HG ' HD11 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -67.86 136.98 54.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.598 -0.889 . . . . 1.69 108.598 175.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 7.5 mm-40 -133.66 -179.06 0.97 Allowed Pre-proline 0 N--CA 1.443 -0.823 0 C-N-CA 120.821 -0.352 . . . . 3.45 111.138 -167.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 2.9 Cg_endo -41.53 -175.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.075 3.85 . . . . 3.06 115.134 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -44.39 30.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 119.378 3.103 . . . . 3.24 119.378 -156.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.895 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -40.4 109.51 0.12 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.097 0.951 . . . . 1.45 111.581 174.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.9 m -74.03 104.95 5.05 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.081 -0.963 . . . . 0.32 110.699 -173.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.1 pt -138.54 172.53 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-N 114.296 -1.32 . . . . 0.2 110.235 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.885 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 11.1 p -122.56 176.27 6.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.741 -1.118 . . . . 1.29 110.151 -173.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 124' ' ' MET . 62.3 mtpt -56.03 -43.91 78.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.275 0.472 . . . . 3.26 112.275 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.485 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 26.2 t-20 -83.95 -18.36 37.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 122.042 -0.411 . . . . 2.17 110.016 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.959 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -67.36 -23.81 65.64 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 119.785 -0.766 . . . . 0.5 109.997 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.681 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.32 -27.59 25.81 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 118.576 -1.249 . . . . 3.06 109.81 177.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.01 -32.16 55.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.886 -1.052 . . . . 0.35 111.461 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.789 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.32 -40.01 31.38 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.813 -1.085 . . . . 1.51 110.291 170.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.17 -37.57 80.57 Favored 'General case' 0 CA--C 1.472 -2.037 0 CA-C-O 117.424 -1.274 . . . . 0.4 114.11 -173.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.867 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.94 -40.02 95.48 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 116.103 -2.239 . . . . 0.32 109.227 175.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' H ' HD22 ' A' ' 128' ' ' LEU . 19.7 mt-10 -64.67 -28.82 69.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.685 1.231 . . . . 2.51 108.062 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -94.38 -6.82 43.31 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 112.827 -1.988 . . . . 0.33 111.135 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.3 t -122.52 -2.26 8.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.36 109.758 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 74.72 52.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.042 -1.436 . . . . 2.19 112.032 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.867 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -148.41 142.55 26.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.511 -1.292 . . . . 0.27 107.511 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.637 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -147.19 163.99 34.59 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.747 -1.205 . . . . 0.69 107.747 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -46.28 144.78 1.9 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 122.094 0.95 . . . . 1.96 113.202 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.7 t -137.37 151.18 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.375 0 CA-C-N 114.034 -1.439 . . . . 0.27 112.562 -173.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 m -59.77 -50.89 72.07 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.889 -1.05 . . . . 0.73 111.602 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.1 ptmt -157.72 117.65 3.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.019 -1.446 . . . . 0.51 108.605 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.916 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -78.69 100.34 7.0 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 123.466 1.603 . . . . 2.71 111.991 -167.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.806 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 3.1 t -159.71 95.03 1.18 Allowed 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 114.095 -1.411 . . . . 0.35 109.274 162.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.806 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -151.99 171.82 6.17 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 114.451 -1.25 . . . . 2.38 107.747 172.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.26 111.71 2.43 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 CA-C-N 120.452 1.197 . . . . 0.79 109.885 164.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.17 0.12 77.67 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.794 -0.717 . . . . 0.38 114.84 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 40.9 mt-10 -119.57 132.09 55.66 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.686 1.243 . . . . 1.49 109.574 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.815 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.8 m-30 -129.3 175.55 8.65 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.365 -0.534 . . . . 0.3 110.328 -166.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.916 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.0 p -111.9 139.2 47.59 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.871 -0.788 . . . . 0.19 108.871 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.435 ' CB ' ' OH ' ' A' ' 133' ' ' TYR . 2.6 p -112.37 154.43 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 112.649 0.611 . . . . 0.86 112.649 -171.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.8 tp-100 -146.16 -95.08 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.334 -0.394 . . . . 2.45 111.146 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.0 -86.09 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.081 0.4 . . . . 0.49 112.081 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -83.19 -9.12 59.34 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.492 0.663 . . . . 1.02 109.665 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 46.9 m -139.51 119.74 13.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.53 -0.759 . . . . 0.94 110.579 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.549 HD11 ' SD ' ' A' ' 124' ' ' MET . 4.7 mt -96.95 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 107.767 -1.197 . . . . 0.2 107.767 172.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.815 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 2.1 tt0 -119.5 151.0 39.31 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.144 -1.428 . . . . 0.97 107.144 164.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.619 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -147.43 128.65 14.73 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.116 -0.634 . . . . 1.32 111.098 -177.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.664 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -71.96 130.61 35.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.049 -0.352 . . . . 0.33 110.049 171.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -95.12 168.0 11.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.978 -0.556 . . . . 3.1 109.57 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -44.14 133.83 4.27 Favored Pre-proline 0 C--O 1.237 0.412 0 O-C-N 123.5 0.5 . . . . 4.26 110.5 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -49.76 153.43 5.8 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.938 2.425 . . . . 2.01 112.338 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -107.39 118.59 37.13 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.887 -1.052 . . . . 5.12 111.01 -169.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.611 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 7.1 m-20 -130.06 118.9 22.25 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.367 -1.288 . . . . 5.15 110.353 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.546 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 2.2 m-30 -121.1 170.85 6.69 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.301 -0.863 . . . . 6.81 110.614 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -74.48 -41.72 0.78 Allowed 'Trans proline' 0 N--CA 1.415 -3.131 0 C-N-CA 122.012 1.808 . . . . 8.97 110.205 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.15 -7.45 55.66 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 112.167 -2.288 . . . . 10.53 109.803 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.2 m -163.52 136.5 5.43 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.179 -1.373 . . . . 7.9 112.883 -169.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.611 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 54.7 mttt -145.97 146.12 30.9 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.276 0.56 . . . . 6.69 111.861 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -168.2 -161.39 0.36 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.59 -1.186 . . . . 5.04 110.376 -174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -94.88 -124.8 4.29 Favored Glycine 0 C--N 1.313 -0.728 0 C-N-CA 120.728 -0.749 . . . . 2.11 113.53 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.404 ' H ' ' CD ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -80.85 161.61 24.36 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.514 0.673 . . . . 2.93 111.455 -172.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.555 HG13 ' HG3' ' A' ' 187' ' ' GLU . 56.0 t -135.91 146.17 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 CA-C-N 114.626 -1.17 . . . . 0.48 108.742 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -123.39 143.96 49.78 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.627 1.203 . . . . 1.61 112.582 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 153' ' ' GLU . . . -115.47 166.37 11.96 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 112.873 -1.967 . . . . 0.2 109.855 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.4 ttp180 -108.82 126.47 53.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.103 -0.703 . . . . 3.69 109.103 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.485 HD23 HG13 ' A' ' 183' ' ' ILE . 1.4 mt -84.59 152.05 24.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.357 -1.292 . . . . 0.61 110.076 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.608 ' CG2' HD23 ' A' ' 197' ' ' LEU . 93.4 m -151.95 143.05 23.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.1 0.476 . . . . 0.21 111.22 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.932 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.3 m-85 -116.77 111.82 20.29 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.882 -1.053 . . . . 0.32 112.738 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.679 ' HA ' HD21 ' A' ' 197' ' ' LEU . 16.8 t70 -99.15 95.0 6.8 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.035 0.445 . . . . 0.74 111.09 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.02 -114.48 3.96 Favored Glycine 0 C--N 1.316 -0.567 0 C-N-CA 120.199 -1.0 . . . . 0.27 113.487 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -110.8 8.77 22.52 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.055 -1.461 . . . . 1.61 107.055 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.744 ' HB3' HG23 ' A' ' 118' ' ' THR . 34.6 p80 -138.49 160.48 39.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.174 -1.375 . . . . 1.28 111.419 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.895 ' HB2' ' O ' ' A' ' 117' ' ' MET . 7.3 tp -62.06 144.59 55.04 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.059 -0.973 . . . . 0.22 111.093 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.3 -51.28 4.87 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.395 -1.275 . . . . 0.15 111.215 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 6.7 t -178.53 176.26 1.04 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.112 -0.949 . . . . 0.28 110.556 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.851 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -154.15 125.82 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-N 113.086 -1.87 . . . . 0.28 106.472 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.772 HG22 ' HA2' ' A' ' 193' ' ' GLY . 98.7 t -128.76 119.51 49.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 120.28 -0.568 . . . . 0.34 111.901 -172.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.26 96.84 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.529 -1.286 . . . . 1.64 107.529 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.7 mmt -53.89 -24.36 15.77 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 112.669 -2.059 . . . . 1.42 112.304 -168.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.555 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.5 mt-10 -68.13 -44.67 75.56 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 113.992 -1.458 . . . . 0.68 110.839 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.2 -27.77 13.65 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.936 -1.484 . . . . 2.36 111.138 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.3 p30 35.81 39.75 0.08 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.019 1.488 . . . . 1.8 115.019 173.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -153.87 -55.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.021 -0.424 . . . . 4.13 110.821 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.49 41.65 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.174 0.511 . . . . 4.05 110.119 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.3 t80 176.96 41.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.029 -0.73 . . . . 1.83 109.029 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.772 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -128.74 140.63 11.88 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.206 -0.997 . . . . 1.84 114.239 -171.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.495 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 57.7 m-85 -133.66 -171.28 2.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.614 -0.793 . . . . 4.57 109.323 175.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -75.8 162.76 27.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.276 0.56 . . . . 6.25 111.292 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -112.47 159.69 18.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.327 -0.851 . . . . 6.4 110.896 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.679 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -76.59 135.21 39.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.924 -0.58 . . . . 1.4 111.352 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -138.81 76.81 33.9 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.657 0.741 . . . . 3.38 110.073 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.58 -65.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.779 2.32 . . . . 4.74 112.248 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.559 -0.734 . . . . 7.73 110.144 179.452 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.923 0.392 . . . . 31.14 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.97 139.94 2.87 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.843 -0.694 . . . . 30.65 112.143 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -70.81 119.96 15.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.13 -0.693 . . . . 30.65 109.13 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m 70.05 151.49 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.787 0.68 . . . . 29.78 110.268 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -86.39 6.26 30.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.434 -0.348 . . . . 29.55 111.838 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 64.67 73.37 0.42 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.634 -0.712 . . . . 29.87 110.68 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -65.33 134.51 53.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 27.89 110.927 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -138.02 173.66 11.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.823 -0.626 . . . . 26.19 109.808 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -58.2 -41.68 84.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.339 0.496 . . . . 26.23 112.339 -171.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -110.39 147.5 33.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.83 -0.348 . . . . 26.64 110.942 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.6 m 67.27 17.98 10.27 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.823 0.675 . . . . 24.71 112.823 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.9 p -160.95 122.24 2.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.789 0.328 . . . . 24.15 110.381 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.12 -20.05 4.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.493 -0.643 . . . . 22.66 111.493 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.97 -51.0 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.397 -0.594 . . . . 20.88 109.397 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.72 101.33 48.36 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.48 -0.782 . . . . 19.88 110.04 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.88 50.23 3.5 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.659 2.239 . . . . 18.7 111.689 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -68.62 113.99 6.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 18.91 110.898 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 105' ' ' SER . . . -89.21 -132.72 4.59 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.039 -0.824 . . . . 15.32 111.039 173.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 104' ' ' GLY . 41.2 t 70.23 159.59 0.19 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.309 0.576 . . . . 14.03 111.123 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -96.48 6.38 48.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 12.65 110.132 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -69.48 150.38 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.918 -0.583 . . . . 11.98 110.614 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.28 131.59 3.45 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.868 -0.682 . . . . 8.1 111.427 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -72.02 140.04 48.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.753 0.311 . . . . 9.18 110.388 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.1 ptp -136.42 23.8 3.2 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.36 1.076 . . . . 6.14 109.233 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.09 128.43 68.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.592 -1.64 . . . . 4.84 109.916 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.32 141.46 48.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.931 -0.577 . . . . 4.29 109.618 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.778 HD11 HD13 ' A' ' 173' ' ' LEU . 3.3 tm? -71.05 138.48 49.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.911 -0.774 . . . . 1.69 108.911 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 14.7 mt-10 -168.32 -171.41 0.23 Allowed Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 118.779 -0.629 . . . . 3.45 109.649 -169.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 3.7 Cg_exo -39.45 -176.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 125.226 3.95 . . . . 3.06 115.696 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -43.05 28.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 119.823 3.268 . . . . 3.24 119.823 -148.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.887 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -42.27 111.88 0.29 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.707 0.765 . . . . 1.45 112.158 173.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.776 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m -73.89 106.51 5.64 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.627 0.727 . . . . 0.32 110.798 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.946 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.4 pt -138.4 172.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 114.595 -1.184 . . . . 0.2 111.318 -177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.898 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 10.2 p -121.18 174.77 6.47 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.502 -1.227 . . . . 1.29 109.9 -174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 124' ' ' MET . 35.8 ttpt -56.22 -43.0 78.14 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.78 0.324 . . . . 3.26 111.824 -175.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.6 t-20 -84.17 -18.03 38.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 122.063 -0.398 . . . . 2.17 110.187 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -68.28 -23.77 64.79 Favored 'General case' 0 N--CA 1.422 -1.868 0 C-N-CA 119.969 -0.693 . . . . 0.5 110.176 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.7 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.27 -26.56 26.57 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 118.495 -1.282 . . . . 3.06 109.581 177.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.5 -32.06 55.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.845 -1.071 . . . . 0.35 111.539 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.786 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.66 -38.97 32.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.792 -1.095 . . . . 1.51 110.348 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.76 -38.18 84.32 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-O 117.548 -1.215 . . . . 0.4 114.236 -174.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.866 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -39.48 94.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 116.216 -2.193 . . . . 0.32 109.257 176.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 22.0 mt-10 -65.02 -29.81 70.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.614 1.197 . . . . 2.51 108.113 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.865 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.72 -7.77 45.77 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.727 -2.033 . . . . 0.33 111.076 -170.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -121.81 -1.65 9.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.705 0.764 . . . . 0.36 109.322 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 71.25 57.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.702 -1.59 . . . . 2.19 111.996 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.866 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.08 145.51 26.4 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.587 -1.635 . . . . 0.27 106.587 178.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.558 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.87 164.52 31.68 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.886 -0.783 . . . . 0.69 108.886 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' CB ' HG12 ' A' ' 147' ' ' VAL . 18.3 tt0 -45.01 144.69 1.15 Allowed 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.285 1.04 . . . . 1.96 113.21 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 138' ' ' LYS . 5.1 t -139.98 150.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 CA-C-N 113.507 -1.679 . . . . 0.27 111.781 -173.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.3 p -63.64 -49.11 74.53 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.935 -1.484 . . . . 0.73 111.887 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -155.43 113.49 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.886 -1.506 . . . . 0.51 108.996 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.036 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -79.06 100.24 7.27 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 123.518 1.628 . . . . 2.71 111.187 -166.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.729 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.0 t -156.74 94.9 1.49 Allowed 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.313 -1.767 . . . . 0.35 107.899 164.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 140' ' ' THR . 1.8 mpt_? -151.78 171.82 6.14 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 113.675 -1.602 . . . . 2.38 107.783 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.75 111.89 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.732 0 CA-C-N 120.066 1.059 . . . . 0.79 110.15 163.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.96 4.54 86.97 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.717 -0.754 . . . . 0.38 114.665 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 81.7 mm-40 -119.28 132.59 55.92 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 117.976 0.888 . . . . 1.49 108.64 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.797 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.8 m-30 -128.81 172.93 10.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.833 -0.747 . . . . 0.3 110.255 -166.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 1.036 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.5 p -106.84 139.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.983 -0.747 . . . . 0.19 108.983 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.494 HG23 HG12 ' A' ' 152' ' ' ILE . 2.0 p -113.67 128.92 70.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.134 -0.627 . . . . 0.86 112.35 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 151' ' ' SER . 26.7 mp0 -116.51 -88.03 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.23 -0.441 . . . . 2.45 111.865 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.79 -84.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.935 0.346 . . . . 0.49 111.935 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -82.3 -9.41 59.48 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.69 0.757 . . . . 1.02 109.352 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 174' ' ' THR . 17.5 m -140.35 144.13 36.13 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 114.921 -1.036 . . . . 0.94 109.643 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.5 mt -108.73 168.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.105 -1.072 . . . . 0.2 108.105 168.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.797 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 22.7 tt0 -123.76 110.59 15.11 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.476 -0.89 . . . . 0.97 110.236 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.595 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -114.86 130.04 56.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.024 0.44 . . . . 1.32 111.021 -169.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.37 134.21 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 109.894 -0.41 . . . . 0.33 109.894 172.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.475 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 40.7 ttp85 -88.36 154.88 20.04 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.014 -0.735 . . . . 3.1 109.014 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.421 ' HD3' ' HD2' ' A' ' 158' ' ' PRO . 16.3 tpp180 -57.61 111.54 3.58 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.591 -0.522 . . . . 4.26 109.591 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.555 ' HB2' ' O ' ' A' ' 166' ' ' GLU . 51.6 Cg_endo -70.64 179.57 4.07 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 123.489 2.793 . . . . 2.01 114.227 -171.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -56.8 143.09 38.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.767 -1.106 . . . . 5.12 111.78 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.501 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 15.1 m-20 -123.06 132.73 54.23 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.761 -1.109 . . . . 5.15 111.112 -172.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.655 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 66.6 m-85 -119.06 170.79 6.09 Favored Pre-proline 0 N--CA 1.425 -1.704 0 CA-C-O 121.618 0.723 . . . . 6.81 110.85 170.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 3.9 Cg_endo -80.36 -42.62 0.14 Allowed 'Trans proline' 0 N--CA 1.414 -3.178 0 C-N-CA 122.201 1.934 . . . . 8.97 111.521 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.67 -7.13 44.7 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 112.822 -1.99 . . . . 10.53 109.527 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -165.88 167.86 16.39 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 113.745 -1.57 . . . . 7.9 110.996 -170.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.655 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 70.5 mttt -150.45 141.08 22.6 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 118.356 0.526 . . . . 6.69 110.546 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 7.2 pt-20 -164.82 -161.74 0.58 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.77 -0.65 . . . . 5.04 112.237 -166.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 162.6 35.91 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.326 -0.852 . . . . 2.11 112.298 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.519 ' HA ' HE21 ' A' ' 168' ' ' GLN . 0.0 OUTLIER -150.46 109.8 3.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.803 0.335 . . . . 2.93 110.677 176.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 187' ' ' GLU . 69.3 t -132.31 142.69 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.267 0 CA-C-N 116.215 -0.448 . . . . 0.48 110.376 173.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -128.54 144.42 51.14 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 122.164 0.983 . . . . 1.61 112.41 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -115.3 167.22 11.04 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.481 -1.691 . . . . 0.2 110.619 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.7 ttp180 -115.08 120.74 40.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.847 -1.168 . . . . 3.69 107.847 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.778 HD13 HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -113.41 114.1 26.13 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.927 -1.488 . . . . 0.61 110.282 -164.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.605 ' CG2' HD23 ' A' ' 197' ' ' LEU . 64.5 m -112.36 146.42 38.34 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.022 -0.535 . . . . 0.21 111.744 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.946 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -118.8 117.75 29.72 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.417 -0.811 . . . . 0.32 111.905 178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.785 ' HA ' HD21 ' A' ' 197' ' ' LEU . 14.1 t70 -98.08 99.65 10.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.69 -0.686 . . . . 0.74 111.128 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.22 -111.99 3.47 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.829 -1.176 . . . . 0.27 113.78 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.67 6.55 21.76 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.135 -1.431 . . . . 1.61 107.135 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.776 ' HB3' HG23 ' A' ' 118' ' ' THR . 22.9 p80 -140.94 160.27 40.42 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.979 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.887 ' HB2' ' O ' ' A' ' 117' ' ' MET . 6.0 tp -60.73 145.43 49.52 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.774 0.797 . . . . 0.22 111.562 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 174' ' ' THR . . . -97.74 -49.64 4.76 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.282 -1.326 . . . . 0.15 111.162 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.554 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t -178.95 177.69 0.81 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.316 -0.856 . . . . 0.28 110.657 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 180' ' ' LEU . 2.7 mp -152.93 123.22 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 106.495 -1.668 . . . . 0.28 106.495 175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.74 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 88.4 t -127.94 123.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 112.804 0.668 . . . . 0.34 112.804 -170.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.475 ' OD1' ' HD3' ' A' ' 156' ' ' ARG . 8.3 m-20 -59.67 101.36 0.11 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.339 1.066 . . . . 1.64 108.255 172.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.43 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 80.6 mmm -60.45 -13.85 15.95 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 113.05 -1.887 . . . . 1.42 112.788 -169.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.2 mt-10 -73.76 -45.58 50.93 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.48 -1.236 . . . . 0.68 110.752 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -104.96 -20.23 13.6 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.936 -1.029 . . . . 2.36 111.495 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.74 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 20.2 p30 37.6 33.6 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.254 1.575 . . . . 1.8 115.254 174.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.3 -68.13 0.32 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 4.13 110.39 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.49 73.78 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 4.05 110.336 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.9 t80 178.78 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.809 . . . . 1.83 108.944 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 176.48 -161.6 29.81 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.499 -0.773 . . . . 1.84 111.953 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.547 ' O ' HG21 ' A' ' 182' ' ' THR . 99.6 m-85 -143.5 122.42 12.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.806 0.336 . . . . 4.57 110.232 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -80.65 86.88 5.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.528 0.68 . . . . 6.25 111.146 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -134.81 142.15 46.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.599 -0.728 . . . . 6.4 110.268 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.785 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -153.63 130.29 10.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.952 0.406 . . . . 1.4 110.162 175.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -121.4 90.44 47.72 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 3.38 110.389 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.36 44.33 1.5 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.851 2.367 . . . . 4.74 111.858 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.535 -0.745 . . . . 7.73 110.387 -174.266 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.695 ' N ' ' HG ' ' A' ' 90' ' ' SER . 49.3 tpp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.69 0.281 . . . . 31.14 110.565 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.99 -101.81 1.1 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.353 -0.699 . . . . 30.65 111.353 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -84.73 52.61 2.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 30.65 109.876 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.695 ' HG ' ' N ' ' A' ' 87' ' ' MET . 25.5 m -75.35 104.36 5.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.613 -0.722 . . . . 29.78 111.236 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -83.17 -59.15 2.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.554 -0.748 . . . . 29.55 110.111 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 46.1 m170 59.67 83.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.724 0.64 . . . . 29.87 110.472 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.05 -43.9 90.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 27.89 111.079 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.0 m80 55.61 49.41 16.57 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.279 0.561 . . . . 26.19 109.558 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -77.96 -62.7 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.448 -0.797 . . . . 26.23 110.409 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -178.02 137.85 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 26.64 109.742 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.5 m -106.85 90.88 3.45 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.681 -0.489 . . . . 24.71 109.681 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 m -75.46 -65.79 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.821 -0.627 . . . . 24.15 110.95 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.14 60.79 2.2 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.518 -0.849 . . . . 22.66 112.467 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.79 81.39 4.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.909 -0.404 . . . . 20.88 109.909 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.1 120.72 60.43 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.689 -0.687 . . . . 19.88 110.765 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 110' ' ' MET . 74.0 Cg_exo -42.64 113.05 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.695 2.93 . . . . 18.7 113.122 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -89.97 141.48 28.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 18.91 110.602 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.1 -64.07 0.55 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.995 -0.842 . . . . 15.32 110.995 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 106' ' ' HIS . 46.5 m -126.12 86.52 2.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.361 -0.607 . . . . 14.03 109.361 175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 105' ' ' SER . 52.1 m80 71.9 -61.0 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.357 0.663 . . . . 12.65 110.315 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.2 ptm -100.96 176.79 5.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.572 -0.529 . . . . 11.98 109.572 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -173.37 164.89 36.8 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.378 -0.915 . . . . 8.1 112.083 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -135.59 135.69 40.48 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.949 -0.389 . . . . 9.18 109.949 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.415 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 28.0 ptm -107.16 4.08 26.39 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.418 1.104 . . . . 6.14 108.614 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 m -145.16 132.09 15.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 112.592 -2.095 . . . . 4.84 110.122 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.24 70.16 1.3 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.0 0.905 . . . . 4.29 109.43 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.749 ' HB3' ' SD ' ' A' ' 154' ' ' MET . 2.8 tm? -118.11 131.62 56.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.667 -1.151 . . . . 1.69 109.781 -175.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.435 ' H ' HD22 ' A' ' 113' ' ' LEU . 9.4 tp10 176.27 145.32 0.25 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.495 -2.039 . . . . 3.45 105.495 -171.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 183' ' ' ILE . 76.2 Cg_endo -90.22 103.04 0.31 Allowed 'Trans proline' 0 N--CA 1.433 -2.073 0 CA-C-N 122.379 1.885 . . . . 3.06 113.938 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -113.29 -4.32 13.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.463 -2.792 . . . . 3.24 103.463 140.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.535 ' HG3' HG23 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -75.05 142.07 43.79 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 111.338 -2.664 . . . . 1.45 112.194 -161.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 179' ' ' HIS . 18.4 m -127.37 101.12 6.32 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.722 -1.127 . . . . 0.32 108.84 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.851 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.6 pt -128.7 172.04 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 122.275 1.036 . . . . 0.2 112.218 -172.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.844 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 6.3 t -120.95 170.13 9.8 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.804 -1.543 . . . . 1.29 109.398 -169.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -52.02 -46.0 64.81 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.252 0.549 . . . . 3.26 112.278 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.443 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 18.3 m120 -84.14 -17.12 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.403 -0.362 . . . . 2.17 110.088 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.972 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -66.86 -30.87 71.15 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 120.468 -0.493 . . . . 0.5 110.361 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.84 -22.68 27.46 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 117.771 -1.572 . . . . 3.06 109.649 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' HD21 ' A' ' 128' ' ' LEU . 2.1 t -68.22 -29.39 44.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.566 -1.197 . . . . 0.35 111.674 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.95 -39.06 26.69 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.956 -1.02 . . . . 1.51 109.326 171.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.972 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -55.57 -45.37 77.33 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 114.525 1.306 . . . . 0.4 114.525 -174.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -60.35 -39.54 87.49 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 116.784 -1.966 . . . . 0.32 109.719 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.0 mt-10 -66.54 -29.62 69.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.51 108.022 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -91.34 -8.59 47.66 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 112.926 -1.943 . . . . 0.33 110.886 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.98 -1.87 9.29 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.783 0.802 . . . . 0.36 109.552 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 70.44 56.75 0.26 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.761 -1.563 . . . . 2.19 111.882 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.08 146.41 27.71 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.378 -1.712 . . . . 0.27 106.378 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -147.69 163.83 35.43 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.127 -1.435 . . . . 0.69 107.127 -176.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.549 ' CB ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -47.0 158.73 0.12 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 122.453 1.12 . . . . 1.96 112.853 -176.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -148.27 150.23 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 CA-C-N 113.772 -1.558 . . . . 0.27 111.412 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -61.48 -49.45 76.7 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.375 -0.829 . . . . 0.73 111.866 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 17.4 ptmt -153.77 115.76 4.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.187 -1.37 . . . . 0.51 108.85 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.874 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -76.34 99.37 4.79 Favored 'General case' 0 N--CA 1.417 -2.092 0 CA-C-O 123.842 1.782 . . . . 2.71 112.277 -168.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.738 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -158.73 91.63 1.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.29 -1.777 . . . . 0.35 108.684 159.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.2 mmt-85 -154.9 126.44 3.69 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.126 -1.805 . . . . 2.38 106.126 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.67 110.8 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 CA-C-N 121.3 1.5 . . . . 0.79 110.417 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.56 2.5 57.56 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.477 -0.783 . . . . 0.38 114.293 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 28.6 mt-10 -130.46 133.03 45.99 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.982 0.891 . . . . 1.49 108.789 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -128.34 175.17 8.69 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 120.014 -0.675 . . . . 0.3 109.985 -168.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.874 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.9 p -111.43 137.03 49.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 109.662 -0.495 . . . . 0.19 109.662 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 152' ' ' ILE . 1.3 p -113.37 140.72 32.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 115.443 -0.799 . . . . 0.86 111.57 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 151' ' ' SER . 0.6 OUTLIER -138.35 -91.35 0.21 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.0 0.37 . . . . 2.45 112.0 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.34 -93.21 0.13 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.685 0.624 . . . . 0.49 112.685 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.437 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 80.9 m-20 -80.33 -3.62 50.22 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.004 0.431 . . . . 1.02 110.44 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 148' ' ' GLN . 20.4 m -144.67 148.09 33.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 116.019 -0.537 . . . . 0.94 109.609 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.561 ' CG2' HD23 ' A' ' 173' ' ' LEU . 9.3 mt -108.18 167.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 107.694 -1.224 . . . . 0.2 107.694 168.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.2 tt0 -123.43 106.17 10.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.931 -1.108 . . . . 0.97 111.051 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.749 ' SD ' ' HB3' ' A' ' 113' ' ' LEU . 6.0 ttt -106.27 130.26 54.15 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.191 -0.204 . . . . 1.32 111.168 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.09 120.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 169.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -73.98 147.28 43.16 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.771 -0.825 . . . . 3.1 108.771 -178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.529 ' N ' ' HD3' ' A' ' 156' ' ' ARG . 3.1 tmt_? -45.68 126.41 6.51 Favored Pre-proline 0 C--O 1.234 0.24 0 O-C-N 123.694 0.622 . . . . 4.26 109.826 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -48.77 155.43 2.48 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.676 2.917 . . . . 2.01 113.102 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -92.37 120.74 33.18 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.21 1.005 . . . . 5.12 113.462 -172.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.634 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 35.1 m-20 -130.09 119.69 23.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.691 -1.595 . . . . 5.15 110.603 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.631 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 34.4 m-85 -120.71 172.29 4.9 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 115.071 -0.968 . . . . 6.81 110.174 176.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.2 Cg_endo -76.81 -44.06 0.23 Allowed 'Trans proline' 0 N--CA 1.411 -3.33 0 C-N-CA 121.695 1.596 . . . . 8.97 110.343 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -90.92 -3.94 56.92 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 112.398 -2.183 . . . . 10.53 109.705 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -163.11 145.4 10.18 Favored 'General case' 0 C--O 1.203 -1.38 0 CA-C-N 113.968 -1.469 . . . . 7.9 112.094 -171.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.634 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 59.6 mttt -150.33 139.53 21.21 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.219 0.533 . . . . 6.69 111.22 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.2 pt-20 -155.51 -164.44 1.75 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.994 -1.003 . . . . 5.04 111.489 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -98.04 -135.33 8.71 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.606 -0.724 . . . . 2.11 113.663 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -93.02 159.23 15.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.737 0.779 . . . . 2.93 111.638 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.567 HG13 ' HG3' ' A' ' 187' ' ' GLU . 55.1 t -139.17 148.83 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 CA-C-N 114.204 -1.362 . . . . 0.48 108.176 172.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -119.58 143.36 47.68 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 122.516 1.15 . . . . 1.61 113.151 176.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.84 166.46 13.25 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.719 -2.037 . . . . 0.2 110.653 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.74 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 28.6 ttp180 -114.17 114.94 26.71 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.737 -1.209 . . . . 3.69 107.737 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.642 HD13 HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -103.32 105.58 15.89 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.303 -1.771 . . . . 0.61 109.573 -168.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.677 ' CG2' HD23 ' A' ' 197' ' ' LEU . 55.1 m -104.16 149.25 25.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.463 -0.79 . . . . 0.21 112.655 -167.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.851 ' CD1' HD11 ' A' ' 119' ' ' ILE . 14.7 m-85 -115.51 107.51 15.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.372 -1.285 . . . . 0.32 113.078 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.779 ' HA ' HD21 ' A' ' 197' ' ' LEU . 25.3 t70 -100.56 102.71 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 0.74 110.842 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.26 -121.85 5.53 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.196 -1.002 . . . . 0.27 112.925 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -110.34 15.59 22.16 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.511 -1.663 . . . . 1.61 106.511 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.768 ' HB3' HG23 ' A' ' 118' ' ' THR . 20.8 p-80 -138.16 161.15 37.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.292 -1.322 . . . . 1.28 111.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -70.54 131.67 44.34 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 114.62 -1.173 . . . . 0.22 110.364 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.636 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -80.7 -49.82 10.7 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.131 -1.395 . . . . 0.15 111.022 -175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.7 t 177.7 178.22 0.33 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 114.765 -1.107 . . . . 0.28 110.413 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 180' ' ' LEU . 2.2 mp -148.28 121.2 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.759 -1.571 . . . . 0.28 106.759 174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.723 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -126.18 122.6 61.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.535 0.569 . . . . 0.34 112.535 -171.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.3 99.75 0.06 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 122.069 0.938 . . . . 1.64 108.806 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 1.8 mmt -54.04 -23.55 13.96 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-N 112.663 -2.062 . . . . 1.42 112.635 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.567 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -68.12 -42.21 80.55 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 114.382 -1.281 . . . . 0.68 110.556 -175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.563 ' C ' HD22 ' A' ' 189' ' ' ASN . 94.4 m-20 -102.1 -27.03 13.15 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.097 -1.411 . . . . 2.36 111.363 177.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.723 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 0.1 OUTLIER 33.98 51.89 0.43 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 115.241 1.571 . . . . 1.8 115.241 174.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -143.96 -75.3 0.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.508 -0.477 . . . . 4.13 111.704 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -101.86 19.14 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.529 0.566 . . . . 4.05 112.529 -170.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -95.55 -22.39 17.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.475 -0.49 . . . . 1.83 109.776 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.631 ' HA3' HG22 ' A' ' 184' ' ' VAL . . . -153.97 -137.21 2.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.105 -1.045 . . . . 1.84 113.256 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -127.88 -172.63 2.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.045 0.45 . . . . 4.57 111.714 -172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -78.13 175.03 10.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 6.25 111.367 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -72.79 161.01 31.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.57 -0.741 . . . . 6.4 111.773 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -74.0 146.19 43.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.98 -1.009 . . . . 1.4 111.017 -176.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.55 109.19 7.21 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.497 -0.557 . . . . 3.38 109.497 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.41 156.31 52.33 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.701 2.267 . . . . 4.74 112.469 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.538 -0.744 . . . . 7.73 109.777 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.789 0.328 . . . . 31.14 110.639 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.45 121.86 2.11 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.927 -0.654 . . . . 30.65 111.987 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -73.98 -50.1 21.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.866 0.365 . . . . 30.65 110.722 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 m -96.86 -15.87 21.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 29.78 110.013 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -123.51 72.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.467 -0.788 . . . . 29.55 109.843 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -59.33 -63.1 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 29.87 109.979 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.2 t60 48.74 69.54 0.55 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.79 0.681 . . . . 27.89 111.112 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 97' ' ' SER . 57.6 t60 -128.54 -73.12 0.59 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.407 -0.361 . . . . 26.19 110.732 -177.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 72.2 m-70 52.91 67.53 0.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.467 0.479 . . . . 26.23 110.822 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 12.2 m-70 69.93 178.78 0.25 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.91 -0.586 . . . . 26.64 111.27 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.465 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 18.2 t -169.52 136.75 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.504 -0.316 . . . . 24.71 110.516 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.2 m -122.86 4.27 9.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.01 0.434 . . . . 24.15 110.413 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.05 -59.52 4.88 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.005 -0.617 . . . . 22.66 112.575 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 3.8 mm? -62.48 146.76 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.735 0.302 . . . . 20.88 110.748 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.9 t -103.97 100.89 22.38 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.189 -0.459 . . . . 19.88 110.485 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 100' ' ' LEU . 17.2 Cg_exo -68.16 -28.31 34.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.813 2.342 . . . . 18.7 112.646 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 67.43 -179.93 0.22 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.719 -0.673 . . . . 18.91 111.021 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.13 -153.39 25.05 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.567 -0.825 . . . . 15.32 112.425 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.9 p -64.86 144.49 57.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.045 0.45 . . . . 14.03 111.429 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -152.6 -14.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 12.65 111.385 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.4 ttm -78.23 -36.89 46.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.424 0.631 . . . . 11.98 109.588 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -114.14 90.25 0.53 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.319 -0.855 . . . . 8.1 111.664 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -72.73 -54.53 8.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.955 0.407 . . . . 9.18 110.081 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.0 ptm -156.8 30.64 0.31 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.838 0.828 . . . . 6.14 109.948 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -105.65 -29.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.424 -1.262 . . . . 4.84 110.154 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.31 75.79 3.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.668 -0.697 . . . . 4.29 109.339 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.788 HD12 ' N ' ' A' ' 114' ' ' GLU . 0.6 OUTLIER -67.21 126.08 28.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.434 -0.803 . . . . 1.69 110.267 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.788 ' N ' HD12 ' A' ' 113' ' ' LEU . 40.5 mt-10 -160.7 161.53 24.52 Favored Pre-proline 0 CA--C 1.5 -0.975 0 N-CA-C 107.883 -1.154 . . . . 3.45 107.883 -173.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 69.5 Cg_endo -91.03 101.19 0.24 Allowed 'Trans proline' 0 N--CA 1.428 -2.354 0 CA-C-N 120.004 1.037 . . . . 3.06 112.764 171.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -111.97 -6.25 14.24 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 102.583 -3.117 . . . . 3.24 102.583 138.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.579 ' HG3' HG23 ' A' ' 119' ' ' ILE . 9.8 tpt -77.03 139.02 39.93 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 111.1 -2.773 . . . . 1.45 111.083 -168.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 179' ' ' HIS . 7.2 m -123.89 103.14 8.17 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.759 -1.11 . . . . 0.32 108.805 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.9 pt -134.68 171.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-N 114.906 -1.043 . . . . 0.2 110.51 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.872 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -119.58 173.91 6.72 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.872 -1.058 . . . . 1.29 108.801 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.6 -44.8 66.23 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.379 0.424 . . . . 3.26 111.011 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 64.1 t30 -82.91 -18.52 39.86 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.425 -0.352 . . . . 2.17 110.344 -178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -71.35 -25.69 62.5 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 120.363 -0.535 . . . . 0.5 110.666 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.2 tpt -88.81 -24.65 22.54 Favored 'General case' 0 C--N 1.286 -2.154 0 C-N-CA 118.065 -1.454 . . . . 3.06 109.515 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 2.3 t -60.0 -31.9 48.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.651 -1.159 . . . . 0.35 111.839 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.73 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -80.24 -39.8 28.32 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.124 -0.944 . . . . 1.51 110.415 170.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.902 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.03 -37.05 83.45 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-O 117.411 -1.28 . . . . 0.4 114.077 -175.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.773 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -63.39 -38.82 92.62 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 116.189 -2.204 . . . . 0.32 108.935 176.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 25.7 mt-10 -65.39 -29.19 69.87 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 122.788 1.28 . . . . 2.51 108.116 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.902 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.94 -6.72 44.86 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 112.446 -2.161 . . . . 0.33 110.777 -169.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 128' ' ' LEU . 8.8 t -122.83 0.52 9.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.86 0.838 . . . . 0.36 109.555 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 71.62 53.47 0.22 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.85 -1.523 . . . . 2.19 111.691 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.748 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.02 144.24 25.68 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.276 -1.379 . . . . 0.27 107.276 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.627 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -144.79 163.02 35.32 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.236 -1.024 . . . . 0.69 108.236 -174.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -47.35 145.88 2.22 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 121.85 0.833 . . . . 1.96 112.358 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -136.81 150.09 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.304 -1.316 . . . . 0.27 112.289 -172.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.4 m -60.43 -49.16 78.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.667 -1.151 . . . . 0.73 111.723 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 18.3 ptmt -157.19 113.95 3.01 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.148 -1.387 . . . . 0.51 108.619 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.896 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.8 OUTLIER -75.36 99.47 4.13 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 123.674 1.702 . . . . 2.71 112.089 -167.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.812 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.9 t -159.01 92.84 1.12 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.665 -1.607 . . . . 0.35 109.527 161.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.812 ' HD3' ' O ' ' A' ' 140' ' ' THR . 11.0 mmt180 -152.44 154.68 32.21 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 106.583 -1.636 . . . . 2.38 106.583 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -73.04 110.86 3.14 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 120.577 1.242 . . . . 0.79 109.911 168.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 15.38 63.48 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.536 -0.84 . . . . 0.38 113.933 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 26.6 mt-10 -134.48 131.4 38.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 107.743 -1.206 . . . . 1.49 107.743 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.913 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -133.75 176.25 8.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.504 -0.878 . . . . 0.3 110.612 -167.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.896 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.5 p -107.45 142.98 36.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.639 0.733 . . . . 0.19 111.609 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.5 t -106.23 134.45 47.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.344 -1.298 . . . . 0.86 111.629 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 151' ' ' SER . 24.8 mt-30 -120.1 -87.81 0.63 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.669 -0.241 . . . . 2.45 111.096 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -164.27 -81.08 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.693 0.283 . . . . 0.49 110.93 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.499 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 75.4 m-20 -82.69 -4.28 57.6 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.065 0.46 . . . . 1.02 109.908 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 18.0 m -145.71 148.34 32.92 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 120.305 -0.558 . . . . 0.94 110.318 175.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 128' ' ' LEU . 6.2 mt -110.23 168.75 4.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.562 -1.273 . . . . 0.2 107.562 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.913 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.3 tt0 -124.03 108.75 12.7 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.712 -0.795 . . . . 0.97 110.017 172.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.564 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -111.81 125.62 54.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.376 0.607 . . . . 1.32 111.45 -170.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -64.76 123.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.549 -0.75 . . . . 0.33 109.699 173.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.539 ' HD3' ' N ' ' A' ' 157' ' ' ARG . 2.3 tmt_? -76.89 146.3 37.73 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.15 -0.685 . . . . 3.1 109.15 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 156' ' ' ARG . 35.5 ttp180 -44.89 120.11 4.12 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 123.779 0.675 . . . . 4.26 111.153 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 1.6 Cg_endo -77.01 175.85 10.88 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.755 2.303 . . . . 2.01 112.268 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -76.31 124.53 27.64 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.677 0.751 . . . . 5.12 111.421 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.654 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 20.4 m-20 -119.88 131.7 55.33 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.323 -0.853 . . . . 5.15 111.736 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.611 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 49.8 m-85 -120.71 170.14 7.68 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-N 115.479 -0.782 . . . . 6.81 110.706 168.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.9 Cg_endo -77.45 -45.35 0.16 Allowed 'Trans proline' 0 N--CA 1.414 -3.204 0 C-N-CA 122.055 1.837 . . . . 8.97 110.856 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -91.35 -4.15 56.05 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 112.9 -1.954 . . . . 10.53 109.795 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.9 m -163.77 151.67 12.93 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.197 -1.365 . . . . 7.9 111.611 -169.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.654 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 58.0 mttt -149.69 136.41 19.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.232 0.539 . . . . 6.69 110.771 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.26 -169.48 2.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.244 -0.889 . . . . 5.04 111.881 -167.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 67.4 145.51 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.996 -1.002 . . . . 2.11 113.315 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.603 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 12.7 pm0 -148.38 132.61 17.42 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.58 0.705 . . . . 2.93 109.234 164.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 155' ' ' ILE . 84.1 t -135.1 143.91 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 CA-C-N 115.511 -0.768 . . . . 0.48 109.173 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.82 145.01 49.98 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.231 1.015 . . . . 1.61 112.765 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -117.61 163.73 16.01 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.414 -1.721 . . . . 0.2 110.627 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.593 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 39.6 ttt180 -113.69 118.9 35.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.646 -1.242 . . . . 3.69 107.646 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.651 HD22 HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -113.51 106.42 14.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 113.805 -1.543 . . . . 0.61 109.973 -164.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.494 HG21 HD23 ' A' ' 197' ' ' LEU . 53.5 m -105.01 149.37 25.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.609 -0.723 . . . . 0.21 112.306 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.854 ' CD1' HD11 ' A' ' 119' ' ' ILE . 9.0 m-85 -112.62 115.12 28.09 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.058 -1.428 . . . . 0.32 111.559 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 14.5 t70 -107.1 100.18 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.18 0.514 . . . . 0.74 111.121 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.8 -119.29 5.15 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.143 -1.027 . . . . 0.27 112.653 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.75 12.4 21.03 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 106.807 -1.553 . . . . 1.61 106.807 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.755 ' HB3' HG23 ' A' ' 118' ' ' THR . 14.5 p-80 -137.22 160.04 40.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.544 -1.207 . . . . 1.28 111.82 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -67.82 134.1 50.36 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.755 -1.111 . . . . 0.22 110.82 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.481 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -82.14 -54.57 5.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.327 -1.306 . . . . 0.15 111.066 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.531 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.2 t 178.69 177.12 0.48 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.13 -0.941 . . . . 0.28 109.896 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.39 132.22 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.007 -1.479 . . . . 0.28 107.007 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 73.6 t -135.17 115.77 18.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.887 0.699 . . . . 0.34 112.887 -167.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -59.38 100.45 0.08 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.946 -1.131 . . . . 1.64 107.946 171.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.593 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 2.7 mmt -56.87 -15.97 5.83 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 112.962 -1.926 . . . . 1.42 112.622 -169.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.468 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -73.88 -45.39 51.18 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 114.44 -1.255 . . . . 0.68 110.692 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -97.09 -24.72 15.63 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.072 -1.422 . . . . 2.36 111.368 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.716 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 3.5 p-10 36.24 43.26 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.236 1.199 . . . . 1.8 114.236 174.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -174.2 -56.47 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.729 -0.669 . . . . 4.13 109.431 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -79.43 60.78 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 4.05 110.598 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 26.6 t80 177.08 -40.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.235 -0.893 . . . . 1.83 109.183 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.566 ' C ' HG22 ' A' ' 184' ' ' VAL . . . 173.31 164.93 29.42 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.469 -0.787 . . . . 1.84 111.901 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -171.93 126.81 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.27 0.628 . . . . 4.57 110.228 170.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.408 ' CD2' ' HB1' ' A' ' 181' ' ' ALA . 53.0 t80 -162.18 143.57 10.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.265 -0.272 . . . . 6.25 110.265 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.91 142.57 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 6.4 110.1 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -82.66 140.27 33.23 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.954 -0.387 . . . . 1.4 109.954 175.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.67 82.36 48.36 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.353 0.597 . . . . 3.38 111.586 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.65 -46.41 2.66 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.2 1.933 . . . . 4.74 110.25 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.018 -0.992 . . . . 7.73 109.096 176.723 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.217 0.532 . . . . 31.14 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.25 57.74 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.689 -0.767 . . . . 30.65 112.178 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t -79.16 -32.21 44.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.574 -0.528 . . . . 30.65 109.574 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -70.8 106.94 3.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.756 -0.656 . . . . 29.78 110.5 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -118.24 167.19 11.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.72 -0.673 . . . . 29.55 110.669 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 46.8 m170 62.76 78.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.61 0.569 . . . . 29.87 110.758 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -96.85 136.43 37.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.272 -0.422 . . . . 27.89 109.886 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -122.1 38.0 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.705 0.288 . . . . 26.19 111.253 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 61.9 87.6 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.682 -0.69 . . . . 26.23 111.385 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -70.31 -27.3 64.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.037 -0.528 . . . . 26.64 111.194 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.5 t -83.89 -4.42 58.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.853 0.358 . . . . 24.71 110.33 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 m -116.53 -77.53 0.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.198 -0.456 . . . . 24.15 110.025 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.35 -151.49 10.01 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.203 -0.453 . . . . 22.66 112.772 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.7 129.38 47.03 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.946 -0.761 . . . . 20.88 108.946 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.4 m -82.91 121.76 77.64 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.111 0.481 . . . . 19.88 110.77 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -87.51 61.04 3.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.831 2.354 . . . . 18.7 111.994 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -112.42 54.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.4 0.619 . . . . 18.91 110.145 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.19 56.32 4.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.758 -0.655 . . . . 15.32 111.493 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.3 m -143.27 151.78 40.94 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.04 -0.356 . . . . 14.03 110.04 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -142.02 80.98 1.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.149 0.5 . . . . 12.65 109.749 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 115' ' ' PRO . 91.7 mmm -81.19 101.11 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.722 -0.672 . . . . 11.98 110.609 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.49 102.69 0.21 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.433 -0.667 . . . . 8.1 111.433 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -89.8 -80.15 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.541 0.171 . . . . 9.18 111.452 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.495 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 27.0 ptt? -161.06 33.18 0.14 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.881 0.848 . . . . 6.14 111.174 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.5 -35.76 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 114.945 -1.025 . . . . 4.84 109.723 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -143.76 138.37 28.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.487 -0.779 . . . . 4.29 109.01 175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.441 ' O ' HD13 ' A' ' 183' ' ' ILE . 1.6 tt -88.46 100.98 13.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.802 -0.814 . . . . 1.69 108.802 176.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.585 ' N ' ' HD3' ' A' ' 115' ' ' PRO . 37.1 tt0 178.09 60.64 0.07 OUTLIER Pre-proline 0 C--N 1.317 -0.818 0 O-C-N 124.36 1.038 . . . . 3.45 109.288 165.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.639 ' C ' ' H ' ' A' ' 117' ' ' MET . 5.1 Cg_exo -79.41 178.69 7.12 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.437 2.092 . . . . 3.06 109.273 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -63.98 21.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.451 -0.34 . . . . 3.24 111.189 171.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.654 ' HG3' HG23 ' A' ' 119' ' ' ILE . 18.1 tpp -49.31 132.41 20.08 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.975 0.893 . . . . 1.45 110.11 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.85 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.1 m -125.36 95.59 4.52 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.597 -1.183 . . . . 0.32 108.435 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.4 pt -125.71 171.24 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 122.344 1.069 . . . . 0.2 111.391 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.86 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.0 m -111.08 167.3 10.37 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 113.449 -1.705 . . . . 1.29 108.634 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -51.81 -45.92 64.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.031 0.443 . . . . 3.26 111.195 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.43 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 23.0 t-20 -83.66 -17.87 40.0 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.419 -0.355 . . . . 2.17 110.4 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.897 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.8 mt-10 -66.1 -25.1 66.85 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 120.409 -0.516 . . . . 0.5 110.876 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.74 ' O ' HD13 ' A' ' 128' ' ' LEU . 6.1 tpt -88.86 -24.15 22.61 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.102 -1.439 . . . . 3.06 109.723 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 122' ' ' ASN . 2.1 t -61.36 -31.19 49.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.624 -1.171 . . . . 0.35 111.786 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.734 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.89 -40.81 27.49 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.014 -0.993 . . . . 1.51 110.399 169.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.13 -36.9 81.0 Favored 'General case' 0 CA--C 1.475 -1.929 0 CA-C-O 117.393 -1.289 . . . . 0.4 114.108 -175.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.774 ' HA ' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -64.05 -37.24 86.71 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.314 -2.154 . . . . 0.32 109.008 176.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.478 ' N ' HD23 ' A' ' 128' ' ' LEU . 25.6 mt-10 -65.45 -32.29 73.83 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 122.88 1.324 . . . . 2.51 107.802 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.898 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -90.9 -7.03 53.32 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 112.383 -2.189 . . . . 0.33 110.617 -169.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.4 t -122.11 0.91 9.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.949 0.88 . . . . 0.36 109.38 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 66.1 58.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 113.62 -1.627 . . . . 2.19 111.997 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -150.49 143.24 24.6 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.055 -1.832 . . . . 0.27 106.055 178.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.704 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -145.08 163.81 33.14 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.489 -1.3 . . . . 0.69 107.489 -175.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -52.28 160.12 0.85 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.383 1.087 . . . . 1.96 111.821 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 146' ' ' THR . 2.3 t -145.34 152.65 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.326 0 CA-C-N 113.629 -1.623 . . . . 0.27 110.938 -170.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -60.08 -50.12 74.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.862 0.839 . . . . 0.73 111.55 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 17.7 ptmt -157.48 110.06 2.44 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.19 -1.368 . . . . 0.51 108.902 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.88 ' HE1' ' HG2' ' A' ' 153' ' ' GLU . 5.8 ttp -68.97 100.5 1.22 Allowed 'General case' 0 N--CA 1.398 -3.075 0 CA-C-O 122.364 1.078 . . . . 2.71 113.509 -171.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.782 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.8 t -160.11 94.85 1.13 Allowed 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.162 -1.836 . . . . 0.35 108.389 157.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HD3' ' O ' ' A' ' 140' ' ' THR . 18.3 mmt180 -149.37 169.98 8.35 Favored Pre-proline 0 N--CA 1.433 -1.28 0 CA-C-N 114.056 -1.429 . . . . 2.38 107.445 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -80.55 111.32 2.55 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 CA-C-N 119.578 0.885 . . . . 0.79 110.87 168.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.25 13.14 83.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.797 -0.716 . . . . 0.38 114.188 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 2.9 mm-40 -122.14 132.96 54.74 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.949 -1.5 . . . . 1.49 106.949 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.817 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.0 m-85 -130.02 174.36 9.85 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 118.47 -1.292 . . . . 0.3 111.493 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.574 ' CG2' ' HB2' ' A' ' 139' ' ' MET . 9.4 p -111.86 139.35 47.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.801 0.81 . . . . 0.19 111.406 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 55.1 t -100.16 141.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.801 -1.545 . . . . 0.86 111.064 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 151' ' ' SER . 35.9 tt0 -129.16 -80.85 0.57 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.803 -0.18 . . . . 2.45 111.146 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -170.45 -88.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.638 0.256 . . . . 0.49 111.388 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 88.9 m-20 -81.59 -2.25 49.39 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 121.464 0.65 . . . . 1.02 109.264 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 16.3 m -144.02 148.03 34.67 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.53 -0.759 . . . . 0.94 109.87 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 173' ' ' LEU . 4.9 mt -109.31 171.44 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 107.075 -1.454 . . . . 0.2 107.075 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.88 ' HG2' ' HE1' ' A' ' 139' ' ' MET . 11.0 tt0 -115.77 140.06 49.58 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.762 -1.57 . . . . 0.97 106.762 169.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.413 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.2 ppp? -138.82 131.46 29.01 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.832 0.742 . . . . 1.32 111.969 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -75.14 144.46 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 110.016 -0.365 . . . . 0.33 110.016 171.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 40.2 ttt180 -69.27 178.36 2.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.841 -0.8 . . . . 3.1 108.841 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 110' ' ' MET . 36.1 mtm180 -65.95 114.54 16.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 118.167 0.44 . . . . 4.26 111.031 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 168' ' ' GLN . 63.3 Cg_endo -77.99 176.08 10.4 Favored 'Trans proline' 0 CA--C 1.515 -0.425 0 C-N-CA 122.904 2.403 . . . . 2.01 113.416 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -125.49 126.62 45.17 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.302 -1.317 . . . . 5.12 110.158 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.53 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 4.5 m-20 -129.57 123.37 31.18 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.879 -1.055 . . . . 5.15 110.365 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CB ' ' CD ' ' A' ' 162' ' ' PRO . 0.7 OUTLIER -121.77 172.31 5.2 Favored Pre-proline 0 C--N 1.306 -1.292 0 CA-C-O 121.812 0.815 . . . . 6.81 111.204 177.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 161' ' ' PHE . 1.2 Cg_endo -76.08 -42.96 0.34 Allowed 'Trans proline' 0 N--CA 1.416 -3.053 0 C-N-CA 122.239 1.959 . . . . 8.97 110.385 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.79 -6.06 57.64 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 112.204 -2.271 . . . . 10.53 109.348 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.9 m -163.82 137.02 5.37 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.943 -1.48 . . . . 7.9 112.768 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 48.6 mttt -148.62 141.66 24.89 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.027 0.441 . . . . 6.69 110.763 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -165.05 -168.82 1.51 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.153 -0.93 . . . . 5.04 111.518 -172.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -107.98 -169.59 21.54 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.057 -0.974 . . . . 2.11 111.908 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 6.6 tp-100 -134.22 -178.02 4.85 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.169 0.509 . . . . 2.93 110.891 -166.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.722 HG13 ' HG3' ' A' ' 187' ' ' GLU . 3.0 t -87.9 144.9 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 108.203 -1.036 . . . . 0.48 108.203 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.644 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -120.03 144.23 47.65 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.781 1.277 . . . . 1.61 114.029 -176.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -110.84 167.73 10.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 112.462 -2.153 . . . . 0.2 110.414 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.431 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 3.1 ptp180 -115.59 118.76 34.01 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.078 -1.453 . . . . 3.69 107.078 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -110.45 111.01 21.98 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.097 -1.411 . . . . 0.61 109.826 -165.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.438 HG21 HD23 ' A' ' 197' ' ' LEU . 55.1 m -109.85 149.77 29.37 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.742 0.782 . . . . 0.21 112.998 -167.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.913 ' CD1' HD11 ' A' ' 119' ' ' ILE . 5.2 m-85 -114.82 117.42 30.67 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.623 -1.626 . . . . 0.32 110.535 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.533 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 0.5 OUTLIER -113.4 108.04 16.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.964 0.888 . . . . 0.74 110.491 174.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 88.81 -122.0 6.23 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.183 -1.008 . . . . 0.27 112.788 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -111.95 12.1 20.72 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.779 -1.563 . . . . 1.61 106.779 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.85 ' HB3' HG23 ' A' ' 118' ' ' THR . 6.7 p80 -140.29 160.98 38.77 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.747 -1.115 . . . . 1.28 112.326 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.714 HD21 HD11 ' A' ' 183' ' ' ILE . 9.1 tp -65.9 135.91 55.41 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 114.574 -1.193 . . . . 0.22 110.551 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.533 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.62 -51.67 6.0 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.449 -1.251 . . . . 0.15 111.444 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 195' ' ' PHE . 4.5 t 175.72 177.42 0.2 Allowed 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.225 -0.898 . . . . 0.28 110.115 -174.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -149.31 123.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 107.523 -1.288 . . . . 0.28 107.523 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 94.3 t -126.9 119.97 54.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.395 0.517 . . . . 0.34 112.395 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 171' ' ' ALA . 8.5 m120 -60.54 97.44 0.05 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.492 1.139 . . . . 1.64 108.458 171.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.431 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 75.0 mtp -54.17 -28.65 41.73 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 112.015 -2.357 . . . . 1.42 112.652 -166.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.722 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.0 mt-10 -61.61 -42.15 98.47 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.0 -1.454 . . . . 0.68 110.122 -172.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -106.26 -27.48 11.0 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.525 -1.671 . . . . 2.36 111.218 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.771 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 28.5 t-20 37.25 53.4 1.26 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.676 0.751 . . . . 1.8 111.333 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 192' ' ' PHE . 5.0 ptp180 -90.8 -147.73 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.072 -0.967 . . . . 4.13 109.76 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -75.17 26.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 4.05 111.217 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 190' ' ' ARG . 20.9 t80 -73.6 -27.6 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.824 -0.806 . . . . 1.83 108.824 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.46 ' CA ' HG22 ' A' ' 184' ' ' VAL . . . -174.25 175.06 46.66 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 115.12 -0.946 . . . . 1.84 112.207 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -163.01 134.12 4.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.95 0.9 . . . . 4.57 108.869 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.563 ' HB3' HG22 ' A' ' 182' ' ' THR . 44.7 p90 -144.49 149.36 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.497 0.555 . . . . 6.25 112.497 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -135.1 118.07 16.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.194 -0.912 . . . . 6.4 109.09 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 150' ' ' ASN . 2.8 mm? -120.7 126.05 49.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.141 0.496 . . . . 1.4 111.148 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.696 ' H ' ' HD2' ' A' ' 199' ' ' PRO . 5.0 m-20 -125.86 -57.66 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 3.38 111.194 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.696 ' HD2' ' H ' ' A' ' 198' ' ' ASP . 19.9 Cg_endo -60.68 121.45 9.74 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.74 1.626 . . . . 4.74 112.221 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.219 -0.896 . . . . 7.73 109.938 178.927 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.194 -0.298 . . . . 31.14 110.194 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 147.14 46.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.685 -0.769 . . . . 30.65 112.376 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m 63.77 12.88 7.02 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.811 0.444 . . . . 30.65 112.063 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 m -100.91 95.51 6.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.072 0.463 . . . . 29.78 111.049 -173.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -130.92 40.73 3.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.9 -0.591 . . . . 29.55 109.826 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -75.54 -29.01 59.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 29.87 110.921 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -71.35 -43.5 66.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 27.89 110.412 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -100.78 90.32 4.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 26.19 110.306 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -64.16 139.24 58.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.739 -0.664 . . . . 26.23 110.57 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -94.88 102.27 14.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.189 -0.46 . . . . 26.64 110.449 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.7 m -77.8 96.34 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.266 -0.425 . . . . 24.71 110.463 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.5 m -72.88 92.78 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.805 -0.634 . . . . 24.15 110.97 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -154.74 26.6 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.713 -0.676 . . . . 22.66 112.23 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.3 mt -77.38 -12.96 60.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.975 0.417 . . . . 20.88 110.694 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.0 m -99.13 117.94 63.38 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.053 -0.521 . . . . 19.88 110.399 175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.13 -2.52 12.61 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.685 2.256 . . . . 18.7 111.95 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -102.23 124.33 47.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.885 -0.598 . . . . 18.91 110.105 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.47 -71.22 2.96 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.053 -0.594 . . . . 15.32 112.683 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.8 m -85.59 83.22 7.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.09 0.472 . . . . 14.03 111.043 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -167.24 144.98 4.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.795 -0.639 . . . . 12.65 109.635 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.0 tpt -78.58 -27.15 45.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.209 0.528 . . . . 11.98 110.141 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 171.88 -118.99 0.76 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.973 -0.851 . . . . 8.1 110.973 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 131' ' ' THR . 60.3 mtp180 -127.79 139.24 52.78 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.294 -0.632 . . . . 9.18 109.294 175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.3 ptm -125.83 23.15 7.33 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.709 1.242 . . . . 6.14 109.377 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.74 133.94 49.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.088 -1.869 . . . . 4.84 109.297 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -71.65 135.17 46.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.41 -0.359 . . . . 4.29 110.375 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 114' ' ' GLU . 4.0 tt -75.79 131.06 39.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.101 -0.703 . . . . 1.69 109.101 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.63 ' N ' HD23 ' A' ' 113' ' ' LEU . 45.9 mt-10 -159.63 159.89 27.84 Favored Pre-proline 0 CA--C 1.498 -1.035 0 N-CA-C 108.422 -0.955 . . . . 3.45 108.422 -171.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 97.8 Cg_endo -91.2 100.61 0.23 Allowed 'Trans proline' 0 N--CA 1.424 -2.568 0 C-N-CA 117.808 -0.994 . . . . 3.06 112.478 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -110.99 -7.74 14.52 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 102.582 -3.118 . . . . 3.24 102.582 139.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.645 ' HG3' HG23 ' A' ' 119' ' ' ILE . 29.8 tpp -76.71 140.88 41.01 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 110.921 -2.854 . . . . 1.45 111.229 -169.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.823 HG23 ' HB3' ' A' ' 179' ' ' HIS . 6.2 m -126.67 103.09 7.37 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.24 -0.891 . . . . 0.32 109.083 176.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.888 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.2 pt -135.12 172.74 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 115.105 -0.952 . . . . 0.2 111.096 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.842 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.4 p -124.78 177.3 6.07 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.574 -1.194 . . . . 1.29 110.482 -172.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 124' ' ' MET . 65.4 tttp -50.7 -48.76 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.422 0.451 . . . . 3.26 111.864 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 63.3 t30 -84.23 -18.64 35.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 122.273 -0.267 . . . . 2.17 110.285 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.74 -23.53 63.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.877 -0.729 . . . . 0.5 109.813 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.766 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.5 -28.32 25.04 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 118.401 -1.32 . . . . 3.06 109.855 177.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.89 -33.06 56.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 122.463 1.125 . . . . 0.35 111.767 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.765 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.38 -41.71 32.46 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.379 -1.282 . . . . 1.51 110.17 169.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.912 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.39 -38.32 86.62 Favored 'General case' 0 CA--C 1.461 -2.467 0 CA-C-O 117.525 -1.226 . . . . 0.4 114.215 -173.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 116.184 -2.206 . . . . 0.32 108.566 176.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.665 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 61.5 mm-40 -67.94 -29.69 68.81 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 123.189 1.471 . . . . 2.51 108.741 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.55 -6.97 59.12 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.016 -2.357 . . . . 0.33 110.028 -174.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.742 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.3 t -122.54 -0.66 9.18 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.152 -0.931 . . . . 0.36 109.657 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 77.4 51.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 113.865 -1.516 . . . . 2.19 112.436 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.709 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.95 145.05 24.57 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.195 -1.409 . . . . 0.27 107.195 -178.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.632 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -142.62 160.83 39.54 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.166 -1.79 . . . . 0.69 106.166 -176.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -53.04 160.17 1.05 Allowed 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 119.383 0.992 . . . . 1.96 111.656 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.44 153.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-N 114.333 -1.303 . . . . 0.27 111.979 -169.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -60.9 -50.13 74.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.556 0.693 . . . . 0.73 111.886 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.537 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.6 ptmt -157.0 114.64 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.35 -1.296 . . . . 0.51 108.793 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.009 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.18 107.28 15.62 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 122.798 1.285 . . . . 2.71 111.242 -167.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.635 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.8 t -156.92 95.49 1.52 Allowed 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.882 -1.508 . . . . 0.35 108.584 163.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 140' ' ' THR . 19.3 mmt85 -151.54 169.64 9.08 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 113.622 -1.626 . . . . 2.38 108.099 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.03 110.47 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 N-CA-C 109.43 -1.027 . . . . 0.79 109.43 161.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.61 26.95 58.05 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.356 -0.926 . . . . 0.38 114.09 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 32.8 mt-10 -138.82 130.6 27.72 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.41 -1.33 . . . . 1.49 107.41 171.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.796 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -134.0 176.8 8.25 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.61 -0.836 . . . . 0.3 110.482 -165.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 1.009 HG23 ' HB3' ' A' ' 139' ' ' MET . 14.3 p -113.5 138.92 49.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.829 0.823 . . . . 0.19 112.291 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.18 141.47 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 113.696 -1.593 . . . . 0.86 110.862 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -127.48 -81.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.771 -0.372 . . . . 2.45 111.071 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.48 -88.06 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.744 0.307 . . . . 0.49 111.712 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.673 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 15.6 m120 -85.53 -3.02 58.74 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.296 0.569 . . . . 1.02 109.564 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.7 m -142.41 146.63 35.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.786 -0.643 . . . . 0.94 110.286 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.733 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.34 169.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.467 -1.308 . . . . 0.2 107.467 169.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.796 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.5 tt0 -115.71 135.57 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.561 -1.644 . . . . 0.97 106.561 166.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.484 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.0 ppp? -134.66 127.9 32.01 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.874 0.761 . . . . 1.32 111.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -65.05 122.02 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.356 -0.609 . . . . 0.33 109.356 173.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.4 155.96 25.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.463 -0.569 . . . . 3.1 109.463 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -59.36 131.21 87.75 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.642 -0.503 . . . . 4.26 109.642 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -53.26 153.32 17.11 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.608 2.205 . . . . 2.01 112.819 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.458 ' CE1' HG21 ' A' ' 169' ' ' VAL . 2.9 p90 -139.81 157.37 45.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.444 -0.798 . . . . 5.12 112.162 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.631 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 3.4 m-20 -130.14 131.32 45.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.413 -1.267 . . . . 5.15 110.035 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.606 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 58.9 m-85 -119.33 168.68 9.49 Favored Pre-proline 0 N--CA 1.432 -1.348 0 CA-C-O 121.741 0.781 . . . . 6.81 110.83 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -75.5 -44.22 0.31 Allowed 'Trans proline' 0 N--CA 1.413 -3.241 0 C-N-CA 121.843 1.696 . . . . 8.97 110.428 -178.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -90.73 -2.5 57.81 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 112.524 -2.125 . . . . 10.53 109.397 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.2 m -164.21 137.98 5.38 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.091 -1.413 . . . . 7.9 112.836 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.631 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 58.1 mttt -146.13 138.09 25.07 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.405 0.621 . . . . 6.69 111.482 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -160.24 -167.64 1.98 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.64 -1.164 . . . . 5.04 110.874 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -108.34 -122.57 4.73 Favored Glycine 0 C--N 1.312 -0.8 0 C-N-CA 120.595 -0.812 . . . . 2.11 113.028 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -82.08 152.37 26.61 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.806 0.813 . . . . 2.93 109.692 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 54.4 t -138.11 149.12 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 CA-C-N 114.354 -1.294 . . . . 0.48 108.351 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.4 OUTLIER -120.81 142.71 49.35 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 122.524 1.155 . . . . 1.61 113.083 176.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.16 166.88 11.52 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 112.772 -2.013 . . . . 0.2 110.46 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 20.0 ttt180 -116.88 119.38 35.21 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 107.503 -1.295 . . . . 3.69 107.503 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.632 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -113.0 114.57 27.08 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.795 -1.548 . . . . 0.61 110.027 -164.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 182' ' ' THR . 54.2 m -110.8 150.98 28.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 112.76 0.652 . . . . 0.21 112.76 -168.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.888 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.8 m-85 -113.59 103.47 11.28 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.38 -1.282 . . . . 0.32 112.873 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.69 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 9.9 t0 -89.76 96.1 10.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.209 0.528 . . . . 0.74 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.63 -115.56 4.04 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.099 -1.048 . . . . 0.27 113.159 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -111.07 9.44 22.04 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 106.756 -1.572 . . . . 1.61 106.756 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.823 ' HB3' HG23 ' A' ' 118' ' ' THR . 9.5 p-80 -137.65 161.09 37.4 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.221 -1.354 . . . . 1.28 111.807 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.805 HD21 HD11 ' A' ' 183' ' ' ILE . 10.5 tp -67.03 137.32 56.38 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.177 -0.919 . . . . 0.22 110.849 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.69 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -89.16 -54.23 4.21 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.173 -1.376 . . . . 0.15 111.631 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.504 ' HA ' ' HG3' ' A' ' 115' ' ' PRO . 6.2 t -176.97 177.09 1.33 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.123 -0.944 . . . . 0.28 110.12 -174.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.805 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -151.84 124.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.455 -1.683 . . . . 0.28 106.455 176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.734 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 69.4 t -128.23 123.8 60.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.776 0.658 . . . . 0.34 112.776 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.87 98.49 0.05 Allowed 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.317 -0.994 . . . . 1.64 108.317 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.446 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 72.0 mmm -58.9 -16.72 18.93 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 113.332 -1.758 . . . . 1.42 112.896 -168.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.8 mt-10 -72.35 -42.59 65.13 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.473 -1.24 . . . . 0.68 110.175 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.96 -26.73 13.31 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.082 -1.417 . . . . 2.36 112.007 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.734 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.5 p-10 41.21 29.38 0.08 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.342 1.608 . . . . 1.8 115.342 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -139.05 -64.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.738 0.304 . . . . 4.13 110.624 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -77.42 64.81 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 4.05 110.859 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 178.61 -21.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.237 -0.892 . . . . 1.83 109.193 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 152.88 -157.82 27.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.897 -0.668 . . . . 1.84 112.494 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.402 ' O ' HG21 ' A' ' 182' ' ' THR . 33.2 p90 -162.8 147.35 11.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.954 -0.758 . . . . 4.57 108.954 177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -110.64 102.69 11.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.404 0.621 . . . . 6.25 112.011 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -135.72 125.6 25.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.667 -0.697 . . . . 6.4 110.211 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.673 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 11.8 mt -131.74 125.73 32.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 1.4 111.979 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -136.61 73.44 54.99 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.281 -1.007 . . . . 3.38 108.281 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.39 81.85 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.527 2.818 . . . . 4.74 113.632 -171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.462 -0.78 . . . . 7.73 111.088 173.746 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.968 -0.382 . . . . 31.14 109.968 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.16 95.39 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.061 -0.59 . . . . 30.65 112.899 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -115.17 84.55 2.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.979 0.419 . . . . 30.65 110.602 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.3 m -75.28 97.97 3.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.163 -0.471 . . . . 29.78 110.656 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -74.83 119.86 19.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.68 -0.691 . . . . 29.55 110.453 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -90.1 78.03 6.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.908 -0.405 . . . . 29.87 109.908 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 58.58 69.26 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.897 -0.592 . . . . 27.89 111.459 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -128.21 129.95 47.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.146 -0.479 . . . . 26.19 110.075 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -94.39 -168.24 1.81 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.984 -0.553 . . . . 26.23 110.493 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -54.48 115.04 1.9 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.017 -0.364 . . . . 26.64 110.017 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -112.29 73.58 0.82 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.142 0.496 . . . . 24.71 110.757 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.9 m -71.14 138.54 49.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.071 -0.513 . . . . 24.15 110.467 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.44 -61.37 1.24 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.865 -0.683 . . . . 22.66 112.727 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -81.29 48.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.331 0.586 . . . . 20.88 111.388 -176.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.2 m -136.52 93.74 14.09 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.762 -0.654 . . . . 19.88 110.68 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.24 -53.53 2.39 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.845 2.363 . . . . 18.7 111.694 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -130.28 77.09 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 18.91 109.844 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.28 -168.46 29.49 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.596 -0.811 . . . . 15.32 112.406 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m 56.07 49.56 15.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.109 0.481 . . . . 14.03 111.341 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.83 28.4 7.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.192 0.52 . . . . 12.65 110.26 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 68.0 mtm -127.45 147.93 50.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.812 -0.631 . . . . 11.98 110.127 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.46 44.2 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 8.1 112.349 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.472 ' NE ' ' HA ' ' A' ' 109' ' ' ARG . 5.9 mmp_? 59.16 44.47 15.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.93 0.395 . . . . 9.18 111.278 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.6 ptm -112.07 12.74 20.61 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.539 1.162 . . . . 6.14 109.698 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.68 -37.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 113.102 -1.863 . . . . 4.84 109.33 172.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.2 84.38 2.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.723 -0.843 . . . . 4.29 108.723 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.794 HD12 ' N ' ' A' ' 114' ' ' GLU . 0.6 OUTLIER -64.53 125.23 24.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 1.69 109.583 179.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.794 ' N ' HD12 ' A' ' 113' ' ' LEU . 31.0 tt0 -176.76 155.52 1.29 Allowed Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 106.421 -1.696 . . . . 3.45 106.421 -171.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.618 ' HA ' ' H ' ' A' ' 117' ' ' MET . 3.7 Cg_exo -83.84 101.84 0.93 Allowed 'Trans proline' 0 N--CA 1.424 -2.579 0 CA-C-N 121.252 1.483 . . . . 3.06 112.119 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -110.39 4.11 20.35 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 102.015 -3.328 . . . . 3.24 102.015 139.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.618 ' H ' ' HA ' ' A' ' 115' ' ' PRO . 9.6 tpt -96.2 139.78 31.86 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 111.261 -2.7 . . . . 1.45 111.194 -163.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.78 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.4 m -127.94 102.94 6.98 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.52 -1.218 . . . . 0.32 108.751 175.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.847 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.8 pt -131.56 170.6 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 CA-C-N 115.104 -0.953 . . . . 0.2 110.773 -174.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.6 m -119.57 177.05 5.08 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.648 -1.16 . . . . 1.29 109.461 -170.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 124' ' ' MET . 51.3 pttt -51.6 -48.02 63.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.397 . . . . 3.26 111.671 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 121' ' ' LYS . 27.8 t-20 -84.07 -18.1 38.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.474 -0.33 . . . . 2.17 110.406 -177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.916 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.0 mt-10 -69.03 -22.67 64.04 Favored 'General case' 0 N--CA 1.422 -1.825 0 C-N-CA 119.911 -0.716 . . . . 0.5 110.627 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.692 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.09 -27.15 22.13 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.212 -0.995 . . . . 3.06 109.925 176.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.55 -31.77 54.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.569 -1.196 . . . . 0.35 111.565 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.777 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.27 -41.38 34.22 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.942 -1.026 . . . . 1.51 109.808 170.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.916 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.69 -40.27 83.13 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-O 117.58 -1.2 . . . . 0.4 114.116 -173.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.79 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.44 -38.35 90.8 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 116.299 -2.16 . . . . 0.32 109.285 177.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 28.0 mt-10 -65.55 -32.66 74.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.679 1.228 . . . . 2.51 108.013 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.826 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -88.74 -7.51 56.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.474 -2.148 . . . . 0.33 110.632 -169.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -121.39 0.73 10.07 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.222 -0.899 . . . . 0.36 109.116 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 66.46 56.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.636 -1.62 . . . . 2.19 111.981 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.79 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.58 146.88 27.57 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.92 -1.511 . . . . 0.27 106.92 179.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.584 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -145.88 160.21 42.12 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.78 -1.193 . . . . 0.69 107.78 -174.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -46.99 147.78 1.27 Allowed 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 122.021 0.915 . . . . 1.96 112.664 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -139.09 151.94 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 CA-C-N 113.981 -1.463 . . . . 0.27 112.127 -172.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 m -60.1 -50.08 75.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.914 . . . . 0.73 111.438 173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.502 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.4 ptmt -158.04 116.65 3.11 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 113.969 -1.469 . . . . 0.51 108.73 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.979 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -78.47 102.32 7.78 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 123.082 1.42 . . . . 2.71 111.196 -167.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.658 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 4.1 t -157.84 95.96 1.45 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.984 -1.462 . . . . 0.35 108.646 161.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.2 mmt180 -151.51 168.84 10.36 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 113.614 -1.63 . . . . 2.38 106.905 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -80.84 111.39 2.49 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 CA-C-N 119.91 1.004 . . . . 0.79 109.796 162.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.5 20.63 59.81 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.469 -0.872 . . . . 0.38 114.164 172.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 38.8 mt-10 -136.94 132.11 33.96 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.074 -1.084 . . . . 1.49 108.074 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.939 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -134.29 175.98 9.02 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.702 -0.799 . . . . 0.3 110.408 -165.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.979 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.8 p -110.32 139.74 45.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.759 0.79 . . . . 0.19 112.516 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 52.3 t -101.2 129.2 52.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 113.733 -1.576 . . . . 0.86 110.887 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 151' ' ' SER . 7.2 tp60 -113.22 -78.55 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 121.071 -0.251 . . . . 2.45 110.775 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -169.24 -80.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.858 0.361 . . . . 0.49 111.271 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.803 ' HB3' HD13 ' A' ' 197' ' ' LEU . 17.7 m120 -86.7 -2.55 58.62 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.625 -0.509 . . . . 1.02 109.625 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 p -145.2 143.97 30.59 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.957 -0.565 . . . . 0.94 110.533 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.652 ' CG2' HD23 ' A' ' 173' ' ' LEU . 7.4 mt -106.82 169.4 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.303 -1.369 . . . . 0.2 107.303 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.939 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 27.9 tt0 -126.09 111.02 14.2 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.585 -0.846 . . . . 0.97 110.518 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 10.2 tmm? -112.95 124.29 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.092 0.473 . . . . 1.32 111.872 -169.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.725 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -65.99 115.09 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.33 110.537 172.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 169' ' ' VAL . 73.5 ttt180 -69.51 146.99 51.44 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.479 -0.782 . . . . 3.1 109.235 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -58.63 122.39 60.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.171 -0.468 . . . . 4.26 110.182 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -50.11 153.08 7.05 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.404 2.736 . . . . 2.01 113.556 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -146.6 157.28 43.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.763 -1.108 . . . . 5.12 112.021 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.554 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 6.5 m-20 -129.82 133.69 47.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.67 -1.15 . . . . 5.15 109.784 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.596 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 42.4 m-85 -119.58 169.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.327 0 CA-C-O 121.777 0.799 . . . . 6.81 111.3 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.7 Cg_endo -76.58 -43.25 0.29 Allowed 'Trans proline' 0 N--CA 1.414 -3.153 0 C-N-CA 122.154 1.903 . . . . 8.97 110.548 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.19 -2.85 57.42 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 112.558 -2.11 . . . . 10.53 109.647 -174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.1 m -164.12 140.79 6.59 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.08 -1.418 . . . . 7.9 112.507 -172.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.554 ' HE2' ' HB3' ' A' ' 160' ' ' ASP . 58.7 mttt -145.62 148.17 32.83 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.28 0.562 . . . . 6.69 111.46 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.45 -168.02 0.66 Allowed 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.421 -1.263 . . . . 5.04 109.639 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.68 -120.5 3.31 Favored Glycine 0 C--N 1.309 -0.951 0 C-N-CA 120.654 -0.784 . . . . 2.11 112.347 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -79.08 149.61 32.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.58 0.705 . . . . 2.93 109.33 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 187' ' ' GLU . 77.7 t -136.71 148.94 26.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.996 -1.002 . . . . 0.48 108.563 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.725 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -121.07 144.2 48.67 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 122.367 1.08 . . . . 1.61 112.591 177.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -118.18 161.18 20.3 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 113.391 -1.732 . . . . 0.2 109.657 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.416 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 34.7 ttt180 -109.53 118.82 37.62 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.836 -1.172 . . . . 3.69 107.836 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.652 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -108.52 103.87 13.08 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.693 -1.594 . . . . 0.61 110.161 -165.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.416 ' CG2' HD12 ' A' ' 197' ' ' LEU . 56.3 m -104.43 149.55 25.32 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.727 -0.67 . . . . 0.21 112.096 -169.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.847 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.0 m-85 -115.37 108.09 16.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.397 -1.274 . . . . 0.32 112.16 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.557 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 20.7 t70 -99.57 97.25 8.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.974 0.416 . . . . 0.74 110.729 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 85.51 -115.58 4.18 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.223 -0.989 . . . . 0.27 113.699 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -110.74 7.55 22.17 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 106.864 -1.532 . . . . 1.61 106.864 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.78 ' HB3' HG23 ' A' ' 118' ' ' THR . 16.9 p-80 -138.84 161.0 38.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 113.811 -1.54 . . . . 1.28 111.837 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -68.47 131.64 45.63 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.455 -1.248 . . . . 0.22 110.459 177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.557 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -79.3 -53.53 6.85 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.228 -1.351 . . . . 0.15 110.49 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.719 ' OG1' ' HA3' ' A' ' 193' ' ' GLY . 6.2 t 178.49 178.19 0.42 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 114.831 -1.077 . . . . 0.28 110.375 -177.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.5 mp -146.36 116.49 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.707 -1.59 . . . . 0.28 106.707 175.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.631 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 99.4 t -115.77 123.66 71.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 113.243 0.831 . . . . 0.34 113.243 -170.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -61.13 91.83 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 174.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.482 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 70.5 mmm -58.35 -20.47 43.78 Favored 'General case' 0 CA--C 1.486 -1.483 0 CA-C-N 113.408 -1.724 . . . . 1.42 113.667 -163.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.5 mt-10 -71.15 -42.78 68.7 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.787 -1.097 . . . . 0.68 110.215 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -98.44 -31.08 12.18 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 113.768 -1.56 . . . . 2.36 110.981 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.631 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.9 p-10 36.46 40.99 0.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.955 0.883 . . . . 1.8 112.35 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -105.74 90.04 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.15 -0.932 . . . . 4.13 110.538 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 55.48 26.39 8.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.463 -0.79 . . . . 4.05 111.907 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.585 ' HD1' ' HA ' ' A' ' 184' ' ' VAL . 0.6 OUTLIER -81.1 2.91 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.817 -0.438 . . . . 1.83 109.817 178.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.719 ' HA3' ' OG1' ' A' ' 182' ' ' THR . . . 128.4 -5.36 6.71 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 119.769 -1.205 . . . . 1.84 115.418 171.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.556 ' HB3' HG21 ' A' ' 184' ' ' VAL . 3.9 p90 -56.65 122.52 12.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.408 0.623 . . . . 4.57 112.244 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -144.92 171.52 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.074 -0.966 . . . . 6.25 109.209 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -94.3 137.13 33.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.088 0.471 . . . . 6.4 111.503 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.803 HD13 ' HB3' ' A' ' 150' ' ' ASN . 0.2 OUTLIER -88.42 154.39 20.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.548 -0.751 . . . . 1.4 110.267 176.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t70 60.1 79.7 0.29 Allowed Pre-proline 0 N--CA 1.465 0.309 0 O-C-N 123.654 0.596 . . . . 3.38 111.066 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.26 -41.57 6.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.768 2.312 . . . . 4.74 112.28 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.343 -0.837 . . . . 7.73 110.523 -177.31 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.666 0.27 . . . . 31.14 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.88 -141.43 28.26 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.569 -0.824 . . . . 30.65 112.039 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -98.71 80.01 2.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.872 0.368 . . . . 30.65 110.605 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m -97.64 -64.15 1.07 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.126 -0.488 . . . . 29.78 111.245 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -139.55 -51.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.806 -0.179 . . . . 29.55 110.73 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.6 t60 62.95 95.62 0.04 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.649 0.593 . . . . 29.87 110.607 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -66.92 153.25 44.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.884 -0.598 . . . . 27.89 110.241 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -73.08 135.94 44.86 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.054 -0.721 . . . . 26.19 109.054 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -78.78 82.91 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.913 0.387 . . . . 26.23 110.709 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -86.14 139.26 31.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.403 . . . . 26.64 110.169 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.5 p -115.49 10.79 15.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.402 0.62 . . . . 24.71 110.395 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 m -103.8 36.79 2.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.518 -0.765 . . . . 24.15 110.737 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.73 49.07 3.98 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.057 -0.592 . . . . 22.66 112.461 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.17 116.62 24.48 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.389 -0.597 . . . . 20.88 109.389 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.9 121.38 45.97 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.058 -0.519 . . . . 19.88 110.322 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.67 80.93 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.703 2.269 . . . . 18.7 111.955 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 mtm180 -78.26 -40.88 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.518 . . . . 18.91 110.157 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.57 166.28 12.14 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.225 -0.75 . . . . 15.32 111.225 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.0 m 61.43 -161.67 0.29 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.119 -0.326 . . . . 14.03 110.119 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 62.66 72.67 0.49 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.985 0.421 . . . . 12.65 110.785 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.404 ' SD ' ' HD3' ' A' ' 109' ' ' ARG . 51.5 ttm -65.87 -40.87 92.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.845 -0.616 . . . . 11.98 111.588 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.89 67.97 1.79 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.487 -0.863 . . . . 8.1 111.428 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' HD3' ' SD ' ' A' ' 107' ' ' MET . 15.2 tpt180 -80.81 124.45 29.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.983 -0.377 . . . . 9.18 109.983 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -138.22 26.06 2.67 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.481 1.134 . . . . 6.14 109.129 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 112' ' ' ASN . 9.3 p -118.45 168.35 10.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 113.319 -1.764 . . . . 4.84 109.106 177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 111' ' ' VAL . 15.5 m120 -54.46 106.31 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.97 0.414 . . . . 4.29 111.254 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.575 HD23 ' HD3' ' A' ' 115' ' ' PRO . 2.3 tt -78.52 107.0 10.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 1.69 110.331 -177.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.631 ' HA ' HD13 ' A' ' 183' ' ' ILE . 5.9 tp10 178.42 57.79 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.168 0.918 . . . . 3.45 109.221 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 11.6 Cg_endo -89.59 178.32 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.211 2.608 . . . . 3.06 110.866 177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.48 20.66 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.882 -0.599 . . . . 3.24 111.124 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.621 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 7.4 tpt -49.1 138.2 12.39 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 123.565 0.746 . . . . 1.45 111.601 -172.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 23.4 m -124.66 99.66 6.27 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.295 -0.866 . . . . 0.32 109.061 171.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.911 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -130.92 171.14 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-N 115.276 -0.874 . . . . 0.2 110.889 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 17.5 t -123.35 178.97 4.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.494 -1.23 . . . . 1.29 109.507 -172.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 121' ' ' LYS . 12.7 mptt -56.99 -43.39 81.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.06 0.457 . . . . 3.26 111.295 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 14.1 m120 -83.6 -17.87 40.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.483 -0.326 . . . . 2.17 110.614 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.893 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.2 mt-10 -73.52 -21.61 60.35 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.288 -0.565 . . . . 0.5 111.08 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.688 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -87.87 -26.89 22.54 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.276 -0.97 . . . . 3.06 109.716 174.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 2.1 t -63.05 -30.66 50.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.62 -1.173 . . . . 0.35 111.613 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.754 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.95 -41.97 28.06 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.767 -1.106 . . . . 1.51 109.847 170.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -61.07 -36.43 79.61 Favored 'General case' 0 CA--C 1.472 -2.042 0 CA-C-O 117.389 -1.291 . . . . 0.4 114.27 -172.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.861 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -64.68 -40.53 95.56 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 116.274 -2.17 . . . . 0.32 109.511 175.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 23.4 mt-10 -64.62 -29.02 70.02 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.873 1.32 . . . . 2.51 108.03 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -93.07 -7.73 44.79 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 112.548 -2.115 . . . . 0.33 110.858 -169.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.4 t -122.09 -1.78 9.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.741 0.781 . . . . 0.36 109.853 -173.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 70.88 57.31 0.22 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.796 -1.547 . . . . 2.19 111.746 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.861 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.95 145.02 26.24 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 106.766 -1.568 . . . . 0.27 106.766 178.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.662 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.35 163.68 35.68 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.67 -1.604 . . . . 0.69 106.67 -177.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 147' ' ' VAL . 2.2 pt20 -46.93 159.63 0.1 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.476 1.132 . . . . 1.96 112.828 -176.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 138' ' ' LYS . 3.4 t -149.75 148.59 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.091 0 CA-C-N 113.513 -1.676 . . . . 0.27 111.481 -172.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 m -60.36 -49.61 76.9 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.241 -0.89 . . . . 0.73 111.57 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -157.68 115.29 3.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.047 -1.433 . . . . 0.51 108.861 -176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.781 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -75.99 104.41 6.51 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 122.999 1.381 . . . . 2.71 111.506 -168.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.8 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 2.9 t -157.33 94.12 1.36 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.012 -1.449 . . . . 0.35 109.02 159.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.8 ' HG3' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -152.3 166.26 15.7 Favored Pre-proline 0 CA--C 1.502 -0.882 0 CA-C-N 113.906 -1.497 . . . . 2.38 107.883 171.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -80.95 111.34 2.46 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 CA-C-N 119.84 0.979 . . . . 0.79 109.767 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.98 12.21 68.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.621 -0.8 . . . . 0.38 114.353 172.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 45.8 mt-10 -128.72 131.79 47.93 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.583 -0.895 . . . . 1.49 108.583 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 2.7 m-85 -130.75 174.29 10.09 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.549 -0.861 . . . . 0.3 110.788 -165.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 139' ' ' MET . 5.9 p -111.39 137.66 48.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.905 -0.776 . . . . 0.19 108.905 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.454 HG12 ' CB ' ' A' ' 135' ' ' GLN . 4.0 p -111.06 146.36 16.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 113.353 0.871 . . . . 0.86 113.353 -168.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.666 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.5 tt0 -154.69 174.97 14.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.591 -0.892 . . . . 2.45 108.591 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.48 ' H ' ' HG2' ' A' ' 148' ' ' GLN . . . -64.54 -81.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.94 1.089 . . . . 0.49 113.94 -170.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.903 ' HB3' HD13 ' A' ' 197' ' ' LEU . 78.2 m-20 -84.71 -4.67 59.14 Favored 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 122.239 -0.288 . . . . 1.02 111.185 -174.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.666 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 28.6 p -149.95 134.68 17.65 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.65 -0.82 . . . . 0.94 110.845 177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.581 ' CG2' HD23 ' A' ' 173' ' ' LEU . 8.0 mt -100.57 171.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.565 -1.272 . . . . 0.2 107.565 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 8.6 tt0 -117.11 137.72 52.11 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 106.982 -1.488 . . . . 0.97 106.982 167.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.498 ' CA ' ' HE1' ' A' ' 139' ' ' MET . 1.8 tmt? -135.11 123.55 23.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 118.615 0.643 . . . . 1.32 112.373 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.67 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -67.4 137.09 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.932 -0.576 . . . . 0.33 110.767 174.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -86.06 145.18 27.18 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.905 -0.776 . . . . 3.1 108.905 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -46.37 132.32 7.74 Favored Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.7 0.625 . . . . 4.26 110.668 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 168' ' ' GLN . 7.1 Cg_endo -52.88 154.06 13.76 Favored 'Trans proline' 0 CA--C 1.512 -0.606 0 C-N-CA 122.64 2.226 . . . . 2.01 112.518 -176.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -82.01 116.16 21.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.897 -1.047 . . . . 5.12 112.135 -172.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.37 121.65 29.61 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.334 -1.303 . . . . 5.15 110.242 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 75.0 m-85 -120.45 173.38 3.78 Favored Pre-proline 0 N--CA 1.426 -1.642 0 CA-C-N 115.177 -0.92 . . . . 6.81 110.3 176.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.0 Cg_endo -79.44 -43.79 0.14 Allowed 'Trans proline' 0 N--CA 1.411 -3.359 0 C-N-CA 121.837 1.691 . . . . 8.97 110.601 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -92.16 -1.56 57.08 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 112.756 -2.02 . . . . 10.53 109.899 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -164.31 153.59 13.68 Favored 'General case' 0 C--O 1.203 -1.393 0 CA-C-N 114.313 -1.312 . . . . 7.9 111.807 -172.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.476 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 56.2 mttt -153.73 144.22 22.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 118.227 0.467 . . . . 6.69 110.834 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -157.81 -163.83 1.41 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.482 -0.781 . . . . 5.04 111.983 -172.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -87.02 -153.16 23.78 Favored Glycine 0 C--N 1.317 -0.491 0 CA-C-N 115.767 -0.651 . . . . 2.11 114.449 -169.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.618 ' NE2' ' H ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -99.69 160.77 14.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.563 0.697 . . . . 2.93 111.846 -172.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.524 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t -127.11 147.56 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.389 0 CA-C-N 114.483 -1.235 . . . . 0.48 108.029 170.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.67 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -126.37 144.43 50.83 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.132 0.968 . . . . 1.61 113.308 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 163.09 16.49 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.457 -1.701 . . . . 0.2 110.181 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.404 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 29.0 ttm180 -113.0 118.13 33.97 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 108.46 -0.941 . . . . 3.69 108.46 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -107.32 111.36 23.68 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.677 -1.601 . . . . 0.61 110.604 -164.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.568 ' CG2' HD12 ' A' ' 197' ' ' LEU . 58.7 m -109.21 152.43 25.17 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.736 0.643 . . . . 0.21 112.736 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.911 ' CD1' HD11 ' A' ' 119' ' ' ILE . 13.2 m-85 -118.46 97.87 5.98 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.141 -0.936 . . . . 0.32 112.887 -178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.759 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 33.9 t70 -86.05 97.02 10.06 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.113 0.482 . . . . 0.74 110.83 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 86.07 -118.31 4.82 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.164 -1.017 . . . . 0.27 112.645 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.32 13.55 21.63 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.532 -1.285 . . . . 1.61 107.532 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 30.8 p80 -139.37 160.98 38.56 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.413 -1.267 . . . . 1.28 111.261 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 183' ' ' ILE . 10.2 tp -63.71 139.32 58.76 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.347 -0.842 . . . . 0.22 110.876 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.759 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -92.04 -50.48 5.67 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.414 -1.266 . . . . 0.15 111.462 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.6 t 176.33 177.34 0.25 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.573 -1.194 . . . . 0.28 110.026 -173.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -148.83 134.27 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 105.839 -1.911 . . . . 0.28 105.839 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.745 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 75.0 t -134.02 116.58 23.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 120.162 -0.615 . . . . 0.34 112.236 -171.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -60.1 97.81 0.05 Allowed 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.845 -1.169 . . . . 1.64 107.845 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 85.0 mmm -59.48 -16.12 22.04 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.695 -2.048 . . . . 1.42 112.98 -165.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.524 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.2 mt-10 -72.21 -44.05 63.54 Favored 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 114.499 -1.228 . . . . 0.68 109.791 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -94.4 -33.52 13.12 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.675 -1.602 . . . . 2.36 111.109 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.745 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 5.0 p30 40.02 22.94 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.394 1.627 . . . . 1.8 115.394 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -141.59 -61.04 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.308 -0.245 . . . . 4.13 111.571 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -57.88 -36.3 72.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.03 0.443 . . . . 4.05 110.961 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.487 ' O ' HG13 ' A' ' 184' ' ' VAL . 39.2 t80 -117.14 103.76 10.54 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.38 -0.6 . . . . 1.83 109.38 175.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.613 ' CA ' HG22 ' A' ' 184' ' ' VAL . . . 168.75 158.98 13.35 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.025 -1.559 . . . . 1.84 114.62 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 70.7 m-85 -135.71 -172.89 3.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.503 -0.849 . . . . 4.57 109.281 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -77.4 156.01 31.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.61 0.719 . . . . 6.25 112.064 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.67 164.19 13.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.648 -1.16 . . . . 6.4 110.621 -173.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.903 HD13 ' HB3' ' A' ' 150' ' ' ASN . 1.1 mp -68.03 147.63 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.854 -0.612 . . . . 1.4 111.81 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.507 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 19.0 t70 -161.99 -56.02 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.94 . . . . 3.38 109.443 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 198' ' ' ASP . 60.9 Cg_endo -74.28 125.74 9.92 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.558 1.506 . . . . 4.74 111.561 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 200' ' ' ARG . 1.2 tmm_? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.286 -0.864 . . . . 7.73 110.349 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.179 0.514 . . . . 31.14 109.962 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.65 7.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.76 -0.733 . . . . 30.65 111.684 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -58.03 -38.39 76.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 30.65 110.999 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.178 -0.464 . . . . 29.78 111.477 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -133.81 83.18 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 29.55 111.565 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 49.0 p-80 -158.97 18.3 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 29.87 110.052 175.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 55.8 m80 68.63 104.18 0.05 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.705 -0.68 . . . . 27.89 109.977 -170.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -62.83 -43.37 98.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 26.19 109.972 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 51.83 67.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.565 -0.743 . . . . 26.23 111.308 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -119.31 20.11 12.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.968 -0.56 . . . . 26.64 110.395 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 m 61.76 -164.31 0.25 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.876 0.735 . . . . 24.71 110.066 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.9 t 68.15 106.56 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.176 0.512 . . . . 24.15 111.125 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.26 -29.85 67.96 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.783 -0.722 . . . . 22.66 112.06 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.9 tp -88.12 83.76 6.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 20.88 110.477 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.421 ' N ' ' HD3' ' A' ' 102' ' ' PRO . 8.2 p -151.71 66.03 6.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.983 0.896 . . . . 19.88 110.616 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 12.6 Cg_exo -70.62 -6.46 19.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.047 2.498 . . . . 18.7 112.821 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.604 ' HD3' ' H ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -103.63 2.18 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 18.91 110.209 177.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.47 -22.22 71.19 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 116.013 -0.54 . . . . 15.32 112.581 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.4 t -68.74 -14.31 62.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.83 0.348 . . . . 14.03 110.749 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -90.44 -77.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.106 -0.331 . . . . 12.65 110.106 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 42.9 ttp 51.76 59.71 4.36 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.319 0.58 . . . . 11.98 110.38 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -165.39 142.12 7.5 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.814 -0.708 . . . . 8.1 111.976 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -80.49 72.89 7.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.591 . . . . 9.18 110.42 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.0 ptm -157.95 28.02 0.26 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.949 0.88 . . . . 6.14 109.678 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.81 156.32 42.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.335 -1.302 . . . . 4.84 110.575 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.26 142.14 32.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.004 -0.544 . . . . 4.29 109.855 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 114' ' ' GLU . 5.0 tt -72.42 129.25 37.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.45 -0.944 . . . . 1.69 108.45 174.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.62 ' N ' HD23 ' A' ' 113' ' ' LEU . 43.1 mt-10 -159.07 162.65 25.87 Favored Pre-proline 0 CA--C 1.499 -1.017 0 N-CA-C 107.428 -1.323 . . . . 3.45 107.428 -171.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.487 ' HA ' ' H ' ' A' ' 117' ' ' MET . 57.2 Cg_endo -90.41 99.67 0.27 Allowed 'Trans proline' 0 N--CA 1.419 -2.86 0 C-N-CA 117.177 -1.416 . . . . 3.06 111.991 173.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -112.18 -5.42 14.21 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 102.401 -3.185 . . . . 3.24 102.401 141.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 119' ' ' ILE . 9.1 tpt -82.07 143.96 31.15 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 110.786 -2.916 . . . . 1.45 111.444 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.846 HG23 ' HB3' ' A' ' 179' ' ' HIS . 10.3 m -132.31 102.82 5.91 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.917 -1.038 . . . . 0.32 108.927 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.876 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.3 pt -131.75 171.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-N 114.95 -1.023 . . . . 0.2 111.945 -171.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.837 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 21.1 t -123.93 174.76 7.36 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.57 -1.195 . . . . 1.29 109.39 -172.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -52.2 -42.68 63.72 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.033 0.753 . . . . 3.26 113.033 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 4.8 t30 -85.61 -18.04 34.44 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.397 -0.815 . . . . 2.17 110.202 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.56 -25.07 63.82 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.621 -0.432 . . . . 0.5 111.409 -175.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.668 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -88.72 -25.28 22.41 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.096 -1.442 . . . . 3.06 109.696 175.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.32 -30.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 114.766 -1.107 . . . . 0.35 111.737 -177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.77 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.64 -41.44 26.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.698 -1.137 . . . . 1.51 109.822 170.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.894 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.77 -40.33 83.64 Favored 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 117.598 -1.191 . . . . 0.4 114.167 -174.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.839 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -62.97 -38.22 90.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.35 -2.14 . . . . 0.32 109.273 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' HD23 ' A' ' 128' ' ' LEU . 24.2 mt-10 -66.69 -31.36 71.98 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 122.86 1.314 . . . . 2.51 108.129 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.86 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.8 -7.27 54.76 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 112.491 -2.14 . . . . 0.33 110.711 -169.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.9 t -121.54 -0.47 9.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.36 109.289 -174.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 69.16 55.66 0.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 113.767 -1.56 . . . . 2.19 111.737 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.839 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.17 144.95 26.92 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.582 -1.266 . . . . 0.27 107.582 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.655 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.86 162.45 38.62 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.834 -1.172 . . . . 0.69 107.834 -175.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -47.3 146.94 1.73 Allowed 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 113.349 0.87 . . . . 1.96 113.349 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.8 t -140.73 151.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 CA-C-N 113.968 -1.469 . . . . 0.27 112.066 -172.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -61.06 -50.18 74.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.73 111.937 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.9 ptmt -154.32 115.95 4.16 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.658 -1.155 . . . . 0.51 109.296 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.907 ' HB3' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -77.35 100.58 5.98 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 123.667 1.698 . . . . 2.71 112.106 -166.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.69 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.2 t -158.97 96.37 1.34 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.593 -1.64 . . . . 0.35 109.04 163.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.69 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.4 mmt180 -151.1 169.88 8.62 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.835 -1.543 . . . . 2.38 106.835 170.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.4 111.25 2.33 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 CA-C-N 119.967 1.024 . . . . 0.79 109.874 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.1 22.32 61.23 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.265 -0.969 . . . . 0.38 114.014 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 39.3 mt-10 -137.4 131.03 31.44 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.912 -1.144 . . . . 1.49 107.912 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.912 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -133.08 176.57 8.39 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.912 -0.715 . . . . 0.3 109.847 -167.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.907 HG23 ' HB3' ' A' ' 139' ' ' MET . 16.6 p -108.13 143.48 36.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.608 0.718 . . . . 0.19 111.543 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.633 HG22 ' OH ' ' A' ' 133' ' ' TYR . 55.2 t -106.04 119.93 56.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.268 -1.333 . . . . 0.86 110.976 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 151' ' ' SER . 8.1 tp-100 -101.72 -85.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 2.45 110.436 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.99 -82.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 120.537 0.208 . . . . 0.49 110.745 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.945 ' HB3' HD12 ' A' ' 197' ' ' LEU . 2.2 m-20 -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.588 0.709 . . . . 1.02 109.389 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 47.2 p -138.96 143.08 38.42 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.92 -1.036 . . . . 0.94 110.05 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.638 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.0 mt -104.64 171.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.574 -1.269 . . . . 0.2 107.574 170.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.912 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 16.7 tt0 -128.4 106.84 9.27 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.685 -0.806 . . . . 0.97 110.18 171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.532 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.5 tmt? -110.07 125.96 53.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 1.32 111.713 -167.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -66.93 125.22 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.076 -0.511 . . . . 0.33 109.949 173.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.602 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 19.5 mtp180 -91.14 -176.29 4.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 3.1 110.371 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -64.44 132.02 95.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 110.12 -0.326 . . . . 4.26 110.12 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -54.33 159.87 7.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.569 2.179 . . . . 2.01 112.353 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -94.53 123.67 38.1 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.946 0.879 . . . . 5.12 113.05 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.497 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 1.3 m-20 -130.52 118.79 21.6 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.942 -1.481 . . . . 5.15 110.492 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 44.8 m-85 -121.52 172.14 5.32 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.492 -0.776 . . . . 6.81 109.727 174.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.0 Cg_endo -76.97 -43.24 0.26 Allowed 'Trans proline' 0 N--CA 1.412 -3.283 0 C-N-CA 121.619 1.546 . . . . 8.97 110.572 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -95.35 1.06 54.2 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 112.629 -2.078 . . . . 10.53 109.926 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -162.82 143.9 9.86 Favored 'General case' 0 C--O 1.201 -1.468 0 CA-C-N 114.214 -1.357 . . . . 7.9 112.004 -174.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.497 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 51.9 mttt -151.33 145.46 25.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.967 0.413 . . . . 6.69 110.647 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 4.9 pt-20 -158.36 -166.45 1.93 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.353 -0.84 . . . . 5.04 111.399 -173.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -93.22 -149.35 24.97 Favored Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.405 -0.816 . . . . 2.11 113.568 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -79.67 156.55 27.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.341 0.591 . . . . 2.93 110.74 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.603 HG13 ' HG3' ' A' ' 187' ' ' GLU . 44.6 t -125.49 144.22 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.527 0 CA-C-N 115.18 -0.918 . . . . 0.48 109.178 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 2.2 ppt_? -120.47 143.39 48.54 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 122.59 1.186 . . . . 1.61 113.039 176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.88 160.62 22.33 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 112.981 -1.918 . . . . 0.2 110.638 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -109.38 120.24 41.92 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.097 -1.075 . . . . 3.69 108.097 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 180' ' ' LEU . 0.2 OUTLIER -114.54 110.72 20.25 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.388 -1.733 . . . . 0.61 110.576 -163.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.433 ' CG2' ' HG ' ' A' ' 197' ' ' LEU . 71.1 m -108.38 148.05 30.67 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.093 -0.38 . . . . 0.21 110.946 -173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.876 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -115.82 99.9 7.63 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.034 0.753 . . . . 0.32 113.034 176.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.614 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 11.0 t0 -77.33 92.69 3.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.373 0.606 . . . . 0.74 111.321 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 84.54 -109.78 3.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.131 -1.033 . . . . 0.27 114.2 171.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -110.29 7.8 23.23 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 107.613 -1.255 . . . . 1.61 107.613 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.846 ' HB3' HG23 ' A' ' 118' ' ' THR . 10.3 p-80 -142.29 160.82 39.49 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.071 -1.422 . . . . 1.28 112.1 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 183' ' ' ILE . 7.9 tp -65.61 136.43 56.33 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.165 -0.925 . . . . 0.22 110.978 177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.614 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.29 -53.42 4.85 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.521 -1.218 . . . . 0.15 111.54 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 8.8 t -177.84 176.51 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.314 -0.857 . . . . 0.28 110.382 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.791 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -152.2 118.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 113.895 -1.502 . . . . 0.28 107.274 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.71 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 71.9 t -124.48 123.43 66.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.573 0.583 . . . . 0.34 112.573 -171.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.602 ' OD1' ' HD3' ' A' ' 156' ' ' ARG . 94.3 m-20 -60.98 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 122.194 0.997 . . . . 1.64 108.91 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 88.0 mmm -58.27 -16.49 14.28 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 112.482 -2.145 . . . . 1.42 112.844 -168.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.603 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.8 mt-10 -68.3 -41.64 80.62 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.256 -1.338 . . . . 0.68 109.915 -176.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -112.87 -20.54 11.55 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.651 -1.613 . . . . 2.36 112.542 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.71 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 13.1 p30 41.54 30.26 0.13 Allowed 'General case' 0 C--N 1.349 0.559 0 N-CA-C 114.098 1.147 . . . . 1.8 114.098 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -133.99 -27.98 1.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 4.13 110.997 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -51.02 -54.24 26.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.081 -0.711 . . . . 4.05 109.081 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -116.38 164.17 14.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.371 -1.344 . . . . 1.83 107.371 169.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 176.9 126.41 0.96 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 119.528 -1.32 . . . . 1.84 113.125 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.477 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 29.8 m-85 -137.64 -175.24 4.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.139 -0.53 . . . . 4.57 110.936 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -79.14 164.32 24.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.804 -0.635 . . . . 6.25 110.821 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.657 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -94.4 154.97 17.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.613 -0.721 . . . . 6.4 109.72 177.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.945 HD12 ' HB3' ' A' ' 150' ' ' ASN . 7.0 mt -69.61 163.01 26.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.382 -0.372 . . . . 1.4 110.727 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 199' ' ' PRO . 4.8 m-20 57.11 63.23 5.27 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.635 . . . . 3.38 110.908 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -84.42 50.14 2.92 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.048 2.499 . . . . 4.74 111.174 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.479 -0.772 . . . . 7.73 109.829 -176.934 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.0 mtp . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.945 0.402 . . . . 31.14 111.199 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.67 -49.48 0.92 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.432 -0.667 . . . . 30.65 111.432 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -122.44 -179.79 4.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.438 -0.579 . . . . 30.65 109.438 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.5 m 57.87 59.46 3.16 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.53 0.518 . . . . 29.78 111.088 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -81.22 149.8 28.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.2 -0.455 . . . . 29.55 109.986 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 60.81 72.71 0.51 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.32 0.581 . . . . 29.87 109.671 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -55.75 119.79 6.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.2 -0.909 . . . . 27.89 112.06 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -82.87 57.35 3.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.604 -0.725 . . . . 26.19 109.363 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -129.66 114.15 15.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 26.23 110.338 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -132.36 32.96 3.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.847 -0.615 . . . . 26.64 110.562 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 t -77.08 79.36 3.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.572 . . . . 24.71 109.461 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.2 m -65.99 103.4 0.94 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.453 -0.794 . . . . 24.15 111.311 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.28 -21.09 15.57 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.697 -0.683 . . . . 22.66 112.328 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.3 mm? 54.05 71.9 0.48 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.169 0.509 . . . . 20.88 110.661 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.7 123.16 74.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.777 -0.647 . . . . 19.88 111.089 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.64 71.68 6.77 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.481 2.12 . . . . 18.7 110.995 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 103' ' ' ARG . 12.0 ptp180 -56.76 142.32 40.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.721 -0.672 . . . . 18.91 110.735 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.97 94.35 0.03 OUTLIER Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.644 -0.707 . . . . 15.32 113.209 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 p -160.78 164.04 31.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 14.03 109.259 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.424 ' C ' HG11 ' A' ' 111' ' ' VAL . 39.6 m80 62.01 65.35 0.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.5 0.5 . . . . 12.65 110.492 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.34 22.85 1.5 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.321 0.581 . . . . 11.98 110.339 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.14 41.29 3.03 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.813 -0.63 . . . . 8.1 113.507 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 56.36 23.86 7.75 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.568 0.581 . . . . 9.18 112.568 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -141.82 25.15 1.99 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.597 1.189 . . . . 6.14 109.158 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 2.9 p -143.71 -44.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.329 -1.76 . . . . 4.84 109.018 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.03 120.57 42.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.073 -1.084 . . . . 4.29 108.073 168.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 173' ' ' LEU . 4.7 tt -64.14 113.13 3.34 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.969 -0.752 . . . . 1.69 108.969 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 183' ' ' ILE . 1.2 tm-20 178.68 56.63 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 123.844 0.715 . . . . 3.45 109.157 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 114' ' ' GLU . 15.4 Cg_endo -90.02 178.49 2.24 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.427 2.751 . . . . 3.06 110.685 177.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.46 20.8 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.959 -0.564 . . . . 3.24 111.424 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.621 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 7.3 tpt -52.21 138.87 25.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.656 0.741 . . . . 1.45 111.733 -171.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.859 HG23 ' HB3' ' A' ' 179' ' ' HIS . 17.5 m -128.55 97.09 4.59 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.143 -0.935 . . . . 0.32 109.062 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.5 pt -127.98 172.16 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.202 1.001 . . . . 0.2 111.688 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.835 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 14.7 t -121.27 175.16 6.27 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 113.891 -1.504 . . . . 1.29 109.487 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.627 ' O ' ' HG3' ' A' ' 124' ' ' MET . 96.9 mttt -52.67 -48.93 66.16 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.335 0.397 . . . . 3.26 111.838 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 54.2 m-80 -83.84 -16.21 45.35 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 122.341 -0.224 . . . . 2.17 110.559 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.951 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -69.35 -21.27 63.83 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.451 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.06 -26.96 25.04 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 118.925 -1.11 . . . . 3.06 109.774 176.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 t -62.59 -32.06 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 114.834 -1.076 . . . . 0.35 111.532 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.776 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.85 -40.38 32.78 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.725 -1.125 . . . . 1.51 110.171 170.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -59.79 -38.53 82.17 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 117.469 -1.253 . . . . 0.4 114.364 -174.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.818 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.86 -38.51 91.37 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.247 -2.181 . . . . 0.32 109.181 176.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.505 ' H ' HD22 ' A' ' 128' ' ' LEU . 36.7 mt-10 -64.67 -32.44 74.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 122.893 1.33 . . . . 2.51 107.895 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.66 -6.71 55.9 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.332 -2.213 . . . . 0.33 110.567 -169.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.77 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.5 t -122.11 0.28 9.59 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.351 -0.84 . . . . 0.36 109.258 -174.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 70.12 55.9 0.31 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 113.682 -1.599 . . . . 2.19 111.845 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.818 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.69 146.95 25.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.954 -1.499 . . . . 0.27 106.954 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.575 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -144.17 159.33 42.83 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.109 -1.071 . . . . 0.69 108.109 -178.09 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.4 158.97 0.76 Allowed 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 122.19 0.995 . . . . 1.96 112.116 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -148.67 153.99 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 CA-C-N 113.821 -1.536 . . . . 0.27 111.264 -169.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -60.34 -50.06 75.13 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.937 0.875 . . . . 0.73 111.728 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -157.74 113.8 2.83 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.229 -1.35 . . . . 0.51 108.682 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.957 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.32 105.06 13.08 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.229 1.49 . . . . 2.71 111.339 -166.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -157.49 93.71 1.32 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.303 -1.772 . . . . 0.35 107.969 162.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 23.7 mmt180 -151.35 169.6 9.1 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.447 -1.706 . . . . 2.38 107.813 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 111.4 2.75 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 CA-C-N 119.269 0.775 . . . . 0.79 110.389 165.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.59 19.11 78.4 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.581 -0.819 . . . . 0.38 113.886 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 1.3 mm-40 -129.59 132.2 46.72 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.382 -1.34 . . . . 1.49 107.382 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.807 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.0 OUTLIER -132.6 175.44 9.31 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.258 -0.977 . . . . 0.3 110.413 -169.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.957 HG23 ' HB3' ' A' ' 139' ' ' MET . 12.0 p -111.18 141.9 44.08 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.954 0.883 . . . . 0.19 111.956 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 54.5 t -101.8 119.97 50.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 113.844 -1.526 . . . . 0.86 110.773 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 151' ' ' SER . 64.9 mt-30 -101.99 -78.59 0.53 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.681 -0.236 . . . . 2.45 110.741 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.63 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.717 0.294 . . . . 0.49 111.199 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.685 ' HB3' HD13 ' A' ' 197' ' ' LEU . 84.4 m-20 -89.33 -2.93 58.62 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.84 0.829 . . . . 1.02 109.153 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.572 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 15.4 p -138.16 141.83 40.08 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.779 -1.1 . . . . 0.94 109.636 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.629 ' CG2' HD23 ' A' ' 173' ' ' LEU . 6.9 mt -104.35 170.92 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.103 -1.443 . . . . 0.2 107.103 169.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.807 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.2 tt0 -119.45 139.07 52.64 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.544 -1.651 . . . . 0.97 106.544 166.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.494 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -135.57 127.38 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 118.863 0.756 . . . . 1.32 111.935 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.695 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -71.39 140.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.379 -0.971 . . . . 0.33 108.379 169.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.734 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 30.6 ttp180 -62.3 168.37 3.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.561 -0.903 . . . . 3.1 108.561 175.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 111' ' ' VAL . 21.6 mmm180 -61.98 113.61 9.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 118.454 0.57 . . . . 4.26 110.693 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 168' ' ' GLN . 5.1 Cg_exo -78.55 166.76 23.57 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.143 2.562 . . . . 2.01 111.503 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.96 153.26 45.54 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.841 0.829 . . . . 5.12 112.051 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.664 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 4.2 m-20 -129.39 127.57 41.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.146 -1.388 . . . . 5.15 108.985 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.621 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 42.2 m-85 -119.28 168.79 9.25 Favored Pre-proline 0 N--CA 1.431 -1.413 0 CA-C-O 121.98 0.895 . . . . 6.81 111.433 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.1 Cg_endo -75.52 -41.85 0.53 Allowed 'Trans proline' 0 N--CA 1.414 -3.185 0 C-N-CA 122.094 1.863 . . . . 8.97 110.79 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -91.52 -5.0 54.86 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 112.68 -2.054 . . . . 10.53 109.511 -174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 2.0 m -164.54 139.2 5.47 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.076 -1.42 . . . . 7.9 112.886 -171.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.664 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 53.8 mttt -145.83 141.64 28.09 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.222 0.534 . . . . 6.69 111.711 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -167.77 -165.58 0.66 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.844 -1.071 . . . . 5.04 110.865 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -109.5 -135.53 7.27 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.653 -0.703 . . . . 2.11 111.686 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.734 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 8.1 tp-100 -151.15 172.75 15.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.051 0.929 . . . . 2.93 112.601 -177.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.639 HG11 ' ND2' ' A' ' 185' ' ' ASN . 12.4 t -90.37 148.19 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 113.592 -1.64 . . . . 0.48 108.34 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -119.77 144.81 47.09 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 122.454 1.121 . . . . 1.61 113.223 -179.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -119.49 159.88 23.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 113.296 -1.774 . . . . 0.2 110.24 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.43 ' HA ' ' HG3' ' A' ' 153' ' ' GLU . 24.7 ttm180 -108.93 118.82 37.78 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 122.073 0.94 . . . . 3.69 108.751 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.629 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -110.2 113.33 25.93 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 113.568 -1.651 . . . . 0.61 110.959 -162.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 151' ' ' SER . 63.5 m -112.16 149.14 32.63 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.003 -0.435 . . . . 0.21 112.152 -171.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.967 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -117.84 110.94 18.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.841 -0.618 . . . . 0.32 111.649 175.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.642 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 3.3 t70 -94.35 107.24 19.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.477 -0.783 . . . . 0.74 111.042 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.8 -115.75 4.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.279 -0.962 . . . . 0.27 113.015 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.35 10.82 19.94 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.003 -1.481 . . . . 1.61 107.003 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.859 ' HB3' HG23 ' A' ' 118' ' ' THR . 12.0 p-80 -137.51 160.75 38.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.793 -1.094 . . . . 1.28 112.734 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 183' ' ' ILE . 9.6 tp -63.58 134.96 56.42 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.575 -0.739 . . . . 0.22 110.493 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.642 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -88.69 -49.84 6.61 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.638 -1.164 . . . . 0.15 111.32 -176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.607 HG21 ' O ' ' A' ' 194' ' ' PHE . 5.5 t 177.49 178.47 0.3 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.96 -1.018 . . . . 0.28 110.277 -173.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.794 HD11 HD21 ' A' ' 180' ' ' LEU . 2.0 mp -152.99 124.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 N-CA-C 106.075 -1.824 . . . . 0.28 106.075 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.924 HG22 ' HA2' ' A' ' 193' ' ' GLY . 86.2 t -121.1 121.73 65.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 113.101 0.778 . . . . 0.34 113.101 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.639 ' ND2' HG11 ' A' ' 169' ' ' VAL . 23.6 t-20 -58.94 95.26 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 107.797 -1.186 . . . . 1.64 107.797 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.459 ' HB2' ' HD3' ' A' ' 170' ' ' ARG . 81.4 mmm -62.0 -15.57 45.04 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-N 114.216 -1.356 . . . . 1.42 112.661 -167.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.12 -42.62 55.96 Favored 'General case' 0 N--CA 1.407 -2.598 0 CA-C-N 114.343 -1.299 . . . . 0.68 110.289 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -100.2 -30.39 11.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.379 -1.282 . . . . 2.36 112.039 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.657 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.0 p-10 43.03 20.4 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.665 1.357 . . . . 1.8 114.665 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -136.71 3.87 2.77 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 111.743 0.275 . . . . 4.13 111.743 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.49 -84.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.006 -0.738 . . . . 4.05 109.006 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.62 ' HD1' ' O ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -96.68 100.88 12.42 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.163 -1.051 . . . . 1.83 108.163 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.924 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -146.1 109.16 0.48 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.006 -1.092 . . . . 1.84 113.825 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.607 ' O ' HG21 ' A' ' 182' ' ' THR . 92.5 m-85 -136.47 163.61 30.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.421 -0.585 . . . . 4.57 109.421 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -165.94 102.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.135 0.493 . . . . 6.25 111.113 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.705 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 16.1 mtm-85 -132.12 115.05 15.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.215 -0.661 . . . . 6.4 109.215 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 196' ' ' ARG . 7.3 mt -173.17 -179.16 1.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.863 0.727 . . . . 1.4 109.316 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.537 ' HB2' ' HD3' ' A' ' 199' ' ' PRO . 2.0 m-20 -52.27 -54.32 42.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 123.177 0.298 . . . . 3.38 111.713 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 198' ' ' ASP . 3.5 Cg_endo -86.9 112.9 0.98 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.247 1.965 . . . . 4.74 111.812 177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.688 -0.672 . . . . 7.73 110.568 179.427 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.175 -0.306 . . . . 31.14 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.76 -131.8 10.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.663 -0.779 . . . . 30.65 111.302 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.3 m 61.8 -171.96 0.15 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 30.65 111.497 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.4 t -129.56 124.93 35.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.371 -0.377 . . . . 29.78 111.031 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 65.6 m80 41.63 -97.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.57 1.169 . . . . 29.55 114.005 168.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 10.6 p-80 -101.6 38.79 1.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 29.87 111.956 -169.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.86 -27.11 40.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.253 -0.43 . . . . 27.89 111.961 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -137.2 37.88 2.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.367 0.603 . . . . 26.19 110.374 172.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 92' ' ' HIS . 36.2 m170 -128.57 102.05 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.355 -0.839 . . . . 26.23 109.233 176.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 67.27 177.76 0.24 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.151 0.5 . . . . 26.64 110.791 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.442 ' HB3' HD23 ' A' ' 100' ' ' LEU . 20.2 m -109.95 35.06 3.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.029 0.442 . . . . 24.71 110.552 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 m -71.71 99.8 2.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.741 -0.663 . . . . 24.15 110.475 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.52 56.8 4.1 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.501 -0.857 . . . . 22.66 111.193 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 97' ' ' SER . 4.3 pp -75.13 163.32 27.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.849 0.357 . . . . 20.88 111.058 -177.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.4 125.7 31.75 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.396 . . . . 19.88 110.633 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.68 19.8 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.994 2.463 . . . . 18.7 112.582 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -121.44 167.83 12.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.271 -0.422 . . . . 18.91 110.099 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.99 107.51 1.96 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.784 -0.722 . . . . 15.32 111.403 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 p -66.44 -43.52 85.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.803 0.335 . . . . 14.03 111.18 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -136.5 119.05 15.9 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.684 -0.487 . . . . 12.65 109.684 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 48.3 ttm -81.9 -20.6 38.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.2 0.524 . . . . 11.98 110.062 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -115.77 109.44 2.03 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.917 -0.659 . . . . 8.1 111.808 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -82.07 81.11 8.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.46 0.648 . . . . 9.18 111.612 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.2 ptm -137.8 20.96 2.87 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.384 1.088 . . . . 6.14 108.47 174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.6 -9.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.342 -1.754 . . . . 4.84 110.101 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -143.72 101.16 3.71 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.647 -0.706 . . . . 4.29 110.387 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.768 HD12 ' N ' ' A' ' 114' ' ' GLU . 0.3 OUTLIER -88.09 135.75 33.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.697 -0.683 . . . . 1.69 110.087 178.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.768 ' N ' HD12 ' A' ' 113' ' ' LEU . 52.0 mt-10 -161.78 162.5 20.68 Favored Pre-proline 0 CA--C 1.5 -0.967 0 N-CA-C 107.646 -1.242 . . . . 3.45 107.646 -175.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HG3' ' HA ' ' A' ' 182' ' ' THR . 93.7 Cg_endo -92.61 103.21 0.18 Allowed 'Trans proline' 0 N--CA 1.426 -2.457 0 CA-C-N 119.665 0.916 . . . . 3.06 113.369 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.13 -4.52 14.41 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 102.686 -3.079 . . . . 3.24 102.686 136.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.634 ' HG3' HG23 ' A' ' 119' ' ' ILE . 34.6 tpp -76.08 143.09 41.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 110.903 -2.862 . . . . 1.45 111.879 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.5 m -126.28 100.72 6.42 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.122 -0.945 . . . . 0.32 109.349 176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.885 HD11 ' CD1' ' A' ' 175' ' ' PHE . 4.1 pt -132.14 172.34 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.075 -0.966 . . . . 0.2 111.251 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.857 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 65.4 p -123.97 179.45 4.84 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.697 -1.138 . . . . 1.29 110.403 -169.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 124' ' ' MET . 41.0 mmtm -60.03 -37.81 80.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.273 0.559 . . . . 3.26 110.594 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 15.8 m120 -85.45 -22.22 28.39 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 116.213 -0.449 . . . . 2.17 110.706 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.943 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.5 mt-10 -72.53 -23.16 60.96 Favored 'General case' 0 N--CA 1.418 -2.059 0 C-N-CA 119.805 -0.758 . . . . 0.5 109.74 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.705 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -85.05 -28.12 25.89 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 119.172 -1.011 . . . . 3.06 109.967 178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.29 -32.57 56.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.005 -0.998 . . . . 0.35 111.711 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.782 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.95 -39.96 33.13 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 114.833 -1.076 . . . . 1.51 110.005 171.112 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -58.43 -39.54 80.05 Favored 'General case' 0 CA--C 1.469 -2.155 0 N-CA-C 114.261 1.208 . . . . 0.4 114.261 -174.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.864 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.51 -38.79 92.47 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 116.157 -2.217 . . . . 0.32 109.08 177.253 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.502 ' H ' HD22 ' A' ' 128' ' ' LEU . 21.1 mt-10 -65.7 -31.48 72.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.93 1.348 . . . . 2.51 108.09 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -89.33 -6.98 56.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.472 -2.149 . . . . 0.33 110.556 -170.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.745 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.4 t -122.17 2.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.973 -1.012 . . . . 0.36 109.195 -175.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 68.68 54.85 0.49 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 113.671 -1.604 . . . . 2.19 111.581 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.864 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.0 146.97 25.98 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.647 -1.242 . . . . 0.27 107.647 -177.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.648 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -146.43 161.25 40.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.126 -1.435 . . . . 0.69 107.126 -176.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -52.06 158.23 1.14 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.201 1.001 . . . . 1.96 112.099 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.6 t -148.41 153.58 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 113.826 -1.533 . . . . 0.27 111.48 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.3 m -59.63 -50.89 72.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.038 0.923 . . . . 0.73 111.472 173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.2 ptmt -159.91 116.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.765 -1.561 . . . . 0.51 108.035 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.971 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -82.26 109.07 16.2 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.955 1.36 . . . . 2.71 110.925 -165.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.788 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.7 t -155.71 95.66 1.68 Allowed 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 113.549 -1.659 . . . . 0.35 108.727 162.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.788 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.6 mmt180 -151.17 167.52 12.84 Favored Pre-proline 0 N--CA 1.432 -1.375 0 CA-C-N 113.029 -1.896 . . . . 2.38 107.75 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.44 111.61 2.62 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 N-CA-C 109.644 -0.945 . . . . 0.79 109.644 160.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.77 20.81 59.03 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.657 -0.783 . . . . 0.38 114.393 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 41.2 mt-10 -137.45 131.9 32.6 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.238 -1.023 . . . . 1.49 108.238 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.832 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.6 m-85 -132.12 176.54 8.29 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.827 -0.749 . . . . 0.3 110.036 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 139' ' ' MET . 11.1 p -112.66 139.97 47.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.717 0.77 . . . . 0.19 111.763 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG2' ' OH ' ' A' ' 133' ' ' TYR . 40.1 t -98.44 139.48 20.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.088 -1.415 . . . . 0.86 110.922 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 151' ' ' SER . 64.0 tt0 -125.15 -79.08 0.6 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 121.021 -0.272 . . . . 2.45 111.273 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.54 -81.09 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.75 0.31 . . . . 0.49 111.702 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.464 ' HB3' ' HG ' ' A' ' 197' ' ' LEU . 77.0 m-20 -86.71 -5.4 59.13 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.236 -0.653 . . . . 1.02 109.236 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 13.4 m -143.46 146.54 33.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.275 -0.875 . . . . 0.94 109.348 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.631 HG22 HD23 ' A' ' 173' ' ' LEU . 6.6 mt -107.97 169.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.988 -1.486 . . . . 0.2 106.988 167.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.832 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.1 tt0 -116.19 136.37 53.08 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.521 -1.659 . . . . 0.97 106.521 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.467 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 4.3 ppp? -136.75 125.29 23.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 119.143 0.883 . . . . 1.32 112.692 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -65.99 140.19 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.928 -0.578 . . . . 0.33 110.08 174.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -85.25 176.98 8.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.701 -0.852 . . . . 3.1 108.701 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -65.51 157.52 78.04 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.022 -0.732 . . . . 4.26 109.022 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -67.6 155.94 68.1 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.215 1.277 . . . . 2.01 110.603 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.414 ' HB3' ' HG3' ' A' ' 166' ' ' GLU . 0.6 OUTLIER -99.55 124.23 44.54 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.904 0.859 . . . . 5.12 112.919 -170.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.79 124.07 30.54 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.128 -1.396 . . . . 5.15 111.958 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.598 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 40.6 m-85 -122.33 173.3 4.29 Favored Pre-proline 0 N--CA 1.423 -1.781 0 CA-C-N 115.017 -0.992 . . . . 6.81 111.003 172.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.5 Cg_endo -78.25 -43.7 0.18 Allowed 'Trans proline' 0 N--CA 1.418 -2.955 0 C-N-CA 122.332 2.021 . . . . 8.97 110.417 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.09 -12.95 54.24 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.691 -2.504 . . . . 10.53 109.653 -172.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -163.2 152.37 14.79 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 112.857 -1.974 . . . . 7.9 112.139 -168.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -149.43 146.29 27.37 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 121.159 0.504 . . . . 6.69 110.734 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 159' ' ' PHE . 4.7 pt-20 -155.22 -164.55 1.8 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.917 -1.038 . . . . 5.04 111.198 -171.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -106.71 -135.84 8.08 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 120.786 -0.721 . . . . 2.11 113.298 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -90.16 153.42 20.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.878 0.847 . . . . 2.93 111.227 -173.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.546 HG13 ' HG3' ' A' ' 187' ' ' GLU . 53.8 t -131.94 148.08 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.359 0 CA-C-N 114.273 -1.331 . . . . 0.48 108.467 174.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -128.03 144.1 51.1 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 122.288 1.042 . . . . 1.61 113.427 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -111.68 168.01 9.9 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.333 -1.758 . . . . 0.2 110.664 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.526 ' HB3' ' SD ' ' A' ' 186' ' ' MET . 39.5 ptt180 -118.42 122.34 42.54 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.147 -1.427 . . . . 3.69 107.147 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.69 HD22 HD21 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -117.78 106.82 13.43 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.574 -1.194 . . . . 0.61 110.443 -162.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.659 ' CG2' HD23 ' A' ' 197' ' ' LEU . 51.8 m -105.67 150.81 25.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.67 -0.695 . . . . 0.21 112.328 -169.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.885 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.5 m-85 -115.56 106.66 14.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.32 -1.309 . . . . 0.32 112.71 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.802 ' HA ' HD21 ' A' ' 197' ' ' LEU . 34.5 t70 -95.96 103.18 15.06 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.886 0.374 . . . . 0.74 111.173 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 80.67 -118.44 4.65 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.259 -0.972 . . . . 0.27 112.602 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.31 12.82 21.65 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 106.578 -1.638 . . . . 1.61 106.578 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.685 ' HB3' HG23 ' A' ' 118' ' ' THR . 25.4 p80 -133.8 161.05 35.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.546 -1.207 . . . . 1.28 111.694 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 183' ' ' ILE . 7.6 tp -69.14 135.35 50.56 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.706 -1.134 . . . . 0.22 110.423 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.561 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -85.78 -50.87 6.81 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 114.289 -1.323 . . . . 0.15 110.946 -177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 194' ' ' PHE . 6.1 t -179.08 177.09 0.83 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.065 -0.97 . . . . 0.28 110.727 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 180' ' ' LEU . 2.8 mp -150.18 121.54 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 106.488 -1.671 . . . . 0.28 106.488 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.756 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 72.1 t -131.63 122.18 49.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 112.563 0.579 . . . . 0.34 112.563 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -59.1 99.11 0.05 OUTLIER 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.001 -1.111 . . . . 1.64 108.001 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 172' ' ' ARG . 82.4 mtp -55.6 -22.9 24.41 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 112.606 -2.088 . . . . 1.42 112.179 -169.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.7 mt-10 -66.47 -45.69 78.84 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.098 -1.41 . . . . 0.68 110.603 -177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.71 -20.0 13.76 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.399 -1.273 . . . . 2.36 111.668 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.756 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 8.6 p30 36.16 46.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.581 0.956 . . . . 1.8 113.581 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -161.64 -26.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.117 -0.947 . . . . 4.13 110.029 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -47.81 -51.9 20.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.62 -0.718 . . . . 4.05 111.34 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.12 -78.86 0.52 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.473 -0.936 . . . . 1.83 108.473 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.641 ' H ' HG22 ' A' ' 184' ' ' VAL . . . 66.82 101.0 0.02 OUTLIER Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.306 -0.861 . . . . 1.84 114.849 169.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 182' ' ' THR . 64.7 m-85 -133.9 -174.41 3.53 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.985 -0.746 . . . . 4.57 108.985 172.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.2 143.97 36.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.175 0.512 . . . . 6.25 111.262 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -101.19 160.77 14.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.615 -0.72 . . . . 6.4 110.466 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.3 OUTLIER -70.57 135.15 48.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.646 -0.706 . . . . 1.4 111.878 -177.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.55 119.88 75.55 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.836 -0.62 . . . . 3.38 109.58 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.2 132.68 40.01 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.58 2.187 . . . . 4.74 112.149 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.522 -0.751 . . . . 7.73 110.332 -178.973 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.642 0.258 . . . . 31.14 110.685 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.15 -75.59 2.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.914 -0.66 . . . . 30.65 112.069 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 p -148.81 -58.84 0.22 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.16 0.505 . . . . 30.65 109.912 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.5 m -150.81 166.49 30.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 29.78 109.96 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 68.03 109.72 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.888 0.742 . . . . 29.55 111.896 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -62.59 -40.87 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.809 -0.632 . . . . 29.87 109.808 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -96.07 103.06 14.93 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.35 -0.611 . . . . 27.89 109.35 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 2.7 t60 -73.91 145.13 45.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.151 -0.685 . . . . 26.19 109.151 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 94' ' ' HIS . 93.3 m-70 70.34 172.53 0.31 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.633 0.583 . . . . 26.23 110.324 -172.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 62.51 80.72 0.22 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.237 -0.438 . . . . 26.64 110.017 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.1 t 60.59 42.5 13.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.541 0.686 . . . . 24.71 110.151 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -110.19 30.77 6.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.634 -0.712 . . . . 24.15 109.59 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.37 102.65 0.9 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.573 -0.74 . . . . 22.66 111.826 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.94 131.04 35.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.097 -0.334 . . . . 20.88 110.097 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.33 112.75 36.01 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.863 -0.421 . . . . 19.88 109.863 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.63 101.92 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.793 2.328 . . . . 18.7 112.322 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.64 117.51 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.149 -0.478 . . . . 18.91 109.922 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.16 166.0 47.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.85 -0.69 . . . . 15.32 112.963 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 t 63.59 48.31 3.43 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.361 0.601 . . . . 14.03 111.05 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -109.22 33.83 4.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.49 0.662 . . . . 12.65 109.217 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -125.25 27.95 6.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.497 -0.774 . . . . 11.98 109.924 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.68 177.16 32.15 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.534 -0.757 . . . . 8.1 111.514 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.432 ' HB3' ' NE ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER 59.78 43.33 15.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.03 0.443 . . . . 9.18 110.899 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -100.46 13.41 34.64 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.161 1.458 . . . . 6.14 108.201 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.9 p -82.52 -17.64 11.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 111.772 -2.467 . . . . 4.84 108.902 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -113.01 156.26 23.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.901 -1.045 . . . . 4.29 109.091 176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 114' ' ' GLU . 2.7 tt -80.62 154.44 27.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.037 -0.529 . . . . 1.69 111.855 -169.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.732 ' N ' HD23 ' A' ' 113' ' ' LEU . 31.2 tt0 -179.53 151.88 0.63 Allowed Pre-proline 0 CA--C 1.511 -0.547 0 N-CA-C 107.518 -1.29 . . . . 3.45 107.518 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.613 ' HD3' HD13 ' A' ' 183' ' ' ILE . 78.2 Cg_endo -91.03 103.46 0.26 Allowed 'Trans proline' 0 N--CA 1.431 -2.204 0 CA-C-N 121.238 1.478 . . . . 3.06 113.627 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -111.92 -4.7 14.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 103.118 -2.919 . . . . 3.24 103.118 138.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.602 ' HG3' HG23 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -78.01 139.7 39.14 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 111.107 -2.77 . . . . 1.45 112.028 -162.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 179' ' ' HIS . 16.5 m -126.82 101.56 6.65 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.774 -1.103 . . . . 0.32 108.938 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 175' ' ' PHE . 6.2 pt -131.01 172.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 122.374 1.083 . . . . 0.2 112.452 -172.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.84 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 7.4 m -111.9 171.32 7.57 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.547 -1.66 . . . . 1.29 110.031 -173.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.623 ' O ' ' HG3' ' A' ' 124' ' ' MET . 63.9 mttm -49.27 -54.49 16.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.093 0.473 . . . . 3.26 111.885 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 20.9 t-20 -82.51 -15.81 51.04 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 109.956 -0.387 . . . . 2.17 109.956 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -64.58 -24.88 67.74 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.149 -0.621 . . . . 0.5 110.19 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.763 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.59 -28.36 24.89 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.327 -1.349 . . . . 3.06 109.769 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.18 -32.69 55.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.453 1.12 . . . . 0.35 111.684 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -78.57 -42.35 29.43 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.493 -1.23 . . . . 1.51 109.917 169.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -60.41 -38.51 84.26 Favored 'General case' 0 CA--C 1.463 -2.399 0 CA-C-O 117.429 -1.272 . . . . 0.4 114.101 -173.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD12 HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -62.47 -40.93 98.23 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 116.329 -2.148 . . . . 0.32 108.717 177.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.651 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.4 mm-40 -66.87 -32.24 73.37 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.098 1.427 . . . . 2.51 108.589 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.98 -7.53 59.11 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 111.911 -2.404 . . . . 0.33 110.296 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.0 t -121.46 1.71 10.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.214 1.007 . . . . 0.36 108.744 -176.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 70.95 54.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 113.238 -1.801 . . . . 2.19 112.109 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -151.65 143.27 23.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.202 -1.407 . . . . 0.27 107.202 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -143.2 162.38 35.75 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.088 -1.449 . . . . 0.69 107.088 -178.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -52.39 158.28 1.25 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.232 1.015 . . . . 1.96 112.059 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -147.04 152.32 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 CA-C-N 114.002 -1.454 . . . . 0.27 111.903 -168.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.5 m -59.61 -49.65 76.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.958 0.885 . . . . 0.73 111.544 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -158.54 113.55 2.58 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.982 -1.463 . . . . 0.51 108.627 -177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.003 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -82.78 106.18 14.41 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.851 1.31 . . . . 2.71 111.056 -168.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.805 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.7 t -157.45 93.94 1.34 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.942 -1.481 . . . . 0.35 109.171 162.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.805 ' HD3' ' O ' ' A' ' 140' ' ' THR . 13.0 mmt180 -152.15 170.0 8.66 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 113.145 -1.843 . . . . 2.38 107.779 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -81.88 111.71 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 CA-C-N 119.755 0.948 . . . . 0.79 110.299 162.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.64 72.85 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.575 -0.821 . . . . 0.38 114.345 172.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.434 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 3.2 mm-40 -127.78 130.84 49.39 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 106.799 -1.556 . . . . 1.49 106.799 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.778 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.5 m-85 -133.97 176.71 8.33 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.868 -1.133 . . . . 0.3 110.638 -168.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 1.003 HG23 ' HB3' ' A' ' 139' ' ' MET . 15.3 p -112.86 139.86 48.13 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.657 0.742 . . . . 0.19 111.799 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -98.65 141.37 16.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.097 -1.411 . . . . 0.86 111.065 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.599 ' HB3' ' O ' ' A' ' 151' ' ' SER . 10.0 tt0 -124.95 -78.73 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.833 -0.167 . . . . 2.45 110.956 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.76 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.612 0.244 . . . . 0.49 111.183 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.883 ' HB3' HD13 ' A' ' 197' ' ' LEU . 85.8 m-20 -81.72 -1.19 46.14 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.324 -0.621 . . . . 1.02 109.324 175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 148' ' ' GLN . 15.1 m -140.63 144.73 35.92 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.69 -0.686 . . . . 0.94 110.045 172.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.772 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -106.88 172.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.728 -1.212 . . . . 0.2 107.728 169.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 13.0 tt0 -118.87 135.2 54.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.512 -1.662 . . . . 0.97 106.512 166.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.485 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -136.19 127.11 27.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.111 0.868 . . . . 1.32 111.893 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.3 OUTLIER -63.66 128.18 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.33 110.813 176.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 169' ' ' VAL . 34.7 ttt180 -70.62 153.53 42.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.406 -0.815 . . . . 3.1 110.558 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.432 ' NE ' ' HB3' ' A' ' 109' ' ' ARG . 56.5 mtt85 -49.08 118.83 8.0 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.503 -0.771 . . . . 4.26 110.716 174.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.603 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 18.0 Cg_endo -63.02 175.28 2.54 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.785 2.323 . . . . 2.01 112.967 176.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -90.04 125.55 35.45 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 5.12 109.689 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.462 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 1.9 m-20 -120.67 130.71 54.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.781 -0.645 . . . . 5.15 112.062 -169.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 1.4 m-30 -119.5 168.37 10.22 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 115.472 -0.785 . . . . 6.81 109.822 169.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.1 Cg_endo -74.47 -44.59 0.39 Allowed 'Trans proline' 0 N--CA 1.414 -3.155 0 C-N-CA 121.963 1.776 . . . . 8.97 110.542 -176.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.44 -6.64 56.33 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.469 -2.15 . . . . 10.53 109.544 -173.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.8 m -164.28 140.09 6.11 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.133 -1.394 . . . . 7.9 112.617 -170.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.462 ' HD3' ' OD1' ' A' ' 160' ' ' ASP . 71.5 mttt -142.97 135.6 27.66 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-O 121.145 0.498 . . . . 6.69 111.607 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -174.7 -163.93 0.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.75 -1.113 . . . . 5.04 111.442 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 77.4 147.06 2.64 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.317 -0.856 . . . . 2.11 112.933 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -149.08 143.0 25.76 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.453 0.644 . . . . 2.93 110.45 170.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.619 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.8 t -140.03 147.28 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 N-CA-C 107.986 -1.116 . . . . 0.48 107.986 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -125.31 144.4 50.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 122.337 1.065 . . . . 1.61 113.862 177.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -114.69 164.92 13.38 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 113.162 -1.836 . . . . 0.2 110.737 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -118.46 122.78 43.57 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.815 -1.18 . . . . 3.69 107.815 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 180' ' ' LEU . 0.1 OUTLIER -116.75 121.24 41.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 113.922 -1.49 . . . . 0.61 110.575 -161.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.523 ' CG2' HD12 ' A' ' 197' ' ' LEU . 54.3 m -114.62 151.83 32.85 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.307 0.484 . . . . 0.21 112.307 -170.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.859 ' CD1' HD11 ' A' ' 119' ' ' ILE . 18.4 m-85 -116.16 100.08 7.68 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.747 -1.115 . . . . 0.32 113.375 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.641 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 27.1 t70 -92.22 99.38 12.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.74 111.325 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.69 -113.72 3.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 119.954 -1.117 . . . . 0.27 113.948 172.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.74 8.07 20.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.016 -1.475 . . . . 1.61 107.016 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.802 ' HB3' HG23 ' A' ' 118' ' ' THR . 20.9 p80 -138.6 161.7 36.45 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.025 -1.443 . . . . 1.28 111.786 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.81 HD21 HD11 ' A' ' 183' ' ' ILE . 8.7 tp -67.41 137.28 55.81 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 114.705 -1.134 . . . . 0.22 110.464 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.641 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.33 -49.67 7.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.572 -1.195 . . . . 0.15 111.44 -175.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 194' ' ' PHE . 7.6 t 179.46 177.92 0.55 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.195 -0.911 . . . . 0.28 110.277 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.81 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -153.02 128.02 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 105.767 -1.938 . . . . 0.28 105.767 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.856 HG22 ' HA2' ' A' ' 193' ' ' GLY . 84.0 t -129.58 118.11 44.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 120.172 -0.611 . . . . 0.34 112.146 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.621 HD22 ' HB2' ' A' ' 171' ' ' ALA . 11.2 m120 -60.5 96.58 0.04 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.554 -1.276 . . . . 1.64 107.554 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 77.8 mmm -56.85 -19.07 15.48 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-N 113.157 -1.838 . . . . 1.42 112.971 -166.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.619 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.1 mt-10 -73.32 -43.18 61.33 Favored 'General case' 0 N--CA 1.404 -2.766 0 CA-C-N 114.342 -1.299 . . . . 0.68 109.961 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -91.93 -34.14 14.6 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.681 -1.599 . . . . 2.36 111.174 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.671 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 9.6 p30 35.48 37.34 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 115.216 1.561 . . . . 1.8 115.216 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -146.9 -62.28 0.29 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.948 -0.47 . . . . 4.13 111.445 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.94 -43.81 97.77 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.254 0.55 . . . . 4.05 110.409 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 12.1 t80 -98.87 59.96 1.22 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.564 -0.744 . . . . 1.83 108.998 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.856 ' HA2' HG22 ' A' ' 184' ' ' VAL . . . -139.51 143.93 14.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.331 -0.938 . . . . 1.84 113.83 -174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' HB2' ' OG1' ' A' ' 182' ' ' THR . 77.9 m-85 -141.08 -171.17 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.104 0.562 . . . . 4.57 110.216 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -76.13 171.81 13.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 6.25 112.044 -170.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -134.64 164.07 28.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.528 -0.76 . . . . 6.4 111.124 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.883 HD13 ' HB3' ' A' ' 150' ' ' ASN . 1.1 mp -68.29 170.35 8.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.533 0.568 . . . . 1.4 112.533 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 52.72 73.7 0.9 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 114.878 -1.055 . . . . 3.38 111.78 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.86 -38.02 94.13 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.815 2.343 . . . . 4.74 112.035 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.96 -0.564 . . . . 7.73 110.547 179.818 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.879 -0.415 . . . . 31.14 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.2 63.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.4 -0.68 . . . . 30.65 111.4 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.0 m -63.71 115.81 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.661 0.267 . . . . 30.65 110.904 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.0 m 70.08 -57.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.58 0.752 . . . . 29.78 111.665 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -94.52 69.61 3.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 29.55 110.476 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -87.98 96.54 10.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.321 0.582 . . . . 29.87 110.529 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -112.56 13.58 20.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.02 -0.537 . . . . 27.89 110.774 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 65.9 18.97 11.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.503 -0.771 . . . . 26.19 110.712 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -114.73 123.12 48.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 26.23 110.358 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -145.22 127.6 15.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.745 -0.661 . . . . 26.64 109.876 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.4 p -78.61 65.22 3.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.532 0.682 . . . . 24.71 111.396 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 p -84.3 141.56 30.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.569 -0.742 . . . . 24.15 110.048 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.76 -171.46 19.14 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.663 -0.78 . . . . 22.66 111.676 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.7 tp 58.85 49.32 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 20.88 110.243 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 41.8 t -75.16 -46.45 4.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 19.88 111.02 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 3.0 Cg_endo -81.25 131.39 7.65 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.14 1.893 . . . . 18.7 111.358 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -80.25 -8.05 59.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.995 0.426 . . . . 18.91 110.703 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.45 34.05 5.36 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.885 -0.598 . . . . 15.32 111.803 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.8 p -84.28 -30.17 25.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.848 0.356 . . . . 14.03 111.516 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -84.59 -27.23 27.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.767 0.318 . . . . 12.65 110.828 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -19.28 34.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.151 0.5 . . . . 11.98 109.792 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.64 42.62 2.29 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.669 -0.696 . . . . 8.1 111.682 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -95.18 47.12 1.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.897 -0.779 . . . . 9.18 108.897 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.5 ptm -162.55 30.22 0.11 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.729 0.776 . . . . 6.14 110.302 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.43 44.03 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.722 -1.127 . . . . 4.84 110.579 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -118.95 175.42 5.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.559 -0.746 . . . . 4.29 110.12 -178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HG ' HD13 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -135.18 152.42 51.57 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.035 -0.357 . . . . 1.69 110.035 -179.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.592 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 5.1 mp0 -126.13 -178.08 0.68 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.808 . . . . 3.45 113.183 -166.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 114' ' ' GLU . 27.4 Cg_exo -42.58 -174.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.712 3.608 . . . . 3.06 114.785 165.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -47.59 28.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 118.312 2.708 . . . . 3.24 118.312 -165.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.933 ' O ' ' HB2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -40.32 107.59 0.07 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 122.477 1.132 . . . . 1.45 111.616 179.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.774 HG23 ' HB3' ' A' ' 179' ' ' HIS . 24.7 m -78.59 106.73 10.76 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.861 -1.063 . . . . 0.32 110.455 -172.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.916 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.0 pt -137.2 172.25 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.675 -1.148 . . . . 0.2 110.853 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.853 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.5 t -121.63 173.33 7.5 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.191 -1.368 . . . . 1.29 109.482 -172.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 124' ' ' MET . 59.0 tttm -51.51 -48.62 62.89 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.782 0.325 . . . . 3.26 111.645 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.425 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 28.5 t-20 -82.4 -18.24 42.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.844 -0.428 . . . . 2.17 109.844 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.886 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.3 mt-10 -68.8 -24.32 64.39 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 119.927 -0.709 . . . . 0.5 109.785 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.774 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.98 -29.07 23.82 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 118.337 -1.345 . . . . 3.06 109.598 177.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.81 -32.56 54.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.259 1.028 . . . . 0.35 112.052 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.763 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -78.04 -43.44 29.31 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.607 -1.178 . . . . 1.51 109.68 169.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.89 ' HA ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -61.29 -37.28 82.62 Favored 'General case' 0 CA--C 1.461 -2.449 0 CA-C-O 117.539 -1.219 . . . . 0.4 113.929 -172.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -63.34 -41.13 98.85 Favored 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 116.211 -2.196 . . . . 0.32 108.832 176.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.673 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 62.7 mm-40 -67.47 -31.03 70.9 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.924 1.345 . . . . 2.51 108.577 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -84.6 -7.94 59.07 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 111.964 -2.38 . . . . 0.33 110.011 -173.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.5 t -121.98 1.26 9.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.149 -0.932 . . . . 0.36 108.872 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 72.94 55.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.62 -1.627 . . . . 2.19 112.466 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.15 143.76 23.52 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 106.551 -1.648 . . . . 0.27 106.551 179.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.703 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -142.85 159.89 41.37 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 106.833 -1.543 . . . . 0.69 106.833 -174.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -48.05 145.96 2.81 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 122.11 0.957 . . . . 1.96 112.559 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.5 t -136.08 152.85 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.483 0 CA-C-N 113.773 -1.558 . . . . 0.27 111.63 -173.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.7 m -60.48 -49.81 76.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 115.359 -0.837 . . . . 0.73 111.591 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.5 ptmt -156.9 115.74 3.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.207 -1.36 . . . . 0.51 109.099 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.849 ' HB3' HG23 ' A' ' 146' ' ' THR . 2.4 ppp? -77.69 103.11 7.43 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 123.255 1.502 . . . . 2.71 110.917 -168.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.813 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.0 t -158.65 92.21 1.11 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.466 -1.697 . . . . 0.35 108.936 158.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.813 ' HD3' ' O ' ' A' ' 140' ' ' THR . 12.9 mmt180 -152.51 149.5 22.81 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 113.749 -1.569 . . . . 2.38 106.942 174.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.73 110.59 2.15 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 CA-C-N 120.454 1.198 . . . . 0.79 109.821 169.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.06 59.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.534 -0.841 . . . . 0.38 114.222 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 33.8 mt-10 -138.64 131.88 30.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.647 -1.242 . . . . 1.49 107.647 172.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.859 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -132.7 176.14 8.71 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.558 -0.857 . . . . 0.3 110.691 -166.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.849 HG23 ' HB3' ' A' ' 139' ' ' MET . 10.4 p -112.6 139.46 48.18 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.91 0.862 . . . . 0.19 112.038 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.0 t -100.01 139.66 21.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 0.86 111.201 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.614 ' HB2' ' O ' ' A' ' 151' ' ' SER . 56.3 mt-30 -124.12 -94.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.543 -0.299 . . . . 2.45 110.858 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.89 -77.76 0.07 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.729 0.3 . . . . 0.49 111.184 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.18 -4.44 59.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 121.131 0.491 . . . . 1.02 109.704 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 5.6 m -145.43 146.3 31.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.828 -0.623 . . . . 0.94 109.845 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.709 HD11 HD12 ' A' ' 128' ' ' LEU . 4.3 mt -106.36 165.9 3.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.316 -1.365 . . . . 0.2 107.316 167.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.859 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 7.1 tt0 -115.57 129.02 56.38 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.255 -1.387 . . . . 0.97 107.255 169.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.452 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.86 124.93 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 118.613 0.642 . . . . 1.32 112.393 -177.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.2 OUTLIER -68.37 136.05 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 120.865 0.365 . . . . 0.33 110.17 173.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -86.42 139.05 31.28 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.217 -1.031 . . . . 3.1 108.217 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 157' ' ' ARG . 12.8 ptt180 -47.61 139.43 8.54 Favored Pre-proline 0 C--O 1.235 0.303 0 O-C-N 123.527 0.517 . . . . 4.26 110.553 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.78 149.75 7.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.172 2.581 . . . . 2.01 113.201 -173.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -90.16 131.46 35.99 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 114.789 -1.096 . . . . 5.12 113.601 -167.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.42 ' OD1' ' HD3' ' A' ' 165' ' ' LYS . 2.1 m-20 -129.54 121.65 27.6 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.469 -1.696 . . . . 5.15 110.108 174.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.63 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 61.2 m-85 -120.72 172.02 5.2 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 115.628 -0.715 . . . . 6.81 109.896 172.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 2.3 Cg_endo -77.61 -44.5 0.18 Allowed 'Trans proline' 0 N--CA 1.409 -3.458 0 C-N-CA 121.471 1.448 . . . . 8.97 110.403 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.11 0.16 55.68 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.589 -2.096 . . . . 10.53 109.939 -174.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 1.3 m -163.94 149.35 10.77 Favored 'General case' 0 C--O 1.201 -1.485 0 CA-C-N 114.157 -1.383 . . . . 7.9 111.653 -172.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 56.8 mttt -151.54 143.08 23.57 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 120.825 0.345 . . . . 6.69 110.232 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.407 ' HB2' ' H ' ' A' ' 167' ' ' GLY . 5.7 pt-20 -156.03 -164.85 1.79 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.617 -0.72 . . . . 5.04 112.844 -169.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 166' ' ' GLU . . . -93.88 -137.53 8.6 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.053 -0.976 . . . . 2.11 113.297 -171.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -97.39 151.58 19.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.743 0.782 . . . . 2.93 111.587 -171.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.577 HG13 ' HG3' ' A' ' 187' ' ' GLU . 46.8 t -133.69 147.77 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 CA-C-N 114.285 -1.325 . . . . 0.48 108.787 174.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.46 145.8 49.3 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.469 1.128 . . . . 1.61 113.218 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -113.04 167.59 10.4 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.084 -1.871 . . . . 0.2 110.807 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 45.2 ttt180 -117.97 109.43 16.48 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 107.414 -1.328 . . . . 3.69 107.414 176.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -100.0 112.34 24.63 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.529 -1.669 . . . . 0.61 109.665 -170.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.58 ' CG2' HD23 ' A' ' 197' ' ' LEU . 86.5 m -109.06 150.46 27.78 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.541 0.571 . . . . 0.21 112.541 -168.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.916 ' CD1' HD11 ' A' ' 119' ' ' ILE . 11.5 m-85 -115.14 114.66 25.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 114.43 -1.259 . . . . 0.32 111.88 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.65 ' HA ' HD21 ' A' ' 197' ' ' LEU . 20.6 t70 -99.67 96.09 7.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 0.74 110.7 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.11 -115.49 4.03 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.268 -0.968 . . . . 0.27 113.511 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.75 11.09 22.63 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.681 -1.6 . . . . 1.61 106.681 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.774 ' HB3' HG23 ' A' ' 118' ' ' THR . 28.2 p80 -141.06 161.03 38.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.229 -1.351 . . . . 1.28 111.644 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.933 ' HB2' ' O ' ' A' ' 117' ' ' MET . 7.0 tp -64.81 144.39 57.29 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.309 -0.859 . . . . 0.22 111.654 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.468 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -94.1 -50.56 5.24 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 114.193 -1.367 . . . . 0.15 111.544 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.3 t 175.3 178.18 0.16 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.28 109.513 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 180' ' ' LEU . 3.2 mp -145.55 129.13 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.875 -1.528 . . . . 0.28 106.875 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.834 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 67.6 t -133.01 116.66 26.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.66 0.615 . . . . 0.34 112.66 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.452 ' ND2' ' HB2' ' A' ' 171' ' ' ALA . 10.9 m120 -60.8 97.74 0.06 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.333 1.063 . . . . 1.64 108.17 171.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 84.1 mtp -56.29 -22.7 31.87 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 112.168 -2.287 . . . . 1.42 112.951 -165.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.577 ' HG3' HG13 ' A' ' 169' ' ' VAL . 3.1 mt-10 -66.49 -43.5 85.2 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 114.721 -1.127 . . . . 0.68 110.639 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -98.48 -30.86 12.29 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.152 -1.385 . . . . 2.36 110.813 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.834 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 2.1 t30 36.65 55.54 1.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.474 0.916 . . . . 1.8 113.474 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -165.92 -65.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.56 -0.291 . . . . 4.13 110.724 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' A' ' 191' ' ' GLN . 6.0 tp60 -80.11 60.76 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.422 0.63 . . . . 4.05 110.402 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -177.39 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.179 -0.919 . . . . 1.83 109.553 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.538 ' HA3' HG22 ' A' ' 184' ' ' VAL . . . -178.58 176.21 47.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.83 -0.7 . . . . 1.84 112.375 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.8 122.57 10.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.388 -0.967 . . . . 4.57 108.388 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -103.53 117.76 35.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.411 0.624 . . . . 6.25 111.708 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -135.4 119.03 17.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.561 -0.745 . . . . 6.4 109.152 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -147.38 142.35 26.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.831 0.348 . . . . 1.4 111.182 -175.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.44 144.22 73.83 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.393 -0.595 . . . . 3.38 109.393 171.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.53 -11.33 31.23 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.268 2.645 . . . . 4.74 114.43 -170.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 200' ' ' ARG . 40.2 mtm180 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.513 -0.756 . . . . 7.73 110.689 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.686 0.279 . . . . 31.14 111.063 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.3 33.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.555 -0.831 . . . . 30.65 112.213 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.1 m -86.55 177.64 7.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.456 -0.201 . . . . 30.65 110.456 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.3 m 61.09 39.21 16.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.06 0.457 . . . . 29.78 111.059 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -98.48 142.03 30.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.358 -0.383 . . . . 29.55 110.446 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -55.57 -63.22 1.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.18 0.437 . . . . 29.87 112.18 -171.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -86.49 121.32 28.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.946 -0.57 . . . . 27.89 110.437 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -83.57 2.62 36.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.152 -0.476 . . . . 26.19 111.325 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -126.12 29.45 5.85 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.96 -0.756 . . . . 26.23 108.96 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.8 m80 69.98 157.83 0.17 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.244 -0.889 . . . . 26.64 111.211 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 m -100.08 40.95 1.2 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.083 -0.508 . . . . 24.71 110.09 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.0 m -63.47 -31.36 72.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 24.15 111.795 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.99 -10.81 74.58 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.561 -0.828 . . . . 22.66 112.459 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' C ' ' HD2' ' A' ' 102' ' ' PRO . 2.8 mm? -100.9 -41.89 6.65 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.702 -0.293 . . . . 20.88 111.28 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.636 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 10.6 p -58.71 -33.0 14.53 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 114.728 1.381 . . . . 19.88 114.728 -172.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 10.9 Cg_endo -54.31 -32.79 73.28 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 121.973 1.782 . . . . 18.7 113.384 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -120.64 -24.11 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 18.91 111.582 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.88 -101.44 2.06 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.762 -0.935 . . . . 15.32 110.762 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.1 m 54.44 53.08 11.32 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.918 0.422 . . . . 14.03 111.538 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -67.53 -50.56 58.09 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.873 -0.788 . . . . 12.65 108.873 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 84.1 mmm 50.32 64.53 1.76 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.334 -0.848 . . . . 11.98 111.413 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -133.18 120.7 2.66 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.451 -0.88 . . . . 8.1 112.841 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.448 ' HD2' ' OG1' ' A' ' 131' ' ' THR . 6.1 tpm_? -84.54 60.36 6.02 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.422 0.63 . . . . 9.18 109.68 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -121.55 18.71 11.26 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 122.588 1.185 . . . . 6.14 108.615 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.79 147.2 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 112.982 -1.917 . . . . 4.84 109.483 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -65.12 155.66 34.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.206 -0.452 . . . . 4.29 111.01 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.782 HD23 ' HD3' ' A' ' 115' ' ' PRO . 3.1 tt -101.6 113.21 26.15 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.021 -0.733 . . . . 1.69 109.021 177.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.747 ' HA ' HD13 ' A' ' 183' ' ' ILE . 7.3 tt0 -178.2 50.69 0.05 OUTLIER Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.797 0.685 . . . . 3.45 110.208 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.782 ' HD3' HD23 ' A' ' 113' ' ' LEU . 7.8 Cg_endo -89.72 176.31 2.91 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 122.812 2.341 . . . . 3.06 111.413 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.48 21.24 0.14 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.521 -0.763 . . . . 3.24 109.743 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.792 ' HG3' HG23 ' A' ' 119' ' ' ILE . 43.2 tpp -46.57 141.66 3.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.49 1.116 . . . . 1.45 112.474 -172.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.807 HG23 ' HB3' ' A' ' 179' ' ' HIS . 22.7 m -125.44 97.39 5.17 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.081 -0.963 . . . . 0.32 108.983 175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.868 HD11 ' CD1' ' A' ' 175' ' ' PHE . 7.6 pt -126.53 171.81 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 122.097 0.951 . . . . 0.2 111.283 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.859 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 19.4 t -114.05 170.2 8.45 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.831 -1.532 . . . . 1.29 109.319 -170.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -52.66 -48.75 66.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 3.26 111.566 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 46.1 m-80 -83.86 -15.39 48.32 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 116.669 -0.241 . . . . 2.17 110.616 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.95 ' O ' HD12 ' A' ' 127' ' ' LEU . 2.6 mt-10 -65.98 -24.14 66.72 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.277 -0.569 . . . . 0.5 110.471 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -86.27 -26.5 24.95 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.764 -1.174 . . . . 3.06 110.058 178.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG23 ' SD ' ' A' ' 124' ' ' MET . 2.0 t -65.16 -28.69 45.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.796 -1.093 . . . . 0.35 111.349 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.76 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -81.67 -38.53 25.73 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.642 -1.163 . . . . 1.51 110.177 171.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.95 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -56.17 -44.09 79.0 Favored 'General case' 0 CA--C 1.472 -2.041 0 N-CA-C 114.643 1.349 . . . . 0.4 114.643 -175.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.891 ' HB3' ' CD2' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -61.07 -39.78 91.19 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 116.778 -1.969 . . . . 0.32 109.374 177.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HG3' ' CD2' ' A' ' 128' ' ' LEU . 21.9 mt-10 -65.6 -28.98 69.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.7 1.238 . . . . 2.51 108.088 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -92.06 -7.83 47.61 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 112.848 -1.978 . . . . 0.33 110.977 -170.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.1 t -122.13 -2.38 9.14 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.558 0.694 . . . . 0.36 109.996 -173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 71.07 56.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 113.703 -1.589 . . . . 2.19 111.829 -177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -149.62 146.34 27.24 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.198 -1.779 . . . . 0.27 106.198 178.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.666 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -147.09 163.81 35.09 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.668 -1.234 . . . . 0.69 107.668 -176.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.526 ' CB ' HG12 ' A' ' 147' ' ' VAL . 4.3 pt20 -48.97 159.33 0.26 Allowed 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.404 1.097 . . . . 1.96 112.3 -177.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.9 t -148.43 151.83 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 CA-C-N 113.557 -1.656 . . . . 0.27 111.093 -172.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 m -60.19 -50.12 74.92 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.987 0.899 . . . . 0.73 111.37 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 19.1 ptmt -159.06 115.76 2.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.879 -1.509 . . . . 0.51 108.424 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.943 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -83.71 108.14 16.59 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.79 1.281 . . . . 2.71 110.708 -167.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.791 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 3.3 t -157.33 93.95 1.35 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.649 -1.614 . . . . 0.35 108.55 161.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.791 ' HD3' ' O ' ' A' ' 140' ' ' THR . 10.9 mmt180 -151.98 170.17 8.37 Favored Pre-proline 0 C--N 1.308 -1.208 0 CA-C-N 113.352 -1.749 . . . . 2.38 107.589 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -81.16 111.75 2.46 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 CA-C-N 119.868 0.989 . . . . 0.79 110.478 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.8 22.69 65.88 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.824 -0.703 . . . . 0.38 114.217 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -132.22 132.56 43.21 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.92 -1.511 . . . . 1.49 106.92 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 3.4 m-85 -133.42 173.83 11.06 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 118.89 -1.124 . . . . 0.3 110.507 -167.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 139' ' ' MET . 7.7 p -112.53 136.39 52.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.276 0.56 . . . . 0.19 109.953 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 135' ' ' GLN . 1.2 p -111.41 143.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.097 -0.956 . . . . 0.86 111.803 -171.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -129.16 -85.14 0.56 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.398 -0.364 . . . . 2.45 111.501 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.1 -83.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.141 0.423 . . . . 0.49 112.141 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.616 ' CB ' HD13 ' A' ' 197' ' ' LEU . 48.3 m-80 -88.24 -5.55 58.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 121.444 0.64 . . . . 1.02 109.709 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.9 m -143.22 146.78 33.96 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.154 -0.618 . . . . 0.94 109.643 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 133' ' ' TYR . 8.8 mt -114.48 168.48 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.552 -0.907 . . . . 0.2 108.552 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 20.8 tt0 -111.49 132.71 54.3 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 106.728 -1.582 . . . . 0.97 106.728 167.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 145' ' ' PHE . 2.1 tmt? -134.71 124.48 25.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 118.691 0.678 . . . . 1.32 111.151 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -61.44 118.64 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.33 111.283 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 169' ' ' VAL . 13.5 tpt180 -62.69 120.24 10.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.289 -1.004 . . . . 3.1 108.289 173.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -47.32 127.56 9.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.807 0.692 . . . . 4.26 112.085 -174.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.433 ' HB2' ' O ' ' A' ' 166' ' ' GLU . 28.2 Cg_endo -66.47 175.82 4.73 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.971 2.447 . . . . 2.01 112.499 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.62 ' CE1' ' HA3' ' A' ' 167' ' ' GLY . 9.4 p90 -91.69 155.79 18.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.535 0.683 . . . . 5.12 110.893 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.47 127.75 54.85 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.083 -0.962 . . . . 5.15 111.216 -173.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.637 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 19.4 m-85 -119.98 169.35 8.61 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-N 115.286 -0.87 . . . . 6.81 109.435 170.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 1.9 Cg_endo -75.31 -42.01 0.53 Allowed 'Trans proline' 0 N--CA 1.412 -3.279 0 C-N-CA 121.565 1.51 . . . . 8.97 111.296 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -96.12 -5.49 40.63 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 112.728 -2.033 . . . . 10.53 108.526 -172.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 10.2 p -162.46 146.36 11.76 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-N 114.138 -1.392 . . . . 7.9 112.523 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.44 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 78.5 mttt -145.55 119.09 9.08 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.3 0.572 . . . . 6.69 111.842 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 158' ' ' PRO . 9.7 pt-20 -176.13 -163.84 0.11 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.567 -1.197 . . . . 5.04 112.194 -166.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.62 ' HA3' ' CE1' ' A' ' 159' ' ' PHE . . . 78.38 58.33 3.15 Favored Glycine 0 CA--C 1.502 -0.772 0 CA-C-N 115.37 -0.832 . . . . 2.11 112.115 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -91.64 155.97 17.95 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.736 0.779 . . . . 2.93 110.983 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 187' ' ' GLU . 71.7 t -146.33 150.83 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.615 0 CA-C-N 114.069 -1.423 . . . . 0.48 107.775 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.756 ' HB3' ' CE ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -106.5 150.15 26.39 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.986 0.898 . . . . 1.61 112.445 176.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -124.97 159.33 31.5 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 113.443 -1.708 . . . . 0.2 111.313 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.85 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 6.4 tpt180 -108.02 101.24 10.5 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.819 -1.178 . . . . 3.69 107.819 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.552 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.2 OUTLIER -93.68 113.55 25.65 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 112.988 -1.915 . . . . 0.61 110.115 -170.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 181' ' ' ALA . 52.6 m -112.5 148.79 33.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.654 0.613 . . . . 0.21 112.654 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 119' ' ' ILE . 8.2 m-85 -116.35 112.68 21.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.011 -0.995 . . . . 0.32 111.807 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.594 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 21.8 t70 -102.35 95.68 6.44 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.067 0.46 . . . . 0.74 110.537 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 82.44 -114.02 3.76 Favored Glycine 0 CA--C 1.504 -0.637 0 C-N-CA 120.17 -1.014 . . . . 0.27 114.187 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -105.75 5.0 30.56 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 108.07 -1.085 . . . . 1.61 108.07 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.807 ' HB3' HG23 ' A' ' 118' ' ' THR . 21.8 p80 -141.58 160.2 40.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.604 -1.18 . . . . 1.28 112.517 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.766 HD21 HD11 ' A' ' 183' ' ' ILE . 9.5 tp -65.99 134.6 53.26 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 114.391 -1.277 . . . . 0.22 109.698 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.594 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -86.36 -48.28 8.61 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 114.387 -1.279 . . . . 0.15 111.122 -175.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.502 HG22 ' HB ' ' A' ' 174' ' ' THR . 6.2 t 175.76 177.96 0.19 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.044 -0.98 . . . . 0.28 110.386 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.766 HD11 HD21 ' A' ' 180' ' ' LEU . 2.1 mp -149.38 122.51 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.999 -1.482 . . . . 0.28 106.999 175.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.696 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 97.0 t -127.09 123.66 62.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 118.965 -0.541 . . . . 0.34 112.279 -170.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -59.52 94.18 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.777 0.799 . . . . 1.64 109.379 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.85 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 50.2 mmm -43.22 -37.87 2.31 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 112.734 -2.03 . . . . 1.42 112.752 -172.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.589 ' HG3' HG13 ' A' ' 169' ' ' VAL . 4.3 mt-10 -63.19 -40.53 97.78 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 113.488 -1.687 . . . . 0.68 111.224 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -101.68 -30.58 11.25 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.896 -1.502 . . . . 2.36 111.471 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.696 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 14.4 p30 38.58 31.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.141 1.376 . . . . 1.8 114.512 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -141.65 154.37 45.32 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.798 -0.816 . . . . 4.13 108.798 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 46.86 27.11 0.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.061 0.945 . . . . 4.05 112.883 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -127.83 -33.44 2.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.891 -0.781 . . . . 1.83 108.891 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' CA ' HG22 ' A' ' 184' ' ' VAL . . . 177.67 -164.28 33.22 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.209 -0.905 . . . . 1.84 112.236 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -166.35 136.25 3.24 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.372 -0.603 . . . . 4.57 109.372 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -114.04 130.46 56.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.16 0.505 . . . . 6.25 111.913 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 197' ' ' LEU . 75.6 mtm180 -134.85 121.08 20.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 6.4 109.497 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.616 HD13 ' CB ' ' A' ' 150' ' ' ASN . 10.5 mt -156.84 138.59 14.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 1.4 111.83 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 8.8 p-10 -138.61 140.03 26.41 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.285 -0.635 . . . . 3.38 109.285 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 36.0 Cg_exo -57.98 107.97 0.35 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.992 2.461 . . . . 4.74 113.08 -175.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.578 -0.725 . . . . 7.73 109.576 177.217 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.494 0.188 . . . . 31.14 111.013 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.58 171.45 24.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.57 -0.824 . . . . 30.65 112.053 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 p -89.25 77.87 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 30.65 111.361 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 m 60.87 74.05 0.46 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.718 -0.673 . . . . 29.78 111.312 176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -82.09 90.44 6.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.789 -0.641 . . . . 29.55 110.487 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 93' ' ' HIS . 62.0 m80 -79.86 81.87 6.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.619 -0.719 . . . . 29.87 109.729 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 34.7 m80 71.65 -80.19 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.3 -0.864 . . . . 27.89 111.096 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 54.87 52.14 12.49 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.501 0.667 . . . . 26.19 110.755 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -172.19 -50.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.001 -0.74 . . . . 26.23 109.001 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -136.52 135.89 38.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.723 -0.671 . . . . 26.64 109.872 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.6 m -103.73 -26.1 12.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.072 -0.513 . . . . 24.71 110.552 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.8 m -154.53 57.72 0.69 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.311 0.577 . . . . 24.15 110.046 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.22 110.52 1.89 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.894 -0.669 . . . . 22.66 112.227 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -79.42 67.69 5.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.323 0.583 . . . . 20.88 110.391 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.54 123.85 41.31 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.794 -0.639 . . . . 19.88 110.671 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.63 120.7 4.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.457 2.105 . . . . 18.7 112.698 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 0.8 OUTLIER -81.56 110.17 16.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.491 -0.559 . . . . 18.91 109.491 176.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.68 -110.54 3.94 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.724 -0.95 . . . . 15.32 110.724 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.4 t 53.0 50.83 17.08 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.108 0.48 . . . . 14.03 111.502 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -144.79 -175.02 4.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.499 -0.319 . . . . 12.65 111.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.453 ' O ' HG12 ' A' ' 111' ' ' VAL . 5.7 tpt 73.55 -59.94 0.55 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.02 0.928 . . . . 11.98 111.961 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.89 7.94 8.67 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.617 0.607 . . . . 8.1 114.617 -172.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -115.09 6.5 15.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.843 0.821 . . . . 9.18 111.157 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.2 ptp -129.57 14.63 5.99 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.058 0.932 . . . . 6.14 109.674 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 107' ' ' MET . 8.2 p -158.92 150.17 7.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.773 -1.558 . . . . 4.84 109.556 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.46 138.67 50.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.064 -0.717 . . . . 4.29 109.064 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.726 HD23 ' N ' ' A' ' 114' ' ' GLU . 3.8 tt -64.24 145.24 56.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.234 -0.439 . . . . 1.69 110.406 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.726 ' N ' HD23 ' A' ' 113' ' ' LEU . 5.7 tp10 -175.63 155.39 1.64 Allowed Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 107.046 -1.464 . . . . 3.45 107.046 -172.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 114' ' ' GLU . 11.7 Cg_endo -89.64 102.98 0.35 Allowed 'Trans proline' 0 N--CA 1.423 -2.647 0 CA-C-N 121.793 1.676 . . . . 3.06 112.553 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.52 -4.26 15.59 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 102.197 -3.261 . . . . 3.24 102.197 142.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.569 ' HG3' HG23 ' A' ' 119' ' ' ILE . 8.4 tpt -83.54 144.31 29.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 110.825 -2.898 . . . . 1.45 111.88 -161.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 179' ' ' HIS . 15.7 m -132.52 98.24 4.3 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.87 -1.059 . . . . 0.32 109.039 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.887 HD11 ' CD1' ' A' ' 175' ' ' PHE . 5.8 pt -129.76 172.67 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 122.227 1.013 . . . . 0.2 112.0 -171.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.852 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.6 m -114.64 173.79 6.29 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.709 -1.587 . . . . 1.29 110.215 -172.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.632 ' O ' ' HG3' ' A' ' 124' ' ' MET . 2.5 mppt? -51.58 -53.1 41.74 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.343 0.402 . . . . 3.26 111.962 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 126' ' ' LYS . 5.3 m-20 -82.93 -15.26 52.05 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.624 -0.262 . . . . 2.17 110.71 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.904 ' O ' HD12 ' A' ' 127' ' ' LEU . 3.0 mt-10 -65.36 -23.72 67.06 Favored 'General case' 0 N--CA 1.422 -1.854 0 C-N-CA 120.095 -0.642 . . . . 0.5 110.002 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.784 ' O ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.28 -29.56 24.48 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 118.474 -1.29 . . . . 3.06 110.057 178.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.17 -31.94 51.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.466 1.127 . . . . 0.35 111.833 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.755 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -79.93 -42.51 23.9 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 114.169 -1.378 . . . . 1.51 109.73 170.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -60.53 -38.49 84.6 Favored 'General case' 0 CA--C 1.462 -2.424 0 CA-C-O 117.523 -1.227 . . . . 0.4 114.067 -173.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -62.57 -39.82 94.88 Favored 'General case' 0 N--CA 1.421 -1.898 0 C-N-CA 116.153 -2.219 . . . . 0.32 108.72 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.682 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 63.1 mm-40 -68.82 -30.68 69.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 123.04 1.4 . . . . 2.51 108.923 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . . . -85.41 -7.6 58.85 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 111.857 -2.429 . . . . 0.33 110.23 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.9 t -121.77 -3.94 9.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.245 -0.889 . . . . 0.36 109.387 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 131' ' ' THR . 49.1 mt-30 79.96 55.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 113.757 -1.565 . . . . 2.19 112.235 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.72 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -154.28 146.5 23.79 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.886 -1.524 . . . . 0.27 106.886 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.607 ' N ' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -144.52 161.33 39.35 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.371 -1.714 . . . . 0.69 106.371 -177.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -54.24 159.4 1.94 Allowed 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 119.281 0.946 . . . . 1.96 112.029 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 138' ' ' LYS . 2.4 t -145.91 155.82 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.075 0 CA-C-N 114.19 -1.368 . . . . 0.27 112.019 -168.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.2 m -59.51 -51.15 71.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.05 0.929 . . . . 0.73 111.639 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.532 ' N ' HG12 ' A' ' 136' ' ' VAL . 18.3 ptmt -159.78 114.51 2.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 113.931 -1.486 . . . . 0.51 108.117 -178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.972 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -80.89 105.08 11.85 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 123.035 1.398 . . . . 2.71 111.24 -166.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.803 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.0 t -157.41 94.25 1.37 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.558 -1.655 . . . . 0.35 108.47 162.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.803 ' HD3' ' O ' ' A' ' 140' ' ' THR . 7.6 mmt180 -151.44 168.02 11.93 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 113.477 -1.692 . . . . 2.38 107.158 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.45 111.69 2.63 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 CA-C-N 119.897 0.999 . . . . 0.79 109.899 164.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.81 27.76 58.11 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.2 -1.0 . . . . 0.38 113.902 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 141' ' ' ARG . 25.9 mt-10 -140.85 131.25 25.21 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.407 -1.331 . . . . 1.49 107.407 172.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.78 ' HB3' ' O ' ' A' ' 153' ' ' GLU . 1.4 m-85 -133.88 176.35 8.65 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.419 -0.913 . . . . 0.3 110.511 -167.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.972 HG23 ' HB3' ' A' ' 139' ' ' MET . 17.3 p -113.09 137.54 51.28 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.962 0.886 . . . . 0.19 112.505 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 51.6 t -97.62 138.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 113.451 -1.704 . . . . 0.86 111.12 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 151' ' ' SER . 16.6 mm100 -123.14 -90.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.935 -0.12 . . . . 2.45 110.972 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.79 -87.31 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.653 0.263 . . . . 0.49 111.337 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' A' ' 197' ' ' LEU . 47.8 m-80 -82.98 -3.14 56.84 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.062 0.458 . . . . 1.02 109.786 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 148' ' ' GLN . 20.4 m -141.33 146.13 36.32 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.371 -0.532 . . . . 0.94 110.357 172.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 128' ' ' LEU . 5.6 mt -107.26 170.66 2.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.351 -1.351 . . . . 0.2 107.351 168.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB3' ' A' ' 145' ' ' PHE . 17.6 tt0 -116.33 136.26 53.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.764 -1.569 . . . . 0.97 106.764 165.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.429 ' HA ' ' CG ' ' A' ' 145' ' ' PHE . 1.1 tmt? -136.5 124.81 23.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 118.592 0.633 . . . . 1.32 112.367 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -63.14 128.06 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.594 -0.521 . . . . 0.33 109.594 175.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.16 164.67 23.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.514 -0.55 . . . . 3.1 109.514 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -60.21 118.94 37.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.527 -0.306 . . . . 4.26 110.512 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 10.2 Cg_endo -61.79 168.75 8.15 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.617 2.211 . . . . 2.01 113.003 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.64 147.95 40.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.174 -0.921 . . . . 5.12 111.333 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.46 ' HB3' ' HE2' ' A' ' 165' ' ' LYS . 7.2 m-20 -126.99 133.21 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.07 -0.968 . . . . 5.15 110.643 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.687 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 86.4 m-85 -120.16 171.59 5.52 Favored Pre-proline 0 N--CA 1.424 -1.746 0 CA-C-O 121.557 0.694 . . . . 6.81 109.941 167.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 161' ' ' PHE . 5.6 Cg_endo -80.91 -46.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.522 0 C-N-CA 121.845 1.696 . . . . 8.97 110.846 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -95.86 2.18 53.52 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.012 -1.903 . . . . 10.53 110.166 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -163.17 162.66 25.63 Favored 'General case' 0 C--O 1.203 -1.382 0 CA-C-N 113.934 -1.485 . . . . 7.9 110.297 -172.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.687 ' HG2' ' H ' ' A' ' 161' ' ' PHE . 65.5 mttt -153.2 138.71 17.7 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 118.594 0.634 . . . . 6.69 110.55 169.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -169.4 -167.02 0.66 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 112.877 0.695 . . . . 5.04 112.877 -168.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 158' ' ' PRO . . . 77.45 160.64 13.07 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.146 -0.934 . . . . 2.11 112.526 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 0.5 OUTLIER -150.53 138.23 19.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.033 -0.729 . . . . 2.93 109.033 170.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 170' ' ' ARG . 89.9 t -142.14 145.44 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.387 0 CA-C-N 115.202 -0.908 . . . . 0.48 109.166 175.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.663 ' HB2' ' CE ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -126.41 144.9 50.68 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 122.197 0.999 . . . . 1.61 113.165 177.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 184' ' ' VAL . . . -116.19 167.67 10.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.313 -1.767 . . . . 0.2 110.517 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.764 ' HB2' ' SD ' ' A' ' 186' ' ' MET . 48.2 ttp180 -116.22 122.74 45.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 107.419 -1.326 . . . . 3.69 107.419 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -112.11 110.53 20.86 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.288 -1.324 . . . . 0.61 110.203 -164.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.512 ' CG2' HD11 ' A' ' 197' ' ' LEU . 51.9 m -107.64 150.25 27.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.229 0.538 . . . . 0.21 112.308 -169.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.887 ' CD1' HD11 ' A' ' 119' ' ' ILE . 12.6 m-85 -115.66 102.46 9.77 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.566 -1.197 . . . . 0.32 113.212 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.621 ' N ' ' HB2' ' A' ' 181' ' ' ALA . 31.0 t70 -92.11 101.65 14.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.85 0.357 . . . . 0.74 110.972 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 81.66 -117.21 4.36 Favored Glycine 0 C--N 1.318 -0.461 0 C-N-CA 120.048 -1.072 . . . . 0.27 113.485 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.66 10.61 22.85 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.5 -1.667 . . . . 1.61 106.5 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.804 ' HB3' HG23 ' A' ' 118' ' ' THR . 24.4 p80 -137.89 161.66 36.06 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.287 -1.324 . . . . 1.28 112.083 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.765 HD21 HD11 ' A' ' 183' ' ' ILE . 8.5 tp -68.19 136.38 53.53 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.607 -1.178 . . . . 0.22 110.502 176.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.621 ' HB2' ' N ' ' A' ' 176' ' ' ASP . . . -87.46 -50.06 6.79 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.392 -1.276 . . . . 0.15 111.364 -176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 9.6 t 179.23 178.4 0.49 Allowed 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.036 -0.984 . . . . 0.28 109.903 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.765 HD11 HD21 ' A' ' 180' ' ' LEU . 2.6 mp -147.89 112.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 106.459 -1.682 . . . . 0.28 106.459 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.767 ' CG1' ' HA ' ' A' ' 189' ' ' ASN . 74.3 t -115.16 129.8 70.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 113.15 0.796 . . . . 0.34 113.15 -169.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 188' ' ' ASN . 25.1 p-10 -60.07 95.52 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.108 0.956 . . . . 1.64 109.693 174.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 66.6 mmm -51.47 -25.61 6.78 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 113.37 -1.741 . . . . 1.42 112.949 -169.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 169' ' ' VAL . 2.6 mt-10 -68.26 -42.6 79.36 Favored 'General case' 0 N--CA 1.407 -2.593 0 CA-C-N 114.452 -1.249 . . . . 0.68 110.635 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.416 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 5.5 t-20 -103.49 -25.73 13.12 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.707 -1.588 . . . . 2.36 111.663 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.767 ' HA ' ' CG1' ' A' ' 184' ' ' VAL . 10.3 p30 36.69 38.6 0.08 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.843 1.423 . . . . 1.8 114.843 176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -141.63 -37.33 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.254 -0.43 . . . . 4.13 110.402 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.581 ' HA ' HE21 ' A' ' 191' ' ' GLN . 0.1 OUTLIER -52.57 -60.72 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.838 -0.619 . . . . 4.05 111.789 -177.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 184' ' ' VAL . 1.4 m-85 -93.99 20.02 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.59 -0.444 . . . . 1.83 109.827 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.68 133.09 41.1 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.965 -0.636 . . . . 1.84 113.623 -170.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -123.65 -174.2 2.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.861 -0.669 . . . . 4.57 111.023 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -78.51 158.88 28.47 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.981 -0.554 . . . . 6.25 111.028 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 199' ' ' PRO . 52.4 ttp85 -82.94 144.83 29.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.57 -0.741 . . . . 6.4 110.441 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.628 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 21.1 mt -75.64 124.64 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.177 -0.465 . . . . 1.4 111.684 -176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 52.72 73.92 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.03 -0.986 . . . . 3.38 111.096 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.407 ' HA ' ' NH2' ' A' ' 196' ' ' ARG . 2.8 Cg_exo -75.88 66.14 6.78 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.242 2.628 . . . . 4.74 112.399 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.949 -0.569 . . . . 7.73 110.368 177.562 . . . . . . . . 0 0 . 1 stop_ save_